Citrus Sinensis ID: 011385
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 487 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFP7 | 493 | Probable receptor-like pr | yes | no | 0.967 | 0.955 | 0.746 | 0.0 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.905 | 0.9 | 0.762 | 0.0 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.724 | 0.860 | 0.602 | 1e-126 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.778 | 0.974 | 0.562 | 1e-124 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.731 | 0.864 | 0.596 | 1e-124 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.698 | 0.829 | 0.637 | 1e-124 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.720 | 0.888 | 0.571 | 1e-120 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.856 | 0.978 | 0.520 | 1e-119 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.708 | 0.886 | 0.551 | 1e-115 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.749 | 0.856 | 0.567 | 1e-115 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/500 (74%), Positives = 404/500 (80%), Gaps = 29/500 (5%)
Query: 1 MGFDGENGKVKKASWDSSKSKA---KKKKKKVEDE-----VEVEEEEETGCWVKLRFFGS 52
MG D K +W S K K K KKK D+ E EE E +GCWVK RF
Sbjct: 1 MGLDAVKAK---GNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIG 57
Query: 53 CISSRSKVDSSVS-----GTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 107
CI S+S +D+S S + ESKS N+ S DQP V S+TTTSNAES+SST +
Sbjct: 58 CIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVI 117
Query: 108 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 167
EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 118 SEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 177
Query: 168 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 227
AVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 178 AVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 237
Query: 228 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287
FRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 238 FRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLA 297
Query: 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347
KD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRP
Sbjct: 298 KDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 357
Query: 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
NGEHNLVEWARPHL ++RRFYRL+DPRLEGHFSIKGAQK QLAA CLSRDPK RP MS+
Sbjct: 358 NGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSD 417
Query: 408 VVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ-----RSLS 462
VVEALKPLP+LKDMASSSYYFQTMQAER+ +NG G SRNGQ R+LS
Sbjct: 418 VVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLS 471
Query: 463 IPNGSYASPYHHQFPHPSPK 482
P+GS SPY HQ P P PK
Sbjct: 472 SPHGS--SPYRHQIPSPKPK 489
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 694 bits (1790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/450 (76%), Positives = 379/450 (84%), Gaps = 9/450 (2%)
Query: 37 EEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTS 96
EEE GCWVK R+ C SS S V++S++ ST S+S S DQP V S+TTTS
Sbjct: 42 EEEANGCWVKFRYIVCCASSTSDVETSLT-LSTSTVGSQSAIVQSNDQPVGPVSSTTTTS 100
Query: 97 NAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 156
NAES+ ST + EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGT
Sbjct: 101 NAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 160
Query: 157 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 216
APVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYE
Sbjct: 161 APVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYE 220
Query: 217 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276
FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +
Sbjct: 221 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGE 280
Query: 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 336
YNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEML
Sbjct: 281 YNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
Query: 337 TGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 396
TGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFS+KGAQK QLAA CLS
Sbjct: 341 TGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLS 400
Query: 397 RDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRN 456
RD K RP MSEVVE LKPLP+LKDMAS+SYYFQTMQAER+ + + +G SRN
Sbjct: 401 RDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSGRGFG----SRN 456
Query: 457 GQ---RSLSIPNGSY-ASPYHHQFPHPSPK 482
GQ R+LS P+G +SPY HQ P P PK
Sbjct: 457 GQPVFRTLSSPHGQAGSSPYRHQIPSPKPK 486
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 224/372 (60%), Positives = 281/372 (75%), Gaps = 19/372 (5%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE 109
G C+S++ K +SS G ST Y A + S + +++ S + + E
Sbjct: 1 MGICLSAQVKAESS--GASTKY-------------DAKDIGSLGSKASSVSVRPSPRTEG 45
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
E+ + L+ F+F +LK ATRNFRP+S+LGEGGFGCVFKGWI+E +PGTGL +AV
Sbjct: 46 EILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAV 105
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
K LN DG QGH+EWLAEVN+LG H +LVKLIGYC+ED+ RLLVYEFMPRGSLENHLFR
Sbjct: 106 KKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFR 165
Query: 230 RSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
R L PL W +R+K+ALGAAKGLAFLH R VIYRDFKTSNILLD++YNAKLSDFGL
Sbjct: 166 RGLYFQPLSWKLRLKVALGAAKGLAFLHSSETR-VIYRDFKTSNILLDSEYNAKLSDFGL 224
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
AKDGP GDK+HVSTRVMGT+GYAAPEY+ TGHLT++SDVYSFGVVLLE+L+GRR++DKNR
Sbjct: 225 AKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNR 284
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
P+GE NLVEWA+P+L +R+ +R+ID RL+ +S++ A K A L+ CL+ + K RP MS
Sbjct: 285 PSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMS 344
Query: 407 EVVEALKPLPNL 418
EVV L+ + +L
Sbjct: 345 EVVSHLEHIQSL 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 224/398 (56%), Positives = 286/398 (71%), Gaps = 19/398 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE 109
G C S+R K D + S+ + SK SRD + S+ S S + E
Sbjct: 1 MGGCFSNRIKTDIA----SSTWLSSKFL---SRD--------GSKGSSTASFSYMPRTEG 45
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+ +AV
Sbjct: 46 EILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAV 105
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
K LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLENHLFR
Sbjct: 106 KRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFR 165
Query: 230 RSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
R PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLSDFGL
Sbjct: 166 RGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGL 224
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
A+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++DKN+
Sbjct: 225 ARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQ 284
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
P GEHNLV+WARP+L +RR R++DPRL+G +S+ A K A LA C+S D K+RP M+
Sbjct: 285 PVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMN 344
Query: 407 EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRN 444
E+V+ ++ L K+ + Q I SP N
Sbjct: 345 EIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVN 382
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 223/374 (59%), Positives = 277/374 (74%), Gaps = 18/374 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE 109
G C+S++ K S G S Y S++ ND+ + ++ I + + E
Sbjct: 1 MGICLSAQIKAVSP--GASPKYMSSEA-NDSLGSKSSSVSIRTN-----------PRTEG 46
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+ +AV
Sbjct: 47 EILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAV 106
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
K LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLENHLFR
Sbjct: 107 KKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFR 166
Query: 230 RS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
R PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLSDFGL
Sbjct: 167 RGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGL 225
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
AKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++DKNR
Sbjct: 226 AKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNR 285
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
P GE LVEWARP L +R+ +R+ID RL+ +S++ A K A LA CL+ + K RP M+
Sbjct: 286 PPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMN 345
Query: 407 EVVEALKPLPNLKD 420
EVV L+ + L +
Sbjct: 346 EVVSHLEHIQTLNE 359
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-124, Method: Compositional matrix adjust.
Identities = 222/348 (63%), Positives = 268/348 (77%), Gaps = 8/348 (2%)
Query: 100 SNSSTSKLEEELKVA---SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 156
S+ ST + ++ + +++ FT +L+ T++FRP+ +LGEGGFG V+KG+I++N
Sbjct: 34 SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93
Query: 157 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 216
+K L VAVK LN +GLQGH+EWL EVNFLG L H NLVKLIGYC EDD RLLVYE
Sbjct: 94 VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150
Query: 217 FMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275
FM RGSLENHLFR++ PL WS RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209
Query: 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
DY AKLSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEM
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269
Query: 336 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 395
LTGR+S+DK RP+ E NLV+WARP L ++R+ ++IDPRLE +S++ AQKA LA +CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329
Query: 396 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 443
S++PKARPLMS+VVE L+PL D A +G P+ R
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGDALIPCATTTAGAAFAMGGVPDYR 377
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 212/371 (57%), Positives = 269/371 (72%), Gaps = 20/371 (5%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE 109
GSC SSR K D +G S+ ++ S AAA K E
Sbjct: 1 MGSCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAAA----------------QKTEG 44
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
E+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL +AV
Sbjct: 45 EILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAV 104
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
K LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLENHLFR
Sbjct: 105 KKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFR 164
Query: 230 RSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
R PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLSDFGL
Sbjct: 165 RGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGL 223
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
A+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +RSDVYSFGV+LLE+L+G+R++D NR
Sbjct: 224 ARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNR 283
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
P E NLV+WARP+L +R+ ++D RL+ + + A + A +A CLS +PK+RP M
Sbjct: 284 PAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMD 343
Query: 407 EVVEALKPLPN 417
+VV AL+ L +
Sbjct: 344 QVVRALQQLQD 354
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 227/436 (52%), Positives = 290/436 (66%), Gaps = 19/436 (4%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE 109
G+C+ S +KVDSS + A S + + S + ++ + T + E
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+ VAV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
K L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 230 R-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288
R + PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDFGLAK
Sbjct: 181 RGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAK 239
Query: 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348
GP GDKTHVST+VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK++
Sbjct: 240 AGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVG 299
Query: 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
E +LV+WA P+LG++R+ +R++D RL G + KGA AA LA CL+ D K RP MSEV
Sbjct: 300 MEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEV 359
Query: 409 VEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 468
+ L L + K +G+ + R GS+ + R SY
Sbjct: 360 LAKLDQLESTK------------PGTGVGNRQAQIDSPRGSNGSIVQKSPRRY-----SY 402
Query: 469 ASPYHHQFPHPSPKPN 484
P H P SP P
Sbjct: 403 DRPLLHITPGASPLPT 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1071), Expect = e-115, Method: Compositional matrix adjust.
Identities = 205/372 (55%), Positives = 263/372 (70%), Gaps = 27/372 (7%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE 109
GSC+SSR SS H + KS++ + + ++SSTT
Sbjct: 1 MGSCLSSRVLNKSSSGLDDLHLSSCKSSSSATAHKTEGEILSSTT--------------- 45
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
++ F+FN+LKLATRNFR +S++GEGGFGCVF+GW++E P K +GL +AV
Sbjct: 46 -------VKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAV 98
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF- 228
K LN DG QGH+EWL E+N+LG L H NLVKLIGYC+ED+QRLLVYEFM +GSLENHLF
Sbjct: 99 KRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFA 158
Query: 229 ---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285
+ PL W +R+K+AL AAKGLAFLH + + VIYRD K SNILLD+D+NAKLSDFG
Sbjct: 159 NGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFG 217
Query: 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
LA+DGP G++++VSTRVMGT+GYAAPEYV TGHL +RSDVYSFGVVLLE+L GR+++D N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405
RP E NLV+WARP+L RR+ ++D RL + +GA + A +A CLS +PK+RP M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337
Query: 406 SEVVEALKPLPN 417
+VV AL L +
Sbjct: 338 DQVVRALVQLQD 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1069), Expect = e-115, Method: Compositional matrix adjust.
Identities = 210/370 (56%), Positives = 272/370 (73%), Gaps = 5/370 (1%)
Query: 50 FGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQ---PAAAVISSTTTSNAESNSSTSK 106
G+C+ S +KVD+S + A S S + + P+ +S +T ++ T +
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 107 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 166
E E+ + L+ FTFN+LK AT+NFR ++LLGEGGFGCVFKGWI++ +PG+G+
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 167 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 226
VAVK L +G QGHKEWL EVN+LG L H NLV L+GYC E + RLLVYEFMP+GSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 227 LFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285
LFRR + PL W+IRMK+A+GAAKGL FLHE A+ VIYRDFK +NILLDAD+NAKLSDFG
Sbjct: 181 LFRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
LAK GP GD THVST+V+GT+GYAAPEYV TG LT++SDVYSFGVVLLE+++GRR+MD +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405
E++LV+WA P+LG++R+ +R++D +L G + KGA AA LA CL+ D K RP M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 406 SEVVEALKPL 415
SEV+ L+ L
Sbjct: 360 SEVLVTLEQL 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 487 | ||||||
| 359473277 | 481 | PREDICTED: probable receptor-like protei | 0.977 | 0.989 | 0.886 | 0.0 | |
| 255558222 | 495 | Protein kinase APK1B, chloroplast precur | 0.993 | 0.977 | 0.872 | 0.0 | |
| 351722951 | 485 | serine/threonine protein kinase-like pro | 0.983 | 0.987 | 0.885 | 0.0 | |
| 356498172 | 491 | PREDICTED: probable receptor-like protei | 0.993 | 0.985 | 0.888 | 0.0 | |
| 356567562 | 487 | PREDICTED: probable receptor-like protei | 0.991 | 0.991 | 0.901 | 0.0 | |
| 356526888 | 487 | PREDICTED: probable receptor-like protei | 0.991 | 0.991 | 0.901 | 0.0 | |
| 147857978 | 495 | hypothetical protein VITISV_008843 [Viti | 0.979 | 0.963 | 0.855 | 0.0 | |
| 224100247 | 478 | predicted protein [Populus trichocarpa] | 0.977 | 0.995 | 0.860 | 0.0 | |
| 224100451 | 445 | predicted protein [Populus trichocarpa] | 0.909 | 0.995 | 0.930 | 0.0 | |
| 53689728 | 603 | serine/threonine protein kinase-like [So | 0.969 | 0.782 | 0.850 | 0.0 |
| >gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/492 (88%), Positives = 455/492 (92%), Gaps = 16/492 (3%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 119
VDSS+SGTSTHY E++STNDTSRDQP A V+SSTTTSNAESNSSTSKLEEELKVASRLRK
Sbjct: 51 VDSSISGTSTHY-ENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRLRK 109
Query: 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 179
F+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 110 FSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 169
Query: 180 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 239
HKEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR+LPLPW+IR
Sbjct: 170 HKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRALPLPWAIR 229
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVS
Sbjct: 230 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVS 289
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359
TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP
Sbjct: 290 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 349
Query: 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419
HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMSEVVEALKPLPNLK
Sbjct: 350 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLPNLK 409
Query: 420 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSIPNGSYASPYH-HQ 475
DMASSSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSIPNGS+ASPYH +Q
Sbjct: 410 DMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYHQNQ 469
Query: 476 FPHPSPKPNGKP 487
+P+ SPKPNGKP
Sbjct: 470 YPYQSPKPNGKP 481
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2262), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/496 (87%), Positives = 451/496 (90%), Gaps = 12/496 (2%)
Query: 1 MGFDGENG-KVKKASWDSSKSKAKKKKKK-VEDEV------EVEEEEETGCWVKLRFFGS 52
MG E+G + K +SW+ K K + KKK+ V + +V EE ETGCW K RF GS
Sbjct: 1 MGLGSEDGNRAKASSWEVCKPKGRNKKKQDVSNSSGGASPGDVVEEAETGCWFKFRFIGS 60
Query: 53 CISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELK 112
CISSRSKVDSSVSGTSTH ESKSTNDTSRDQP A ISSTTTSNAESNSSTSKLEEELK
Sbjct: 61 CISSRSKVDSSVSGTSTH-CESKSTNDTSRDQPTAPTISSTTTSNAESNSSTSKLEEELK 119
Query: 113 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 172
+ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL
Sbjct: 120 IASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 179
Query: 173 NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 232
NHDGLQGHKEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL
Sbjct: 180 NHDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 239
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE
Sbjct: 240 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 299
Query: 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352
GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRP GEHN
Sbjct: 300 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPIGEHN 359
Query: 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE L
Sbjct: 360 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEVL 419
Query: 413 KPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYAS 470
KPLPNLKDMASSSYYFQ+MQA++I SSPN ++ R QGG L RNG QRSLSIPNGS+AS
Sbjct: 420 KPLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRTQGG-LLRNGQQQRSLSIPNGSHAS 478
Query: 471 PYHHQFPHPSPKPNGK 486
PYHHQ+P SPKPNGK
Sbjct: 479 PYHHQYPFQSPKPNGK 494
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2252), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/491 (88%), Positives = 454/491 (92%), Gaps = 12/491 (2%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG ENGKV + SWD KSK +KKKK E E E GCWV+LRF GSCISSRSKV
Sbjct: 1 MGLGAENGKVVE-SWDVCKSKGRKKKKGDE-----GGEAEAGCWVRLRFIGSCISSRSKV 54
Query: 61 DSSVSG--TSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSS-TSKLEEELKVASRL 117
D+SVSG TSTHYAESKSTNDTSRDQP A +SSTTTSNAESNSS TSKLEEELK+ASRL
Sbjct: 55 DTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSSTSKLEEELKIASRL 114
Query: 118 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 177
RKF+FN+LKLATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL
Sbjct: 115 RKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 174
Query: 178 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 237
QGHKEWLAEVNFLGDLVH NLVKL+GYCIE+DQRLLVYEFMPRGSLENHLFRRS+PLPWS
Sbjct: 175 QGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLVYEFMPRGSLENHLFRRSIPLPWS 234
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTH
Sbjct: 235 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTH 294
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
VSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEWA
Sbjct: 295 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEWA 354
Query: 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417
RPHLGERRRFYRLIDPRLEGHFS+KGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPN
Sbjct: 355 RPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAAHCLSRDPKARPLMSEVVEALKPLPN 414
Query: 418 LKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQ 475
LKDMASSSYYFQ MQA+RIG+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHHQ
Sbjct: 415 LKDMASSSYYFQAMQADRIGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHHQ 473
Query: 476 FPHPSPKPNGK 486
FP PSPKPNGK
Sbjct: 474 FPQPSPKPNGK 484
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2247), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/492 (88%), Positives = 455/492 (92%), Gaps = 8/492 (1%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETG--CWVKLRFFGSCISSRS 58
MG GENGKV + SWD KSK +KKKK D EVEE E CWV+LRF GSCISSRS
Sbjct: 1 MGLGGENGKVVE-SWDVCKSKGGRKKKKKGDAEEVEEGAEAEAGCWVRLRFIGSCISSRS 59
Query: 59 KVDSSVS--GTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASR 116
KVD+SVS G STHYAESKSTNDTSRDQP A +SSTTTSNAESNSSTSKLEEELK+ASR
Sbjct: 60 KVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAESNSSTSKLEEELKIASR 119
Query: 117 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 176
LRKF+FNDLK ATRNFRPES LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 120 LRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 179
Query: 177 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 236
LQGHKEWLAEVNFLGDLVH NLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRRS+PLPW
Sbjct: 180 LQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSMPLPW 239
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT
Sbjct: 240 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 299
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356
HVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDK+RPNGEHNLVEW
Sbjct: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKHRPNGEHNLVEW 359
Query: 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416
ARPHLGERRRFYRLIDPRLEGHFS+KGAQKAAQLAAHCLSRDPK+RPLMSEVVEALKPLP
Sbjct: 360 ARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDPKSRPLMSEVVEALKPLP 419
Query: 417 NLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHH 474
+LKDMASSSYYFQ MQA+R G+SPNTRNG R QG L+RNG QRSLSIPNG+YASPYHH
Sbjct: 420 SLKDMASSSYYFQAMQADRFGASPNTRNG-RMQGALLTRNGQQQRSLSIPNGTYASPYHH 478
Query: 475 QFPHPSPKPNGK 486
QFP PSPKPNGK
Sbjct: 479 QFPQPSPKPNGK 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2241), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/489 (90%), Positives = 457/489 (93%), Gaps = 6/489 (1%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEE+EETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEKEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 119
VDSSVSGTST+YAESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEE KV+SRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESNSSTSKLEEEFKVSSRLRK 118
Query: 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 179
FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 180 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 239
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGLAKDGPEGDKTHVS
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKTHVS 298
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359
TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP
Sbjct: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
Query: 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419
HLGERRRFYRLIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLK
Sbjct: 359 HLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
Query: 420 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFP 477
DMASSSYYFQTMQA+R +SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP
Sbjct: 419 DMASSSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFP 477
Query: 478 HPSPKPNGK 486
PSPKPNGK
Sbjct: 478 QPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/489 (90%), Positives = 456/489 (93%), Gaps = 6/489 (1%)
Query: 1 MGFDG-ENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSK 59
MG G ENGKV S D KSK +KKKKK + EVEEEEETGCW +LRF GSCISSRSK
Sbjct: 1 MGLGGAENGKVVVESLDVCKSKGRKKKKKED--GEVEEEEETGCWFRLRFIGSCISSRSK 58
Query: 60 VDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRK 119
VDSSVSGTST+YAESKST DTSRDQP V+SSTTTSNAESNSSTSKLEEELKVASRLRK
Sbjct: 59 VDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESNSSTSKLEEELKVASRLRK 118
Query: 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 179
F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG
Sbjct: 119 FAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 178
Query: 180 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 239
HKEWLAEVN+LGDLVH +LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR
Sbjct: 179 HKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 238
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YN+KLSDFGLAKDGPEGDKTHVS
Sbjct: 239 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSKLSDFGLAKDGPEGDKTHVS 298
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359
TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP
Sbjct: 299 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 358
Query: 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419
HLGERRRFY+LIDPRLEGHFSIKGAQKAA LAAHCLSRDPKARPLMSEVVEALKPLPNLK
Sbjct: 359 HLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPKARPLMSEVVEALKPLPNLK 418
Query: 420 DMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFP 477
DMASSSYYFQTMQA+R SPNTRNG R QG L+RNG QRSLSIP+G++ASPYHHQFP
Sbjct: 419 DMASSSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQRSLSIPHGTHASPYHHQFP 477
Query: 478 HPSPKPNGK 486
PSPKPNGK
Sbjct: 478 QPSPKPNGK 486
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2230), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/505 (85%), Positives = 450/505 (89%), Gaps = 28/505 (5%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGC-WVKLRFFGSCISSRSK 59
MG G + KV+ SW+ KSK +KKK EEETGC WVKLRF SCISSRSK
Sbjct: 1 MGLGGNDVKVE--SWEVGKSKGRKKKDG--------GEEETGCCWVKLRFMASCISSRSK 50
Query: 60 VDSSVSGTSTHY-------AESKSTN------DTSRDQPAAAVISSTTTSNAESNSSTSK 106
VDSS+SGTSTHY E +S N RDQP A V+SSTTTSNAESNSSTSK
Sbjct: 51 VDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSSTSK 110
Query: 107 LEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 166
LEEELKVASRLRKF+FNDLK+ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT
Sbjct: 111 LEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 170
Query: 167 VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 226
VAVKTLNHDGLQGHKEWLAEVNFLGDL+H NLVKLIGYCIEDDQRLLVYEFMPRGSLENH
Sbjct: 171 VAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 230
Query: 227 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
LFRR+LPLPW+IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA+YNAKLSDFGL
Sbjct: 231 LFRRALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGL 290
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR
Sbjct: 291 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 350
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK RPLMS
Sbjct: 351 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMS 410
Query: 407 EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG---QRSLSI 463
EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPN RNG+R Q G LSRNG QRSLSI
Sbjct: 411 EVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSI 470
Query: 464 PNGSYASPYH-HQFPHPSPKPNGKP 487
PNGS+ASPYH +Q+P+ SPKPNGKP
Sbjct: 471 PNGSHASPYHQNQYPYQSPKPNGKP 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100247|ref|XP_002311801.1| predicted protein [Populus trichocarpa] gi|222851621|gb|EEE89168.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/489 (86%), Positives = 442/489 (90%), Gaps = 13/489 (2%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
MG E GKVK +SWD KSK +KKK + + GCWVKLR G CISSRSKV
Sbjct: 1 MGLGSEEGKVK-SSWDVCKSKERKKK----------DGTKAGCWVKLRLVGGCISSRSKV 49
Query: 61 DSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKF 120
DSSVSGT ESKS NDTS DQPA V+SS+TTSN ESNSS SKLEEELKVASRLRKF
Sbjct: 50 DSSVSGTICESTESKSINDTSTDQPAVPVVSSSTTSNTESNSSLSKLEEELKVASRLRKF 109
Query: 121 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH
Sbjct: 110 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 169
Query: 181 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 240
KEWLAEVN+LGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM
Sbjct: 170 KEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 229
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD PEGDKTHVST
Sbjct: 230 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEGDKTHVST 289
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRSMDKNRPNGEHNLVEWARP+
Sbjct: 290 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKNRPNGEHNLVEWARPY 349
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 420
LGERRRFYRLIDPRL+GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV+ LKPLPNLKD
Sbjct: 350 LGERRRFYRLIDPRLQGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVDTLKPLPNLKD 409
Query: 421 MASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QRSLSIPNGSYASPYHHQFPH 478
MASSSYYFQTMQ +R+GSSPN +NG+R+Q G LSRNG QRS SIP+G +ASP+HHQ+PH
Sbjct: 410 MASSSYYFQTMQGDRVGSSPNAKNGVRSQAGLLSRNGHQQRSFSIPHGPHASPFHHQYPH 469
Query: 479 PSPKPNGKP 487
SPKP+GKP
Sbjct: 470 QSPKPSGKP 478
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100451|ref|XP_002311881.1| predicted protein [Populus trichocarpa] gi|222851701|gb|EEE89248.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2162), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/445 (93%), Positives = 426/445 (95%), Gaps = 2/445 (0%)
Query: 42 GCWVKLRFFGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESN 101
GCWVKLRF GSCISSRSKVDSSVSGT ESKSTNDTS DQPAA V+S++TTSN ESN
Sbjct: 1 GCWVKLRFIGSCISSRSKVDSSVSGTICESTESKSTNDTSIDQPAALVVSTSTTSNTESN 60
Query: 102 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 161
SSTSKLEEELKVASRLRKFTFNDLK ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP
Sbjct: 61 SSTSKLEEELKVASRLRKFTFNDLKFATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 120
Query: 162 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 221
GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRG
Sbjct: 121 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRG 180
Query: 222 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281
SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE ERPVIYRDFKTSNILLDADYNAKL
Sbjct: 181 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEETERPVIYRDFKTSNILLDADYNAKL 240
Query: 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 341
SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM+TGRRS
Sbjct: 241 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRS 300
Query: 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 401
MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA
Sbjct: 301 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 360
Query: 402 RPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNG--QR 459
RPLMSEVV ALKPLPNLKDMAS+SYYFQTMQAER+GSSPN RNG+R+Q G LSRNG QR
Sbjct: 361 RPLMSEVVNALKPLPNLKDMASTSYYFQTMQAERVGSSPNARNGVRSQAGLLSRNGHQQR 420
Query: 460 SLSIPNGSYASPYHHQFPHPSPKPN 484
SLSIP+GS+ASPYH+Q+PH SPKPN
Sbjct: 421 SLSIPHGSHASPYHYQYPHKSPKPN 445
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|53689728|gb|AAU89742.1| serine/threonine protein kinase-like [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/502 (85%), Positives = 445/502 (88%), Gaps = 30/502 (5%)
Query: 1 MGFDGENGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKV 60
+G DGE G+ SWD KSK KKKK+ EEETGCW KL F GSCISSRSKV
Sbjct: 115 LGGDGEKGE----SWDVEKSKGKKKKEV--------TEEETGCWTKLWFIGSCISSRSKV 162
Query: 61 DSSVSGTSTH-------------YAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKL 107
DSS+SG STH AESKSTN TSRDQP A +ISSTTTSNAESNSSTSKL
Sbjct: 163 DSSISGISTHCDKSTYVLTSCIALAESKSTN-TSRDQPVAPIISSTTTSNAESNSSTSKL 221
Query: 108 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 167
EEELKV+SRLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV
Sbjct: 222 EEELKVSSRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 281
Query: 168 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 227
AVKTLNHDGLQ W AEVNFLGDLVH NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL
Sbjct: 282 AVKTLNHDGLQVLSIWQAEVNFLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 341
Query: 228 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287
FRRS+PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 342 FRRSMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 401
Query: 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347
KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKNRP
Sbjct: 402 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMITGRRSMDKNRP 461
Query: 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
NGEHNLVEWARPHLGERRRFYRL+DPRLEGHFSIKGAQKAAQLAA CLSRDPKARP+MS+
Sbjct: 462 NGEHNLVEWARPHLGERRRFYRLVDPRLEGHFSIKGAQKAAQLAARCLSRDPKARPMMSD 521
Query: 408 VVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ---RSLSIP 464
VVEALKPLPNLKDMASSSYYFQTMQA+R+GSSP+T+NG+R Q GS SRNGQ RSLSIP
Sbjct: 522 VVEALKPLPNLKDMASSSYYFQTMQADRVGSSPSTKNGVRTQ-GSFSRNGQQHPRSLSIP 580
Query: 465 NGSYASPYHHQFPHPSPKPNGK 486
NGS+ASPYH QFP SPKPNGK
Sbjct: 581 NGSHASPYHQQFPQNSPKPNGK 602
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 487 | ||||||
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.889 | 0.878 | 0.750 | 1.7e-176 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.895 | 0.889 | 0.728 | 1.9e-170 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.755 | 0.812 | 0.8 | 8.4e-161 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.644 | 0.742 | 0.663 | 2.9e-112 | |
| TAIR|locus:2150019 | 410 | AT5G01020 [Arabidopsis thalian | 0.599 | 0.712 | 0.720 | 3.6e-112 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.694 | 0.868 | 0.611 | 7.6e-112 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.634 | 0.782 | 0.632 | 3.9e-108 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.749 | 0.856 | 0.577 | 8.1e-108 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.706 | 0.807 | 0.582 | 2.5e-106 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.644 | 0.811 | 0.611 | 1.6e-104 |
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1714 (608.4 bits), Expect = 1.7e-176, P = 1.7e-176
Identities = 340/453 (75%), Positives = 366/453 (80%)
Query: 41 TGCWVKLRFF-GXXXXXXXXXXXXXXXXXTHYA----ESKSTNDTSRDQPAAAVIXXXXX 95
+GCWVK RF G ++ ESKS N+ S DQP V
Sbjct: 46 SGCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTT 105
Query: 96 XXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 155
+ EEL ++S LRKFTFNDLKL+TRNFRPESLLGEGGFGCVFKGWIEENG
Sbjct: 106 SNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENG 165
Query: 156 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 215
TAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLG+L+H NLVKL+GYCIEDDQRLLVY
Sbjct: 166 TAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVY 225
Query: 216 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275
EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLDA
Sbjct: 226 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA 285
Query: 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
DYNAKLSDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM
Sbjct: 286 DYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 345
Query: 336 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 395
LTGRRSMDKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFSIKGAQK QLAA CL
Sbjct: 346 LTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCL 405
Query: 396 SRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGI-RAQGGSLS 454
SRDPK RP MS+VVEALKPLP+LKDMASSSYYFQTMQAER+ +NG R+QG S
Sbjct: 406 SRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFG-S 458
Query: 455 RNGQ-----RSLSIPNGSYASPYHHQFPHPSPK 482
RNGQ R+LS P+GS SPY HQ P P PK
Sbjct: 459 RNGQHQPVFRTLSSPHGS--SPYRHQIPSPKPK 489
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1657 (588.4 bits), Expect = 1.9e-170, P = 1.9e-170
Identities = 324/445 (72%), Positives = 354/445 (79%)
Query: 42 GCWVKLRFFGXXXXXXXXXXXXXXXXXTHYAESKSTNDTSRDQPAAAVIXXXXXXXXXXX 101
GCWVK R+ T S+S S DQP V
Sbjct: 47 GCWVKFRYI-VCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESS 105
Query: 102 XXXXKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 161
+ EEL + S L+KF+F DLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 106 LSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 165
Query: 162 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRG 221
GTGLTVAVKTLN DGLQGHKEWLAE+N+LG+L+H NLVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 166 GTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 225
Query: 222 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281
SLENHLFRRSLPLPWSIRMKIALGAAKGL+FLHEEA +PVIYRDFKTSNILLD +YNAKL
Sbjct: 226 SLENHLFRRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKL 285
Query: 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 341
SDFGLAKD P+ KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRS
Sbjct: 286 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345
Query: 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 401
MDKNRPNGEHNLVEWARPHL ++RRFYRL+DPRLEGHFS+KGAQK QLAA CLSRD K
Sbjct: 346 MDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKI 405
Query: 402 RPLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQ--- 458
RP MSEVVE LKPLP+LKDMAS+SYYFQTMQAER+ + + +G R G SRNGQ
Sbjct: 406 RPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSG-RGFG---SRNGQPVF 461
Query: 459 RSLSIPNGSY-ASPYHHQFPHPSPK 482
R+LS P+G +SPY HQ P P PK
Sbjct: 462 RTLSSPHGQAGSSPYRHQIPSPKPK 486
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1566 (556.3 bits), Expect = 8.4e-161, P = 8.4e-161
Identities = 304/380 (80%), Positives = 335/380 (88%)
Query: 110 ELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
ELK +S+LR F FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV
Sbjct: 81 ELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 140
Query: 170 KTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
KTLN DGLQGHKEWLAE+NFLG+LVH +LVKL+GYC+E+DQRLLVYEFMPRGSLENHLFR
Sbjct: 141 KTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFR 200
Query: 230 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289
R+LPLPWS+RMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD +YNAKLSDFGLAKD
Sbjct: 201 RTLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 260
Query: 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 349
P+ K+HVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGRRS+DK+RPNG
Sbjct: 261 APDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNG 320
Query: 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 409
E NLVEW RPHL +++RFYRL+DPRLEGH+SIKGAQKA Q+AA CL+RD KARP MSEVV
Sbjct: 321 EQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVV 380
Query: 410 EALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGS-LSRNG--QRSLSIPNG 466
EALKPLPNLKD ASSS FQTMQ P +NG+R QGG +SRNG RSLS N
Sbjct: 381 EALKPLPNLKDFASSSSSFQTMQ-------PVAKNGVRTQGGGFVSRNGPPMRSLSSLNL 433
Query: 467 SYASPYHHQFPHPSPKPNGK 486
ASPY ++ SPKP GK
Sbjct: 434 PQASPY--RYARQSPKPKGK 451
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 211/318 (66%), Positives = 255/318 (80%)
Query: 106 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 165
+ E E+ + L+ FTF +LK ATRNFRP+S+LGEGGFG VFKGWI+E KPGTG+
Sbjct: 54 RTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGV 113
Query: 166 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 225
+AVK LN DG QGH+EWLAEVN+LG H NLVKLIGYC+ED+ RLLVYEFMPRGSLEN
Sbjct: 114 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 173
Query: 226 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282
HLFRR PL W++R+K+ALGAAKGLAFLH AE VIYRDFKTSNILLD++YNAKLS
Sbjct: 174 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLS 232
Query: 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 342
DFGLAKDGP GDK+HVSTR+MGTYGYAAPEY+ TGHLT++SDVYS+GVVLLE+L+GRR++
Sbjct: 233 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 292
Query: 343 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
DKNRP GE LVEWARP L +R+ +R+ID RL+ +S++ A K A LA CL+ + K R
Sbjct: 293 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 352
Query: 403 PLMSEVVEALKPLPNLKD 420
P M+EVV L+ + L +
Sbjct: 353 PNMNEVVSHLEHIQTLNE 370
|
|
| TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 214/297 (72%), Positives = 250/297 (84%)
Query: 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG 179
FT +L+ T++FRP+ +LGEGGFG V+KG+I++N +K L VAVK LN +GLQG
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQG 113
Query: 180 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSI 238
H+EWL EVNFLG L H NLVKLIGYC EDD RLLVYEFM RGSLENHLFR++ PL WS
Sbjct: 114 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSR 173
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
RM IALGAAKGLAFLH AERPVIYRDFKTSNILLD+DY AKLSDFGLAK GP+GD+THV
Sbjct: 174 RMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 232
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358
STRVMGTYGYAAPEYVMTGHLT+RSDVYSFGVVLLEMLTGR+S+DK RP+ E NLV+WAR
Sbjct: 233 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWAR 292
Query: 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
P L ++R+ ++IDPRLE +S++ AQKA LA +CLS++PKARPLMS+VVE L+PL
Sbjct: 293 PKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
Identities = 209/342 (61%), Positives = 265/342 (77%)
Query: 106 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 165
+ E E+ + L+ F+ ++LK ATRNFRP+S++GEGGFGCVFKGWI+E+ AP KPGTG+
Sbjct: 42 RTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGI 101
Query: 166 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 225
+AVK LN +G QGH+EWLAE+N+LG L H NLVKLIGYC+E++ RLLVYEFM RGSLEN
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 226 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282
HLFRR PL W+ R+++ALGAA+GLAFLH A+ VIYRDFK SNILLD++YNAKLS
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 342
DFGLA+DGP GD +HVSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLE+L+GRR++
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 343 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
DKN+P GEHNLV+WARP+L +RR R++DPRL+G +S+ A K A LA C+S D K+R
Sbjct: 281 DKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSR 340
Query: 403 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRN 444
P M+E+V+ ++ L K+ + Q I SP N
Sbjct: 341 PTMNEIVKTMEELHIQKEASKEQQNPQISIDNIINKSPQAVN 382
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 3.9e-108, P = 3.9e-108
Identities = 198/313 (63%), Positives = 250/313 (79%)
Query: 106 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 165
K E E+ ++ ++ FTFN+LKLATRNFRP+S++GEGGFGCVFKGW++E+ P KPGTGL
Sbjct: 41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100
Query: 166 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 225
+AVK LN +G QGH+EWL E+N+LG L H NLVKLIGYC+ED+ RLLVYEFM +GSLEN
Sbjct: 101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160
Query: 226 HLFRRSL---PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282
HLFRR PLPW +R+ +AL AAKGLAFLH + + VIYRD K SNILLDADYNAKLS
Sbjct: 161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLS 219
Query: 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 342
DFGLA+DGP GD ++VSTRVMGTYGYAAPEY+ +GHL +RSDVYSFGV+LLE+L+G+R++
Sbjct: 220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRAL 279
Query: 343 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
D NRP E NLV+WARP+L +R+ ++D RL+ + + A + A +A CLS +PK+R
Sbjct: 280 DHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSR 339
Query: 403 PLMSEVVEALKPL 415
P M +VV AL+ L
Sbjct: 340 PTMDQVVRALQQL 352
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 216/374 (57%), Positives = 267/374 (71%)
Query: 106 KLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 165
+ E E+ + L+ FTFN+LK ATRNFRP+SLLGEGGFG VFKGWI+ KPG+G+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 166 TVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 225
VAVK L +G QGHKEWL EVN+LG L H NLVKL+GYC+E + RLLVYEFMP+GSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 226 HLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284
HLFRR PL W+IRMK+A+GAAKGL FLH+ A+ VIYRDFK +NILLDA++N+KLSDF
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDF 235
Query: 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 344
GLAK GP GDKTHVST+VMGT+GYAAPEYV TG LT++SDVYSFGVVLLE+L+GRR++DK
Sbjct: 236 GLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDK 295
Query: 345 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 404
++ E +LV+WA P+LG++R+ +R++D RL G + KGA AA LA CL+ D K RP
Sbjct: 296 SKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPK 355
Query: 405 MSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSL-SI 463
MSEV+ L L + K QA+ SP NG Q + R L I
Sbjct: 356 MSEVLAKLDQLESTKPGTGVG----NRQAQI--DSPRGSNGSIVQKSPRRYSYDRPLLHI 409
Query: 464 PNGSYASPYHHQFP 477
G+ P H+ P
Sbjct: 410 TPGASPLPTHNHSP 423
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 2.5e-106, P = 2.5e-106
Identities = 202/347 (58%), Positives = 256/347 (73%)
Query: 74 SKSTNDTSRDQ-PAAAVIXXXXXXXXXXXXXXXKLEEELKVASRLRKFTFNDLKLATRNF 132
SK ++ TSR P+ + E E+ + L+ FTFN+LK AT+NF
Sbjct: 27 SKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTEGEILSSPNLKAFTFNELKNATKNF 86
Query: 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 192
R ++LLGEGGFGCVFKGWI++ +PG+G+ VAVK L +G QGHKEWL EVN+LG
Sbjct: 87 RQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLTEVNYLGQ 146
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLA 251
L H NLV L+GYC E + RLLVYEFMP+GSLENHLFRR PL W+IRMK+A+GAAKGL
Sbjct: 147 LSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAVGAAKGLT 206
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
FLHE A+ VIYRDFK +NILLDAD+NAKLSDFGLAK GP GD THVST+V+GT+GYAAP
Sbjct: 207 FLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAP 265
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371
EYV TG LT++SDVYSFGVVLLE+++GRR+MD + E++LV+WA P+LG++R+ +R++
Sbjct: 266 EYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLGDKRKLFRIM 325
Query: 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 418
D +L G + KGA AA LA CL+ D K RP MSEV+ L+ L ++
Sbjct: 326 DTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESV 372
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 195/319 (61%), Positives = 249/319 (78%)
Query: 108 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 167
E EL + L+ FTFN+LK ATRNF+P S++GEGGFGCV+KGWI E +P KPG+G+ V
Sbjct: 60 EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVV 119
Query: 168 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL 227
AVK L +G QGHKEWL EV++LG L H+NLVKLIGYC+E ++RLLVYE+MP+GSLENHL
Sbjct: 120 AVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHL 179
Query: 228 FRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
FRR P+PW RMK+A AA+GL+FLHE VIYRDFK SNILLD D+NAKLSDFGL
Sbjct: 180 FRRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGL 236
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
AK GP GD+THV+T+V+GT GYAAPEY+ TG LTS+SDVYSFGVVLLE+L+GR ++DK++
Sbjct: 237 AKAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSK 296
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
E NLV+WA P+L +RR+ +R++D +L G + KGA AA +A CL+ +PK RP M+
Sbjct: 297 VGVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMA 356
Query: 407 EVVEALKPLP-NLKDMASS 424
+V+ L+ L + K M S+
Sbjct: 357 DVLSTLQQLETSSKKMGST 375
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LFP7 | Y5158_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.746 | 0.9671 | 0.9553 | yes | no |
| Q9SRH7 | Y3130_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7622 | 0.9055 | 0.9 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 487 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 66/278 (23%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVHL 196
LGEGGFG V+ ++ G VA+K + + E L E+ L L H
Sbjct: 1 LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
N+VKL G +++ LV E+ GSL++ L L ++I L +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 257 AERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+I+RD K NILLD+D KL+DFGL+K ++GT Y APE ++
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166
Query: 316 -TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374
G+ + +SD++S GV+L E+
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL--------------------------------------- 187
Query: 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
+ L L +DP+ RP E++E L
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 8e-53
Identities = 89/281 (31%), Positives = 128/281 (45%), Gaps = 30/281 (10%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 193
LGEG FG V+KG ++ + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H N+VKL+G C E++ +V E+M G L ++L + L S + AL A+G+ +L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 313
+ I+RD N L+ + K+SDFGL++D + D + APE
Sbjct: 119 E---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPES 174
Query: 314 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRLI 371
+ G TS+SDV+SFGV+L E+ T P + E +L G R
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRLPQPPNC 228
Query: 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
P L L C + DP+ RP SE+VE L
Sbjct: 229 PPEL------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 90/284 (31%), Positives = 128/284 (45%), Gaps = 33/284 (11%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 189
+ LG G FG V+K GTG VAVK L + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
L L H N+V+LI + D LV E+ G L R PL KIAL +G
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRG 110
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L +LH +I+RD K NILLD + K++DFGLAK + ++T V GT Y
Sbjct: 111 LEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYM 165
Query: 310 APEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
APE ++ G + DV+S GV+L E+LTG+ L + +
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIR 212
Query: 369 RLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
R++ P LE G+++A L CL++DP RP E+++
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-52
Identities = 93/282 (32%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 193
LGEG FG V+KG ++ G + VAVKTL D Q +E+L E + L
Sbjct: 4 GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 252
H N+VKL+G C E++ ++V E+MP G L ++L R L S + AL A+G+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
L + I+RD N L+ + K+SDFGL++D + D V + APE
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE 174
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL--GERRRFYRL 370
+ G TS+SDV+SFGV+L E+ T P + E +L G R
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRLPKPPN 228
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
P L +L C + DP+ RP SE+VE L
Sbjct: 229 CPPEL------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 7e-51
Identities = 91/282 (32%), Positives = 134/282 (47%), Gaps = 37/282 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
LGEG FG V+KG ++ GT VAVKTL + +E+L E + + L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
N+V+L+G C + + +V E+MP G L + L + L +++AL AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------RVMGTYGYAA 310
+ ++RD N L+ + K+SDFGL++D E D + M A
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------A 172
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
PE + G TS+SDV+SFGV+L E+ T P + E L + YRL
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YRL 223
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
PR E + +L C + DP+ RP SE+VE L
Sbjct: 224 --PRPEN-----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 94/295 (31%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 196
LGEG FG V+KG K G VAVKTL D + K++L E + L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------LPWSIRMKIALGAAK 248
N+V+L+G C E++ LV E+M G L ++L + L + A+ AK
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------RV 302
G+ +L + ++RD N L+ D K+SDFGL++D + D T R
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE---HNL-VEWAR 358
M APE + G TS+SDV+SFGV+L E+ T G L E
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217
Query: 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
+L R+ YRL P + + +L C DP+ RP SE+VE L+
Sbjct: 218 EYL---RKGYRLPKPE---YCP----DELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-47
Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 190
+ LGEG FG V+ TG VA+K + ++ +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKG 249
L H N+V+L ++D+ LV E+ G L + L R L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L +LH + +++RD K NILLD D + KL+DFGLA+ G+K T V GT Y
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRRFY 368
APE ++ D++S GV+L E+LTG+ P G+ L+E + + F
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPF- 216
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
P E S +A L L +DP+ R E ++
Sbjct: 217 ----PPPEWDIS----PEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
F +G+GGFG V+K K TG VA+K + + + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKAR--------HKR-TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 192 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
H N+VK G ++ D+ +V EF GSL++ L + L S + KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+LH +I+RD K +NILL +D KL DFGL+ + + ++GT + AP
Sbjct: 113 YLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAP 166
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
E + ++D++S G+ +E+ G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 34/272 (12%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 194
LLG G FG V+ ++++ TG +AVK+ L+ D + + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKD--------TGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 195 HLNLVKLIGYCIEDDQR-LLVY-EFMPRGSLENHLFRRSLPLPWS-IRMKIALGAAKGLA 251
H N+V+ G ++++ L ++ E++ GSL + L ++ LP IR K +GLA
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIR-KYTRQILEGLA 115
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+LH +++RD K +NIL+D+D KL+DFG AK + + + V GT + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371
E + +D++S G ++EM TG+ P E A +G
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIG-----SSGE 221
Query: 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
P + H S ++A CL RDPK RP
Sbjct: 222 PPEIPEHLS----EEAKDFLRKCLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHL 196
LGEG FG V + G TG VAVK+LNH G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 197 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
N+VK G C + R L+ E++P GSL ++L R + + + KG+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST--RVMGTYGYAAPE 312
+ I+RD NIL++++ K+SDFGLAK PE + + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLT 337
+ T +S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGDLV 194
L+G G FG V+KG E TG VA+K L + K + E++ L +L
Sbjct: 7 LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 195 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H N+VK IG IE L ++ E+ GSL + ++ P P S+ +GLA+L
Sbjct: 58 HPNIVKYIG-SIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 313
HE+ VI+RD K +NIL D KL+DFG+A + K V+GT + APE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEV 170
Query: 314 V-MTGHLTSRSDVYSFGVVLLEMLTGR 339
+ M+G T+ SD++S G ++E+LTG
Sbjct: 171 IEMSGASTA-SDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 2e-30
Identities = 99/377 (26%), Positives = 146/377 (38%), Gaps = 44/377 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 187
++R LGEG FG V+ + VA+K L KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48
Query: 188 NFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIAL 244
L L H N+VKL + ++ LV E++ GSLE+ L R PL S + I
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAK----DGPEGDKTHVS 299
L +LH + +I+RD K NILLD D KL DFGLAK G +
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 300 TRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356
+ +GT GY APE ++ + +S SD++S G+ L E+LTG + + + +
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-L 224
Query: 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-ALKPL 415
+ P S + A+ L L++DPK R S + L
Sbjct: 225 KIILELPTPSLASPLSPSNPELIS----KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 416 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQ---------GGSLSRNGQRSLSIPNG 466
LK+ S A S P + + + L + PNG
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNG 340
Query: 467 SYASPYHHQFPHPSPKP 483
+SP++ S
Sbjct: 341 VSSSPHNSSSLLLSTAS 357
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 30/278 (10%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 195
+G+G FG V+KG ++ VAVKT K +L E L H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
N+VKLIG C++ +V E +P GSL L ++ L ++++L AA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE- 110
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+ I+RD N L+ + K+SDFG++++ G T + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 316 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 375
G TS SDV+S+G++L E + + N + R + YR+ P+L
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPAPQL 219
Query: 376 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
+ +L C + DP+ RP SE+ L+
Sbjct: 220 CPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 84/293 (28%), Positives = 132/293 (45%), Gaps = 45/293 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
LG+G FG V++G VK VA+KT+N + + E+L E + + +
Sbjct: 14 LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--------FRRSLPLPWSIRM-KIALGAA 247
++V+L+G L+V E M +G L+++L L P + ++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
G+A+L A + ++RD N ++ D K+ DFG+ +D E D + +
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----E 363
+ APE + G T++SDV+SFGVVL EM T L E +P+ G E
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQGLSNEE 229
Query: 364 RRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414
+F +ID GH K +L C +PK RP E+V +LK
Sbjct: 230 VLKF--VID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 91/298 (30%), Positives = 135/298 (45%), Gaps = 28/298 (9%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 188
R + +LGEG FG V + P GTG VAVKTL + Q + W E+N
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L L H N+VK G C E + L+ E++P GSL ++L + L L + + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQI 116
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRVMGT 305
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + + V
Sbjct: 117 CEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
+ A E + + SDV+SFGV L E+LT ++ P ++ + + R
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVR 232
Query: 366 ------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417
R RL P+ Q+ L +C + K RP ++ LK + +
Sbjct: 233 LIELLERGMRLPCPK-------NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 195
+ +G+G FG V G G VAVK L D +LAE + + L H
Sbjct: 12 ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLH 254
NLV+L+G ++ + +V E+M +GSL ++L R + + ++ AL +G+ +L
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD---GPEGDKTHVSTRVMGTYGYAAP 311
E+ ++RD N+L+ D AK+SDFGLAK+ G + K V + AP
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAP 168
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT-GR 339
E + +++SDV+SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 75/210 (35%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDL 193
LG+G FG V V K TG A+K L + KE L E N L +
Sbjct: 1 LGKGSFGKVLL----------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR-SLPLPWSIRM--KIALGAAKG 249
H +VKL Y + +++L LV E+ P G L +HL + + +I L
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA---- 105
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L +LH +IYRD K NILLDAD + KL+DFGLAK+ + +T GT Y
Sbjct: 106 LEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYL 160
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE ++ D +S GV+L EMLTG+
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 70/215 (32%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGDLVH 195
LGEG FG VF G ++P VAVKTL K++ E L + H
Sbjct: 13 LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSL-------PLPWSIRMKI 242
N+VK G C E D ++V+E+M G L L L S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
A+ A G+ +L A + ++RD T N L+ D K+ DFG+++D D V
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
M + PE +M T+ SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 137 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV 194
LG+G FG V +G W G + VAVK L D L ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFL 253
H NL++L G + ++V E P GSL + L + +L S A+ A G+ +L
Sbjct: 55 HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST---RVMGTYGYAA 310
+ I+RD NILL +D K+ DFGL + P+ + +V +V + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLT 337
PE + T + SDV+ FGV L EM T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVH 195
LGEG FG V+KG E G T +VA+KTL N + + +E+ E + DL H
Sbjct: 13 LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRM 240
N+V L+G C ++ +++E++ G L L R S L S +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
IA+ A G+ +L + ++RD N L+ K+SDFGL++D D V +
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
+ + + PE ++ G T+ SD++SFGVVL E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 195
LG G FG V+KG WI E VK + VA+K L + + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 249
++V+L+G C+ Q L+ + MP G L +++ L W +++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
+++L E + +++RD N+L+ + K++DFGLAK +K + + +
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 355
A E ++ T +SDV+S+GV + E++T G + + +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 33/276 (11%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+G G FG V+ G W+E+ VA+KT+ +G ++++ E + L H
Sbjct: 12 IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
LV+L G C E LV+EFM G L ++L + + + L +G+A+L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
VI+RD N L+ + K+SDFG+ + + D+ ST +++PE
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSF 175
Query: 317 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 376
+S+SDV+SFGV++ E+ + ++ +NR N E +VE +RL PRL
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKPRL- 225
Query: 377 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
+Q +L HC P+ RP S ++ L
Sbjct: 226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 42/273 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
+G+G FG VFK V+ A+K ++ + +E + E L L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLP----WSIRMKIALGAAKGL 250
+++ ++ + +V E+ G L L +R PLP W ++I LG L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
A LH + +++RD K+ N+ LDA N K+ D G+AK D T+ + ++GT Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLS 169
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
PE +SDV++ GVVL E TG+ D N + L+ + R
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRG 216
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
+ P + +S Q+ AQL CL++D + RP
Sbjct: 217 VFPPVSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVH 195
+LG+G +G V+ G + VK V + T N + E L EV+ L L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
+N+V+ +G C++D+ + EF+P GS+ + L R PLP + K G+A+LH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRVMGTYGYAAP 311
V++RD K +N++L + KL DFG A+ G G +++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFY 368
E + +SD++S G + EM TG+ SMD+ A ++G R
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGAHRGLM 227
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
PRL FS A CL+RD RP
Sbjct: 228 ----PRLPDSFS----AAAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 132 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
F E LG G FG V++G W + VA+K L D L +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGA 246
L H +L+ L C + ++ E M +GSL R + LP+ I M A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDM--ACQV 113
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
A+G+A+L E + I+RD NIL+ D K++DFGLA+ E ++ Y
Sbjct: 114 AEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PY 168
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE G +++SDV+SFG++L EM T
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 90/278 (32%), Positives = 126/278 (45%), Gaps = 54/278 (19%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V+ G W NGT V AVKTL G + +L E + L H
Sbjct: 14 LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 253
LV+L C E++ +V E+M +GSL + L + L LP + M A A+G+A+L
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYL 119
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 306
R I+RD NIL+ + K++DFGLA+ EG K +
Sbjct: 120 ES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------- 169
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERR 365
+ APE G T +SDV+SFG++L E++T R P G N R L +
Sbjct: 170 -WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVE 218
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
R YR+ PR ++ L C +DP+ RP
Sbjct: 219 RGYRM--PRPPNC-----PEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 84/285 (29%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 137 LLGEGGFGCVFKGWIEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 195
LLG G FG V++G ++G VK V++ G + K+ E+ L L H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS-IRM---KIALGAAKGLA 251
N+V+ +G E+D + E +P GSL L ++ P IR+ +I LG L
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLG----LE 116
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-----GTY 306
+LH+ R ++RD K +NIL+D + KL+DFG+AK V G+
Sbjct: 117 YLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165
Query: 307 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
+ APE + G +D++S G +LEM TG+ P + V A +G +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA-AVFKIGRSK 218
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
P + H S +A CL RDP RP +E++E
Sbjct: 219 EL-----PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 45/305 (14%)
Query: 118 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDG 176
+ T ND+ + + E+++ G G +KG +NG V VK +N +
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728
Query: 177 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 236
+ +E+ +G L H N+VKLIG C + L++E++ +L L L W
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSW 779
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
R KIA+G AK L FLH V+ + I++D L L+ G
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----L 832
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVE 355
T+ + Y APE T +T +SD+Y FG++L+E+LTG+ D G H ++VE
Sbjct: 833 CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIVE 890
Query: 356 WAR-----PHLGERRRFYRLIDPRLEGHFSIKGAQ--KAAQLAAHCLSRDPKARPLMSEV 408
WAR HL IDP + G S+ + + LA HC + DP ARP ++V
Sbjct: 891 WARYCYSDCHLD------MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
Query: 409 VEALK 413
++ L+
Sbjct: 945 LKTLE 949
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 29/229 (12%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 189
N +G+G FG VF+ G P +P T VAVK L + ++ E
Sbjct: 6 NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------ 231
+ + H N+VKL+G C L++E+M G L L RS
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 232 ---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288
LPL + ++ IA A G+A+L +ER ++RD T N L+ + K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ D S + PE + T+ SDV+++GVVL E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGD 192
E ++G G FG V +G ++ G + VA+KTL G + L E + +G
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
H N+++L G + +++ E+M GSL+ L + + G A G+ +
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAA 310
L +E ++RD NIL++++ K+SDFGL++ + E T ++ + A
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-LGERRRFYR 369
PE + TS SDV+SFG+V+ E+++ GE + + + YR
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGYR 226
Query: 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
L P QL C +D RP S++V L
Sbjct: 227 LPPPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 73/206 (35%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V KG K G + VAVKTL G KE+L E + + L H
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
+V+LIG C + +LV E P G L +L +R +P S ++A A G+A+L E
Sbjct: 57 CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYL--E 112
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG-----YAAP 311
++ V +RD N+LL + AK+SDFG+++ G + +T T G + AP
Sbjct: 113 SKHFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAP 167
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT 337
E + G +S+SDV+S+GV L E +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 196
LG G G V K +P TG +AVKT+ + K+ L E++ L
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
+V G + + E+M GSL+ L +P I KIA+ KGL +LHE+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM--------GTYGY 308
+I+RD K SNIL+++ KL DFG VS +++ GT Y
Sbjct: 120 --HKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE + + +SD++S G+ L+E+ TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 50/280 (17%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV 194
+LG+G G V+K TG A+K ++ DG + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
+VK G ++ + +V E+M GSL + L ++ +P + IA KGL +LH
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAP 311
+R +I+RD K SN+L+++ K++DFG++K + + T V GT Y +P
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSP 169
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371
E + + +D++S G+ LLE G+ F+ L+
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELM 212
Query: 372 D-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 403
P L FS + + CL +DPK RP
Sbjct: 213 QAICDGPPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 39/279 (13%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V G W + + VA+K + +G +++ E + L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
NLV+L G C + +V E+M G L N+L R L + + + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEY 313
I+RD N L+ D K+SDFGLA+ D D+ S +A PE
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPEV 172
Query: 314 VMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373
+S+SDV+SFGV++ E+ + + + N E +VE G YRL P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRP 223
Query: 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
+L + + C P+ RP +++ L
Sbjct: 224 KL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 194
+LGEG FG V +G + ++ + +K VAVKT+ D +E+L+E + D
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 195 HLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 243
H N++KLIG C E +++ FM G L + L L LP +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVST 300
+ A G+ +L + R I+RD N +L D ++DFGL+K GD + ++
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
+ + A E + TS+SDV++FGV + E+ T R H + ++
Sbjct: 177 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL--- 228
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
R RL P + L C DPK RP +++ E L+ +
Sbjct: 229 ----RHGNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 64/297 (21%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 188
+ +G+G FG V+ + +G +K L++ + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGK---------LYVLKEIDLSNMSEKEREDALNEVK 51
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSL---PLP----WSIRM 240
L L H N++K E+ +L V E+ G L + ++ P P +
Sbjct: 52 ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
++ L L +LH R +++RD K NI L ++ KL DFG++K T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 301 RVMGTYGYAAPE------YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354
V GT Y +PE Y +SD++S G VL E+ T + + L
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE---L- 211
Query: 355 EWARPHLGERRRFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
+++ P + +S + L + L +DP+ RP ++++
Sbjct: 212 ------------ALKILKGQYPPIPSQYS----SELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LGEG FG VF E +P K + VAVK L L K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP----------------LPWSIRMK 241
+VK G C + D ++V+E+M G L N R P L S +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
IA A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
M + PE +M T+ SDV+SFGV+L E+ T
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 73/217 (33%), Positives = 110/217 (50%), Gaps = 26/217 (11%)
Query: 137 LLGEGGFGCVFKGW---IEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD 192
LG G FG V++G I G+ P++ VAVKTL Q KE+L E + + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIR------VAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-------FRRSLPLPWSIRMKIALG 245
H N+VKL+G C+ ++ + ++ E M G L ++L F L L + I L
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL-LTLKELLDICLD 114
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDGPEGDKTHVST 300
AKG +L + I+RD N L+ DAD K+ DFGLA+D + D
Sbjct: 115 VAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ + APE ++ G T++SDV+SFGV++ E+LT
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 43/300 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 189
LGEG FG V + P V+ G L VAVK L D + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------PL 234
L L N+++L+G C+++D ++ E+M G L L L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 235 P---WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291
P +S + +AL A G+ +L + ++RD T N L+ + K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 350
GD + R + + A E ++ G T+ SDV++FGV L E+L + K +P GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245
Query: 351 --HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
++E A ++ R L P Q +L C SRD + RP S++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
R+ + LG+G FG V E P++ TG VAVK L H + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 190 LGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
L L H N+VK G C +R LV E++P GSL ++L + L + A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--- 304
KG+ +L + ++RD T NIL++++ K+ DFGL K P+ DK + R G
Sbjct: 119 KGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESP 174
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ Y APE + + SDV+SFGVVL E+ T
Sbjct: 175 IFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 9e-23
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 127 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 184
L R LLG G FG V KG WI E + + VA+KT+ + G Q +E
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
+ +G L H +V+L+G C LV + P GSL +H+ + L + +
Sbjct: 58 DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
AKG+ +L E +++R+ NILL +D +++DFG+A DK + +
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ A E ++ G T +SDV+S+GV + EM++
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 74/224 (33%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHL 196
LG G FG V++G V+ L VAVKTL Q ++L E + H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMK----IALGAAKG 249
N+V+LIG E R ++ E M G L++ L R + P P S+ MK A AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 250 LAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+L E I+RD N LL AK++DFG+A+D R M
Sbjct: 129 CKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 350
+ PE + G TS++DV+SFGV+L E+ + R N E
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-22
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V++G W N T PV AVKTL + K++LAE + L H
Sbjct: 14 LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 253
L++L C ++ +V E M GSL +L R+L LP I M A A G+A+L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTY 306
+ I+RD N+L+ + K++DFGLA+ + EG K +
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------- 169
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GR 339
+ APE + + +SDV+SFG++L E++T GR
Sbjct: 170 -WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 66/207 (31%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 194
LG+GGFG V A TG A K L+ L +G + L E L + V
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKV 50
Query: 195 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAF 252
+ + Y E L LV M G L+ H++ P P + + A GL
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
LH+ R ++YRD K N+LLD N ++SD GLA + G K GT GY APE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+ D ++ G L EM+ GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 138 LGEGGFG----CVFKGWIEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 191
LGEG FG C +G E G AP G + VAVK L D + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 192 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI--------- 242
L + N+++L+G C+ DD ++ E+M G L L +R + ++ I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 243 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
A+ A G+ +L A ++RD T N L+ Y K++DFG++++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
R + + A E ++ G T+ SDV++FGV L EM T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 19/208 (9%)
Query: 137 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGDLV 194
++G+G FGCV+ G I+ +G + AVK+LN L+ +++L E + D
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQK-------IHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 195 HLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--AAKGLA 251
H N++ L+G C+ + L+V +M G L N F RS +++ I G AKG+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYA 309
+L A + ++RD N +LD + K++DFGLA+D E H T +
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT 337
A E + T T++SDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGDL 193
+GEG G VFK E TG TVA+K + G+ + L E+ L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H +VKL+ +LV E+MP L L PLP + KG+A++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 313
H +++RD K +N+L+ AD K++DFGLA+ E + S +V T Y APE
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE- 170
Query: 314 VMTG--HLTSRSDVYSFGVVLLEMLTGR 339
++ G D+++ G + E+L G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 5e-22
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 39/233 (16%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 187
+F+ ++GEG F V + T A+K L+ L + K E
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52
Query: 188 NFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIAL 244
L L H ++KL Y +D++ L V E+ P G L ++ SL R A
Sbjct: 53 EVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE 110
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM- 303
L +LH + +I+RD K NILLD D + K++DFG AK +
Sbjct: 111 -ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 304 -----------------GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
GT Y +PE + SD+++ G ++ +MLTG+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 5e-22
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 22/213 (10%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 187
+ LGEG +G V+K ++ G VA+K + +G+ L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
+ L +L H N+VKL+ + + LV+E+ L+ +L +R PL ++ I
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+GLA+ H +++RD K NIL++ D KL+DFGLA+ +T+ + V+ T
Sbjct: 109 RGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLW 163
Query: 308 YAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
Y APE ++ S + D++S G + EM+TG+
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 79/275 (28%), Positives = 113/275 (41%), Gaps = 30/275 (10%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 194
S LGEG G V K + TG+ A+KT+ D K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 195 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGAAKG 249
+VK G +++ + E+ GSL++ + +R + + KIA KG
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGY 308
L++LH R +I+RD K SNILL KL DFG++ + T GT Y
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
APE + + SDV+S G+ LLE+ R P GE L
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPNP 226
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
L D E IK +++ CL +DP RP
Sbjct: 227 ELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LGEG FG VF E P + + VAVKTL K++ E L +L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------LPWSIRMKIAL 244
+VK G C+E D ++V+E+M G L N R P L S + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
A G+ +L A + ++RD T N L+ + K+ DFG+++D D V M
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ PE +M T+ SDV+S GVVL E+ T
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 8e-22
Identities = 81/284 (28%), Positives = 112/284 (39%), Gaps = 48/284 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGDLVH 195
+G G FG V+ V TG +AVK + D KE E+ L L H
Sbjct: 8 IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
NLVK G + ++ + E+ G+LE L L + L +GLA+LH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV---MGTYGYAAPE 312
+++RD K +NI LD + KL DFG A T + V GT Y APE
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPE 173
Query: 313 YVMTGHLTSR---SDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEWA---RPHLGE 363
+ G +D++S G V+LEM TG+R +D E+ G
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGAGH 223
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
+ + EG + CL DPK RP SE
Sbjct: 224 KPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 138 LGEGGFGCV-------FKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 189
LGEG FG V + + E+ + VAVK L D +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIR 239
L L N+ +L+G C D ++ E+M G L L + S L +S
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
+ +A A G+ +L ++RD T N L+ +Y K++DFG++++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
R + A E V+ G T++SDV++FGV L E+LT
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 26/210 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+GEG FG V +G TG VAVK + D + +L E + L H N
Sbjct: 14 IGEGEFGAVLQGEY-----------TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM-KIALGAAKGLAFLHEE 256
LV+L+G I + +V E M +G+L N L R L I++ + +L A+G+ +L
Sbjct: 61 LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVM 315
+ +++RD NIL+ D AK+SDFGLA+ G G D + + + + APE +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170
Query: 316 TGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 344
+S+SDV+S+GV+L E+ + GR K
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVH 195
+GEG G V+K TG VA+K + L+ + L E+ + D H
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
N+V + D+ +V E+M GSL + + + + + + +GL +LH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+ VI+RD K+ NILL D + KL+DFG A + S V+GT + APE V+
Sbjct: 135 ---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VI 188
Query: 316 TGHL-TSRSDVYSFGVVLLEMLTG 338
+ D++S G++ +EM G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 5e-21
Identities = 84/278 (30%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 195
LLG+G FG VFKG +++ VAVKT D Q K ++L+E L H
Sbjct: 2 LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
N+VKLIG C + +V E +P G + L ++ L +K AL AA G+A+L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT-YGYAAPEYV 314
+ I+RD N L+ + K+SDFG+++ E D + S+ + + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 315 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374
G +S SDV+S+G++L E S+ G N + AR + + YR+ P+
Sbjct: 167 NYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRMSCPQ 217
Query: 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
K ++ C P+ RP SE+ + L
Sbjct: 218 -------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 37/286 (12%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 186
L+G+G +G V+ + N T TG +AVK + HD Q K +E
Sbjct: 8 LIGKGTYGRVY---LALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
+ L DL HLN+V+ +G+ ++ + E++P GS+ + R +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQV 117
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+GLA+LH + +++RD K N+L+DAD K+SDFG++K + + + G+
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 307 GYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
+ APE + + +++ D++S G V+LEM GR RP + + A LG +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFKLGNK 227
Query: 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
R P + S+ + A C + +P RP E+++
Sbjct: 228 RS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRMKI 242
+V+ G C E L+V+E+M G L N R P L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
A A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
M + PE ++ T+ SD++SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
+GEG +G V+K + TG VA+K + L+ E L E+ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54
Query: 193 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
L H N++KL+ L LV+EFM L + R LP S+ +GLA
Sbjct: 55 LNHPNIIKLLD-VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGY 308
F H +++RD K N+L++ + KL+DFGLA+ P TH V TR Y
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WY 164
Query: 309 AAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
APE ++ ++ D++S G + E+L+ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 185
N+R LLG+G FG V+ TG +AVK + D KE A
Sbjct: 3 NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
E+ L +L H +V+ G C+ DD+ L ++ E+MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTR 111
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVSTRV 302
+G+ +LH +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167
Query: 303 MGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLT 337
GT + +PE V++G R +DV+S G ++EMLT
Sbjct: 168 TGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 33/210 (15%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G +G V++G W + + LTVAVKTL D ++ E+L E + ++ H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLH 254
NLV+L+G C + ++ EFM G+L ++L R + + + +A + + +L
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE 121
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 307
++ I+RD N L+ ++ K++DFGL++ G K +
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-------- 170
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + + +SDV++FGV+L E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLVHL 196
LGEG FG V E P TG VAVK+L + H L E+ L +L H
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 197 NLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
N+VK G C ED L+ EF+P GSL+ +L R + ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL- 125
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPE 312
R ++RD N+L+++++ K+ DFGL K E DK + + + + + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLT 337
++ SDV+SFGV L E+LT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-20
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 138 LGEGGFG----CVFKG---WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 189
LGEG FG C +G +++++ + V + VAVK L D + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP----------WSIR 239
+ L N+++L+ CI D ++ E+M G L L R +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
+ +A A G+ +L + ++RD T N L+ +Y K++DFG++++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
R + + + E ++ G T+ SDV++FGV L E+LT
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 75/299 (25%), Positives = 110/299 (36%), Gaps = 51/299 (17%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDL 193
++GEG +G V K + TG VA+K + D K L EV L L
Sbjct: 7 GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-HLFRRSLPLPWSIRMKIALGAAKGLAF 252
H N+V L + LV+E++ R LE LP P ++R + +A+
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
H +I+RD K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 116 CHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 313 ----YVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHN 352
G DV++ G ++ E+L G + + P H
Sbjct: 172 LLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQ 226
Query: 353 LVEWARPHLGERRRFYRLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
+ + P +P LE + K + A CL DPK R E
Sbjct: 227 ELFSSNPRF----AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 47/293 (16%)
Query: 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 186
L + + +G+G FG V G G VAVK + +D + +LAE
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLP-LPWSIRMKIAL 244
+ + L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 50 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+ + +L ++RD N+L+ D AK+SDFGL K E T + ++
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL-- 161
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
+ APE + +++SDV+SFG++L E+ + R V + R L +
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKD- 207
Query: 365 RRFYRLIDPRLEGHFSIKGAQKAA----QLAAHCLSRDPKARPLMSEVVEALK 413
+ PR+E + + + C D RP ++ E L+
Sbjct: 208 ------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 73/256 (28%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 166 TVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 224
VA+K ++ + Q E EV + H N+VK + D+ LV ++ GSL
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87
Query: 225 NHLFRRSLP---LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281
+ + S P L +I + KGL +LH + I+RD K NILL D + K+
Sbjct: 88 -DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKI 143
Query: 282 SDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEM 335
+DFG LA G V +GT + APE VM ++D++SFG+ +E+
Sbjct: 144 ADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIEL 200
Query: 336 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA-AQLAAHC 394
TG K P L P P LE K K+ ++ + C
Sbjct: 201 ATGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFRKMISLC 247
Query: 395 LSRDPKARPLMSEVVE 410
L +DP RP E+++
Sbjct: 248 LQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 193
+ ++G G FG VF+G ++ G V VA+KTL + + ++L+E + +G
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H N+++L G + +++ E+M G+L+ +L + + G A G+ +L
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAA 310
++ ++RD NIL++++ K+SDFGL++ D PEG T ++ + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
PE + TS SDV+SFG+V+ E+++ G R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 196
LG+G FG V++G + G +P T VA+KT+N ++ E+L E + + +
Sbjct: 14 LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-----------PLPWSIRMKIALG 245
++V+L+G + L++ E M RG L+++L RSL P +++A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL--RSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 128 IADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 187
+F ++G+G FG V +++ T A+K +N + L E
Sbjct: 1 HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L +L H LV L Y +D++ + LV + + G L HL ++ ++ I
Sbjct: 52 RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EI 109
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
L +LH + +I+RD K NILLD + ++DF +A T T GT
Sbjct: 110 VLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTP 163
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
GY APE + + D +S GV E L G+R +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
F LGEG +G V+K +E G VA+K + + +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53
Query: 192 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
+VK G ++ +V E+ GS+ + + + L I KGL
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+LH I+RD K NILL+ + AKL+DFG++ G D V+GT + AP
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAP 168
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
E + +++D++S G+ +EM G+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 69/232 (29%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 188
N LGEG FG V K +K G T VAVK L + ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---------------FRRSLP 233
L + H +++KL G C +D LL+ E+ GSL + L R S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 234 L------PWSIRMKI--ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285
L ++ I A ++G+ +L AE +++RD N+L+ K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
L++D E D ++ + A E + T++SDV+SFGV+L E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 194
LGEG FG V K E G P TVAVK L D + K+ L DLV
Sbjct: 19 PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATE--KD-------LSDLVSE 65
Query: 195 ---------HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSI 238
H N++ L+G C ++ +V E+ G+L + L R S P
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 239 RMKI--------ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290
+ A A+G+ FL A + I+RD N+L+ D+ K++DFGLA+D
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
D +T + APE + T +SDV+SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 81/293 (27%), Positives = 123/293 (41%), Gaps = 62/293 (21%)
Query: 123 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 182
LKL + LG G FG V+ G+ + VA+K+L G +
Sbjct: 6 ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47
Query: 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIR 239
+LAE N + L H LV+L + + ++ E+M GSL + L L + I
Sbjct: 48 FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPE 292
M A A+G+AF+ + I+RD + +NIL+ K++DFGLA+ E
Sbjct: 107 M--AAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161
Query: 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 350
G K + + APE + G T +SDV+SFG++L E++T R N E
Sbjct: 162 GAKFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
Query: 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
NL R YR+ P ++ +L C P+ RP
Sbjct: 214 QNL-----------ERGYRMPRPD-------NCPEELYELMRLCWKEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 137 LLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV 194
+LG G FG V+KG W+ E T + VA+K LN G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H +LV+L+G C+ +L V + MP G L +++ + + + + AKG+ +L
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 314
E R +++RD N+L+ + + K++DFGLA+ +K + + + A E +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 315 MTGHLTSRSDVYSFGVVLLEMLT 337
T +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 72/284 (25%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+F+ LG+G +G V+K + A+K ++ G KE VN +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ---------FYALKEVDL-GSMSQKEREDAVNEI 50
Query: 191 GDLVHLNLVKLIGY--CIEDDQRL-LVYEFMPRGSLENHLFRRSL---PLPWSIRMKIAL 244
L +N +I Y D +L +V E+ P G L + +R +P +I +
Sbjct: 51 RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+GL LHE + +++RD K++NILL A+ K+ D G++K K +++ +G
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
T Y APE + +SD++S G +L EM T + AR R
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARSMQDLR 210
Query: 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
+ R P + +S Q L PK RP ++
Sbjct: 211 YKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 193
E ++G G FG V +G ++ G + VA+KTL + +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H N++ L G + +++ EFM G+L++ L + + + G A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG---TYGYAA 310
+E ++RD NIL++++ K+SDFGL++ + T +G + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369
PE + TS SDV+S+G+V+ E+++ G R N +E + YR
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QDYR 229
Query: 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
L P + QL C +D ARP ++V L +
Sbjct: 230 LPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 39/289 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 196
LG+G FG V++G N +K VAVKT+N L+ E+L E + +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----------PLPWSIRMKIALGA 246
++V+L+G + L+V E M G L+++L RSL P P +++ I + A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPP-TLQEMIQMAA 126
Query: 247 --AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
A G+A+L+ + ++RD N ++ D+ K+ DFG+ +D E D + +
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
+ APE + G T+ SD++SFGVVL E+ + L E L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNE 228
Query: 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
+ ++D ++ L C +PK RP E+V LK
Sbjct: 229 QVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 55/284 (19%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGDLV 194
+G+G FG V K V+ G + K +++ + K+ L +EVN L +L
Sbjct: 8 IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 195 HLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRS----LPLP----WSIRMKIAL 244
H N+V+ I+ + L V E+ G L L ++ + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 245 GAAKGLAFLH--EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD---KTHVS 299
L H + V++RD K +NI LDA+ N KL DFGLAK KT+V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359
GT Y +PE + +SD++S G ++ E+ P AR
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-------SPPFT------ARN 214
Query: 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
L + R+ +S + ++ L+ DP RP
Sbjct: 215 QLQLASKIKEGKFRRIPYRYS----SELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 41/222 (18%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHDGLQGHKE---WLA 185
+F LG G FG V V+ G+G A+K L+ + K+ L
Sbjct: 1 DDFEFIKTLGTGSFGRVML----------VRHKGSGKYYALKILSKAKIVKLKQVEHVLN 50
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM--- 240
E L + H LV L G +DD L LV E++P G L +HL + P P + R
Sbjct: 51 EKRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA 108
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
++ L L +LH ++YRD K N+LLD+D K++DFG AK V
Sbjct: 109 QVVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKG 153
Query: 301 RVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 338
R GT Y APE ++ G+ D ++ G+++ EML G
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 195
+GEG FG V++G + VAVKT + +E +L E + H
Sbjct: 13 CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
++VKLIG ++ +V E P G L ++L L + + + + LA+L
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+ ++RD N+L+ + KL DFGL++ E + + +++ + APE +
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESIN 181
Query: 316 TGHLTSRSDVYSFGVVLLEML 336
TS SDV+ FGV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 41/218 (18%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 187
+LG+G FG V A +K GT AVK L D K LA
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSI--RMKIA 243
L L+ C + RL V E++ G L H+ R P + +I
Sbjct: 53 GKHPFLTQLHS------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 302
LG L FLHE R +IYRD K N+LLD++ + K++DFG+ K+G G T +
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STF 156
Query: 303 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
GT Y APE +++ + D ++ GV+L EML G+
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
+GEG +G V+K N TG VA+K + ++ KE + E+ L
Sbjct: 7 IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54
Query: 193 LVHLNLVKLIGYCIEDDQR--LLVYEFMP---RGSLENHLFRRSLPLPWSIR--MKIALG 245
L H N+V+L + +V+E+M G L++ + + I+ MK L
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLL- 110
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
+GL +LH +++RD K SNIL++ D KL+DFGLA+ + T + T
Sbjct: 111 --EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVIT 164
Query: 306 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
Y PE ++ D++S G +L E+ G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 45/273 (16%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V+ G W NG VAVKTL G + +L E + L H
Sbjct: 14 LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 253
LV+L + ++ +V E+M +GSL + L R+L LP + M A A G+A++
Sbjct: 62 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI 118
Query: 254 HEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAA 310
ER I+RD +++NIL+ K++DFGLA+ + + T R + + A
Sbjct: 119 ----ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTA 171
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
PE + G T +SDV+SFG++L E++T R N R L + R YR+
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRM 222
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
P+ +L C +DP+ RP
Sbjct: 223 PCPQ-------DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 31/275 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG G FG V G K + VA+K +N +G ++++ E + L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
LV+L G C + +V EFM G L N+L +R L + + + +G+ +L +
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 317
I+RD N L+ + K+SDFG+ + + D+ S+ ++ PE
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 318 HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 377
+S+SDV+SFGV++ E+ T + + + N E +VE R +RL P+L
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVE-------MISRGFRLYRPKLAS 227
Query: 378 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
+ + C P+ RP +E++ A+
Sbjct: 228 MTVYE-------VMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 55/284 (19%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 190
F +G+G FG V+K + T VA+K ++ + + E + E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
+ K G ++ + ++ E+ GS + L + L + I GL
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGL 111
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYG 307
+LHEE I+RD K +NILL + + KL+DFG++ G T ++ +GT
Sbjct: 112 EYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPF 163
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRR 366
+ APE + ++D++S G+ +E+ G P + H + R
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG------EPPLSDLHPM------------R 205
Query: 367 FYRLID----PRLEGH-FS--IKGAQKAAQLAAHCLSRDPKARP 403
LI P LEG+ FS K + CL++DPK RP
Sbjct: 206 VLFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDL-VH 195
LG G FG V +E K + VAVK L +E L +E+ + L H
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLH 254
N+V L+G C L++ E+ G L N L R R L + + AKG+AFL
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVMGTYGYAAP 311
A + I+RD N+LL K+ DFGLA+D D +V + R+ + AP
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVVKGNARL--PVKWMAP 212
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT 337
E + T SDV+S+G++L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 182
+L L+ F E LGE FG ++KG + G + VA+KTL + + Q E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53
Query: 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------- 231
+ E + + +L H N+V L+G ++ +++E++ +G L L RS
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 232 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
L + IA+ A G+ +L + +++D NIL+ + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+++ D V + + + PE +M G +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 19/190 (10%)
Query: 162 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 215
TG +AVK + N Q + E+ + L H ++++++G ED L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 216 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275
E+M GS+ +HL + ++ + +GL++LH E +I+RD K +N+L+D+
Sbjct: 83 EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDS 138
Query: 276 D-YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFG 329
+++DFG LA G + +++GT + APE V+ G RS DV+S G
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVG 195
Query: 330 VVLLEMLTGR 339
V++EM T +
Sbjct: 196 CVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 67/223 (30%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 183
+ LGEG + V+K +E G VA+K L DG+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIR--M 240
L E+ L +L H N++ L+ LV+EFM LE + +S+ L P I+ M
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM 108
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH- 297
+ L +GL +LH +++RD K +N+L+ +D KL+DFGLA+ P TH
Sbjct: 109 LMTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
Query: 298 VSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
V TR Y APE + H D++S G + E+L
Sbjct: 163 VVTRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 16/210 (7%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGD 192
E +LG G FG + +G ++ L VA+ TL G + +LAE LG
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRE------LPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
H N+V+L G + ++V E+M G+L++ L + L M + G A G+ +
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHVSTRVMGTYGYAAP 311
L +E +++ +L+++D K+S F L +D E T +S + +AAP
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAP 177
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
E + H +S SDV+SFG+V+ E+++ G R
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 131 NFRPESL-----LGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQG-HKEW 183
+ R E L LG G G V K VK TG +A K ++ K+
Sbjct: 1 DLRNEDLETISDLGAGNGGSVSK----------VKHIPTGTVMAKKVVHIGAKSSVRKQI 50
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L E+ + + +V G + ++ + EFM GSL+ ++++ P+P I KIA
Sbjct: 51 LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIA 109
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH-VSTRV 302
+ +GL +L+ +++RD K SNIL+++ KL DFG++ G+ + ++
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+GT Y +PE + G T +SDV+S G+ ++E+ G+
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 45/285 (15%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 184
++ + R + LG+G FG V+ G W NGT VA+KTL G + +L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 241
E + L H LV L + ++ +V EFM +GSL + L + L LP + M
Sbjct: 50 QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107
Query: 242 IALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
A A G+A++ ER I+RD + +NIL+ + K++DFGLA+ + + T
Sbjct: 108 -AAQIADGMAYI----ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---A 159
Query: 301 RVMGTY--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358
R + + APE + G T +SDV+SFG++L E++T R N R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------R 210
Query: 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
L + R YR+ P+ + +L C +DP RP
Sbjct: 211 EVLEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 32/291 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 189
N + + LG G FG VF + G V VK L E+ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIA 243
L H N+V+L+G C E + ++ E+ G L+ L + P P S + K+A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 244 LGA--AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
L A G+ L + ++RD N L+ + K+S L+KD + +
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRN 177
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
+ + APE V +++SDV+SFGV++ E+ T E L
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGL 222
Query: 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
+ RL +LE + +L C + +PK RP SE+V AL
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 195
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 240
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 52/222 (23%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
LG+G FG V+ +E G VA+K + + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53
Query: 193 L-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-----RRSLPLPWSIRMKIALGA 246
L H N+VKL E+D+ V+E+M E +L+ R+ P S+ I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD----GPEGDKTHVSTRV 302
+GLA +H+ +RD K N+L+ K++DFGLA++ P D +VSTR
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR- 162
Query: 303 MGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGR 339
Y APE + L S S D+++ G ++ E+ T R
Sbjct: 163 ----WYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG+G FG V+K TGL A K + + + ++++ E++ L + H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
+V L +++ ++ EF G+L++ + L + + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
VI+RD K NILL D + KL+DFG+ AK+ K +GT + APE V
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
Query: 317 GHLTS-----RSDVYSFGVVLLEMLTGR 339
++D++S G+ L+E+
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 57/302 (18%)
Query: 125 LKLATRNFRPESLL------GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ 178
L+L P S L GEG G V TG VAVK ++ Q
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58
Query: 179 GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 238
+ EV + D H N+V++ + D+ +V EF+ G+L + +
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--------IVTHT 110
Query: 239 RMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAK 288
RM + L K L+FLH + VI+RD K+ +ILL +D KLSDFG ++K
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167
Query: 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348
+ P ++GT + APE + + D++S G++++EM+ G P
Sbjct: 168 EVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP- 220
Query: 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
L +R + P+L+ K + + L RDP R +E+
Sbjct: 221 ------------LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAEL 266
Query: 409 VE 410
+
Sbjct: 267 LN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 22/217 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VH 195
LGEG FG V + E G +P +TVAVK L + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP---------------WSIRM 240
N++ L+G C ++ ++ E+ +G+L L R P P + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
A A+G+ +L R I+RD N+L+ D K++DFGLA+ + D ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 71/303 (23%), Positives = 125/303 (41%), Gaps = 58/303 (19%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 185
NF+ E +G+G F V+K +G VA+K + + K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE---NHLFRRSLPLP----WSI 238
E++ L L H N++K + IE+++ +V E G L H ++ +P W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+++ L +H + +++RD K +N+ + A KL D GL + KT
Sbjct: 112 FVQLC----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358
+ ++GT Y +PE + +SD++S G +L EM
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204
Query: 359 PHLGERRRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
P G++ Y L P H+S ++ L + C++ DP+ RP +S V++
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYS----EELRDLVSRCINPDPEKRPDISYVLQ 260
Query: 411 ALK 413
K
Sbjct: 261 VAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 195
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---------------LPWSIRM 240
N++ L+G C +D ++ E+ +G+L +L R P L + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + T +SDV+SFGV+L E+ T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 186
+L+G G FG V+ G + +G +AVK +++ + L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
+ L +L H N+V+ +G ++ D + E++P GS+ L ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVRNFVRQI 115
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR----- 301
KGL +LH R +I+RD K +NIL+D K+SDFG++K E + T
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPS 171
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+ G+ + APE V T ++D++S G +++EMLTG+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 58/211 (27%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 189
+ E ++G G FG V G ++ G + VA+KTL + + ++L+E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLKAGYTEKQRRDFLSEASI 58
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
+G H N++ L G + ++V E+M GSL+ L + + + G A G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTY 306
+ +L ++ ++RD NIL++++ K+SDFGL++ D PE T ++
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PI 173
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + TS SDV+S+G+V+ E+++
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 83/280 (29%), Positives = 129/280 (46%), Gaps = 45/280 (16%)
Query: 131 NFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
+ R E LG+G FG V+ G W NGT VA+KTL G + +L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 246
+ L H LV+L + ++ +V E+M +GSL + L + L LP + M A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQI 111
Query: 247 AKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
A G+A++ ER ++RD + +NIL+ + K++DFGLA+ + + T R
Sbjct: 112 ASGMAYV----ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAK 164
Query: 306 Y--GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
+ + APE + G T +SDV+SFG++L E+ T R N R L +
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQ 215
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
R YR+ P + + L C ++P+ RP
Sbjct: 216 VERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 194
+G G FG V+ N T VAVK +++ G Q +++W + EV FL L
Sbjct: 29 IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H N ++ G +++ LV E+ GS + L PL I GA +GLA+LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 314
+I+RD K NILL KL+DFG A K+ + +GT + APE +
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVI 189
Query: 315 MT---GHLTSRSDVYSFGVVLLEM 335
+ G + DV+S G+ +E+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 77/241 (31%), Positives = 106/241 (43%), Gaps = 40/241 (16%)
Query: 111 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 170
L + + NDL+ +G G G V+K ++ G +AVK
Sbjct: 3 LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46
Query: 171 TLNHDGLQGHKEWLAEVNFLGDL-VHL------NLVKLIGYCIEDDQRLLVYEFMPRGSL 223
+ G +KE + L DL V L +VK GY I D + E M L
Sbjct: 47 QMRRTG---NKEENKRI--LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CL 100
Query: 224 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283
+ L R P+P I K+ + K L +L E+ VI+RD K SNILLDA N KL D
Sbjct: 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCD 158
Query: 284 FGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYVMTGHLTS----RSDVYSFGVVLLEMLTG 338
FG++ G D K TR G Y APE + R+DV+S G+ L+E+ TG
Sbjct: 159 FGIS--GRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
Query: 339 R 339
+
Sbjct: 215 Q 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 69/209 (33%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 195
+GEG +G VFK E TG VA+K + D K L E+ L L H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
NLV LI ++L LV+E+ ++ N L + +P + KI + + F H
Sbjct: 60 PNLVNLI-EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 311
+ I+RD K NIL+ KL DFG A+ GP D T +V+TR Y AP
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 312 EYVMTGHLT--SRSDVYSFGVVLLEMLTG 338
E ++ G DV++ G V E+LTG
Sbjct: 170 E-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 56/157 (35%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 205 CIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 258
C + + RL V EF+ G L H+ R R LP +S + +AL FLHE
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHE--- 114
Query: 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTG 317
R +IYRD K N+LLDA+ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 318 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 352
D ++ GV++ EM+ GR D N + N
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 73/245 (29%), Positives = 100/245 (40%), Gaps = 57/245 (23%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 187
+F ++G G FG V+ TG A+K L + + AE
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MK 241
+ L D +VKL Y +D++ L LV E+MP G L N L R+ + + R +
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----- 296
+AL + L F+H RD K NIL+DAD + KL+DFGL K +
Sbjct: 112 LALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 297 -----------------HVSTRVM-----GTYGYAAPEYVMTGH-LTSRSDVYSFGVVLL 333
H RV GT Y APE V+ G D +S GV+L
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221
Query: 334 EMLTG 338
EML G
Sbjct: 222 EMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG G FG V+ G+ N T VAVKTL G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLH 254
LV+L +++ ++ E+M +GSL + L + LP I + A+G+A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMGTYG 307
+ I+RD + +N+L+ K++DFGLA+ EG K +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-------- 169
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + G T +SDV+SFG++L E++T
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 51/290 (17%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 186
LG G FGCV+K + NG +A+K +N K+ ++E
Sbjct: 7 HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 187 VNFLGD-LVHLNLVKLIGYCIEDDQRLLVYEFM---PRGSLENHLFRRSLPLP----WSI 238
V + + L H N+V+ +E+D+ +V + + P G N L + W+I
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+++ L L +LH+E + +++RD +NI+L D ++DFGLAK K
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358
T V+GT Y+ PE V ++DV++FG +L +M T P N++ A
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA- 222
Query: 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
+ + +P EG +S + + CL+ D +ARP + +V
Sbjct: 223 -----TKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 205 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 263
C + RL LV E++ G L H+ +R LP A L FLHE R +IY
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119
Query: 264 RDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 322
RD K N+LLDAD + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176
Query: 323 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIK 382
D ++ GV++ EM+ GR D N + N ++ + E+ R+ S+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPRFLSV- 228
Query: 383 GAQKAAQLAAHCLSRDPKAR 402
KA+ + L++DPK R
Sbjct: 229 ---KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 76/282 (26%), Positives = 115/282 (40%), Gaps = 49/282 (17%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 190
++ L+G G +G V++G TG VA+K +N D + EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 191 GDLVHL---NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK----I 242
L N+ K G RL ++ E+ GS+ R+L I K I
Sbjct: 54 SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVI 106
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
L ++H+ VI+RD K +NIL+ N KL DFG+A + ST V
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV 162
Query: 303 MGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
GT + APE + G +++D++S G+ + EM TG L+ ++P
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-- 219
Query: 362 GERRRFYRLIDPRLEG-HFSIKGAQKAAQLAAHCLSRDPKAR 402
PRLE +S + + A CL +PK R
Sbjct: 220 -----------PRLEDNGYS----KLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 189
NF+ LGEG + V+KG N T TG VA+K ++ D +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIRMKIALGA 246
+ +L H N+V+L +++ +LV+E+M + ++ H R +L L
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
KG+AF HE V++RD K N+L++ KL+DFGLA+ T + V T
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TL 164
Query: 307 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
Y AP+ ++ S S D++S G ++ EM+TGR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 141 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLN 197
G +G VF K TG A+K + + + L E + L
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 198 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
+VKL Y + + L LV E++P G L L L + L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS------TRVMGTYGYAA 310
+I+RD K NIL+D++ + KL+DFGL+K G + +++ R++GT Y A
Sbjct: 113 G---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 311 PEYVMTGHLTSRS-DVYSFGVVLLEMLTG 338
PE V+ G S++ D +S G +L E L G
Sbjct: 170 PE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 73/215 (33%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNHD-----GLQGH----KEWLAEV 187
LG GGFG V VK T A+K + G Q H KE L E
Sbjct: 1 LGVGGFGRVEL----------VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC 50
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
N H +VKL Y D++ +Y E+ G L L R L ++ R IA
Sbjct: 51 N------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIA- 100
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+LH R +IYRD K N+LLD++ KL DFG AK G KT G
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCG 154
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
T Y APE ++ D +S G++L E+LTGR
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 87/283 (30%), Positives = 128/283 (45%), Gaps = 58/283 (20%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 189
+LG+GG+G VF+ + + A TG A+K L + H + AE N
Sbjct: 2 KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 190 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP-----WSIRMKIA 243
L + H +V LI Y + +L L+ E++ G L HL R + + + + +A
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRV 302
L LH++ +IYRD K NILLDA + KL+DFGL K+ EG TH
Sbjct: 113 LE------HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---F 160
Query: 303 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
GT Y APE +M +GH D +S G ++ +MLTG A P
Sbjct: 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------APPFT 201
Query: 362 GERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKAR 402
E R+ + ID L+G ++ +A L L R+P +R
Sbjct: 202 AENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVK----PGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFL 190
+LG+G FG VF V+ P G A+K L L+ E + L
Sbjct: 3 VLGQGSFGKVFL----------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL 52
Query: 191 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
++ H +VKL Y + + +L L+ +F+ G L L + + ++ +A A
Sbjct: 53 AEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L LH +IYRD K NILLD + + KL+DFGL+K+ + +K S GT Y
Sbjct: 111 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 310 APEYV-MTGHLTSRSDVYSFGVVLLEMLTG 338
APE V GH S +D +SFGV++ EMLTG
Sbjct: 166 APEVVNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDL-VH 195
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRM-------------- 240
N++ L+G C +D ++ E+ +G+L +L RR + +S +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 71/237 (29%), Positives = 102/237 (43%), Gaps = 43/237 (18%)
Query: 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 185
R++ LGEG FG V+K + TG VA+K L H+ G L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56
Query: 186 EVNFLGDLVHLNLVKLIGYCIE-----DDQRLLVYEFMP------RGSLENHLFRRSLPL 234
E+ L L H N+V LI +E +R VY P G LEN + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES- 115
Query: 235 PWSIR--MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---- 288
I+ M L +G+ +LHE +++RD K +NIL+D K++DFGLA+
Sbjct: 116 --QIKCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 289 -----DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
G G T T ++ T Y PE ++ T+ D++ G V EM T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 83/282 (29%), Positives = 121/282 (42%), Gaps = 47/282 (16%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 188
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 189 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAA 109
Query: 248 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+ GL LH E +YRD K NILLD + ++SD GLA PEG+ + RV G
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-G 163
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
T GY APE + T D + G ++ EM+ G+ P G +
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRK 205
Query: 365 RRFYR-LIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 402
+ R +D R+ E +S K +++A + L++DPK R
Sbjct: 206 EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 82/276 (29%), Positives = 115/276 (41%), Gaps = 35/276 (12%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 188
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 189 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGA 246
L + V+ V + Y E D LV M G L+ H++ + A
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
GL LH+E ++YRD K NILLD + ++SD GLA PEG + RV GT
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 165
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
GY APE V T D ++ G +L EM+ G+ + + + VE
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214
Query: 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
RL+ ++ +S K + A L L +DPK R
Sbjct: 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 39/240 (16%)
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRM 240
L E+ L L H N++ + ++D+ L+ E+ G+L + + R+ +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
+ +A ++++H+ +++RD KT NI L KL DFG++K G + ++
Sbjct: 107 LFQIVSA--VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAE 159
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 354
V+GT Y +PE +SD+++ G VL E+LT +R+ D P NLV
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQG 216
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414
+ P + + + + L L +DP+ RP EV++
Sbjct: 217 NYT---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHL 196
LG G FGCV KG + + VA+K L ++ + E + E + L +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
+V++IG C E + +LV E G L L + + S +++ + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEYV 314
+ ++RD N+LL + AK+SDFGL+K D ++ R G + + APE +
Sbjct: 114 --KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 315 MTGHLTSRSDVYSFGVVLLEMLT 337
+SRSDV+S+G+ + E +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 67/260 (25%), Positives = 111/260 (42%), Gaps = 34/260 (13%)
Query: 163 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLI--GYCIEDDQRLLVYEF 217
TG VA+K L D + + + E L H N+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 218 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---D 274
+P +L L LP ++ L LA H + +++RD K NI++
Sbjct: 61 VPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 275 ADYNAKLSDFGLAKDGP---EGDKTHVS--TRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 329
+AK+ DFG+ P + D ++ T V+GT Y APE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 330 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 389
++ LE LTG+R + G ++ E L + P + GH Q
Sbjct: 177 LIFLECLTGQRVVQ-----GA-SVAEILYQQLSPVD---VSLPPWIAGH-------PLGQ 220
Query: 390 LAAHCLSRDPKARPLMSEVV 409
+ L++DP+ R + +
Sbjct: 221 VLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG+G FG V+K +E TG+ A K ++ + ++++ E++ L H N
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
+VKL+ ++ ++ EF G+++ + PL + + L +LHE
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG 317
+I+RD K NIL D + KL+DFG++ + S +GT + APE VM
Sbjct: 124 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 318 HLTSR-----SDVYSFGVVLLEM 335
R +DV+S G+ L+EM
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/224 (29%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 195
++GEG +G V+K + TG VA+K ++ +E E N L H
Sbjct: 13 VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 196 LNLVKLIG------YCIEDDQRLLVYEFMPRGSLEN-----HLFRRSLPLPWSIRMKIAL 244
N+ G DDQ LV E GS+ + + L W IA
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117
Query: 245 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 299
+GLA+LHE VI+RD K NILL + KL DFG++ D G + +
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG-RRNTF 173
Query: 300 TRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG 338
GT + APE + +RSDV+S G+ +E+ G
Sbjct: 174 I---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVH 195
LGEG FG V +G + ++ + L VAVKT+ +++L+E + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 196 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIAL 244
N+++LIG C++ + +++ FM G L + L L LP + +K
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
A G+ +L + + I+RD N +L+ + N ++DFGL+K GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ A E + T++SDV+SFGV + E+ T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 44/124 (35%), Positives = 73/124 (58%), Gaps = 7/124 (5%)
Query: 216 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275
E M GSL+ L +++ +P +I KI++ +GL +L E+ +++RD K SNIL+++
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNS 135
Query: 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
KL DFG++ G D ++ +GT Y +PE + H T +SD++S G+ L+EM
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 336 LTGR 339
GR
Sbjct: 192 AIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 188
+ ++G G FG V + V +K + + + + A E
Sbjct: 1 KYEKIRVVGRGAFGIV---HLCRRKADQKL------VIIKQIPVEQMTKDERLAAQNECQ 51
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLE-------NHLFRRSLPLPWSIRMK 241
L L H N+++ +ED ++V E+ P G+L N L L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTHVST 300
+A LH + +++RD KT NILLD K+ DFG++K K+ T
Sbjct: 112 LA---------LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT 160
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343
V+GT Y +PE +SD+++ G VL E+ + +R+ +
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 181
++ L+T F E LGE FG V+KG + GTAP + VA+KTL D +G +
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53
Query: 182 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------- 231
E+ E L H N+V L+G ++ +++ + L L RS
Sbjct: 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 232 -----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
L + + I A G+ FL + V+++D T N+L+ N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
++ D + + + +PE +M G + SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 67/209 (32%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLV 194
LG+GGFG E VK TG A K L+ L+ G K L E L +
Sbjct: 1 LGKGGFG--------EVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 195 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGL 250
+V L Y E L LV M G L+ H++ R L + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
LH ++YRD K N+LLD N +LSD GLA + +G T+ GT GY A
Sbjct: 109 LHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMA 162
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
PE + + D ++ G + EM+ GR
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 26/220 (11%)
Query: 127 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 184
L F+ +LG G FG V+KG WI P + VA+K L + +KE L
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWS 237
E + + + ++ +L+G C+ +L + + MP G L ++++ + L L W
Sbjct: 58 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-LNWC 115
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
+++ AKG+ +L E R +++RD N+L+ + K++DFGLAK +K +
Sbjct: 116 VQI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ + A E ++ T +SDV+S+GV + E++T
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 39/276 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG G FG V G K VA+K + +G E++ E + L H
Sbjct: 12 LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEK 60
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
LV+L G C + +V E+M G L N+L S +++ +G+A+L
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--- 117
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAPEYV 314
+ I+RD N L+D K+SDFGL++ D + S+ +G+ ++ PE +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVL 173
Query: 315 MTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373
+ +S+SDV++FGV++ E+ + G+ ++ N E VE + + R YR P
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KVSQGLRLYR---P 223
Query: 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 409
L ++K + C + RP +++
Sbjct: 224 HL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 71/220 (32%), Positives = 96/220 (43%), Gaps = 36/220 (16%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 182
FR ++LG G FG V A K TG A+K L + L K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
N H LV L C + + + V E+ G L H+ P R
Sbjct: 52 IFETAN---SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAV 104
Query: 242 I-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP-EGDKTHVS 299
A GL +LHE ++YRD K N+LLD + K++DFGL K+G GD+T S
Sbjct: 105 FYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTG 338
T GT + APE V+T +R+ D + GV++ EML G
Sbjct: 160 T-FCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-15
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG+G FG V+K +E TG A K + + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHE 255
+VKL+G D + ++ EF P G+++ + R L P I++ I + L +LH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+I+RD K N+LL D + KL+DFG++ + + S +GT + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVM 183
Query: 316 TGHLTS-----RSDVYSFGVVLLEM 335
+ ++D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 34/283 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 196
+G+G FG VFKG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
+ K G ++D + ++ E++ GS + L PL + I KGL +LH E
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE 120
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
+ I+RD K +N+LL KL+DFG+A G D +GT + APE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 317 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 376
S++D++S G+ +E+ G + P L+ P P LE
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLE 222
Query: 377 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419
G++S + + CL+++P RP E+++ + K
Sbjct: 223 GNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHL 196
+G G FG V G G + + V VK L +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 251
N+++ +G CIE LLV EF P G L+N+L + + ++A A GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLL 114
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+LH+ I+ D N L AD + K+ D+GLA + D + AP
Sbjct: 115 WLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171
Query: 312 EYV-------MTGHLTSRSDVYSFGVVLLEMLT 337
E V + T +S+++S GV + E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 194
+LG+G FG V + ++ G+ VAVK L D +E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 195 HLNLVKLIGYCIED--DQRL----LVYEFMPRGSLENHLFRRSL-----PLPWSIRMKIA 243
H N++KLIG + RL ++ FM G L L + LP ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
+ A G+ +L + + I+RD N +L+ + ++DFGL+K GD
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ A E + T+ SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 194
+G G FG V+ VA+K +++ G Q +++W + EV FL L
Sbjct: 23 IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H N ++ G + + LV E+ GS + L PL I GA +GLA+LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 314
I+RD K NILL KL+DFG A + +GT + APE +
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSAS------LVSPANSFVGTPYWMAPEVI 183
Query: 315 MT---GHLTSRSDVYSFGVVLLEM 335
+ G + DV+S G+ +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 41/98 (41%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 305
A GL FLH + +IYRD K N++LDA+ + K++DFG+ K+ G KT TR GT
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGT 164
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343
Y APE + D ++FGV+L EML G+ D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 36/223 (16%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 193
E ++GEG FG V + I+ K G + A+K L + H+++ E+ L L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 194 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR---------- 239
H N++ L+G C + E+ P G+L + L R+S L P +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 240 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
++ A A G+ +L +E+ I+RD N+L+ + +K++DFGL++ G++
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEV 171
Query: 297 HVSTRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+V + MG + A E + T++SDV+SFGV+L E+++
Sbjct: 172 YVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)
Query: 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 268
D LV E++ G + L + LP + G+ LH+ R +I+RD K
Sbjct: 70 DYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKP 125
Query: 269 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 328
N+L+D + KL+DFGL+++G + + +GT Y APE ++ SD +S
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSL 179
Query: 329 GVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 356
G V+ E L G P N + W
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 35/224 (15%)
Query: 132 FRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 189
LL EG FG +F G I+E KPG V VKT+ +H L E
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 190 LGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIRMK-- 241
L L H N++ ++ CIED + ++Y +M G+L+ LF + L P ++ +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQL 119
Query: 242 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPE-----G 293
+A+ A G+++LH+ R VI++D N ++D + K++D L++D P G
Sbjct: 120 VHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
D + + M A E ++ +S SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 68/212 (32%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV 194
LG+GGFG V A TG A K LN L +G++ + E L V
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAK-V 50
Query: 195 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK---GL 250
H + + Y + L LV M G L H++ P + A+ GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGTYG 307
LH+ R +IYRD K N+LLD D N ++SD GLA KDG K + GT G
Sbjct: 111 EHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPG 162
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+ APE + D ++ GV L EM+ R
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
+G G FG VF G + + T VAVK+ K ++L E L H
Sbjct: 3 IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES- 112
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 314
+ I+RD N L+ K+SDFG++++ E D + ST M + APE +
Sbjct: 113 --KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 315 MTGHLTSRSDVYSFGVVLLEMLT 337
G +S SDV+SFG++L E +
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 72/208 (34%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGDL 193
+G+G FG V + G AVK L + KE +AE N L ++
Sbjct: 3 IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGL 250
H LV L Y + +L V +++ G L HL R RS P P R + A A L
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
+LH +IYRD K NILLD+ + L+DFGL K+G E KT ++ GT Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
PE + D + G VL EML G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 50/297 (16%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 187
NFR E +G G F V++ +G VA+K + L + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIAL 244
+ L L H N++K IED++ +V E G L H ++ +P K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
L +H R V++RD K +N+ + A KL D GL + KT + ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
T Y +PE + +SD++S G +L EM P G++
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210
Query: 365 RRFYRLID--------PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
Y L P H+S ++ QL C++ DP+ RP ++ V + K
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 80/281 (28%), Positives = 119/281 (42%), Gaps = 45/281 (16%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 188
FR +LG+GGFG V + TG A K L ++ G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 189 FLGDLVHLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
L + V+ V + Y E D LV M G L+ H++ ++ P + AA
Sbjct: 53 IL-EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFDEQRAIFYAA 109
Query: 248 K---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+ GL L E ++YRD K NILLD + ++SD GLA PEG+ V RV G
Sbjct: 110 ELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-G 163
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
T GY APE + T D + G ++ EM+ G+ K + V+
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE------ 212
Query: 365 RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKAR 402
+D R+ + +S K ++ A + L+++PK R
Sbjct: 213 ------VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G G +G V+K G VA+K + + + E++ L + H N
Sbjct: 11 IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKIAL---GAAKGLAF 252
+V G + D+ +V E+ GSL++ + R L +IA KGLA+
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAY 116
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGYA 309
LHE I+RD K +NILL D + KL+DFG++ T + +GT +
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWM 168
Query: 310 APEYV---MTGHLTSRSDVYSFGVVLLEM 335
APE G + D+++ G+ +E+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 55/233 (23%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 189
+ +G G +G V V TG VA+K +++ D L K L E+
Sbjct: 2 YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 190 LGDLVHLNLVKLIGYCIEDDQRL------LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L L H N++ L+ + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDI-LRPPSPEDFNDVYIVTELM-----ETDLHK-------VIKSPQP 99
Query: 244 LGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPE 292
L +GL +LH VI+RD K SNIL++++ + K+ DFGLA+ P+
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 293 GDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
D+ +V TR Y APE +++ +++ D++S G + E+LT +
Sbjct: 157 EDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 84/307 (27%), Positives = 119/307 (38%), Gaps = 65/307 (21%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLV 194
L+GEG +G V K +E TG VA+K + D K + E+ L L
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H NLV LI + LV+EF+ L + L + L S K +G+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT-HVSTRVMGTYGYAAP 311
+I+RD K NIL+ KL DFG A+ P T +V+TR Y AP
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAP 169
Query: 312 EYVMTGHLTSRS-DVYSFGVVLLEMLTG---------------------------RRSMD 343
E ++ R+ D+++ G ++ EMLTG +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 344 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
KN L E + +RF P+L G LA CL DP RP
Sbjct: 230 KNPLFAGMRLPE-VKEIEPLEKRF-----PKLSG--------LVLDLAKQCLRIDPDDRP 275
Query: 404 LMSEVVE 410
S+++
Sbjct: 276 SSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
GL FLH+ + +IYRD K N+LLD D + K++DFG+ K+ G+ ++ GT Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE + D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 32/207 (15%)
Query: 205 CIEDDQRLL-VYEFMPRGSLENHLFR-RSLPLP----WSIRMKIALGAAKGLAFLHEEAE 258
C + + RL V E++ G L H+ R R LP +S + +AL +LHE
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE--- 114
Query: 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG 317
R +IYRD K N+LLD++ + KL+D+G+ K+G GD T + GT Y APE +
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 318 HLTSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGERRRFYRLIDPRL 375
D ++ GV++ EM+ GR D + N + N ++ + E++ R+
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------IRI 224
Query: 376 EGHFSIKGAQKAAQLAAHCLSRDPKAR 402
S+ KAA + L++DPK R
Sbjct: 225 PRSLSV----KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 127 LATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 184
L + +LG G FG V+KG WI P + VA+K L + + +KE L
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 57
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
E + + + +L+G C+ +L V + MP G L +++ + + +
Sbjct: 58 DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPE--GDKTHV 298
AKG+++L E +++RD N+L+ + + K++DFGLA+ D E D V
Sbjct: 117 QIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ M A E ++ T +SDV+S+GV + E++T
Sbjct: 174 PIKWM------ALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 186
NF+ +GEG +G V+K + TG VA+K + D G+ + E
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 243
++ L +L H N+VKL+ +++ LV+EF+ + F + P +P +
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---HQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
+GLAF H + R V++RD K N+L++ + KL+DFGLA+ G T +
Sbjct: 107 FQLLQGLAFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEV 161
Query: 304 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSM 342
T Y APE ++ + ++ D++S G + EM+T RR++
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 194
E LG G FG V+ ++ VAVKT+ G + +LAE N + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLA 251
H LVKL + + ++ EFM +GSL + L PLP I + A+G+A
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DGPEGDKTHVSTRVMG 304
F+ + R I+RD + +NIL+ A K++DFGLA+ EG K +
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----- 168
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 340
+ APE + G T +SDV+SFG++L+E++T R
Sbjct: 169 ---WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 39/278 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
LG G G V+K + T +AVK + D ++ K+ ++E+ L
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
++ G +++ + EFM GSL+ ++R+ +P + +IA+ KGL +L
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYLWS- 113
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
+++RD K SN+L++ KL DFG++ ++ +GT Y APE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG 167
Query: 317 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID---P 373
SDV+S G+ +E+ GR + + N + L + ++D P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKN---------QGSLMPLQLLQCIVDEDPP 218
Query: 374 RL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
L G FS +K C+ + PK RP +++
Sbjct: 219 VLPVGQFS----EKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 47/221 (21%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+LG+G FG VF A +K GT A+K L D V + D V
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKD-----------VVLMDDDVEC 41
Query: 197 NLV--KLIG-----------YCI--EDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSI 238
+V +++ YC + V E++ G L H+ + LP
Sbjct: 42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY 101
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+I G L FLH + ++YRD K NILLD D + K++DFG+ K+ GD
Sbjct: 102 AAEIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+ GT Y APE ++ + D +SFGV+L EML G+
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 42/198 (21%)
Query: 226 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285
++ + L +P I KIA+ K L +LH + VI+RD K SN+L++ + KL DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 286 --------LAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLL 333
+AK G K Y APE + +SDV+S G+ ++
Sbjct: 150 ISGYLVDSVAKTIDAGCKP-----------YMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 334 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAA 392
E+ TGR D W P + ++ P+L FS +
Sbjct: 199 ELATGRFPYDS-----------WKTP-FQQLKQVVEEPSPQLPAEKFSP----EFQDFVN 242
Query: 393 HCLSRDPKARPLMSEVVE 410
CL ++ K RP E+++
Sbjct: 243 KCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDL 193
+ ++GEG FG V K I+ K G + A+K + + H+++ E+ L L
Sbjct: 12 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 194 -VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA------LGA 246
H N++ L+G C L E+ P G+L + L R+S L IA L +
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 123
Query: 247 AKGLAFLHEEA-------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
+ L F + A ++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179
Query: 300 TRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 180 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 9e-14
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVH 195
++GEG FG V K I+ K G + A+K + + H+++ E+ L L H
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 196 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL---PWSIR------------ 239
N++ L+G C L E+ P G+L + L R+S L P
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 240 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ G + +V
Sbjct: 114 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 299 STRVMGTYG--YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ MG + A E + T+ SDV+S+GV+L E+++
Sbjct: 167 K-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 188
+ + +G+G G V+ TA + TG VA+K +N Q KE + E+
Sbjct: 19 KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
+ + H N+V + + D+ +V E++ GSL + + + + +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--GQIAAVCRECLQ 126
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 307
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT
Sbjct: 127 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPY 180
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
+ APE V + D++S G++ +EM+ G
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 14/141 (9%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262
Y + D +L L+ +++ G L HL++R +R+ IA L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ---LGII 127
Query: 263 YRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMT---G 317
YRD K NILLD++ + L+DFGL+K+ E ++ + GT Y APE + G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAPEVIRGGSGG 184
Query: 318 HLTSRSDVYSFGVVLLEMLTG 338
H D +S GV+ E+LTG
Sbjct: 185 H-DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
LG G FG V KG + + TVAVK L +D E L E N + L +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
+V++IG C E + +LV E G L L + +I ++ + G+ +L E
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEE 113
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY--GYAAPEY 313
++RD N+LL + AK+SDFGL+K D+ + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 314 VMTGHLTSRSDVYSFGVVLLE 334
+ +S+SDV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 187
N+R LLG+G FG V+ + V G L + + + KE A E+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55
Query: 188 NFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
L +L H +V+ G C+ D ++ L ++ E+MP GS+++ L + L S+ K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTR 113
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR-VM 303
+G+++LH +++RD K +NIL D+ N KL DFG +K + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
GT + +PE + ++DV+S G ++EMLT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 33/232 (14%)
Query: 118 RKFTFNDLKLATRNFR--PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 169
R + D ++A F+ PE L +G G FG V+ + + T V VA+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV-------VAI 55
Query: 170 KTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 226
K +++ G Q +++W + EV FL + H N ++ G + + LV E+ GS +
Sbjct: 56 KKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDL 114
Query: 227 LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
L PL I GA +GLA+LH +I+RD K NILL KL+DFG
Sbjct: 115 LEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS 171
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 335
A + +GT + APE ++ G + DV+S G+ +E+
Sbjct: 172 ASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 31/222 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 185
N+R LLG+G FG V+ + + TG +AVK + + + + KE A
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
E+ L +L+H +V+ G + +R L E MP GS+++ L + L ++ K
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYT 112
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKTH 297
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
V GT + +PE + ++D++S G ++EMLT +
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 184
+L +F S LG G G VFK KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
E+ L + +V G D + + E M GSL+ + +++ +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSI 110
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
KGL +L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
T Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L FLH VIYRD K NILLDA+ + KL+DFG+ K+G T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE + D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 34/274 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 196
+G+G FG V+KG +N T V VA+K ++ + + E + E+ L
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
+ + G ++ + ++ E++ GS + L + PL + I KGL +LH E
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE 120
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
+ I+RD K +N+LL + KL+DFG+A G D +GT + APE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 317 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE 376
++D++S G+ +E+ G P L+ P P LE
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 377 GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
G +S + + CL++DP+ RP E+++
Sbjct: 223 GQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 73/256 (28%), Positives = 100/256 (39%), Gaps = 58/256 (22%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 190
+G+GG+G VF K TG VA+K + L L EV L
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 191 GDLVHLNLVKLIGYCIEDDQRL-LVYEFMP----------RGSLENHLFRRSLPLPWSIR 239
LVKL+ Y +DD+ L L E++P G L R +
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM-----AE 109
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
M A+ A L ++H RD K N L+DA + KL+DFGL+K +
Sbjct: 110 MFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA 357
V+G+ Y APE V+ G + D +S G +L E L G + PN NL W
Sbjct: 156 NSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK 214
Query: 358 ----RPHLGERRRFYR 369
RP + R
Sbjct: 215 ETLQRPVYDDPRFNLS 230
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 192
+GEG +G V+KG TG VA+K + L+ +E + E++ L +
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI---RMKIAL-GAAK 248
L H N+V L +++ + L++EF+ L+ +L SLP + +K L +
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQ 112
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+ F H R V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 113 GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 309 AAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
APE ++ S D++S G + EM T +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 40/284 (14%)
Query: 134 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 186
PE L +G+G FG VFKG +N T V VA+K ++ + + E + E
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
+ L + K G ++ + ++ E++ GS + L R+ P +
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEI 110
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
KGL +LH E + I+RD K +N+LL + KL+DFG+A G D +GT
Sbjct: 111 LKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTP 165
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
+ APE + S++D++S G+ +E+ G P L+ P
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP------- 218
Query: 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
P L G FS + + CL++DP RP E+++
Sbjct: 219 ------PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 74/235 (31%), Positives = 103/235 (43%), Gaps = 43/235 (18%)
Query: 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGL 177
FT DLK +G G FG V K + +GT +AVK D
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEK 44
Query: 178 QGHKEWLAEVNFLGDLVH-----LNLVKLIGYCIEDDQRLLVYEFMPRGSLEN-----HL 227
+ K L ++ D+V +VK G + + E M SL+ +
Sbjct: 45 E-QKRLLMDL----DVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYE 98
Query: 228 FRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287
+S+ +P I KIA+ K L +L EE + +I+RD K SNILLD + N KL DFG++
Sbjct: 99 VLKSV-IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS 155
Query: 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGR 339
G D TR G Y APE + RSDV+S G+ L E+ TG+
Sbjct: 156 --GQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 134 PESL------LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 184
PE L +G G FG V+ N VA+K +++ G Q +++W +
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
EV FL L H N ++ G + + LV E+ GS + L PL +
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
GA +GLA+LH +I+RD K NILL KL DFG A + +G
Sbjct: 123 GALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANXFVG 173
Query: 305 TYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEM 335
T + APE ++ G + DV+S G+ +E+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 96/363 (26%), Positives = 143/363 (39%), Gaps = 68/363 (18%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 193
LLG+G FG V ++E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 250
H L L Y + RL V E+ G L HL R + +S GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSAL 108
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
+LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT Y A
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
PE + D + GVV+ EM+ GR L+ L E RF R
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPRT 218
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPK---------ARPLMS---------EVVEAL 412
+ P +A L + L +DPK A+ +M + V
Sbjct: 219 LSP------------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266
Query: 413 KPLPNLKDMASSS----YYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 468
K +P K +S Y+ + A+ I +P ++ + +R P SY
Sbjct: 267 KLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN-----ERRPHFPQFSY 321
Query: 469 ASP 471
++
Sbjct: 322 SAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
GL FLH + +IYRD K N++LD D + K++DFG+ K+ GD ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE + T D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 184
+L +F S LG G G V K KP +GL +A K ++ + + +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
E+ L + +V G D + + E M GSL+ + + + +P I K+++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSI 110
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+GLA+L E+ + +++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 111 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
T Y +PE + H + +SD++S G+ L+E+ GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
++G GGFG V+ K TG A+K L+ ++ + E L + + L
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIML 48
Query: 197 NLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
+LV + Y +L + + M G L HL + + +R A
Sbjct: 49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEII 107
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+G
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTHG 160
Query: 308 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353
Y APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 36/217 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 192
LG+G +G V+K + T VA+K + D + + A E+ FL +
Sbjct: 15 LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62
Query: 193 LV-HLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKIALGA 246
L H N+VKL+ E+D+ + LV+E+M E L R ++ R I
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQL 116
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVM 303
K L ++H VI+RD K SNILL++D KL+DFGLA+ + E + V T +
Sbjct: 117 LKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 304 GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
T Y APE ++ ++ D++S G +L EML G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 50/145 (34%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 195 HLNLVKLIGYCIEDDQRLL-VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H L +L C + RL V EF+ G L H+ ++S + A L FL
Sbjct: 55 HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEITSALMFL 112
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 313
H+ + +IYRD K N+LLD + + KL+DFG+ K+G KT ++ GT Y APE
Sbjct: 113 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEI 167
Query: 314 VMTGHLTSRSDVYSFGVVLLEMLTG 338
+ D ++ GV+L EML G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 162 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFM 218
GTG A+K L + K+ E + L +L H +V ++ ++++ + EF+
Sbjct: 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100
Query: 219 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278
G L HL R++ P + +LH + +IYRD K N+LLD +
Sbjct: 101 VGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGH 156
Query: 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 337
K++DFG AK P+ T + GT Y APE + + GH D ++ GV+L E +
Sbjct: 157 VKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIA 210
Query: 338 G 338
G
Sbjct: 211 G 211
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 85/275 (30%), Positives = 112/275 (40%), Gaps = 48/275 (17%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 193
LLG+G FG V + E T G A+K L + + E + E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 250
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF---YGAEIVSAL 108
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
+LH R V+YRD K N++LD D + K++DFGL K+G T + GT Y A
Sbjct: 109 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRF 367
PE + D + GVV+ EM+ GR + D R L E L E RF
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIRF 214
Query: 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
R + P +A L A L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 42/258 (16%)
Query: 163 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 222
TG VAVK ++ Q + EV + D H N+V + + D+ +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 223 LENHLFRRSLPLPWSIRMK------IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276
L + + RM + L + L++LH + VI+RD K+ +ILL +D
Sbjct: 106 LTD--------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSD 154
Query: 277 YNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 332
KLSDFG ++K+ P+ ++GT + APE + + D++S G+++
Sbjct: 155 GRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMV 208
Query: 333 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 392
+EM+ G + P L RR + PR++ + +
Sbjct: 209 IEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLD 253
Query: 393 HCLSRDPKARPLMSEVVE 410
L R+P R E+++
Sbjct: 254 LMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 163 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGS 222
+G VAVK ++ Q + EV + D H N+V++ + ++ ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 223 LENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279
L + + + L +IA + L +LH + VI+RD K+ +ILL D
Sbjct: 105 LTDIVSQTRLN-----EEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRV 156
Query: 280 KLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
KLSDFG ++KD P+ ++GT + APE + + D++S G++++EM
Sbjct: 157 KLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 336 LTG 338
+ G
Sbjct: 211 VDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 70/214 (32%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
FR +LG+GGFG V A TG A K L ++ K +N
Sbjct: 2 FRHYRVLGKGGFGEV---------CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 192 DLVHLN--LVKLIGYCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
L +N V + Y E D LV M G L+ H++ ++ P + AA+
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAE 110
Query: 249 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
GL LH E ++YRD K NILLD + ++SD GLA + PEG+ + RV GT
Sbjct: 111 ITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GT 164
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
GY APE V T D + G ++ EM+ G+
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 185
N+R LLG G FG V+ + + TG +AVK + + D + KE A
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 186 EVNFLGDLVHLNLVKLIGYCIED--DQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKI 242
E+ L +L H +V+ G C+ D +++L ++ E+MP GS+++ L + L ++ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRY 111
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------GPEGDKT 296
+G+++LH +++RD K +NIL D+ N KL DFG +K G K+
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
V GT + +PE + ++DV+S ++EMLT
Sbjct: 169 -----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 46/297 (15%)
Query: 131 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
NF+ E +G G F V++ + + +K V+ + ++ + E++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIRMKIALGA 246
L L H N++K + IED++ +V E G L + ++ +P K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+ +H R V++RD K +N+ + A KL D GL + KT + ++GT
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
Y +PE + +SD++S G +L EM P G++
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDKMN 212
Query: 367 FYRLID-------PRLEG-HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
+ L P L H+S +K +L + C+ DP RP + V + K +
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHYS----EKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 47/277 (16%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVH 195
++G GGFG V+ K TG A+K L+ ++ + E LA L + +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLA----LNERIM 47
Query: 196 LNLVKL--------IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L+LV + Y +L + + M G L HL + + +R A
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEI 106
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
GL +H R V+YRD K +NILLD + ++SD GLA D + K H S +GT+
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS---VGTH 159
Query: 307 GYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
GY APE + G S +D +S G +L ++L G +++ +H E
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----------EID 208
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
R + L FS + L L RD R
Sbjct: 209 RMTLTMAVELPDSFS----PELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 51/283 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+GEG G V A VK +G VAVK ++ Q + EV + D H N
Sbjct: 28 IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK------IALGAAKGLA 251
+V++ + D+ +V EF+ G+L + + RM + L K L+
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD--------IVTHTRMNEEQIAAVCLAVLKALS 130
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 307
LH + VI+RD K+ +ILL D KLSDFG ++K+ P ++GT
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPY 181
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367
+ APE + D++S G++++EM+ G P ++ R +L + +
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKN 238
Query: 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ P L+G L RDP R +E+++
Sbjct: 239 LHKVSPSLKGFLD------------RLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 27/162 (16%)
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHL-----FRRSLPLPWSI 238
E L ++ H +++L + E DQR L + E++P G L ++L F S L ++
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+ AL +LH + ++YRD K NILLD + + KL+DFG AK K
Sbjct: 109 EIVCAL------EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRD 153
Query: 299 STRVM-GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTG 338
T + GT Y APE + GH + D ++ G+++ EML G
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 187
+F +LG+G FG V A K GT A+K L D + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMK 241
L + + C + RL V E++ G L H+ F+ + ++ +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
+ GL FLH R +IYRD K N++LD++ + K++DFG+ K E V+TR
Sbjct: 112 V------GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTR 159
Query: 302 VM-GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343
GT Y APE + D +++GV+L EML G+ D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 35/94 (37%), Positives = 56/94 (59%), Gaps = 5/94 (5%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTY 306
+GL ++H V++RD K SN+LL+ + + K+ DFGLA+ PE D T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 307 GYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
Y APE ++ +++ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 192
++G+G FG V + +G AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 193 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGL 250
+ H LV L Y + ++L V +F+ G L HL R RS P P + R A A L
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
+LH ++YRD K NILLD+ + L+DFGL K+G T +T GT Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
PE + + D + G VL EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 69/263 (26%), Positives = 118/263 (44%), Gaps = 50/263 (19%)
Query: 85 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 144
P+++ SS+++S + S S +K EL+ R+ + +G G G
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELE---RVNR------------------IGSGAGG 88
Query: 145 CVFKGWIEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGDLVHLNLVKLI 202
V+K + TG A+K + NH+ ++ E+ L D+ H N+VK
Sbjct: 89 TVYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCH 138
Query: 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262
+ + ++ EFM GSLE L +A G+A+LH R ++
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR---RHIV 190
Query: 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAPEYVMTGHLTS 321
+RD K SN+L+++ N K++DFG+++ + D + S +GT Y +PE + T
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHG 247
Query: 322 R-----SDVYSFGVVLLEMLTGR 339
D++S GV +LE GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 68/207 (32%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGD 192
++G+G FG V + +G+ AVK L + KE +AE N L +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 193 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
L H LV L Y + ++L V +++ G L HL R L R A A +
Sbjct: 53 LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIG 110
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+LH +IYRD K NILLD+ + L+DFGL K+G E ++T ++ GT Y AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAP 165
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTG 338
E + D + G VL EML G
Sbjct: 166 EVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 52/230 (22%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 186
F + +GEG +G V++ +G VA+K + DG+ L E
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56
Query: 187 VNFLGDLVHLNLVKL---------------IGYCIEDDQRLLVYEFMPRGSLENHLFRRS 231
+ L +L H N+V+L + YC +D LL + MP
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103
Query: 232 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291
P S + L +GL +LHE +I+RD K SN+LL K++DFGLA+
Sbjct: 104 -PFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR--T 157
Query: 292 EGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGR 339
G T + T Y APE + T + T+ D+++ G +L E+L +
Sbjct: 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
+GEG +G V+K + TG VA+K + L+ E + E++ L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54
Query: 193 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA---- 247
L H N+V+L+ + + +L LV+EF+ L+ + S P L
Sbjct: 55 LNHPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSP-------LTGLDPPLIKS 103
Query: 248 ------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
+G+A+ H V++RD K N+L+D + KL+DFGLA+ G T
Sbjct: 104 YLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTH 158
Query: 302 VMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
+ T Y APE ++ S D++S G + EM+ R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 87/275 (31%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 193
LLG+G FG V + E T G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA--AKGL 250
H L L Y + RL V E+ G L HL R + R GA L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF---YGAEIVSAL 108
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG-PEGDKTHVSTRVMGTYGYA 309
+LH V+YRD K N++LD D + K++DFGL K+G +G GT Y
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYL 162
Query: 310 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRF 367
APE V+ + R+ D + GVV+ EM+ GR N +H L E L E RF
Sbjct: 163 APE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIRF 214
Query: 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
R + P +A L A L +DPK R
Sbjct: 215 PRTLSP------------EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+LG+G +G V+ A T + +A+K + + + E+ L H
Sbjct: 15 VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA--KGLAFLH 254
N+V+ +G E+ + E +P GSL L + PL + + I +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 255 EEAERPVIYRDFKTSNILLDADYNA--KLSDFG----LAKDGPEGDKTHVSTRVMGTYGY 308
+ +++RD K N+L++ Y+ K+SDFG LA P + GT Y
Sbjct: 126 DNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQY 175
Query: 309 AAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGR 339
APE + G + +D++S G ++EM TG+
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 47/229 (20%)
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAF 252
H ++V L G C+ D + ++V EF+ G L+ + R+S L PW + K+A A L++
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 253 LHEEAERPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDGPEGDKTHVSTR--VM 303
L ++ +++ + T NILL D + KLSD G+ V +R +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 304 GTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
+ APE V + +L+ +D +SFG L E+ NGE L + L
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216
Query: 363 ERRRFYRLIDPRLEGHFSI--KGAQKAAQLAAHCLSRDPKARPLMSEVV 409
E+ RFY EG + ++ A L HC++ DP RP ++
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI----RMKIALGAAKGLAFLHEEAE 258
Y +DD+ L +V E+MP G L N + +P W+ + +AL A + F+H
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 316
RD K N+LLD + KL+DFG T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 317 --GHLTSRSDVYSFGVVLLEMLTG 338
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
+GEG +G V+K T T+A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAA 247
+ H N+V+L + + LV+E++ L+ H+ F ++ L + +I
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----L 112
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+G+A+ H V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 307 GYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
Y APE ++ + H ++ D++S G + EM+ +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
+G G FG V G + +G P + V VK L +Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKG 249
NL++ +G C E LLV EF P G L+ +L RS P P +++ ++A A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-RMACEIALG 112
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L LH+ I+ D N LL AD K+ D+GL+ + + D ++ +
Sbjct: 113 LLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 310 APEYV--MTGHL-----TSRSDVYSFGVVLLEML 336
APE V + G+L T S+V+S GV + E+
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 24/172 (13%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 303
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
+ APE + T++SDV+SFGV+L E+ + S P + N R G
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGT 294
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
R R P + + C DPK RP S +VE L L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 65/191 (34%), Positives = 81/191 (42%), Gaps = 26/191 (13%)
Query: 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272
LV F+ G L +HL R R A + L L + VIYRD K NIL
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENIL 125
Query: 273 LDADYNAKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV 331
LD + L DFGL K + + DKT+ GT Y APE ++ T D ++ GV+
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 332 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLA 391
L EMLTG P + N+ E R L E RF D + A L
Sbjct: 183 LYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGFD------------RDAKDLL 224
Query: 392 AHCLSRDPKAR 402
LSRDP R
Sbjct: 225 IGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G+G G VF + TG VA+K +N + + E+ + +L + N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFLH 254
+V + + D+ +V E++ GSL + + + +IA + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCRECLQALEFLH 132
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEY 313
VI+RD K+ N+LL D + KL+DFG A+ PE K + ++GT + APE
Sbjct: 133 ANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 314 VMTGHLTSRSDVYSFGVVLLEMLTG 338
V + D++S G++ +EM+ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 41/125 (32%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 230 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289
RS PLP + I + LA+LH R +I+RD KT NI LD NA L DFG A
Sbjct: 178 RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234
Query: 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPN 348
T GT +PE + +++D++S G+VL EM ++ K +
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
Query: 349 GEHNL 353
L
Sbjct: 295 SSSQL 299
|
Length = 392 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 167 VAVKTLNHDGLQGHKEWLA----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFM 218
V ++T +GHK + E+ L + N++K+ G+ I+ L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 219 PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278
RG L L + L + ++ +A+ KGL L++ +P Y++ + + L+ +Y
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161
Query: 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEML 336
K+ GL K +V+ V Y + + + T + D+YS GVVL E+
Sbjct: 162 LKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
Query: 337 TGR 339
TG+
Sbjct: 217 TGK 219
|
Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 160 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 219
KPG V +K G +G L E L ++ H +++++ + +V +P
Sbjct: 87 KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137
Query: 220 --RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
L +L +RS PLP + I +GL +LH A+R +I+RD KT NI ++
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQR-IIHRDVKTENIFINDVD 194
Query: 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ D G A+ P + + GT APE + S++D++S G+VL EML
Sbjct: 195 QVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
Query: 338 GRRSMDKNRPNGEHNLVEWARPHL 361
++ ++ P+ V+ HL
Sbjct: 252 YPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)
Query: 205 CIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 258
C + RL V E++ G L + F+ + ++ + I GL FLH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG- 121
Query: 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTG 317
+IYRD K N++LD++ + K++DFG+ K E V+T+ GT Y APE +
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 318 HLTSRSDVYSFGVVLLEMLTGRRSMD 343
D ++FGV+L EML G+ +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 190
+GEG +G V+K TG VA+K + L KE + E+ L
Sbjct: 13 GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60
Query: 191 GDLVHLNLVKLIGYCIEDDQRL----------LVYEFMPR---GSLENHLFRRSLPLPWS 237
L H N+V L + L LV+E+M G LE+ L S S
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
MK L +GL + H+ + ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 121 F-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
+ +V+ T Y PE ++ + DV+S G +L E+ T +
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 47/145 (32%), Positives = 67/145 (46%), Gaps = 20/145 (13%)
Query: 204 YC-IEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEA 257
+C +DD+ L +V E+MP G L N + +P W + + +AL A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 316
RD K N+LLD + KL+DFG E T V GT Y +PE + +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 317 ---GHLTSRSDVYSFGVVLLEMLTG 338
G+ D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G+G G V+ + TG VA++ +N + + E+ + + + N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSNQ 136
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 317 GHLTSRSDVYSFGVVLLEMLTG 338
+ D++S G++ +EM+ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G+G G V+ + TG VA+K +N + + E+ + + + N
Sbjct: 27 IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
+V + + D+ +V E++ GSL + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSNQ 135
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
VI+RD K+ NILL D + KL+DFG A+ PE K + ++GT + APE V
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 189
Query: 317 GHLTSRSDVYSFGVVLLEMLTG 338
+ D++S G++ +EM+ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 58/252 (23%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGD 192
L+G+GG G V+ + P VA+K + D L K +L E D
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFR-----RSLPLPWSIR------ 239
L+H +V + Y I D VY MP G L + SL + +
Sbjct: 59 LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTH 297
+ I + ++H + V++RD K NILL + D+G A K E D
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 298 VST--------------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT------ 337
+ +++GT Y APE ++ + +D+Y+ GV+L +MLT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 338 ---GRRSMDKNR 346
GR+ ++
Sbjct: 233 RKKGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+GL ++H +I+RD K SNI ++ D K+ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 308 YAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGR 339
Y APE +M H D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 10/139 (7%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262
Y + D +L L+ +++ G L HL +R +++ L LH+ +I
Sbjct: 72 YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-EIVLALEHLHKLG---II 127
Query: 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHL 319
YRD K NILLD++ + L+DFGL+K+ E D+ + GT Y AP+ V GH
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRGGDGGH- 185
Query: 320 TSRSDVYSFGVVLLEMLTG 338
D +S GV++ E+LTG
Sbjct: 186 DKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 51/282 (18%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 193
LG+G F ++KG ++ V PG ++V +K L H++ LA + + L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H +LVKL G C+ D + ++V E++ G L+ L R + ++ +A A L +L
Sbjct: 59 SHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 254 HEEAERPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
++ +++ + NIL+ N KLSD G+ + R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 307 GYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
+ APE + G LT +D +SFG LLE+ + NGE L + E+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS---SEK 215
Query: 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAA---HCLSRDPKARP 403
RFY+ + H A+LA C + DP RP
Sbjct: 216 ERFYQ------DQH--RLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 75/285 (26%), Positives = 118/285 (41%), Gaps = 45/285 (15%)
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 243
+E++ L H +VK DD+ LL+ E+ G L + +R LP+ ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
L + + L E R +++RD K++NI L KL DFG +K + V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
GT Y APE + ++D++S GV+L E+LT RP G
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274
Query: 364 RRR------FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV--EALKPL 415
+R Y DP F + L LS++P RP +++ E LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329
Query: 416 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRS 460
NL FQ + SP+ R I Q L +G+R+
Sbjct: 330 ANL---------FQDIVRHSETISPHDREEILRQ---LQESGERA 362
|
Length = 478 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 19/144 (13%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW----SIRMKIALGAAKGLAFLHEEAE 258
Y +DD+ L +V E+MP G L N + +P W + + +AL A + F+H
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165
Query: 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-- 316
RD K N+LLD + KL+DFG + T V GT Y +PE + +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 219
Query: 317 --GHLTSRSDVYSFGVVLLEMLTG 338
G+ D +S GV L EML G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH-------LFRRSLPLPWSI 238
EV L + H N+V E+ + +V E+ G L LF L W +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTH 297
+I+LG L +H+ R +++RD K+ NI L + AKL DFG+A+ D
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
++ +GT Y +PE +++D++S G VL E+ T + + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 138 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 194
LGEG + VFKG + EN VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H N+V L D LV+E++ + L+ ++ + +GLA+ H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 314
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 176
Query: 315 M-TGHLTSRSDVYSFGVVLLEMLTGR 339
+ + +++ D++ G + EM +GR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWL 184
NF +LG G +G VF + + TG A+K L L H
Sbjct: 1 NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM--- 240
E N L + + + Y + + +L L+ +++ G + HL++R +R
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
+I L L LH+ ++YRD K NILLD++ + L+DFGL+K+ +K +
Sbjct: 113 EIILA----LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 301 RVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTG 338
GT Y APE + GH D +S G+++ E+LTG
Sbjct: 166 -FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGDLVH 195
+GEG +G VFK E T VA+K L+ D L E+ L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMP----------RGSLENHLFRRSLPLPWSIRMKIALG 245
N+V+L D + LV+E+ G ++ + + +
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-----------FQ 107
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
KGLAF H V++RD K N+L++ + KL+DFGLA+ G + + T
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162
Query: 306 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 340
Y P+ + L S S D++S G + E+ R
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 45/184 (24%)
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
L LH+ ++YRD K NILLDA + L DFGL+K +KT + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 310 APEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367
APE ++ G+ T D +S GV++ EM G W+ + + ++
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG-----------------WSPFYAEDTQQM 205
Query: 368 YRLID------PR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417
YR I P+ EG +KG L+R+P+ R LK P
Sbjct: 206 YRNIAFGKVRFPKNVLSDEGRQFVKG----------LLNRNPQHRLGAHRDAVELKEHPF 255
Query: 418 LKDM 421
D+
Sbjct: 256 FADI 259
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVH 195
LG+G +G V+K +P TG+T+A+K + + L K + + E++ L V
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGAAKGLAF 252
+V G + + E+M GSL+ L+ + +P + +I KGL F
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 311
L EE +I+RD K +N+L++ + KL DFG++ + KT++ G Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170
Query: 312 EYVMTGHLTSR------SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
E + +G SDV+S G+ +LEM GR P N+
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFA---------- 217
Query: 366 RFYRLID---PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ ++D P L +S A A CL++ P RP ++++E
Sbjct: 218 QLSAIVDGDPPTLPSGYS----DDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 24/160 (15%)
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGL 250
N+V L Y + +D LV + G L +H+ + L +P W+ M +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDA---- 100
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYA 309
LH E ++ RD +NILLD + +L+ F + D V Y
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 349
APE T D +S G +L E+LTG +++ + P+G
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 33/219 (15%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 187
+ P + +G G +G V+K P +G VA+K++ N DGL + EV
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50
Query: 188 NFLGDLVHL---NLVKLIGYC--IEDDQRL---LVYEFMPRGSLENHLFRRSLP-LPWSI 238
L L N+V+L+ C D+ LV+E + + L +L + P LP
Sbjct: 51 ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162
Query: 299 S-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 336
+ T V+ T Y APE ++ + D++S G + EM
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/175 (33%), Positives = 79/175 (45%), Gaps = 10/175 (5%)
Query: 168 AVKTLNHDGLQGHKE---WLAEVN-FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL 223
AVK L + KE ++E N L ++ H LV L D+ V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 224 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283
HL R L R A A L +LH ++YRD K NILLD+ + L+D
Sbjct: 84 FYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTD 139
Query: 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
FGL K+ E + T ++ GT Y APE + D + G VL EML G
Sbjct: 140 FGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 20/207 (9%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL 193
LLG+G FG V + E + G A+K L + + E L E L +
Sbjct: 2 LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
H L L Y + RL V E++ G L HL R + R A L +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
LH ++YRD K N++LD D + K++DFGL K+G T + GT Y APE
Sbjct: 111 LHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+ D + GVV+ EM+ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 62/240 (25%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 188
++P +G G +G V + +G VA+K + H D K L E+
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRR 230
L H N++ I D R +V + M L R
Sbjct: 57 ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111
Query: 231 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-- 288
L + + +GL ++H VI+RD K SN+L++ D ++ DFG+A+
Sbjct: 112 FL---YQL--------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 289 -DGPEGDKT----HVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSM 342
P K +V+TR Y APE +++ + + D++S G + EML GRR +
Sbjct: 158 SSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 163 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMP 219
TG VA+K + K E+ L L H N++ L I + + V E +
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 220 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279
+ H S PL +GL ++H V++RD K SNIL++ + +
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL 147
Query: 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTG 338
K+ DFGLA+ +VSTR Y APE ++T D++S G + EML G
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 339 R 339
+
Sbjct: 203 K 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 184
+ + + +GEG +G VFK +NG G VA+K + +Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 185 ---AEVNFLGDLVHLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLP-LP 235
A + L H N+V+L C + + LV+E + + L +L + P +P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108
Query: 236 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 295
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSF 162
Query: 296 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
T V+ T Y APE ++ + D++S G + EM +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 49/151 (32%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
+H + +I+RD K++NILL ++ KL DFG +K V GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372
+ ++D++S GV+L E+LT +R D GE N+ E L R D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR------YD 263
Query: 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
P L S + ++ LS DPK RP
Sbjct: 264 P-LPPSIS----PEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
LGEG + VFKG + T VA+K + + +G + EV+ L +L H
Sbjct: 13 LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
N+V L + LV+E++ L+ +L + +GL++ H+
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK- 121
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM- 315
R +++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ ++
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177
Query: 316 TGHLTSRSDVYSFGVVLLEMLTGR 339
+ ++ D++ G +L EM TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 191
+ +GEG +G V+K TG VA+K L+ +G+ L E+ L
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53
Query: 192 DLV---HLNLVKLIGYC--IEDDQRL---LVYEFMPR---GSLENHLFRRSLPLPWSIR- 239
L H N+V+L+ C D+ L LV+E + + L + LP P +I+
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP-KPGLP-PETIKD 111
Query: 240 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
M+ L +G+ FLH +++RD K NIL+ +D K++DFGLA+
Sbjct: 112 LMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMA 162
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
T V+ T Y APE ++ + D++S G + E+
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 32/93 (34%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+GL +LH +++RD K N+L++++ K+ DFGLA+ + H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 308 YAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
Y APE +M + H TS D++S G + E+L R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
LGEG + V+KG NG VA+K ++ +G + E + L L H
Sbjct: 13 LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 255
N+V L + V+E+M L ++ + L P+++R+ +GLA++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG 121
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+ +++RD K N+L+ KL+DFGLA+ +T+ S V T Y P+ ++
Sbjct: 122 ---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 316 -TGHLTSRSDVYSFGVVLLEMLTGR 339
+S D++ G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 46/282 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
+GEG FG +E+G V +K +N + +E EV L ++ H
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSIRMKIALGAAK 248
N+V+ E+ +V ++ G L LF L W +++ +AL
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
+H+ R +++RD K+ NI L D KL DFG+A+ ++ +GT Y
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYY 167
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
+PE ++SD+++ G VL EM T + + + NLV L R Y
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV------LKIIRGSY 218
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
P + H+S +QL R+P+ RP ++ ++E
Sbjct: 219 ----PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 61/260 (23%), Positives = 120/260 (46%), Gaps = 39/260 (15%)
Query: 92 STTTSNAESNSSTSKLEEELKVASRLRKFTFNDL-KLATRNFRPESLLGEGGFGCVFKGW 150
N++ + E+E K+ ND+ + ++++ +++G G FG V++
Sbjct: 34 KLDEEERSHNNNAGEDEDEEKMID-------NDINRSPNKSYKLGNIIGNGSFGVVYEA- 85
Query: 151 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY----CI 206
+ T VA+K + D ++E L + +L H+N++ L Y C
Sbjct: 86 --------ICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYYTECF 133
Query: 207 EDDQRLL----VYEFMPRG--SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 260
+ +++ + V EF+P+ H R + LP + + + LA++H +
Sbjct: 134 KKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--- 190
Query: 261 VIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGH 318
+ +RD K N+L+D + + KL DFG AK+ G + S + + Y APE ++ +
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATN 247
Query: 319 LTSRSDVYSFGVVLLEMLTG 338
T+ D++S G ++ EM+ G
Sbjct: 248 YTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 81/296 (27%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
F L+G G +G V+KG VK TG A+K ++ G + +E E+N L
Sbjct: 8 FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57
Query: 192 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 241
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
I +GL+ LH+ VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 168
Query: 302 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354
+GT + APE + +SD++S G+ +EM G + P L+
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
R PRL+ S K ++K CL ++ RP ++++
Sbjct: 229 P-------------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 26/145 (17%)
Query: 231 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290
S PL ++ + A+G+ FL A + I+RD N+LL AK+ DFGLA+D
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARD- 261
Query: 291 PEGDKTHVSTRVMGT----YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
D +V V G + APE + T +SDV+S+G++L E+ S+ K+
Sbjct: 262 IMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGKS- 313
Query: 347 PNGEHNLVEWARPHLGERRRFYRLI 371
P + +FY+++
Sbjct: 314 ----------PYPGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 53/170 (31%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
AKG+ FL A R I+RD NILL + K+ DFGLA+D +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGERR 365
+ APE + T +SDV+SFGV+L E+ S+ + G E+ R G R
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF----SLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
R P + Q C +P RP SE+VE L L
Sbjct: 302 RAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 308 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 339
Y APE ++ H D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 140 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGDLV 194
EG +G V++ TG VA+K L + KE L E+N L L
Sbjct: 15 EGTYGVVYRA---------RDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 195 HLNLVKL----IGYCIEDDQRLLVYEFMP---RGSLENHLFRRSLPLPWSIR-----MKI 242
H N+V + +G + D+ +V E++ + +E P+ M
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM------KQPFLQSEVKCLMLQ 114
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
L G+A LH+ +++RD KTSN+LL+ K+ DFGLA+ G T++
Sbjct: 115 LL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQL 166
Query: 303 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
+ T Y APE ++ ++ D++S G + E+LT +
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGDLV 194
LGEG + V+KG + G VA+K L H+ +G + E + L DL
Sbjct: 13 LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRG---SLENHLFRRSLPLPWSIRM---KIAL-GAA 247
H N+V L LV+E++ +++ + M ++ L
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--------GGGLSMHNVRLFLFQLL 113
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+GLA+ H+ R V++RD K N+L+ KL+DFGLA+ KT+ + V T
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168
Query: 308 YAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGR 339
Y P+ ++ T + TS D++ G + EM TGR
Sbjct: 169 YRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 62/232 (26%)
Query: 139 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVH 195
G G +G V+K G A+K D Q + E+ L +L H
Sbjct: 9 GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 196 LNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLF----------RRSLP------LPWS 237
N+V L+ +E + L++++ E+ L+ R S+P L W
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGP 291
I G+ +LH V++RD K +NIL+ + K+ D GLA+ + P
Sbjct: 117 I--------LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 292 -----EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 337
+ D V+ T Y APE ++ H T D+++ G + E+LT
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 62/228 (27%), Positives = 90/228 (39%), Gaps = 26/228 (11%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 183
K+ +F LG G FG V A K VA+K + K+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77
Query: 184 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 242
+E L + H V L G ++ LV EF+ G L RR+ P +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG--- 133
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR- 301
AA+ + ++YRD K N+LLD D K++DFG AK V TR
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRT 185
Query: 302 --VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347
+ GT Y APE ++ +D ++ G+ + E+L G N P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 138 LGEGGFGCVFKGW--IEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLV 194
LGEG + V+KG + +N VA+K + + +G + EV+ L DL
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H N+V L + LV+E++ + L+ +L + +GL + H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 314
R V++RD K N+L++ KL+DFGLA+ KT+ + V T Y P+ +
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 315 M-TGHLTSRSDVYSFGVVLLEMLTGR 339
+ + +++ D++ G + EM TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 69/240 (28%), Positives = 101/240 (42%), Gaps = 46/240 (19%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
+G+G FG VFK A K T VA+K + ++ KE L E+ L
Sbjct: 20 IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67
Query: 193 LVHLNLVKLIGYCIEDDQR--------LLVYEFMPR---GSLENHLFRRSLPLPWSIRMK 241
L H N+V LI C LV+EF G L N + +L + MK
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTHVS 299
+ L GL ++H +++RD K +NIL+ D KL+DFGLA+ + K +
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354
T + T Y PE + L R D++ G ++ EM T M N + L+
Sbjct: 181 TNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 308 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 339
Y APE ++ H T D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 59/245 (24%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 183
DL + RP LG G G VF + V VAVK + Q K
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49
Query: 184 LAEVNFLGDLVHLNLVKL--------------IGYCIEDDQRLLVYEFMP--------RG 221
L E+ + L H N+VK+ +G E + +V E+M +G
Sbjct: 50 LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 222 SL-ENH--LFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DY 277
L E H LF L +GL ++H V++RD K +N+ ++ D
Sbjct: 110 PLSEEHARLFMYQL--------------LRGLKYIHSAN---VLHRDLKPANVFINTEDL 152
Query: 278 NAKLSDFGLAK--DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLE 334
K+ DFGLA+ D K ++S ++ + Y +P +++ + T D+++ G + E
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAE 211
Query: 335 MLTGR 339
MLTG+
Sbjct: 212 MLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
GL ++H +I+RD K N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 308 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 339
Y APE ++ H D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 68/224 (30%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
F ++G G +G V+KG VK TG A+K ++ + +E E+N L
Sbjct: 18 FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67
Query: 192 DLVH-LNLVKLIGYCIE------DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMK 241
H N+ G I+ DDQ LV EF GS+ + + +L W
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AY 125
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
I +GLA LH VI+RD K N+LL + KL DFG++ + D+T V R
Sbjct: 126 ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 178
Query: 302 --VMGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 338
+GT + APE + RSD++S G+ +EM G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 67/259 (25%), Positives = 99/259 (38%), Gaps = 76/259 (29%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEV-- 187
+F ++G G FG V K TG A+K L + L+ KE +A V
Sbjct: 2 DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 188 --NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI-- 242
+ L + + +VKL Y +D+ L L+ E++P G + L ++ R I
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 243 ---ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHV 298
A+ + L ++H RD K N+LLDA + KLSDFGL G K+H
Sbjct: 110 TILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHR 156
Query: 299 ST----------------------------------RVM-----GTYGYAAPEYVMTGHL 319
+ R + GT Y APE +
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216
Query: 320 TSRSDVYSFGVVLLEMLTG 338
D +S GV++ EML G
Sbjct: 217 NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
+ P +G G +G V + T VA+K + + D K L E
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENH-LFRRSLPLPWSIR 239
+ L L H N++ + + R +VYE M + H + R S L
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
+GL ++H V++RD K SN+LL+A+ + K+ DFGLA+ +K
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFM 165
Query: 300 TRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
T + T Y APE ++ T+ DV+S G + E+L +
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGDLV-H 195
+G+G +G V+K +++G+ AVK L D + E + AE N L L H
Sbjct: 30 IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78
Query: 196 LNLVKLIGYCIEDD-----QRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGAA 247
N+VK G + D Q LV E GS L L L ++ I GA
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 302
GL LH +I+RD K +NILL + KL DFG++ STR+
Sbjct: 139 LGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTS 188
Query: 303 MGTYGYAAPEYVMTGH-----LTSRSDVYSFGVVLLEMLTG 338
+GT + APE + +R DV+S G+ +E+ G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
AKG++FL A + I+RD NILL K+ DFGLA+D V
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
+ APE + T SDV+S+G++L E+ + L P + +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325
Query: 367 FYRLIDPRLEGH--FSIKGA-QKAAQLAAHCLSRDPKARPLMSEVVE 410
FY++I EG+ S + A + + C DP RP ++V+
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLV- 194
+G+G +G VFK ++NG+ AVK L+ HD +E AE N L L
Sbjct: 26 IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73
Query: 195 HLNLVKLIG-YCIED----DQRLLVYEFMPRGS---LENHLFRRSLPLPWSIRMKIALGA 246
H N+VK G Y +D DQ LV E GS L +R + I I A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
GL LH I+RD K +NILL + KL DFG++ +GT
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTP 188
Query: 307 GYAAPEYV-----MTGHLTSRSDVYSFGVVLLEMLTG 338
+ APE + + +R DV+S G+ +E+ G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 65/247 (26%), Positives = 92/247 (37%), Gaps = 55/247 (22%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 186
++F+ LLG+G G VF + GT + A+K L+ + + L E
Sbjct: 1 KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIA 243
L L H L L + LV ++ P G L + P L +
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEV---AR 106
Query: 244 LGAAK---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------ 288
AA+ L +LH ++YRD K NILL + LSDF L+K
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 289 --DGPEGDKTH----------VSTRVM---GTYGYAAPEYVM-TGHLTSRSDVYSFGVVL 332
G + S R GT Y APE + GH S D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222
Query: 333 LEMLTGR 339
EML G
Sbjct: 223 YEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 189
F ++GEG +G V K +E T VA+K + + + KE L E+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---LPWSIRMKIALGA 246
L L N+V+L + LV+E++ + LE +P P +R I
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI-YQL 109
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
K + + H+ +++RD K N+L+ + KL DFG A++ EG + T + T
Sbjct: 110 IKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATR 165
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
Y +PE ++ D++S G +L E+ G+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV---STRVM 303
A+G+ FL A R I+RD NILL + K+ DFGLA+D + D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARL- 237
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + T++SDV+SFGV+L E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 36/258 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 195
+G G FG V I TG+ V VK L + + E+L + + L H
Sbjct: 3 IGNGWFGKVLLSEI--------YTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL------FRRSLPLPWSIRMKIALGAAKG 249
N+++ +G C+E LLV+E+ G L+++L R S L + ++A A G
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAG 111
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
+ +H+ ++ D N L +D K+ D+G+ + D +
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 310 APEYV-------MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
APE V +T T S+V++ GV L E+ +N +L + +
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLNHV 221
Query: 363 ERRRFYRLIDPRLEGHFS 380
+ + +L P+LE +S
Sbjct: 222 IKDQQVKLFKPQLELPYS 239
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 34/102 (33%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGT 305
GL ++H V++RD K N+L++AD K+ DFGLA+ + P + + T + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 306 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNR 346
Y APE +++ +++ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 79 DTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLL 138
++ D P+ A S + + + + L A K +D LA +FR L
Sbjct: 103 ASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQA----KLKHDDEFLA--HFRVIDDL 156
Query: 139 GEGGFG----CVFKGWIEE-------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 187
G FG C + EE N T KP +A + E E+
Sbjct: 157 PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--NEI 214
Query: 188 NFLGDLVHLNLVKL--------IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR 239
LG L H N++K+ Y I +Y FM + + + PL R
Sbjct: 215 LALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQTR 270
Query: 240 --MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
MK L A + ++H+ + +I+RD K NI L+ D L DFG A E ++
Sbjct: 271 AIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREA 323
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+GT +PE + +D++S G++LL+ML+
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 74/304 (24%), Positives = 121/304 (39%), Gaps = 47/304 (15%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 189
++ + ++G+G +G V + + TG VA+K +N + + L E+
Sbjct: 2 YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 190 LGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
L L H ++V++ + +R +V+E M S + + + + L
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTHVST 300
+ L ++H V +RD K NIL +AD K+ DFGLA+ D P T
Sbjct: 111 QLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP---TAIFWT 164
Query: 301 RVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N 352
+ T Y APE + T D++S G + E+LTG+ N H +
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITD 222
Query: 353 LVEWARPHLGER------RRFYRLIDPRLEGHFSIK---GAQKAAQLAAHCLSRDPKARP 403
L+ P R RR+ + + FS K A +L L+ DPK RP
Sbjct: 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282
Query: 404 LMSE 407
E
Sbjct: 283 TAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 186 EVNFLGDLVHLNLVKLI-GYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIA 243
E L L H N+V + ED +V F G L + L ++ LP + ++
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
+ A L +LHE+ +++RD KT N+ L K+ D G+A+ ++ +++ ++
Sbjct: 109 VQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
GT Y +PE +SDV++ G + EM T + + + N +LV
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 409
YR+I+ +L + + +L A LS+ P+ RP + ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/143 (30%), Positives = 62/143 (43%), Gaps = 11/143 (7%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262
Y +D L LV E+ P G L + L R + A+ + +H + +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYV 124
Query: 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY--VMTGHLT 320
+RD K N+L+D + KL+DFG A +K S +GT Y APE M G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 321 SRSDV----YSFGVVLLEMLTGR 339
V +S GV+ EM+ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 42/221 (19%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
++ +GEG F V K + G A+K + H + L +VN L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46
Query: 192 DLV-------HLNLVKLIGYCIEDDQ--RL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
++ H N+++LI + D + RL LV+E M +L + R PLP
Sbjct: 47 EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS 104
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGPEGDKTH 297
K L +H + +RD K NIL+ D KL+DFG + P + +
Sbjct: 105 YMYQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTE--Y 158
Query: 298 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT 337
+STR Y APE ++T G+ + D+++ G V E+L+
Sbjct: 159 ISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+GL ++H +I+RD K SN+ ++ D ++ DFGLA+ + +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 308 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGR 339
Y APE ++ H D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
LGEG + V+KG + NG VA+K + +G + E + L L H
Sbjct: 13 LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHE 255
N+V L + LV+E++ L ++ + L P ++++ + +GL+++H+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIHQ 121
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
R +++RD K N+L+ KL+DFGLA+ + +H + + T Y P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 316 -TGHLTSRSDVYSFGVVLLEMLTG 338
+ ++ D++ G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 39/220 (17%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGDL 193
+GEG +G V+K TG VA+K ++ +G+ L E++ L L
Sbjct: 9 IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 194 VHLN-LVKLIGYCIEDDQR-------LLVYEFMP---RGSLENHLFRRSLPLPWSIRMKI 242
+V+L+ +E + LV+E++ + ++++ PLP
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG--PEGDKTHVS 299
KG+A H+ V++RD K N+L+D K++D GL + P TH
Sbjct: 116 MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170
Query: 300 TRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 338
+ T Y APE ++ H ++ D++S G + EM
Sbjct: 171 --EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 63/251 (25%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+F ++G G FG V K TG A+K L + KE +A +
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAE 51
Query: 191 GD-LVHLN---LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKI--- 242
D LV + +VK+ Y +D + L L+ EF+P G + L ++ + + I
Sbjct: 52 RDILVEADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 243 --ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------------- 287
A+ A L F+H RD K N+LLDA + KLSDFGL
Sbjct: 111 VLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 288 --KDGPEGD------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYS 327
P D + ++ +GT Y APE M D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 328 FGVVLLEMLTG 338
GV++ EML G
Sbjct: 222 LGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 66/252 (26%), Positives = 96/252 (38%), Gaps = 65/252 (25%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-DGLQ----GHKEWLA 185
+F ++G G FG V K TG A+K L D L+ GH A
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--A 50
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA- 243
E + L + L +VK+ Y +D L L+ EF+P G + L ++ + IA
Sbjct: 51 ERDILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 244 ----LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--- 296
+ + L F+H RD K N+LLD+ + KLSDFGL + +T
Sbjct: 110 TVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 297 ------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVY 326
++ +GT Y APE M D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 327 SFGVVLLEMLTG 338
S GV++ EML G
Sbjct: 221 SLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G G +G V+K TG A+K + + + E+ + D H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA 257
+V G + D+ + EF GSL++ ++ + PL S ++ +GL +LH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT- 316
+ ++RD K +NILL + + KL+DFG++ S +GT + APE
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVE 181
Query: 317 --GHLTSRSDVYSFGVVLLEM 335
G D+++ G+ +E+
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 305
A+G+ FL A + ++RD N+LL K+ DFGLA+D D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMH-DSNYVSKGSTFLP 302
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
+ APE + T+ SDV+S+G++L E+ + L P +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS---------------LGGTPYPGMIVDS 347
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEALKP 414
FY I Q+ + C + +P+ RP +S++VE+L P
Sbjct: 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE ++ D++S G ++ EM+ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 138 LGEGGFGCVFKGWIEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGD 192
LGEG +G V K + G VK K G+ G H L E+ + +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
+ H N++ L+ +E D LV + M L+ + R + L S I L GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGLNV 134
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DGPEGDKTHVSTRVMG 304
LH+ ++RD +NI +++ K++DFGLA+ D D+T M
Sbjct: 135 LHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 305 ----TYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
T Y APE +M D++S G + E+LTG+
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 30/91 (32%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
APE ++ D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 25/192 (13%)
Query: 163 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMP 219
T VAVK +N D ++ E+ L H N++ + I D + +V M
Sbjct: 24 TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 220 RGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
GS E+ L + P LP I L ++H + I+R K S+ILL D
Sbjct: 83 YGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDG 138
Query: 278 NAKLSDFGLAKDGPEGDKTHV--------STRVMGTYGYAAPEYV---MTGHLTSRSDVY 326
LS + + K S + + + +PE + + G+ +SD+Y
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKSDIY 194
Query: 327 SFGVVLLEMLTG 338
S G+ E+ G
Sbjct: 195 SVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 117 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 176
LR+ +D +L R +G G +G V+K TG AVK + +
Sbjct: 3 LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46
Query: 177 LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 236
E+ + + H N+V G + ++ + E+ GSL++ ++ + PL
Sbjct: 47 GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSE 105
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
+ +GLA+LH + + ++RD K +NILL + + KL+DFG+A
Sbjct: 106 LQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162
Query: 297 HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEM 335
S +GT + APE G D+++ G+ +E+
Sbjct: 163 RKS--FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL-------ENHLFRRSLPLPWSI 238
E L + H N+V D +V E+ G L LF L W +
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKT 296
+M + G+ +HE + V++RD K+ NI L + KL DFG A+ P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GA 155
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
+ T V GT Y PE ++SD++S G +L E+ T + N
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 51/185 (27%), Positives = 78/185 (42%), Gaps = 36/185 (19%)
Query: 199 VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLA 251
+ + Y +D+ L LV ++ G L L + LP + M IA+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYG 307
++H RD K NIL+D + + +L+DFG L +DG T S+ +GT
Sbjct: 123 YVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQSSVAVGTPD 168
Query: 308 YAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
Y +PE + G D +S GV + EML G P +LVE +
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMN 222
Query: 363 ERRRF 367
+ RF
Sbjct: 223 HKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 60/208 (28%)
Query: 198 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-----FRRSLPLPWSIRMKIALGAAKGLA 251
+VKL Y +D L V +++P G + + L F L + + A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL---------AKDGPEGDKTHVS--- 299
F+H RD K NIL+D D + KL+DFGL +K +GD
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 300 ------------------------TRVM-----GTYGYAAPEYVM-TGHLTSRSDVYSFG 329
R + GT Y APE ++ TG+ T D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVG 231
Query: 330 VVLLEMLTGRRSMDKNRPNG-EHNLVEW 356
V+L EML G+ + P + ++ W
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 49/179 (27%), Positives = 78/179 (43%), Gaps = 32/179 (17%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+ LH +I+RD K SNI++ +D K+ DFGLA+ G ++ V+ Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 184
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 352
APE ++ D++S G ++ EM+ GR +D+ N+ P
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 353 LVEWARPHLGERRRFYRLIDPRL---------EGHFSIKGAQKAAQLAAHCLSRDPKAR 402
L R ++ R ++ L P+L H +K +Q A L + L DP R
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKR 302
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-RVMGT 305
A G+ FL A + ++RD N+L+ K+ DFGLA+D D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR-DSNYISKGSTFLP 304
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ APE + T+ SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG+G F +FKG E G T V +K L+ + + + + L H +
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEE 256
LV G C+ D+ ++V E++ GSL+ +L + + S ++++ AK LA+ LH
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFL 116
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT--YGYAAPEYV 314
++ + + + N+LL + + K + K G V + + + PE +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 315 MTG-HLTSRSDVYSFGVVLLEMLTG 338
+L+ +D +SFG L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+ LH +I+RD K SNI++ +D K+ DFGLA+ + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
APE ++ D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 66/264 (25%), Positives = 96/264 (36%), Gaps = 77/264 (29%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+F ++G+G FG V K TG A+KTL + K+ LA V
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51
Query: 191 GDLVHLN----LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-- 243
D++ + +V L Y +D Q L L+ EF+P G L L + R +A
Sbjct: 52 RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110
Query: 244 ---LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-------------- 286
+ A L F+H RD K NIL+D + KLSDFGL
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 287 -------AKDGPEGDKTHV-------------------STRVM-----GTYGYAAPEYVM 315
K+ + + + R+M GT Y APE +
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IF 220
Query: 316 TGHLTSRS-DVYSFGVVLLEMLTG 338
+ D +S G ++ E L G
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 73/256 (28%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGDLV 194
LG G FG V K T A+KTL + + AE + L +
Sbjct: 9 LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59
Query: 195 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAK 248
+ +VKL Y +D L V +++P G + + L R L + + +A+ +
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-------------------KD 289
+ F+H RD K NIL+D D + KL+DFGL +D
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 290 GPE-------------GD----------KTH---VSTRVMGTYGYAAPEYVMTGHLTSRS 323
E GD K H ++ ++GT Y APE ++ T
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 324 DVYSFGVVLLEMLTGR 339
D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 204 YCIEDDQRLL--VYEFMPRGSLENHLFRRSLPLPWSI-RMKIALGAAKGLAFLHEEAERP 260
+C + +R L V E++ G L + LP + RM A L +LH
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFA-ETVLALEYLHNYG--- 121
Query: 261 VIYRDFKTSNILLDADYNAKLSDFGLAKDG--------PEGD-----KTHVSTRVMGTYG 307
+++RD K N+L+ + + KL+DFGL+K G EG + + +V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
Y APE ++ D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 44/151 (29%), Positives = 65/151 (43%), Gaps = 30/151 (19%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSI------RMKIALGAAKGLAFLHEE 256
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 312
RD K N+LLD + + +L+DFG L DG T S +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG-----TVQSNVAVGTPDYISPE 173
Query: 313 YVM-----TGHLTSRSDVYSFGVVLLEMLTG 338
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRM 240
E L L H +VK +E D ++ E+ L+ L ++L
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
I L G+ ++H+ R +++RD K NI L + K+ DFG+++ ++T
Sbjct: 112 FIQL--LLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLAT 163
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335
GT Y +PE + S+SD++S G +L EM
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 30/151 (19%)
Query: 204 YCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP------WSIRMKIALGAAKGLAFLHEE 256
Y +D+ L LV ++ G L L + LP + M +A+ + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFG----LAKDGPEGDKTHVSTRVMGTYGYAAPE 312
RD K N+LLD + + +L+DFG + +DG T S+ +GT Y +PE
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPE 173
Query: 313 YVMT-----GHLTSRSDVYSFGVVLLEMLTG 338
+ G D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH 254
H++L + G C+ + ++V EF+ G L+ L + +P + ++ +A A L++L
Sbjct: 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE 134
Query: 255 EEAERPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+ + +++ + NILL A+ + KLSD G++ ++ RV
Sbjct: 135 D---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIP 185
Query: 308 YAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
+ APE V G L++ +D +SFG LLE+ +GE L E E+ R
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EKER 232
Query: 367 FY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
FY RL +P ++ A L + CL+ +P RP
Sbjct: 233 FYEKKHRLPEP---------SCKELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 12/160 (7%)
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKI 242
E + L + H ++++L G + L+ +PR + + + +R++ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI--CDILAI 187
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
+ + +LHE +I+RD K NI ++ + L DFG A P +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 342
GT APE + D++S G+VL EM T S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 50/206 (24%), Positives = 78/206 (37%), Gaps = 61/206 (29%)
Query: 185 AEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHL-----FRRSLPLPWSI 238
AE + L + + +V+L Y +D D V +++P G + + L F L +
Sbjct: 50 AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL------------ 286
+ A+ + + F+H RD K NIL+D D + KL+DFGL
Sbjct: 109 ELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 287 --AKDGPEGDKTHVSTR-------------------------------VMGTYGYAAPEY 313
+ D D S ++GT Y APE
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 314 VMTGHLTSRSDVYSFGVVLLEMLTGR 339
++ T D +S GV+L EML G+
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 3/115 (2%)
Query: 220 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279
R L +L R PL + +A + ++H E +I+RD KT N+L++ +
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDI 299
Query: 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 334
L DFG A T + GT APE + T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 26/105 (24%), Positives = 43/105 (40%), Gaps = 10/105 (9%)
Query: 56 SRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVAS 115
SRS + SG+ + ST+ A + T+ +N + ++ KV
Sbjct: 45 SRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTY 104
Query: 116 RLRKFTFN----------DLKLATRNFRPESLLGEGGFGCVFKGW 150
L + D+ ++T+ F+ SLLGEG FG V + W
Sbjct: 105 ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW 149
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 41/136 (30%), Positives = 66/136 (48%), Gaps = 21/136 (15%)
Query: 217 FMPRGSLENHLFRRSLP--LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274
FM GS N L + P + ++ I GA +GL +LH+ I+R+ K S+IL+
Sbjct: 80 FMAYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 275 ADYNAKLSD----FGLAKDGPEG----DKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 323
D LS + L ++G + D ST V+ + +PE + + G+ +S
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKS 191
Query: 324 DVYSFGVVLLEMLTGR 339
D+YS G+ E+ TGR
Sbjct: 192 DIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 10/97 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGDL 193
LG G FG V +E K +TVAVK L +E L +++LG+
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 230
H+N+V L+G C L++ E+ G L N L R+
Sbjct: 98 -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 26/171 (15%)
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMP----------RGSLENHLFRRSLP 233
E+ L +L H N++ L + R L++++ R S N ++ +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQ 104
Query: 234 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAK- 288
LP S+ + G+ +LH V++RD K +NIL+ + K++D G A+
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
Query: 289 -DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT 337
+ P + V+ T+ Y APE ++ H T D+++ G + E+LT
Sbjct: 162 FNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 135 ESLLGEGGFGCVFK------GWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
+ L+G GGFGCV++ I A ++ T+ ++TL ++ + + +A
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY-DIDKIALWK 75
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSL---ENHLFRRSLPLPWSIRMKIALG 245
+ ++ HL + K G C + + Y F+ L +F+R + I
Sbjct: 76 NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK----DGP--EGDKTHVS 299
L ++HE + + D K NI++D + + D+G+A G E K
Sbjct: 135 MLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 334
GT YA + +T R D+ S G +L+
Sbjct: 192 LH-RGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 487 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.58 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.07 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.77 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.7 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.64 | |
| PLN02236 | 344 | choline kinase | 97.39 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.21 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.19 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.77 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.69 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.59 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.55 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.45 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.27 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.22 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.95 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.63 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.34 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.23 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=429.20 Aligned_cols=288 Identities=58% Similarity=1.000 Sum_probs=252.7
Q ss_pred ccccChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC
Q 011385 117 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196 (487)
Q Consensus 117 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp 196 (487)
...|.+.++..++++|....+||+|+||.||+|...+ |..||||++........++|.+|+.+|.+++||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~ 131 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHP 131 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCc
Confidence 5679999999999999999999999999999999864 468999988765543146699999999999999
Q ss_pred CceeEEEEEEeCC-eeEEEEeeCCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 197 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 197 nIv~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
|+|+|+|||.+.+ +.+||+||+++|+|.++|..... .++|..+++|+.++|+||+|||.....+|||||||++|||||
T Consensus 132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 9999999999998 59999999999999999987665 899999999999999999999998877899999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+++++||+|||+|+..... .....+...||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....++
T Consensus 212 ~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999999776541 111111117999999999999999999999999999999999999999877766677788
Q ss_pred HhhhhhhhcccccccccCCccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 355 EWARPHLGERRRFYRLIDPRLE-GHFSI-KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.|+.+.+.+. .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.||++.|+.+.
T Consensus 291 ~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9987777665 78899999987 66664 57778999999999999999999999999996554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-53 Score=425.50 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=213.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.+|...++||+|||+.||.+++.. +|+.||+|++.+.... ..+.+.+||+|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 579999999999999999999865 7889999999764332 3467899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+++|||+|+|..++|..++. +.+.+++..+..++.||+.||.|||+.+ |||||||..||||+++.+|||+||||
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccce
Confidence 9999999999999999999885 6678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|......... ..+.||||.|.|||++....++..+||||+|||||-||+|++||+...-.+..+-+. .
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-----~----- 232 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-----L----- 232 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----h-----
Confidence 9988754332 345899999999999999999999999999999999999999997643221111111 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
- ...++...+..+++||.++|+.||.+|||+++||.+=
T Consensus 233 ----~----~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 233 ----N----EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred ----c----CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 0 1122234457899999999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=408.63 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=210.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-------HHHHHHHHHHHhcCCCCCcee
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~ 200 (487)
..+.|.+.+.||+|+||.|-+|..+. +|+.||||++++..... ...+.+|++||++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 45778999999999999999997765 88999999997654322 234679999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---C
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---Y 277 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~ 277 (487)
++++|...+..||||||++||+|.+.+..+ +.+.+..-..++.|++.||.|||++| |+||||||+||||..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 999999999999999999999999999655 45788888999999999999999999 9999999999999665 7
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCC---CCchhhhhhHHHHHHHHHhCCCCCCCCCCCC-cchh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNL 353 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~---~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~ 353 (487)
.+||+|||+|+..... ..+.++|||+.|.|||++.+.. |..++||||||||||-+|+|.+||....... ..+.
T Consensus 317 llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ 393 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ 393 (475)
T ss_pred EEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence 7999999999987643 3466799999999999998654 3458899999999999999999997654432 1111
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+. .....+ ........++++.+||.+||..||++||++.|+|++-+
T Consensus 394 I~------~G~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 394 IL------KGRYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred Hh------cCcccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 11 111111 11122345688999999999999999999999998644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=400.27 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=212.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+++.++.||+|..|+|||++++. +++.+|+|.+.... ....+++.+|++++++.+|||||.+||+|..
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 3456677899999999999999976 78899999994332 2335779999999999999999999999999
Q ss_pred CC-eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 208 DD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 208 ~~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+. ...|+||||++|+|++++... +.+++.....|+.+|++||.|||. .+ ||||||||+||||+..|.|||||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecccc
Confidence 98 499999999999999988544 679999999999999999999996 55 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC--CCcchhhHhhhhhhhc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHLGE 363 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~ 363 (487)
.++...+. ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||....+ ....+++.+..
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----- 295 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----- 295 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-----
Confidence 99987553 34568999999999999999999999999999999999999999976522 12222222111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.-..|.+... .++++++.|+..||++||.+||++.|+++|-.
T Consensus 296 -----~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 296 -----DEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred -----cCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 1112222222 35688999999999999999999999998643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-53 Score=404.11 Aligned_cols=264 Identities=28% Similarity=0.370 Sum_probs=215.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|+++++||+|+||.||+++.++ +++.||+|++++..... .+....|..||.+++||+||.++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 3689999999999999999998875 78899999998765543 34578999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
++.+.+|||+||+.||+|..+|.+. +.+++..+..++..|+.||.|||+++ ||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 9999999999999999999999554 57999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
|++....... ...++|||+.|||||++.+.+|+.++|+|||||++|||++|.+||....... +.......+
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k- 241 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGK- 241 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCc-
Confidence 9996443322 2344899999999999999999999999999999999999999997653321 111111111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCccCCCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 424 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~ 424 (487)
....+...+.++++|+.++|..||++|.....=.+.++.++.+.++.+.
T Consensus 242 ----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 242 ----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred ----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 0011111346789999999999999997533333346777777666543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=401.47 Aligned_cols=203 Identities=32% Similarity=0.537 Sum_probs=182.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..+|.+.+.||.|+||+||+|+++. ++..||||.+.+..+ ...+.+..|+.+|+.++|||||+++++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 3578889999999999999999987 567999999987743 33455789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC------CcEE
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------YNAK 280 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~------~~~k 280 (487)
.++.+|||||||+||+|.+||.+++ .+++..+..++.||+.||++||+++ ||||||||.||||+.. -.+|
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 9999999999999999999996664 7999999999999999999999988 9999999999999764 4589
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 347 (487)
|+|||+|+.+.++. ...+.||++.|||||++....|+.|+|+||+|+|||+|++|+.||+....
T Consensus 156 IADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 156 IADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred ecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99999999987543 34558999999999999999999999999999999999999999986544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=407.33 Aligned_cols=255 Identities=35% Similarity=0.582 Sum_probs=211.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcE-EEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++.+.+.||.|+||+||+|.++ |.. ||||++....... .++|.+|+.+|.+|+|||||+++|++.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3444556999999999999996 445 9999997654332 4589999999999999999999999998
Q ss_pred CC-eeEEEEeeCCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011385 208 DD-QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 284 (487)
Q Consensus 208 ~~-~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~DF 284 (487)
.. .++|||||+++|+|.+++.. ....+++..++.|+.||+.||.|||++++ ||||||||+||||+.++ ++|||||
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence 87 79999999999999999987 46789999999999999999999999874 99999999999999997 9999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceec--cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|+++...... ...+...||+.|||||++. ...|+.|+|||||||+||||+||..||....... +...
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~------ 257 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASA------ 257 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH------
Confidence 9998765422 2234468999999999999 5699999999999999999999999998664411 1111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
++.......++..++..+..|+.+||..||..||++.+|+..|+.+.
T Consensus 258 -------v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 258 -------VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred -------HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 11111222333346778999999999999999999999999998653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=382.67 Aligned_cols=265 Identities=28% Similarity=0.364 Sum_probs=213.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
+.|+.+.++|+|+||+||+|++++ ||+.||||++..... .-.+-.++|+++|++|+|+|+|.++.+|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 367888899999999999999876 899999999854432 122447899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
...++||+|||+. ++.+-|.+....++...+..++.|++.|+.|+|+++ ||||||||+||||+.+|.+||||||+|
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhh
Confidence 9999999999987 555567777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCC-CCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh---
Q 011385 288 KDGP-EGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--- 362 (487)
Q Consensus 288 ~~~~-~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--- 362 (487)
+... +++ ..+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+....+....+......+.
T Consensus 149 R~L~~pgd---~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 149 RTLSAPGD---NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred HhhcCCcc---hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 9876 333 3566789999999999887 6899999999999999999999999988766544433332221111
Q ss_pred -----cccccccccCCc------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 -----ERRRFYRLIDPR------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 -----~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....|..+.-|. ++..++ ....-+.+|++.||..||++|++.++++.+
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111111 111122 234568899999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=374.66 Aligned_cols=260 Identities=27% Similarity=0.350 Sum_probs=216.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|+.++.||.|+||.|.+++.+. +|..||+|+++....-.. +...+|..+|+.+.||+++++++.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t 112 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT 112 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence 34689999999999999999999886 567999999987765443 346789999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
|.+.+++||||||++||.|..+|++ .+++++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+||
T Consensus 113 ~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 113 FKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999999954 467999999999999999999999998 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+|+..... .-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...++....+
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~------------ 251 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE------------ 251 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH------------
Confidence 999986543 345799999999999999999999999999999999999999998766522111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCCCccCCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNLKDMAS 423 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~~~~~~~~ 423 (487)
.++.. .-.|+...+..+++|+.++|+.|-.+|. ++..=.+-++.++.++.+.+
T Consensus 252 ----KI~~~--~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 252 ----KILEG--KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred ----HHHhC--cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 11111 1123444557899999999999999994 44433444556666665544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=399.99 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=216.7
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcC-CCCCceeEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLI 202 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~ 202 (487)
....+|.+++.||+|+|++|++|+.+. ++..||||++.+.-+.. .+-+.+|-.+|.+| .||.|++||
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy 140 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY 140 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE
Confidence 345789999999999999999998765 77899999997654322 23467899999999 899999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
..|+++..+|+|+||+++|+|.++|.+. +.|++.....++.||+.||+|||++| ||||||||+|||||.+|++||+
T Consensus 141 ~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 141 FTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred EEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 9999999999999999999999999665 57999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc---------ee--eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 283 DFGLAKDGPEGDKT---------HV--STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 283 DFGla~~~~~~~~~---------~~--~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
|||.|+.+.+.... .. ...++||..|++||++.....+..+|||+||||||+|+.|.+||.+.++...
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli- 295 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI- 295 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-
Confidence 99999876543221 11 2458999999999999999999999999999999999999999976544211
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCccCCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMAS 423 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~ 423 (487)
|.+++. +.-.|+...++.+.+|++++|..||.+|+++.+|.+ ++.+..+.+
T Consensus 296 ---------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----HpFF~~Vdw 346 (604)
T KOG0592|consen 296 ---------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA----HPFFEGVDW 346 (604)
T ss_pred ---------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh----CcccccCCh
Confidence 112221 122344444578999999999999999999977765 444544443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=376.86 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=206.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEE-EE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIG-YC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~-~~ 205 (487)
..+|+++++||+|.||+||++.... +|..||.|.+..+.... .+++..|+.+|++|+|||||++++ .+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 3578889999999999999998876 67799999998554432 456899999999999999999998 45
Q ss_pred EeCCe-eEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCcEEEcCCCcEE
Q 011385 206 IEDDQ-RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAER-PVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 206 ~~~~~-~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~-~iiHrDLKp~NIll~~~~~~k 280 (487)
.++.. ++||||||.+|+|.+.|. +....+++..+|+++.|++.||..+|++-++ -|+||||||.||+|+.+|.+|
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 55544 889999999999999885 3356799999999999999999999995422 289999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
|+||||++.+.... ......+|||.||+||.+...+|+.++||||+||++|||..-++||.+.+- ..... .
T Consensus 169 LGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~-K 239 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCK-K 239 (375)
T ss_pred eccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHH-H
Confidence 99999999875532 234568999999999999999999999999999999999999999987621 11110 0
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+. .---+.++ ....+.++..||..|+..||..||+...++..+
T Consensus 240 I~------qgd~~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 240 IE------QGDYPPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HH------cCCCCCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 00 00001111 134467899999999999999999865555443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=392.41 Aligned_cols=268 Identities=27% Similarity=0.376 Sum_probs=215.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
+..++|+++++||+|+||.||+|+-+. ||..||+|++++..... ...+..|-.+|...++|+||+||.
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 345899999999999999999998765 88999999998765533 345788999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
.|++.+++||||||++||++..+|.+. ..|++..+..++.+++.|++.||+.| +|||||||+|+|||..|++||+|
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecc
Confidence 999999999999999999999999655 57999999999999999999999998 99999999999999999999999
Q ss_pred cCCCCCCCC----------------------CCcc----ee-------------------eeeccccccccCCceeccCC
Q 011385 284 FGLAKDGPE----------------------GDKT----HV-------------------STRVMGTYGYAAPEYVMTGH 318 (487)
Q Consensus 284 FGla~~~~~----------------------~~~~----~~-------------------~~~~~Gt~~y~APE~~~~~~ 318 (487)
|||+.-... .+.. .. ....+|||.|||||++.+.+
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999853211 0000 00 01268999999999999999
Q ss_pred CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhccc
Q 011385 319 LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 397 (487)
Q Consensus 319 ~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 397 (487)
|+..+|+|||||||||||.|.+||....+...-. ++.|. ..+. + | -......++.+||.+||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~----f-----P-----~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-ETLK----F-----P-----EEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhcc----C-----C-----CcCcccHHHHHHHHHHhc-
Confidence 9999999999999999999999998876654322 22221 1111 0 0 011224789999999998
Q ss_pred CCCCCCCHHHHHHHhcCCCCCccCCCC
Q 011385 398 DPKARPLMSEVVEALKPLPNLKDMASS 424 (487)
Q Consensus 398 dP~~RPs~~ell~~L~~l~~~~~~~~~ 424 (487)
||++|.- .-=++.++.++.++.+.+.
T Consensus 429 d~~~RLG-~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 429 DPENRLG-SKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred CHHHhcC-cccHHHHhcCCccccCCcc
Confidence 9999997 4445556667777766553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=390.43 Aligned_cols=267 Identities=27% Similarity=0.343 Sum_probs=217.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH--HHHHHHHHhcCC-CCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDLV-HLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~~~~~ 204 (487)
.-++|.+++.||.|+||.||+|+... +|..||||+++..-.. .++ -++|++.|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 44688999999999999999998876 6778999999765332 333 368999999999 9999999999
Q ss_pred EEeCC-eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+.+ .+|+|||||+. +|.+++..++..+++..+..|+.||++||+|+|.+| +.|||||||||||.....+||+|
T Consensus 78 i~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred hhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence 99988 99999999965 999999888899999999999999999999999988 99999999999999888999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh-
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL- 361 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~- 361 (487)
||+||...... -.+..+-|.+|+|||++. ..-|+.++||||+|||++|+.+-++.|.+..+.++...+......-
T Consensus 154 FGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 154 FGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred cccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 99999865433 245678999999999876 6789999999999999999999999999877655443322111100
Q ss_pred ----hccc--------ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 362 ----GERR--------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 362 ----~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+.. .+.......+...++. ++.++.+||.+||+.||.+|||+.|++++-
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0001 1111222222223333 678899999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=381.78 Aligned_cols=259 Identities=30% Similarity=0.437 Sum_probs=206.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|...+.||+|+||.||++.+.. +|..+|||.+........+.+.+|+++|.+|+|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 357778899999999999999875 47799999997664333566899999999999999999999754444
Q ss_pred --eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCC
Q 011385 210 --QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 286 (487)
Q Consensus 210 --~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~~kl~DFGl 286 (487)
.++|.|||+++|+|.+++.+.+..+++..+..+.+||++||+|||+++ ||||||||+||||+. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 688999999999999999876658999999999999999999999988 999999999999999 79999999999
Q ss_pred CCCCCC-CCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 287 AKDGPE-GDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 287 a~~~~~-~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++.... ...........||+.|||||++..+ ....++|||||||++.||+||++||... ... ..+..
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~---~~~~~------ 233 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEE---AEALL------ 233 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cch---HHHHH------
Confidence 987653 1111123347899999999999853 3345999999999999999999999653 110 11110
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+......+.++...+.++.+++.+|+..||.+|||+.++|++....
T Consensus 234 ----~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 234 ----LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ----HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 00000111234444567899999999999999999999999977543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=355.89 Aligned_cols=266 Identities=27% Similarity=0.399 Sum_probs=217.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.+|..++.||+|.||+||+|++.. +|+.||||+++.....+ ....++||+.|+.++|+||+.++++|-+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 467888999999999999999876 78899999998664432 2457899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+.+.||+||++. +|+..|..+...+....+..|+.+++.||+|||++. |+||||||+|+||+.+|.+||+|||+|
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccch
Confidence 9999999999965 999999888889999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 358 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-------- 358 (487)
+.+...+... +..+-|.+|+|||.+.+ ..|+..+||||.|||+.||+-|.+.|.+....+....+-.+.
T Consensus 149 r~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 149 RFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW 226 (318)
T ss_pred hccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence 9877654432 33377999999998875 579999999999999999999999998776544433322111
Q ss_pred hh---hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PH---LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+. +.+..++.....+.+...|+ .+..++.+|+..||..||.+|+++.|++++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 11122222222233333333 456677999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-49 Score=385.06 Aligned_cols=270 Identities=25% Similarity=0.303 Sum_probs=216.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
...+.|+.++.||+|+||.||+|++.. +|+.||+|++..+.. ....-..+||.||++|+||||++|.+.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ei 184 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEI 184 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence 345678899999999999999999876 788999999987653 234557899999999999999999999
Q ss_pred EEeC--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 205 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 205 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
..+. ..+|||+|||++ ||.-++....-.|++.++..++.||+.||+|||.++ |+|||||.+|||||.+|.+||+
T Consensus 185 vt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 185 VTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEec
Confidence 8776 689999999977 999988777778999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||||+.+...... ..+..+-|.+|.|||++.+ ..|+.++|+||.||||.||++|++.|++..+......+-..+..-
T Consensus 261 DFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 261 DFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred cccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 99999987654433 2556678999999999886 589999999999999999999999999887665544432222111
Q ss_pred hc----ccccc--cccCCc------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 GE----RRRFY--RLIDPR------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~~----~~~~~--~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+ ..++. ..+.+. +.+. -...+..+.+|+..+|..||.+|.|+.++|+.
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 00111 111111 1111 11234567899999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=388.38 Aligned_cols=260 Identities=33% Similarity=0.493 Sum_probs=213.9
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+.+..+.+.+++.||+|-||.||+|+++. ...||+|.++.... ....|.+|+++|.+|+|+|||+++++
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 33444566677889999999999999974 23699999977643 34779999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
|..++.+||||||++.|+|.++|.. .+..+.....+.++.|||+||+||++++ +|||||..+||||+++..+||+|
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcc
Confidence 9998899999999999999999986 5667999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
||||+...+ +.........-...|.|||.+..+.|+.++|||||||+||||+| |+.||......+ +++ .+
T Consensus 347 FGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~----~l- 417 (468)
T KOG0197|consen 347 FGLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLE----LL- 417 (468)
T ss_pred cccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHH----HH-
Confidence 999995443 33333333334678999999999999999999999999999999 888886553322 111 11
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.+-+++..|. .|+..+.+|+..||..+|++|||+..+...|+.+.
T Consensus 418 --e~GyRlp~P~-------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 418 --ERGYRLPRPE-------GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred --hccCcCCCCC-------CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 1222333332 35788999999999999999999999998887653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=383.77 Aligned_cols=254 Identities=27% Similarity=0.355 Sum_probs=210.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCC-CCCceeE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLV-HLNLVKL 201 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~ 201 (487)
....|.+.+.||+|+||.|++|++.. +|..||||++..... ...+.+.+|+.+++.++ ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 45689999999999999999998876 678999998766411 22345678999999999 9999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEE
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAK 280 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~k 280 (487)
+.++.....+|||||||.||+|.+++.+ .+.+.+..+..+++||+.||+|||+.+ |+||||||+|||++.+ +++|
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999999999999999977 678999999999999999999999988 9999999999999999 9999
Q ss_pred EeecCCCCCCC-CCCcceeeeeccccccccCCceeccCC-CC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 281 LSDFGLAKDGP-EGDKTHVSTRVMGTYGYAAPEYVMTGH-LT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 281 l~DFGla~~~~-~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
|+|||++.... .+. .....|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||..... ....
T Consensus 162 l~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~ 232 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLY 232 (370)
T ss_pred EeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHH
Confidence 99999999873 222 345689999999999999877 85 789999999999999999999986321 1111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.........+ ...+. +.++..|+.+||..||.+|+++.+|+++-+-
T Consensus 233 ~ki~~~~~~~--------p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 233 RKIRKGEFKI--------PSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred HHHhcCCccC--------CCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 1111111111 11111 5788999999999999999999999965443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=387.08 Aligned_cols=269 Identities=26% Similarity=0.427 Sum_probs=218.7
Q ss_pred cChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCC
Q 011385 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN 197 (487)
Q Consensus 120 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn 197 (487)
....++.+..+.+.+...||+|.||+||+|+|.. .||||+++..... ..+.|.+|+.++++-+|.|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3346677777888899999999999999999975 6999999876654 3467999999999999999
Q ss_pred ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 198 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
|+-++|||..+.. .||..+|+|-+|+.+|......|+....+.|++||++||.|||.++ |||||||..||||.+++
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDL 525 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCC
Confidence 9999999988776 9999999999999999877778999999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+|||+||||+................|...|||||++. ..+|++.+||||||||+|||+||..||.........
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--- 602 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--- 602 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE---
Confidence 99999999997644332222233356889999999987 458999999999999999999999999733222111
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
|. .+...-..+. -....++++++.+|+..||..++++||.+.+|+..|+.++.
T Consensus 603 -fm---VGrG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 603 -FM---VGRGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -EE---ecccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11 0111000011 11223567899999999999999999999999998876644
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=365.14 Aligned_cols=271 Identities=27% Similarity=0.320 Sum_probs=218.9
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcCCCCCceeEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
.+..++|++++.||.|.-|+||++..+. ++..+|+|++.+..+... .++..|-+||..++||.++.||
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 3455678889999999999999999876 556899999987765543 3567799999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
+.|+.+...|||||||+||+|..+++++ +..+++..+..++..|+-||+|||-.| ||+|||||+||||.++|+|.|
T Consensus 144 a~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 144 ASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIML 220 (459)
T ss_pred heeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEe
Confidence 9999999999999999999999988755 567999999999999999999999999 999999999999999999999
Q ss_pred eecCCCCCCCC---------------------------------CCcc---------------------eeeeecccccc
Q 011385 282 SDFGLAKDGPE---------------------------------GDKT---------------------HVSTRVMGTYG 307 (487)
Q Consensus 282 ~DFGla~~~~~---------------------------------~~~~---------------------~~~~~~~Gt~~ 307 (487)
+||.|+..... .... .....++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998753210 0000 01224789999
Q ss_pred ccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHH
Q 011385 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKA 387 (487)
Q Consensus 308 y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 387 (487)
|+|||++.+.+.+.++|||+|||+|||||.|..||.+.+...... .++...+...-....+..+
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~----------------NIv~~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR----------------NIVGQPLKFPEEPEVSSAA 364 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH----------------HHhcCCCcCCCCCcchhHH
Confidence 999999999999999999999999999999999998765433211 1111111111111345679
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHhcCCCCCccCCCC
Q 011385 388 AQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASS 424 (487)
Q Consensus 388 ~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~ 424 (487)
++||+++|..||.+|.....=...++.++.++.+.+.
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 9999999999999999966656666777777777654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=364.68 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=213.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||.|..++||+|+... +++.||||+++.+.... ...+.+|++.|+.++||||++++.+|.
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 44689999999999999999999875 56899999998776654 477899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+..+|+||.||.+|++.+++... ...+++..+..|+++++.||.|||.++ .||||||+.||||+.+|.|||+|||
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence 999999999999999999998643 445999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC-cceee-eeccccccccCCceec--cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 286 LAKDGPEGD-KTHVS-TRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 286 la~~~~~~~-~~~~~-~~~~Gt~~y~APE~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
.+-.+.... ..... ..++||++|||||++. ..+|+.|+||||||++..||.+|..||....+.... ...+
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tL 245 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTL 245 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHh
Confidence 876554432 22222 5579999999999964 468999999999999999999999999866543211 1111
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..... ......+..+-.......++.++..||+.||.+|||+++++++
T Consensus 246 qn~pp--~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 246 QNDPP--TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCCCC--CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11100 0000111111122334578899999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=381.06 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=213.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
...|.....||+|+.|.||.|.... +++.||||++........+-+++|+.+|+.++|+|||.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 3568888899999999999998764 6778999999877766666688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.+|+||||++||+|.+.+... .+++.++..|++++++||+|||.++ |||||||.+|||++.+|.+||+|||++.
T Consensus 343 deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence 9999999999999999988543 4899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ...+.+|||+|||||++....|+.++||||||++++||+-|.+||....+.....++..
T Consensus 418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------------ 483 (550)
T KOG0578|consen 418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------ 483 (550)
T ss_pred ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------------
Confidence 8765432 34567899999999999999999999999999999999999999975443222111110
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ....-..+...+..+++|+.+||+.|+++|+++.|||+|
T Consensus 484 -n--g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 484 -N--GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -c--CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 0 111112233456789999999999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=385.34 Aligned_cols=250 Identities=28% Similarity=0.368 Sum_probs=210.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-cc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.-|++++.||.|+-|.|-+|++.. ||+.+|||++.... .. ....+.+||-||+-+.||||+++|++|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 457889999999999999999876 89999999997652 11 1245789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+..++|+|+||+++|.|+++|.++ +++++..+.++++||+.|+.|+|..+ |+||||||+|+|||..++|||+|||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999999999999766 47888999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
|..-.++. ...+-||+|.|.|||++.+..| +.++||||.|||||.||||+.||++.+-. .+..- ....
T Consensus 159 AsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlK---V~~G-- 227 (786)
T KOG0588|consen 159 ASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLK---VQRG-- 227 (786)
T ss_pred eecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHH---HHcC--
Confidence 98765543 3345799999999999999998 56899999999999999999999854321 11111 0011
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..+++...+.++++||.+||..||.+|.|+.||++|..
T Consensus 228 ----------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 228 ----------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ----------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 11223344578999999999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=386.07 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=214.2
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCC-CCCceeE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKL 201 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~ 201 (487)
.+..++|.++++||+|.||.|+++..+. +++.||||+++++.+-. .+..+.|.+|+.... ||.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 3456799999999999999999999875 67799999999886533 455778988888775 9999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
+.+|+..+++|+||||+.||++..++ +...+++..+..|+..|+.||.|||+++ |||||||.+|||||.+|++||
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEe
Confidence 99999999999999999999965543 4457999999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
+|||+++....... ...++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+.++.+..+-+ +
T Consensus 510 ADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~ 581 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------V 581 (694)
T ss_pred cccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------h
Confidence 99999998653332 345699999999999999999999999999999999999999999876543322211 1
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHhcCCCCCccCC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE-VVEALKPLPNLKDMA 422 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-ll~~L~~l~~~~~~~ 422 (487)
.+ ...++...+.++..|++++|..+|++|.-+.| =.+.++..+.+..+.
T Consensus 582 ~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 582 ND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred cC------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 11 12234445678999999999999999996621 112233455555444
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=373.25 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=210.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|.+.+.||+|+||+||||+.+. +.+.||+|.+.+.... ..+.+.+|++|++.|+|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 467888899999999999998654 7889999999665432 34568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
..++|+|.|||.| +|..+|.. ...++++.+..|+.|++.||.|||+.+ |+|||+||.||||+..|.+|+||||+|
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhh
Confidence 9999999999976 99999854 457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
+.... .+...+...|||.|||||++.+..|+..+|+||||||+|||++|++||.... +.......+.
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~----- 214 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK----- 214 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc-----
Confidence 98765 3456677899999999999999999999999999999999999999995321 1111111111
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
++.. .+...+..+..|+..+|..||..|.+-.+++.|
T Consensus 215 ----d~v~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 215 ----DPVK---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCCC---CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1111 223556788999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=376.84 Aligned_cols=266 Identities=29% Similarity=0.437 Sum_probs=206.3
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||.||+|.+.... +..++..||||+++.... .....+.+|+.+|..+ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 34578999999999999999999864211 122466899999975432 2235688999999999 89999999998
Q ss_pred EEeC-CeeEEEEeeCCCCChhHHHhhcC----------------------------------------------------
Q 011385 205 CIED-DQRLLVYEFMPRGSLENHLFRRS---------------------------------------------------- 231 (487)
Q Consensus 205 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------- 231 (487)
+... ..+++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 45789999999999999986431
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeec
Q 011385 232 ---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302 (487)
Q Consensus 232 ---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 302 (487)
..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..............
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 24778888999999999999999988 999999999999999999999999999865433222222234
Q ss_pred cccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCH
Q 011385 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI 381 (487)
Q Consensus 303 ~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (487)
.+++.|+|||++.+..++.++|||||||+||||++ |..||....... .+.. .+.... .. ..+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~------~~----~~~~ 300 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ----RLKDGT------RM----RAPE 300 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH----HHhcCC------CC----CCCC
Confidence 56788999999999999999999999999999997 999997543211 1100 011100 00 0112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 382 KGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 382 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=369.79 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=213.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..|...++||+|.||.||+|.+.. +++.||+|++..+.... ..++.+|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 357777899999999999998876 67899999998765543 46788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..++++||||.||++.+.|. .+..+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||++.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence 99999999999999999884 4445688888899999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
........ ..+++||+.|||||++....|+.++||||||++.+||++|.+|+....+.... ..+.
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------------flIp 224 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------------FLIP 224 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------------Eecc
Confidence 87654432 35689999999999999999999999999999999999999999776552111 1112
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+...|.+.+ .++..+++|+..||..||+.||++.++|++
T Consensus 225 k~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 225 KSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 233444444 345678999999999999999999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.97 Aligned_cols=270 Identities=27% Similarity=0.350 Sum_probs=213.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEec--CCCccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
....|..++.||+|+||.|+.+.+.. +|+.||||++. .......++..+|+++|+.++|+||+.+++++
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~ 90 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF 90 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence 34567778999999999999998875 67899999997 34444567889999999999999999999998
Q ss_pred Ee-----CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 206 IE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 206 ~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
.. -..+|+|+|+| +.+|.+.| +.+..++...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+|
T Consensus 91 ~p~~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 91 RPPSRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred ccccccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEE
Confidence 65 35689999999 55898888 44456999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|||||+|+...........+..+-|.+|.|||++. ...|+.++||||+||||.|||+|++.|.+........++.....
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999999875432333456778999999999876 57899999999999999999999999998776554444332221
Q ss_pred hhhc----------ccccccccCC----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGE----------RRRFYRLIDP----RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~----------~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.-.+ .....+-+.. .+...|+ .....+.+|+.+||.+||.+|+|++|+|++-
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 1100 0000011111 1111222 3456889999999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=350.16 Aligned_cols=269 Identities=23% Similarity=0.292 Sum_probs=213.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|+.+..|++|+||.||+|+++. +++.||+|+++.+.... --.-++||.+|.+++|||||.+-.+..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 3568888899999999999998765 78899999998664211 123579999999999999999988876
Q ss_pred e--CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 207 E--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 207 ~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
. -+.+|||||||+. +|..++.....++...++..++.|++.||+|||... |+|||||++|+|++..|.+||+||
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 4 4679999999977 999999888889999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-----
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----- 358 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~----- 358 (487)
|+|+.+.... ...+..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++++.|.+....+..+.+-...
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 9999876543 23566788999999999886 579999999999999999999999999877655444321111
Q ss_pred ---hhhhcc-----cccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 ---PHLGER-----RRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ---~~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+.+.+. ..+.......+...|... ..+...+|+..+|..||.+|.|+.|.|++=
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 111100 001111111122233322 346678999999999999999999999753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=373.64 Aligned_cols=249 Identities=28% Similarity=0.443 Sum_probs=208.0
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
++..+...-++.||.|+.|.||+|+++ ++.||||+++.- -..+|+.|++|+||||+.|.|+|
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeecc-----------CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeee
Confidence 334444555678999999999999985 468999998532 23689999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.....+|||||||..|-|...|. .+..+.......|..+|+.||.|||.+. |||||||.-||||+.+..|||+|||
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred cCCceeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999999984 4557888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
.++...+. ...-.++||..|||||++.+...+.|+|||||||||||||||..||.+..... +.|
T Consensus 258 TS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw--------- 321 (904)
T KOG4721|consen 258 TSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW--------- 321 (904)
T ss_pred chHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE---------
Confidence 99876543 22345899999999999999999999999999999999999999996533211 111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+-...+.-..+..|+..+.-|++.||+..|..||++.+|+.||+..
T Consensus 322 ---GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 322 ---GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ---eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 11112223334556778899999999999999999999999999743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=358.64 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=212.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH---HHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..+|++.+.||+|.||.|-+|+.+. .|..||||.++++.+.+.++ +.+||+||..|+||||+.+|.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 3578899999999999999997654 68899999999888776555 56899999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+..+.+.|||||..+|+|++|+.++ ..+++..+..+++||+.|+.|+|.++ ++|||||.+|||||.++++||+|||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 9999999999999999999999655 57999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+-.+.... ..+++||++.|.+||++.+..| ++.+|-|||||+||-|+.|..||++..-. .++. ..-
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvr---QIs--- 266 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVR---QIS--- 266 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHH---Hhh---
Confidence 998876543 3456999999999999999988 57899999999999999999999865321 1111 100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.... +....+.++.-||++||..||++|.|+.+|..+.+
T Consensus 267 -------~GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 267 -------RGAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -------cccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 0000 11122356789999999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=336.36 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=212.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++++.||+|-||.||+|+.+. ++..||+|++.+..+. ...++.+|++|-..|+||||+++|++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred chhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34689999999999999999999876 5668999998655432 23568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
|.+....||++||..+|+|...|.. ....+++.....+..|++.||.|+|..+ ||||||||+|+|++..+.+||+|
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAd 167 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIAD 167 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccC
Confidence 9999999999999999999999973 3456999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||.+...... ...+.|||..|.+||++.+..++..+|+|++|++.||++.|.+||....... .. .+
T Consensus 168 fGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tY--kr----- 233 (281)
T KOG0580|consen 168 FGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TY--KR----- 233 (281)
T ss_pred CCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HH--HH-----
Confidence 9999875432 2445899999999999999999999999999999999999999997654211 10 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ..++ -.++...+..+.+||.+||..+|.+|....|++++-+
T Consensus 234 I----~k~~----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 234 I----RKVD----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred H----HHcc----ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 0 0011 1122334578999999999999999999999998765
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=360.62 Aligned_cols=272 Identities=28% Similarity=0.438 Sum_probs=208.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCC-------CccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCcee
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
.++|++.+.||+|+||.||+|.+...... ..+.+++..||+|.+...... ...++.+|+++|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 46899999999999999999987543211 123345668999998754322 2356889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
+++++.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 23677889999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh--CCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRR 340 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt--G~~ 340 (487)
||||||+|||++.++.+||+|||+++...............++..|||||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987654433333334556889999999988899999999999999999987 456
Q ss_pred CCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 341 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 341 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
||...... ................ .....+..++..+.+|+.+||+.||.+||++.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67543221 1111111111100000 000011123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=356.76 Aligned_cols=252 Identities=29% Similarity=0.405 Sum_probs=203.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.|++.+.||+|+||.||+|.+.. +|..||||.+...... ....+.+|+.++..++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 37788999999999999998865 5779999998654322 22357789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999887643 346899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ .....||..|+|||++.+..|+.++|||||||++|||++|+.||.............. ...
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~---- 218 (285)
T cd05631 149 AVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVK---- 218 (285)
T ss_pred cEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhh----
Confidence 987543221 2345799999999999999999999999999999999999999976543221111100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
. ....++...+..+.+|+.+||+.||.+||+ +.+++++
T Consensus 219 -----~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 -----E--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -----c--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 001122233567899999999999999997 7787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.43 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=210.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEE-E
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG-Y 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~-~ 204 (487)
+...++++.+.|.+|||+.||+|.... .|..||+|++-..+....+.+.+||++|+.|. |+|||.|++ .
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 345678889999999999999999875 33689999997777677788999999999997 999999999 3
Q ss_pred EEe------CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 205 CIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 205 ~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
... .-+++|+||||.||.|-+++..+ ...|++..+++|+.|+++||++||... .+|||||||-|||||+.+|
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADG 183 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCC
Confidence 221 12567999999999999999643 345999999999999999999999987 6799999999999999999
Q ss_pred cEEEeecCCCCCCCCCCccee-------eeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 011385 278 NAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~-------~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 347 (487)
+.||||||.|+-....-.... .-...-|+.|+|||++. +..++.|+|||||||+||-|+....||+....
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 999999999875332211000 00134689999999874 67899999999999999999999999976533
Q ss_pred CCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011385 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 418 (487)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 418 (487)
.. +++......-.......+.+||..||+.||.+||++-+++..+.++.+.
T Consensus 264 la--------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 LA--------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ee--------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 21 2222221111134578899999999999999999999999998876554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=358.23 Aligned_cols=262 Identities=26% Similarity=0.333 Sum_probs=208.0
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--------------cCHHHHHHHHHHHh
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------------QGHKEWLAEVNFLG 191 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~ 191 (487)
....+.|++++.||+|.||.|-+|++.. +++.||||++.+... ...+++.+||.||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 4456899999999999999999999876 577999999964322 12357889999999
Q ss_pred cCCCCCceeEEEEEEe--CCeeEEEEeeCCCCChhHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011385 192 DLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 268 (487)
Q Consensus 192 ~l~HpnIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 268 (487)
+|+|||||+|+.+..+ .+.+|||+|||..|.+.. . ....+ +.+.++++|+++++.||+|||.++ ||||||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKP 238 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-C-PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKP 238 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc-C-CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 9999999999999876 468999999999998854 2 22334 899999999999999999999999 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCC---cceeeeeccccccccCCceeccCC----CCchhhhhhHHHHHHHHHhCCCC
Q 011385 269 SNILLDADYNAKLSDFGLAKDGPEGD---KTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 269 ~NIll~~~~~~kl~DFGla~~~~~~~---~~~~~~~~~Gt~~y~APE~~~~~~----~~~~~DiwSlGvil~elltG~~p 341 (487)
+|+||+++|++||+|||.+.....+. ........+|||.|||||.+.++. .+.+.||||+||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999999999999999998653221 111122368999999999887632 35689999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
|.+....... .++++..+......+....+++||++||..||+.|.+..+|..|.+....
T Consensus 319 F~~~~~~~l~----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 319 FFDDFELELF----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccchHHHHH----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 9765322111 12333333322223456789999999999999999999999998875444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=385.96 Aligned_cols=266 Identities=30% Similarity=0.462 Sum_probs=222.2
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
+...+.++.+.||+|+||.||+|+...... ......||||.++..... ..++|.+|+++|+.|+|||||+|+|+|
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p----~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLP----GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCC----CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 345677788999999999999998764221 123468999999887665 567899999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC---------C----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS---------L----PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------~----~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
..++.+|||+|||..|||.++|..+. . +++..+.+.||.|||.||+||-++. +|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 99999999999999999999996331 2 2788899999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 351 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 351 (487)
|.++..|||+||||++..-..+++.......-.++||+||.+..++|+.++|||||||+|||+++ |..||.+....+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-- 713 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-- 713 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence 99999999999999998777676665545556789999999999999999999999999999999 899997654432
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
+++.... . .+ -.-+..++.+++.|+..||+.+|.+||+++||-..|..+.
T Consensus 714 -VIe~i~~----g---------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 -VIECIRA----G---------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred -HHHHHHc----C---------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2222211 0 11 1123457889999999999999999999999999987653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=360.19 Aligned_cols=247 Identities=24% Similarity=0.308 Sum_probs=202.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 378899999999999999998865 577999999865432 22356789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCc
Confidence 999999999999999999998654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++..... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~---i~~~~-- 214 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEK---ILAGK-- 214 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCC--
Confidence 9875432 123579999999999999999999999999999999999999997543211 1100 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L 412 (487)
. .++...+..+.+|+.+||+.||.+||+ +.+++++-
T Consensus 215 ------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 ------L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ------c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 0 111222457899999999999999995 77777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=370.46 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=206.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|++... ....++..||||+++.... ...+.+.+|+.+|..+ +|||||++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345799999999999999999976321 1223567899999975432 2345688999999999 899999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC------------------------------------------------------
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS------------------------------------------------------ 231 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~------------------------------------------------------ 231 (487)
.+.+..++|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999985432
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 232 --------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 232 --------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 14678889999999999999999988 9999999999999999999999999998754
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...... .... ..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~~---~~ 336 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEGY---RM 336 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhCc---cC
Confidence 4332222222345678999999999999999999999999999998 888886542211 111111 1000 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
..+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 337 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 -------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0111124578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=363.99 Aligned_cols=243 Identities=30% Similarity=0.381 Sum_probs=197.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
++||+|+||.||+|++.. +|+.||||+++.... .....+.+|+.++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 479999999999998765 577999999975422 22345778999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 999999999999988554 57899999999999999999999988 99999999999999999999999999976432
Q ss_pred CCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccC
Q 011385 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372 (487)
Q Consensus 293 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (487)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||....... .... .... +
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~---~~~~--------~ 211 (323)
T cd05571 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILME--------E 211 (323)
T ss_pred CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH---HHcC--------C
Confidence 211 1234679999999999999999999999999999999999999996532211 1100 0000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 373 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
. .++...+..+.+||.+||+.||++|| ++.+++++
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 11223346789999999999999999 78888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.50 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=204.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||.||+|+... ++..||+|.++..... ....+.+|+.+++.++||||+++++++.++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 579999999999999999998765 5679999998654322 234678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++ +|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 999999999974 999988766667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------h
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 359 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------~ 359 (487)
....... ......|++.|+|||++.+ ..++.++|||||||++|||++|..||................ +
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 6433221 1223568999999998865 568999999999999999999999997654322211110000 0
Q ss_pred hhhcccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.......+.....+.... ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000001111111111000 0001224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=365.73 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=201.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|++.. +|+.||||++..... .....+.+|+.+|..++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 578999999999999999998865 577999999965422 23456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999999998654 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++...... ...+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~~-- 231 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEK---ILAGR-- 231 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHH---HhcCC--
Confidence 98754322 23579999999999999999999999999999999999999996543211 1100 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
. .++...+..+.+|+.+||+.||.+||+ +.+++.+
T Consensus 232 ------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 ------L----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ------c----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 011112457889999999999999996 5666654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=370.99 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=207.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
...++|++.+.||+|+||.||+|++...+. ..++..||||+++..... ....+.+|+++++.+ +|+|||+++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 345689999999999999999998754221 224568999999754332 235688999999999 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-----------------------------------------------------
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 231 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 231 (487)
+...+..++|||||++|+|.+++....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985321
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCc
Q 011385 232 ----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 295 (487)
Q Consensus 232 ----------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (487)
..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 24678889999999999999999988 99999999999999999999999999986544322
Q ss_pred ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCc
Q 011385 296 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374 (487)
Q Consensus 296 ~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (487)
........++..|||||++.+..++.++|||||||++|||++ |..||....... ..... .... ..+
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~~~------~~~- 334 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VKRG------YQM- 334 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HHcc------cCc-
Confidence 222222345678999999988999999999999999999997 999997543211 11000 0000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..+...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 335 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 ---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.32 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=206.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|++.. +++.||||+++.... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368999999999999999999865 577999999975422 23456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcC
Confidence 999999999999999999998544 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+. ...
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~~- 214 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK-------YWK- 214 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH-------hcc-
Confidence 986543 1234579999999999999999999999999999999999999997543321111000 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+............+..+.+|+.+||..+|.+||++.+++++.
T Consensus 215 --~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 215 --ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred --ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00000000000012356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=360.47 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=206.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||++++.. +|..||+|.+..... .....+.+|+++|++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 4689999999999999999998865 577899999875432 223568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 99999999999999999998554 46899999999999999999999853 2999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-hhhhccc-
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHLGERR- 365 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~- 365 (487)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +..... +......
T Consensus 152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~ 224 (331)
T cd06649 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEG 224 (331)
T ss_pred ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccC
Confidence 8654321 233579999999999999999999999999999999999999996433211 100000 0000000
Q ss_pred ------------------------------cccc-ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 ------------------------------RFYR-LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 ------------------------------~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+.. +.............+.++.+|+.+||+.||++||++.+|+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000 00000000001123567899999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=353.56 Aligned_cols=268 Identities=23% Similarity=0.293 Sum_probs=204.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 368999999999999999998865 567899999875432 223567899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..++||||++++.|..+. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999987665543 44557899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL------ 361 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~------ 361 (487)
+........ ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........+......+
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 876432221 1233578999999999998899999999999999999999999997643321111110000000
Q ss_pred --hcccccccccCCccC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 --GERRRFYRLIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 --~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.....+.....+... ..+....+..+.+|+.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 00111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=352.48 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=198.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEEEe----C
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE----D 208 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~ 208 (487)
..||+|++|.||+|.+ +|..||||.++...... .+.+.+|+.+|.+++|||||++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5799999999999987 36789999997654433 3567799999999999999999999877 3
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
...++||||+++|+|.+++... ..+++...+.++.|++.||.|||+. + ++||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchH
Confidence 4688999999999999999654 4688999999999999999999984 5 889999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+...... ....|+..|+|||++.+ ..|+.++|||||||++|||++|..||...... .+.... ....
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i---~~~~- 238 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLI---INKN- 238 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HhcC-
Confidence 8653321 23468999999999876 68999999999999999999999999754321 111110 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
....++..++..+.+|+.+||+.||++||++.|+++.|+.+.
T Consensus 239 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 ---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011122234678999999999999999999999999997653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=364.59 Aligned_cols=251 Identities=26% Similarity=0.373 Sum_probs=212.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|..++.+|+|+||.+++++++.+ +..||+|.+....... .+....|+.+++++.|||||.+.+.|..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 5789999999999999999988764 4589999997665433 3457899999999999999999999999
Q ss_pred CCe-eEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 208 DDQ-RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 208 ~~~-~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
++. ++|||+||+||+|.+.|.+.. ..+++..++.|+.|++.||.|||+.. |+|||||+.|||++.++.|||+|||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence 888 999999999999999997554 77999999999999999999999877 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+|+....... ...+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+... ++....
T Consensus 152 laK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~------- 219 (426)
T KOG0589|consen 152 LAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKIN------- 219 (426)
T ss_pred hhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHh-------
Confidence 9999876541 2345789999999999999999999999999999999999999997654321 111110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.. ....+.....++..|+..||..+|..||++.++|.+
T Consensus 220 ---~~~----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 ---RGL----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---hcc----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 011 112233445789999999999999999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=360.32 Aligned_cols=255 Identities=25% Similarity=0.306 Sum_probs=214.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCC-CCCceeEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLV-HLNLVKLIG 203 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~~~~ 203 (487)
....|++.+.||+|.||.||+|+.+. +|..||+|.+.+..... ...+.+|+.+|++|. |||||.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34678899999999999999998865 68899999998766543 357899999999998 999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----CcE
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNA 279 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----~~~ 279 (487)
+|.+.+.+++|||+|.||.|.+.|... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 999999999999999999999999776 3999999999999999999999988 9999999999999533 579
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|++|||++.....+ ......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.........+...
T Consensus 179 k~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-- 253 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-- 253 (382)
T ss_pred EEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--
Confidence 99999999987662 2345689999999999999999999999999999999999999999876544332211100
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ..+....-...+..+.+++.+||..||.+|+++.++|+|.+
T Consensus 254 ----~--------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 ----D--------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ----C--------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 0 01111112234578999999999999999999999999754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.26 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=219.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCH--HHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
+..-|.+.+.||+|.|.+|-+|++.- +|+.||||++.+..+... ..+..|++.|+.++|||||++|.+.
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi 86 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI 86 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence 34568889999999999999998754 899999999987766543 4588999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~~kl~DF 284 (487)
.....+|||+|+-++|+|++||.++...+.+..+.+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-+||+||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeec
Confidence 9999999999999999999999999889999999999999999999999998 99999999998874 5589999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|++-.+.++.. .++.||+..|-|||++.+..|+ +++||||||||||.|++|++||+..+..+...
T Consensus 164 GFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------- 229 (864)
T KOG4717|consen 164 GFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------- 229 (864)
T ss_pred cccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-----------
Confidence 99998877654 4558999999999999999997 57999999999999999999998655433221
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.++|- ....+...+.++++||..||..||.+|.+.+||+..-+
T Consensus 230 -----mImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 230 -----MIMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred -----hhhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 12221 23455667889999999999999999999999987543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=347.98 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=208.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|++.+.||+|+||.||+|++.... ..+..||+|.++..... ....+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 357889999999999999999876432 24678999999765332 23468899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..+|||||+++|+|.+++......+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999776667899999999999999999999988 999999999999999999999999987
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
......... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... .... +.+.
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~-- 224 (266)
T cd05064 155 QEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----VEDG-- 224 (266)
T ss_pred ccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HHCC--
Confidence 664322111 1112345678999999999999999999999999999775 999997543211 1111 1110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... ..+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 225 ----~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 11223456789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.65 Aligned_cols=266 Identities=21% Similarity=0.305 Sum_probs=201.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|+... ++..||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 3689999999999999999998865 5678999999754322 23457899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcc
Confidence 999999999995 6888888776667899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc---
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 363 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 363 (487)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .........+..
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 226 (303)
T cd07869 151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNE 226 (303)
T ss_pred eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCCh
Confidence 75432211 1233568999999998865 468999999999999999999999997543211 111000000000
Q ss_pred --c---cccccc--------cCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 --R---RRFYRL--------IDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 --~---~~~~~~--------~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ...... ....+...+. ......+.+|+.+||+.||.+|||+.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 000000 0000000000 0012467899999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=354.20 Aligned_cols=257 Identities=28% Similarity=0.349 Sum_probs=201.7
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
+|++.+.||+|+||.||+++.... ..++..||+|++..... ...+.+..|+.++..+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG------HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc------CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 588899999999999999987532 23678999999864321 2234577899999999 599999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
..++..++||||+++|+|.+++..+ ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+++........ .....+||+.|||||++.+. .++.++|||||||++|||++|..||............. ....
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~--- 224 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRIL--- 224 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHh---
Confidence 99865432221 12346799999999998765 47899999999999999999999996543222111110 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
..++.+. ...+..+.+|+.+||+.||++|| ++.+++++-
T Consensus 225 -----~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 225 -----KCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -----cCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 0111122 22346788999999999999999 677777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=368.45 Aligned_cols=270 Identities=29% Similarity=0.446 Sum_probs=217.0
Q ss_pred hHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCce
Q 011385 123 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLV 199 (487)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv 199 (487)
..|.+..++..+.++||+|+||.||+|.+...... ....||||..+... .....+|++|+++|++++|||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 34556667888889999999999999999753221 01128999998532 34457899999999999999999
Q ss_pred eEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 200 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 200 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
++||++.....++||||+|.||+|.++|.+....++...++.++.+.+.||+|||+++ +|||||..+|||++.++.+
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence 9999999999999999999999999999887777999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeee-eccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~-~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
||+|||+++.... ..... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....... .+.
T Consensus 302 KISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI 375 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKI 375 (474)
T ss_pred EeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHH
Confidence 9999999987541 11111 1124579999999999999999999999999999999 88899765432111 111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCc
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 419 (487)
+.....-.++...+..+..++.+||..||++||+|.++.+.|+.+....
T Consensus 376 -------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 376 -------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 0011111222245678899999999999999999999999998765443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=357.65 Aligned_cols=244 Identities=30% Similarity=0.374 Sum_probs=197.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
+.||+|+||.||++.... +|..||+|+++.... .....+.+|+++++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 479999999999998765 577999999975422 22345778999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
|||||+++|+|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 999999999999888544 46899999999999999999999988 99999999999999999999999999876432
Q ss_pred CCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccC
Q 011385 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372 (487)
Q Consensus 293 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (487)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .... .
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~---~~~~--------~ 211 (323)
T cd05595 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFEL---ILME--------E 211 (323)
T ss_pred CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcC--------C
Confidence 211 1233579999999999999999999999999999999999999996543211 1000 0000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 373 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
. .++...+..+.+|+.+||+.||.+|| ++.+++++-
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 0 11222346789999999999999998 888888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=358.22 Aligned_cols=244 Identities=29% Similarity=0.375 Sum_probs=198.4
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
+.||+|+||.||++.... +|..||||++..... .....+.+|+++++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 469999999999998865 577999999975422 22356788999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
|||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 72 lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 999999999999888544 46899999999999999999999988 99999999999999999999999999876432
Q ss_pred CCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccC
Q 011385 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372 (487)
Q Consensus 293 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (487)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... .... .
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~---~~~~--------~ 211 (328)
T cd05593 148 DAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILME--------D 211 (328)
T ss_pred ccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHH---hccC--------C
Confidence 211 123467999999999999999999999999999999999999999653221 11100 0000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 373 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
.. ++...+..+.+|+.+||+.||.+|| ++.+++++.
T Consensus 212 ~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 212 IK----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred cc----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 11 1222346788999999999999997 889998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.28 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=209.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|++.+.||+|+||.||+|.+..... ......||+|.+...... ....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 478899999999999999998765321 123468999998754332 235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
...+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 99999999999999999996532 35788899999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 352 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 352 (487)
+.++.++|+|||+++.....+.........+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~ 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---E 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986544333223334567889999999988899999999999999999998 99999754321 1
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
+..... . ......+..++..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 235 ~~~~i~----~----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIR----S----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHH----c----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111100 0 00111223445789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=374.17 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=204.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
.|.+.+.||+|+||.||+|....+ .+..||+|.+..........+.+|+.+|+.++|||||++++++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 488899999999999999987542 256789998765544444567789999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 211 RLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.||||||+++|+|.++|.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 9999999999999998853 2446889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
+..............+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+... ....
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~---~~~~---- 286 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQ---VLYG---- 286 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhC----
Confidence 8765433222334567999999999999999999999999999999999999999653221 11110 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... .++...+..+.+||.+||..||++||++.+++.+
T Consensus 287 --~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 287 --KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000 1112234678999999999999999999999764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.94 Aligned_cols=269 Identities=24% Similarity=0.341 Sum_probs=204.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|++++..++|+||+++++++.
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 34689999999999999999998764 577899999875432 22356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++..+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ +|+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 999999999999999999998554 46889999999999999999999742 299999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh----hhhh
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----PHLG 362 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~----~~~~ 362 (487)
+....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||................ ....
T Consensus 151 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred chhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 97653321 223578999999999998899999999999999999999999997543211110000000 0000
Q ss_pred ---ccc--------------------ccccccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ---ERR--------------------RFYRLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ---~~~--------------------~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... .+...+.......++ ...+.++.+|+.+||+.||++||++.|++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 000 000000000000000 01245688999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=360.21 Aligned_cols=248 Identities=25% Similarity=0.296 Sum_probs=201.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|.+.+.||+|+||.||+|.+... .+..||+|++.... ......+.+|+.++..++|||||++++++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 35789999999999999999987542 23579999986432 22345678999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++..... ....+||+.|||||++.+..++.++|||||||++|||++|..||....+.. .... .....
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~---i~~~~- 244 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQK---ILEGI- 244 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHH---HhcCC-
Confidence 99865332 223579999999999998899999999999999999999999997543211 0000 00000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
..++...+..+.+++.+||+.||.+|+ ++.+++++
T Consensus 245 -----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 001112245688999999999999995 78887765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=341.35 Aligned_cols=266 Identities=26% Similarity=0.376 Sum_probs=205.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCC-ceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLN-LVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~ 206 (487)
..|..++.||+|+||+||+|+.+. +|+.||+|+++....+ .-....+|+.+|+.|+|+| ||.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 356667789999999999999876 6789999999765432 2245789999999999999 999999999
Q ss_pred eCC------eeEEEEeeCCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 207 EDD------QRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 207 ~~~------~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
..+ .++|||||++. +|..++.... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|
T Consensus 82 ~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSG 157 (323)
T ss_pred ecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCC
Confidence 877 78899999955 9999997655 35788889999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH-
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE- 355 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~- 355 (487)
.+||+|||+|+...-... ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+.........+-
T Consensus 158 ~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 999999999997553222 24556899999999999876 89999999999999999999999998776532221110
Q ss_pred ---------hhhhh-hhccc-ccccccCCc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 356 ---------WARPH-LGERR-RFYRLIDPR-LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 356 ---------~~~~~-~~~~~-~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
|-... +.+.. .+...-.+. +...++ .......+++.+||+.+|.+|.|+..++++
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10000 00000 011110000 000000 112478899999999999999999999986
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.50 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=194.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHH---hcCCCCCceeEEEEE
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFL---GDLVHLNLVKLIGYC 205 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~~~~~~ 205 (487)
|++.+.||+|+||.||+|.+.. +|..||||+++... ....+.+.+|++++ ..++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6778999999999999998865 57799999997532 12234566666554 567899999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..||||||+++|+|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCccc
Confidence 999999999999999999988743 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++....... .....+|++.|||||++.+..++.++|||||||++|||++|..||....... .... ....
T Consensus 147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~~---i~~~-- 216 (324)
T cd05589 147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFDS---IVND-- 216 (324)
T ss_pred CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhC--
Confidence 9875432211 1234679999999999999999999999999999999999999997543211 1100 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
... ++...+..+.+|+.+||+.||.+||+ +.+++++
T Consensus 217 ------~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ------EVR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ------CCC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 001 11123467889999999999999994 5555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=363.50 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=198.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.|++++.||+|+||+||+|++.. ++..||||++...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999998765 5779999999654322 23457899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 99999999999999999998654 46889999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCCc---------------------------------------------ceeeeeccccccccCCceeccCCCCch
Q 011385 288 KDGPEGDK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTSR 322 (487)
Q Consensus 288 ~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~APE~~~~~~~~~~ 322 (487)
+....... .......+||+.|+|||++.+..|+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 64311000 000123579999999999998999999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhc--ccCCC
Q 011385 323 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL--SRDPK 400 (487)
Q Consensus 323 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~ 400 (487)
+|||||||++|||++|..||........... ....... + .+.. ....+..+.+||.+|| ..+|.
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~------i~~~~~~----~--~~~~--~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLK------VINWENT----L--HIPP--QVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHH------HHccccc----c--CCCC--CCCCCHHHHHHHHHHccCccccc
Confidence 9999999999999999999976433211000 0000000 0 0000 0112467889998844 55666
Q ss_pred CCCCHHHHHHHh
Q 011385 401 ARPLMSEVVEAL 412 (487)
Q Consensus 401 ~RPs~~ell~~L 412 (487)
.||++.+++.+-
T Consensus 295 ~R~~~~~~l~hp 306 (381)
T cd05626 295 GRNGADDIKAHP 306 (381)
T ss_pred CCCCHHHHhcCc
Confidence 699999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=361.09 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=197.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||+||+|.+.. +++.||||++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 478999999999999999998765 577999999965322 22345778999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccC
Confidence 999999999999999999998654 57899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc---------------------------------eeeeeccccccccCCceeccCCCCchhhhhhHHHHHH
Q 011385 287 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 333 (487)
Q Consensus 287 a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ 333 (487)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 011385 334 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS--RDPKARPLMSEVVEA 411 (487)
Q Consensus 334 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~ell~~ 411 (487)
||++|..||.......... .. ..... ... +.... ..+..+.+|+.+|+. .++..||++.||+++
T Consensus 228 ell~G~~Pf~~~~~~~~~~---~i---~~~~~---~~~---~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 228 EMLIGYPPFCSETPQETYK---KV---MNWKE---TLI---FPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHhCCCCCCCCCHHHHHH---HH---HcCcC---ccc---CCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999997543221110 00 00000 000 01100 123567888888664 233356899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.47 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=207.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc----CH----HHHHHHHHHHhcC-CCCCc
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----GH----KEWLAEVNFLGDL-VHLNL 198 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l-~HpnI 198 (487)
....|...+.||+|..++|-++.++. +|..+|+|++...... .. +.-..|+.||+++ -||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 44678889999999999999887765 7788999998543221 12 3356799999998 59999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
+.+.++|+.+..+|+|+|.|+.|.|+++|... -.+++.....|++|+.+|++|||..+ ||||||||+|||++++.+
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN 161 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence 99999999999999999999999999999543 57899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceecc------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
+||+|||+++...++.. ....||||+|+|||.+.. .+|+..+|+||+|||||-||.|.+||....+..
T Consensus 162 i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml--- 235 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML--- 235 (411)
T ss_pred eEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH---
Confidence 99999999999887764 345899999999999863 478999999999999999999999995432110
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..+..+.....+ -.|.+ .+.+....+||.+||+.||.+|.|+.|+|.+-.
T Consensus 236 ---MLR~ImeGkyqF---~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 236 ---MLRMIMEGKYQF---RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ---HHHHHHhccccc---CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 111111111111 11111 234567899999999999999999999998643
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.50 Aligned_cols=241 Identities=32% Similarity=0.339 Sum_probs=195.2
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||+|+||.||+|++.. +++.||+|+++... ......+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999998865 56789999986432 22335678899999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 72 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 9999999999998654 46899999999999999999999988 9999999999999999999999999998643222
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCc
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (487)
. .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..........
T Consensus 148 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~---------- 209 (312)
T cd05585 148 D--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP---------- 209 (312)
T ss_pred C--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC----------
Confidence 1 223467999999999999999999999999999999999999999753211 1111111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 411 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 411 (487)
..++...+..+.+|+.+||+.||.+||+ +.+++.+
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1122233467899999999999999985 5566554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=355.86 Aligned_cols=267 Identities=25% Similarity=0.355 Sum_probs=198.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||+|++.. +|..||||++.... ......+.+|+++++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 58889999999999999998765 57799999986432 22335688999999999999999999988643
Q ss_pred -----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 209 -----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 209 -----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
...|+|||||. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEcc
Confidence 24799999995 6899888544 46899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 011385 284 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 358 (487)
Q Consensus 284 FGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 358 (487)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999864332211 11234579999999998865 688999999999999999999999997543211111000000
Q ss_pred ------hhh--hcccccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 ------PHL--GERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ------~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... .....+...+.......+. ...+..+.+|+.+||+.||++||++.|++++
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0000000000000000000 0123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=362.15 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=208.2
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCC-CCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~ 204 (487)
...++|+++++||+|+||.||+|.+.... ....+..||||++...... ..+.+.+|+++|.++. |||||+++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 34578999999999999999999875321 1123557999999754332 2356889999999996 9999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-----------------------------------------------------
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 231 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 231 (487)
+.+.+..|||||||++|+|.++|..+.
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999885421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 232 ------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 232 ------------------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 23677888999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999986543322222233457789999999998999999999999999999997 99998653221
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. ... ..... .. ...+...+..+.+|+.+||+.||++||++.+|.+.|+.+
T Consensus 347 ~~--~~~----~~~~~------~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 347 ST--FYN----KIKSG------YR----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HH--HHH----HHhcC------CC----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 10 000 00000 00 011123456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=362.79 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=201.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||.||+|++.. +|+.||||++..... .....+.+|+.+|..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 478999999999999999999865 577999999965322 22345778999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeeccc
Confidence 999999999999999999998654 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce------------------------------------eeeeccccccccCCceeccCCCCchhhhhhHHH
Q 011385 287 AKDGPEGDKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 330 (487)
Q Consensus 287 a~~~~~~~~~~------------------------------------~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGv 330 (487)
++......... .....+||+.|+|||++....++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 87543211000 011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 011385 331 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSE 407 (487)
Q Consensus 331 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e 407 (487)
++|||++|..||........ .... ......+ .. ... ...+..+.+||.+||. +|.+|++ +.+
T Consensus 228 il~el~~G~~Pf~~~~~~~~---~~~i---~~~~~~~-~~-----~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQET---YRKI---INWKETL-QF-----PDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHH---HHHH---HcCCCcc-CC-----CCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 99999999999975432111 0000 0000000 00 000 0124678899999996 9999998 888
Q ss_pred HHHHh
Q 011385 408 VVEAL 412 (487)
Q Consensus 408 ll~~L 412 (487)
++++-
T Consensus 293 ll~h~ 297 (364)
T cd05599 293 IKSHP 297 (364)
T ss_pred HhcCC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=359.78 Aligned_cols=268 Identities=23% Similarity=0.249 Sum_probs=205.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
...+|++++.||+|+||.||+|..... .++..||||.+... ..+.+|+++|+.++|||||++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 346899999999999999999976432 24678999988653 345689999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
....|+|||++. ++|.+++ .....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred CCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence 999999999995 6898888 44467999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc---
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--- 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--- 364 (487)
+...............||+.|+|||++.+..|+.++|||||||+||||++|+.||.+................+...
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 87654333222334679999999999999999999999999999999999999997655432211111110000000
Q ss_pred -------------cccccccCCcc--CCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 -------------RRFYRLIDPRL--EGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 -------------~~~~~~~~~~~--~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+.....+.. ...+ ....+..+.+||.+||..||++||++.|++.+-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000000000 0000 001235688999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=359.29 Aligned_cols=264 Identities=20% Similarity=0.213 Sum_probs=200.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
...+|++++.||+|+||.||+|.+.. +++.||||.... ..+.+|+++|++|+|||||++++++..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 34689999999999999999998865 677999997542 356799999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
....++|||++. ++|..++... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 999999999994 6898888544 46899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc----hhhHhhhhhhhc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----NLVEWARPHLGE 363 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~----~~~~~~~~~~~~ 363 (487)
+........ .....+||+.|+|||++.+..|+.++|||||||+||||++|..||......... ............
T Consensus 230 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred ccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 754322111 123467999999999999999999999999999999999999887543221100 000000000000
Q ss_pred ------------ccccc----c--ccCCccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 ------------RRRFY----R--LIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ------------~~~~~----~--~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....+ . ...+.....+ ....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00000 0 0000000000 012355788999999999999999999999743
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.52 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=202.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC-
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD- 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 209 (487)
.|...+++|.|+||.||+|.... +++.||||++-.+.. ---+|+++|+.++|||||++..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 56777899999999999999876 467999999865532 2237999999999999999998886432
Q ss_pred ----eeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEE
Q 011385 210 ----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKL 281 (487)
Q Consensus 210 ----~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl 281 (487)
.+.|||||++. +|.+.+.. .+..++...+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||
T Consensus 92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence 33489999976 99988863 3567888889999999999999999988 9999999999999977 99999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 358 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 358 (487)
||||.|+....+... ....-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.........+....
T Consensus 168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 999999988765543 33567899999998875 589999999999999999999999998865443322221111
Q ss_pred hhhhc---------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGE---------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+...+ ...+.++....+..-+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00000 011112222222122444556889999999999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=356.85 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=195.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|+.++.||+|+||.||+|++.. +|+.||||++...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 456778899999999999998765 5679999998654322 235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.+++||||+++|+|.+.. ...+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999986532 3567778899999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
....... ......||..|+|||++.. ..++.++|||||||++|||++|+.||..........+..... ..
T Consensus 217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~- 291 (353)
T PLN00034 217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MS- 291 (353)
T ss_pred ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--cc-
Confidence 6543211 1233579999999998743 234568999999999999999999997332221111110000 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. ........+..+.+||.+||+.||++||++.||+++-
T Consensus 292 -------~----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 292 -------Q----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred -------C----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 0111123356789999999999999999999999854
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=340.02 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=209.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+..... +...||||.++..... ...++.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 3578999999999999999999865321 3457999998754332 23568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence 99999999999999999999776667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~ 226 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDGYR 226 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCC
Confidence 87653222222222345678999999998899999999999999999998 99998543211 111110 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus 227 ----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 ----------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001112346789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=353.21 Aligned_cols=248 Identities=29% Similarity=0.384 Sum_probs=197.7
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
++.||+|+||.||+++..... .+++.||||+++.... .....+..|+.+|+.++||||+++++++..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 368999999999999875322 2578999999875322 223456789999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.|+||||+++|+|.+++.+. ..+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 99999999999999998554 46888889999999999999999988 999999999999999999999999998754
Q ss_pred CCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
..... .....+||+.|+|||++.+..++.++|||||||+||||++|..||....... ... ......
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~---~~~~~~------ 216 (323)
T cd05584 151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TID---KILKGK------ 216 (323)
T ss_pred ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCC------
Confidence 32221 1233579999999999998899999999999999999999999997543211 000 000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
. .++...+..+.+|+.+||+.||++|| ++.+++++-
T Consensus 217 --~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 217 --L----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred --C----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 0 11112346788999999999999999 788877653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=351.43 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=206.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|++.+.||+|+||.||+|.+...+. .....||||.++.... ...+++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGE-----KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCC-----ccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 3579999999999999999998765322 1234599999875432 234678899999999999999999999876
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
. ..++|+||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccc
Confidence 4 568999999999999999776667899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +.. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~ 229 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER 229 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCCCC
Confidence 87654333222222345678999999999999999999999999999998 999986532211 110 0010000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. .+..++..+.+|+.+||..||.+||++.+++..|..+.
T Consensus 230 ---~~-------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 ---LP-------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ---CC-------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 01123456889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.80 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=208.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..+.|++.+.||+|.|+.||++.+.. +|+.+|+|+++.... .+.+++.+|++|-+.|+|||||++...+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 45678888899999999999987654 788999999865433 3567899999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~~kl~ 282 (487)
......|||+|+++|++|..-|..+ ..+++..+-.+++||+++|.|+|.++ |||||+||+|+||... --+||+
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 9999999999999999997766544 45788889999999999999999988 9999999999999543 458999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+|.....+. .-...+|||.|||||++...+|+..+|||+.|||||-||.|.+||.+.... .+.+.. ..
T Consensus 156 ~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I---~~ 226 (355)
T KOG0033|consen 156 DFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQI---KA 226 (355)
T ss_pred ccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH---hc
Confidence 999999877332 234478999999999999999999999999999999999999999763321 111110 01
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.. -.+++..+... .+.+++|+++||..||.+|.|+.|.|++-+
T Consensus 227 g~----yd~~~~~w~~i----s~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 227 GA----YDYPSPEWDTV----TPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred cc----cCCCCcccCcC----CHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 10 11233233333 467899999999999999999999998765
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.27 Aligned_cols=253 Identities=26% Similarity=0.304 Sum_probs=197.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
+|++++.||+|+||.||+|+... +++.||||++..... .....+.+|+.+++.++|+|||++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58889999999999999998765 577999999965432 223467889999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCC
Confidence 99999999999999999998654 46889999999999999999999988 999999999999999999999999997
Q ss_pred CCCCCCC---------------------------------------------cceeeeeccccccccCCceeccCCCCch
Q 011385 288 KDGPEGD---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSR 322 (487)
Q Consensus 288 ~~~~~~~---------------------------------------------~~~~~~~~~Gt~~y~APE~~~~~~~~~~ 322 (487)
+...... ........+||+.|+|||++.+..|+.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0000123579999999999999999999
Q ss_pred hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011385 323 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402 (487)
Q Consensus 323 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 402 (487)
+|||||||+||||++|+.||....+..... . ....... ...+ .....+..+.+||.+|+ .+|.+|
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~---~---i~~~~~~---~~~p-----~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQM---K---VINWQTS---LHIP-----PQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHH---H---HHccCCC---cCCC-----CcccCCHHHHHHHHHHc-cCHhHc
Confidence 999999999999999999997543321100 0 0000000 0000 01122456788888876 599999
Q ss_pred CC---HHHHHHH
Q 011385 403 PL---MSEVVEA 411 (487)
Q Consensus 403 Ps---~~ell~~ 411 (487)
++ +.+++++
T Consensus 294 ~~~~~~~ei~~h 305 (382)
T cd05625 294 LGKNGADEIKAH 305 (382)
T ss_pred CCCCCHHHHhcC
Confidence 97 7777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.17 Aligned_cols=254 Identities=24% Similarity=0.272 Sum_probs=203.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|.+.+.||+|+||.||+|.... +|+.||||+++.... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 468899999999999999998765 577999999975432 22345788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCC
Confidence 999999999999999999999776567999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceec------cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
+......... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ . ...
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~---~~i 221 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT---Y---NNI 221 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH---H---HHH
Confidence 9876443222 223357999999999886 45688999999999999999999999975432110 0 000
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. .......... ....+..+.+|+.+||. ||.+||++.+++++
T Consensus 222 ~-~~~~~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 222 M-NFQRFLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred H-cCCCccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0000000000 01234678899999997 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.59 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=201.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCC-CceeEEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHL-NLVKLIGYCI 206 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hp-nIv~~~~~~~ 206 (487)
+|++++.||+|+||.||+|.... +++.||||++..... ...+.+..|++++..+.|+ +|+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 58889999999999999998765 567899999975422 2345678899999999765 5888999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCc
Confidence 999999999999999999988544 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ...
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~--- 216 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI---MEH--- 216 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC---
Confidence 875332221 123467999999999999999999999999999999999999999754321 111100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCCcc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKD 420 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~L~~l~~~~~ 420 (487)
. ..++...+..+.+|+.+||..||.+|++.. +..+.+..++.+..
T Consensus 217 -----~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 217 -----N----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred -----C----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 0 111222346788999999999999999862 23333444444433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=356.10 Aligned_cols=244 Identities=30% Similarity=0.378 Sum_probs=196.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
+.||+|+||.||++.+.. +|..||+|++..... .....+..|++++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999998765 577999999975422 22345778999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|||||+++|+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 999999999999888544 468999999999999999999997 56 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......||+.|+|||++.+..++.++|||||||+||||++|..||....... .... ....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~---i~~~-------- 211 (325)
T cd05594 148 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILME-------- 211 (325)
T ss_pred CCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHH---HhcC--------
Confidence 2211 1233579999999999999999999999999999999999999996543211 1100 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
... ++...+..+.+|+.+||+.||++|+ ++.+++++.
T Consensus 212 ~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 212 EIR----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCC----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 001 1112346788999999999999996 899998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=363.90 Aligned_cols=255 Identities=24% Similarity=0.270 Sum_probs=199.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||.||+|++.. +++.||||++..... .....+.+|+.+|+.++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 378999999999999999998765 577999999864322 22355789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++.+|||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 999999999999999999998654 46889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCC-----------------------------------------cceeeeeccccccccCCceeccCCCCchhhh
Q 011385 287 AKDGPEGD-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 325 (487)
Q Consensus 287 a~~~~~~~-----------------------------------------~~~~~~~~~Gt~~y~APE~~~~~~~~~~~Di 325 (487)
+....... ........+||+.|||||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 75321000 0000123579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC--
Q 011385 326 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-- 403 (487)
Q Consensus 326 wSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-- 403 (487)
|||||+||||++|..||...........+ ..... ....... ...+..+.+||.+|+ .+|.+|+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~~---~~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKV-------INWET---TLHIPSQ----AKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHH-------hccCc---cccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999999999999765432111000 00000 0000001 122456788999877 5999999
Q ss_pred -CHHHHHHHh
Q 011385 404 -LMSEVVEAL 412 (487)
Q Consensus 404 -s~~ell~~L 412 (487)
++.+++++-
T Consensus 293 ~t~~ell~h~ 302 (376)
T cd05598 293 NGADEIKAHP 302 (376)
T ss_pred CCHHHHhCCC
Confidence 889998763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=345.14 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=197.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC---CCCCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~~~~~ 204 (487)
++|++.+.||+|+||.||+|.+... +|..||||.++..... ....+.+|+.++..+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 3789999999999999999987432 3568999998654322 224566777777665 69999999998
Q ss_pred EE-----eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 205 CI-----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 205 ~~-----~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
+. ....+++||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence 85 2456899999996 6999988654 345899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~ 357 (487)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...........+ ...
T Consensus 149 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 149 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred EEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 9999999998654321 223457999999999998889999999999999999999999999765432211111 000
Q ss_pred hhhh-hcccccc----cccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 RPHL-GERRRFY----RLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~~~~-~~~~~~~----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... .+..... ....+.. ...+....+..+.+|+.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0000000 0000000 000111234677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.54 Aligned_cols=264 Identities=30% Similarity=0.440 Sum_probs=217.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.....+.+.||+|+||.||.|......... ....||||.++... .+...+|++|..+|+.++|||||+++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 456677889999999999999987633210 13469999997653 3445789999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
....+|++|||++|+|..+|++. ...+.....+.++.|||+|+.||++++ +|||||..+|+||+....+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence 99999999999999999999876 567899999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
+|||+|+.....+.+.......-...|||||.+..+.|+.++|||||||+|||++| |..||...........+
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------ 917 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------ 917 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------
Confidence 99999997666665554444344579999999999999999999999999999999 88999765543221111
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
+.. . ++. .+..|+..+.+||..||+.+|++||++..|++.+..+.
T Consensus 918 ~~g-g---RL~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 918 LEG-G---RLD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HhC-C---ccC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 111 1 111 22346778999999999999999999999999776553
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.88 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|.+++.||+|+||.||+|.... +|+.||||++..... .....+.+|++++..++|||||++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 378899999999999999998765 577999999864322 22345788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..|||||||++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999998644 56889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc---------------------------------------------eeeeeccccccccCCceeccCCCCc
Q 011385 287 AKDGPEGDKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTS 321 (487)
Q Consensus 287 a~~~~~~~~~---------------------------------------------~~~~~~~Gt~~y~APE~~~~~~~~~ 321 (487)
++........ ......+||+.|+|||++.+..|+.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9643211000 0001246999999999999999999
Q ss_pred hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 011385 322 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 401 (487)
Q Consensus 322 ~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 401 (487)
++|||||||+||||++|..||........ .... ...... + .+... ...+..+.+||.+||. +|.+
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~i---~~~~~~----~--~~p~~--~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHET---YRKI---INWRET----L--YFPDD--IHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHH---HHHH---HccCCc----c--CCCCC--CCCCHHHHHHHHHHhc-CHhh
Confidence 99999999999999999999965432111 0000 000000 0 00000 0124578899999997 7776
Q ss_pred C---CCHHHHHHHhc
Q 011385 402 R---PLMSEVVEALK 413 (487)
Q Consensus 402 R---Ps~~ell~~L~ 413 (487)
| +++.+++++..
T Consensus 293 r~~r~~~~~~l~hp~ 307 (377)
T cd05629 293 RLGRGGAHEIKSHPF 307 (377)
T ss_pred cCCCCCHHHHhcCCC
Confidence 5 59999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=336.94 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=202.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|++.+.||+|+||.||++.+.. +..+|+|.+..... ...++.+|+.+|+.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468888999999999999998753 34799998864432 3467889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccc
Confidence 999999999999999998765557899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....... .. .
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~----~~---~ 218 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMIS----RG---F 218 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CC---C
Confidence 5432211 1122345678999999988899999999999999999999 89999654321 1111110 00 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....+ ...+..+.+|+.+||+.||++||++.++++.|
T Consensus 219 ~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 219 RLYRP-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01111 11235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=355.45 Aligned_cols=265 Identities=28% Similarity=0.414 Sum_probs=206.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++|++.++||+|+||.||+|.....+ ...+++.||+|+++..... ..+.+..|+.++.++ +|+||+++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 4568999999999999999999764321 1235678999998754322 235678899999999 899999999987
Q ss_pred Ee-CCeeEEEEeeCCCCChhHHHhhcC-----------------------------------------------------
Q 011385 206 IE-DDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 231 (487)
Q Consensus 206 ~~-~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 231 (487)
.. +..++++|||+++++|.++|....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 456789999999999999985321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccc
Q 011385 232 -------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304 (487)
Q Consensus 232 -------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 304 (487)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 25789999999999999999999988 99999999999999999999999999987644332222233456
Q ss_pred cccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHH
Q 011385 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 383 (487)
Q Consensus 305 t~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (487)
+..|+|||++.+..++.++|||||||+||||++ |..||........ +.. .+.... ....+...
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~----------~~~~~~~~ 301 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGT----------RMRAPEYA 301 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccC----------CCCCCccC
Confidence 778999999999999999999999999999998 9999965332111 100 111100 00111123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 384 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 384 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...+.+|+.+||+.+|++||++.||+++|+.+
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 46789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=336.33 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=198.3
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+++++.++||||+++++++......+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 469999999999998865 466899998864432 2235688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc
Confidence 9999999999999766667899999999999999999999988 9999999999999999999999999998654322
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
.........++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... ... ...
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~----~~~------~~~-- 213 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TRE----AIE------QGV-- 213 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHH----HHH------cCC--
Confidence 1111111123467999999998899999999999999999998 888886432211 000 000 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...++...+..+.+|+.+||+.||++||++.++++.|+
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 --RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11112233567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.74 Aligned_cols=261 Identities=30% Similarity=0.435 Sum_probs=208.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|.+.+.||+|+||.||+|.+.... ...++..||||.++..... ..+.+.+|+++|..+.|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 356888899999999999999875421 1124568999999765443 34678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS-------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
....++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEc
Confidence 999999999999999999996432 34788889999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 353 (487)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~ 233 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---V 233 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence 999999999999976533322222233456789999999999999999999999999999998 999986543211 1
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..... . . .....+...+..+.+|+.+||+.||++||++.||++.|+
T Consensus 234 ~~~~~---~--~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECIT---Q--G---------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHH---c--C---------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11110 0 0 000111123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=360.35 Aligned_cols=255 Identities=29% Similarity=0.359 Sum_probs=205.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|.+.+.||+|+||.||+|++.. +|+.||||+++.... .....+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 378899999999999999998865 577999999975422 23456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++..|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999999999999999665 57899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCC---------------------------cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCC
Q 011385 287 AKDGPEGD---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339 (487)
Q Consensus 287 a~~~~~~~---------------------------~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 339 (487)
++...... .........||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98654432 001123357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHh
Q 011385 340 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 412 (487)
Q Consensus 340 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L 412 (487)
.||.......... .... ... ....+. .. ..+..+.+||.+||. ||.+||+ +.+++++.
T Consensus 228 ~Pf~~~~~~~~~~------~i~~-~~~--~~~~p~-~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 228 PPFYSDTLQETYN------KIIN-WKE--SLRFPP-DP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCCCCCHHHHHH------HHhc-cCC--cccCCC-CC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 9997654211100 0000 000 000000 00 135678999999997 9999999 99999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=343.14 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=205.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+... ....++..||||.+..... ....++.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 457899999999999999999987531 1223567899999864332 23356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
.....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCC
Confidence 9999999999999999999986432 23567888999999999999999987 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 356 (487)
.++|+|||+++...............+++.|||||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~ 233 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRF 233 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986544332222223456788999999998899999999999999999999 68888654321 11111
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.. .. .+ ..++...+..+.+|+.+||+.||++||++.|+++.|+
T Consensus 234 ~~----~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VM----EG-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH----cC-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 00 00 0111123457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.05 Aligned_cols=242 Identities=29% Similarity=0.372 Sum_probs=195.2
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 213 (487)
+.||+|+||.||+++.... ..+|..||+|++...... ....+..|+++|.+++||||+++++++.+++..||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITG------PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEecc------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 5799999999999986432 236889999999754322 23457789999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 99999999999998544 46899999999999999999999988 999999999999999999999999999865432
Q ss_pred CcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 294 ~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 152 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~---i~~~~--------- 214 (318)
T cd05582 152 EK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTM---ILKAK--------- 214 (318)
T ss_pred CC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHH---HHcCC---------
Confidence 21 123467999999999999889999999999999999999999999754321 11110 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 407 (487)
..++...+..+.+|+.+||+.||.+||++.+
T Consensus 215 ---~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 ---LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0111223467889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=367.48 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=196.9
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC------CCc
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH------LNL 198 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------pnI 198 (487)
+....++|+++++||+|+||+||+|++.. +++.||||+++... ....++..|++++..+.| .+|
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 34456889999999999999999998865 56789999996432 122345667777776654 458
Q ss_pred eeEEEEEEeC-CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCC
Q 011385 199 VKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 199 v~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~ 276 (487)
+.+++++..+ .++|||||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.+
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETS 268 (467)
T ss_pred eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecC
Confidence 8999988764 5788999998 77899988654 468999999999999999999997 46 9999999999999876
Q ss_pred C----------------cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCC
Q 011385 277 Y----------------NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 340 (487)
Q Consensus 277 ~----------------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 340 (487)
+ .+||+|||++..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 5 499999998865322 1234689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhHhhhhhhh----------cccccccc---cCCccC-----------CCCCHHHHHHHHHHHHHhcc
Q 011385 341 SMDKNRPNGEHNLVEWARPHLG----------ERRRFYRL---IDPRLE-----------GHFSIKGAQKAAQLAAHCLS 396 (487)
Q Consensus 341 pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---~~~~~~-----------~~~~~~~~~~l~~li~~cl~ 396 (487)
||...........+......+. +...+... +.+... ..........+.+||.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 9976543222111111100000 00000000 000000 00000123567899999999
Q ss_pred cCCCCCCCHHHHHHHhc
Q 011385 397 RDPKARPLMSEVVEALK 413 (487)
Q Consensus 397 ~dP~~RPs~~ell~~L~ 413 (487)
.||.+|||+.|+|+|-.
T Consensus 424 ~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPY 440 (467)
T ss_pred cChhhCCCHHHHhcCcc
Confidence 99999999999998654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=351.32 Aligned_cols=250 Identities=30% Similarity=0.368 Sum_probs=194.6
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||+||+|++.. +|+.||||++..... ....++..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 479999999999999865 577999999865322 12234555555 56789999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 9999999999999988554 57899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~------- 212 (323)
T cd05575 148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKP------- 212 (323)
T ss_pred cCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC-------
Confidence 2221 2334679999999999999999999999999999999999999996542211 110011100
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 418 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 418 (487)
..+.. ..+..+.+|+.+||+.||.+||++.+.+..+...+.+
T Consensus 213 -~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 213 -LRLKP----NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred -CCCCC----CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 01111 2246788999999999999999986433333334443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=341.96 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=206.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|++.+.||+|+||.||+|.+...+. ..+..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 578889999999999999998643221 2467899999975432 2235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR----------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
+..|+||||+++++|.+++..+ ...+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence 9999999999999999998532 124788889999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 351 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 351 (487)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--- 233 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--- 233 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999987544332222333456778999999988889999999999999999998 98898654321
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.+...... . .. . ..+..++..+.+++.+||+.||.+||++.+|+++|+.
T Consensus 234 ~~~~~~~~----~-~~-----~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRK----R-QL-----L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHc----C-Cc-----C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111110 0 00 0 0111234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=350.47 Aligned_cols=242 Identities=29% Similarity=0.425 Sum_probs=192.8
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhc-CCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||.||+|.+.. +++.||||+++.... .....+..|..++.. ++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999998865 567899999975421 223445667777765 4899999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 9999999999999988554 46899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+... ....
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~---i~~~-------- 211 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDS---ILND-------- 211 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHcC--------
Confidence 322 1233467999999999999889999999999999999999999999754321 11110 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 410 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 410 (487)
.+ .++...+..+.+|+.+||+.||.+||++. ++++
T Consensus 212 ~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11 11222346788999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=350.77 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=195.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
++||+|+||.||+|++.. ++..||||+++.... .....+..|+.++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 479999999999998865 567999999975432 2234577899999988 799999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 9999999999999888544 57999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC--cchhhHhhhhhhhccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 369 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----- 220 (329)
T cd05588 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----- 220 (329)
T ss_pred cCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-----
Confidence 2111 1234679999999999999999999999999999999999999996432211 111111111111000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL------MSEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ell~~ 411 (487)
...+.. ..+..+.+|+.+||+.||.+|++ +.+++++
T Consensus 221 --~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 --QIRIPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 001111 23457889999999999999998 5666653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=351.17 Aligned_cols=237 Identities=29% Similarity=0.404 Sum_probs=191.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||.||+|++.. ++..||||++.... ......+..|+.++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999998865 56799999986532 12335577888888876 699999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 9999999999999988554 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... +... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~---i~~~~------- 212 (320)
T cd05590 148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEA---ILNDE------- 212 (320)
T ss_pred cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH---HhcCC-------
Confidence 2221 2234679999999999999999999999999999999999999997543211 1111 01000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
. .++...+..+.+|+.+||+.||.+||++
T Consensus 213 -~----~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -V----VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -C----CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 0111234678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=365.24 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=196.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
...+|++.+.||+|+||.||+|.+.. ++..||||++.... ....+|+.+|+.++|||||++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 34689999999999999999998765 57799999986442 334579999999999999999988643
Q ss_pred C--------CeeEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 208 D--------DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 208 ~--------~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
. ..+++||||+++ +|.+++. .....+++..++.++.||+.||.|||+.+ ||||||||+||||+.+
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~ 206 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPN 206 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCC
Confidence 2 246799999975 7777664 23567899999999999999999999988 9999999999999866
Q ss_pred C-cEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 277 Y-NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 277 ~-~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+ .+||+|||+++....... .....||+.|+|||++.+ ..|+.++|||||||+||||++|.+||.+.........+
T Consensus 207 ~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 207 THTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred CCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4 699999999987644322 223578999999998865 47999999999999999999999999765432111100
Q ss_pred Hhhh--hhhhcc---------cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 355 EWAR--PHLGER---------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 355 ~~~~--~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... +..... ..+.......+...++...+.++.+||.+||+.||.+||++.|++++-
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0000 000000 000000001111112223356789999999999999999999999764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=343.82 Aligned_cols=264 Identities=30% Similarity=0.448 Sum_probs=209.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|.+.+.||+|+||.||++...... ...++..||+|.+..........+.+|+.++.+++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 457889999999999999999764311 1224567999998765544456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999999986432 24899999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 355 (487)
+.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE 233 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999986544332222233456788999999998999999999999999999998 899986543211 111
Q ss_pred hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
... .. .. ..... ..+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 234 ~i~----~~-~~-----~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CIT----QG-RV-----LQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHH----cC-Cc-----CCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 100 00 00 00111 12357899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=351.02 Aligned_cols=242 Identities=25% Similarity=0.341 Sum_probs=195.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
+|++.+.||+|+||.||+|++.. ++..||||+++.... .....+..|..++..+ +|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 58889999999999999998765 567999999975432 2234467788888777 5899999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+.+||||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCC
Confidence 999999999999999999988554 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.... ...
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i---~~~--- 216 (323)
T cd05616 148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---MEH--- 216 (323)
T ss_pred ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC---
Confidence 975432221 123467999999999999999999999999999999999999999754321 111100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
...++...+..+.+|+.+||+.||.+|++.
T Consensus 217 ---------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 ---------NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011122334678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=369.21 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=204.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|.+.+.||+|+||+||+|++.. +|+.||||++...... ....+.+|+.++..++|+||++++..+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 44689999999999999999998765 5779999999765432 234578899999999999999998877
Q ss_pred EeCC--------eeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 206 IEDD--------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 206 ~~~~--------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
...+ .+++||||+++|+|.++|..+ ...+++..+..++.||+.||.|||+.+ |+||||||+||||+
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~ 177 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC 177 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence 5432 367999999999999998643 346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
.++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||+||||++|..||...... .+.
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~ 254 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVM 254 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHH
Confidence 99999999999998754332222234468999999999999999999999999999999999999999653211 111
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ..... ..+ .++...+..+.+|+.+||+.||.+||++.+++++
T Consensus 255 ~---~~~~~------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 H---KTLAG------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred H---HHhcC------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 00000 000 1122335678999999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=341.93 Aligned_cols=253 Identities=30% Similarity=0.409 Sum_probs=203.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.|++.++||+|+||.||++.+.. ++..||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47888999999999999998764 5679999998654322 22456789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999888654 346899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... .....|++.|+|||++.+..++.++|||||||++|||++|..||............. ..+..
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~--- 219 (285)
T cd05605 149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE--- 219 (285)
T ss_pred ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh---
Confidence 987543221 223578999999999998899999999999999999999999997543221111000 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
....++...+..+.+|+.+||..||.+|| ++.+++++-
T Consensus 220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 01112223456789999999999999999 788887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=343.06 Aligned_cols=263 Identities=29% Similarity=0.439 Sum_probs=210.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|.+.+.||+|+||.||+|.+..... ..++..+++|.+........+.+.+|+++++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 468888999999999999998643211 1245579999987666555567899999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 9999999999999999996432 34789999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 353 (487)
.++.++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V 234 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999986544332222333557889999999999999999999999999999999 999986543211 1
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.... ... . ........+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 235 ~~~~----~~~-~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 235 IECI----TQG-R---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHH----hCC-C---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1110 000 0 00111123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=350.57 Aligned_cols=243 Identities=27% Similarity=0.382 Sum_probs=195.1
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
++||+|+||.||+|++.. +++.||||+++.... .....+..|++++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 469999999999998764 577999999975422 2234577899998866 799999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999999988544 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~---i~~~~------- 212 (321)
T cd05591 148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFES---ILHDD------- 212 (321)
T ss_pred cCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCC-------
Confidence 2221 2234679999999999998999999999999999999999999997543211 1111 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-------LMSEVVEA 411 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~ell~~ 411 (487)
. .++...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 213 -~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 -V----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 01112246788999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=338.08 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=206.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....++.+|+++++.++|+||+++++++..+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 3568888999999999999998865 46689999987543 3346789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccc
Confidence 9999999999999999998654 345899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .... +.
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~---- 219 (263)
T cd05052 152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LE---- 219 (263)
T ss_pred cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HH----
Confidence 876543221 1112234678999999988999999999999999999998 899986542211 1000 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. ....++...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 220 --~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 --KG----YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CC----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00 11112223356789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=349.10 Aligned_cols=243 Identities=28% Similarity=0.395 Sum_probs=194.0
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||.||+|++.. +|..||||+++.... .....+..|..++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 479999999999998865 577999999975421 2234567788888754 899999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+.+|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 9999999999999988554 56899999999999999999999988 9999999999999999999999999987533
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+..... ..
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~-----------~~ 211 (316)
T cd05620 148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIR-----------VD 211 (316)
T ss_pred cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----------hC
Confidence 2221 233467999999999999999999999999999999999999999754321 1111100 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 411 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~ 411 (487)
.+.+. ...+.++.+|+.+||+.||.+||++. +++++
T Consensus 212 ~~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 212 TPHYP----RWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11111 12346788999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=349.29 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=195.1
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
++||+|+||.||+|++.. +++.||+|+++.... .....+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 479999999999998865 567999999975422 2234577899988876 799999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+++|+|..++... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 9999999999999888544 56899999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc--chhhHhhhhhhhccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 369 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ .....+.......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------ 219 (329)
T cd05618 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------ 219 (329)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc------
Confidence 2111 12346799999999999999999999999999999999999999964222111 1111111100000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 411 (487)
. ...++...+..+.+|+.+||+.||.+||++ .+++++
T Consensus 220 ---~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 220 ---K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 0 001222234678899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.44 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=199.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||++++.. +++.||||++..... ...+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 478999999999999999998865 567999999864221 22345788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++.+||||||+++|+|.+++.+....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCc
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
+......... .....+||+.|||||++.. ..++.++|||||||++|||++|+.||....... ......
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~ 221 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM 221 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHH
Confidence 8765432221 1223469999999999863 457889999999999999999999996542211 000000
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 412 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 412 (487)
.. .....+ .+ .. ...+..+.+|+.+||..++.+ |+++.+++++-
T Consensus 222 ~~-~~~~~~-~~-~~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 222 NH-KEHFQF-PP-DV----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred cC-CCcccC-CC-cc----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 00 000000 00 00 113467889999988654443 78999998864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.85 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=195.9
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||+|+||+||++.+.. +|+.||+|.+...... ..+.+..|+++++.++|+||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999998765 5779999998654322 224567899999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 215 YEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999988743 3456899999999999999999999988 9999999999999999999999999997654
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. ...
T Consensus 149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~----------~~~ 214 (280)
T cd05608 149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQ----------RIL 214 (280)
T ss_pred CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HH----------hhc
Confidence 4322 123357999999999999999999999999999999999999999754322111000 00 000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
.. ...++...+..+.+|+.+||+.||++|| ++.+++++
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 ND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 0112223456789999999999999999 56666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.34 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=204.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|++.+.||+|+||+||+|.+..++.. ....|++|.+..... ....++..|+.+++.++||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 5788899999999999999998653221 122588888854322 22356778899999999999999999875 4
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+++|+|.+++......+++..++.|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 5678999999999999999776677999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
...............|+..|+|||++.+..++.++|||||||++|||++ |..||.........++. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~- 229 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGER- 229 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCc-
Confidence 7644333222334567789999999988899999999999999999998 99999754322111111 00000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
...+ ..++..+.+++.+||..||.+||++.|+++.|..+.
T Consensus 230 --~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 --LAQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred --CCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0011 112356788999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.07 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=222.2
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC-CccCHHHHHHHHHHHhcCCCCCcee
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
...+.+......+.++||.|.||.||+|.+.... ++...-||||.++.+ ...+.+.|+.|.-+|++++|||||+
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhh
Confidence 3344455666777889999999999999997642 344567999999874 4455678999999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
++|+|.+ ...|||||+++.|.|..||..+...++......++.||+.||.|||+.. +|||||..+|||+.....+|
T Consensus 456 LIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 456 LIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred eeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceee
Confidence 9999875 4679999999999999999988888999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||+++...+....... ...-...|||||.+.-..++.++|||.|||+|||+|. |..||.+-...+..-.+
T Consensus 532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----- 605 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----- 605 (974)
T ss_pred ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-----
Confidence 9999999998877665433 3445678999999999999999999999999999876 99999865443221111
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.... .-..+..|++.+..|+.+||+.||.+||.+.||...|..+.
T Consensus 606 --EnGe----------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 606 --ENGE----------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred --cCCC----------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 1111 11234467788999999999999999999999999987653
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=339.74 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=210.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCC-------ccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCcee
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~-------~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
..+|++.+.||+|+||.||+|.+...+... .....+..||+|.+...... ....+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999886533211 12234567999998765432 3456889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
+++++..++..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCC
Q 011385 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPN 348 (487)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~~~~ 348 (487)
||++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986544333333334567889999999988899999999999999999998 6677754321
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.............. ........+..++.++.+|+.+||+.||.+||++.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111110000 000001111223467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.72 Aligned_cols=265 Identities=26% Similarity=0.346 Sum_probs=210.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|||+-||++.... ++..||+|++.....++.+..++|++..++++||||++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 345789999999999999999998654 67799999998888777888999999999999999999988765
Q ss_pred eC-----CeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 207 ED-----DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
.+ ...||+++|...|+|.+.+.+. +..+++.+++.|+.+|++||++||+.. .++.||||||.|||+.+.+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence 43 3589999999999999998643 457999999999999999999999987 47999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcce-------eeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 011385 279 AKLSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 348 (487)
++|.|||.++...-.-... .-.....|..|.|||.+. +...+.++|||||||+||+|+.|..||+.....
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 9999999998643211110 001134688999999886 446789999999999999999999999754332
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.--. ..+.++.+...-....+..+.+|+++||+.||.+||++.+++..++.+
T Consensus 248 GgSla--------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 GGSLA--------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred CCeEE--------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 21100 011111111111111457899999999999999999999999988765
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.69 Aligned_cols=242 Identities=28% Similarity=0.428 Sum_probs=193.4
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhc-CCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||.||+|.+.. ++..||||+++.... .....+..|..++.. ++||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999998865 567899999975421 223456678888876 4899999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
+|||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 9999999999999988543 46889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+..... ..
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~-----------~~ 211 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR-----------MD 211 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----------hC
Confidence 2221 123467999999999999999999999999999999999999999754321 1111100 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVE 410 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~ 410 (487)
.+. ++...+..+.+|+.+||+.||.+||++. ++++
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111 1112345788999999999999999997 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=357.73 Aligned_cols=257 Identities=23% Similarity=0.280 Sum_probs=203.2
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
...++|++.+.||+|+||.||+|++.. ++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 445789999999999999999998865 577999999964321 22345778999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++.+++..|||||||++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999999988543 5788889999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccC----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
||+++....... ......+||+.|+|||++.+. .++.++|||||||+||||++|..||........ .. .
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~ 258 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS---K 258 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HH---H
Confidence 999986543221 112345799999999988653 488999999999999999999999975432111 00 0
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 412 (487)
....... . .+.. ....+..+.+||.+||..+|.+ |+++.+++++-
T Consensus 259 i~~~~~~---~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 259 IMDHKNS---L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHcCCCc---C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0000000 0 0000 0123467899999999999988 99999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=346.29 Aligned_cols=238 Identities=28% Similarity=0.367 Sum_probs=188.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
++||+|+||.||+|++.. +|..||+|++..... .....+..|+. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 479999999999998865 567999999865322 12234555554 67889999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|||||||++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 999999999999988854 356888999999999999999999988 9999999999999999999999999987642
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.. ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~~~------- 212 (321)
T cd05603 148 EPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NILHKP------- 212 (321)
T ss_pred CCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHhcCC-------
Confidence 2221 223467999999999999889999999999999999999999999654211 1110 000000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 406 (487)
..++...+..+.+++.+||+.||.+||++.
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 011112345788999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=348.50 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=195.3
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||+||+|++.. ++..||+|++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 469999999999998865 566899999865321 12234445544 56788999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+||||+++|+|.+++... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 9999999999999988554 46788888999999999999999988 9999999999999999999999999997643
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~~~~------- 212 (325)
T cd05602 148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDN---ILNKP------- 212 (325)
T ss_pred cCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHH---HHhCC-------
Confidence 2221 2234679999999999999999999999999999999999999997543211 1110 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 418 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 418 (487)
. .+....+..+.+|+.+||+.||.+||++.+.+..+...+.+
T Consensus 213 -~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 213 -L----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred -c----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 0 01112346788999999999999999988655555555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.26 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=203.1
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
|.+.+.||+|+||.||+|.+..+.. ++..||||+++..... ....+.+|+++++.++|+||+++++++...+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678899999999999998865321 4568999999754332 2356889999999999999999999887655
Q ss_pred e------eEEEEeeCCCCChhHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 210 Q------RLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 210 ~------~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
. .++||||+++|+|..++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT 151 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence 4 78999999999999988532 235889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+....
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL 228 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987544332222222345678999999988899999999999999999999 88888654321 111111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .. . ....+..++..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 229 ~----~~------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 R----HG------N----RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred H----cC------C----CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00 0 0011223356789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.52 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=207.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-C-----CCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H-----LNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~~~ 202 (487)
..+|+++++||+|+||.|.+|++.. |++.||||+++... .-..+...|+.+|..|+ | -|||+++
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 3478999999999999999999876 78899999997653 22355678999999997 4 4899999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CcE
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNA 279 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~--~~~ 279 (487)
++|...+++|||+|++ .-+|.++|..+ -..++...+..|+.||+.||.+||+.+ |||+|||||||||..- ..|
T Consensus 255 d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCce
Confidence 9999999999999999 55999999754 356999999999999999999999988 9999999999999543 479
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 358 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~- 358 (487)
||+|||.|........ ..+-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+..+.+....+....
T Consensus 331 KVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred eEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 9999999998654322 4567889999999999999999999999999999999999998877654432221100
Q ss_pred -------hhhhcccccccc------------------------------c---CC----ccCCCCCHHHHHHHHHHHHHh
Q 011385 359 -------PHLGERRRFYRL------------------------------I---DP----RLEGHFSIKGAQKAAQLAAHC 394 (487)
Q Consensus 359 -------~~~~~~~~~~~~------------------------------~---~~----~~~~~~~~~~~~~l~~li~~c 394 (487)
........++.- . .| .+...+.......+.+++++|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 000000000000 0 00 011112223345679999999
Q ss_pred cccCCCCCCCHHHHHHHhc
Q 011385 395 LSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 395 l~~dP~~RPs~~ell~~L~ 413 (487)
|..||.+|+|..++|+|-.
T Consensus 486 L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPF 504 (586)
T ss_pred hccCchhcCCHHHHhcCcc
Confidence 9999999999999998653
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.30 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=205.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+.. +..||||.++.... ..+++.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 45679999999999999999998642 45799999876543 35678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence 999999999999999999996543 56899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||....... +.. ......
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~ 221 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGY 221 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCC
Confidence 9876432111 1111223457999999998999999999999999999999 999996543211 110 010000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. ...+...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 222 ~----------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 R----------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C----------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 001112346789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.84 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=204.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|++.+.||+|+||.||+|.... ++..||+|++..........+.+|+.++..++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3589999999999999999998764 5678999999765444456678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence 9999999999999999988544 46899999999999999999999987 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
....... ......|+..|+|||++. ...++.++|||||||++|||++|..||....+...... .. ..
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--~~------~~ 224 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--MS------KS 224 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--ee------cC
Confidence 6532211 122356899999999874 45578899999999999999999999864432211000 00 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....+... .....+..+.+|+.+||..||++||++.+|+++|
T Consensus 225 ---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 ---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00001111 0112346789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=340.21 Aligned_cols=254 Identities=34% Similarity=0.556 Sum_probs=196.8
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
+.+.||.|.||.||+|.+... ....+..|+||.++..... ..+.+.+|++++++++||||++++|++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 456899999999999999831 1225678999999654332 3578999999999999999999999999888899
Q ss_pred EEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
+|||||++|+|.++|... ...+++..++.|+.||+.||.|||+.+ ++|+||+++|||++.++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 999999999999999876 567999999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
............+...|+|||.+....++.++||||||+++|||++ |+.||..... .++.... .+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~----~~~~~---- 223 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKL----KQGQR---- 223 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHH----HTTEE----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----ccccc----
Confidence 3333222333457789999999998899999999999999999999 6788754421 1111111 11111
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...+..++..+.+|+..||..||++||++.+|++.|
T Consensus 224 ------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001112346788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.94 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=193.4
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
++||+|+||.||+|.+.. ++..||||+++.... ...+.+.+|+.++.++ +||||+.+++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 479999999999998865 567899999975432 2234577899999888 699999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+++|+|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 9999999999999888544 46999999999999999999999988 9999999999999999999999999997532
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.............+........
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 218 (327)
T cd05617 148 GPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------- 218 (327)
T ss_pred CCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------
Confidence 2111 2234679999999999999999999999999999999999999996543322222111111111000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
.. .++...+..+.+++.+||+.||.+|+++
T Consensus 219 ~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PI----RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC----CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 00 1111234568899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.44 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=206.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|.+.+.||+|+||.||++..... ....++..+|+|.+..........+.+|+++++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35788899999999999999976431 12235668999998765544456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 99999999999999999986542 24788999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 353 (487)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H
Confidence 999999999999976543322222223346788999999998999999999999999999998 899986433211 1
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.... ... ... ..+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 234 ~~~~----~~~------~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECI----TQG------REL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHH----HcC------ccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1000 000 000 011123467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=355.64 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=201.5
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
....++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||++++
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3445789999999999999999998865 577999999864321 2234577899999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+++.+++..|+|||||++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999988543 5888999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccC----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
|||++........ ......+||+.|||||++.+. .++.++|||||||+||||++|..||........ ..
T Consensus 185 DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~ 257 (370)
T cd05621 185 DFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YS 257 (370)
T ss_pred ecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 9999987543221 112346799999999998754 378999999999999999999999975432111 00
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 412 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 412 (487)
........ + .+.. ....+..+.+++.+||..++.+ |+++.|++++-
T Consensus 258 ~i~~~~~~----~--~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 258 KIMDHKNS----L--NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred HHHhCCcc----c--CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 00000000 0 0000 1123467889999999855543 88999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.74 Aligned_cols=274 Identities=26% Similarity=0.369 Sum_probs=206.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe--
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 207 (487)
.+|++.+.||+|+||.||+|.... ....++..||||.+........+.+.+|++++..++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 578899999999999999998642 1223577999999976655555678999999999999999999998754
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
...+++||||+++|+|.+++.+....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence 34688999999999999999766567899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccee-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh---c
Q 011385 288 KDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---E 363 (487)
Q Consensus 288 ~~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~ 363 (487)
+.......... .....++..|+|||++.+..++.++|||||||++|||++|..++...... .......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 231 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMI 231 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccc
Confidence 87654332111 11123455699999998889999999999999999999988766432211 0000000000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...+...+............+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000100001111122346789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=336.84 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=209.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
...+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 34678899999999999999998864 45799999987765556778999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccc
Confidence 99999999999999999999653 446899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+........ ......++..|+|||++....++.++|||||||++|+|++ |..||...... ....... .
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~-- 219 (261)
T cd05148 151 ARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT----A-- 219 (261)
T ss_pred hhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH----h--
Confidence 987643221 1223446778999999988899999999999999999998 89999654321 1111110 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
......+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 220 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 --------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00111122334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=332.59 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=207.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|+... ++..||||.+..... .....+.+|+++++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 578999999999999999998865 567999998864332 22345789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999988853 2345888999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||++........ ......|++.|+|||.+.+..++.++|||||||++|||++|..||....... ..+.... .
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~----~- 221 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI----E- 221 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH----h-
Confidence 999887543221 1223568899999999988889999999999999999999999986432211 1111110 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... .........+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus 222 -----~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 222 -----QCD---YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----cCC---CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000 01111223456789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.35 Aligned_cols=272 Identities=27% Similarity=0.433 Sum_probs=204.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCC-----CccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTA-----PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-----~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
.++|++.+.||+|+||.||+|++...... ....+....||+|.++..... ....+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987542110 011123346899999754322 234688999999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 271 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 271 (487)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999985432 23678889999999999999999988 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCCC
Q 011385 272 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNG 349 (487)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~~~~~ 349 (487)
|++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999986544332222233456789999999988899999999999999999998 55677543221
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
................ .. ...+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENTGEFFRNQGRQ--IY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHhhhhcccc--cc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111000000000 00 0001112467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=336.77 Aligned_cols=272 Identities=32% Similarity=0.436 Sum_probs=204.7
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC--
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 208 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-- 208 (487)
|++.+.||+|+||+||++.+... ...++..||+|.++.... .....+.+|+++|+.++||||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 48899999999999999876431 223677899999976532 2345688999999999999999999987653
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 4578999999999999998653 5899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
......... ......++..|+|||++.+..++.++|||||||++|||++|..||........ ......... .....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhh
Confidence 765432211 11223456779999999888999999999999999999999999864332110 010000000 000001
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...++.......+...+..+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111111112223456899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=342.68 Aligned_cols=268 Identities=24% Similarity=0.342 Sum_probs=203.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|.+.+.||+|+||.||+|+... ++..||+|.++..... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 578999999999999999998764 5668999998754322 234578999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++ +|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 999999999965 898888766667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------h
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 359 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------~ 359 (487)
....... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||................ +
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 6433221 1223468999999998764 568999999999999999999999997654322211111100 0
Q ss_pred hhhcccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.......+.....+.... ......+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 000000000000000000 00012345788999999999999999999999744
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.37 Aligned_cols=243 Identities=28% Similarity=0.405 Sum_probs=195.8
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||.||+|.+.. ++..||||+++.... .....+..|++++..+ +||||+++++++.+.+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999998865 567899999975422 2234577899999887 699999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 9999999999999888544 46999999999999999999999988 9999999999999999999999999987532
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+... ....
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~---i~~~-------- 211 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQS---ILED-------- 211 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHH---HHcC--------
Confidence 2221 123357999999999999999999999999999999999999999654311 11110 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVEA 411 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 411 (487)
.. .++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 212 ~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 EV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 00 1112234678999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=335.99 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=200.3
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||+|+||.||+++... +|+.||+|.+...... ....+..|++++++++||||+++++++.++...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999998865 5779999998653322 123456799999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
|||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999888543 345889999999999999999999988 999999999999999999999999999875432
Q ss_pred CcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 294 ~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
. ......|+..|+|||++.+..++.++|||||||++|||++|..||.......... ......... .+..
T Consensus 149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~------~~~~ 217 (277)
T cd05607 149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLED------EVKF 217 (277)
T ss_pred c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhcc------cccc
Confidence 2 1233578999999999998889999999999999999999999996543211111 111100100 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCc
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 419 (487)
.. ...+..+.+|+.+||+.||.+||++.|+++.+..++.++
T Consensus 218 -~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~ 258 (277)
T cd05607 218 -EH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK 258 (277)
T ss_pred -cc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence 00 123457899999999999999999988887666665553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=347.90 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=197.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
...+|++++.||+|+||.||+|+... ++..||+|+.... ....|+.++++++|+||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34579999999999999999998765 4668999985433 23579999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
....++||||+ .++|.+++......+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccc
Confidence 99999999999 46899988777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-------hh
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------PH 360 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-------~~ 360 (487)
+...... ......||+.|+|||++.+..|+.++|||||||++|||+++..++....+........... ..
T Consensus 205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~ 281 (357)
T PHA03209 205 QFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281 (357)
T ss_pred cccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence 7543221 1223579999999999999999999999999999999999665553332221111000000 00
Q ss_pred hhc-ccccc---------cccC--Ccc---CCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGE-RRRFY---------RLID--PRL---EGHF----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~-~~~~~---------~~~~--~~~---~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.. ...+. ..++ ... ...+ ....+..+.+||.+||+.||.+|||+.|++++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 00000 0000 000 0000 00123456789999999999999999999975
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=334.58 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=206.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 72 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34689999999999999999998643 45799999865432 34678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCcc
Confidence 99999999999999999998653 456888999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++........ ......++..|+|||++....++.++|||||||++|+|++ |..||....... ..... ..
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~-- 219 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSAL----QR-- 219 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHH----Hc--
Confidence 9875432211 1222346778999999988889999999999999999998 999996543211 11111 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
........ ..+..+.+|+.+||..||++||++.++++.|+.+
T Consensus 220 ----~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 ----GYRMPRME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00001111 2345788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.60 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=207.1
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCC-CCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLV-HLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-HpnIv~~~~~ 204 (487)
+..++|.+.+.||+|+||.||+|++.... ...++..||||+++...... .+.+.+|+++|..+. |||||+++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 34457888999999999999999986421 12245689999997653322 346889999999997 9999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-----------------------------------------------------
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 231 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 231 (487)
+...+..+||||||++|+|.++|.+..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011385 232 --------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 267 (487)
Q Consensus 232 --------------------------------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 267 (487)
..+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk 266 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA 266 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence 13567778899999999999999987 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 346 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~ 346 (487)
|+|||++.++.+||+|||+++...............+++.|||||++.+..++.++|||||||++|||++ |..||....
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999986533222112223467889999999998899999999999999999998 888986432
Q ss_pred CCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ... .+... ..+ ..+...+..+.+|+.+||..+|.+||++.+|++.|+.+
T Consensus 347 ~~~~--~~~----~~~~~------~~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 347 MNEQ--FYN----AIKRG------YRM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred chHH--HHH----HHHcC------CCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2110 000 00000 000 11122346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.95 Aligned_cols=266 Identities=29% Similarity=0.406 Sum_probs=209.3
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~ 203 (487)
.+..++|++.+.||+|+||.||++.+..... ......||+|.+..... ....++.+|+.++..+ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3455689999999999999999998764221 12446899999875432 2234688999999999 8999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 268 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 268 (487)
++..++..++||||+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp 160 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA 160 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence 999999999999999999999998542 345889999999999999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCC
Q 011385 269 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRP 347 (487)
Q Consensus 269 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~ 347 (487)
+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999987654332222222345678999999988899999999999999999998 9899865432
Q ss_pred CCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... ..... .....+..++..+.+|+.+||..||++|||+.++++.|+.+
T Consensus 241 ~~~~~-------~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 EELFK-------LLKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHH-------HHHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11100 00000 01111223346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.13 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=212.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
|.++.+||+|+||.||+|.++. +|..+|||.+..+ .+.+++..|+.||.+++.|++|++||.|.....+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 5566789999999999998876 7889999998765 3568899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|||||||..|++.+.++.++.++.+..+..+++..+.||+|||... -||||||..||||+.+|++||+|||.|..+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999999999999988899999999999999999999999987 7999999999999999999999999998765
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
+. .....++.|||.|||||++..-+|+.++||||||++..||..|++||.+..+.-....+ --
T Consensus 181 DT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---------------PT 243 (502)
T KOG0574|consen 181 DT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---------------PT 243 (502)
T ss_pred hh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---------------cC
Confidence 42 22345578999999999999999999999999999999999999999765432111000 00
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+|.....-+...+.++.+++++||..+|++|-|+.+++++-
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 11111122345567899999999999999999999999864
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.23 Aligned_cols=268 Identities=27% Similarity=0.387 Sum_probs=207.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+..++|.+.+.||+|+||.||+|.+..... .....+..||+|.+..... ....++.+|+.++..+ +|+||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 344689999999999999999998753211 1112345799999975432 2345688899999999 79999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
+...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 999999999999999999999996532 24788999999999999999999987 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999986543222111222334578999999988899999999999999999998 88888643221
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.+... +... ....++...+..+.+|+.+||..+|.+||++.++++.|+.+.
T Consensus 250 ---~~~~~----~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 250 ---ELFKL----LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HHHHH----HHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11110 0000 011112233567889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.33 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=202.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|.+.+.||+|+||.||+|.+.. +..||||.+..... ....+.+|+.++..++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468889999999999999997753 33699999875433 3467899999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCcccee
Confidence 999999999999999999765557899999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...... .. .
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~~-~--- 218 (256)
T cd05113 150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS---QG-L--- 218 (256)
T ss_pred cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh---cC-C---
Confidence 5433211 1112345678999999988889999999999999999998 999986443211 111110 00 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...... ..+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 219 ---~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 ---RLYRPH----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000011 12467899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=356.33 Aligned_cols=265 Identities=24% Similarity=0.274 Sum_probs=200.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
...|.+.+.||+|+||.||+|.+.. ++..||||.... ..+.+|+++|++|+|+|||++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999998865 567899996432 3467899999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..+||||++ .++|.+++......+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999999 47999988766667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc-----chhh---Hhhhhh
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLV---EWARPH 360 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-----~~~~---~~~~~~ 360 (487)
...............||+.|+|||++.+..++.++|||||||+||||++|..++........ ..+. ......
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 65433222222346799999999999999999999999999999999998876543221110 0111 110000
Q ss_pred hhcccc---------c----ccccCCcc-CCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 361 LGERRR---------F----YRLIDPRL-EGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 361 ~~~~~~---------~----~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+... + .....+.. ...+. ...+..+.+||.+||+.||.+|||+.|||++-
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 000000 0 00000000 00000 01234688999999999999999999999863
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=354.71 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=198.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.... ++..||||++.... ......+..|+.++..++|+||+++++++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368899999999999999998865 57799999996432 222356788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+.+|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999999998554 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc---------------------------------eeeeeccccccccCCceeccCCCCchhhhhhHHHHHH
Q 011385 287 AKDGPEGDKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLL 333 (487)
Q Consensus 287 a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ 333 (487)
++........ ......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 011385 334 EMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL---MSEVVE 410 (487)
Q Consensus 334 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~ 410 (487)
||++|..||....+......+ ......+ .+.+ .. ..+..+.+||.+|+ .||.+|++ +.++++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i------~~~~~~~--~~p~----~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKV------MNWKETL--VFPP----EV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHH------HcCCCce--ecCC----CC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 999999999765432111100 0000000 0011 00 12457889999987 49999996 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=348.87 Aligned_cols=252 Identities=28% Similarity=0.355 Sum_probs=197.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
+.||+|+||+||+|++.. +|+.||||++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 469999999999998765 577999999865421 22234556655 46779999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 999999999999988854 457899999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... +. ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~~-------- 211 (325)
T cd05604 148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILHK-------- 211 (325)
T ss_pred CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHcC--------
Confidence 2211 2234679999999999999999999999999999999999999997543211 10 000000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCcc
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKD 420 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~ 420 (487)
...+.. ..+..+.+++.+||+.||.+||++.+.++.+..++.+..
T Consensus 212 ~~~~~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 212 PLVLRP----GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred CccCCC----CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 000111 123568899999999999999998766666655655543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=330.63 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=204.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-----CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
++|.+.+.||+|+||.||+|.... ++..||+|.+...... ....+.+|++++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 468899999999999999998764 5779999998644221 23467889999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 99999999999999999999988544 46889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCccee-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++.......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~------- 218 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFK------- 218 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHH-------
Confidence 99976533211111 123568889999999999899999999999999999999999996432210 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.........++...+..+.+|+.+||..+|.+||++.+++++.
T Consensus 219 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 219 ------IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ------HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0000011122233456789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=336.57 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=204.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|.+.+.||+|+||.||+|.+..... ..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4678899999999999999998864110 114568999988654332 23468899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---c
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 278 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~ 278 (487)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence 999999999999999999986543 25889999999999999999999988 99999999999998754 5
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~ 234 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV 234 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence 99999999987633222111222334568999999998899999999999999999997 999997543221 11110
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
... ....++...+..+.+|+.+||+.||++||++.+|+++|.
T Consensus 235 ----~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 ----TGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 001112223467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=332.25 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=202.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ...++.+|+++++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 468889999999999999998752 34699999865433 3357889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++++|.+++..+...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .... ...
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~----- 216 (256)
T cd05059 150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVES----VSA----- 216 (256)
T ss_pred ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHH----HHc-----
Confidence 5432211 1111234567999999998999999999999999999999 889986543211 1110 000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... ..+...+..+.+|+.+||..+|++||++.++++.|
T Consensus 217 -~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 -GYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0011 11112356799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=350.07 Aligned_cols=245 Identities=25% Similarity=0.391 Sum_probs=206.1
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEe
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 216 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 216 (487)
+||+|.||+||-|++.+ +...+|||.+........+-+..||.+.+.|+|.|||+++|++..++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999999876 556899999987766666779999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEeecCCCCCCCCC
Q 011385 217 FMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 217 ~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~~kl~DFGla~~~~~~ 293 (487)
-++||+|.++|+..-+++ .+.+.-.+..||++||.|||+.. |||||||-.|+||+ -.|.+||+|||.++....-
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC
Confidence 999999999998776677 77888999999999999999988 99999999999996 4689999999999886543
Q ss_pred CcceeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 294 DKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 294 ~~~~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
. ....++.||..|||||++.. .+|+.++|||||||++.||.||++||-....... . ... ..++
T Consensus 730 n--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---A-MFk------VGmy--- 794 (1226)
T KOG4279|consen 730 N--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---A-MFK------VGMY--- 794 (1226)
T ss_pred C--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---h-hhh------hcce---
Confidence 3 23456889999999999975 4799999999999999999999999964322110 0 000 0111
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
...+.++...+.+++.+|.+|+..||.+||++.++|+
T Consensus 795 --KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 --KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1234456677889999999999999999999999986
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=340.19 Aligned_cols=265 Identities=26% Similarity=0.369 Sum_probs=208.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++|.+.+.||+|+||.||+|..... ....++..||||+++.... ...+.+.+|+.+++++ +|+||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 446799999999999999999986421 1123566899999875432 2235688999999999 799999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
...+..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999996543 34899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ ..... ..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~----~~ 259 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI----KE 259 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH----Hc
Confidence 99986544332222223456788999999998899999999999999999998 9999865432111 10000 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
......+...+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus 260 ----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 ----------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000011112246789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=333.72 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=206.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|+..+.||+|+||.||+|+....+. ....+|+|.+..... .....+..|+++++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 3578888999999999999999865321 234799999865432 234568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999776677999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceee-eeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 288 KDGPEGDKTHVS-TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 288 ~~~~~~~~~~~~-~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
............ .....+..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~~i----~~~~ 227 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMKAI----NDGF 227 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHH----hcCC
Confidence 865433221111 11223567999999988899999999999999999997 99999654321 111110 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
......+.+..+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 228 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0001112346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=352.51 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=211.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+-|+++..||.|+||.||+|..+. ++...|.|++.........+++-||.||+.++||+||+|++.|..+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 3567888899999999999998875 5667788999777767778899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.++|+.|||.||-.+..+..-+..+.+.++..+++|++.||.|||+++ |||||||..|||++-+|.|+|+|||.+-
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence 9999999999999999988887889999999999999999999999988 9999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
.... .......+.|||+|||||++. ..+|+.++||||||++|.||..+.+|....++.- .++..+
T Consensus 179 Kn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKia------ 248 (1187)
T KOG0579|consen 179 KNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA------ 248 (1187)
T ss_pred cchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHh------
Confidence 5332 122345689999999999875 4689999999999999999999999875443211 111100
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.--.|.+. -+......+.+|+.+||..||..||++.+|+++-
T Consensus 249 -----KSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 249 -----KSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred -----hcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 01111111 1234566788999999999999999999999864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=336.54 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=205.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
...+|++.+.||+|+||+||+|.+..++.. ....||+|.++..... ...++.+|+.++..+.|+||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 346789999999999999999987653221 1235899998754332 2456889999999999999999999987
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
. ...+++|||+++|+|.+++..+...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCc
Confidence 5 4578999999999999999766667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... +..+.. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~- 227 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KG- 227 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CC-
Confidence 987643322211222345678999999988899999999999999999998 899986432211 111110 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... ..+...+..+.+++.+||..||++||++.++++.|+.+
T Consensus 228 -----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 228 -----ERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----CcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 000 01112345788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=338.12 Aligned_cols=261 Identities=28% Similarity=0.400 Sum_probs=204.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
+|++.+.||+|+||.||+|+...... ......+|+|.+..... ....++.+|+.+++.++||||+++++++...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 47888999999999999998753211 11335789998865432 22356889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRR-----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 266 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 266 (487)
..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999988532 124788899999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCC
Q 011385 267 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 345 (487)
Q Consensus 267 Kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~ 345 (487)
||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986543322212223456778999999988899999999999999999998 99999654
Q ss_pred CCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+.. +..... .. . ....+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 234 ~~~~---~~~~~~----~~------~----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 234 APER---LFNLLK----TG------Y----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CHHH---HHHHHh----CC------C----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 3211 111110 00 0 0111122346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=348.08 Aligned_cols=265 Identities=29% Similarity=0.455 Sum_probs=220.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCH-HHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
...+...+.+.||+|-||.|.+|.... +..||||.++.+..... ++|.+|+++|.+|+|||||+++|+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 355678889999999999999998752 57899999987766544 7899999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPL-PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l-~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
..++.++|||||+++|+|.++|.++..+. .......|+.||+.||+||.+.+ +|||||.+.|||++.++++||+||
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 99999999999999999999998774443 55667789999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|+++.+-.++......+.+-..+|||+|.+..++++.++|||+||++|||+++ ...||..... .++++.....+.
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~ 758 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFR 758 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcC
Confidence 99998877888887778888999999999999999999999999999999865 6688864432 223332222222
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
....- .-...+..|+..+.+|+.+||..|-.+||+++++..+|..
T Consensus 759 ~~~~~-------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 759 DQGRQ-------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCCcc-------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 21111 1112233567889999999999999999999999988864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=341.91 Aligned_cols=269 Identities=26% Similarity=0.390 Sum_probs=209.5
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
....+|.+.+.||+|+||.||+|.+..... .....+..||+|.+.... .....++.+|+.++..+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 445688999999999999999998643111 111245689999987542 23346788999999999 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
+......++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 999999999999999999999996532 24778889999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999987654332222223456778999999988899999999999999999998 78888543221
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
. +... +.... ....+..++..+.+|+.+||..+|.+||++.++++.|+.+..
T Consensus 247 ~---~~~~----~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 E---LFKL----LKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred H---HHHH----HHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1 1110 11000 001112345678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.46 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=202.2
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCcee
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
+.....++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+.+|+.+++.++||||++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344556899999999999999999998865 577999999864321 12345778999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
+++++.+++..|+|||||++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999988543 4788889999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccC----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
|+|||+++....... ......+||+.|||||++.+. .++.++|||||||+||||++|..||........
T Consensus 183 L~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------ 255 (371)
T cd05622 183 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------ 255 (371)
T ss_pred EEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------
Confidence 999999987543221 122346799999999998753 388999999999999999999999975432110
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhc
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 413 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~ 413 (487)
.......... +. +. .....+..+.+||.+||..++.+ |+++.+++++..
T Consensus 256 ~~~i~~~~~~----~~--~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 256 YSKIMNHKNS----LT--FP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHHHHcCCCc----cc--CC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0000000000 00 00 01123467889999999843332 779999988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=337.78 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=205.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|++.+.||+|+||.||+|.+..... ...+..||||+++...... ...+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 357778899999999999998754211 1235689999997554322 34588999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
+..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~ 157 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLV 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEe
Confidence 9999999999999999998522 134788889999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 352 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 352 (487)
++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~ 234 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D 234 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999987644333222333456789999999988899999999999999999998 88888653221 1
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
+..... .. . ...++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 235 ~~~~i~----~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIR----NR---------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH----cC---------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111110 00 0 011122345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=351.99 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=201.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++++.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 57889999999999999998754 57799999986432 22345788999999999999999999999877
Q ss_pred C-----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 209 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 209 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+ ..|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999996 588887744 457899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh--h
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--H 360 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~--~ 360 (487)
||+++....... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+..... .
T Consensus 147 fg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999986543221 122335689999999988764 589999999999999999999999976544322111110000 0
Q ss_pred hhc--------ccccc-cccC-CccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 361 LGE--------RRRFY-RLID-PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 361 ~~~--------~~~~~-~~~~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ...+. .... +... ..+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000 00000 0000 0000 011112246788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=335.95 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=207.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|.+.+.||+|+||.||+|....... ..++..||+|.+..... .....+.+|+.++..++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45688999999999999999998864221 12456899999865432 22356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
.....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 9999999999999999999986431 23678889999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 356 (487)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~ 233 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF 233 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH
Confidence 999999999986544332222233457889999999988889999999999999999998 999986543211 1111
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.. ... ...++..++..+.+|+.+||+.+|++|||+.++++.|+
T Consensus 234 ~~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VI----DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred Hh----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 000 00111123567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=344.61 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=200.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 206 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 206 (487)
+|++.+.||+|+||.||+|.+.. +|..||||++..... ...+.+..|+.++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47788999999999999998765 577999999975422 22345778999998886 577888999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+.+||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccc
Confidence 999999999999999999988544 46899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.... ...
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~--- 216 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSI---MEH--- 216 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC---
Confidence 876432221 123357999999999999899999999999999999999999999754321 111110 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCCc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLK 419 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~L~~l~~~~ 419 (487)
...++...+..+.+|+.+||+.||.+|++.. +..+.+..++.+.
T Consensus 217 ---------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 217 ---------NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred ---------CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 0011122346788999999999999999853 2333444454443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.39 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||++++.. ++..||+|++..... .....+..|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 478899999999999999998865 566899999864221 12234778999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+.+||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecch
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
+........ ......+||+.|+|||++. ...++.++|||||||+||||++|+.||........ .....
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~ 221 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIM 221 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHh
Confidence 876433221 1223357999999999886 34688999999999999999999999975432111 00000
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~ 411 (487)
.....+ .+. ......+..+.+|+.+||..++.+ |+++.+++++
T Consensus 222 ~~~~~~------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 NHKERF------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccc------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000000 000 001123567889999998665544 6889999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=332.50 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=198.3
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 208 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 208 (487)
|.+.+.||+|+||.||+|.+...+. ...||+|.++.... .....+.+|+++++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~-------~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDS-------ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCC-------eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 3567899999999999998865321 23689999865432 2245688999999999999999999987432
Q ss_pred -----CeeEEEEeeCCCCChhHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 209 -----DQRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 209 -----~~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
...++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 150 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN 150 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence 246899999999999998742 2245889999999999999999999987 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 227 (272)
T cd05075 151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL 227 (272)
T ss_pred EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999987644332222222356778999999998999999999999999999999 78888653221 111111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .. +....+..+.+|+.+||+.||++||++.+|++.|+.+
T Consensus 228 ----~~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 ----RQGNR------LK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----HcCCC------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 00 1112345689999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=336.34 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=205.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
...++|++.+.||+|+||.||+|..+... ....+..||+|.+..... .....+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34578999999999999999999865311 112355799999865432 2234578899999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
.+.+..++||||+++|+|.+++.... ..+.+..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~ 155 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence 99999999999999999999996421 23466788899999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 355 (487)
+.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~ 232 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK 232 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence 9999999999986543332222223456778999999988899999999999999999998 78888643221 1111
Q ss_pred hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... +.. ...++...+..+.+|+.+||+.||++||++.++++.|+..
T Consensus 233 ~~~-------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVM-------------DGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHH-------------cCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 100 000 0011112346799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.17 Aligned_cols=243 Identities=29% Similarity=0.369 Sum_probs=203.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH---HHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.-++|.++++||+|.||.|.+++-+. +|+.||+|+++++......+ -+.|-++|...+||.+..+-..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 34688999999999999999997654 78899999999887665554 3569999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
|+..+.+|+||||+.||.|.-+|.+ ...+++.....+-..|+.||.|||+.+ ||+||||.+|+|||.+|+|||+||
T Consensus 237 FQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred hccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeec
Confidence 9999999999999999999988854 456889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++...... ....++||||.|+|||++....|+.++|+|.+||+||||++|+.||..........++ +.+.
T Consensus 313 GLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l~ed 384 (516)
T KOG0690|consen 313 GLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------LMED 384 (516)
T ss_pred ccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------Hhhh
Confidence 9998643322 2345699999999999999999999999999999999999999999754332211111 1111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 403 (487)
-.|+...++++..|+.-+|..||.+|.
T Consensus 385 ------------~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 ------------LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------------ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 123344457899999999999999996
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=345.97 Aligned_cols=267 Identities=23% Similarity=0.315 Sum_probs=199.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 34789999999999999999998765 577999999965422 2345688999999999999999999998
Q ss_pred EeCC------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
...+ ..|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 6543 47899999965 6766653 24788889999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-h----
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-V---- 354 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-~---- 354 (487)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997643221 12335789999999999999999999999999999999999999975432110000 0
Q ss_pred -------Hhhhhh----hhccccc-----ccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 355 -------EWARPH----LGERRRF-----YRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 355 -------~~~~~~----~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...... ....... .+...... ........+..+.+||.+||+.||++|||+.|++++-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000000 0000000 00000000 00011112456889999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.64 Aligned_cols=272 Identities=26% Similarity=0.434 Sum_probs=205.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCC-------CccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCcee
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
.++|++.+.||+|+||.||++.+...... .....++..||+|.+...... ...++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 35799999999999999999875431110 012234567999999755322 2457889999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
+++++...+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999986532 23677889999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh--CCCCCCCCCCC
Q 011385 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT--GRRSMDKNRPN 348 (487)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt--G~~pf~~~~~~ 348 (487)
||++.++.++|+|||+++...............++..|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986544332222223445678999998888899999999999999999998 67888643321
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. .............. ....+ .+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 Q---VIENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 11111000000000 00000 01123467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=332.55 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=205.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|++.+.||+|+||.||+|.+...+. .+..||||.+.... .....+|..|+.+++.++||||+++++++.++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 457888999999999999999875332 23479999987542 22345789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999999999766667899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeecc---ccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 289 DGPEGDKTHVSTRVM---GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~---Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
............... ++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~- 226 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----Q- 226 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----c-
Confidence 654322211111111 2457999999998999999999999999999886 99999654321 1111110 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .+.+++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 227 -----~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 -----DYRLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CCcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 1112346788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=328.71 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=205.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|.+.+.||+|+||.||+|.+.. ++..|++|.+..... ....++.+|+++++.++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788999999999999998865 567899999865432 2345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence 9999999999999999999764 457899999999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
+....... ......|++.|+|||++.+..++.++|||||||++|||++|..||...... ...... .
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~------ 214 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKI---I------ 214 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---H------
Confidence 87544322 123357899999999999889999999999999999999999999654311 111100 0
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... ...++...+..+.+++.+||+.+|++||++.+++++
T Consensus 215 -~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 -RGV----FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -cCC----CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000 011112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=338.50 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=202.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 207 (487)
++|++.++||+|+||.||+|+...++ ....+++|.++... ....+.+.+|++++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 57899999999999999999886532 12357888887432 22345688999999999 79999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 999999999999999999986432 24788999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 351 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 351 (487)
++.++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-- 226 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-- 226 (297)
T ss_pred ECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 9999999999999987532111 1111223567999999988899999999999999999997 999996543211
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
+.... . ..... ..+..++..+.+|+.+||+.||.+||++.++++.|+.+.+
T Consensus 227 -~~~~~---~-------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 227 -LYEKL---P-------QGYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HHHHH---h-------cCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11100 0 00011 1112234678999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=331.42 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=207.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|++.+.||+|+||.||+|.+...+. .+..||+|.++..... ....+.+|+.++..++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578889999999999999998754321 2347999998754322 235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence 9999999999999999999776667899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccee-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 289 DGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 289 ~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... .+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~- 226 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGY- 226 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCC-
Confidence 7654322111 111234568999999998899999999999999999886 999996543211 11111 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. ..+...+..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 227 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -----RL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----cC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 01112346788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.82 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=200.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.++||+|+||.||+|.+.. ++..||+|.+..... ....++.+|++++.+++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 368889999999999999998764 577899999865422 2235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999999999996542 4778889999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhhhhhccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~ 367 (487)
...... ....+|+..|+|||++.+..++.++|||||||++|+|++|..||........... ..... ....
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~---- 214 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVD---- 214 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhc----
Confidence 654321 2335799999999999999999999999999999999999999965332211100 00000 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...+.+. ....+..+.+|+.+||+.||.+||++.|++++..
T Consensus 215 --~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 215 --EDPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred --cCCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 0001110 1112457899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.53 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=204.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||+|+||.||++.+.. ++..||+|.+...... ...++.+|++++.+++||||+++++++.++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368899999999999999998765 5678999998754322 234588999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+ ++||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999999998654 568999999999999999999997 35 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc--
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR-- 365 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 365 (487)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......................
T Consensus 148 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred ccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc
Confidence 7653321 2335789999999999888899999999999999999999999965432111111000000000000
Q ss_pred -----------------ccc-cccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 -----------------RFY-RLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 -----------------~~~-~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
... ..... .....+ ...+..+.+|+.+||..||++||++.+|+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000 00000 000010 113456899999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.62 Aligned_cols=247 Identities=29% Similarity=0.411 Sum_probs=208.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.|.-++.||.|+||.||-|++.. +.+.||||++.....+. .++++.||+.|.+|+|||+|.+-|||..
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 35556789999999999998865 56799999998766544 4568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+...||||||| -|+-.|+|.....++.+..+..|+.+.+.||.|||+.+ .||||||..||||++.|.|||+|||.|
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence 99999999999 66999999888889999999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
....+ ...++|||+|||||++. .+.|+-++||||||++..||.-.++|+...+... +..+
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYH---- 236 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH---- 236 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHH----
Confidence 87654 34589999999999986 5789999999999999999999999986433211 1111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+...-.|.+. ..+.+..++.|+..||+.-|.+|||..+++++-
T Consensus 237 --IAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 237 --IAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred --HHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1111222222 345677899999999999999999999999874
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.68 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=207.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.+.. ++..||||.+...... ...++.+|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468888999999999999998765 4678999988653322 2346889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
.++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence 99999999999999999998853 2346899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ......
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~------- 219 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKK------- 219 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhh-------
Confidence 999887543321 1223568999999999988899999999999999999999999996432210 011000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.....+.+ .....+..+.+|+.+||..||++|||+.+|++.++++
T Consensus 220 ---~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 220 ---IEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---hhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 000011111 1123456799999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=334.74 Aligned_cols=265 Identities=25% Similarity=0.335 Sum_probs=195.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC---CCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~~~~~~ 205 (487)
+|++.+.||+|+||+||+|.+.. +|+.||+|.++..... ....+.+|+.++..+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 48889999999999999998865 5779999998754322 123456777777655 799999999988
Q ss_pred Ee-----CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IE-----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~-----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
.. ....++||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV 147 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 64 345789999997 4898888654 345899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR 358 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~ 358 (487)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|.+||.......... +.....
T Consensus 148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 999999998754322 1223568999999999998899999999999999999999999996543221110 000000
Q ss_pred h-hhhcccccc----cccCCc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 P-HLGERRRFY----RLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~-~~~~~~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ......... ....+. ....+....+..+.+|+.+||+.||.+||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000000000 000000 0001111234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.20 Aligned_cols=253 Identities=31% Similarity=0.406 Sum_probs=202.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.|+..+.||+|+||.||+|.+.. +++.||||.+....... ...+.+|+.+++.++|+||+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 36778899999999999998875 57799999986543222 2346789999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999988543 345899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||................ .
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~---~---- 218 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---K---- 218 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh---h----
Confidence 876543221 123479999999999998999999999999999999999999997543221111110000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L 412 (487)
... ..+....+..+.+|+.+||+.||.+||+ +.|++++-
T Consensus 219 ---~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 219 ---EVQ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred ---hhh----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 000 0111223457889999999999999999 78888743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=344.71 Aligned_cols=257 Identities=21% Similarity=0.262 Sum_probs=199.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||++++.. ++..||+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 478999999999999999998765 567899999864321 12234778999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..||||||+++|+|.+++.+....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccc
Confidence 999999999999999999999765667899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
++........ .....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ... ...
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~i~ 221 (331)
T cd05624 149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYG---KIM 221 (331)
T ss_pred eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHH---HHH
Confidence 9765433221 2233579999999998875 568899999999999999999999996543211 000 000
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 412 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 412 (487)
.....+ .+...+ ...+..+.+|+.+||..++.+ |+++.+++++.
T Consensus 222 ~~~~~~------~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 222 NHEERF------QFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred cCCCcc------cCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 000000 001101 123467899999999866544 45787777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.77 Aligned_cols=249 Identities=23% Similarity=0.422 Sum_probs=193.5
Q ss_pred eecccCceeEEEEEEccCCCCC---------------ccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~---------------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
.||+|+||.||+|.+...+... ........||+|++.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999875432111 1122334689999865543334568889999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---- 277 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---- 277 (487)
++++......+|||||+++|+|..++.+....+++..++.++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998766667899999999999999999999987 99999999999997643
Q ss_pred ---cEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHH-hCCCCCCCCCCCCcch
Q 011385 278 ---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHN 352 (487)
Q Consensus 278 ---~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~ell-tG~~pf~~~~~~~~~~ 352 (487)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999998654321 12357888999998865 56899999999999999995 6899986543321111
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ..... .+.. .....+.+||.+||+.+|++||++.+|++.|.
T Consensus 233 ~-------~~~~~--------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 F-------YEKKH--------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-------HHhcc--------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 00000 0111 11246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=326.34 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=208.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||.|+||.||+|.+.. ++..+|+|.+........+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 3578999999999999999998765 4568999999866555567899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.+|++|||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999999998766567999999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceeccC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
....... ......|+..|+|||++.+. .++.++|||||||++|||++|..||.......... ....
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~~~------- 218 (262)
T cd06613 150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LISK------- 218 (262)
T ss_pred hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh-------
Confidence 6543211 12335688999999998776 88999999999999999999999997543211100 0000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+. ........+..+.+|+.+||..||.+||++.+|+.+
T Consensus 219 ---~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 ---SNFPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ---ccCCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 011223345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=345.68 Aligned_cols=250 Identities=26% Similarity=0.308 Sum_probs=189.7
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC---CCCCceeEEEEEEeCCee
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL---VHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~HpnIv~~~~~~~~~~~~ 211 (487)
||+|+||+||+|++.. +|..||||++...... ....+..|..++..+ .||||+.+++++.+.+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999998865 5779999998643221 123355677777655 699999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
||||||+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 999999999999998854 456899999999999999999999988 9999999999999999999999999997643
Q ss_pred CCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||....... .... .....
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~~---i~~~~------ 213 (330)
T cd05586 148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYRN---IAFGK------ 213 (330)
T ss_pred CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHHH---HHcCC------
Confidence 3221 12346799999999988754 58999999999999999999999996543211 1000 00000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCc
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLK 419 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~ 419 (487)
..+.. ...+..+.+|+.+||+.||.+||++.+.++.|..++.+.
T Consensus 214 --~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 214 --VRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred --CCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 00010 012457889999999999999995433333333344443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=343.83 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=207.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC-CCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~~~ 204 (487)
....|++++.||+||.+.||++...+ ...||+|++..... +...-+.+|+..|.+|. |.+||++|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 44679999999999999999997754 34678887754432 23456899999999995 8999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
-..++.+||||||- ..+|..+|.++....+...+..+..|++.++.++|.++ |||.||||.|+|+ -.|.+||+||
T Consensus 429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDF 503 (677)
T KOG0596|consen 429 EVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDF 503 (677)
T ss_pred eccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeee
Confidence 99999999999997 45999999877666665588899999999999999998 9999999999999 4679999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCC-----------CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-----------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-----------~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
|+|.....+.........+||+.||+||.+.... .+.++||||||||||+|+.|+.||....
T Consensus 504 GIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------- 576 (677)
T KOG0596|consen 504 GIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------- 576 (677)
T ss_pred chhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------
Confidence 9999988877777778899999999999885332 4678999999999999999999995321
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHH-HHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQ-KAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....++..+.+|.-.-+|+..... .+.++++.||++||.+||++.|+|++-
T Consensus 577 --------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 577 --------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred --------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 012234456666443344432222 399999999999999999999999853
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=326.00 Aligned_cols=252 Identities=33% Similarity=0.506 Sum_probs=205.5
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|...... .++..||+|.+....... ...+.+|++++..++|+||+++++++.+....++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 47999999999999987531 236689999997664433 56788999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 215 YEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence 9999999999999765 467999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+................++..|+|||.+....++.++|||||||++|||++ |..||...... .+.... ...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~- 223 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYL----RKG- 223 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcC-
Confidence 987655432222334568899999999988899999999999999999999 69999765221 111110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.....+...+..+.+++.+||..||.+||++.+++++|+
T Consensus 224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=326.66 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=196.9
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
.||+|+||.||+|.+... .++..||+|+++..... ..+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 589999999999976532 24678999998654322 2456889999999999999999999875 4567899
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||.|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 74 MELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 9999999999998544 46899999999999999999999988 9999999999999999999999999998764432
Q ss_pred cce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccC
Q 011385 295 KTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372 (487)
Q Consensus 295 ~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (487)
... ......++..|+|||.+....++.++|||||||++|||++ |..||...... .+..... ..
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~----~~-------- 214 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIE----SG-------- 214 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----CC--------
Confidence 211 1122344679999999988889999999999999999998 99999754321 1111110 00
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 373 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.....+...+..+.+||.+||+.||++||++.+|.+.|+.
T Consensus 215 --~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 215 --ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0011122345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=345.37 Aligned_cols=265 Identities=30% Similarity=0.413 Sum_probs=202.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.... ...+++.||||+++..... ....+.+|+.+|.++ +|+||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 4568999999999999999999864211 1235778999999754322 235688999999999 689999999987
Q ss_pred EeC-CeeEEEEeeCCCCChhHHHhhcC-----------------------------------------------------
Q 011385 206 IED-DQRLLVYEFMPRGSLENHLFRRS----------------------------------------------------- 231 (487)
Q Consensus 206 ~~~-~~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------- 231 (487)
... ...++|||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46789999999999999986421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCccee
Q 011385 232 -------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298 (487)
Q Consensus 232 -------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (487)
..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 23677888899999999999999988 99999999999999999999999999986533222111
Q ss_pred eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCC
Q 011385 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 377 (487)
Q Consensus 299 ~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (487)
.....++..|+|||++.+..++.++|||||||++|||++ |..||....... .... .+..... ...
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~------~~~-- 303 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTR------MRA-- 303 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCC------CCC--
Confidence 222345678999999988999999999999999999997 999986532211 1110 0100000 000
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 378 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 378 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+...+..+.+++.+||+.||.+||++.||+++|+.+
T Consensus 304 --~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 --PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111235688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=325.46 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=207.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.+.. +|..||+|.++.... .....+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 578999999999999999998864 577899998864322 22456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
..+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence 99999999999999999998853 2345889999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...... ....... ..
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~- 221 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IE- 221 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-hh-
Confidence 999876543221 122356899999999998889999999999999999999999999643211 1110000 00
Q ss_pred ccccccccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 364 RRRFYRLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. .....+ ...+..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus 222 -----~~----~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 -----KC----DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----cC----CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 001111 134567889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.80 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=198.1
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 215 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 215 (487)
.||+|+||.||+|.+.... .+..||+|++...... ..+.+.+|+.++++++|+||+++++++. .+..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 3899999999999875321 3557999998755332 2356889999999999999999999875 45789999
Q ss_pred eeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCc
Q 011385 216 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 295 (487)
Q Consensus 216 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (487)
||+++|+|.+++......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 999999999999766667999999999999999999999988 99999999999999999999999999986543322
Q ss_pred cee-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 296 THV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 296 ~~~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
... .....++..|+|||++....++.++|||||||++|||++ |..||....... +.... ...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~--------- 214 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQG--------- 214 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCC---------
Confidence 111 111234578999999988889999999999999999996 999996543211 11111 000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....++..++..+.+|+.+||..||++||++.+|++.|+.+
T Consensus 215 -~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 -KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00111223356888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=339.39 Aligned_cols=267 Identities=25% Similarity=0.393 Sum_probs=206.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
...+|.+.+.||+|+||.||+|....... ........||+|.++.... ....++..|++++..+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 44688899999999999999998643111 1122455799999875432 2245688999999999 699999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
.+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 99999999999999999999996432 34788899999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 011385 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 349 (487)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 349 (487)
||++.++.+||+|||+++...............++..|||||++.+..++.++|||||||++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987643322111122234568999999988899999999999999999999 888886543211
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
+.... .... ...++..++..+.+|+.+||..||.+||++.++++.|+.+.
T Consensus 245 ---~~~~~----~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 245 ---LFKLL----REGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHH----HcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11110 0000 00111223457889999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=345.95 Aligned_cols=266 Identities=23% Similarity=0.295 Sum_probs=199.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 45789999999999999999998754 567899999975432 2235678999999999999999999988
Q ss_pred EeC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
... ...|+||||+++ +|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 654 356899999965 67776632 4788899999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hh--
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW-- 356 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~-- 356 (487)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......... ..
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998653321 223457899999999999999999999999999999999999999764321111000 00
Q ss_pred -------------hhhhhhcccccc-----cccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 357 -------------ARPHLGERRRFY-----RLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 357 -------------~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
............ ......+ ...........+.+||.+||+.||++|||+.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 000000000000 0000000 0011112245688999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.10 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=202.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|.+.+.||+|+||.||+|++.. ++..||+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 477888899999999999998765 56789999987665444456789999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999999999988544 47899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
..... .......|+..|+|||++. ...++.++|||||||++|+|++|..||....+....... .. .
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~------~- 224 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TK------S- 224 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hc------c-
Confidence 53321 1123357999999999874 456889999999999999999999998654322111000 00 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+..... ...+..+.+++.+||+.||++||++.+|+++
T Consensus 225 --~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 --NFQPPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred --CCCCCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000111100 0123568899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.52 Aligned_cols=269 Identities=22% Similarity=0.315 Sum_probs=203.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||.||+|++.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 578999999999999999998764 5678999998654322 234678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||++ ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 5999988766667899999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------h
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------P 359 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------~ 359 (487)
....... ......+++.|+|||++.+ ..++.++|||||||++|||++|++||................ .
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 153 AKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred ccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 6433221 1223457899999998765 458889999999999999999999997553321111000000 0
Q ss_pred hhhcccccccccCCccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 360 HLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.......+.....+.... ......+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000000000000000000 011123457889999999999999999999998554
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.90 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=202.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
+|++.+.||.|+||.||++.+.. ++..||+|.++... ....+.+.+|+.+++.++|+||+++++++.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 57888999999999999998764 56789999986433 223456889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
.+|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999999998864 3446889999999999999999999988 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ... .....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~---~~~~~----- 215 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LIL---KVCQG----- 215 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHH---HHhcC-----
Confidence 6543221 1233578999999999988889999999999999999999999996532111 000 00000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ...++...+..+.+|+.+||+.||++||++.+|+..
T Consensus 216 -~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 -S-----YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -C-----CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 001112234578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=326.95 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=193.8
Q ss_pred CeecccCceeEEEEEEccCCCC---CccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~---~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
+.||+|+||.||+|.+...... .........||+|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999987532110 0111234468999886554444456888999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-------EEEeecC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-------AKLSDFG 285 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-------~kl~DFG 285 (487)
+||||+++|+|..++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988766667999999999999999999999988 999999999999987664 8999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||........ ... ...
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~----~~~ 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---ERF----YEG 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---HHH----Hhc
Confidence 98764321 2245788999999886 567899999999999999998 58888754321110 000 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..... ......+.+|+.+||+.||.+||++.+|++.|+
T Consensus 225 ---~~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 ---QCMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ---CccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00001 012356889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=332.49 Aligned_cols=250 Identities=30% Similarity=0.414 Sum_probs=199.0
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
|+..+.||+|+||+||+|.+.. +++.||+|.+...... ....+.+|+++|+.++|+||+.+++++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 6677899999999999998865 5779999998654322 223477899999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999999888654 346999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ .....|+..|+|||++.+..++.++|||||||++|||++|..||.............. ....
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~---~~~~---- 219 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR---RVLE---- 219 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hhhc----
Confidence 76533221 1235799999999999888999999999999999999999999975432111111100 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 410 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 410 (487)
. ...+....+..+.+|+.+||+.||.+||+ +.++++
T Consensus 220 --~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 220 --T-----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --c-----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0 01112223456889999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=325.31 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=204.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||.|+||.||+|... |..||||.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 467899999999999999999763 56899999976644 456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence 99999999999999999986543 36899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...... ....++..|+|||++....++.++|||||||++|||++ |..||...... .+... ....
T Consensus 150 ~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~-- 215 (256)
T cd05039 150 KEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPH----VEKG-- 215 (256)
T ss_pred ccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhcC--
Confidence 8763321 12345678999999988899999999999999999997 99998644221 11111 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
. ....+...+..+.+|+.+||..+|++||++.++++.|+.
T Consensus 216 ----~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 ----Y----RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----C----CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0 001112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.58 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=199.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 4689999999999999999998765 56789999997542 223456889999999999999999999876
Q ss_pred eC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
.. ...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred ccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 43 357999999965 77777642 4788899999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh----
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW---- 356 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~---- 356 (487)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998653321 22345789999999999999999999999999999999999999976443211110000
Q ss_pred --------h----hhhhhcccccc-----cccCC---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 357 --------A----RPHLGERRRFY-----RLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 357 --------~----~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. .........+. ..... .............+.+||.+||+.||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0 00000000000 00000 000011111235788999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.46 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=204.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+.|++++.||.|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 4679999999999999999998865 5678999999766555556788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+++++|..++.+....+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999888666667999999999999999999999987 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
...... .......|++.|+|||++. ...++.++|||||||++|||++|..||....... ..... .
T Consensus 159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~----~-- 228 (292)
T cd06644 159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKI----A-- 228 (292)
T ss_pred eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHH----h--
Confidence 543221 1123356889999999885 3457889999999999999999999996543211 00000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+.. ..+...+..+.+|+.+||..||++||++.+++++
T Consensus 229 -----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 -----KSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----cCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0111234578899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.26 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=203.1
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
|++.+.||+|+||.||+|.+.. ++..+++|.+........+.+.+|+++++.++|+||+++++++...+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 6778899999999999998765 5678999998765544556788999999999999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
++||||+++++|..++.+....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999999988665667999999999999999999999988 9999999999999999999999999987653
Q ss_pred CCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
.... ......|+..|+|||++. +..++.++|||||||++|||++|.+||....... ...... ..
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~----~~--- 223 (282)
T cd06643 155 RTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIA----KS--- 223 (282)
T ss_pred cccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHh----hc---
Confidence 3211 123356899999999874 4567889999999999999999999996543211 001100 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..+.+ ..+...+..+.+|+.+||+.||.+||++.+++++-.
T Consensus 224 ----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 224 ----EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ----CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 00000 011123467899999999999999999999987543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.98 Aligned_cols=267 Identities=28% Similarity=0.393 Sum_probs=205.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..|++++.||+|+||.||+|.+... ...++..||+|.++.... .....+.+|+++++.+.||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccC-----CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 3578899999999999999986431 123677999999875432 2335688999999999999999999998775
Q ss_pred --CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 209 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
...++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcc
Confidence 5688999999999999999766556899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC---------CcchhhHh
Q 011385 287 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN---------GEHNLVEW 356 (487)
Q Consensus 287 a~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---------~~~~~~~~ 356 (487)
++........ .......|+..|+|||++.+..++.++|||||||++|||++++.|+...... ...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-R 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-H
Confidence 9876443221 1122345777899999998889999999999999999999987765321110 000000 0
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
........ . .......++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 235 ~~~~~~~~------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEG------K----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcC------c----cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000 0 0001112356799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.72 Aligned_cols=269 Identities=27% Similarity=0.390 Sum_probs=208.1
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+...+|++.+.||+|+||.||+|.+..... .....+..||+|.++.... ....++.+|++++.++ +|+||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 344579999999999999999998753211 1112344799998875432 2245788999999999 79999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
+...+..++||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999986432 24778889999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986544322222222345678999999999999999999999999999998 88888654221
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
. .... +... .....+...+..+.+|+.+||+.+|.+||++.|+++.|+.+..
T Consensus 244 ~------~~~~-~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 E------LFKL-LKEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H------HHHH-HHcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 1100 0000 0001111234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=338.10 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=200.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|.+..++. ...+|+|.++.... .....+.+|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCc-------eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 3578899999999999999999865321 23568887764322 2335688999999999 8999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 271 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 271 (487)
.++..|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Ni 155 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 155 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheE
Confidence 9999999999999999999986432 25789999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCc
Q 011385 272 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGE 350 (487)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~ 350 (487)
|++.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 231 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231 (303)
T ss_pred EecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence 99999999999999986432111 1111234678999999988889999999999999999998 999996443211
Q ss_pred chhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .. .. ....+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 232 --~~~~~----~~------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 232 --LYEKL----PQ------GY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --HHHHH----hc------CC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11100 00 00 0011112345788999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=324.68 Aligned_cols=255 Identities=27% Similarity=0.375 Sum_probs=193.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|..... .++..+|+|.++..... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCC-------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 3689999999999987532 14567999998755432 234688899999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
|||+++|+|.+++.... ...++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999986432 24567788899999999999999988 999999999999999999999999999764
Q ss_pred CCCCcceeeeeccccccccCCceeccC-------CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTG-------HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~-------~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
.............|+..|+|||++.+. .++.++|||||||++|||++ |..||....... ...... .
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~--~- 224 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV--R- 224 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh--h-
Confidence 433222222335678899999987532 46789999999999999996 999996543211 111100 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
........+.+.. ..+..+.+|+.+|| .+|++||++.||+..|.
T Consensus 225 --~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 --EQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --cccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0001112222221 22356788999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.13 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=202.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.... +..||+|.+..... ....+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS- 71 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence 34678999999999999999997653 45799999876443 3467899999999999999999999875
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCcee
Confidence 45689999999999999998653 345899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ....... .
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~-- 218 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE----R-- 218 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----c--
Confidence 9865432211 1122345678999999988899999999999999999999 88999653221 1111110 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.. ....+...+..+.+|+.+||..||++||++.++++.|+.
T Consensus 219 ----~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 ----GY----RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----CC----CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 011122334678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=339.84 Aligned_cols=267 Identities=30% Similarity=0.413 Sum_probs=219.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..+.|+.-++||+||||.||-+..+. ||+.||.|.+.+..+. ...-.++|-+||.+++.+.||.+-..
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred cccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 34678889999999999999998765 7889999998654432 22346789999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
|+..+.+||||..|.||+|.-+|.+.+ ..+++..+..++.+|+.||++||... ||+|||||+|||||+.|+++|+|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeec
Confidence 999999999999999999999887664 46999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+|||.....+... ...+||.+|||||++.+..|+...|+|||||+||||+.|+.||..........-++ +..+.
T Consensus 331 LGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~- 404 (591)
T KOG0986|consen 331 LGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE- 404 (591)
T ss_pred cceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc-
Confidence 9999988776532 23489999999999999999999999999999999999999997544332221111 00000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCCccCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDMAS 423 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~L~~l~~~~~~~~ 423 (487)
....++..+++++.+|...+|+.||.+|.... +=.+.++.++.++++..
T Consensus 405 -----------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 405 -----------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred -----------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 12345566778999999999999999998765 44455566666666554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.02 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=200.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE-e
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-E 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~ 207 (487)
..+|.+.+.||+|+||.||++... |..||+|.++... ..+.+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 357899999999999999999763 5679999986543 2457899999999999999999999764 4
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
++..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCcc
Confidence 567899999999999999987543 34889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+... ...
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~----~~~-- 214 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEK-- 214 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----Hhc--
Confidence 87643321 12345678999999988899999999999999999998 99998643211 11111 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. .......++..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 215 ----~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 ----GY----KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CC----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 0111123356789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=334.27 Aligned_cols=199 Identities=24% Similarity=0.381 Sum_probs=162.1
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRL 212 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~ 212 (487)
.+.||+|+||+||+|++... .++..||+|.+..... ...+.+|+++|++++||||+++++++.. +...|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 45899999999999987532 1456899999875432 2457899999999999999999998854 45688
Q ss_pred EEEeeCCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcEE
Q 011385 213 LVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAK 280 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~~k 280 (487)
+||||+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 9999995 5888877422 235889999999999999999999988 9999999999999 4567899
Q ss_pred EeecCCCCCCCCCCcc-eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 281 LSDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 281 l~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
|+|||+++........ .......||+.|+|||++.+ ..|+.++|||||||++|||++|.+||....
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9999999875432211 11234678999999998876 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.71 Aligned_cols=276 Identities=29% Similarity=0.375 Sum_probs=209.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe-
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 207 (487)
++|++.+.||+|+||.||+|.+...+ ..++..||||.+...... ....+.+|+++++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 46788899999999999999876432 235779999999765443 34678999999999999999999999877
Q ss_pred -CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 -DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
....++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence 56789999999999999999776657999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCccee-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+........... .....++..|+|||.+.+..++.++|||||||++|||++|..||............. . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHH
Confidence 987653322111 112345667999999988899999999999999999999999986432211000000 0 0000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+...+........+..++..+.+|+.+||+.+|++||++.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00001111111111223346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=331.97 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=205.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|++.+.||+|+||.||+|.... ++..||+|.+..........+.+|+.+++.+.|+||+++++++...
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 3589999999999999999998754 5678999999776655567788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999999999998854 35788999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ..... ..
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~----~~----- 231 (296)
T cd06654 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA----TN----- 231 (296)
T ss_pred hcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----cC-----
Confidence 6543221 12234689999999999888899999999999999999999999965433111 00000 00
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+ ....+...+..+.+|+.+||..||++||++.+++++
T Consensus 232 --~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 --GTP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCC--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 001112334678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=325.07 Aligned_cols=253 Identities=31% Similarity=0.493 Sum_probs=199.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|.+.... +++..||+|.+...... ..+++.+|+++++.+.|+|||++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 46999999999999875422 13468999999766543 3456889999999999999999999876 4567999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++|+|.+++.... .+++..++.++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999996554 7899999999999999999999988 9999999999999999999999999998764433
Q ss_pred ccee-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccC
Q 011385 295 KTHV-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372 (487)
Q Consensus 295 ~~~~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (487)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+...... ... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~~---~-- 217 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GER---L-- 217 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CCc---C--
Confidence 2111 111224568999999998899999999999999999998 9999965432 111111110 000 0
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 373 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
..+...+..+.+|+.+||..||++||++.++++.|+.++
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011123467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=326.17 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=202.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|++.+.||+|+||.||+|.+.. ...||+|+++.... ....+.+|+++++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 4579999999999999999997753 23699999975433 3467899999999999999999999874 4
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence 5689999999999999999653 345889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....... .... ...
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~----~~~--- 218 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ----VER--- 218 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHH----Hhc---
Confidence 865443221 1122346778999999988899999999999999999999 888886543211 1100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. ........+..+.+|+.+||+.||++||++.++++.|+..
T Consensus 219 ---~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 ---GY----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CC----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00 0011223456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=324.56 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=201.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|.+.... +....||||.+..... ...+.+.+|++++++++||||+++++++.+ ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 46899999999999886421 1334799999987766 445678999999999999999999999988 889999
Q ss_pred EeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence 99999999999997654 56899999999999999999999988 999999999999999999999999999876443
Q ss_pred Ccce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 294 DKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 294 ~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... +...... ....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~------ 218 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKID---KEGE------ 218 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---hcCC------
Confidence 2211 1123457889999999988899999999999999999998 99999643221 1111100 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
....+...+..+.+|+.+||+.+|.+||++.++++.|.
T Consensus 219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 ----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00011123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=327.80 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=200.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
+.+.|++.+.||+|+||.||+|.... +++.||+|++.... .....+..|+.++..+ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 34678888999999999999998765 56799999986543 3346788999999998 6999999999987
Q ss_pred eC------CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 207 ED------DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 207 ~~------~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
.. ...|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence 53 4678999999999999998753 356899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+|+|||++........ ......|+..|+|||++. ...|+.++|||||||++|||++|..||........
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---- 224 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---- 224 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH----
Confidence 9999999986533211 123467899999999886 34688899999999999999999999964322111
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... .. ....... .....+..+.+|+.+||..||.+||++.+++++
T Consensus 225 -~~~--~~------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 225 -LFL--IP------RNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -HHH--Hh------cCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000 00 0000000 011234578999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=329.72 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=194.0
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 215 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 215 (487)
+.||.|+||.||+|.....+.. .......||+|.+........+.+..|+.++..++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 4699999999999988643211 01123468889886554444467889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--------EEEeecCCC
Q 011385 216 EFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLA 287 (487)
Q Consensus 216 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--------~kl~DFGla 287 (487)
||+++|+|.+++..+...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999766667899999999999999999999988 999999999999987765 699999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||........ .. .....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~~~- 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYEDR- 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHHcc-
Confidence 764332 22468889999999876 45899999999999999999995 55543221110 00 00000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. .++......+.+|+.+||+.||++||++.+|++.|+
T Consensus 222 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -------H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111122356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=329.49 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=201.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHH--HHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
|++.+.||+|+||+||++.... +++.||+|++......... ...+|+.++++++||||+++++++.+..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 6778899999999999999875 5678999999877544322 2456999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999996 3456899999999999999999999988 99999999999999999999999999975
Q ss_pred CCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
... .........++..|+|||++. +..++.++||||||+++|+|++|..||............. ...... ..
T Consensus 148 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~--~~ 220 (260)
T PF00069_consen 148 LSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRP--LP 220 (260)
T ss_dssp STS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTH--HH
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccccc--cc
Confidence 411 112234467899999999988 8899999999999999999999999997551111111111 000000 00
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... . .......+.+|+.+||+.||++||++.+++++
T Consensus 221 ~~~~---~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQ---Q---SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTT---S---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccc---c---cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0 00012679999999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=322.86 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=207.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|++.+.||.|+||.||+|.+.. ++..||+|.+..... ..++.+|+++++.++|+||+++++++.+..
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 578999999999999999998865 456899999875533 577999999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..|++|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchh
Confidence 999999999999999999766678999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+....... ..
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~~ 213 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------PN 213 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------cc
Confidence 654321 123356889999999999889999999999999999999999999754332110000 00
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+ ....+...+..+.+++.+||+.||++||++.+++++
T Consensus 214 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 KPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000 011122334678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=326.57 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=204.3
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|+++++||+|+||.||+|... ++..||+|.+..... ...++.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 34578999999999999999999864 356899999875543 3467899999999999999999999864
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+..++||||+.+++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCc
Confidence 56789999999999999998643 456899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++......... ......++..|+|||++....++.++|||||||++|||++ |..||...... ...... ..
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~- 218 (260)
T cd05067 148 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNL----ER- 218 (260)
T ss_pred ceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH----Hc-
Confidence 99775432211 1222346778999999988899999999999999999999 99999754321 111110 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
....... ...+..+.+|+.+||+.+|++||++++++..|+.
T Consensus 219 -----~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 -----GYRMPRP----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000111 1224579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=331.42 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=204.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+... ....++..||+|.+..... ....++.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 46799999999999999999987421 1112466899999875432 223568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 266 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 266 (487)
++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999999986431 24778889999999999999999988 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCC
Q 011385 267 KTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKN 345 (487)
Q Consensus 267 Kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~ 345 (487)
||+|||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876433222111222345678999999988899999999999999999998 88888643
Q ss_pred CCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
... ..... +... .. . ..+...+..+.+|+.+||+.||.+||++.|+++.|+.
T Consensus 237 ~~~---~~~~~----~~~~-~~---~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHE---EVIYY----VRDG-NV---L------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHH---HHHHH----HhcC-CC---C------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 221 11111 0000 00 0 0111234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.74 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=204.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 207 (487)
++.+.+..||.|+.|+|++++++. +|..+|||.+..... +..++++..+.++..- +.|+||+.+|||..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 456677889999999999999976 677999999976543 3345677777776655 48999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++|.||.| ...++.++.+-..++++..+-++..-++.||.||..++ +|||||+||+|||||+.|++||||||++
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 99999999998 44677777776778999999999999999999999865 4999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
..+.+.. ..++..|-+.|||||.+. ...|+.++||||||++|+||.||+.||.+.... .+++....
T Consensus 240 GrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvl------ 308 (391)
T KOG0983|consen 240 GRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVL------ 308 (391)
T ss_pred ceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHH------
Confidence 8775532 345567999999999886 457999999999999999999999999764332 12221111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....|.+.++.. +++.+++|+..||..|+.+||...++|++-
T Consensus 309 ----n~ePP~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 309 ----NEEPPLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred ----hcCCCCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 111233332221 457889999999999999999999999854
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=329.10 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=207.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|++.+.||+|+||.||+|.+..++. .....||+|.+...... ...++.+|+.++..++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGE-----KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCC-----CcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 3578899999999999999999865322 12336899988765432 33568899999999999999999999887
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
...++||||+++|+|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccc
Confidence 7889999999999999999776667999999999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............++..|+|||.+....++.++|||||||++|||++ |..||....... +.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~- 228 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLL----EKGE- 228 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----hCCC-
Confidence 87654332222222234678999999988899999999999999999998 999997543211 11111 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
....+..++..+.+++.+||..||.+||++.++++.|+.+.
T Consensus 229 ---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 229 ---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111123356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.46 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=208.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.... ..++..|++|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4568899999999999999999987522 12367899999865432 22456889999999999999999999876
Q ss_pred e-CCeeEEEEeeCCCCChhHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 207 E-DDQRLLVYEFMPRGSLENHLFRRS-------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 207 ~-~~~~~lv~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
. ....++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQ 155 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCc
Confidence 6 567889999999999999986432 45889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||....+. .+..+.
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~ 232 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYL 232 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHH
Confidence 99999999987644332222233456778999999988899999999999999999999 99999654321 111111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. ... .. .....++..+.+++.+||..||++||++.++++.|+.+
T Consensus 233 ~----~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 233 K----DGY------RL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred H----cCC------CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 000 00 01112346789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=330.79 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=206.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||.|+||.||+|.+.. ++..||+|.+........+.+..|++++++++|+||+++++++..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 3578899999999999999998864 4678999999766555556788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...|+||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence 9999999999999999998776667999999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
....... ......|++.|+|||++. ...++.++|||||||++|||++|..||....... ..... .
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~-- 221 (280)
T cd06611 152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKI----L-- 221 (280)
T ss_pred hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHH----h--
Confidence 6533221 123356899999999875 3457889999999999999999999996542211 00000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....+.+ ..+...+..+.+|+.+||+.||.+||++.+++++-
T Consensus 222 -----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 222 -----KSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred -----cCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 0000000 01112345788999999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.16 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=201.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---------HHHHHHHHHHHhcCCCCCceeE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
+|.+.+.||.|+||.||+|.+.. ++..||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 47788999999999999998764 46689999886543321 1457789999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEe
Confidence 99999999999999999999999999554 56889999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 282 SDFGLAKDGPEGDKT----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 282 ~DFGla~~~~~~~~~----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
+|||+++........ .......|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .. .
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~--~ 222 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AI--F 222 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HH--H
Confidence 999999876421110 11123468899999999988899999999999999999999999997532110 00 0
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.......+ .++...+..+.+++.+||+.||.+||++.+|+++
T Consensus 223 --------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 --------KIGENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --------HHhccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00001111 1222345678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=329.56 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=199.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||+|++.. ++..||||.+..... .....+.+|+.++..++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 57888999999999999998765 567999999865432 2235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+..++||||++ ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999997 6898888543 256899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhh------
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR------ 358 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~------ 358 (487)
+....... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........... .....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87643221 11223467899999998765 4578999999999999999999999975432111000 00000
Q ss_pred -hhhhcccccccccCC---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 -PHLGERRRFYRLIDP---RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 -~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
........+....+. ..........+.++.+||.+||+.||.+||++.+|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000 00000011134678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=321.00 Aligned_cols=247 Identities=31% Similarity=0.447 Sum_probs=197.3
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
++||+|+||.||+|... ++..||+|.+....... ...+.+|+++++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 37999999999999764 35589999987554322 24688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++......+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999998766667899999999999999999999988 9999999999999999999999999987643321
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .... ... ..
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~----~~~------~~-- 211 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQ----VEK------GY-- 211 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH----HHc------CC--
Confidence 11 1112244678999999988899999999999999999998 999996542211 1100 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...++...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00111123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=325.08 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=194.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEE-eCCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-EDDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~~l 213 (487)
+.||+|+||.||+|.+.... ..+..||+|.+.... ......+.+|+.+++.++||||+++++++. .+...++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 46899999999999875422 134579999985432 233457889999999999999999999775 4556889
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
||||+.+|+|.+++.+....+.+..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999999766556778888999999999999999987 999999999999999999999999999865332
Q ss_pred Ccce--eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 294 DKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 294 ~~~~--~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
.... ......++..|+|||.+.+..++.++|||||||++|||++| .+||...... ...... ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~---~~~------- 218 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL---LQG------- 218 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---hcC-------
Confidence 1111 11123467789999999888999999999999999999995 5566433211 111111 000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..+... ...+..+.+|+.+||..+|++||++.+|++.|+.+
T Consensus 219 ~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 219 RRLLQP----EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000011 11245788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=321.45 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=199.4
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
++||+|+||.||+|.+.. +..||+|.+...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 479999999999998753 558999998765443 345788999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 9999999999999766667889999999999999999999988 9999999999999999999999999998654322
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
.........++..|+|||++.+..++.++|||||||++|||++ |..||........... . ..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~----~~---------- 210 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---I----ES---------- 210 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---H----hc----------
Confidence 1111112234667999999988899999999999999999999 8888865432111110 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
......+...+..+.+|+.+||..+|++||++.|+++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0001112233467999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=329.08 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=207.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||+||++.+.. +|..||+|++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 3578888999999999999998865 467899998865432 234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+.+++||||+++++|.+++.+ ...+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999999998854 3568999999999999999999997 35 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-----hhhHhhhhhh
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-----NLVEWARPHL 361 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-----~~~~~~~~~~ 361 (487)
+....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||......... .+........
T Consensus 151 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 151 SGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred ccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 87543221 12357899999999998889999999999999999999999999754432111 1111111110
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.+ ..+.+. ....+..+.+|+.+||+.||++||++.|++++..-+.
T Consensus 227 ~~-------~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 227 QE-------PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hc-------cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00 001111 1124567899999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=324.83 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=201.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++.+.....||+|+||.||+|.+.. ++..||+|.+........+.+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 34455556789999999999998765 466899999876655555678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~~kl~DF 284 (487)
++..++||||+++++|.+++......+ ++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.++|+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 999999999999999999997654455 78888999999999999999988 999999999999976 679999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|++........ ......|++.|+|||++... .++.++|||||||++|+|++|..||........ ..+.....
T Consensus 154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~- 227 (268)
T cd06624 154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF- 227 (268)
T ss_pred hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh-
Confidence 99876533221 12234689999999988654 488999999999999999999999964322110 00100000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.....++......+.+|+.+||+.+|.+||++.+++++
T Consensus 228 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111222345678999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.15 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=197.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|.+++.||+|+||.||+|.+.. ++..||||++..... .....+.+|+++|+.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 34689999999999999999998764 567899999875422 2235677999999999999999999987
Q ss_pred EeC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
... ...|++||++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence 543 3568999998 7899887743 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 357 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~ 357 (487)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ...
T Consensus 158 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07878 158 RILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232 (343)
T ss_pred EEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999875432 233578999999999876 57899999999999999999999999754321110000 000
Q ss_pred hh-------hhh--cccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 358 RP-------HLG--ERRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 358 ~~-------~~~--~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. .+. ....+...+....... ........+.+|+.+||..||.+|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 000 0000000000000000 0001234578999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=329.48 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=205.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|++.+.||+|+||.||+|.... ++..||+|.+........+.+.+|+.+++.++|+||+++++++...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999998754 5679999999766555556788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999998854 35788999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+....... .
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------~------ 228 (297)
T cd06656 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------A------ 228 (297)
T ss_pred EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------c------
Confidence 6543221 122356899999999998889999999999999999999999999654332110000 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+ ....+...+..+.+|+.+||..||++||++.+++++
T Consensus 229 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 229 TNGTP--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCCCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 001122334668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=367.78 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=200.5
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
.....+|++++.||+|+||+||+|++.. ++..||+|.+...... ....+..|+.+|..|+|||||++++
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 3455789999999999999999999865 5678999998754332 2356889999999999999999999
Q ss_pred EEEe--CCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCcEEEc
Q 011385 204 YCIE--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAE----RPVIYRDFKTSNILLD 274 (487)
Q Consensus 204 ~~~~--~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~----~~iiHrDLKp~NIll~ 274 (487)
+|.+ ...+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||+
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 8865 35689999999999999998642 3569999999999999999999998541 3499999999999996
Q ss_pred C-----------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHH
Q 011385 275 A-----------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEM 335 (487)
Q Consensus 275 ~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~el 335 (487)
. .+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 4 2458999999998754322 1234579999999998854 4589999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 336 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 336 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
++|..||....... .+.. .+... +.+.. ...+..+.+||..||..+|.+||++.++|.+
T Consensus 237 LTGk~PF~~~~~~~--qli~----~lk~~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 237 CSGKTPFHKANNFS--QLIS----ELKRG--------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHCCCCCCcCCcHH--HHHH----HHhcC--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99999996432211 1110 01100 00000 0124678999999999999999999999953
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=333.51 Aligned_cols=262 Identities=24% Similarity=0.408 Sum_probs=204.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|+..+.||+|+||.||+|.+...+.. ....||+|.+....... ..++.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 45788899999999999999988653321 12368999886543322 3468899999999999999999999875
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
. ..++|+||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccc
Confidence 4 467999999999999999776667899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+. .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCC
Confidence 87543322212222346778999999988999999999999999999997 889986542211 11111 10000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. .+..++..+.+++.+||..||++||++.++++.|..+.
T Consensus 230 ---~~-------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 ---LP-------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred ---CC-------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 01122457889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=322.53 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=202.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ...++.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 468888999999999999998752 45799999865433 3467899999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++++|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceee
Confidence 999999999999999999766667899999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..... +... .
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~---~ 218 (256)
T cd05112 150 VLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET----INAG---F 218 (256)
T ss_pred cccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HhCC---C
Confidence 5432211 1112335678999999988899999999999999999998 99998643211 11110 0000 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
....+. ..+..+.+|+.+||+.+|++||++.++++.|.
T Consensus 219 ~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 219 RLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111111 12467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=328.35 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=201.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++++.||+|+||.||+|.+.. +|..||+|.+..... .....+.+|+.++.+++|+||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368899999999999999998864 567899999865422 2235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+..++||||+++++|..++... ...+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence 9999999999999999888653 23689999999999999999999963 5 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccC------CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~------~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
++....... .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.............
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---- 220 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---- 220 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----
Confidence 997653321 2234688899999988543 35889999999999999999999996533211111000
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+... ....++...+..+.+|+.+||+.+|++||++.+++++-
T Consensus 221 ---------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 221 ---------AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred ---------HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 00000 01112233567789999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=323.73 Aligned_cols=256 Identities=29% Similarity=0.426 Sum_probs=206.0
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|+||.||+|.+.. +..||||.+..... ...++.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 345789999999999999999998653 35799999875443 3567999999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccc
Confidence 8899999999999999999996543 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....... .
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~----~- 219 (261)
T cd05034 149 LARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVE----R- 219 (261)
T ss_pred cceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c-
Confidence 99876432111 1112235678999999988899999999999999999999 99999654321 1111100 0
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
..... .+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 220 -----~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 -----GYRMP----RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----CCCCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00000 111224678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=325.51 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=194.8
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~l 213 (487)
++||+|+||.||+|.+..++. ...+|+|.++.... ...+.+.+|++++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCC-------eeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 369999999999998865321 23578898874332 2345688999999999 89999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 214 VYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence 999999999999986432 24788999999999999999999987 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||...... ......
T Consensus 151 ~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~ 224 (270)
T cd05047 151 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL 224 (270)
T ss_pred EEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHHH
Confidence 9999999986432111 1111234567999999988899999999999999999997 99999643221 111100
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. ......+...+..+.+|+.+||..||.+||++.++++.|+.+
T Consensus 225 ----~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 ----PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----hC----------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 000011112345788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=328.91 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=199.3
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||+|++.. +|..||+|.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 47888999999999999998865 5779999998654221 224577899999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||++ ++|.+++......+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999996 5888888666667999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh----------h
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW----------A 357 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~----------~ 357 (487)
....... ......++..|+|||++.+. .++.++|||||||++|||++|..||........ .+... .
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEES 224 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHH
Confidence 6543221 12234678999999988764 579999999999999999999988643322110 00000 0
Q ss_pred hhhhhccccc--ccccCCccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 RPHLGERRRF--YRLIDPRLE-GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+........ ......... .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000000 000000000 00111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=329.62 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=205.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|++.+.||.|+||.||+|.... +|+.||+|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 468999999999999999998754 57799999997665555677889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++++|..++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999999988543 5899999999999999999999988 99999999999999999999999999886
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...... .. ..
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~---~~------ 230 (296)
T cd06655 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---TN------ 230 (296)
T ss_pred cccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---hc------
Confidence 543322 12235689999999999888899999999999999999999999965433111000 00 00
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+ ..+...+..+.+||.+||..||.+||++.+++.+
T Consensus 231 -~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 231 -GTPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000 0111234578899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=325.56 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=204.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||.||+|.+.. ++..||+|.+.... ......+.+|+++++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 368888999999999999998865 57799999987553 23345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++|+||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999999998644 7899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||....+... ... ..
T Consensus 147 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~----~~------ 211 (274)
T cd06609 147 QLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFL----IP------ 211 (274)
T ss_pred eeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHH----hh------
Confidence 7654321 12335788999999999988899999999999999999999999965432111 000 00
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+.+... ..+..+.+++.+||..||++||++.+++++
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0011111111 134578899999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=325.75 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=205.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|.+.+.||+|+||.||+|.+.... +....||||...... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 356888999999999999999876421 123468999987554 2334578899999999999999999998875
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++|+|.+++......+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence 5578999999999999999766556899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ ..+...++..|+|||.+....++.++|||||||++|||++ |..||........ ... +....
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~----~~~~~- 225 (270)
T cd05056 155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGR----IENGE- 225 (270)
T ss_pred eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----HHcCC-
Confidence 865443211 1222335568999999988899999999999999999986 9999965432211 111 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
... .+..++..+.+|+.+||..+|++||++.++++.|+.+.
T Consensus 226 -----~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 -----RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -----cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001 11233467899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.08 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=205.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||.|+||.||.++... ++..+++|.+.... ....+++.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58889999999999999998765 56789999986543 23346688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++|||||++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999999999999999754 456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ ......|++.|+|||++.+..++.++|||||||++|||++|..||....... .. ......
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~~~~~~---- 216 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LV---VKIVQG---- 216 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHcC----
Confidence 86544321 2234578999999999988889999999999999999999999996533211 10 000000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...+ .....+..+.+++.+||..||.+||++.++++++
T Consensus 217 --~~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 --NYTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CCCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0000 1122346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=325.13 Aligned_cols=255 Identities=30% Similarity=0.471 Sum_probs=199.8
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|++..... ....+..||||.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 369999999999998864221 112346799998865432 3346788999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-----cEEEee
Q 011385 215 YEFMPRGSLENHLFRR------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-----NAKLSD 283 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-----~~kl~D 283 (487)
|||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999999642 234788999999999999999999987 99999999999999877 899999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
||++................++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~ 227 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----T 227 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----h
Confidence 999986544332222223456789999999998999999999999999999998 99998643221 111110 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
... ....+...+..+.+|+.+||..+|.+||++.+|++.|+
T Consensus 228 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 00112234567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=346.21 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=208.8
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
..+.++||+|.||+|++|.|..... +-..||||+++.+... ...+|++|+.+|.+|+|+|+++|||+..+ ..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psg------k~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSG------KHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCC------cEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 3445789999999999999976322 3347999999887665 56789999999999999999999999887 67
Q ss_pred eEEEEeeCCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..||||+++.|+|.+.|.+ ....|.......++.||+.||.||.+++ +|||||..+||||.....||||||||++.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence 7899999999999999976 4566888889999999999999999988 99999999999999999999999999998
Q ss_pred CCCCCcceeeee-ccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 290 GPEGDKTHVSTR-VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 290 ~~~~~~~~~~~~-~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
+...+....+.. ..-...|+|||.+....|+.++|||+|||+||||+| |..||.+.......
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL---------------- 325 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL---------------- 325 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------
Confidence 876655444332 334568999999999999999999999999999999 77899765432211
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.+|..-.-.-+..|+++++++++.||..+|.+||++..|.+.
T Consensus 326 -~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 326 -KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1112111112234678999999999999999999999999743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=365.64 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=195.5
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+...+|+.+++||+||||.||+++++. +|..||||++..... .....+.+|++.|++|+|||||+||..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysA 545 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSA 545 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehh
Confidence 3456789999999999999999999987 567999999976642 223568899999999999999999987
Q ss_pred EEeCC---------------------------------------------------------------------------
Q 011385 205 CIEDD--------------------------------------------------------------------------- 209 (487)
Q Consensus 205 ~~~~~--------------------------------------------------------------------------- 209 (487)
|.+..
T Consensus 546 WVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~de 625 (1351)
T KOG1035|consen 546 WVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDE 625 (1351)
T ss_pred hhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccc
Confidence 75321
Q ss_pred --------------------------------------------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHH
Q 011385 210 --------------------------------------------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245 (487)
Q Consensus 210 --------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~q 245 (487)
.+||.||||+...|.+++.++...-.....++++++
T Consensus 626 dg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFre 705 (1351)
T KOG1035|consen 626 DGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFRE 705 (1351)
T ss_pred cccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHH
Confidence 238999999987777776544322256778999999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC----------------CCCcceeeeecccccccc
Q 011385 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP----------------EGDKTHVSTRVMGTYGYA 309 (487)
Q Consensus 246 i~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~Gt~~y~ 309 (487)
|++||.|+|+++ ||||||||.||||++++.|||+|||+|+... .+......+..+||.-|+
T Consensus 706 IlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 706 ILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV 782 (1351)
T ss_pred HHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence 999999999999 9999999999999999999999999998721 011111345678999999
Q ss_pred CCceeccC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccC--CCCCHHHH
Q 011385 310 APEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLE--GHFSIKGA 384 (487)
Q Consensus 310 APE~~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 384 (487)
|||++.+. .|+.|+|+|||||||+||+. ||...-. ...++. .+. ++.+. ..|.....
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL~----~LR---------~g~iP~~~~f~~~~~ 844 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASILT----NLR---------KGSIPEPADFFDPEH 844 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHHH----hcc---------cCCCCCCcccccccc
Confidence 99998754 59999999999999999995 4643211 111111 111 11111 22333444
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 385 QKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 385 ~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.....+|++||+.||.+|||+.|+|+.
T Consensus 845 ~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred hHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 567799999999999999999999974
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.68 Aligned_cols=265 Identities=19% Similarity=0.230 Sum_probs=196.4
Q ss_pred CCCeeccc--CceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 134 PESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 134 ~~~~LG~G--~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++++||+| +|++||++.... +|+.||||++...... ....+.+|+++++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 46789999 789999998875 6789999999765322 2345678999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..++||||+++|+|.+++..+ ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++++|||.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999999999999998654 345899999999999999999999988 9999999999999999999999998754
Q ss_pred CCCCCCcce-----eeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 289 DGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 289 ~~~~~~~~~-----~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
......... ......++..|+|||++.+ ..|+.++|||||||++|||++|..||........ .........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 432211100 0112356788999999875 4689999999999999999999999975322110 000000000
Q ss_pred h---c------------------ccccccc---------cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 G---E------------------RRRFYRL---------IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~---~------------------~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. + ...+... ........+....+..+.+|+.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0 0000000 00000001122335678899999999999999999999975
Q ss_pred h
Q 011385 412 L 412 (487)
Q Consensus 412 L 412 (487)
-
T Consensus 308 p 308 (327)
T cd08227 308 S 308 (327)
T ss_pred h
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=343.07 Aligned_cols=263 Identities=26% Similarity=0.411 Sum_probs=217.1
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeE
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
++.|+....+.....+||-|.||.||.|.|+.. ...||||.++.+... ..+|+.|+.+|+.++|||+|+|
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqL 328 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL 328 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHH
Confidence 355666666777788999999999999999874 448999999876544 5789999999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
+|+|..+..+|||.|||..|+|.+||++.+ ..++....+.++.||..||+||..++ +|||||..+|+|+.++..+|
T Consensus 329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 329 LGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred hhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEE
Confidence 999999999999999999999999997654 45777788999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+||||++.+..+.++. .....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+......
T Consensus 406 vADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV--------- 475 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------- 475 (1157)
T ss_pred eeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH---------
Confidence 99999999986654322 222223568999999999999999999999999999998 8888876432111
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.++...+.-.-+..|++.+.+|++.||+..|.+||++.|+-+.++.+
T Consensus 476 --------Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 476 --------YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred --------HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 111111122222345678999999999999999999999999988754
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.91 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=201.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+++++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 3568899999999999999998753 33689998865432 3467889999999999999999999875 5
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.++|+|||++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccc
Confidence 5688999999999999999654 345889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ..
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~--- 218 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQV----ER--- 218 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc---
Confidence 765432211 1122346778999999988899999999999999999999 899986543211 11110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.... ..+...+..+.+|+.+||..||++||++.+|++.|+.
T Consensus 219 ---~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 ---GYRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0001 1112335678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.00 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=189.1
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe--CCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~l 213 (487)
..||+|+||.||+|+..... ++..||+|.+..... ...+.+|+++|+.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-------~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-------DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-------ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 57999999999999875421 456899999875432 2467899999999999999999998854 567889
Q ss_pred EEeeCCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcEEE
Q 011385 214 VYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKL 281 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~~kl 281 (487)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence 999996 4787776421 235888999999999999999999988 9999999999999 55678999
Q ss_pred eecCCCCCCCCCCcc-eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-------h
Q 011385 282 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-------N 352 (487)
Q Consensus 282 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-------~ 352 (487)
+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||.+||......... .
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999999875432211 11233578999999998876 45899999999999999999999999654321110 0
Q ss_pred hhHhhhh----------hhhccccccccc---------CCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 353 LVEWARP----------HLGERRRFYRLI---------DPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 353 ~~~~~~~----------~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
+...... .......+.... ...+ ...........+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000000000000 0000 00001112346889999999999999999999987
Q ss_pred H
Q 011385 411 A 411 (487)
Q Consensus 411 ~ 411 (487)
+
T Consensus 314 h 314 (317)
T cd07867 314 D 314 (317)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=361.86 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=201.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.++||+|+||.||+|++.. +|..||||++...... ..+++.+|+++++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 478999999999999999998765 5779999999754322 2356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR----------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
+.+..|+||||++||+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d 149 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF 149 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence 999999999999999999988531 123556778899999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCc----------------ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCC
Q 011385 277 YNAKLSDFGLAKDGPEGDK----------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 340 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~----------------~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 340 (487)
+.+||+|||+++....... .......+||+.|||||++.+..++.++|||||||++|||+||..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999986521100 001123579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011385 341 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 415 (487)
Q Consensus 341 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l 415 (487)
||........ . .. .. ...+.... .....+..+.+++.+||+.||++|| ++.++++.|+.+
T Consensus 230 PF~~~~~~ki---~-~~-~~---------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 230 PYRRKKGRKI---S-YR-DV---------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCCcchhhh---h-hh-hh---------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9965322110 0 00 00 00000000 0012345688999999999999997 566676666543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.08 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe-
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 207 (487)
+|++.+.||+|+||.||++.+.. +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48899999999999999998865 466899999865433 233568899999999999999999998764
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+..+|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence 44678999999999999998653 446899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... . ........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~---~~~~~~~~--- 217 (257)
T cd08223 149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---S---LVYRIIEG--- 217 (257)
T ss_pred eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H---HHHHHHhc---
Confidence 876533221 223456899999999999999999999999999999999999998643211 1 10000000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. ...+...+..+.+|+.+||+.||.+||++.+++++
T Consensus 218 ---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 218 ---KL-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CC-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 11222345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=322.22 Aligned_cols=255 Identities=29% Similarity=0.399 Sum_probs=190.6
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|..... .....+|+|.+...... ....+.+|+.+++.++|+||+++++++.+....+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3589999999999976431 13457899987644322 234678999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
|||+++|+|.+++.... ...++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999999999996543 23467788899999999999999988 999999999999999999999999998764
Q ss_pred CCCCcceeeeeccccccccCCceec-------cCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~-------~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
.............++..|+|||++. ...++.++|||||||++|||++ |..||....... ..... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~---~~ 224 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQV---VR 224 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH---hh
Confidence 3322221122345677899999864 2456889999999999999999 778886442211 11000 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. .......+.+ ....+..+.+++..|| .||++||++.+|++.|.
T Consensus 225 ~--~~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 E--QDIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c--cCccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0 0011112222 2233456778999998 59999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.50 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=205.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||.||+|+.+.... ......|++|.+...... ...++.+|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 578899999999999999999865321 234568999998654433 345789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS--------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 99999999999999999996443 15899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+.....
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~~- 232 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRLQ- 232 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHHH-
Confidence 9999998754322211 1223456788999999988889999999999999999999 78888643221 1111100
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ... .......++..+.+++.+||+.||.+||++.+++..|.
T Consensus 233 ---~-~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 ---A-GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---c-CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 000 00011123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=318.61 Aligned_cols=248 Identities=25% Similarity=0.470 Sum_probs=193.7
Q ss_pred CeecccCceeEEEEEEccCCCCCc-cCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~-~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
+.||+|+||.||+|.+........ .+.....|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999876431100 1112246788887654433 5778999999999999999999999888 778999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-------cEEEeecCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-------NAKLSDFGLA 287 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-------~~kl~DFGla 287 (487)
|||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999766557899999999999999999999988 99999999999999887 7999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccC--CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
..... .....++..|+|||++... .++.++|||||||++|||++ |..||.......... +.. ..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~----~~ 222 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ----DQ 222 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh----cC
Confidence 87543 1224577889999998876 78999999999999999999 577775543211100 000 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. . . + ......+.+|+.+||..+|.+||++.++++.|+
T Consensus 223 ~---~-~-~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H---R-L-P-------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C---C-C-C-------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 0 0 001157889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=321.16 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=197.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+|+..+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 368899999999999999998764 577999999864422 122457889999999999999999998
Q ss_pred EEe--CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 205 CIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 205 ~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+.+ ....+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 875 35678999999999999998654 45889999999999999999999987 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||+++........ .......|+..|+|||++.+..++.++|||||||++|||++|..||........ . .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~----~--- 219 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--I----F--- 219 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--H----H---
Confidence 99998764321111 111234688999999999988899999999999999999999999964321110 0 0
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..........++......+.+++ +||..+|++||++.||+++
T Consensus 220 -------~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 220 -------KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -------HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00000011222333456677888 6888999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.47 Aligned_cols=260 Identities=28% Similarity=0.380 Sum_probs=202.1
Q ss_pred hHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeE
Q 011385 123 NDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKL 201 (487)
Q Consensus 123 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~ 201 (487)
+.+....++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.++..+ +|+||+++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~ 80 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKF 80 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeee
Confidence 3444567899999999999999999998865 56789999886432 2235678899999999 69999999
Q ss_pred EEEEE-----eCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 202 IGYCI-----EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 202 ~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili 157 (286)
T cd06638 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILL 157 (286)
T ss_pred eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEE
Confidence 99874 34578999999999999998752 3356888999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 348 (487)
+.++.+||+|||+++....... ......|++.|+|||++. +..++.++|||||||++|||++|..||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred CCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 9999999999999886543221 122346899999999875 345889999999999999999999999654321
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. +.. .. ....+.+ ..+...+..+.+|+.+||+.||++||++.||++++
T Consensus 236 ~~--~~~-----~~------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 RA--LFK-----IP------RNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HH--Hhh-----cc------ccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 11 000 00 0000000 01111235688999999999999999999999865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.50 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=206.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..|+..+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.+++.+.|+||+++++++.+.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 357778899999999999998765 567899999875432 2345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccce
Confidence 999999999999999998854 35888999999999999999999987 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......++..|+|||++.+..++.++|||||||++|||++|..||....+......
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--------------- 212 (277)
T cd06640 150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL--------------- 212 (277)
T ss_pred eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh---------------
Confidence 6543321 12235688999999999888899999999999999999999999975432211100
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+.......+....+..+.+|+.+||+.+|++||++.+++.+-.
T Consensus 213 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 213 --IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred --hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 0001112233456678999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.44 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=200.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc----------CHHHHHHHHHHHhcCCCCCcee
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
+|.+.+.||.|+||.||+|.... +|..||+|.++..... ..+.+..|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 57788999999999999998754 5678999988532110 1235778999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
+++++...+..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEE
Confidence 999999999999999999999999998655 57899999999999999999999987 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
|+|||+++...............|+..|+|||++.... ++.++||||||+++|||++|..||...... .....
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~ 223 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK 223 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH
Confidence 99999998654322111223356899999999887654 899999999999999999999999533211 00000
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... ......+........+..+.+++.+||..||++||++.+++++
T Consensus 224 --~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 224 --LGN-----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --hhc-----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0001111111222335678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.07 Aligned_cols=267 Identities=28% Similarity=0.343 Sum_probs=202.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||+|+||.||+|.+.. +|+.||+|++..... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 468899999999999999998865 567899999864322 223567899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
....++||||++++.|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999999988877663 4456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhhhhhc--
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGE-- 363 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~~~~~~-- 363 (487)
........ ......++..|+|||++.+ ..++.++|||||||++|||++|..||.+........... ........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87644321 1223467889999998875 568899999999999999999999997654322111110 00000000
Q ss_pred ----ccccc-cccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 ----RRRFY-RLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ----~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+. ....+......+ ...+..+.+|+.+||+.||++||++.|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 000010000000 1224678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.66 Aligned_cols=265 Identities=26% Similarity=0.341 Sum_probs=203.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||.|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 58889999999999999998865 467899999876543 2245788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 99999998766677999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh-----
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----- 362 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----- 362 (487)
....... .......|+..|+|||++.+. .++.++|||||||++|||++|.++|........ .......+.
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~ 223 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEE 223 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChH
Confidence 7654322 112235689999999988654 568999999999999999999888865432111 100000000
Q ss_pred ------cccccccccCCcc----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ------ERRRFYRLIDPRL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+.........+.. ........+..+.+|+.+||..||.+||++.+++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000000 0000112346789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.01 Aligned_cols=268 Identities=27% Similarity=0.357 Sum_probs=203.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||+|+||.||+|.+.. +++.||||.++.... ...+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368899999999999999998865 567999999865322 234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||++++.|..++ .+...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999886666554 44456899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc---
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 363 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 363 (487)
........ .......++..|+|||++.+. .++.++|||||||++|+|++|..||..................+..
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 87654332 122335788999999999887 8899999999999999999999999754321111000000000000
Q ss_pred -----ccccc--cccCCc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 -----RRRFY--RLIDPR----LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 -----~~~~~--~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+. +..... +...++...+..+.+||++||..+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 000000 0001122235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=318.06 Aligned_cols=255 Identities=33% Similarity=0.493 Sum_probs=203.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
|++.+.||.|+||.||+|.+...+. ..+..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 4577899999999999999875321 13478999999765443 45678899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.++||||+++++|.+++...... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999999999655434 899999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
......... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... .+.... ....
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~----~~~~--- 221 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYL----KKGY--- 221 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcCC---
Confidence 654422211 12337789999999988889999999999999999998 78888653211 111110 0000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
........+..+.+++.+||..||++||++.++++.|
T Consensus 222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0001112356789999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=317.74 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=190.6
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY 215 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 215 (487)
.||+|+||.||+|...... ....+++|.+..... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 6999999999999764322 233567887765432 33467899999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 216 EFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 216 E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
||+++|+|.+++.+. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence 999999999999653 234667778899999999999999988 99999999999999999999999999865322
Q ss_pred CCcceeeeeccccccccCCceecc-------CCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 293 GDKTHVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 293 ~~~~~~~~~~~Gt~~y~APE~~~~-------~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
...........|+..|+|||++.. ..++.++|||||||++|||++ |..||...... ...... +.+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~- 224 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IKD- 224 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hhh-
Confidence 221112234578899999998743 245789999999999999997 56677543221 111110 111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
......++.+... ....+.+|+..|| .+|++||++.+|++.|.
T Consensus 225 -~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 -QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1112223333222 3356788999999 78999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.98 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=199.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+|++.+.||+|+||.||+|.+.. +|..||||.+..... ...+.+.+|++++..++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 478899999999999999998765 577999998854321 123467889999999999999999999
Q ss_pred EEeC--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 205 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 205 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+.+. ..+++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEEC
Confidence 8764 4678999999999999998654 45788889999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||+++........ .......|+..|+|||++.+..++.++|||||||++|||++|..||....... ....
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~--- 220 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AIFK--- 220 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HHHH---
Confidence 99999864321111 11223568999999999988889999999999999999999999996432110 0000
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..........+......+.+++.+|| .+|.+||++.+|+++-
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~ 262 (265)
T cd06652 221 --------IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHT 262 (265)
T ss_pred --------HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCc
Confidence 00000112233344567889999999 5999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=320.00 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=199.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+|.+.+.||.|+||.||+|... +|..+|||.+...... ....+.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788999999999999999753 4668999998644221 12457889999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccc
Confidence 99999999999999999999999654 46889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCC----cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 285 GLAKDGPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 285 Gla~~~~~~~----~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
|++....... .........|+..|+|||++.+..++.++|||||||++|+|++|..||.......... .
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------~ 219 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-------Y 219 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-------H
Confidence 9987642211 1111223568999999999998899999999999999999999999996432211100 0
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... ....+.+ +...+..+.+++.+||+.+|.+||++.+++++
T Consensus 220 ~~~~----~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 220 IGAH----RGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred hhhc----cCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0001111 22234678999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.55 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=202.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|+||.||++.+.. +..||+|.+.... .....+.+|+++++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 345789999999999999999997643 3469999887543 23457889999999999999999999988
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+ ...++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCc
Confidence 7 7789999999999999999653 445788899999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++......... ......++..|+|||++....++.++|||||||++|+|++ |..||...... ...... ...
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~ 219 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERG 219 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCC
Confidence 99765432211 1222346678999999988889999999999999999999 89999654221 111110 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.... .....+..+.+++.+||+.||++||++.++++.|+.
T Consensus 220 ------~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 ------YRMP----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ------CCCC----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000 111234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.55 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=201.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+++++.++|+||+++++++...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 45566789999999999998764 567899999875432 22356889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999999999998843 46889999999999999999999987 99999999999999999999999999986
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
...... ......|+..|+|||++.+..++.++|||||||++|||++|..||....+... ... .. .
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~------~ 215 (277)
T cd06642 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IP------K 215 (277)
T ss_pred ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hh------c
Confidence 543221 12234688999999999988999999999999999999999999864332111 000 00 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...+ .+....+..+.+|+.+||+.+|++||++.+++++-
T Consensus 216 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 216 NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0111 12223456789999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=324.47 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=199.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 578999999999999999998764 4678999998654322 224567899999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+.+ +|.+++.+....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 999999999974 999998766667899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh-----
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----- 362 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----- 362 (487)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ........+.
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 227 (291)
T cd07844 152 AKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEE 227 (291)
T ss_pred ccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChh
Confidence 5432111 1122357889999998865 5689999999999999999999999965431110 0000000000
Q ss_pred ------ccccc----cccc-CCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ------ERRRF----YRLI-DPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ------~~~~~----~~~~-~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..... .... ...+...+. ......+.+++.+||+.||.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 0000 000000000 0012567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.74 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=205.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||+||+|.... ++..+|+|++..... .....+.+|+++++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 478999999999999999998764 466899999865432 2456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+..++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence 9999999999999999998654 246899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce--eeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+.......... ......|+..|+|||++... .++.++|||||||++|+|++|..||........ ...... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----~ 222 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----N 222 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc----C
Confidence 87655432221 22335689999999998776 789999999999999999999999965433211 111100 0
Q ss_pred ccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+.... ....+..+.+|+.+||..||++||++.+|+++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 223 -------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001111100 11334678999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=329.20 Aligned_cols=253 Identities=28% Similarity=0.354 Sum_probs=201.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.... ++..||+|.+...... ..+.+..|++++..++|+||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368889999999999999998865 5679999999765433 3356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+....|+||||+.+++|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||||+.++.++|+|||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence 999999999999999999998653 356899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcc---------------------------eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhC
Q 011385 286 LAKDGPEGDKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338 (487)
Q Consensus 286 la~~~~~~~~~---------------------------~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG 338 (487)
++......... .......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98754322110 011134689999999999988999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 011385 339 RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL----MSEVVE 410 (487)
Q Consensus 339 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~ 410 (487)
..||........ .. .+.............+..+.+|+.+||+.||++||+ +.+++.
T Consensus 229 ~~pf~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 229 TTPFKGSNRDET--FS--------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCCchHHH--HH--------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 999965432110 00 000000000001114578999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=324.19 Aligned_cols=257 Identities=28% Similarity=0.387 Sum_probs=201.2
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEE
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 202 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~ 202 (487)
+.....+.|++.+.||.|+||.||+|.+.. +++.||+|++.... ....++..|+.++.++ +|+||++++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~ 79 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYY 79 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence 333456789999999999999999998865 56789999986543 2235678899999998 799999999
Q ss_pred EEEEe------CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011385 203 GYCIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275 (487)
Q Consensus 203 ~~~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 275 (487)
+++.. .+..|+||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~ 156 (282)
T cd06636 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE 156 (282)
T ss_pred eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 99853 46789999999999999988653 345888889999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 011385 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 350 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 350 (487)
++.++|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|..||....+...
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 99999999999876432111 122356899999999875 35688899999999999999999999965432111
Q ss_pred chhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... .....+. ......+..+.+||.+||+.||.+||++.||+++
T Consensus 235 ~~~~-------------~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 235 LFLI-------------PRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hhhH-------------hhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 1000 0000010 0111234678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=319.39 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=203.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+|+..+.||+|+||.||+|.... ++..||+|.+...... ..+.+.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 47888999999999999998754 5778999998654321 23568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~D 283 (487)
+.+.+..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcc
Confidence 99999999999999999999998544 46889999999999999999999988 99999999999998776 599999
Q ss_pred cCCCCCCCCCCc--ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 284 FGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 284 FGla~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
||++........ ........|+..|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------ 221 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------ 221 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------
Confidence 999877543211 111223568999999999988899999999999999999999999996433211111110
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.........++...+..+.+++.+||..||++||++.+++++
T Consensus 222 -------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 -------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0000011122333456788999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=338.16 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=210.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
....|.+.+.||+|.|+.|.+|++.. ++..||||.+.+..... ...+.+|+++|..|+|||||+++.+.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~ 124 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI 124 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34578999999999999999999986 67799999998765543 34588999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.....+|+||||+.+|.|+++|.+++ .+.+..+..++.|++.|++|||++. |||||||.+||||+.+.++||+|||
T Consensus 125 ~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 125 ETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 99999999999999999999997665 4555888999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++..+..+. ...++||++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..-.....- .+...
T Consensus 201 fS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r------vl~gk 271 (596)
T KOG0586|consen 201 FSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR------VLRGK 271 (596)
T ss_pred cceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch------heeee
Confidence 999876433 3456899999999999998877 5789999999999999999999987543322111 11111
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.++ +.-...++.+||+++|..+|.+|++++++.++-+
T Consensus 272 ~rI------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 272 YRI------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ecc------------cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 111 1112346789999999999999999999988654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=318.16 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=201.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe-
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 207 (487)
+|++.+.||.|+||.||++.+.. +|..||+|.+...... ..+.+..|+++++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 57888999999999999998765 5678999998754332 23468889999999999999999998764
Q ss_pred -CCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCcEEEcCCCc
Q 011385 208 -DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLH-----EEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH-----~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
....+++|||+++++|.+++... ...+++..++.++.||+.||.||| +.+ |+|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~ 148 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN 148 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence 45678999999999999998643 457899999999999999999999 655 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .+.....
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 223 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK 223 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence 99999999987654332 122356899999999998888999999999999999999999999754311 1111100
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
......++...+..+.+|+.+||+.+|.+||++.+|+++
T Consensus 224 --------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 --------------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --------------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000111222345678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=362.94 Aligned_cols=259 Identities=25% Similarity=0.297 Sum_probs=212.3
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCc
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNL 198 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnI 198 (487)
..+++...++|.++++||+|+||.|.+++++. +++.||+|++++.... ...-|..|-.+|..-+.+-|
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi 137 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI 137 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence 34456677999999999999999999999876 7789999999874332 22347889999999899999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
++++..|+++.++||||||++||+|..++.+.. .+++..+..++..|+-||.-||+.| +|||||||.|||||..|+
T Consensus 138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 999999999999999999999999999997666 8999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceec----c-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----T-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~----~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
+||+|||.+-.+..+. .......+|||.|.+||++. + +.|+..+|+||+||++||||.|..||.... +
T Consensus 214 ikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------l 286 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------L 286 (1317)
T ss_pred EeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------H
Confidence 9999999988765433 33455679999999999986 3 579999999999999999999999996432 1
Q ss_pred hHhhhhhhhcccccccccCCccCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPL---MSEVVEA 411 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~ 411 (487)
+.... ++++-.-.-.|| .+.+..+.+||.+++ .+|+.|.. +.++..|
T Consensus 287 veTY~----------KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 287 VETYG----------KIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHH----------HHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 11111 112211112233 345788999999998 78999987 7777654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=352.19 Aligned_cols=261 Identities=27% Similarity=0.473 Sum_probs=218.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
....+.++||.|.||.|++|+++..++ ....||||.++....+. ..+|+.|+.||.+++||||++|.|+....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 455778899999999999999987654 34589999998765443 46799999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..++||.|||++|+|+.+|+.+.+.+.+.++.-++++|+.||.||-+++ +|||||..+||||+.+...||+||||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999999988888999999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCcceeeeeccc--cccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 289 DGPEGDKTHVSTRVMG--TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~G--t~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
...++... ..+..-| ..+|.|||.+....++.++|||||||+|||.++ |..||-+.... +++.. +.+.
T Consensus 780 vledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIka----Ie~g- 850 (996)
T KOG0196|consen 780 VLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKA----IEQG- 850 (996)
T ss_pred ecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHH----HHhc-
Confidence 87665422 2222223 469999999999999999999999999999887 88998654332 22211 1111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
+++. -+.+|+..+.+|+..||++|..+||.+.+|+.+|+++..
T Consensus 851 --yRLP-------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 851 --YRLP-------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred --cCCC-------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1221 234678899999999999999999999999999987643
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=323.99 Aligned_cols=266 Identities=25% Similarity=0.325 Sum_probs=200.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-----CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
+|.+.+.||+|+||.||+|.+.. +|..||||.+...... ....+..|+++++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47788999999999999998765 4679999999765432 234567899999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..++||||+ +|+|.+++......+++..++.++.||++||.|||+++ |+|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 89999999655447999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh-hhh-
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-PHL- 361 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~-~~~- 361 (487)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|.++|............ .... +..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 148 LARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 9987644321 1222457889999998854 46789999999999999999998888654321111000 0000 000
Q ss_pred --hcccccccccCCccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 --GERRRFYRLIDPRLE-----GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 --~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
............... .......+..+.+|+.+||+.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 00111235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.88 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=200.2
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
|.+.+.||+|+||.||+|.+..+. +++..||||++..... ...+++.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567889999999999999876432 2578999999865432 22456889999999999999999999886542
Q ss_pred ------eeEEEEeeCCCCChhHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 210 ------QRLLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 210 ------~~~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
..++++||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~ 151 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT 151 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence 236889999999999887422 224788899999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++...............+++.|++||.+....++.++|||||||++|||++ |..||...... .+..+.
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 228 (273)
T cd05074 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL 228 (273)
T ss_pred EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987543322222223456678999999988899999999999999999999 88888644221 111111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .... .. .+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 229 ~----~~~~------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 I----KGNR------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H----cCCc------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0000 00 0112346789999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.48 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=199.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
+.+|.+.+.||+|+||.||+|.... +|..||+|++....... ...+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 4689999999999999999998765 46689999986543322 2457899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..|+||||+. ++|.+++......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence 999999999995 6888777665566888889999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh-------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP------- 359 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~------- 359 (487)
+....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||.............+...
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 76433221 1223457899999998875 4588999999999999999999999975433111000000000
Q ss_pred --hhhcccccc-cccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 --HLGERRRFY-RLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 --~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+....... ..........+. ...+..+.+|+.+||..||.+|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000 000000000000 0113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=325.20 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=201.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||++.+.. +++.||+|.+..... .....+.+|++++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368899999999999999998865 467899999865432 23456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||||+.++.+||+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCC
Confidence 999999999999999999998654 57899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..... ....
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~--- 213 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEK---ILEG--- 213 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HhcC---
Confidence 9876543 22356899999999998888999999999999999999999999654311 10000 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
... ++...+..+.+++.+||..||.+|+ ++.|++++
T Consensus 214 -----~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 -----KVR----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -----Ccc----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011 1112246789999999999999999 66666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=319.16 Aligned_cols=254 Identities=29% Similarity=0.395 Sum_probs=204.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||.||+|.+.. +++.||+|.+..... ....++.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 367888899999999999998865 567899999876533 3345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++++|.+++......+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~ 148 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVS 148 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999997655678999999999999999999999 77 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ ....|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ...........
T Consensus 149 ~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~----- 218 (265)
T cd06605 149 GQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN----- 218 (265)
T ss_pred hhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc-----
Confidence 76532211 115789999999999989999999999999999999999999965432111 11111110000
Q ss_pred ccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+ .++.. .+..+.+||.+||..||.+||++.+++.+
T Consensus 219 --~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 --EPPP----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --CCCC----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0011 11111 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=317.19 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=201.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
+|+..+.||+|+||.||+|.... ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 47788999999999999998864 466899999865432 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+....++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999998654 46889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||....... ..... ...
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~-----~~~ 217 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKI-----GRS 217 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHH-----Hhc
Confidence 988754332 123456899999999887766 8999999999999999999999996543111 00000 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. ...++...+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 218 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 KE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00 011122234678899999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=318.03 Aligned_cols=246 Identities=30% Similarity=0.474 Sum_probs=197.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|++.+.||+|+||.||++.. ++..||+|.++... ....+.+|+.++..++||||+++++++..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 5688999999999999999864 45689999986543 235788999999999999999999998654
Q ss_pred eeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence 5799999999999999996543 35889999999999999999999987 9999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
...... .....+..|+|||.+.+..++.++|||||||++|||++ |..||........ .. .....
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~--- 213 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KE----CVEKG--- 213 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HH----HHhCC---
Confidence 643221 12234568999999988899999999999999999998 9999965432111 10 00000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
. ........+..+.+|+.+||+.+|++||++.++++.|+.
T Consensus 214 ---~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 ---Y----RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---C----CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 001111234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.94 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=196.4
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC----CccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++..+||+|+|-+||+|.+.. +|..||--.++.. .....++|..|+.+|+.|+|||||++|.+|.+.
T Consensus 43 k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 445689999999999998865 5667765444322 122346799999999999999999999999987
Q ss_pred Ce--eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeecC
Q 011385 209 DQ--RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG 285 (487)
Q Consensus 209 ~~--~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl~DFG 285 (487)
.+ ..+|+|++..|+|..|+.+. +.+....+..|++||+.||.|||++. .||||||||..||||+.+ |.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchh
Confidence 66 66899999999999999655 46888999999999999999999987 689999999999999765 999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
||+...... .....|||.|||||+.. ..|+..+||||||++|+||+|+..||..... .....
T Consensus 192 LAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIY-------- 253 (632)
T KOG0584|consen 192 LATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIY-------- 253 (632)
T ss_pred HHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHH--------
Confidence 999865432 23368999999999765 8999999999999999999999999964321 11110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.++........|.....+++++||.+||.. ..+||++.|+|+.
T Consensus 254 --KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 254 --KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111111112223333356899999999999 9999999999974
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=326.11 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=200.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368899999999999999998865 567899999875532 22346789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCC
Confidence 999999999999999999999554 56899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCC-------------cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 287 AKDGPEGD-------------KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 287 a~~~~~~~-------------~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
++...... .........|+..|+|||.+.+..++.++|||||||++|||++|..||.+..... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~ 224 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L 224 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87421110 0001112467889999999988899999999999999999999999996543211 1
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
... .... ....+.... ..+..+.+|+.+||+.||++||++.++++.|+
T Consensus 225 ~~~---~~~~-----~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 225 FGQ---VISD-----DIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHH---HHhc-----ccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 100 0000 000111111 23467899999999999999999665555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.21 Aligned_cols=267 Identities=28% Similarity=0.343 Sum_probs=200.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||+|+||.||+|.+.. +++.||+|++...... ..+.+.+|+++++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368889999999999999998865 4678999998643322 23568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..++||||++++.|..++.. ...+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeee
Confidence 9999999999999888877643 345899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc--
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-- 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-- 364 (487)
........ ......|+..|+|||++.+ ..++.++|||||||++|||++|.+||..................+...
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 86543221 2233568899999998865 457889999999999999999999996543211000000000000000
Q ss_pred -----ccc-ccccCCccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 -----RRF-YRLIDPRLEGH-----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 -----~~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+ .....+..... .....+..+.+|+.+||+.||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 00000000000 001234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=315.74 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=208.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++.+.||.|+||.||+|.+.. ++..||||++..... .....+.+|+.++..++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 368889999999999999998865 577999999876544 3346789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999654 578999999999999999999999 88 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||................
T Consensus 148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------- 216 (264)
T cd06623 148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--------- 216 (264)
T ss_pred eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------
Confidence 876443221 123568899999999998899999999999999999999999997654311111111111
Q ss_pred ccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+ .++.. .+..+.+++.+||..+|++||++.+++++
T Consensus 217 -~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 -DGPPP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCCC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00111 11112 35679999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=323.04 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=202.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||.|+||.||+|.+.. ++..||+|.++..... ....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 478889999999999999998865 5678999999754332 22356789999999999999999999887
Q ss_pred C--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 208 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 208 ~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
. +..||||||++ ++|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 7 88999999996 5999988766567999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh------
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA------ 357 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~------ 357 (487)
++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|..||...........+ ...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9987654321 12234678899999988654 4689999999999999999999999754322111000 000
Q ss_pred -hhhhhc-----ccccccccCCccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 -RPHLGE-----RRRFYRLIDPRLEGHFSIK-GAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 -~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+.... ...........+...++.. .+..+.+||.+||+.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 0000000011111222222 35678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=317.28 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=202.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||++.... +|+.||+|.+..... ...+++.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 58889999999999999998765 467899999865432 2335788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence 9999999999999999988654 345889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ... ......
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~---~~~~~~---- 216 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV---LKIIRG---- 216 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHH---HHHhcC----
Confidence 76543221 122346889999999998889999999999999999999999998643211 111 000000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ....+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus 217 --~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 --S-----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --C-----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 001122335678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=314.70 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=201.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||+|.... ++..||||.+..... .....+.+|+++++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 58889999999999999998765 567899999865432 2345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl~DFGl 286 (487)
+..++||||+++++|.+++... ...+++..++.++.|++.+|.|||+++ |+|+||||+||+++.+ +.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999999999999999754 345899999999999999999999988 9999999999999865 4589999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ .....|+..|+|||.+.+..++.++|||||||++|+|++|..||....... ..... ...
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~~~--- 216 (256)
T cd08220 149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---MSG--- 216 (256)
T ss_pred ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---Hhc---
Confidence 987644321 223568999999999998889999999999999999999999996543211 11100 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ...++...+..+.+++.+||..||++||++.|++.+
T Consensus 217 ----~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 217 ----T----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----C----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 001111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=326.66 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=200.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
.|.....||+|+||.||++.... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 34445679999999999998764 567899999876554445678899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999999999998743 35889999999999999999999988 999999999999999999999999998764
Q ss_pred CCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|..||....... ..... ...
T Consensus 169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~----------~~~ 233 (292)
T cd06658 169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRI----------RDN 233 (292)
T ss_pred ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----------Hhc
Confidence 33221 1233568999999999988899999999999999999999999996533211 10000 001
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.+.+.. ....+..+.+++.+||..||.+||++.+++++
T Consensus 234 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111 11234578899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=320.39 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=195.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHH-HhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||+|+||.||+|.+.. +|..||||+++.... ....++..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 478899999999999999998765 577999999876432 223456667665 566789999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 208 DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++..|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence 999999999996 688887753 235689999999999999999999986 6 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceecc----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
||++....... ..+...|+..|+|||++.+ ..++.++|||||||++|||++|..||....... .....
T Consensus 148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~--- 219 (283)
T cd06617 148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQ--- 219 (283)
T ss_pred ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHH---
Confidence 99998654321 1233568899999998864 457889999999999999999999996422110 00000
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ...+.+. ....+..+.+|+.+||..+|++||++.+++++-
T Consensus 220 ~~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 220 VVE-------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred HHh-------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000 0001110 112346789999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=317.81 Aligned_cols=254 Identities=30% Similarity=0.402 Sum_probs=200.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.. ++..|++|++..... ....+.+|+.+++++ .|+||+++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 35789999999999999999998864 466899999876543 336688999999999 7999999999997
Q ss_pred eCC------eeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 207 EDD------QRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 207 ~~~------~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
... .+++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA 150 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence 644 489999999999999988542 357899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
.++|+|||++........ ......|+..|+|||++.. ..++.++|||||||+||+|++|..||....... .
T Consensus 151 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 226 (275)
T cd06608 151 EVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--A 226 (275)
T ss_pred eEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--H
Confidence 999999999876433211 1233568999999998753 357889999999999999999999996432211 0
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+... . ....+.+ ..+...+..+.+|+.+||..||++||++.+++++
T Consensus 227 ~~~~----~-------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 227 LFKI----P-------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHh----h-------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 0 0000111 1112245678999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=318.92 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=203.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
+|++.+.||.|+||.||+|.+.. ++..||+|.+..... ...+.+.+|++++++++||||+++++++.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 47888999999999999998764 577999999975433 234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+.+++|.+++... ..+++..+..++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccc
Confidence 99999999999999999998655 57899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||..........+... ...
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~---- 216 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET---- 216 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc----
Confidence 8765432 12335688999999999888899999999999999999999999976543211111110 000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM--SEVVE 410 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ell~ 410 (487)
. ...++...+..+.++|.+||..||.+||++ .|+++
T Consensus 217 ---~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ---A----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---c----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0 111222334788999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.63 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=200.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..|.+.+.||+|+||.||+|.... +|..||+|.+...... ..+++.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 568899999999999999998764 5678999998654332 2346889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..++||||++ |+|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence 9999999999996 5787877665567999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+...... ....|++.|+|||++. ...++.++|||||||++|||++|..||........ .. ....
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~~----~~~~ 228 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY----HIAQ 228 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---HH----HHhc
Confidence 8765332 2346889999999874 45688999999999999999999999864322110 00 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...+.+ .....+..+.+|+.+||+.||++||++.+|+.+..
T Consensus 229 ------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 229 ------NDSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ------CCCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000101 11234567899999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.35 Aligned_cols=258 Identities=29% Similarity=0.368 Sum_probs=201.1
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEE
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLI 202 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~ 202 (487)
++....++|.+.+.||+|+||.||+|.... +++.||+|++.... .....+.+|+.++.++ +||||++++
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~ 85 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY 85 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 333456889999999999999999998765 57789999986532 2235678899999999 899999999
Q ss_pred EEEEeC-----CeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 203 GYCIED-----DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 203 ~~~~~~-----~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
+++... +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~ 162 (291)
T cd06639 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLT 162 (291)
T ss_pred EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence 998754 358999999999999998853 3456899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-----CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 349 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 349 (487)
.++.+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 999999999999886543221 12234689999999987543 36889999999999999999999996543211
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. +..... ...+.+. .+......+.+|+.+||+.||++||++.|++++
T Consensus 241 ~--~~~~~~-----------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 T--LFKIPR-----------NPPPTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H--HHHHhc-----------CCCCCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 111000 0000000 111233568999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.37 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=200.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----------cCHHHHHHHHHHHhc-CCCCCce
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGD-LVHLNLV 199 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~HpnIv 199 (487)
+|++.+.||+|+||.||+|.+... ++..+|+|.+..... ....++..|+.++.+ ++|+||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 478889999999999999988642 356899998853321 123457788988875 7999999
Q ss_pred eEEEEEEeCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcC
Q 011385 200 KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDA 275 (487)
Q Consensus 200 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~ 275 (487)
++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~ 149 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE 149 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence 999999999999999999999999988743 34568999999999999999999996 45 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011385 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~ 355 (487)
++.+||+|||++....... ......|+..|+|||.+.+..++.++|||||||++|||++|..||....... ...
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~ 223 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LAT 223 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHH
Confidence 9999999999998754432 2234578999999999998889999999999999999999999986432111 000
Q ss_pred hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. .... ...+... ...+..+.+|+.+||+.||++||++.|+..+|+
T Consensus 224 ~---~~~~------~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 K---IVEA------VYEPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred H---Hhhc------cCCcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0000 0001001 122467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=324.67 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=200.3
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
|.....||+|+||.||+|.... ++..||+|.+........+.+.+|+.++..++||||+++++++..++..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3445579999999999998764 4678999998765545556788999999999999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
++||||+++++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 999999999999987743 45889999999999999999999988 9999999999999999999999999987543
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......|+..|+|||++.+..++.++|||||||++|||++|..||....... ...... .. .
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~----~~------~ 233 (297)
T cd06659 169 KDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLR----DS------P 233 (297)
T ss_pred cccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh----cc------C
Confidence 3221 1223578999999999988899999999999999999999999996433211 111000 00 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+... .....+..+.+++.+||+.+|.+||++.+++++-
T Consensus 234 ~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 234 PPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 00000 0112245688999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=316.85 Aligned_cols=258 Identities=29% Similarity=0.385 Sum_probs=202.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|+..+.||.|++|.||+|.+.. ++..||+|.+..... ....++.+|+++++.++||||+++++++.+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 367888999999999999999865 567899999875433 2345689999999999999999999988654
Q ss_pred --CeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 209 --DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+++||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence 468999999999999988643 3456889999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC--CcchhhHhhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN--GEHNLVEWARPHL 361 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~~~~~~~~~ 361 (487)
||++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ...+...+....
T Consensus 149 fg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 223 (287)
T cd06621 149 FGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM- 223 (287)
T ss_pred ccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-
Confidence 99987653322 12346788999999999899999999999999999999999999755321 111111111100
Q ss_pred hcccccccccCCccCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 362 GERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..+.+..... ...+..+.+|+.+||..||.+||++.|++++-.
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 224 ---------PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred ---------CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000110000 123567899999999999999999999998554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=319.71 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=204.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|.+.+.||+|+||.||++.... ++..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 689999999999999999997654 46689999987554444567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..|+||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999998543 5788899999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
...... ......|++.|+|||.+....++.++|||||||++|+|++|..||............. ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-----~~~------ 231 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-----TNG------ 231 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-----cCC------
Confidence 543322 1223468899999999988889999999999999999999999997543321110000 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+.+ ......+..+.+|+.+||+.+|++||++.+++.+
T Consensus 232 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 --TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111234578899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=316.84 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=201.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
-|++.+.||.|+||.||+|.+.. ++..||||.+..... .....+.+|+.++..++||||+++++++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 46778899999999999998754 467899999865432 22356889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999999999998853 35889999999999999999999988 99999999999999999999999999876
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .... ...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~----~~~------ 215 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFL----IPK------ 215 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHH----Hhc------
Confidence 543221 1223568899999999988889999999999999999999999996432211 0000 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. ...+....+..+.+++.+||+.+|.+||++.+++++
T Consensus 216 ~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NN----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 111122334678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.61 Aligned_cols=265 Identities=25% Similarity=0.362 Sum_probs=198.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++++.||.|+||.||+|++.. +|..||||.+..... .....+.+|++++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 47889999999999999998764 577999999865432 2235688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+. ++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence 99999999995 6898888643 356899999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhhh-----
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPH----- 360 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~----- 360 (487)
........ ......++..|+|||++.+.. ++.++|||||||++|||+||..||......... .........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 76533221 122345788999999887644 688999999999999999999999654321110 000000000
Q ss_pred --hhc----ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 --LGE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 --~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... ...+.......+. ......+..+.+||.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 0000000000000 0001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.30 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=200.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC---CCCceeEEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV---HLNLVKLIGYCI 206 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~ 206 (487)
.|++.+.||.|+||.||+|.+.. ++..||+|.++.... ....++.+|+.+++.+. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47788899999999999998765 567999999865432 33456889999999986 999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+...++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCc
Confidence 999999999999999999988543 6899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||........... ..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~--- 215 (277)
T cd06917 148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------IP--- 215 (277)
T ss_pred eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------cc---
Confidence 987654332 1233568999999998765 4578999999999999999999999975432211100 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+.+... ..+..+.+++.+||+.||++||++.+++++
T Consensus 216 ---~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 ---KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0011111111 134578899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.02 Aligned_cols=270 Identities=24% Similarity=0.325 Sum_probs=198.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3579999999999999999998765 5779999998644322 2245678999999999999999999987
Q ss_pred eCC--------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 207 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 207 ~~~--------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
... ..++||||+. ++|.+++......+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI 157 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence 654 3499999995 5888888666667899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcc--eeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011385 279 AKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~ 355 (487)
+||+|||++......... .......++..|+|||++.+. .++.++|||||||++|||++|..||...........+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999865432211 112234678899999987654 47889999999999999999999997654322211111
Q ss_pred hhhhhhhc-----c--cccccccC-C-ccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 356 WARPHLGE-----R--RRFYRLID-P-RLEGHF-----SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 356 ~~~~~~~~-----~--~~~~~~~~-~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
........ . ......+. + ...... .......+.+||.+||..||.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 11100000 0 00000000 0 000000 00113467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=312.79 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=202.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|.+.+.||+|+||.||+|.... ++..||+|.++..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 57888999999999999998764 4678999999766543 456789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence 9999999999999999998654 45888999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCccee--eeeccccccccCCceeccCC---CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 289 DGPEGDKTHV--STRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 289 ~~~~~~~~~~--~~~~~Gt~~y~APE~~~~~~---~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
.......... .....++..|+|||++.+.. ++.++|||||||++|+|++|..||....... ... +... ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~-~~~~-~~- 222 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIM-FHVG-AG- 222 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHH-HHHh-cC-
Confidence 7644322111 11256889999999988766 8999999999999999999999996432110 000 0000 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+.. ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 223 -------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 -------HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -------CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0011111 01225678899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.74 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=199.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|..||||.+.... ......+.+|+.+++.++|+||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 45789999999999999999998765 57799999986432 22335678899999999999999999988
Q ss_pred EeC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
... ...|+||||+. ++|.+++... +++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCE
Confidence 643 35799999995 5888877432 888999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-H---
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E--- 355 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~--- 355 (487)
||+|||+++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .
T Consensus 158 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999998754322 123356889999999999999999999999999999999999999754321110000 0
Q ss_pred --------hhhh----hhhcc-----cccccccCCcc----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 356 --------WARP----HLGER-----RRFYRLIDPRL----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 356 --------~~~~----~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... ..... ..+.......+ ........+..+.+||.+||+.||++||++.|+|++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000 00000 00001110000 0000112356788999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.13 Aligned_cols=269 Identities=26% Similarity=0.324 Sum_probs=200.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|.+.. +|..||+|.++...... ...+.+|+.++++++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 4689999999999999999998764 57799999986543221 234678999999999999999999987
Q ss_pred eC--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 207 ED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 207 ~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+. +..++||||+. ++|.+++......+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 65 56899999996 4898888765567999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~~~~~ 362 (487)
|++......... .....+++.|+|||++.+ ..++.++|||||||++|||++|..||...........+... .....
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 999876443211 222346888999998865 56899999999999999999999999755432211111000 00000
Q ss_pred cc-------cccccc-cCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ER-------RRFYRL-IDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ~~-------~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. ...... ........+. ...+..+.+||.+||+.||++||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00 000000 0000000000 01246678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=308.17 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=206.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
+|.+.+.||+|+||.||++.+.. ++..|++|++..........+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47888999999999999998864 466899999977655455779999999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.+++|||+++++|.+++......+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 99999999999999998766567999999999999999999999977 999999999999999999999999999876
Q ss_pred CCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
..... .....|+..|+|||++.+..++.++||||||+++|+|++|..||........... .. . ......
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~---~--~~~~~~ 217 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IA---T--NGPPGL 217 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH---h--cCCCCc
Confidence 55332 2335689999999999888899999999999999999999999965432111100 00 0 000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. ....+..+.+++.+||+.||++||++.+++++
T Consensus 218 ~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Cc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 11124678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=320.99 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=201.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.|...+.||+|+||.||+|++.. ++..||+|.+...... ....+.+|+++++.++|+||+++++++.+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 47778899999999999998765 5678999998654322 23468899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..+|||||+. |+|.+++......+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 999999999996 5888887666667999999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
...... ....|++.|+|||++. ...++.++|||||||++|||++|..||.......... .. ...
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~----~~~- 239 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HI----AQN- 239 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HH----Hhc-
Confidence 764332 2346889999999874 4578999999999999999999999986432111000 00 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
..+ .......+..+.+|+.+||+.+|.+||++.++++++..+..
T Consensus 240 ------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 240 ------ESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ------cCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 000 00111234678999999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.50 Aligned_cols=260 Identities=24% Similarity=0.316 Sum_probs=196.3
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC-CCCceeEEEEEEeC-
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED- 208 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~- 208 (487)
|++.+.||+|+||.||+|.... ++..||+|+++.... .......+|+.++.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6778899999999999998765 466899999875422 22234568999999985 99999999999987
Q ss_pred -CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||++ |+|.+++......+++..++.++.||+.||.|||+.+ ++||||||+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccc
Confidence 88999999996 5888888665567899999999999999999999988 999999999999999 99999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc---
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE--- 363 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--- 363 (487)
+....... .....++..|+|||++. +..++.++|||||||++|||++|..||........ ..........
T Consensus 147 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~ 220 (282)
T cd07831 147 RGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDA 220 (282)
T ss_pred cccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 87543221 12346889999999765 45678899999999999999999999976443211 1111000000
Q ss_pred ----ccccccccCCccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 ----RRRFYRLIDPRLEG-------HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ----~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
........+..... .+....+..+.+||.+||+.||++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0011235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.90 Aligned_cols=244 Identities=26% Similarity=0.341 Sum_probs=189.4
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHH---HhcCCCCCceeEEEEEEeCCe
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF---LGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~---l~~l~HpnIv~~~~~~~~~~~ 210 (487)
+||+|+||.||++.... ++..||+|.+....... ...+.+|..+ +...+||||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999998765 57799999986543221 1223444433 334579999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 99999999999999988544 46999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
.... .....|+..|+|||++. +..++.++|||||||++|||++|..||..........+.... .
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------~ 212 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----------L 212 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-----------h
Confidence 3321 12346899999999886 456899999999999999999999999754332211111000 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
..+ ..++...+..+.+++.+||..||.+|| ++.|++++.
T Consensus 213 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 213 TVN----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCC----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 011 112223456889999999999999999 588887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=315.51 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=200.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
+|++.+.||.|++|.||+|++.. +|..||||.++..... ....+.+|+.+++.++|+||+++++++.+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 58889999999999999999865 5779999999765432 2356778999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
..+|||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 99999999975 8988886543 46899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhh-h-----
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR-P----- 359 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~-~----- 359 (487)
+....... ......++..|++||++.+ ..++.++|||||||++|+|++|..||........... ..... +
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 76433211 1223457889999998765 4578999999999999999999999976543211110 00000 0
Q ss_pred -hhhcccccccccCCc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 -HLGERRRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 -~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+.....+....... ....+....+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000000000 0001111235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=317.00 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=201.3
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
.|...+.||+|+||.||++.... ++..||+|++........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 45556799999999999998754 467899999876554445668899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 9999999999999999865 46889999999999999999999988 999999999999999999999999988764
Q ss_pred CCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|..||....+... ..... ..
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~----------~~ 230 (285)
T cd06648 166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIR----------DN 230 (285)
T ss_pred ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHH----------hc
Confidence 33221 12235689999999999888899999999999999999999999965332111 10000 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+.. ....+..+.+|+.+||+.||++||++.+++++
T Consensus 231 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 231 LPPKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCCCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0011110 11134678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=344.78 Aligned_cols=279 Identities=19% Similarity=0.216 Sum_probs=190.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCcc------CCCCcE----EEEEEecCCCccCHHHHHHHHHHHhcCCCCC
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVK------PGTGLT----VAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~------~~~g~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn 197 (487)
...+|++++.||+|+||+||+|.++........ ...+.. +++|.+... ......+.+|+.+|..++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999987542110000 000011 111211111 112345789999999999999
Q ss_pred ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 198 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
||++++++.+.+..|+|||++. ++|.+++.... .......+..|+.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999994 57877775332 22335667789999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCC-CCCCCCCcch
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHN 352 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~ 352 (487)
+.++.+||+|||+++........ .....+||+.|+|||++.+..|+.++|||||||+||||++|..++ ..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876443221 223467999999999999999999999999999999999988544 3222211111
Q ss_pred hhHhhhhh---hhc----ccccccccCCc----cCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 353 LVEWARPH---LGE----RRRFYRLIDPR----LEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 353 ~~~~~~~~---~~~----~~~~~~~~~~~----~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+....... ..+ ...++..++.. ....++ ...+..+.++|.+||+.||.+||++.|++.+-
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 11111000 000 00000000000 000000 01234567889999999999999999999753
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.41 Aligned_cols=254 Identities=29% Similarity=0.419 Sum_probs=205.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+-+|.-...||.|.||.||-|.+.+ +|+..|+|.++..... ..+.+.+|+.+|..|+|||+|++||+-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 3467778899999999999998765 7889999998654332 3356789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..+|.||||++|+|.+++ +++.-.++.....+..|++.|+.|||+++ ||||||||+||||+.+|.+|++|||.
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence 999999999999999999988 45556777778888999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCcce--eeeeccccccccCCceecc---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 287 AKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 287 a~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|.......... .....+||+.|||||++.+ .+...++||||||||+.||+||+.||...... |+.
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI--- 1450 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI--- 1450 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH---
Confidence 98765542111 1123689999999999974 46778999999999999999999999643221 111
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
++.. ...-.+.++...+.+-.++|.+||..||..|.++.||+++
T Consensus 1451 -----My~V-~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 -----MYHV-AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----HhHH-hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 0100 0011223444567788999999999999999999999875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=308.15 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=206.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|.+.+.||+|+||.||+|.+.. ++..|++|++..... ...+.+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47788999999999999998865 567899999876543 3356788999999999999999999999988
Q ss_pred --CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 209 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccccc
Confidence 88999999999999999986554 7999999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+................++..|+|||.+....++.++||||||+++|+|++|..||..... ..... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~-~---------- 214 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAAL-Y---------- 214 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHH-H----------
Confidence 9876554321112335689999999999888899999999999999999999999975441 00000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..........++...+..+.+++.+||+.||++||++.+++++
T Consensus 215 --~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 215 --KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0000011112222335789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.47 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=196.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 207 (487)
++|...+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|+.++.++. |+||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 356667889999999999998865 577999999875432 23456889999999996 9999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHH---h-hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 208 DDQRLLVYEFMPRGSLENHL---F-RRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l---~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+...+++|||+.. +|.++. . .....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEe
Confidence 9999999999854 665543 2 2235789999999999999999999974 5 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccC---CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|||+++....... .....|+..|+|||++.+. .++.++|||||||++|||++|..||..... .......
T Consensus 151 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~ 222 (288)
T cd06616 151 DFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQ 222 (288)
T ss_pred ecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhh
Confidence 9999976543221 1234689999999998765 689999999999999999999999964321 1000000
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. ....+.+........+..+.+|+.+||+.||.+||++.+|+++-
T Consensus 223 ~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 223 VV-------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred hc-------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00 00111122222223456789999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=336.58 Aligned_cols=266 Identities=29% Similarity=0.386 Sum_probs=200.9
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC-
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD- 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~- 209 (487)
|...+.||+||||.||+|+++. +|+.||||.++.... ...+.+.+|+++|++|+|+|||+++++-.+..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4455789999999999999876 789999999976543 33466889999999999999999999755433
Q ss_pred -----eeEEEEeeCCCCChhHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCCc--
Q 011385 210 -----QRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYN-- 278 (487)
Q Consensus 210 -----~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll--~~~~~-- 278 (487)
...+|||||.||+|...|.+ +...+++...+.++.+++.||.|||+++ ||||||||.||++ ..+|+
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence 45799999999999999963 4567999999999999999999999988 9999999999998 33343
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
-||+|||.|+...++. ..+.++||..|++||++. ...|+..+|.|||||++|++.||..||..........-+.|.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~ 239 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH 239 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence 6999999999987654 466789999999999998 488999999999999999999999999754433211111111
Q ss_pred hhhhh-----------cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHh
Q 011385 358 RPHLG-----------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP--LMSEVVEAL 412 (487)
Q Consensus 358 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~ell~~L 412 (487)
..... +...+..-..-....+++......+-.++..+|..+|.+|. .+.+....+
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~ 307 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV 307 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence 11100 00000000000112234444455677899999999999998 544444433
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.25 Aligned_cols=254 Identities=24% Similarity=0.267 Sum_probs=199.5
Q ss_pred HhcCCCCC-CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
.+++|.+. ++||-|-.|.|..|.++. ||+.+|+|++... ....+|+++.-.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 34566554 479999999999998765 8889999998644 4567888875554 599999999987
Q ss_pred Ee----CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CC
Q 011385 206 IE----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DY 277 (487)
Q Consensus 206 ~~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~ 277 (487)
.. ...++||||.++||+|+..|..++ ..+++..+..|+.||+.|+.|||+.+ |.||||||+|+|... +.
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence 64 356789999999999999997654 46999999999999999999999998 999999999999964 45
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
.+||+|||+|+...... ...+.|-||.|.|||++....|+..+|+||+||++|-||+|.+||....-...
T Consensus 202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------- 271 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------- 271 (400)
T ss_pred ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------
Confidence 68999999999754322 23457889999999999999999999999999999999999999965432110
Q ss_pred hhhhhccc--ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 358 RPHLGERR--RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 358 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+.+..+- ..+.+.++ .-...++.++++|+.+|..+|.+|.|+.+++++-+
T Consensus 272 spgMk~rI~~gqy~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ChhHHhHhhccCccCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 01111000 00111111 11245678899999999999999999999998765
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=319.49 Aligned_cols=270 Identities=23% Similarity=0.308 Sum_probs=198.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
+|++.+.||+|+||.||+|..... +++..||+|.+.... ......+.+|+.++..++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 478889999999999999998642 246799999997643 2233567899999999999999999999998
Q ss_pred C--CeeEEEEeeCCCCChhHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----CC
Q 011385 208 D--DQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----DY 277 (487)
Q Consensus 208 ~--~~~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~----~~ 277 (487)
. +.+++||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence 8 889999999965 777766422 236889999999999999999999988 999999999999999 89
Q ss_pred cEEEeecCCCCCCCCCCc-ceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch---
Q 011385 278 NAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--- 352 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--- 352 (487)
.+||+|||+++....... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 999999999987543222 111223568899999998765 468999999999999999999999997654432100
Q ss_pred ---hhHhhhhhhh-----------ccccccc---ccC-CccC-CC----CCH--HHHHHHHHHHHHhcccCCCCCCCHHH
Q 011385 353 ---LVEWARPHLG-----------ERRRFYR---LID-PRLE-GH----FSI--KGAQKAAQLAAHCLSRDPKARPLMSE 407 (487)
Q Consensus 353 ---~~~~~~~~~~-----------~~~~~~~---~~~-~~~~-~~----~~~--~~~~~l~~li~~cl~~dP~~RPs~~e 407 (487)
........+. +...+.. ... .... .. +.. ..+..+.+++.+||+.||++||++.|
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000000000 0000000 000 0000 00 000 22356889999999999999999999
Q ss_pred HHHH
Q 011385 408 VVEA 411 (487)
Q Consensus 408 ll~~ 411 (487)
++++
T Consensus 310 il~~ 313 (316)
T cd07842 310 ALEH 313 (316)
T ss_pred HhcC
Confidence 9874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=314.98 Aligned_cols=265 Identities=18% Similarity=0.220 Sum_probs=190.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCH-----------HHHHHHHHHHhcCCCC
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGDLVHL 196 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~Hp 196 (487)
..++|++.++||+|+||.||+|.+..... .+..+|+|+......... .....++..+..+.|+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 44689999999999999999998765321 144677776543322110 1123344556678999
Q ss_pred CceeEEEEEEeCC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 197 NLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 197 nIv~~~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
||+++++++.... ..+++||++. .++.+.+.. ....++..++.|+.|++.||.|||+.+ |+||||||+|||
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999876543 3468888874 467666643 334678889999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 347 (487)
++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999865332211 111234699999999999999999999999999999999999999976533
Q ss_pred CCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.... ........ +.++....+. ...++..+.+++..||..+|++||++.+|++.|+
T Consensus 239 ~~~~--~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNL--IHAAKCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHH--HHHhHHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2211 10000000 0000001000 0122467899999999999999999999998763
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=310.84 Aligned_cols=243 Identities=26% Similarity=0.355 Sum_probs=196.7
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||.|+||.||+|++.. ++..||+|++..... ...+.+.+|+++++.++||||+++++++.++...++|
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 7999999999999864 567999999865432 2235688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 9999999999999654 45899999999999999999999988 9999999999999999999999999998765432
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCc
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (487)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... ..... . .....
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~----------~~~~~ 210 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN---D----------ILKGN 210 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH---H----------HhccC
Confidence 1223568999999999988889999999999999999999999997554211 01110 0 00000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVE 410 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~ 410 (487)
....++...+..+.+++.+||+.||++||+ +.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111222223568999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=310.52 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=199.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-----ccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|++++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 478899999999999999998764 57799999875321 1223468899999999999999999999
Q ss_pred EEeC--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 205 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 205 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+.+. ..+++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 8764 4578999999999999998654 35889999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||+++........ .......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~------ 220 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFK------ 220 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHH------
Confidence 99999865321110 11123568999999999988889999999999999999999999996432111 0000
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.........++......+.+++.+||. +|..||++.+++.+.
T Consensus 221 --------~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 221 --------IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred --------HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 000111122333445779999999998 679999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=314.69 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=206.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+.|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+|+++++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 45678889999999999999998864 466899999976543 45678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++......+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchh
Confidence 99999999999999999999766557999999999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ ......++..|+|||++.+..++.++|||||||++|+|++|..||....+... .... .. ..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~-----~~-~~- 232 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLI-----TT-KG- 232 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-----Hh-cC-
Confidence 75433211 12234588999999999888899999999999999999999999864322110 0000 00 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. +... .....+..+.+|+.+||+.+|.+||++.+++++.
T Consensus 233 ---~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 233 ---I-PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ---C-CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 0 0000 0112346789999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=315.02 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=198.0
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
|++.+.||.|++|.||+|.+.. +|..||+|++...... ....+.+|+++++.++|+||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6778899999999999998865 5679999998754322 2356889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..++||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||+|+|||++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999999995 68999886543 36899999999999999999999987 9999999999999999999999999997
Q ss_pred CCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhhh------
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH------ 360 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~------ 360 (487)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.......... +.......
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 6532211 11223578899999987654 57899999999999999999999997543211100 00000000
Q ss_pred -hhcccc----cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 -LGERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 -~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...... +........ .......+..+.+++.+||+.||.+||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 000000000 00111223578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=317.12 Aligned_cols=267 Identities=22% Similarity=0.292 Sum_probs=196.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.+.. +|..||||.+..... .....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368899999999999999998865 577999999865432 22356889999999995 699999999988
Q ss_pred eCCe-----eEEEEeeCCCCChhHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-C
Q 011385 207 EDDQ-----RLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-D 276 (487)
Q Consensus 207 ~~~~-----~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~ 276 (487)
..+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~ 147 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK 147 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence 7665 8999999975 898888543 245899999999999999999999988 999999999999998 8
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-h
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-V 354 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-~ 354 (487)
+.+||+|||+++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........... .
T Consensus 148 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 148 GLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred CeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999999999876533211 1122357889999998764 4679999999999999999999999975432211000 0
Q ss_pred Hhh-hhh------hhccccccc--ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 355 EWA-RPH------LGERRRFYR--LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 355 ~~~-~~~------~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... .+. ......... ...+..........+..+.+||.+||..||.+||++.|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 000 000000000 000000000011235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.40 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=209.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH---HHHHHHHHhcC-CCCCceeEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDL-VHLNLVKLIG 203 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l-~HpnIv~~~~ 203 (487)
...+|.++.+||+|+||.|.+|..+ ++.+.||||+++++......+ -+.|-++|+.. +-|.+++++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk---------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS 417 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS 417 (683)
T ss_pred eecccceEEEeccCccceeeeeccc---------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH
Confidence 3468999999999999999999654 477899999998876543322 45788888776 4678999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+|+.-+.+|+||||+.||+|.-.|++- +.+.+..+..++..|+-||-|||+++ ||+||||..||||+.+|++||+|
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 999999999999999999999888655 46888889999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....++.+ ..++||||.|+|||++..++|+..+|+|||||+|||||.|++||++........
T Consensus 494 FGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~----------- 560 (683)
T KOG0696|consen 494 FGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----------- 560 (683)
T ss_pred cccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----------
Confidence 9999875544432 446899999999999999999999999999999999999999998764422111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHhcCCCCCccC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEALKPLPNLKDM 421 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~L~~l~~~~~~ 421 (487)
.+++. .-.++...+.++..+++..|...|.+|..+. +--+.+..++.+..+
T Consensus 561 -----aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 561 -----AIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred -----HHHHc--cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 11111 2234455567889999999999999997442 222344445554443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=308.29 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=205.8
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|.+.+.||.|+||.||++.+.. ++..||+|++..... .....+.+|+++++.++|+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 57888999999999999999865 467899999976544 3456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence 9999999999999999998764 367999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++....... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... +... ...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~--- 217 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALK---ILK--- 217 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHH---Hhc---
Confidence 998764432 12233578999999999888889999999999999999999999996543211 1110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+ .++...+..+.+++.+||..+|++||++.+++++
T Consensus 218 ----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 ----GQYP----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001 1111334678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=311.20 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=201.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|.+.+.||+|+||.||+|.... +|..||+|.+..... ...+.+.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 47888999999999999998865 566899999865432 2335678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-EEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-~kl~DFGl 286 (487)
+..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. +||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence 99999999999999999986543 35789999999999999999999988 999999999999988864 69999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ ......|++.|+|||++.+..++.++|||||||++|||++|..||...... .........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--- 217 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQG--- 217 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhcc---
Confidence 987643221 122346899999999998888999999999999999999999999643221 111111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... ......+..+.+++.+||..+|++||++.+++++
T Consensus 218 ---~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 218 ---YFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---cCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0111234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=325.10 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=196.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999998764 577999999864322 234567889999999999999999998765
Q ss_pred CC-----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 208 DD-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 208 ~~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
.+ ..|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEC
Confidence 43 5799999996 588877743 46899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 283 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 283 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
|||++......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~ 225 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGV 225 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHH
Confidence 99999765432211 11223578999999998654 578999999999999999999999996543211000 00000
Q ss_pred hhc--ccc-----------cccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGE--RRR-----------FYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~--~~~-----------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.. ... ............ .....+..+.+|+.+||+.||.+||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 226 LGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred cCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000 000000000000 001124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=307.66 Aligned_cols=275 Identities=22% Similarity=0.283 Sum_probs=201.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..|+.++.||+|.||.||+|...+.... ....+|||.++..... -.....+|+.+++.|+||||+.+..++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~k-----r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDK-----RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcc-----cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 4788999999999999999965542210 1237999999765221 12457899999999999999999999887
Q ss_pred -CCeeEEEEeeCCCCChhHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----Cc
Q 011385 208 -DDQRLLVYEFMPRGSLENHLFRR----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YN 278 (487)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----~~ 278 (487)
+..++|++||.+. +|...|.-+ ...++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 7789999999977 898888522 346899999999999999999999988 9999999999999877 99
Q ss_pred EEEeecCCCCCCCCCCcce-eeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc-----
Q 011385 279 AKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----- 351 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~----- 351 (487)
|||+|||+++.+...-... ....++-|.+|.|||.+.+ ..|+.+.||||+|||+.||||-.+.|.+.......
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999876543332 2334678999999999886 47999999999999999999999999754332111
Q ss_pred -hhhHhhhhhhh-----cccccc---------cccCCccCCCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011385 352 -NLVEWARPHLG-----ERRRFY---------RLIDPRLEGHFSI--------KGAQKAAQLAAHCLSRDPKARPLMSEV 408 (487)
Q Consensus 352 -~~~~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~--------~~~~~l~~li~~cl~~dP~~RPs~~el 408 (487)
+.+......++ +...+. ..+........+. .-++...+|+.++|..||.+|.|+.++
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11111110110 000000 0000000000000 011237899999999999999999999
Q ss_pred HHHhc
Q 011385 409 VEALK 413 (487)
Q Consensus 409 l~~L~ 413 (487)
+++.-
T Consensus 335 leh~y 339 (438)
T KOG0666|consen 335 LEHPY 339 (438)
T ss_pred hcccc
Confidence 98753
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=322.34 Aligned_cols=268 Identities=28% Similarity=0.352 Sum_probs=198.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC--CccCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|.+.. +|..||||++... .......+.+|+.++.++ +|+||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 45688999999999999999998764 5678999988542 222335577899999999 99999999998
Q ss_pred EEeC--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 205 CIED--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 205 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+... ...|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 8654 36799999996 5999888544 6888999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc---eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 283 DFGLAKDGPEGDKT---HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 283 DFGla~~~~~~~~~---~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||................
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999875443221 12234578999999998764 567899999999999999999999996543221100000000
Q ss_pred hh--------h--hccccccccc----CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PH--------L--GERRRFYRLI----DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~--------~--~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. + .....+...+ ...+...+ ...+..+.+|+.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 0 0000000000 00000001 1135678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=313.97 Aligned_cols=266 Identities=24% Similarity=0.317 Sum_probs=200.9
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 208 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 208 (487)
|++.+.||.|+||.||+|.+.. +|..||+|.+.... ......+.+|+++++.++|+||+++++++.+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6778899999999999998865 46789999997653 22345688999999999999999999999988
Q ss_pred -CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..++||||+++ +|.+++......+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccce
Confidence 889999999974 899888666567999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hhhhcc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~~~~~ 364 (487)
......... ..+...++..|+|||.+.+ ..++.++|||||||++|||++|..||................ +.....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 876543211 1223457889999997764 468999999999999999999999997654321111100000 000000
Q ss_pred cccc-----ccc------CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFY-----RLI------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~-----~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+. ... ...+...+...++..+.+++.+||..||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 000 0000011111125678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=311.86 Aligned_cols=241 Identities=29% Similarity=0.407 Sum_probs=191.3
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||+|+||+||+|.... +|..||+|.+..... .....+..|+++|+.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6999999999998765 577999999864322 2234567899999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 99999999999986543 36899999999999999999999988 999999999999999999999999998765432
Q ss_pred CcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 294 ~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............... ... .
T Consensus 149 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--------~-- 213 (277)
T cd05577 149 K---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLE--------M-- 213 (277)
T ss_pred C---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--ccc--------c--
Confidence 1 122346788999999998888999999999999999999999999654432111111000 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 407 (487)
...++...+..+.+++.+||+.||.+||++.+
T Consensus 214 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 214 --AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred --cccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 11112223567899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.64 Aligned_cols=275 Identities=26% Similarity=0.347 Sum_probs=212.1
Q ss_pred ChhHHHHH---hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcCC
Q 011385 121 TFNDLKLA---TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGDLV 194 (487)
Q Consensus 121 ~~~~~~~~---~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~ 194 (487)
.|..++++ ..-|..++.||-|+||+|.+++-.+ |...||+|.+++.+.-.. ..+..|..||+..+
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD 687 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD 687 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC
Confidence 34444443 3568888999999999999997655 566899999976544322 34678999999999
Q ss_pred CCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 195 HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
.+-||+||..|.+++.+|+||||++||++..+|.+.+ -|++..+..++..+..|++++|..| +|||||||.|||||
T Consensus 688 n~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILID 763 (1034)
T KOG0608|consen 688 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILID 763 (1034)
T ss_pred CcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEc
Confidence 9999999999999999999999999999999997774 6889999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCCCCC---------CCCcc-------------------------------eeeeeccccccccCCcee
Q 011385 275 ADYNAKLSDFGLAKDGP---------EGDKT-------------------------------HVSTRVMGTYGYAAPEYV 314 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~---------~~~~~-------------------------------~~~~~~~Gt~~y~APE~~ 314 (487)
.+|+|||+||||++-+. .++.. ...-..+||+.|+|||++
T Consensus 764 rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl 843 (1034)
T KOG0608|consen 764 RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL 843 (1034)
T ss_pred cCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh
Confidence 99999999999986331 11000 001126899999999999
Q ss_pred ccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHH
Q 011385 315 MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 393 (487)
Q Consensus 315 ~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 393 (487)
...+|+..+|+||.|||||||+.|+.||-...+.+....+ .|. ..++-...+.+ +.++.+||.+
T Consensus 844 ~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~-----------~~l~~~~~~~l----s~e~~~li~k 908 (1034)
T KOG0608|consen 844 ARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR-----------NFLHIPYQGNL----SKEALDLIQK 908 (1034)
T ss_pred cccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh-----------hcccccccccc----CHHHHHHHHH
Confidence 9999999999999999999999999999888776654322 221 11222223333 4567777777
Q ss_pred hcccCCCCCCCHHHHHHHhcCCCCCccCCCCc
Q 011385 394 CLSRDPKARPLMSEVVEALKPLPNLKDMASSS 425 (487)
Q Consensus 394 cl~~dP~~RPs~~ell~~L~~l~~~~~~~~~~ 425 (487)
++ .+++.|.. +...+.++.++.++.+..+.
T Consensus 909 Lc-~sad~RLG-kng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 909 LC-CSADSRLG-KNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred Hh-cChhhhhc-ccchhhhhcCccccccchHh
Confidence 66 67788874 22333566677776665443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.13 Aligned_cols=262 Identities=31% Similarity=0.511 Sum_probs=206.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
...|...++||+|+||.||+|.+.. +|..||||++...... ...|++++++++|||||++++++.+.
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 3567788899999999999998764 4678999998654322 23568899999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..|+||||+++|+|.+++. .++|..+..|+.||+.||+|||.....+|+||||||+|||++.++..++. ||...
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999999984 38899999999999999999996544559999999999999999888875 66654
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
.... .....||+.|||||++.+..|+.++|||||||++|||+||+.||..... ....+..|....... ....
T Consensus 831 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~ 902 (968)
T PLN00113 831 LLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLD 902 (968)
T ss_pred cccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchh
Confidence 4321 1123689999999999999999999999999999999999999954322 223344454432221 1222
Q ss_pred cccCCccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 369 RLIDPRLEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 369 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
..+++.+.. ........++.+|+.+||+.||++||+|.|+++.|+.+.
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 334444433 233455667889999999999999999999999998653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=306.24 Aligned_cols=246 Identities=21% Similarity=0.219 Sum_probs=191.8
Q ss_pred HhcCCCCCCee--cccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 128 ATRNFRPESLL--GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~L--G~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
..++|++.+.+ |.|+||.||++.... ++..+|+|.+....... .|+.....+ +|+||++++++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEE
Confidence 34567777766 999999999998765 56789999986543221 122222222 79999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~D 283 (487)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999998655 37999999999999999999999988 99999999999999988 999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++..... ....|+..|+|||++.+..++.++|||||||++|||++|..||....... .....+.... .
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~- 224 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q- 224 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c-
Confidence 9998765322 12468999999999998899999999999999999999999997433221 1111111100 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~ 411 (487)
. ........+..+.+||.+||+.||.+||+ +++++++
T Consensus 225 ---------~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 ---------K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 00111234567999999999999999996 6998864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=310.18 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=189.2
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHH---HHHHhcCCCCCceeEEEEEEeCCe
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAE---VNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E---~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
+||+|+||.||+|.+.. +++.||+|.+....... ...+..| +++++...||||+.+++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999998764 57799999986543221 1123334 344555689999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 9999999999999988854 457999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
.... .....|+..|+|||++.++ .++.++|||||||++|||++|..||.............. . .
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~--------~ 212 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---T--------L 212 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---h--------h
Confidence 3321 1234799999999998744 689999999999999999999999975432211111000 0 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
..... ++...+..+.+++.+||..||.+|| ++.+++++
T Consensus 213 ~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 TMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 01111 1222356789999999999999999 89999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=314.90 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=196.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++.+.||+|+||.||+|.+.. +|+.||+|.+..... .....+.+|+++++.++|+||+++++++.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 478899999999999999998764 567899999865432 223567899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFG 285 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~~kl~DFG 285 (487)
.+..|+||||++ ++|.+++.... ..+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999995 58888775433 33678888999999999999999988 999999999999985 4679999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh-hh--
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-PH-- 360 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~-~~-- 360 (487)
++........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||............ .... +.
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9976433211 1223467899999998865 45789999999999999999999999754332111000 0000 00
Q ss_pred -------hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 -------LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.+....................+..+.+++.+||+.||++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000000111224568899999999999999999999974
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=323.99 Aligned_cols=271 Identities=23% Similarity=0.338 Sum_probs=201.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||.|+||.||+|.... +|..||+|++.... ......+.+|+.+|..++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 3689999999999999999998765 57799999987542 233456788999999999999999998875
Q ss_pred e----CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 207 E----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 207 ~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
. ....++||||+. |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence 3 356899999995 6899888543 45999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCc--ceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 283 DFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 283 DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|||++........ ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.................
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 9999976533221 111234578999999998765 5689999999999999999999999975433211111000000
Q ss_pred h----h----h-c-ccccccccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 360 H----L----G-E-RRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 360 ~----~----~-~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. . . + ............. ..+....+..+.+++.+||+.||.+||++.+++.+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0 0 0 0 0000000000000 0011123567899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.29 Aligned_cols=270 Identities=27% Similarity=0.333 Sum_probs=201.0
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
...++|++.+.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+++++.++||||++++++
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~ 74 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence 355789999999999999999999865 567899999975432 223467789999999999999999999
Q ss_pred EEeCC----------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 205 CIEDD----------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 205 ~~~~~----------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
+.+.. .++|||||+++ +|.+++......+++..++.++.||+.||+|||+.+ |+||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~ 150 (302)
T cd07864 75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLN 150 (302)
T ss_pred ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 87655 78999999976 787777665567899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
.++.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|||++|++||...........
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999876443221 1122356788999998764 4578999999999999999999999975432211111
Q ss_pred hHhhh--------hhhhcccccc-----cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 354 VEWAR--------PHLGERRRFY-----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 354 ~~~~~--------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.... +.+.....+. ..........+. ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11100 0000000000 000000000011 124678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=322.95 Aligned_cols=266 Identities=25% Similarity=0.340 Sum_probs=199.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|.+.+.||+|+||+||+|++.. ++..||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 3579999999999999999998764 67799999986532 223456788999999999999999999876
Q ss_pred eC-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 207 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
.. ...||||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 54 34799999995 689888854 357999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 359 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~~ 359 (487)
+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||............... ..
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998754322 12233568899999998764 56899999999999999999999999654221100000000 00
Q ss_pred ---------hhhccccccc----ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 ---------HLGERRRFYR----LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 ---------~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.........+ ..++.+. ......+..+.+|+.+||+.||.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0000000 0111245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=312.33 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=202.9
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
|++.+.||.|++|.||+|.... +|+.+|+|.+...... ....+.+|+++++.++|+||+++++++.+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 6678899999999999998754 5678999998755433 3456889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 99999999965 898888766668999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--hhhhhcccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPHLGERRR 366 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--~~~~~~~~~ 366 (487)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||............... .+.......
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 654321 12234688899999998776 7899999999999999999999999654432111100000 000000000
Q ss_pred ccc-----------ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYR-----------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.. ..... ........+..+.+||.+||+.||.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMP-LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred chhhhhhhhhhhccccccC-HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 00000 011112346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=304.30 Aligned_cols=248 Identities=31% Similarity=0.480 Sum_probs=203.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||++.+.. ++..||+|.+..... .....+.+|++++.+++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 47888999999999999998764 466899999976654 3346789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999999999998654 57899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .........
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~------ 214 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQD------ 214 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhcc------
Confidence 76543321 23356899999999988888999999999999999999999999643311 000000000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
. ...++...+..+.+++.+||..+|++||++.+++.
T Consensus 215 --~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 --D----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --C----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 01112223467889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=307.03 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=203.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||+|+||.||++.+.. ++..||+|.+..... ....++.+|+++++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 47888999999999999998764 567899999875432 2234678999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
...++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+.+ ++|+||+|.||+++.++.+||+|||
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence 9999999999999999998652 346889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++...... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... .+.... .
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~----~--- 214 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV----Q--- 214 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----h---
Confidence 99876543 122246889999999999889999999999999999999999999654321 010000 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.......+...+.++.+++.+||..+|++||++.+++++
T Consensus 215 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 215 -------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111223455779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.94 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=193.7
Q ss_pred Ceeccc--CceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G--~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
..||+| +||+||++.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 356666 999999998865 5779999998754322 235678899999999999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
++||||+.+++|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999999999999998654 345889999999999999999999988 999999999999999999999999865432
Q ss_pred CCCCcce-----eeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-hhhh
Q 011385 291 PEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHLG 362 (487)
Q Consensus 291 ~~~~~~~-----~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~~ 362 (487)
....... ......++..|+|||++.+ ..++.++|||||||++|||++|..||........ +..... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~ 229 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYS 229 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCC
Confidence 2111000 0011235667999999876 3578999999999999999999999975432110 000000 0000
Q ss_pred c----------------cccc---------c-----cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 E----------------RRRF---------Y-----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ~----------------~~~~---------~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. .... . ......+.......++..+.+|+.+||+.||++|||+.|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 0000 0 00001111122234567889999999999999999999999754
Q ss_pred c
Q 011385 413 K 413 (487)
Q Consensus 413 ~ 413 (487)
.
T Consensus 310 ~ 310 (328)
T cd08226 310 F 310 (328)
T ss_pred H
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.57 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=197.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
...||+|+||.||++.... +|..||||.+..........+.+|+.+++.++|+||+++++++...+..++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 3579999999999998865 5779999998655444456688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170 (292)
T ss_pred EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence 999999999987743 35889999999999999999999988 9999999999999999999999999987654322
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCc
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (487)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ...+.
T Consensus 171 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~----------~~~~~ 235 (292)
T cd06657 171 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD----------NLPPK 235 (292)
T ss_pred c--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----------hCCcc
Confidence 1 12335689999999999888899999999999999999999999965322111 111000 01111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.. ....+..+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 236 LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 100 01124568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=313.79 Aligned_cols=245 Identities=29% Similarity=0.422 Sum_probs=196.4
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
|...+.||+|+||.||+|+... +|..||+|.+...... ....+.+|+++++.++||||+++++++.+.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 93 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE 93 (313)
T ss_pred hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence 6667789999999999998754 5778999998654332 234678899999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..|+||||+. |+|.+++......+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 99999999995 5888888766667999999999999999999999988 9999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
.... .....|+..|+|||++. ...++.++|||||||++|||++|..||............ ..
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~--- 234 (313)
T cd06633 170 KSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQ--- 234 (313)
T ss_pred ccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------Hh---
Confidence 5332 12356899999999874 456889999999999999999999998654321111000 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+.. .....+..+.+|+.+||+.+|.+||++.+++.+
T Consensus 235 ----~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 ----NDSPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----cCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 111223568899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.39 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=188.6
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHH-HhcCCCCCceeEEEEEEeCCee
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF-LGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
+.||.|+||.||+|.... +|+.||||.+....... ...+..|..+ ...++|+||+++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 579999999999998865 56789999986543221 2234455544 4455899999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||+++...
T Consensus 73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 9999999999999998544 46899999999999999999999988 9999999999999999999999999987643
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
. .....|+..|+|||.+.+..++.++||||||+++|||++|..||....... .... ..... .
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~~------~ 210 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDN---ILSRR------I 210 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcc------c
Confidence 3 223468899999999988889999999999999999999999996543211 1000 00000 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..........+..+.+++.+||+.||++||++.++.+.
T Consensus 211 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 211 --NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred --CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 00111111235678999999999999999977544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.16 Aligned_cols=256 Identities=27% Similarity=0.359 Sum_probs=198.3
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
+|++.+.||.|+||.||+|+.... ..+|..||+|++..... ...+.+.+|++++..+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~------~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSG------HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccC------CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 478889999999999999987532 12578999999875322 2235678899999999 599999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
..+...++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCc
Confidence 9999999999999999999998654 46889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
++......... ......|+..|+|||.+.. ..++.++|||||||++|+|++|..||......... .........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~- 226 (290)
T cd05613 151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK- 226 (290)
T ss_pred cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhc-
Confidence 99875432211 1223568999999998875 35788999999999999999999999643221111 111110000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
..+ .++...+..+.+|+.+||+.||++|| ++.+++.+
T Consensus 227 -------~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 -------SEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------cCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001 11222346788999999999999997 56666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=316.86 Aligned_cols=269 Identities=28% Similarity=0.339 Sum_probs=197.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||.|+||.||+|.+.. ++..||||++...... ....+.+|+++++.++|+||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 4689999999999999999998765 5678999998644322 1245778999999999999999999875
Q ss_pred eCC--------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 207 EDD--------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 207 ~~~--------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
... .+++||||+.+ +|...+......+++..+..++.||++||.|||+.+ |+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 433 46899999964 787777666667999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcc---------eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 011385 279 AKLSDFGLAKDGPEGDKT---------HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~---------~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 348 (487)
++|+|||+++........ ...+...|++.|+|||++.+ ..++.++|||||||++|||++|.+||.+....
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999865432211 11123467889999998765 45899999999999999999999999754432
Q ss_pred CcchhhHhhhhh-----hhccccccc--------ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 349 GEHNLVEWARPH-----LGERRRFYR--------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 349 ~~~~~~~~~~~~-----~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.....+...... ......+.. ...+.+...+. .....+.+++.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-KLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcc-cCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 111110000000 000000000 00000000000 122568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=317.55 Aligned_cols=269 Identities=25% Similarity=0.295 Sum_probs=197.9
Q ss_pred cCCC-CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--------------HHHHHHHHHHHhcCC
Q 011385 130 RNFR-PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGDLV 194 (487)
Q Consensus 130 ~~y~-~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~ 194 (487)
++|. +.+.||.|+||+||+|.+.. +++.||||.++...... ...+.+|+++++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 4565 45779999999999998764 56799999986543221 124779999999999
Q ss_pred CCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 195 HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
|+||+++++++...+..++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 9999999999999999999999996 699998854 446899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCc------------ceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCC
Q 011385 275 ADYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~p 341 (487)
.++.++|+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||++|..|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999976541100 0111224578899999988754 478999999999999999999999
Q ss_pred CCCCCCCCcchhh-Hhhhhhhh----cc------cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 342 MDKNRPNGEHNLV-EWARPHLG----ER------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 342 f~~~~~~~~~~~~-~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
|...........+ ........ .. ..+.....+.... .....+..+.+++.+||+.||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9765432111100 00000000 00 0000000000000 01122467889999999999999999999997
Q ss_pred Hhc
Q 011385 411 ALK 413 (487)
Q Consensus 411 ~L~ 413 (487)
+..
T Consensus 313 ~~~ 315 (335)
T PTZ00024 313 HEY 315 (335)
T ss_pred Ccc
Confidence 554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.22 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=199.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..|...+.||+|+||.||+|+... ++..||+|.+..... ....++.+|+++++.++|+||+++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 447777899999999999998865 567899999864322 22346789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
..+..++||||+. |+|.+++......+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccc
Confidence 9999999999996 6888877665667899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+...... ....|++.|+|||++. ...++.++|||||||++|+|++|..||......... .... .
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~-----~ 228 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA-----Q 228 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHh-----h
Confidence 8765332 2346889999999874 356888999999999999999999998643211100 0000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...+.. .....+..+.+||.+||+.+|.+||++.+++++....
T Consensus 229 ------~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 229 ------NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ------cCCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 000100 1112346788999999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.86 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=210.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..+++.+..||-||||.|=++..+... ..+|+|++++....+ .+.+..|-+||..++.|.||++|-.|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~---------~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQK---------ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccc---------hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 456777888999999999998876521 258999997665433 34577899999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+..++||+||-|-||.|+..|.++ +.++......++..+++|++|||+++ ||+|||||+|+||+.+|-+||.|||
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 9999999999999999999988555 57999999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+|+....+..+ .++||||.|.|||++.+.+.+.++|.||||+++||||+|.+||.+..+....+++-..
T Consensus 566 FAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-------- 634 (732)
T KOG0614|consen 566 FAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-------- 634 (732)
T ss_pred hHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh--------
Confidence 99998776654 3589999999999999999999999999999999999999999887664443332111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHhc
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEALK 413 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L~ 413 (487)
++ .-+|+......+.+||++++..+|.+|.. +.+|.+|-+
T Consensus 635 -----id---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 635 -----ID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred -----hh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 11 12344455677899999999999999985 555555443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=305.95 Aligned_cols=263 Identities=25% Similarity=0.326 Sum_probs=196.1
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcC---CCCCceeEEEEEE
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDL---VHLNLVKLIGYCI 206 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~HpnIv~~~~~~~ 206 (487)
|++.+.||+|+||.||+|++.. ++..||+|+++...... ...+.+|+.++.++ +|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 6678899999999999999865 46789999997543221 23466787776655 6999999999998
Q ss_pred eCCe-----eEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDDQ-----RLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~~-----~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
..+. .+++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+|||++.++.+|
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence 8776 899999996 48998886543 35899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~~ 359 (487)
|+|||++........ .....++..|+|||++.+..++.++|||||||++|||++|.+||........... ......
T Consensus 148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07838 148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGL 224 (287)
T ss_pred EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCC
Confidence 999999987643321 1234578899999999988999999999999999999999999975433211000 000000
Q ss_pred hhh-c--------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 HLG-E--------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 ~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... . ...+....... ...........+.+|+.+||+.||.+||++.+++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 0 00000000000 011112335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=308.97 Aligned_cols=258 Identities=28% Similarity=0.346 Sum_probs=200.4
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
+|++.+.||+|+||.||+++..... .++..||||.++.... ...+.+.+|++++.++ +|+||+++++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 4778899999999999999865322 2567899999864322 2234578999999999 599999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
......++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECc
Confidence 9999999999999999999998654 46889999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+++........ ......|+..|+|||.+.+.. ++.++||||||+++|||++|..||........ ..........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~- 226 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK- 226 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc-
Confidence 98875433221 122356899999999887654 78899999999999999999999964322111 0111110000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. .+. .+...+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 227 ------~-~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 ------S-KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ------c-CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 0 011 11123457889999999999999999888877665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.33 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=195.7
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||.|+||.||++.+.. +|+.||+|.+..... .....+.+|++++..++|+||+++++++......|+|
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999998864 577999999976543 2345688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++.+.. .+++..++.++.||+.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999986544 7899999999999999999999988 9999999999999999999999999987643321
Q ss_pred c------ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 295 K------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 295 ~------~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
. ........++..|+|||.+....++.++||||||+++|+|++|..||....... .... .....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~~~---- 217 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQN---ILNGK---- 217 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcCC----
Confidence 1 112233568899999999988889999999999999999999999996543211 1000 00000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.. ..... ..+..+.+|+.+||+.+|.+||++.++.+.|+
T Consensus 218 --~~--~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 --IE--WPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --cC--CCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 00000 12467899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.52 Aligned_cols=267 Identities=25% Similarity=0.338 Sum_probs=202.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|++.+.||.|+||.||+|.... +|..||||++.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58889999999999999998764 46799999987543 23346789999999999999999999998877
Q ss_pred C-----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 209 D-----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 209 ~-----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+ ..|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||.|||++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999997 5898888544 47999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-
Q 011385 284 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH- 360 (487)
Q Consensus 284 FGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~- 360 (487)
||++......... .......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999876543210 112335689999999999877 8999999999999999999999999765432111100000000
Q ss_pred hh------cc---cccccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LG------ER---RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~------~~---~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. .. ..+........ ........+..+.+|+.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00 00000000000 000011234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=317.15 Aligned_cols=248 Identities=25% Similarity=0.318 Sum_probs=202.1
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~ 212 (487)
.++||.|.||+||-|.++. +|+.||||++.+.... ....+.+|+.||.++.||.||.+...|+..+.+|
T Consensus 569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3689999999999999876 7889999999765443 2356889999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEeecCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSDFGLAKD 289 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~~kl~DFGla~~ 289 (487)
+|||-+.|.-|+-.|....+.+++.....++.||+.||.|||.++ |+|+||||+||||... -.+||||||+|+.
T Consensus 640 VVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceee
Confidence 999999554444444455678999999999999999999999988 9999999999999654 5799999999999
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (487)
..+.. .....+|||.|+|||++.+++|+..-|+||.|||+|--|.|..||....... +.+..+. -
T Consensus 717 IgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAa----------F 781 (888)
T KOG4236|consen 717 IGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAA----------F 781 (888)
T ss_pred cchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccc----------c
Confidence 86643 3445799999999999999999999999999999999999999996543211 1111110 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+..+..+. +.+..+.+||..+|+..-.+|-+....+.+.+
T Consensus 782 MyPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 782 MYPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ccCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 11222222 33467899999999999999999999887654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.43 Aligned_cols=251 Identities=27% Similarity=0.348 Sum_probs=203.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCC-CCCceeEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLV-HLNLVKLIGYC 205 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 205 (487)
++|.+.+.||+|+||.||+|.... +|..||+|++..... .....+.+|+.++.++. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 478899999999999999998865 577999999875332 22356789999999998 99999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..++||||+++++|.+++.+. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999999999999654 47999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcc------------------eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 011385 286 LAKDGPEGDKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347 (487)
Q Consensus 286 la~~~~~~~~~------------------~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 347 (487)
++......... .......|+..|+|||++....++.++|||||||++++|++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98865432211 112235688999999998888899999999999999999999999975532
Q ss_pred CCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 011385 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM----SEVVEA 411 (487)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ell~~ 411 (487)
.. ..... .. ....++...+..+.+|+.+||+.||.+||++ .+++++
T Consensus 228 ~~---~~~~~---~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YL---TFQKI---LK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH---HHHHH---Hh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11 00000 00 0111222235678999999999999999999 787764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=301.87 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=200.8
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv 214 (487)
++||+|+|+.|--+.... +|..||||++.+..--...++.+|++++.+. .|+||++++++|++++.+|||
T Consensus 84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 479999999999887765 7889999999877555567899999999998 599999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---EEEeecCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGP 291 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~---~kl~DFGla~~~~ 291 (487)
||-+.||.|..+|.++ ..+.+..+..+..+|+.||.|||.++ |.||||||+|||...... +|||||.+.....
T Consensus 155 fEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999999665 46999999999999999999999988 999999999999966543 7999998875432
Q ss_pred CCCc-----ceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 292 EGDK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 292 ~~~~-----~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
.... +....+.+|+..|||||++. ...|+.++|.||||||||-||+|.+||.+.-..+.. |.+...
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~ 306 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEV 306 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCc
Confidence 2111 11223478999999999874 357999999999999999999999999765432211 111000
Q ss_pred hc--ccccccccCCccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 362 GE--RRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 362 ~~--~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
-. ...+++-+.. -..+|+. ..+.++.+|+..+|..|+..|.++.+++++-
T Consensus 307 Cr~CQ~~LFesIQE-GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 307 CRVCQNKLFESIQE-GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred cHHHHHHHHHHHhc-cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 00 0011111110 0112332 3456789999999999999999999998854
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=314.74 Aligned_cols=269 Identities=25% Similarity=0.290 Sum_probs=193.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 207 (487)
+|++.+.||+|+||.||++++.... .+..||||++..... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 4778899999999999999986421 166899999864321 2245678999999999 59999999987543
Q ss_pred C----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 208 D----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 208 ~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
. ...|++|||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCc
Confidence 2 45789999985 689988854 456899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc--eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh------
Q 011385 284 FGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------ 354 (487)
Q Consensus 284 FGla~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~------ 354 (487)
||+++........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 9999865432211 11223578999999998765 57899999999999999999999999754321100000
Q ss_pred -------HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 355 -------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 355 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.............................+..+.+|+.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000000000000001124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=309.43 Aligned_cols=256 Identities=30% Similarity=0.437 Sum_probs=197.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCC-CCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. ++..||||.++..... ...++..|+.++..+. |+||+++++++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 44678999999999999999998864 4678999999754322 2345677887776664 99999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
.+....|+||||+. ++|.+++......+++..+..++.||+.||.|||+ .+ |+||||+|+||+++.++.+||+||
T Consensus 84 ~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 84 ITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred ecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence 99999999999984 57888776655679999999999999999999997 46 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCC----CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
|++........ .....|+..|+|||.+.+.. ++.++|||||||++|||++|+.||...... .......
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~--- 231 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI--- 231 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH---
Confidence 99876543221 12345788999999987553 889999999999999999999999642211 1111100
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+... .+.+.. ....+..+.+|+.+||..||.+||++.+++++..
T Consensus 232 ~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 232 LQEE-------PPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred hcCC-------CCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0000 000000 0123467899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=311.10 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=183.5
Q ss_pred CCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHH
Q 011385 163 TGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIR 239 (487)
Q Consensus 163 ~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~ 239 (487)
++..||||+++... ......+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|.+++... ...+++..+
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~ 103 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI 103 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHH
Confidence 57799999997652 234467899999999999999999999999999999999999999999998753 346889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCc-----ceeeeeccccccccCCcee
Q 011385 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYV 314 (487)
Q Consensus 240 ~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~~ 314 (487)
..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+........ ........++..|+|||++
T Consensus 104 ~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 104 AFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHh
Confidence 999999999999999988 99999999999999999999999998875432211 0112234578899999988
Q ss_pred cc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh---cc-------ccccc----ccCC----c
Q 011385 315 MT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---ER-------RRFYR----LIDP----R 374 (487)
Q Consensus 315 ~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~-------~~~~~----~~~~----~ 374 (487)
.. ..|+.++|||||||++|||++|..||....... ........... .. ..... ..++ .
T Consensus 181 ~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred cCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 75 468899999999999999999999997543211 11110000000 00 00000 0000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
............+.+|+.+||..||++||++.+++++-
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 01112233456788999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=275.88 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=204.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+|...++||+|.||+||+|++++ +++.||+|+++.+... .....++|+.+|+.|.|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45667789999999999999876 7889999999765432 234688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..+-+|+|||+. +|..+...-++.++.+.+..++.|+++||.|+|+++ ++||||||.|+||+.+|.+||+|||+++
T Consensus 74 kkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhh
Confidence 999999999954 999998877888999999999999999999999988 9999999999999999999999999999
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc--c
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE--R 364 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~--~ 364 (487)
.+.-.. ......+-|.+|.+|.++.+ .-|+...|+||.|||+.||.. |++.|.+....+...-+-+......+ .
T Consensus 150 afgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 765422 23344567999999999876 468999999999999999987 66667665443322222121111111 0
Q ss_pred cccccccCCccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFS---------IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+..+.|-..-+.++ ......-++|++++|..+|..|.++++.+++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111111111 1222345799999999999999999999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=305.44 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=197.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCC-CCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~ 209 (487)
|.+.+.||.|+||.||+|+... +++.||||++...... ......+|+..+.+++ |+||+++++++.+++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6778899999999999999865 4668999998654321 2234567999999999 999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..++||||+ +|+|.+++.... ..+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999 789999886543 46899999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhhh----hh
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPH----LG 362 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~~----~~ 362 (487)
....... .....|+..|+|||++. ...++.++||||||+++|||++|..||............ ...... ..
T Consensus 148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 6543221 22346889999999875 456899999999999999999999999655332111000 000000 00
Q ss_pred cc----cccccccC----CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ER----RRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ~~----~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+. ..+...+. ..+...++ ..+..+.+|+.+||+.||++||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 00000000 00000011 114678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=317.14 Aligned_cols=268 Identities=23% Similarity=0.291 Sum_probs=196.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
..+|.+.+.||.|+||.||+|.... +|..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 3689999999999999999998765 5779999999776655567789999999999999999999876543
Q ss_pred --------------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 209 --------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 209 --------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence 35789999996 589887743 35889999999999999999999988 99999999999997
Q ss_pred C-CCcEEEeecCCCCCCCCCCcce-eeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 275 A-DYNAKLSDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 275 ~-~~~~kl~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
. ++.+||+|||+++......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||.........
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 5678999999997643221111 1122467889999997654 56889999999999999999999999755432111
Q ss_pred hhhHhhhhhhh--cccccccc----cC-CccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 352 NLVEWARPHLG--ERRRFYRL----ID-PRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 352 ~~~~~~~~~~~--~~~~~~~~----~~-~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.......+... +...+... +. ..... .+....+..+.+|+.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11000000000 00000000 00 00000 0001234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=314.90 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=194.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..+|.+.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|+.+++.++|+||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 3689999999999999999998754 577999999865322 22346789999999999999999999987
Q ss_pred eCC------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
... ..++||||+. .+|..++ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 543 4689999995 4777654 236889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR- 358 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~- 358 (487)
|+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999865332 123467889999998875 468999999999999999999999997643211111000000
Q ss_pred ---hh----hhcc--cccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 ---PH----LGER--RRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ---~~----~~~~--~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+. .... ..............+. ...+..+.+|+.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000 0000000000000000 1124568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.18 Aligned_cols=146 Identities=25% Similarity=0.320 Sum_probs=130.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|.+++.||+|+||.||+|++.. ++..||||+++...... ...+..|+.++..++|+||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 578999999999999999999865 56799999997544322 256788999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
..+.+||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999999999998544 46889999999999999999999987 99999999999999999999999999
Q ss_pred CC
Q 011385 287 AK 288 (487)
Q Consensus 287 a~ 288 (487)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 86
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=305.62 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=201.0
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
|++.+.||+|+||.||+|.... +++.||+|.+.... ....+.+..|+.+++.++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 5677889999999999998865 56799999997653 223456789999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++||||++ ++|.+++.+....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++.
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999997 5999999766567999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh-------hh
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR-------PH 360 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~-------~~ 360 (487)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|..||............ .... ..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 543321 12234567889999988766 8899999999999999999999999654321111000 0000 00
Q ss_pred hhcc---c-ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGER---R-RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~~---~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... . .+...........++ ..+..+.+++.+||..||++||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hcccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0 000000000000111 124678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.49 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=199.0
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
..+.++|++.+.||.|+||.||+|.... +|..||||++..... ...+.+.+|+.++..++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 3467889999999999999999998765 577999998854322 23456889999999999999999999
Q ss_pred EEEe-CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 204 YCIE-DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 204 ~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
++.. ....++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||+|.|||++.++.++|+
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeC
Confidence 9876 56788999999 5689887743 35788888999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhh-
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP- 359 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~- 359 (487)
|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||............ .....
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999864321 123467889999998765 57899999999999999999999999754321111000 00000
Q ss_pred -------hhh-cccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 -------HLG-ERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 -------~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ....+..... .....+ ...+..+.++|.+||+.+|++||++.+++.+-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred CHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000 0000000000 000011 11346789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.93 Aligned_cols=245 Identities=26% Similarity=0.288 Sum_probs=200.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
.+..|.+...||.|+|+.|-.+.+.. +++.++||++.... .+..+|+.++... +||||+++.+++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~ 386 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE 386 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc---------cccchhheeccccc----cccccccchhhhhcCCCcceeecceec
Confidence 35678888899999999999998765 67789999997663 2344677666555 7999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-cCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll-~~~~~~kl~DFG 285 (487)
+..+.|+|||++.|+.|.+.+.... .+. ..+..|+.+|+.|+.|||+++ ||||||||+|||+ +..++++|+|||
T Consensus 387 ~~~~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 387 DGKEIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred CCceeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEec
Confidence 9999999999999999988775443 222 677789999999999999988 9999999999999 588999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
.++..... ....+-|..|.|||++...+|+.++||||||++||+||+|+.||...... .++..
T Consensus 462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~---------- 524 (612)
T KOG0603|consen 462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT---------- 524 (612)
T ss_pred hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------
Confidence 99886553 22346788999999999999999999999999999999999999755432 11111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
++ ..+.|+...+..+++|+.+||+.||.+||++.+++.+-+.
T Consensus 525 ---~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 525 ---RI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---hh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11 1223334556789999999999999999999999876543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.60 Aligned_cols=269 Identities=24% Similarity=0.345 Sum_probs=199.1
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeE
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
++....++|.+.+.||+|+||.||+|.... +|..||+|++..... ...+.+.+|+.++.+++|+||+++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccce
Confidence 344566899999999999999999998754 577999999975422 223567889999999999999999
Q ss_pred EEEEEeC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011385 202 IGYCIED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275 (487)
Q Consensus 202 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 275 (487)
++++... ...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 9988643 3467888887 7899887743 35899999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
++.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||............
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999865332 223568899999998765 57889999999999999999999999654321111000
Q ss_pred -Hhhh-------hhhhc--ccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 355 -EWAR-------PHLGE--RRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 355 -~~~~-------~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... ..+.. ...+...+.......+ ....+..+.+||.+||+.||.+||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 00000 0000000000000000 001245688999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.90 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=196.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.... +|..||||++...... ....+.+|+.+|+.++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 45689999999999999999998765 5678999998643221 234678999999999999999999998
Q ss_pred EeCC------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IEDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
.... ..++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 7654 358999999 7799888743 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 357 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~ 357 (487)
+|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .....
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999865332 123467899999998875 468899999999999999999999997543211000 00000
Q ss_pred hh-------hhh--cccccccccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 RP-------HLG--ERRRFYRLIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~~-------~~~--~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. .+. ....+...+..... ..+....+..+.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000 00000000000000 00111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.90 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=195.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC---Cc--cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---GL--QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
+|.+.+.||+|+||.||++.+... +..+++|.++.. .. .....+..|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 588889999999999999987642 334555555432 11 2234567899999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence 999999999999999999998853 3456899999999999999999999988 999999999999975 579999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ... ....
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~---~~~~- 218 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVV---LRIV- 218 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHH---HHHH-
Confidence 9999876543221 222356889999999988888999999999999999999999999643210 110 0000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... ...++...+..+.+++.+||..||++||++.+++++
T Consensus 219 ------~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 219 ------EGP----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------cCC----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000 111233445688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.80 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=200.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-cc------CHHHHHHHHHHHhcCCCCCce
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQ------GHKEWLAEVNFLGDLVHLNLV 199 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~------~~~~~~~E~~~l~~l~HpnIv 199 (487)
...++|-++.+||+|||+.||+|.+.. ....||||+-.... +. ..+...+|.+|.+.|+||-||
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV 530 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 530 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence 345678899999999999999998765 34589999863221 11 124467999999999999999
Q ss_pred eEEEEEE-eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---
Q 011385 200 KLIGYCI-EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--- 275 (487)
Q Consensus 200 ~~~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--- 275 (487)
++|++|. +.+.+|-|+|||+|.+|+-||.. ...+++..+..|+.||+.||.||.+.. .+|||-||||.||||..
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcc
Confidence 9999985 56778899999999999988854 457899999999999999999999877 67999999999999943
Q ss_pred CCcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCCceecc----CCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 276 DYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~----~~~~~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
-|.|||+||||++.+.+.... .......||.+|++||.+.- ...+.++||||+|||+|.++.|+.||..+.
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 488999999999987654433 23345789999999998753 357889999999999999999999997543
Q ss_pred CCCcchhhHhhhhhhhcccccccccCCccCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS--IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
.. .+++.... ++.. ..-.|+ +..+.++.++|++||+.--++|....++..
T Consensus 689 sQ--QdILqeNT-----------IlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 689 SQ--QDILQENT-----------ILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hH--HHHHhhhc-----------hhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 32 12211110 0000 001111 133567899999999999999998877764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.18 Aligned_cols=255 Identities=27% Similarity=0.357 Sum_probs=197.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhc-CCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGD-LVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~HpnIv~~~~~~~~ 207 (487)
++.+-+..||.|+||+|+|-.++. +|+..|||+++.... ...++++.|.....+ -+.||||++||.+..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 344556789999999999998875 688999999987765 345678888886544 479999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 208 DDQRLLVYEFMPRGSLENHLF----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++..||.||+|+ -+|+.+.. .....+++..+-.|..-++.||.||.... .|||||+||+||||+..|.+||||
T Consensus 135 EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 135 EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeec
Confidence 999999999994 47776542 23457999999999999999999998754 399999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceec--cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~--~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
||++..+.+. ...+...|-..|||||.+. ..+|+.++||||||++|||+.||+.||..... +.+..+...
T Consensus 212 FGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv 283 (361)
T KOG1006|consen 212 FGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV 283 (361)
T ss_pred ccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH
Confidence 9999775432 2344567899999999986 34699999999999999999999999976532 221111111
Q ss_pred -hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 -GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
++.. .+..+ .-.......+.++|.-||..|-.+||...+++++
T Consensus 284 ~gdpp---~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPP---ILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCC---eecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 11111 1112245678999999999999999999998763
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=305.54 Aligned_cols=273 Identities=23% Similarity=0.327 Sum_probs=208.7
Q ss_pred cChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC--CC
Q 011385 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LN 197 (487)
Q Consensus 120 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pn 197 (487)
+.|........+|.+..+||+|.||.|-.++++. ++..||||+++.-. ...+..+-|+++|.++.+ |+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~ 148 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPN 148 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCC
Confidence 4455555668899999999999999999999876 46789999996432 223456789999999942 33
Q ss_pred ----ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 198 ----LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 198 ----Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
+|.+.+||...++.|||+|.+ |-++.++|..+ -.+++...+..|+.|++++++|||+.+ ++|-||||+|||
T Consensus 149 g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENIL 224 (415)
T KOG0671|consen 149 GKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENIL 224 (415)
T ss_pred CceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEE
Confidence 788889999999999999999 66999999754 457999999999999999999999988 999999999999
Q ss_pred EcC--------------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHH
Q 011385 273 LDA--------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 332 (487)
Q Consensus 273 l~~--------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil 332 (487)
+.. +..|+|+|||.|+...... ...+-|..|.|||++.+-+++..+||||+||||
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 831 2358999999999865443 345678999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc----c---cc-----------------ccccCCc--cC--CCCCHHHH
Q 011385 333 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGER----R---RF-----------------YRLIDPR--LE--GHFSIKGA 384 (487)
Q Consensus 333 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~----~---~~-----------------~~~~~~~--~~--~~~~~~~~ 384 (487)
+||.||...|+.....+...+++.....+... . ++ ....++. +. -.-...+.
T Consensus 300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 99999999998876544333333222111100 0 00 0000000 00 00111234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 385 QKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 385 ~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+|+++||..||.+|+|+.|+|.+
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhcC
Confidence 568999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.16 Aligned_cols=273 Identities=26% Similarity=0.345 Sum_probs=207.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..|+-..+||+|.||.||+|+.+. +|+.||+|++-.+.. .--...++|+++|..|.|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 456666789999999999998876 677899987643321 112457899999999999999999887753
Q ss_pred --------CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 208 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 208 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
...+||||.+|+. +|.-+|......++...+.+++.+++.||.|+|... |+|||+|++|+||+.+|.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence 2357999999977 999998777778999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcc--eeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 280 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
||+|||+++.+...+.. ...+..+-|.+|++||.+.+ ..|+++.|||..||||.||.||.+.++++.......++..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 99999999865433221 12334566999999998875 5799999999999999999999999988776555444433
Q ss_pred hhhhhhc-------cccccccc--CCccCCCCC--------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 357 ARPHLGE-------RRRFYRLI--DPRLEGHFS--------IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 357 ~~~~~~~-------~~~~~~~~--~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+..+.. ...++..+ .|-..+.+. ..-++++.+|+.++|..||.+|+++++++.+....
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 3222111 01111111 111111111 01134788999999999999999999999876543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.50 Aligned_cols=265 Identities=24% Similarity=0.338 Sum_probs=198.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|++.. ++..||||++.... ......+.+|+.+++.+.|+||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 35689999999999999999998865 56789999986532 22235677899999999999999999887
Q ss_pred EeCCe------eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 206 IEDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 206 ~~~~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
...+. .++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCE
Confidence 76554 89999999 6799998854 46899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 357 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~ 357 (487)
+|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ...
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999875432 223468889999998765 46789999999999999999999999754332111000 000
Q ss_pred h---hhhhc------ccccccccCCccCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 358 R---PHLGE------RRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 358 ~---~~~~~------~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. ..+.. ...+...+.......+. ...+..+.+|+.+||+.||.+|||+.+|+++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 0 00000 00000000000000000 11256789999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.29 Aligned_cols=269 Identities=30% Similarity=0.463 Sum_probs=212.8
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEE
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLI 202 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~ 202 (487)
+.+..++..+.+.||+|.||.|++|......... ......||||.++..... ..+.+..|+++|..+ .|+||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 3445556677779999999999999876532211 112568999999765443 456789999999999 699999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 267 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 267 (487)
|++.....+++|+|||..|+|.++|+.+. ..+.....+.++.||+.||+||++.. +|||||.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 99999999999999999999999997665 34888999999999999999999987 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccc--cccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDK 344 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~ 344 (487)
.+||||..+..+||+|||+++.....+...... ..| ...|||||.+....|+.++|||||||+|||++| |..||.+
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999766554443221 122 346999999999999999999999999999999 8888865
Q ss_pred CCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 345 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... .++.++ +.+. ..-..+..+..++.+|++.||+.+|++||++.++.+.|+.+
T Consensus 525 ~~~~--~~l~~~----l~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 525 IPPT--EELLEF----LKEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCcH--HHHHHH----HhcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2211 111111 1111 11222334567899999999999999999999999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.75 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=202.5
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC-CCCCceeE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKL 201 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~ 201 (487)
.+..++|.++++||+|+|..|.+++++. +.+.||+|+++++-.. +...+..|-.+..+. +||.+|-+
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGL 316 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEeh
Confidence 4556899999999999999999998875 6779999999765332 234456777777766 79999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
+.||+.+..+++|.||++||+|.-++++. ..++++.+..+...|+-||.|||+.+ ||+||||..|+|||.+|++||
T Consensus 317 hscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikl 392 (593)
T KOG0695|consen 317 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKL 392 (593)
T ss_pred hhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceee
Confidence 99999999999999999999998777544 57999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-CCCcchhhHhhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR-PNGEHNLVEWARPH 360 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~~~~~~~~~ 360 (487)
+|+|+++....... ...++||||.|.|||++.+..|+..+|+|+|||+|+||+.|+.||+--. .+.+.+..++....
T Consensus 393 tdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 393 TDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred cccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 99999987433221 3456899999999999999999999999999999999999999997422 12222333333222
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
+-++.. + ++...+-++..+++..|..||.+|...
T Consensus 471 ilekqi-------r----iprslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 471 ILEKQI-------R----IPRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred Hhhhcc-------c----ccceeehhhHHHHHHhhcCCcHHhcCC
Confidence 222110 0 111223456789999999999999653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=294.31 Aligned_cols=240 Identities=32% Similarity=0.405 Sum_probs=194.6
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
||+|+||.||++.... ++..||+|.+...... ....+..|+.+++.++|+||+++++.+..++..++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6999999999998764 4678999998765433 234688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (487)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 9999999999998654 46899999999999999999999987 9999999999999999999999999998754432
Q ss_pred cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCc
Q 011385 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374 (487)
Q Consensus 295 ~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (487)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... ...
T Consensus 148 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~~----------- 208 (250)
T cd05123 148 S--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI---LKD----------- 208 (250)
T ss_pred C--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---hcC-----------
Confidence 1 12335688999999999888899999999999999999999999965432 1111110 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLM---SEVVE 410 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~ell~ 410 (487)
...++...+..+.+++.+||..||++||++ .++++
T Consensus 209 -~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 209 -PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 011222224678999999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=292.59 Aligned_cols=220 Identities=24% Similarity=0.242 Sum_probs=178.2
Q ss_pred cCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCC
Q 011385 141 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 220 (487)
Q Consensus 141 G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~ 220 (487)
|.||.||++++.. +++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999998865 67799999997642 334555666667799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeee
Q 011385 221 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300 (487)
Q Consensus 221 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 300 (487)
|+|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 9999998654 45899999999999999999999988 999999999999999999999999988665432 12
Q ss_pred eccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCC
Q 011385 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 380 (487)
Q Consensus 301 ~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (487)
...++..|+|||++....++.++|||||||++|||++|..|+....... .. ... ..++
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~------~~~----~~~~ 198 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT------HTT----LNIP 198 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc------ccc----cCCc
Confidence 2456778999999988889999999999999999999998875321100 00 000 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 381 IKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 381 ~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
...+..+.+|+.+||+.||++||++
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 2234678899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=299.33 Aligned_cols=272 Identities=29% Similarity=0.450 Sum_probs=198.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~~~ 207 (487)
....+.++||+|.||.||+|.+. ++.||||++.... ...|..|-+|.+. +.|+||++|+++-..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 45667788999999999999885 4689999997543 3557788777765 589999999998765
Q ss_pred CC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCcEEEcCCC
Q 011385 208 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------ERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 208 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------~~~iiHrDLKp~NIll~~~~ 277 (487)
.+ .++||+||.+.|+|.+||..+ .++|....+|+.-+++||+|||+.. +.+|+|||||..||||..|+
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 55 789999999999999999654 6899999999999999999999864 34699999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCC-----chhhhhhHHHHHHHHHhCCCCCCC-CCCCCc
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SRSDVYSFGVVLLEMLTGRRSMDK-NRPNGE 350 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~-----~~~DiwSlGvil~elltG~~pf~~-~~~~~~ 350 (487)
+..|+|||+|..+..+......-..+||.+|||||++.+. .+. .+.||||+|.|||||++...-++. ..+...
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 9999999999987654433223337899999999998754 222 368999999999999997665532 111111
Q ss_pred chhhH--hhhhhhhcccc--cccccCCccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 351 HNLVE--WARPHLGERRR--FYRLIDPRLEGHFS-IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 351 ~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
.-... ...+.+.+.+. ..+...|.+..... .....-+.+.+..||..||+.|.|+.=+.+.+..+..
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11110 01111111100 00111222211111 0224568899999999999999999888887766543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.78 Aligned_cols=258 Identities=27% Similarity=0.395 Sum_probs=213.0
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
..+..++||+|+||+||+|.+...+. .-...||||++.... .+...++++|+-+|.+|+|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege-----~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGE-----NVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCc-----eecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 34556789999999999999976432 124479999986543 344578999999999999999999999998766
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
+.||++|+++|.|.++++.+...+.....+.|..||++||.|||.+. ++||||..+||||..-..+||.|||+++.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 78999999999999999988888999999999999999999999888 99999999999999999999999999998
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
..............-.+.|||-|.+....|+.++|||||||++||||| |..|+++....+..++.+. ..
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------ge--- 917 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------GE--- 917 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------cc---
Confidence 876554433333344678999999999999999999999999999999 9999987655443333221 11
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
++- -+..++.++..++.+||..|+..||+++++...+.+
T Consensus 918 RLs-------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 918 RLS-------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred cCC-------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 111 223457789999999999999999999999887753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.88 Aligned_cols=255 Identities=28% Similarity=0.382 Sum_probs=208.0
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
...++.|++.+.||.|.+|.||+++.+. +|+..|||++..... ..+++..|.+||+.+ +|||++.+||+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 3456789999999999999999999876 566889998865543 336788899999887 69999999999
Q ss_pred EEe-----CCeeEEEEeeCCCCChhHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 205 CIE-----DDQRLLVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 205 ~~~-----~~~~~lv~E~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
|.. ++.+|||||||.+|+.-+++.. .+..+.|..+..|++.++.||.+||... +||||||-.|||++.++.
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCc
Confidence 863 5789999999999999998853 2567999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
|||+|||++....... ....+.+|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+..+.
T Consensus 162 VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----- 234 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----- 234 (953)
T ss_pred EEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----
Confidence 9999999998764322 12345789999999999964 35788999999999999999999998654331
Q ss_pred hHhhhhhhhccccccccc-CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 354 VEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..++.+. +|...-.-+.+..+++.++|..||..|..+||++.++|++
T Consensus 235 -----------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 -----------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111 2222222345677899999999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.67 Aligned_cols=265 Identities=29% Similarity=0.431 Sum_probs=200.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~ 205 (487)
..++..+.+.||+|.||+||+|.|+ |+.||||++.... ...+.+|.+|... |+|+||+.|++.-
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 4567888899999999999999996 7799999997553 3567788888765 5999999999875
Q ss_pred EeC----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCcEEEcCC
Q 011385 206 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-----EAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 206 ~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-----~~~~~iiHrDLKp~NIll~~~ 276 (487)
..+ ..+|||.+|.+.|+|+|||.+ ..++....++++.-++.||++||- ++...|.|||||..|||+..+
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 443 367899999999999999966 468889999999999999999995 355669999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcc--eeeeeccccccccCCceeccC----CC--CchhhhhhHHHHHHHHHhC----------
Q 011385 277 YNAKLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG----HL--TSRSDVYSFGVVLLEMLTG---------- 338 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~----~~--~~~~DiwSlGvil~elltG---------- 338 (487)
|..-|+|+|||......... ...+..+||.+|||||++... .+ -..+||||||+||||+...
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 99999999999765443211 123346899999999998643 12 2368999999999999762
Q ss_pred CCCCCCCCCCCcchhhHhhhhhhhcccc--cccccCCccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 339 RRSMDKNRPNGEHNLVEWARPHLGERRR--FYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 339 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.||.+..+.+.. +.+..+ ..+.+.|.+... .+..+...+.+|++.||..+|..|.|+-.|.+.|.++
T Consensus 433 ~~Pyyd~Vp~DPs---------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 433 QLPYYDVVPSDPS---------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCcccCCCCCCC---------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 3566543332211 111000 011222322222 2345566788999999999999999999999988876
Q ss_pred CC
Q 011385 416 PN 417 (487)
Q Consensus 416 ~~ 417 (487)
.+
T Consensus 504 ~~ 505 (513)
T KOG2052|consen 504 SN 505 (513)
T ss_pred hc
Confidence 54
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.17 Aligned_cols=268 Identities=21% Similarity=0.265 Sum_probs=172.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEE---
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY--- 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~--- 204 (487)
..++|++.+.||+|+||.||+|++..+.. ..+..||||++...... +.+..| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 45789999999999999999999876311 12678999998643221 111111 1222222333222221
Q ss_pred ---EEeCCeeEEEEeeCCCCChhHHHhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 205 ---CIEDDQRLLVYEFMPRGSLENHLFRRSLP-------------------LPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 205 ---~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
.......+|||||+.+++|.+++...... .....+..|+.||+.||.|||+.+ ||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii 277 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV 277 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 24567889999999999999988644221 112345689999999999999988 99
Q ss_pred ecCCCCCcEEEcC-CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC----------------------CC
Q 011385 263 YRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG----------------------HL 319 (487)
Q Consensus 263 HrDLKp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~----------------------~~ 319 (487)
||||||+||||+. ++.+||+|||+++....... ......+|++.|||||++... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999986 58999999999986543222 223456899999999965422 24
Q ss_pred CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCcc----CCCCC--HHHHHHHHHHHHH
Q 011385 320 TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL----EGHFS--IKGAQKAAQLAAH 393 (487)
Q Consensus 320 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~l~~li~~ 393 (487)
+.++||||||||||||+++..++.... ..+.........+...+.....+.. ...+. ........+||.+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 456799999999999999776543210 0000000000000000000111110 00000 0012345689999
Q ss_pred hcccCCCCCCCHHHHHHHh
Q 011385 394 CLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 394 cl~~dP~~RPs~~ell~~L 412 (487)
||+.||.+|||+.+++++-
T Consensus 433 mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 433 MMRFKGRQRISAKAALAHP 451 (566)
T ss_pred HccCCcccCCCHHHHhCCc
Confidence 9999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.44 Aligned_cols=274 Identities=20% Similarity=0.266 Sum_probs=187.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCC-------CccCCCCcEEEEEEecCCCccCHHH--------------HHH
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTA-------PVKPGTGLTVAVKTLNHDGLQGHKE--------------WLA 185 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~-------~~~~~~g~~vavK~~~~~~~~~~~~--------------~~~ 185 (487)
...++|++.++||+|+||+||+|........ ......+..||||++........++ ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3467999999999999999999976432211 1122356689999987543322222 334
Q ss_pred HHHHHhcCCCCCc-----eeEEEEEEe--------CCeeEEEEeeCCCCChhHHHhhcC---------------------
Q 011385 186 EVNFLGDLVHLNL-----VKLIGYCIE--------DDQRLLVYEFMPRGSLENHLFRRS--------------------- 231 (487)
Q Consensus 186 E~~~l~~l~HpnI-----v~~~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~--------------------- 231 (487)
|+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++|....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776654 667777653 356899999999999999886421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeecccccccc
Q 011385 232 --LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309 (487)
Q Consensus 232 --~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~ 309 (487)
..+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+|+.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 12456778899999999999999988 999999999999999999999999999765432211 111234589999
Q ss_pred CCceeccCC--------------------CC--chhhhhhHHHHHHHHHhCCC-CCCCCCCCCc------chhhHhhhhh
Q 011385 310 APEYVMTGH--------------------LT--SRSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARPH 360 (487)
Q Consensus 310 APE~~~~~~--------------------~~--~~~DiwSlGvil~elltG~~-pf~~~~~~~~------~~~~~~~~~~ 360 (487)
|||++.... |+ .+.||||+|||||+|++|.. ||........ .+...|..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-- 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-- 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence 999875322 22 24799999999999999875 6643211110 00111100
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHhcCC
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDP---KARPLMSEVVEALKPL 415 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ell~~L~~l 415 (487)
..............+....+|+.+||..+| .+|+|+.|+|+|-.-.
T Consensus 456 ---------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 456 ---------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ---------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 000001111112235678999999999876 6899999999876543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=273.56 Aligned_cols=239 Identities=31% Similarity=0.433 Sum_probs=193.1
Q ss_pred CceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCC
Q 011385 142 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPR 220 (487)
Q Consensus 142 ~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~ 220 (487)
+||.||+|.+.. +|+.||+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999998864 46789999997665544 57899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeee
Q 011385 221 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300 (487)
Q Consensus 221 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 300 (487)
++|..++.... .+++..++.++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++....... ...
T Consensus 72 ~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 99999986543 3889999999999999999999987 9999999999999999999999999998765432 223
Q ss_pred eccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCC
Q 011385 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 380 (487)
Q Consensus 301 ~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (487)
...|+..|++||.+....++.++||||||+++|+|++|..||...... ........ .. .... . ...
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~------~~~~-~-~~~ 210 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KP------KPPF-P-PPE 210 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----cc------CCCC-c-ccc
Confidence 456889999999998888999999999999999999999999653111 11111110 00 0000 0 000
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 381 IKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 381 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
...+..+.+++.+||..||++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 003457889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.28 Aligned_cols=269 Identities=26% Similarity=0.357 Sum_probs=219.2
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCcee
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
..++.+...+++...++-+|.||.||.|.+++... ..+.+.|-+|.++....+ ....++.|...+..+.|||+..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt----~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDT----YNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCC----cchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 45566677889999999999999999998876432 223456778888655433 3456889999999999999999
Q ss_pred EEEEEEe-CCeeEEEEeeCCCCChhHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 201 LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 201 ~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
+.+++.+ .+..++++.+..-|+|..+|... ...+...+...++.|++.||+|||..+ |||.||..+|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 9998865 46678899999999999999721 234666778899999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 351 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 351 (487)
||+..++||+|=.+++..-+.+.............||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+..
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999999999999888887776666677889999999999999999999999999999999 88998765554321
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
. .+.+..+ +.. +..|++++..++.-||+.+|++||++++++..|.+
T Consensus 509 ~-------ylkdGyR---laQ-------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 H-------YLKDGYR---LAQ-------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred H-------HHhccce---ecC-------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 1122222 222 22467899999999999999999999999998864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=258.74 Aligned_cols=203 Identities=27% Similarity=0.354 Sum_probs=169.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++...+..||+|++|.|-+-++.. +|...|+|.+...-. +..+++++|+.+..+. .+|.+|.+||.+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 34555666789999999998888876 677999999975533 3345688888876554 799999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
......+|.||.|+ -+|+.+.. +++..+++..+-+|+..|++||.|||++-. +||||+||+||||+.+|++|||
T Consensus 115 ~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 115 FREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred hccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEc
Confidence 99999999999995 48877653 567889999999999999999999999753 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceec----cCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~ 345 (487)
|||++..+.+.- ..+...|-..|||||.+. ...|+-++||||||+++.||.+++.||+..
T Consensus 192 DFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 192 DFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999998765432 223356888999999875 348999999999999999999999999753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=274.86 Aligned_cols=269 Identities=22% Similarity=0.328 Sum_probs=204.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC--CccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.+.+..+.||-|+||+||.+++. .+|+.||+|++..- .....+.+.+|+++|..++|.|++..++...-
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDP---------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDP---------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred ccCCCCCcccccceeEEEeccCC---------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 46778899999999999988654 46889999998542 23345778999999999999999999887654
Q ss_pred C-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 208 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 208 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
. .++|+|.|++ ..+|...| .....++...+.-++.||++||.|||+.+ |+||||||.|+|++.+..+|||
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred CCchHHHHHHHHHHHH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence 3 2467889998 45888877 44567888899999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh--
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-- 359 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-- 359 (487)
|||+++.-..++ ...++..+-|-.|.|||++.+ ..|+.++||||.|||+.|||..+..|+...+....+++.-...
T Consensus 199 DFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 999999765433 334566778999999999986 4799999999999999999999999988777655554432111
Q ss_pred hhh------c--ccc-ccccc-CCccCC--CC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 360 HLG------E--RRR-FYRLI-DPRLEG--HF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 360 ~~~------~--~~~-~~~~~-~~~~~~--~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+. + +.. +..-. .|.+.- .+ +.....+...++..+|.+||++|.+..+.+.++.
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000 0 000 00000 011100 01 1122345778999999999999999999988764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.36 Aligned_cols=246 Identities=29% Similarity=0.400 Sum_probs=187.7
Q ss_pred CCCCCeecccCcee-EEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~-V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~ 209 (487)
|...+++|.|+-|+ ||+|.+. |+.||||++-... ..-..+||..|+.- .|||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44456799999876 8999884 6799999985442 23456999999888 5999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---C--CcEEE
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPL---PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---D--YNAKL 281 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l---~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~--~~~kl 281 (487)
..||+.|.|. .+|.+++....... .....+.++.|++.||++||+.+ ||||||||.||||+. + ..++|
T Consensus 577 F~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 577 FLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred eEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence 9999999995 49999997631111 11335778899999999999988 999999999999965 3 56899
Q ss_pred eecCCCCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhh
Q 011385 282 SDFGLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~ 359 (487)
+|||+++....+.... ......||-+|+|||++....-+.++||||||||+|+.++| ..||...-..+ .++
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI------ 725 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI------ 725 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh------
Confidence 9999999876554322 23346799999999999988888999999999999999996 89996542211 011
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+.....+..+.. ....++.+||.+|+..||..||++.+||.|-
T Consensus 726 -l~~~~~L~~L~~---------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 726 -LTGNYTLVHLEP---------LPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred -hcCccceeeecc---------CchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 111111111110 0111789999999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=268.13 Aligned_cols=132 Identities=25% Similarity=0.357 Sum_probs=112.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-----CC---Ccee
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----HL---NLVK 200 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----Hp---nIv~ 200 (487)
..+|.+.++||.|.|++||+|++... .+.||+|+++... ...+..+.||++|.+++ |+ .||+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~---------~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQN---------KRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccC---------CeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 37899999999999999999999873 4589999997542 22356789999999883 33 5999
Q ss_pred EEEEEEe----CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 201 LIGYCIE----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 201 ~~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
|++.|.. +.++|||+|++ |.+|..+|... -..++...+..|++||+.||.|||... +|||-||||+||||
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 9999875 56899999999 77999998754 356999999999999999999999865 59999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=255.83 Aligned_cols=261 Identities=20% Similarity=0.291 Sum_probs=198.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 206 (487)
..++|++.+.+|+|.|+.||.|.... +.+.++||+++.-. .+.+.+|++||..|. ||||++++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 34789999999999999999998765 45689999997543 367889999999997 999999999988
Q ss_pred eCC--eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEee
Q 011385 207 EDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSD 283 (487)
Q Consensus 207 ~~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl~D 283 (487)
+.. ...||+||+.+.+...+. ..+....+..++.+++.||.|+|++| |+|||+||.|++||.. -.++|+|
T Consensus 104 Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 104 DPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred CccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeee
Confidence 754 456999999988876655 35777888999999999999999999 9999999999999865 5699999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh--
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-- 360 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~-- 360 (487)
+|+|..+.++.... ..+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||.....+.++ ++..+...
T Consensus 177 WGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt 252 (338)
T KOG0668|consen 177 WGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGT 252 (338)
T ss_pred cchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhCh
Confidence 99999887665432 2456788999998864 67899999999999999999999999765544332 22111100
Q ss_pred --hhc-ccccccccCCccCC-----------CCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 --LGE-RRRFYRLIDPRLEG-----------HFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 --~~~-~~~~~~~~~~~~~~-----------~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.. ..+..-.++|.+.. .|- .-..+++.+|+.++|..|-++|+|+.|++.+
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 00000011211111 000 0113678999999999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=282.88 Aligned_cols=273 Identities=23% Similarity=0.277 Sum_probs=207.9
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC------C
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV------H 195 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H 195 (487)
+.-..+...+|.+....|+|-|++|..|.+.. -|..||||+|...... .+.=+.|++||.+|+ .
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhh
Confidence 33445677899999999999999999998765 4569999999766433 245678999999995 3
Q ss_pred CCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 196 pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
-++++|+-.|...+++|||+|-+ .-+|.+.|.+. +..|....+..++.|+.-||..|...+ |+|.||||.|||+
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 47999999999999999999998 55999998654 445788889999999999999999988 9999999999999
Q ss_pred cCC-CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 274 DAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 274 ~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
++. ..+||||||.|....+... +...-+..|.|||++.+..|+...|+||+||+||||.||+..|.+...+....
T Consensus 570 NE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 876 5679999999988765442 22445778999999999999999999999999999999999998876543322
Q ss_pred hhHhh---------------hhhhhc----------------ccccccccCC------ccCC--CCCH---HHHHHHHHH
Q 011385 353 LVEWA---------------RPHLGE----------------RRRFYRLIDP------RLEG--HFSI---KGAQKAAQL 390 (487)
Q Consensus 353 ~~~~~---------------~~~~~~----------------~~~~~~~~~~------~~~~--~~~~---~~~~~l~~l 390 (487)
+..-. ..++.. .......+.| .+.. .++. .....+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 11100 000000 0001111111 0111 1222 234567899
Q ss_pred HHHhcccCCCCCCCHHHHHHHh
Q 011385 391 AAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 391 i~~cl~~dP~~RPs~~ell~~L 412 (487)
+.+||..||++|.+..++|.|-
T Consensus 726 Ldkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred HHHHhccChhhcCCHHHHhcCC
Confidence 9999999999999999998753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.86 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=197.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC--CccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.+|.-++.+|.|.- .|..|.+.. .+..||+|++... .....++..+|+.++..+.|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 46777788999988 565565543 5678999988544 22334678899999999999999999999864
Q ss_pred C------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 208 D------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 208 ~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
. ...|+||||+ .++|.+.+. ..++-..+..|+.|++.|+.|||+.+ |+||||||+||++..++.+||
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence 3 3568999999 559988886 35777889999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-----
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW----- 356 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~----- 356 (487)
.|||+|+..... ..++..+.|..|.|||++.+..|...+||||+||++.||++|...|.+....+.-..+..
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999875432 345668899999999999998899999999999999999999999975433221111100
Q ss_pred -----------hhhhhhcc-----cccccccCCc-cCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 357 -----------ARPHLGER-----RRFYRLIDPR-LEG--HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 357 -----------~~~~~~~~-----~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
++...... ..+.+.+... +.. +.+......+++|+.+||..||++|.++.++|+|-
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00000000 1111111111 111 01112234678999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.31 Aligned_cols=198 Identities=24% Similarity=0.336 Sum_probs=170.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCC---CCC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLV---HLN 197 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---Hpn 197 (487)
..+|..++.||.|+||.|++|.++.+ ...|+||.+.+...-. .-.+--||+||+.|+ |+|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred cccceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 35799999999999999999999874 4489999997654321 112456999999997 999
Q ss_pred ceeEEEEEEeCCeeEEEEeeC-CCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 198 LVKLIGYCIEDDQRLLVYEFM-PRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 198 Iv~~~~~~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
|++++++|++++++||+||-- ++-+|+++|..+ ..+++..+..|+.||+.|+++||+++ |||||||-+|+.++.+
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSN 706 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecC
Confidence 999999999999999999974 566999999544 57999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCC
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMD 343 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~ 343 (487)
|-+||+|||.+.....+. ...++||..|.|||++.+..| +..-|||+||++||-++....||.
T Consensus 707 g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999997765543 345789999999999998888 566899999999999998888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=289.54 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=207.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|+++..+|.|+||.|||+++.. +++..|||+++...-.+..-+..|+-+++..+|||||.|++.+..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh
Confidence 35789999999999999999998875 678999999998877777778899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+.++|+||||.+|+|.+.. .-.+++++.++..+++..++||.|||+++ -+|||||-.|||+++.|.+|++|||.+
T Consensus 84 ~dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred hcCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCch
Confidence 99999999999999999865 44568999999999999999999999998 799999999999999999999999998
Q ss_pred CCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
-.+...- .....+.||+.|||||+.. .+.|...+|||++|++..||---++|.....+.....+.. ...
T Consensus 160 aqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----kS~- 231 (829)
T KOG0576|consen 160 AQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----KSG- 231 (829)
T ss_pred hhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----ccC-
Confidence 7654321 1234578999999999864 5789999999999999999998888765443321111111 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+-..+-|+ ....+.+.+|++.||..+|.+||+++.+|.+
T Consensus 232 ~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 232 FQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 000011111 1234678899999999999999999877653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-31 Score=245.68 Aligned_cols=212 Identities=36% Similarity=0.570 Sum_probs=184.2
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEe
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 216 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 216 (487)
||+|++|.||++.... ++..+++|++...... ....+.+|++.++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999998864 4678999999766432 23568899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCCCCCCCCCCc
Q 011385 217 FMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDK 295 (487)
Q Consensus 217 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~~kl~DFGla~~~~~~~~ 295 (487)
|+++++|.+++......+++..++.++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 99999999998665456899999999999999999999987 999999999999999 89999999999987644321
Q ss_pred ceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCc
Q 011385 296 THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374 (487)
Q Consensus 296 ~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (487)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12235678899999998877 889999999999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 375 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+.+++.+||+.||++||++.+++++|
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=249.06 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=189.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEE-EE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY-CI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~-~~ 206 (487)
.+.|.+.+.||+|-||.+.+|.++. +...+++|.+.... ....+|.+|...--.| .|.||+.-|++ |+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 3578899999999999999999986 56689999986553 3457899999887777 48899987764 67
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-c-CCCcEEEeec
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-D-ADYNAKLSDF 284 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll-~-~~~~~kl~DF 284 (487)
..+.++++|||++.|+|..-+.. ..+.+.....++.|++.||.|+|+++ +||||||.+|||| + +..++|||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence 77888899999999999987744 35778888999999999999999988 9999999999999 3 3458999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc---C--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---G--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+.+...... ....-+..|.+||++.. + ...+.+|||.||+|+|.+|||+.||+.... .+.....|..-
T Consensus 168 G~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w 241 (378)
T KOG1345|consen 168 GLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQW 241 (378)
T ss_pred ccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHH
Confidence 9998753321 11234667999997642 2 346789999999999999999999984322 22233222211
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ....+.+...|. ..+..+.++.++-|..++++|-...++.++
T Consensus 242 ~--------~rk~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 242 L--------KRKNPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred h--------cccCccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1 111112222222 234678899999999999999555554443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=242.78 Aligned_cols=200 Identities=33% Similarity=0.418 Sum_probs=173.3
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCe
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 210 (487)
|.+.+.||.|++|.||++.+.. ++..+|+|.+...... ..+.+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5677899999999999998865 4668999999866544 45778899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
.++++||+++++|.+++......+++..+..++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999998655433889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCcceeeeeccccccccCCcee-ccCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 344 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~ 344 (487)
...... ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 543200 12335688899999988 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=252.42 Aligned_cols=272 Identities=24% Similarity=0.309 Sum_probs=199.2
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
....+.|..+.+||+|.|++||++.+... ...+..||+|.+...... ..+.+|+++|..+ -+.||+++.++
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhh
Confidence 34557899999999999999999988752 225678999998765433 5688999999999 48999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl~D 283 (487)
+..++...+||||++.....+++. .++...+..+++.++.||.++|.+| ||||||||.|+|.+.. +.-.|+|
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 999999999999999998888773 4668889999999999999999988 9999999999999754 7789999
Q ss_pred cCCCCCCC-----------------C--C---------------Cc--------ceeeeeccccccccCCceec-cCCCC
Q 011385 284 FGLAKDGP-----------------E--G---------------DK--------THVSTRVMGTYGYAAPEYVM-TGHLT 320 (487)
Q Consensus 284 FGla~~~~-----------------~--~---------------~~--------~~~~~~~~Gt~~y~APE~~~-~~~~~ 320 (487)
||+|.... . + .. ........||++|.|||++. ....+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99987210 0 0 00 00111257999999999986 45678
Q ss_pred chhhhhhHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhh-------hhhhhcc---------------ccccccc-----
Q 011385 321 SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWA-------RPHLGER---------------RRFYRLI----- 371 (487)
Q Consensus 321 ~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~-------~~~~~~~---------------~~~~~~~----- 371 (487)
.++||||.|||++-+++++.||......... .++... ...+... ..-++-+
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 9999999999999999999999643322110 110000 0000000 0000001
Q ss_pred CC----ccC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 372 DP----RLE-GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 372 ~~----~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+ ... .......+..+.+|+.+||..||.+|.+++++|++-
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 00 000 011112234788999999999999999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=287.56 Aligned_cols=198 Identities=20% Similarity=0.235 Sum_probs=142.3
Q ss_pred cCCC-CCceeEEEEE-------EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011385 192 DLVH-LNLVKLIGYC-------IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 263 (487)
Q Consensus 192 ~l~H-pnIv~~~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 263 (487)
.++| .||++++++| ...+.++++|||+ +++|.++|......+++..++.|+.||+.||.|||+++ |||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4455 5788888877 2334567889988 66999999765567999999999999999999999988 999
Q ss_pred cCCCCCcEEEcCC-------------------CcEEEeecCCCCCCCCCCc--------------ceeeeeccccccccC
Q 011385 264 RDFKTSNILLDAD-------------------YNAKLSDFGLAKDGPEGDK--------------THVSTRVMGTYGYAA 310 (487)
Q Consensus 264 rDLKp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~A 310 (487)
|||||+||||+.. +.+||+|||+++....... .......+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999653 4556666666653211000 000112468999999
Q ss_pred CceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHH
Q 011385 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 390 (487)
Q Consensus 311 PE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 390 (487)
||++.+..|+.++|||||||+||||++|.+|+..... .... +. ...+++... .....+..+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~----~~-----~~~~~~~~~-----~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSS----LR-----HRVLPPQIL-----LNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHH----HH-----HhhcChhhh-----hcCHHHHHH
Confidence 9999999999999999999999999999887642110 0000 00 001111110 112345688
Q ss_pred HHHhcccCCCCCCCHHHHHHHh
Q 011385 391 AAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 391 i~~cl~~dP~~RPs~~ell~~L 412 (487)
+.+||+.||.+||++.||+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHhCCCChhhCcChHHHhhch
Confidence 9999999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=218.52 Aligned_cols=166 Identities=25% Similarity=0.252 Sum_probs=126.4
Q ss_pred CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeee
Q 011385 221 GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300 (487)
Q Consensus 221 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 300 (487)
|+|.+++..+...+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999776677999999999999999999999854 999999999999999 99988654321
Q ss_pred eccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCC
Q 011385 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFS 380 (487)
Q Consensus 301 ~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (487)
..||+.|||||++.+..|+.++|||||||++|||++|..||....... ........... .. .+. .....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~------~~-~~~-~~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMP------AD-DPR-DRSNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhc------cC-Ccc-ccccH
Confidence 268999999999999999999999999999999999999996433211 11111000000 00 000 00011
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 381 IKGAQ--KAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 381 ~~~~~--~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
..... .+.+++.+||..||.+||++.|+++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 12222 68999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=229.06 Aligned_cols=260 Identities=23% Similarity=0.228 Sum_probs=196.6
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC----CCceeEEEEE-
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH----LNLVKLIGYC- 205 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~~~~~~- 205 (487)
+|.+.+.||+|+||.||+|...... ...+|+|............+..|+.++..+.. .++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999876521 34789998876543332367788998888863 5899999998
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----CcE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNA 279 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-----~~~ 279 (487)
..+...||||+.+ |.+|.++..... ..++..+++.|+.|++.+|++||+.+ +|||||||.|+++... ..+
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence 4788899999999 889999875554 67999999999999999999999988 9999999999999754 469
Q ss_pred EEeecCCCC--CCCCCCcc----e-e-eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 280 KLSDFGLAK--DGPEGDKT----H-V-STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 280 kl~DFGla~--~~~~~~~~----~-~-~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
.|.|||+++ ........ . . ...+.||..|+++....+...+.+.|+||++.++.||+.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999999 43222211 0 1 12356999999999999999999999999999999999999999654432221
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....... .. ..... +....+..+..+...+-..+..++|....+...|+..
T Consensus 247 ~~~~~~~--~~------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDP--RK------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHh--hh------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111000 00 00000 1112235566777777779999999999998887644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=218.69 Aligned_cols=259 Identities=20% Similarity=0.221 Sum_probs=196.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~ 208 (487)
-.|++.++||+|.||+.|.|.+.. +++.||||.-..... ..++..|.+..+.|. .++|...|.+...+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccccc---------cCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 378999999999999999998876 577999998754322 245778888887774 68999999988888
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----CcEEEee
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-----YNAKLSD 283 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-----~~~kl~D 283 (487)
.+..||||++ |-+|+|++.-.+..|+..++..+|.|++.-++|+|++. +|+|||||+|+||... ..|.|+|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence 8889999999 88999998777888999999999999999999999988 9999999999999543 4589999
Q ss_pred cCCCCCCCCCCc-----ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 284 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 284 FGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
||+|+.+.+... ........||.+||+-....+.+.+.+-|+-|||-++++.|-|..||++..........+
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe--- 249 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE--- 249 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---
Confidence 999998765432 122334789999999998899999999999999999999999999998765433222111
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+++..+. .....++...+.++..-+.-.=..+-.+-|..+-+...+.
T Consensus 250 -KIGe~Kr~------T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 250 -KIGETKRS------TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred -Hhcccccc------CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 11111110 0011112223445555555555667777787765555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=232.39 Aligned_cols=177 Identities=18% Similarity=0.152 Sum_probs=133.7
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCcee-
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLVHLNLVK- 200 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~- 200 (487)
....+|.+.+.||+|+||+||+|++... ++..||||++..... .....+.+|+++|.+|+|+||+.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 3456899999999999999999987541 356789998753311 12345889999999999999985
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcEEEcCCCcE
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNA 279 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL-Kp~NIll~~~~~~ 279 (487)
++++ +..|||||||+|++|.. +.. .. ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+
T Consensus 87 l~~~----~~~~LVmE~~~G~~L~~-~~~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 87 LLAT----GKDGLVRGWTEGVPLHL-ARP----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred EEEc----CCcEEEEEccCCCCHHH-hCc----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 4432 45799999999999963 211 11 1467889999999999988 999999 9999999999999
Q ss_pred EEeecCCCCCCCCCCccee------eeeccccccccCCceeccC------CCCchhhhh
Q 011385 280 KLSDFGLAKDGPEGDKTHV------STRVMGTYGYAAPEYVMTG------HLTSRSDVY 326 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~------~~~~~Gt~~y~APE~~~~~------~~~~~~Diw 326 (487)
||+|||+++.......... .+...+++.|+|||.+... ..+...|-|
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999987654321111 1346789999999988532 233446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=211.35 Aligned_cols=262 Identities=20% Similarity=0.199 Sum_probs=203.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC-CCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~ 206 (487)
...+|.+++.||.|+||.+|+|.... +|+.||||+-+.... ...+..|.++.+.|+| ..|..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 45789999999999999999998865 688999999865532 3567889999999975 67888888888
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~~kl~D 283 (487)
+.++..|||+++ |.+|++++.-....++..+++-++-|++.-++|+|.++ +|||||||+|+|..- -..+.|+|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEe
Confidence 899999999999 88999988766778999999999999999999999988 999999999999853 35689999
Q ss_pred cCCCCCCCCCCc-----ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 284 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 284 FGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
||+|+.+.+... ........||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||++.......+..+...
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 999997654322 122345789999999887777888999999999999999999999999876544333222111
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
+..-......++...+.++.-.+.-|=..--++-|...-+-+.+..
T Consensus 238 ----------EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 238 ----------EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred ----------HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 1000001111222234566778888888888899988776665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-25 Score=216.64 Aligned_cols=259 Identities=32% Similarity=0.421 Sum_probs=197.5
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCC-CceeEEEEEEe
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHL-NLVKLIGYCIE 207 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~Hp-nIv~~~~~~~~ 207 (487)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.+++.+.|+ +|+++++++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 677889999999999999875 378999997654432 56789999999999988 79999999977
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~DF 284 (487)
....+++++|+.+++|.+++.... ..+.......++.|++.++.|+|..+ ++||||||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence 777899999999999997664443 26889999999999999999999988 99999999999999988 7999999
Q ss_pred CCCCCCCCCCcce----eeeeccccccccCCceecc---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC-CcchhhHh
Q 011385 285 GLAKDGPEGDKTH----VSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW 356 (487)
Q Consensus 285 Gla~~~~~~~~~~----~~~~~~Gt~~y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~~~~ 356 (487)
|+++......... ......||..|+|||.+.+ ..+....|+|++|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9998654433221 2345789999999999887 57899999999999999999999997654331 00011111
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..... .. .................+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELP---TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcC---Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10000 00 000000100001223568899999999999999998887664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=245.57 Aligned_cols=255 Identities=19% Similarity=0.230 Sum_probs=187.0
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC--CccCH----HHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGH----KEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
....++|.|++|.|+.+...... ..++.|..... ..... ..+..|+.+-..|.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~---------~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDL---------KSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCCC---------ccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 45678999999988877665422 22333332210 11111 12567888888999999988777776
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+....+-+||||++ +|..++... ..+....+-.++.|++.||.|||+.+ |.|||||++|+++..+|.+||+|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCc
Confidence 66666666999999 999988544 46788888999999999999999999 99999999999999999999999999
Q ss_pred CCCCCCCCcc--eeeeeccccccccCCceeccCCCCc-hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~~~-~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+......... .....++|+..|+|||++.+..|++ .+||||.|++++.|++|+.||............ .. .
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--~~----~ 540 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--NN----Y 540 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--hc----c
Confidence 9876544333 4556689999999999999999987 589999999999999999999754443322100 00 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
...+ .+.. -...+....+...+.+|.+||+.||.+|.++.+|++
T Consensus 541 ~~~~-~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 SDQR-NIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccc-cccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 0000 000111233456789999999999999999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-26 Score=225.44 Aligned_cols=170 Identities=26% Similarity=0.432 Sum_probs=128.2
Q ss_pred EEEEeeCCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
||.|++|...+|.+||.++ ....++...+.++.|++.|+.| ++ .+||||||.||++..+..+||+|||+.+.
T Consensus 332 yI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheee
Confidence 6899999999999999643 4457788899999999999999 55 99999999999999999999999999987
Q ss_pred CCCCC----cceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 290 GPEGD----KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 290 ~~~~~----~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
..... .....+..+||..||+||++.+..|+.++||||||+||+||+. -...|... ..+.+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------------~t~~d~ 472 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------------ATLTDI 472 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------------Hhhhhh
Confidence 65543 1223456789999999999999999999999999999999997 22222100 000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 407 (487)
. ...+++.....+ +.-..|+.++|...|.+||++.+
T Consensus 473 r--~g~ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 R--DGIIPPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h--cCCCChHHhhcC-----cHHHHHHHHhcCCCcccCchHHH
Confidence 0 011111111111 34568999999999999995444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=201.27 Aligned_cols=173 Identities=9% Similarity=0.076 Sum_probs=134.6
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH---------HHHHHHHHhcCCCC
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLVHL 196 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~Hp 196 (487)
.....+|+++++||.|+||.||++.. ++..+|||.+.......... +.+|++.+.++.|+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 35578999999999999999998643 23469999996544333222 57899999999999
Q ss_pred CceeEEEEEEeC--------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 011385 197 NLVKLIGYCIED--------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 268 (487)
Q Consensus 197 nIv~~~~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp 268 (487)
+|..+.+++... ...+|||||++|.+|.++. .++. ....+++.+|..||..+ ++||||||
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp 163 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHK 163 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCCh
Confidence 999999886643 3578999999999998864 1222 24568999999999988 99999999
Q ss_pred CcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHH
Q 011385 269 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 336 (487)
Q Consensus 269 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ell 336 (487)
+||+++.+| ++|+|||............ .++....|+.++|+|+||+++..+.
T Consensus 164 ~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 164 GNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 999999988 9999999987653221100 0344556778999999999988765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-25 Score=201.04 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=189.2
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
..++.+|.+...|..|+|++.. ..+++|+++..... ..++|..|.-.|+-+.||||+.+++.|....
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 3445578889999999999964 36778888655432 2357889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe-cCCCCCcEEEcCCCcEEEe--ecC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIY-RDFKTSNILLDADYNAKLS--DFG 285 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH-rDLKp~NIll~~~~~~kl~--DFG 285 (487)
++.++..|++.|+|++.|.... -..+..++.+++.+|++|++|||+..+ +|- --|....++||++.+.+|. |--
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccce
Confidence 9999999999999999997553 346778899999999999999999873 444 4689999999999887764 322
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCC---CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~---~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
++... ....-.|.||+||.++...- -.++|+|||.++||||.|...||....+.+..-.+
T Consensus 339 fsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------- 401 (448)
T KOG0195|consen 339 FSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------- 401 (448)
T ss_pred eeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--------
Confidence 22211 11234688999999876543 34799999999999999999999876654332111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.-..+...+++..+..+.+|+.-|+..||.+||.+..|+-.|+.+
T Consensus 402 --------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 402 --------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 111223334444556788999999999999999999999888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-25 Score=222.11 Aligned_cols=229 Identities=28% Similarity=0.351 Sum_probs=182.8
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l 213 (487)
++|+|.||.|++++-.. ....|..||+|++++..... ......|..++...+ ||.+|++...++.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~~------g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG------GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhc------cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 47999999999875432 22356789999987654322 123456888888887 9999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
+++|..+|+|...+... ..+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++.....
T Consensus 75 ~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 99999999998887544 34666666677778889999999988 999999999999999999999999999876543
Q ss_pred CcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCC
Q 011385 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDP 373 (487)
Q Consensus 294 ~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (487)
.. .|||..|||||++. .+..++|+||||++++||+||..||.. ++... ++.
T Consensus 151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~-------------Il~- 201 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKR-------------ILK- 201 (612)
T ss_pred hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHH-------------Hhh-
Confidence 32 28999999999887 788899999999999999999999965 11111 110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 374 RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 374 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
....++...+..+++++..++..+|..|.-.
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1223455667789999999999999999865
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=189.58 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=107.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--C-------H-----------------HHHHHHHH
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--G-------H-----------------KEWLAEVN 188 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~ 188 (487)
...||+|+||.||+|.+. +|+.||||+++..... . . .....|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 468999999999999864 4779999999654211 0 0 11235999
Q ss_pred HHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCC
Q 011385 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRDFK 267 (487)
Q Consensus 189 ~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~~~~iiHrDLK 267 (487)
+|.++.++++.....+.. ...+|||||+++++|...+.. ...++...+..++.|++.+|.|| |+.+ |+|||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999998877644333222 223899999998877655433 35688999999999999999999 6877 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~ 290 (487)
|+|||++ ++.++|+|||+|...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=182.76 Aligned_cols=140 Identities=17% Similarity=0.154 Sum_probs=109.9
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---------------------C-----HHHHHHHHH
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---------------------G-----HKEWLAEVN 188 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~ 188 (487)
.+.||+|+||.||+|.+. +|+.||||+++..... . ...+..|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 568999999999999864 4779999998754211 0 112357899
Q ss_pred HHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCC
Q 011385 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFK 267 (487)
Q Consensus 189 ~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLK 267 (487)
.+.++.|++|.....+... ..+|||||++|+++...+.. ...++......++.|++.+|.+||. .+ |+|||||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred HHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 9999999987554444333 24899999988865443222 2457788899999999999999999 87 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+|||++ ++.++|+|||+++...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecC
Confidence 9999998 8899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-23 Score=219.04 Aligned_cols=212 Identities=25% Similarity=0.383 Sum_probs=149.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|..+++|..|+||.||+++++. +.+.+|+ .++++.+. ++- |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~---------trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc---------cccchhh-cccccchh-----hhc--cccccCCccee----------
Confidence 578899999999999999999876 5678999 45444321 111 22222333333
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
|+-...+ +..++++... +.+++|||+.+ |+|||+||+|+||+.-|++|++|||+++.
T Consensus 136 -----------gDc~tll-k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLL-KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhc-ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 4555544 3334555443 56899999988 99999999999999999999999999875
Q ss_pred CCCCCc-------------ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 290 GPEGDK-------------THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 290 ~~~~~~-------------~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
...... ......+|||+.|.|||++...+|+..+|||++|+|+||.+.|+.||.+..+......+
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v-- 270 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-- 270 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh--
Confidence 322110 01122369999999999999999999999999999999999999999987664332221
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 406 (487)
+.+...+.+- +. ....+++++|.++|+.+|..|.-..
T Consensus 271 ----isd~i~wpE~-de--------a~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 271 ----ISDDIEWPEE-DE--------ALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ----hhhhcccccc-Cc--------CCCHHHHHHHHHHHHhChHhhcccc
Confidence 1111111111 11 1236789999999999999997443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-24 Score=224.78 Aligned_cols=251 Identities=24% Similarity=0.271 Sum_probs=181.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-cc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+|...+.||.+.|=.|.+|++++ |. |+||++-+.. .- ..++.+.|++ ...++|||++++.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57778899999999999998864 54 8899984433 22 2344455666 55678999999988877
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.+...|||-+|+.+ +|.|.|..+ ..+...+.+.|+.|++.||.-+|..+ |+|+|||.+||||+.-.-+.|+||-.
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccc
Confidence 77888999999955 999988443 45777788899999999999999998 99999999999999998999999987
Q ss_pred CCC--CCCC---CcceeeeeccccccccCCceeccC-----------CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 011385 287 AKD--GPEG---DKTHVSTRVMGTYGYAAPEYVMTG-----------HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 349 (487)
Q Consensus 287 a~~--~~~~---~~~~~~~~~~Gt~~y~APE~~~~~-----------~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 349 (487)
-+. .+++ +......+-..-.+|.|||.+... ..+++.||||+||+++||++ |+++|.-.
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---- 242 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---- 242 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence 653 2222 111112222233579999987532 15678999999999999998 68888421
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
++..+............+.+ .+..++.|+..|++.||.+|.++++.|+.-..+
T Consensus 243 --QL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 --QLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 22222211100111111111 123578999999999999999999999865443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=180.38 Aligned_cols=188 Identities=18% Similarity=0.089 Sum_probs=139.2
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC----HHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGDLV-HLNLVKLIGYCIE 207 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 207 (487)
-+...|++|+||+||++.. .+..++.+.+.....-. ...+.+|+++|.+|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3467899999999997643 35577777776543311 124779999999995 5789999886
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF-KTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL-Kp~NIll~~~~~~kl~DFGl 286 (487)
+..+++|||+.|.+|.+.+.. . ...++.|++.+|.++|+.+ |+|||| ||+|||++.++.++|+|||+
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCC
Confidence 346999999999998754311 1 1357789999999999988 999999 79999999999999999999
Q ss_pred CCCCCCCCcc---ee--------eeeccccccccCCceeccC-CCC-chhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 287 AKDGPEGDKT---HV--------STRVMGTYGYAAPEYVMTG-HLT-SRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 287 a~~~~~~~~~---~~--------~~~~~Gt~~y~APE~~~~~-~~~-~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
+......... .. ......++.|+.|+...-. ..+ ...++++.|+-+|.++|+..++....
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9865432210 00 0012367888888854321 333 57899999999999999998875443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=189.96 Aligned_cols=232 Identities=21% Similarity=0.272 Sum_probs=148.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCC----------CC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVH----------LN 197 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H----------pn 197 (487)
.+...+.||.|+|+.||.+++.. ||+.+|||+...... ...+++.+|.-....+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 34556789999999999999875 789999999854332 223556666655444332 11
Q ss_pred ceeEEEEEE---------eC---C-----eeEEEEeeCCCCChhHHHh---hcCC---CCCHHHHHHHHHHHHHHHHHHH
Q 011385 198 LVKLIGYCI---------ED---D-----QRLLVYEFMPRGSLENHLF---RRSL---PLPWSIRMKIALGAAKGLAFLH 254 (487)
Q Consensus 198 Iv~~~~~~~---------~~---~-----~~~lv~E~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~qi~~~l~yLH 254 (487)
++-.++... .. . +.+++|+-+ .++|.+++. .... .+....++.+..|+++.+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 222222211 11 1 346788888 558888753 2221 2344556778899999999999
Q ss_pred hCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc--------CCCCchhhhh
Q 011385 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVY 326 (487)
Q Consensus 255 ~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--------~~~~~~~Diw 326 (487)
..+ ++|+||+|+|+|++.+|.++|+||+........ ... ...+..|.+||.... -.++.+.|.|
T Consensus 163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW 234 (288)
T PF14531_consen 163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW 234 (288)
T ss_dssp HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence 999 999999999999999999999999987764321 111 345678999997643 2578899999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 011385 327 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402 (487)
Q Consensus 327 SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 402 (487)
+||+++|.|.+|..||....+...... . .. .+.+.++.++.||..+|+.||.+|
T Consensus 235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~----------------~-----f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 235 QLGITLYSLWCGRLPFGLSSPEADPEW----------------D-----FS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHSS-STCCCGGGSTSGG----------------G-----GT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHccCCCCCCCccccccc----------------c-----ch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999999975433221110 0 00 111456789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=178.25 Aligned_cols=137 Identities=19% Similarity=0.208 Sum_probs=106.8
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-----CCCCceeEEEEEEe
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-----VHLNLVKLIGYCIE 207 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~~ 207 (487)
.-.++||+|+||.||. +.. ++.. +||++........+.+.+|+.+++.| +||||+++++++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3456899999999995 432 2334 69988765444557799999999999 57999999999988
Q ss_pred CC---eeE-EEEee--CCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCcEEEcC----C
Q 011385 208 DD---QRL-LVYEF--MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL-AFLHEEAERPVIYRDFKTSNILLDA----D 276 (487)
Q Consensus 208 ~~---~~~-lv~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l-~yLH~~~~~~iiHrDLKp~NIll~~----~ 276 (487)
+. .++ +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++ ||||||||+|||++. +
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESE 145 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCC
Confidence 74 434 78999 5579999999543 35555 35677888777 9999988 999999999999974 3
Q ss_pred CcEEEeecCCCC
Q 011385 277 YNAKLSDFGLAK 288 (487)
Q Consensus 277 ~~~kl~DFGla~ 288 (487)
+.++|+||+.+.
T Consensus 146 ~~~~LiDg~G~~ 157 (210)
T PRK10345 146 VIPVVCDNIGES 157 (210)
T ss_pred CcEEEEECCCCc
Confidence 479999955443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=196.28 Aligned_cols=218 Identities=25% Similarity=0.391 Sum_probs=165.7
Q ss_pred HhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 190 l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.....+.++|+.||.|||... . ..|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence 46789999999999999999999999999999999999887788999999999999999999999865 1 299999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC---C----CCchhhhhhHHHHHHHHHhCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG---H----LTSRSDVYSFGVVLLEMLTGRRSM 342 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~---~----~~~~~DiwSlGvil~elltG~~pf 342 (487)
|+++|....+||+|||+.................-...|.|||.+... . .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998776431111111122345679999988753 1 466799999999999999999999
Q ss_pred CCCCCCCcc-hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 343 DKNRPNGEH-NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 343 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
......... .++..... .....+.|.+.... .....+..++..||..+|.+||++.++-..++.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 764443332 22222111 00111222221111 333478899999999999999999999988876644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-21 Score=209.10 Aligned_cols=198 Identities=20% Similarity=0.215 Sum_probs=158.5
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCceeEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLI 202 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~ 202 (487)
.+....|.|.+.||+|+||.||+|...+ |+.||+|+-+.... -+|.-=.+++.+|+ -+-|..+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHH
Confidence 3455788999999999999999998763 67999998765432 22222333444443 23466666
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-------
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA------- 275 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~------- 275 (487)
.++...+.-+||+||.+.|+|.+++. ....+++..+..+..|++..|+.||..+ |||+||||.|+||..
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCc
Confidence 66677778899999999999999985 6667999999999999999999999998 999999999999942
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCC
Q 011385 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 340 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 340 (487)
..-++|+|||.+..+..-.........++|-.+-.+|+..+..++..+|.|.|..+++-||.|+.
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 34589999999976543322234455788999999999999999999999999999999999863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=186.40 Aligned_cols=262 Identities=19% Similarity=0.240 Sum_probs=171.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCC-------cc----CCC---------------CcEEEEEEecCCCccC-HH
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAP-------VK----PGT---------------GLTVAVKTLNHDGLQG-HK 181 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~-------~~----~~~---------------g~~vavK~~~~~~~~~-~~ 181 (487)
.++|++.+.||+|.-..||.|+...++... .. +.+ .-..|||.+-.-...+ ..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 367999999999999999999887633210 00 000 0145677653221111 11
Q ss_pred ----HHHHHH--------------HHHhc--------CCCCCceeEEEEEEeC---------------------------
Q 011385 182 ----EWLAEV--------------NFLGD--------LVHLNLVKLIGYCIED--------------------------- 208 (487)
Q Consensus 182 ----~~~~E~--------------~~l~~--------l~HpnIv~~~~~~~~~--------------------------- 208 (487)
.+-+|. ...+. -.|||||++.++|.+.
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 111111 01111 2599999999887642
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCC--cEEEeec
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADY--NAKLSDF 284 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll--~~~~--~~kl~DF 284 (487)
..+|+||...+. +|..++..+ ..+.....-|+.|+++|+.|||.++ |.|||||..|||| ++|+ .++|+||
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEccc
Confidence 256899998855 999998544 3455566678889999999999998 9999999999999 4443 4789999
Q ss_pred CCCCCCCCCCc----ceeeeeccccccccCCceeccCC------CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 285 GLAKDGPEGDK----THVSTRVMGTYGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 285 Gla~~~~~~~~----~~~~~~~~Gt~~y~APE~~~~~~------~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
|++-....... .......-|...-||||+....+ --.++|.|+.|.+.||++....||....... .+.-
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r 468 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTR 468 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echh
Confidence 98754322111 11112245788999999875321 1348999999999999999999997632211 0110
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. +.+.. .+.++..++..+++|+..+|+.||.+|++..=....|
T Consensus 469 ~-----------Yqe~q----LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 469 T-----------YQESQ----LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred h-----------hhhhh----CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 0 11111 1223344567899999999999999999876555544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=169.06 Aligned_cols=134 Identities=18% Similarity=0.260 Sum_probs=112.2
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
+.||+|++|.||+|.+ .|..|+||+........ ...+.+|+.++..+.|++|.....++.+
T Consensus 2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 5799999999999986 24578999865432211 1347789999999999998877777777
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||++|++|.+++.... . .+..++.+++.+|.+||+.+ ++|+||+|.|||++ ++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcc
Confidence 788899999999999999885432 2 77899999999999999988 99999999999999 789999999998
Q ss_pred CC
Q 011385 288 KD 289 (487)
Q Consensus 288 ~~ 289 (487)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 75
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=172.19 Aligned_cols=143 Identities=18% Similarity=0.172 Sum_probs=110.2
Q ss_pred CCCCCCeecccCceeEEEEE-EccCCCCCccCCCCcEEEEEEecCCCcc-------------------C-----HHHHHH
Q 011385 131 NFRPESLLGEGGFGCVFKGW-IEENGTAPVKPGTGLTVAVKTLNHDGLQ-------------------G-----HKEWLA 185 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~-~~~~~~~~~~~~~g~~vavK~~~~~~~~-------------------~-----~~~~~~ 185 (487)
.|.+.+.||+|+||.||+|+ +.. +|..||||+++..... . ...+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 48889999999999999998 332 5789999998754210 0 022568
Q ss_pred HHHHHhcCCCCC--ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011385 186 EVNFLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 263 (487)
Q Consensus 186 E~~~l~~l~Hpn--Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 263 (487)
|++++.++.+.+ +.+++++ ...+|||||+++++|..++... ..+.......++.||+.+|.|||..+. |+|
T Consensus 100 E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH 172 (237)
T smart00090 100 EFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGE--LVH 172 (237)
T ss_pred HHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence 999999997633 3444443 2358999999998887655332 345666678999999999999998652 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 264 RDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 264 rDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
|||||+|||++ ++.++|+|||++...
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=166.38 Aligned_cols=131 Identities=21% Similarity=0.317 Sum_probs=106.1
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--------CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+||+|+||.||+|.+ .|..|++|........ ...++.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 489999999999985 3557999986533211 124567899999999988766555555667
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..+|||||++|++|.+++..... .++.+++.+|.+||+.+ ++|+||+|.|||++ ++.++|+|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999988744211 78899999999999988 99999999999999 8899999999987
Q ss_pred CC
Q 011385 289 DG 290 (487)
Q Consensus 289 ~~ 290 (487)
..
T Consensus 138 ~~ 139 (199)
T TIGR03724 138 YS 139 (199)
T ss_pred CC
Confidence 64
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=186.88 Aligned_cols=137 Identities=22% Similarity=0.276 Sum_probs=111.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC--Cc---c---CHHHHHHHHHHHhcCCCCCceeE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GL---Q---GHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~--~~---~---~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
..|...+.||+|+||+||+|.+.. ..+++|+.... .. . ....+.+|++++..++|++|+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 455678899999999999998743 23444432111 11 1 12457899999999999999988
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
+.++.+....++||||+++++|.+++. ....++.|++.+|.|||+.+ |+||||||+|||+ .++.++|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 888777778899999999999999884 35678999999999999988 9999999999999 6789999
Q ss_pred eecCCCCCC
Q 011385 282 SDFGLAKDG 290 (487)
Q Consensus 282 ~DFGla~~~ 290 (487)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=162.17 Aligned_cols=138 Identities=17% Similarity=0.076 Sum_probs=108.2
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----c-----------------CHHHHHHHHH
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----Q-----------------GHKEWLAEVN 188 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~-----------------~~~~~~~E~~ 188 (487)
.|.+.+.||+|+||.||+|... +|+.||||++..... . ....+..|+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 4888899999999999999764 477999998754320 0 0112567899
Q ss_pred HHhcCCCCC--ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011385 189 FLGDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 266 (487)
Q Consensus 189 ~l~~l~Hpn--Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 266 (487)
++..+.|++ +...++ ....++||||++|++|..+... .....++.+++.++.++|..+ |+||||
T Consensus 86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 999998874 444443 2455899999999999765421 235678899999999999987 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 267 KTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 267 Kp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
||+||+|+.++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.5e-20 Score=194.71 Aligned_cols=256 Identities=24% Similarity=0.283 Sum_probs=192.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 207 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 207 (487)
.|.+.+.||+|+|+.|-+.....+ ....+|+|.+.... .........|..+-..+. |.|++.+++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 566777899999999988766443 23467888776553 112233445788877887 9999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY-NAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~~~~iiHrDLKp~NIll~~~~-~~kl~DF 284 (487)
.+..+++++|..++++.+.+ .......+......++.|+..++.|+| ..+ +.||||||+|.+++..+ .++++||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence 99999999999999999888 333335667778889999999999999 777 99999999999999999 9999999
Q ss_pred CCCCCCCC-CCcceeeeeccc-cccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 285 GLAKDGPE-GDKTHVSTRVMG-TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 285 Gla~~~~~-~~~~~~~~~~~G-t~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|+|..+.. ..........+| ++.|+|||...+. -.....|+||.|+++.-|++|..||......... ...|...
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~-- 246 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN-- 246 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc--
Confidence 99998776 444444455788 9999999988875 4467899999999999999999999754433211 0111100
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
... ..............+++.+++..+|..|.+.+++..
T Consensus 247 --~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 247 --KGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccc--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000 000111122356778999999999999999887754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=146.08 Aligned_cols=136 Identities=22% Similarity=0.147 Sum_probs=114.2
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC--CCceeEEEEEEeCCee
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQR 211 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~ 211 (487)
+.+.||.|.++.||++... +..+++|....... ...+.+|+.++..+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4578999999999999874 24799999865533 4568899999999976 5899999988888889
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
+++|||++++.+..+ +......++.+++.+|.+||.....+++|+||+|+|||++..+.++++|||+++..
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999999998877653 45667788999999999999865445999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.5e-17 Score=149.44 Aligned_cols=137 Identities=20% Similarity=0.152 Sum_probs=97.5
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHH----------------------HHHHHHHH
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL 190 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l 190 (487)
.+.||+|+||.||+|... +|+.||||++....... ... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 568999999999999764 36789999986532211 111 13566666
Q ss_pred hcCCCCC--ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCC
Q 011385 191 GDLVHLN--LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFK 267 (487)
Q Consensus 191 ~~l~Hpn--Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLK 267 (487)
..+.+.. +.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|||||
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~ 142 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDLS 142 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCC
Confidence 6664433 4455543 245899999998544321111110 11 5577899999999999999 77 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|+||+++ ++.++|+|||.+....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhhEEEE-CCcEEEEECccccccc
Confidence 9999999 8999999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=152.39 Aligned_cols=135 Identities=22% Similarity=0.238 Sum_probs=103.6
Q ss_pred Ceec-ccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-------------cCHHHHHHHHHHHhcCCCCCc--e
Q 011385 136 SLLG-EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLVHLNL--V 199 (487)
Q Consensus 136 ~~LG-~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnI--v 199 (487)
..|| .||.|+||++... +..++||.+..... .....+.+|++++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4687 8889999988663 45789998854221 122457889999999998875 6
Q ss_pred eEEEEEEeCCe----eEEEEeeCCC-CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 200 KLIGYCIEDDQ----RLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 200 ~~~~~~~~~~~----~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
..+++...... .+|||||++| .+|.+++... .++.. .+.+|+.+|.+||+.+ |+||||||+|||++
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~ 176 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLD 176 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEc
Confidence 77776543322 2599999997 6898887442 34543 3568999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCC
Q 011385 275 ADYNAKLSDFGLAKDG 290 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~ 290 (487)
.++.++|+|||.++..
T Consensus 177 ~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 177 PDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCEEEEECCCcccC
Confidence 9899999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-16 Score=162.55 Aligned_cols=253 Identities=25% Similarity=0.303 Sum_probs=188.3
Q ss_pred hcCCCCCCeecc--cCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC-CCCCceeEEE
Q 011385 129 TRNFRPESLLGE--GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL-VHLNLVKLIG 203 (487)
Q Consensus 129 ~~~y~~~~~LG~--G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~~~~ 203 (487)
...|.+.+.+|. |.+|.||.+.... ..++..+|+|.-+.... .....=.+|+...+.+ .|+|.++.+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 456778889999 9999999987721 22567899998433221 2223335677777777 4999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCcEEEcCC-Cc
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILLDAD-YN 278 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~ 278 (487)
.|...+.+|+-+|+| +.+|..+.......++...++.++.+... ||..+|+.. ++|-|+||.||++..+ ..
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence 999999999999999 57888888766666889999999999999 999999988 9999999999999998 88
Q ss_pred EEEeecCCCCCCCCCCcce---eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011385 279 AKLSDFGLAKDGPEGDKTH---VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~---~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~ 355 (487)
.+++|||+........... ...+..|...|++||. ..+.++.+.|||+||.++.+..+|...+.......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------ 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCC------
Confidence 9999999998876654221 1223468889999995 46788999999999999999999877653321110
Q ss_pred hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
|. .....+ +..+|.......+...+..+++.+|..|+++..+..
T Consensus 335 W~-----~~r~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WS-----QLRQGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc-----cccccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 000100 112222222345556999999999999999877665
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-14 Score=150.35 Aligned_cols=142 Identities=20% Similarity=0.149 Sum_probs=97.7
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--------------------------H--------
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------------------H-------- 180 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------------------------~-------- 180 (487)
.+.||.|++|.||+|+.. +|+.||||+.+...... .
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 368999999999999875 47799999986432100 0
Q ss_pred ------HHHHHHHHHHhcCC----CCCceeEEEEE-EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHH-
Q 011385 181 ------KEWLAEVNFLGDLV----HLNLVKLIGYC-IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK- 248 (487)
Q Consensus 181 ------~~~~~E~~~l~~l~----HpnIv~~~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~- 248 (487)
-++.+|++.+.++. |.+-+.+-.++ ......+|||||++|++|.++........+ ...++.+++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS 268 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence 02344555555542 33333332232 224457899999999999887643222222 3345555555
Q ss_pred HHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 249 ~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
.+..+|..+ ++|+|+||.||+++.++.++|+|||++.....
T Consensus 269 ~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 467889877 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.6e-15 Score=139.55 Aligned_cols=204 Identities=23% Similarity=0.283 Sum_probs=141.4
Q ss_pred HHHHhcCCCCCceeEEEEEEeCC-----eeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011385 187 VNFLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAE 258 (487)
Q Consensus 187 ~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~ 258 (487)
+.-|-.+.|-|||+++.||.+.. ...++.||+..|+|..+|++ +...+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34455667999999999987643 46789999999999999964 3455777888899999999999999987
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC---CcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHH
Q 011385 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG---DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335 (487)
Q Consensus 259 ~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~el 335 (487)
.+|+|++|...-|++..+|-|||+- +.-...... ..........|-++|.|||.-.....+.++|||+||.+.+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 6799999999999999999888752 111110000 000011123567899999977667778899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 336 LTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 336 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..|..--........... ...... ..+-+ ..-+.++.+||+..|..||+|.+++.|.
T Consensus 276 ailEiq~tnseS~~~~ee-~ia~~i-------~~len------------~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEE-NIANVI-------IGLEN------------GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeehhh-hhhhhe-------eeccC------------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 887643211111000000 000000 00111 1224688999999999999999998765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-13 Score=124.85 Aligned_cols=131 Identities=19% Similarity=0.049 Sum_probs=97.0
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCce-eEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~l 213 (487)
++.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.+++ +++.+. .+..++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 457899999999998763 55799999765432 123467899999988766654 444433 334589
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
||||++|.++.... .....++.+++++|..||... +..++|+|++|.||+++ ++.++|+|||.+..
T Consensus 69 v~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 69 ITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99999998886430 111345678999999999876 22359999999999998 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.4e-14 Score=145.47 Aligned_cols=249 Identities=22% Similarity=0.157 Sum_probs=179.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH--HHHHHHHHhcC-CCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
...+|..+..||.|.|+.|+.+..+. .++..|++|.+...-.....+ -+.|+.+...+ .|.+++.++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~--------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRP--------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecC--------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 44678899999999999999987542 245689999886554433332 24566666666 58899999998
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl~D 283 (487)
|...++.||-.|||+++++...+ .-...+++..++.+..|++.++.++|+.. ++|+|+||+||++..+ +.-+++|
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 88888889999999999987766 22345777888999999999999999988 9999999999999876 7789999
Q ss_pred cCCCCCCCCCCcceeeeecccccccc--CCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYA--APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~--APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
||+.+.+.-. .....+.-+++ +++......+..++|+|+||+.+.|.++|...-..... |.
T Consensus 411 ~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~---- 473 (524)
T KOG0601|consen 411 FGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL---- 473 (524)
T ss_pred ccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce----
Confidence 9998753211 11123334444 55555577889999999999999999998753321100 10
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.+..-.-+. .+... ..+..+.+.++..|+..||.+.++..+.+.
T Consensus 474 ----~i~~~~~p~----~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 ----TIRSGDTPN----LPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----eeecccccC----CCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000111111 11122 567889999999999999999888765543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.7e-14 Score=152.17 Aligned_cols=249 Identities=22% Similarity=0.205 Sum_probs=172.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+.+.+.+.+-+|.|+.++.+.-. ++|...++|........ ..+....+-.++-...||.++...-.+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa---------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPA---------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccCCcc---------ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 45666778888999999876433 34545566655432211 1122333444444445677776666556
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.....+|||+|+.+++|...|.... ..+.+........+..+++|||... ++|||++|.|+|+..+++.+++|||+
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence 6778899999999999999886544 4555555566667889999999976 89999999999999999999999984
Q ss_pred CCCCCCC-----------------------------CcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh
Q 011385 287 AKDGPEG-----------------------------DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337 (487)
Q Consensus 287 a~~~~~~-----------------------------~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt 337 (487)
....... +.........||+.|.|||.+.+......+|+|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 3221100 00011223679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 011385 338 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406 (487)
Q Consensus 338 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 406 (487)
|.+||....+.....- . +...+. +..-+...+..+++++.+.|..+|.+|..+.
T Consensus 1031 g~pp~na~tpq~~f~n------i------~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFEN------I------LNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhhhhc------c------ccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999986655322110 0 000000 1112223456788999999999999998876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-12 Score=135.78 Aligned_cols=145 Identities=17% Similarity=0.125 Sum_probs=96.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--------------------------C---
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------G--- 179 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~--- 179 (487)
..+|+. +.||.|++|+||+|+++. +|+.||||+.+..-.. .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~ 188 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE 188 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence 345776 799999999999999864 4789999999643100 0
Q ss_pred -----HH------HHHHHHHHHhcCC----CCCceeEEEEEEe-CCeeEEEEeeCCCCChhHHH--hhcCC---CCCHHH
Q 011385 180 -----HK------EWLAEVNFLGDLV----HLNLVKLIGYCIE-DDQRLLVYEFMPRGSLENHL--FRRSL---PLPWSI 238 (487)
Q Consensus 180 -----~~------~~~~E~~~l~~l~----HpnIv~~~~~~~~-~~~~~lv~E~~~~gsL~~~l--~~~~~---~l~~~~ 238 (487)
.+ ++.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++- ...+. .+....
T Consensus 189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~ 268 (537)
T PRK04750 189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG 268 (537)
T ss_pred HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence 01 1344554444442 4444444444433 45668999999999998743 22221 122333
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----cEEEeecCCCCCCCCC
Q 011385 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----NAKLSDFGLAKDGPEG 293 (487)
Q Consensus 239 ~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~~kl~DFGla~~~~~~ 293 (487)
+..++.||. ..+ ++|+|+||.||+++.++ .++++|||++......
T Consensus 269 v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 269 VEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 334444443 345 99999999999999888 9999999999876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.1e-11 Score=128.29 Aligned_cols=164 Identities=16% Similarity=0.177 Sum_probs=123.4
Q ss_pred CCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHH
Q 011385 163 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 242 (487)
Q Consensus 163 ~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i 242 (487)
++..|.|+..+...........+-++.|+.|+||||++|+..+..++..|||+|-+. -|..++.+.. ...+..-
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHH
Confidence 567888888866554333456788999999999999999999999999999999984 4666664332 5556677
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCch
Q 011385 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR 322 (487)
Q Consensus 243 ~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~ 322 (487)
+.||+.||.|||..+ +++|++|.-..|+|+..|..||++|-++......... .....--..|..|+.+.... -.
T Consensus 110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cc
Confidence 889999999998654 3999999999999999999999999988654332210 00011122456666443222 45
Q ss_pred hhhhhHHHHHHHHHhC
Q 011385 323 SDVYSFGVVLLEMLTG 338 (487)
Q Consensus 323 ~DiwSlGvil~elltG 338 (487)
.|.|-|||+++|++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.1e-11 Score=111.56 Aligned_cols=145 Identities=14% Similarity=0.088 Sum_probs=100.4
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---------------------cC-HHH----HHHHHH
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------------------QG-HKE----WLAEVN 188 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---------------------~~-~~~----~~~E~~ 188 (487)
...||.|--+.||.|....... ....+..+|||+.+.... .. .+. ..+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 3579999999999997542100 011346899998752110 00 111 237999
Q ss_pred HHhcCCC--CCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 011385 189 FLGDLVH--LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL-HEEAERPVIYRD 265 (487)
Q Consensus 189 ~l~~l~H--pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~~~~iiHrD 265 (487)
.|.++.. -++...+++ ...+|||||+.++.+.....+. ..++......+..+++.+|.+| |..+ |||+|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999853 456667764 4568999999765443222121 2345556677889999999999 8877 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 266 FKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 266 LKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999996 5789999999887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-11 Score=108.97 Aligned_cols=131 Identities=23% Similarity=0.297 Sum_probs=100.1
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC-----CccC---HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-----GLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++++|+-+.+|.+.+. |..+++|.-... .++. ..+..+|+++|+++.--.|..-+-+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 46889999999998663 445666653221 1111 1346789999999876666655556677
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+...|+|||++|..|.+.|... ...++..|-..+.-||..+ |||+||.++||++..++ +.++||||+
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcc
Confidence 88889999999998898888544 2466777888888999988 99999999999997664 999999998
Q ss_pred CC
Q 011385 288 KD 289 (487)
Q Consensus 288 ~~ 289 (487)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 75
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-11 Score=108.00 Aligned_cols=142 Identities=23% Similarity=0.235 Sum_probs=108.3
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEec-----CCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-----HDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~-----~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.+.+|-+|+-+.|+++.+ .|+.++||.-- +..++ ..++..+|+++|.++.--.|.--.-++
T Consensus 11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 567899999999999987 46777777532 22221 134578899999999766776666667
Q ss_pred EeCCeeEEEEeeCCC-CChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---cEE
Q 011385 206 IEDDQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAK 280 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~~k 280 (487)
.+...-.|+|||++| -++.+++.... ..........++..|-+.+.-||..+ |||+||..+||+|..++ .+.
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence 777778899999976 37888886543 23333444788999999999999988 99999999999996654 358
Q ss_pred EeecCCCCC
Q 011385 281 LSDFGLAKD 289 (487)
Q Consensus 281 l~DFGla~~ 289 (487)
|+|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-11 Score=114.07 Aligned_cols=142 Identities=20% Similarity=0.228 Sum_probs=108.5
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCC--CCceeEEEEEEeC---C
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVH--LNLVKLIGYCIED---D 209 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~---~ 209 (487)
+.|+.|.++.||++...+ |..|++|....... .....+..|++++..+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 578999999999997632 45799999865432 133568899999999976 3457777776553 2
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------- 257 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-------------------------------- 257 (487)
..++||||++|.+|.+.+.. ..++......++.+++++|.+||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 56899999999988775522 34677777788888888888888531
Q ss_pred ---------------------CCCeEecCCCCCcEEEcC--CCcEEEeecCCCCC
Q 011385 258 ---------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKD 289 (487)
Q Consensus 258 ---------------------~~~iiHrDLKp~NIll~~--~~~~kl~DFGla~~ 289 (487)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999988 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.7e-10 Score=112.45 Aligned_cols=214 Identities=16% Similarity=0.217 Sum_probs=151.7
Q ss_pred eeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE----eCCeeEEEEeeCC
Q 011385 144 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMP 219 (487)
Q Consensus 144 g~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~----~~~~~~lv~E~~~ 219 (487)
.+.|+++... +|..|++|++.............-+++++++.|+|||++..+|. .+..+++|++|.+
T Consensus 290 ~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 290 ITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 5689998876 56689999996554444444567789999999999999999887 3456789999987
Q ss_pred C-CChhHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 220 R-GSLENHLFRR--------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 220 ~-gsL~~~l~~~--------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+ ++|.++.... +...++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|...
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecc
Confidence 6 4777765422 234678999999999999999999998 888999999999999999999988
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+......+.. |-+.. -.+-|.=.||.+++.|.||..--.... .......
T Consensus 438 ~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d-----~~~~s~~------ 487 (655)
T KOG3741|consen 438 GIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD-----STQSSHL------ 487 (655)
T ss_pred cceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccccccccc-----chHHHHH------
Confidence 87765433220 11211 235689999999999999964311000 0000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+....+.++++++.-+...++++ -++.+++.++
T Consensus 488 ------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 ------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0011123456778888888888876 5677776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.1e-09 Score=100.58 Aligned_cols=123 Identities=15% Similarity=0.088 Sum_probs=90.1
Q ss_pred CcEEEEEEecCCCcc-----------CHHHHHHHHHHHhcCCCCC--ceeEEEEEEe-----CCeeEEEEeeCCCC-Chh
Q 011385 164 GLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHLN--LVKLIGYCIE-----DDQRLLVYEFMPRG-SLE 224 (487)
Q Consensus 164 g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~-----~~~~~lv~E~~~~g-sL~ 224 (487)
|+.|.||........ ....+.+|.+.+..|..-+ ....+++... ...-+||||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 568999977443311 0113778999888884333 3444555433 23467999999876 798
Q ss_pred HHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-------CCcEEEeecCCCCC
Q 011385 225 NHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-------DYNAKLSDFGLAKD 289 (487)
Q Consensus 225 ~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-------~~~~kl~DFGla~~ 289 (487)
+++... ....+......++.+++..+.-||..+ |+|+||++.||||+. ++.+.|+||+.++.
T Consensus 125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 887532 234556677889999999999999998 999999999999975 46899999998864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.3e-08 Score=97.59 Aligned_cols=259 Identities=16% Similarity=0.163 Sum_probs=158.2
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEE------
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYC------ 205 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~------ 205 (487)
...+.||+|+-+.+|-.-.. + ..+.|+.......... .-+..|... .||-+-.-+.|=
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-----------~-d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-----------R-DQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecchh-----------h-chhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhC
Confidence 45678999999999954211 1 2345877655433222 223334433 566443312211
Q ss_pred Ee-CCeeEEEEeeCCCCC-hhHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 206 IE-DDQRLLVYEFMPRGS-LENHLF-----RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 206 ~~-~~~~~lv~E~~~~gs-L~~~l~-----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
-+ ....-++|..+.+.. +..++. +......|...++.++.++.+.+-||..+ .+-+|+.++|+|+++++.
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~ 155 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSK 155 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCce
Confidence 11 222567888887653 222221 12245789999999999999999999998 888999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcc-
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEH- 351 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~- 351 (487)
+.|.|=..-....++ ......+|...|.+||.-. +..-+...|.|.|||++++||.| +.||.+.......
T Consensus 156 V~LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 999975443332222 1233467999999999643 33456789999999999999997 9999764332211
Q ss_pred -----hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHhcCC
Q 011385 352 -----NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR--DPKARPLMSEVVEALKPL 415 (487)
Q Consensus 352 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~ell~~L~~l 415 (487)
++. ........... .....+.....+ ...+..+..|..+|+.. ++.-||+++..+..|..+
T Consensus 233 ~p~E~~Ia-~g~f~ya~~~~-~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 233 NPLETDIA-HGRFAYASDQR-RGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred Ccchhhhh-cceeeechhcc-CCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111 11111111100 011111111111 12345778888899854 367899999888777654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.3e-09 Score=94.94 Aligned_cols=98 Identities=21% Similarity=0.238 Sum_probs=64.3
Q ss_pred HHHHHHHHhcCCCC--CceeEEEEEEeCCeeEEEEeeCC--CCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCC
Q 011385 183 WLAEVNFLGDLVHL--NLVKLIGYCIEDDQRLLVYEFMP--RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF-LHEEA 257 (487)
Q Consensus 183 ~~~E~~~l~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~y-LH~~~ 257 (487)
..+|++.|.++..- ++.+.+++. ..+|||||++ |..|..+. ... +.......++.+++..+.. +|..+
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~~~g 127 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLHKAG 127 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHHhcC
Confidence 56899999999765 456666542 3479999998 55554433 221 1123345667777775555 57877
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 258 ~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
|||+||.+.|||++++ .+.|+|||.+....
T Consensus 128 ---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 ---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp ---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999877 99999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.2e-08 Score=89.87 Aligned_cols=106 Identities=24% Similarity=0.213 Sum_probs=82.8
Q ss_pred HHHHHHHHHHhcCCCC--CceeEEEEEEeCC----eeEEEEeeCCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011385 181 KEWLAEVNFLGDLVHL--NLVKLIGYCIEDD----QRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253 (487)
Q Consensus 181 ~~~~~E~~~l~~l~Hp--nIv~~~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yL 253 (487)
....+|...+..|..- .+...+++..... ..+||+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 4577888888877533 3455566655422 347999999884 79998865322 66677888999999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEcCCC---cEEEeecCCCCCC
Q 011385 254 HEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 290 (487)
Q Consensus 254 H~~~~~~iiHrDLKp~NIll~~~~---~~kl~DFGla~~~ 290 (487)
|..+ |+|+||++.|||++.++ .+.|+||+-++..
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9998 99999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2e-09 Score=112.33 Aligned_cols=150 Identities=22% Similarity=0.310 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCccee-------eeeccccccccCCceeccC
Q 011385 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-------STRVMGTYGYAAPEYVMTG 317 (487)
Q Consensus 245 qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-------~~~~~Gt~~y~APE~~~~~ 317 (487)
+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+........... ..-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4558999999854 499999999999999999999999998865443211100 0012245689999999988
Q ss_pred CCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 011385 318 HLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 396 (487)
Q Consensus 318 ~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 396 (487)
..+.++|+|||||++|.+.. |+.-+........... ....+..-...++...+.++++=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 88999999999999999994 5544433221111000 00011111122334556789999999999
Q ss_pred cCCCCCCCHHHHHH
Q 011385 397 RDPKARPLMSEVVE 410 (487)
Q Consensus 397 ~dP~~RPs~~ell~ 410 (487)
.++.-||++.+++.
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997776653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.7e-08 Score=103.99 Aligned_cols=143 Identities=15% Similarity=0.124 Sum_probs=94.3
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--------------------------CH----H----
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GH----K---- 181 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~~----~---- 181 (487)
+.|+.++-|.||+|+++ +|+.||||+.+..-.. .. .
T Consensus 131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 68999999999999997 4889999998632110 00 0
Q ss_pred ------HHHHHHHHHhcCC-----CCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 011385 182 ------EWLAEVNFLGDLV-----HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250 (487)
Q Consensus 182 ------~~~~E~~~l~~l~-----HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l 250 (487)
++.+|..-+.++. .++|.--.=|+.-.....|+|||++|-.+.+...-....++...+.....++.--.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q 280 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQ 280 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1345665555552 34432222233345667899999999999887533334455444333333322222
Q ss_pred HHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 251 ~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
-+- .+ ++|.|.+|.||+++.+|.+.+.|||+.....+.
T Consensus 281 ~~~--dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLR--DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHh--cC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 222 34 999999999999999999999999999876554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.8e-08 Score=89.92 Aligned_cols=136 Identities=18% Similarity=0.084 Sum_probs=93.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc----------------------CHHHHHHHHHH
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF 189 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~ 189 (487)
+.+...||.|--+.||.|... .|..+|||.=+..... ......+|+++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 456678999999999999875 3778999975422110 01235689999
Q ss_pred HhcCCCC--CceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011385 190 LGDLVHL--NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 267 (487)
Q Consensus 190 l~~l~Hp--nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 267 (487)
|..|.-. .+.+.+++ +...+||||++|-.|...-. .....-.++..|++-+.-+-..| |||+||.
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 9998644 56666654 34579999999877654321 12223333444444444444556 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~ 290 (487)
+-|||++++|.+.++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.71 E-value=3e-07 Score=86.90 Aligned_cols=138 Identities=17% Similarity=0.143 Sum_probs=85.1
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEEEEeCCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIEDDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~~~~~~l 213 (487)
..||+|..+.||+.. |..+++|...... ......+|.+++..+..-+ +.+.+++..+.+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 478999999999841 2357788876432 2355789999999886443 4677787777778889
Q ss_pred EEeeCCCCC-hhHHH--------------hh-----cC---CCCCHHHH-HHHHH----------HHHH-HHHHHHhC-C
Q 011385 214 VYEFMPRGS-LENHL--------------FR-----RS---LPLPWSIR-MKIAL----------GAAK-GLAFLHEE-A 257 (487)
Q Consensus 214 v~E~~~~gs-L~~~l--------------~~-----~~---~~l~~~~~-~~i~~----------qi~~-~l~yLH~~-~ 257 (487)
|||+++|.. +...+ .+ +. ........ ..+.. .+.. ...+|... .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998863 21111 00 00 01111110 00100 0111 12222211 1
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 258 ~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23478999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.3e-07 Score=83.02 Aligned_cols=138 Identities=17% Similarity=0.123 Sum_probs=100.3
Q ss_pred ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC---C---ccCHHHHHHHHHHHhcCCCC--CceeEEEEEEe--
Q 011385 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---G---LQGHKEWLAEVNFLGDLVHL--NLVKLIGYCIE-- 207 (487)
Q Consensus 138 LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~Hp--nIv~~~~~~~~-- 207 (487)
-|+||.+-|+...+. |..|=+|+-... . ......|.+|+..|..|..- .+.+.+.+...
T Consensus 26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~ 94 (216)
T PRK09902 26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKI 94 (216)
T ss_pred cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeecc
Confidence 477999999987653 346778876411 1 12456799999999998532 24444422211
Q ss_pred C--CeeEEEEeeCCC-CChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--EEE
Q 011385 208 D--DQRLLVYEFMPR-GSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKL 281 (487)
Q Consensus 208 ~--~~~~lv~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--~kl 281 (487)
. -.-+||+|-+++ -+|.+++.+.. .+.+......++.+|+..+.-||+.+ +.|+|+.+.|||++.++. +++
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEE
Confidence 1 234699997753 48988885432 34577778899999999999999988 999999999999986777 999
Q ss_pred eecCCCCC
Q 011385 282 SDFGLAKD 289 (487)
Q Consensus 282 ~DFGla~~ 289 (487)
+||--++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99987664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=2e-09 Score=111.02 Aligned_cols=186 Identities=17% Similarity=0.103 Sum_probs=135.7
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCe
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQ 210 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~ 210 (487)
+....-+++|+++.++|.+... +. ....+.+... ....-++++|.+++||| .+..++-+..++.
T Consensus 244 s~~fh~fvK~altknpKkRpta---------ek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTA---------EK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCCh---------hh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3344457899999999876432 11 2224544333 34556899999999999 7888888888899
Q ss_pred eEEEEeeCCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 211 RLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 211 ~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.+++|+++.++ +-..........+...+...+.+.-+++++|||+.. =+||| ||+..+ +..+..||+....
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 99999999887 222222111223444455567777788999999854 48999 887755 6899999999887
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 343 (487)
+.... ......+|+.|+|||+.....+....|+|++|+--.+|--|.+|-.
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 76543 2345789999999999999999999999999997777777776653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.58 E-value=7.6e-07 Score=82.29 Aligned_cols=139 Identities=12% Similarity=0.076 Sum_probs=92.5
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHH---------HHHHHHHHhcCC---
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGDLV--- 194 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~--- 194 (487)
....+|...+++-.....-|.+-.. .|..+++|..+.......+. ..+++..+..+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g 96 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG 96 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence 4567888888998888777877655 36689999886554322222 223444444432
Q ss_pred CCCceeEEEEEE-----eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 195 HLNLVKLIGYCI-----EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 195 HpnIv~~~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
-..++.++.+.. .....+|||||++|..|.+... +++ .++..|.+++.-||..| ++|+|+.|.
T Consensus 97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpg 164 (229)
T PF06176_consen 97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPG 164 (229)
T ss_pred ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcC
Confidence 222333233222 2344568999999988876531 222 24456778899999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~ 289 (487)
|++++.+ .++++||+..+.
T Consensus 165 NFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 165 NFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred cEEEECC-cEEEEECccccc
Confidence 9999855 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.9e-06 Score=82.39 Aligned_cols=139 Identities=22% Similarity=0.155 Sum_probs=83.8
Q ss_pred eecccCc-eeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEE
Q 011385 137 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 137 ~LG~G~f-g~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 214 (487)
.|-.|.. ..||+.... +..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|
T Consensus 5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 3455555 789988542 2468888876543 235678999888874 44466788877766678999
Q ss_pred EeeCCCCChhHHHh----------------h-cCC-----CCCHH--HHHHHHH--------------------HHHHHH
Q 011385 215 YEFMPRGSLENHLF----------------R-RSL-----PLPWS--IRMKIAL--------------------GAAKGL 250 (487)
Q Consensus 215 ~E~~~~gsL~~~l~----------------~-~~~-----~l~~~--~~~~i~~--------------------qi~~~l 250 (487)
||+++|.+|..... + +.. .+... ....... .+...+
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (244)
T cd05150 71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY 150 (244)
T ss_pred EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence 99999987764320 0 000 11100 0000000 011111
Q ss_pred HHHHh----CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 251 AFLHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 251 ~yLH~----~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..|-. .....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 22211 0123489999999999999887788999997754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.3e-06 Score=82.24 Aligned_cols=141 Identities=18% Similarity=0.157 Sum_probs=82.5
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEEEEe---CC
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIE---DD 209 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~---~~ 209 (487)
++.|+.|..+.||+..... ..+++|..... .....+.+|+.+++.|.... +.+++.+... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 3579999999999997642 37999997654 33456788999988885333 4566664432 33
Q ss_pred eeEEEEeeCCCCChhH----------------HHh---hc---CCCCCHHH---------HHHH------------HHHH
Q 011385 210 QRLLVYEFMPRGSLEN----------------HLF---RR---SLPLPWSI---------RMKI------------ALGA 246 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~----------------~l~---~~---~~~l~~~~---------~~~i------------~~qi 246 (487)
..+++|++++|..+.. .+. .. ...+.... .... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 4689999999988777 111 11 01111100 0000 1112
Q ss_pred HH-HHHHHHh----CCCCCeEecCCCCCcEEEc-CCCcEEEeecCCCC
Q 011385 247 AK-GLAFLHE----EAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAK 288 (487)
Q Consensus 247 ~~-~l~yLH~----~~~~~iiHrDLKp~NIll~-~~~~~kl~DFGla~ 288 (487)
.. .+..++. .....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 22 2333332 1234599999999999999 56667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.6e-06 Score=88.98 Aligned_cols=141 Identities=16% Similarity=0.099 Sum_probs=90.4
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC------------------------------------
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------------ 179 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------------------------------------ 179 (487)
+.||.-+.|.||+|+.+. |+.||||+-+..-...
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 579999999999999874 7899999865321000
Q ss_pred -HHHHHHHHHHHhcC----CCCC------ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHH
Q 011385 180 -HKEWLAEVNFLGDL----VHLN------LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248 (487)
Q Consensus 180 -~~~~~~E~~~l~~l----~Hpn------Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~ 248 (487)
.-+|.+|.+-..++ .|-+ |.++| +.......|+||||+|.-+.+.-.-....++...+..-+.++..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 00234455443333 3545 22322 22245678999999999877764322234555544444444333
Q ss_pred HHHHHHhCCCCCeEecCCCCCcEEEcC----CCcEEEeecCCCCCCCCC
Q 011385 249 GLAFLHEEAERPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 249 ~l~yLH~~~~~~iiHrDLKp~NIll~~----~~~~kl~DFGla~~~~~~ 293 (487)
-+-+.| | ++|.|-+|.||+++. ++.+.+-|||+.......
T Consensus 315 ~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 EQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 233333 3 999999999999983 678999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-06 Score=78.42 Aligned_cols=152 Identities=19% Similarity=0.166 Sum_probs=98.3
Q ss_pred cChhHHHHHhcCCCCCCe---ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------------------
Q 011385 120 FTFNDLKLATRNFRPESL---LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------ 178 (487)
Q Consensus 120 ~~~~~~~~~~~~y~~~~~---LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------ 178 (487)
.+...+....++..+..+ |+.|--+.||+|... .+..||||+.+.....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~ 104 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSR 104 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCC
Confidence 344444445555555554 556777789998653 4678999998643211
Q ss_pred -CHH-----HHHHHHHHHhcCC--CCCceeEEEEEEeCCeeEEEEeeCCCCCh-hHHHhhcCCCCCHHHHHHHHHHHHHH
Q 011385 179 -GHK-----EWLAEVNFLGDLV--HLNLVKLIGYCIEDDQRLLVYEFMPRGSL-ENHLFRRSLPLPWSIRMKIALGAAKG 249 (487)
Q Consensus 179 -~~~-----~~~~E~~~l~~l~--HpnIv~~~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~l~~~~~~~i~~qi~~~ 249 (487)
..+ ...+|+.-|.++. +-.+.+-+.+. ...|||||+....+ .-.| ....+.......+..++++.
T Consensus 105 ~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 105 SNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEY 178 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHH
Confidence 111 1346888888874 44555666554 24799999954311 1111 11123333566777788888
Q ss_pred HHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 250 LAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 250 l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
+.-|-. .+ +||+||..-|||+. ++.+.|+|||-|....
T Consensus 179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 887766 44 99999999999998 8899999999887643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.6e-06 Score=74.58 Aligned_cols=130 Identities=18% Similarity=0.146 Sum_probs=89.8
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCce-eEEEEEEeCCe
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQ 210 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~ 210 (487)
.+..+.|++|.+|.||+|.+. |..+|+|+-+.+... ..+..|+++|..+.-.++- ++|.|..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 345678999999999999885 457999988766543 6788999999999876664 4444432
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCcEEEcCCCcEEEeecCCCCC
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK-TSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK-p~NIll~~~~~~kl~DFGla~~ 289 (487)
.++.|||+.|-.|.++-... +...+. .+++.---|-..+ |-|..|. |..++|..++.+.|+||.-|+.
T Consensus 87 ~~i~me~i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 24669999998887765321 222333 3444433444445 8888876 4444454556999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.4e-06 Score=78.40 Aligned_cols=74 Identities=15% Similarity=0.112 Sum_probs=47.0
Q ss_pred CCeecccCcee-EEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC---CceeEEEEEEeC--
Q 011385 135 ESLLGEGGFGC-VFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCIED-- 208 (487)
Q Consensus 135 ~~~LG~G~fg~-V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~~~~~~~~~-- 208 (487)
++.|+.|+... ||+.. ..+++|...... ....+.+|+++|..|... -+..+++.....
T Consensus 2 ~~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~ 65 (235)
T cd05155 2 IEPVDSGGTDNATFRLG--------------DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG 65 (235)
T ss_pred ceeccCCCcccceEEcC--------------CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC
Confidence 35688777764 98751 247788755422 235688999999887532 344445443332
Q ss_pred -CeeEEEEeeCCCCChh
Q 011385 209 -DQRLLVYEFMPRGSLE 224 (487)
Q Consensus 209 -~~~~lv~E~~~~gsL~ 224 (487)
...++||++++|.++.
T Consensus 66 ~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 66 YPWPWSVYRWLEGETAT 82 (235)
T ss_pred CCcceEEEEeecCCCCC
Confidence 2348899999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1e-05 Score=74.00 Aligned_cols=125 Identities=29% Similarity=0.399 Sum_probs=89.4
Q ss_pred cCCCCCCeecccCc-eeEEEEEEccCCCCCccCCCCcEEEEEEecC---CCc-------c-----------CHHHHHHHH
Q 011385 130 RNFRPESLLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNH---DGL-------Q-----------GHKEWLAEV 187 (487)
Q Consensus 130 ~~y~~~~~LG~G~f-g~V~~~~~~~~~~~~~~~~~g~~vavK~~~~---~~~-------~-----------~~~~~~~E~ 187 (487)
.+++.++.||.|.- |.||++.. .|..||+|++.. ... . ....|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 78999999999999 99999988 467999999421 100 0 012377888
Q ss_pred HHHhcCC---CCCc--eeEEEEEEeC------------------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHH
Q 011385 188 NFLGDLV---HLNL--VKLIGYCIED------------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244 (487)
Q Consensus 188 ~~l~~l~---HpnI--v~~~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~ 244 (487)
+...+|+ +.++ |+++||..-. ....||.||++... .+. ..-+.
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~ 171 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIP 171 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHH
Confidence 8877774 4456 8999987322 12247888876543 122 22345
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 245 qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 172 ~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 6777888999988 999999999986 3489999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.24 E-value=2e-05 Score=72.55 Aligned_cols=128 Identities=18% Similarity=0.248 Sum_probs=89.3
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC----------------ccCHHHHHHHHHHHhcCC----
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGDLV---- 194 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 194 (487)
..+||+|+.-.||.- ..+ ....||++.... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P~d----------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDD----------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC--CCC----------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 457999999999963 222 246789887655 122355667777666665
Q ss_pred --CCCceeEEEEEEeCCeeEEEEeeCCC--C----ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011385 195 --HLNLVKLIGYCIEDDQRLLVYEFMPR--G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 266 (487)
Q Consensus 195 --HpnIv~~~~~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 266 (487)
+..|.+++|+..++....+|+|.+.+ | +|.+++.+. .++. .....+. +-..||-+.+ |+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQALD---EFKRYLLDHH---IVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHHHHH---HHHHHHHHcC---CeecCC
Confidence 78899999999999999999998643 2 577777333 3554 3333333 3455676666 999999
Q ss_pred CCCcEEEcCC--C--cEEEee
Q 011385 267 KTSNILLDAD--Y--NAKLSD 283 (487)
Q Consensus 267 Kp~NIll~~~--~--~~kl~D 283 (487)
+|.||++... + .+.|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999533 2 578887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.4e-05 Score=87.98 Aligned_cols=149 Identities=16% Similarity=0.189 Sum_probs=91.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCC-CCCc--eeEEEEEEeC--
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNL--VKLIGYCIED-- 208 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~~~~~~~~~-- 208 (487)
++.|+.|.++.+|+......+ ....+++|+..... ......+.+|+++|+.|. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 467899999999998664311 11357788765432 223356889999999995 6664 7788877664
Q ss_pred -CeeEEEEeeCCCCChhH--------------------HH---hhcC----------CCCC--HHHHHHHHH--------
Q 011385 209 -DQRLLVYEFMPRGSLEN--------------------HL---FRRS----------LPLP--WSIRMKIAL-------- 244 (487)
Q Consensus 209 -~~~~lv~E~~~~gsL~~--------------------~l---~~~~----------~~l~--~~~~~~i~~-------- 244 (487)
+..|+||||++|..+.+ .| +.-. .+.. ...+..|..
T Consensus 116 ~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~ 195 (822)
T PLN02876 116 IGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGE 195 (822)
T ss_pred CCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcc
Confidence 46789999998864321 01 0000 0000 011211111
Q ss_pred -------HHHHHHHHHHhCCC--------CCeEecCCCCCcEEEcCC-Cc-EEEeecCCCCCC
Q 011385 245 -------GAAKGLAFLHEEAE--------RPVIYRDFKTSNILLDAD-YN-AKLSDFGLAKDG 290 (487)
Q Consensus 245 -------qi~~~l~yLH~~~~--------~~iiHrDLKp~NIll~~~-~~-~kl~DFGla~~~ 290 (487)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus 196 ~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 196 GKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred cCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12234566644332 239999999999999753 33 579999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.8e-06 Score=74.84 Aligned_cols=101 Identities=29% Similarity=0.258 Sum_probs=80.7
Q ss_pred HHHHHHhcCCC-CCceeEEEEEEeCCeeEEEEeeCCCCChhHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011385 185 AEVNFLGDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 261 (487)
Q Consensus 185 ~E~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~i 261 (487)
.|.-+|..+.+ +++.+++|+|- .++|.||+..+++..... ..-...+|..+.+|+.++++.+.+|+......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57888888876 68999999983 378999998776642100 111246899999999999999999998654558
Q ss_pred EecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 262 IYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 262 iHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.-.|++++|+-++++|++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.2e-05 Score=73.38 Aligned_cols=77 Identities=12% Similarity=0.075 Sum_probs=55.2
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC---CCceeEEEEEEeC--
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIED-- 208 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~~~~~~~~~-- 208 (487)
-.+.||.|..+.||+....+ + .+.+|..+... ....+..|...|+.|.- ..+.++++++.+.
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ----------G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEcCC----------C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34579999999999975432 2 46677754311 22568899999998853 3577888877543
Q ss_pred -CeeEEEEeeCCCCCh
Q 011385 209 -DQRLLVYEFMPRGSL 223 (487)
Q Consensus 209 -~~~~lv~E~~~~gsL 223 (487)
+..+||||+++++++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 568999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.1e-05 Score=71.46 Aligned_cols=75 Identities=21% Similarity=0.153 Sum_probs=47.4
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~lv 214 (487)
+.|..|-...||++..... .+..|++|+....... .-+..+|+.++..+...++ .++++.+. -.+|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l 70 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI 70 (235)
T ss_pred EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence 5678888899999864310 1347889977543221 1233578888888854444 44444332 2489
Q ss_pred EeeCCCCCh
Q 011385 215 YEFMPRGSL 223 (487)
Q Consensus 215 ~E~~~~gsL 223 (487)
|||++|.+|
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999998766
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.5e-05 Score=88.10 Aligned_cols=196 Identities=20% Similarity=0.228 Sum_probs=137.0
Q ss_pred HHHHHHHHhcCCCCCceeEEEEEEeCCeeE----EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011385 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAE 258 (487)
Q Consensus 183 ~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~ 258 (487)
...|+..+.++.|+|++.++.|.......- +..|+|..-++...+. .-...+....+.+..++..||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 456777888889999999999876543322 4457888888888774 3456888899999999999999999975
Q ss_pred CCeEecCCCCC---cEEEcCCCcEEEe--ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCch--hhhhhHHHH
Q 011385 259 RPVIYRDFKTS---NILLDADYNAKLS--DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR--SDVYSFGVV 331 (487)
Q Consensus 259 ~~iiHrDLKp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~--~DiwSlGvi 331 (487)
..|.-|... +.-.+.++.+.++ ||+.+....+..... ...-+..|.|+|......+..+ .|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 555544444 3344566677777 999888766543321 2334566888887776666554 699999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 332 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 332 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+..+..|..+-..... ...+++ . .......+...+|+..|+++|+++.+++.+
T Consensus 382 ~~~~~~~~~i~~~~~~-------------------~~~~l~-----~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV-------------------PVSLLD-----V---LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccc-------------------hhhhhc-----c---ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999987654321100 000110 0 111146788999999999999999999986
Q ss_pred h
Q 011385 412 L 412 (487)
Q Consensus 412 L 412 (487)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 5
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.8e-05 Score=73.36 Aligned_cols=137 Identities=17% Similarity=0.116 Sum_probs=77.7
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEEE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLVY 215 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~lv~ 215 (487)
.+..|-.+.+|+... .+..+++|........-.-+..+|..+++.+...++ .+++... . .++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 356688889998763 345788887654322110135678889988865444 3344432 2 36899
Q ss_pred eeCCCCChhHH----------H----h---hc---CCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCC
Q 011385 216 EFMPRGSLENH----------L----F---RR---SLPLPWS-IRMKIALGA---------AKGLAFLHEE-----AERP 260 (487)
Q Consensus 216 E~~~~gsL~~~----------l----~---~~---~~~l~~~-~~~~i~~qi---------~~~l~yLH~~-----~~~~ 260 (487)
||++|..+... + . .. ..+++.. .+..+..++ ...+..+-.. .+..
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99998765421 1 0 00 1111211 111211111 1112222111 1224
Q ss_pred eEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 261 VIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 261 iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
++|+|+.|.|||+++++ +.|+||..+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999877 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.8e-05 Score=74.34 Aligned_cols=141 Identities=18% Similarity=0.122 Sum_probs=84.4
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEE------EE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------CI 206 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~------~~ 206 (487)
.+.|..|....+|+.... +..+++|+... .....+..|++++..|.+.+ +.+++.. ..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 456788888899987542 23688998764 22355677888888875332 4444432 22
Q ss_pred eCCeeEEEEeeCCCCChhH----HH----------hhc--C--C------CCCHHHHH----------HHHHHHHHHHHH
Q 011385 207 EDDQRLLVYEFMPRGSLEN----HL----------FRR--S--L------PLPWSIRM----------KIALGAAKGLAF 252 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~----~l----------~~~--~--~------~l~~~~~~----------~i~~qi~~~l~y 252 (487)
..+..++||+|++|..+.. .+ ... . . ...|.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456689999999876532 00 000 0 0 01111110 011112334445
Q ss_pred HHh----CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 253 LHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 253 LH~----~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
+.. ..+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 443 1234599999999999999887778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00028 Score=69.72 Aligned_cols=146 Identities=23% Similarity=0.259 Sum_probs=84.0
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~lv 214 (487)
+.|..|-...||+....... .....+..|++|+..... ....+..+|++++..+...++ .++++++. -.+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCch
Confidence 45666777899988753210 012235689999976543 222346788888888854333 35555543 2468
Q ss_pred EeeCCCCChhHH--------------H---hhcCCC--------CC--HHHHHH--------------------------
Q 011385 215 YEFMPRGSLENH--------------L---FRRSLP--------LP--WSIRMK-------------------------- 241 (487)
Q Consensus 215 ~E~~~~gsL~~~--------------l---~~~~~~--------l~--~~~~~~-------------------------- 241 (487)
|||++|..+... + +..... .+ +.....
T Consensus 76 ~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (302)
T cd05156 76 EEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSL 155 (302)
T ss_pred hheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHH
Confidence 999988776431 0 000000 01 101111
Q ss_pred HHHHHHHHHHHHHh------CCCCCeEecCCCCCcEEEcCC----CcEEEeecCCCCC
Q 011385 242 IALGAAKGLAFLHE------EAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 289 (487)
Q Consensus 242 i~~qi~~~l~yLH~------~~~~~iiHrDLKp~NIll~~~----~~~kl~DFGla~~ 289 (487)
+...+...+.+|-. ..+..++|+||.+.|||++.+ +.+.|+||..+..
T Consensus 156 ~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 156 FLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11122223334432 123458999999999999875 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00097 Score=68.04 Aligned_cols=77 Identities=19% Similarity=0.155 Sum_probs=52.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecC------CC-ccCHHHHHHHHHHHhcCC---CCCceeEEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGDLV---HLNLVKLIGY 204 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~---HpnIv~~~~~ 204 (487)
.+.||.|.+..||++.... .++.|+||.-.. .. .....++..|.+.|..+. -.++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 3579999999999998743 124799998531 11 123456777888888763 2456677766
Q ss_pred EEeCCeeEEEEeeCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGS 222 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gs 222 (487)
+.+..++||||+++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 4466789999998643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=3.4e-06 Score=94.97 Aligned_cols=158 Identities=15% Similarity=0.016 Sum_probs=116.7
Q ss_pred HHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEEEeeCCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011385 183 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEA 257 (487)
Q Consensus 183 ~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~ 257 (487)
...|..-++...|++++..+.-... ....+.+++||.+|.+.+.|.+.. ..+....+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445556666789998877665433 346689999999999999986542 23444444444444355666666543
Q ss_pred C--CCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHH
Q 011385 258 E--RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEM 335 (487)
Q Consensus 258 ~--~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~el 335 (487)
. .-.+|++||+-|.+|..+..+|++++|+.+...+. ........+++.|++|++...-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2 23699999999999999999999999999943221 1223446789999999988888999999999999999999
Q ss_pred HhCCCCC
Q 011385 336 LTGRRSM 342 (487)
Q Consensus 336 ltG~~pf 342 (487)
-.|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 9888776
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0015 Score=65.05 Aligned_cols=141 Identities=17% Similarity=0.130 Sum_probs=76.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEE------EEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIG------YCI 206 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~------~~~ 206 (487)
.+.|+.|....+|+..... | .+++|+.... ....+..|+.++..|...+ +.+.+. +..
T Consensus 27 ~~~l~~G~~n~~y~v~t~~----------g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~ 92 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ----------G-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE 92 (319)
T ss_pred cchhccccccceEEEEeCC----------C-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee
Confidence 3457778878999876431 2 5889987521 2244455666666553222 333332 122
Q ss_pred eCCeeEEEEeeCCCCChhH-----H------Hh---hcCC----------CCCH-HHHHH------------HHHH-HHH
Q 011385 207 EDDQRLLVYEFMPRGSLEN-----H------LF---RRSL----------PLPW-SIRMK------------IALG-AAK 248 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~-----~------l~---~~~~----------~l~~-~~~~~------------i~~q-i~~ 248 (487)
..+..+++|||++|..+.. + |. .... .+.+ ..... .+.+ +..
T Consensus 93 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (319)
T PRK05231 93 LAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAA 172 (319)
T ss_pred eCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHH
Confidence 3456789999999875421 1 10 0000 0111 11110 1111 111
Q ss_pred HHHHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 249 GLAFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 249 ~l~yLH~~----~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.+..+... -+.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 173 ~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 173 QLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 22233211 234699999999999998665568999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00054 Score=67.93 Aligned_cols=143 Identities=18% Similarity=0.172 Sum_probs=82.8
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEE------E
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------C 205 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~------~ 205 (487)
.++.++.|....||+.... .| .+++|+..... ...++..|++++..|...+ +.+++.. .
T Consensus 26 ~i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred eccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 3567788877899987542 22 57889875432 1245567777777774322 3444432 1
Q ss_pred EeCCeeEEEEeeCCCCChhH-----------HH---hhcCCCC-----------CHHHHH------------HHHHHHHH
Q 011385 206 IEDDQRLLVYEFMPRGSLEN-----------HL---FRRSLPL-----------PWSIRM------------KIALGAAK 248 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~-----------~l---~~~~~~l-----------~~~~~~------------~i~~qi~~ 248 (487)
...+..++||||++|..+.. .+ ......+ .|.... .....+..
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~ 172 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK 172 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence 22456789999998865421 01 1100000 011000 01112334
Q ss_pred HHHHHHh----CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 249 GLAFLHE----EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 249 ~l~yLH~----~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.++++.. ..+..+||+|+.+.||+++.++.+.|+||+.+..
T Consensus 173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 4555543 1235699999999999999887778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.002 Score=64.94 Aligned_cols=144 Identities=17% Similarity=0.105 Sum_probs=82.6
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCce-eEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~lv 214 (487)
+.|-.|-...+|++...... ...+..|++|+........ -+..+|+.++..+..-++. ++++++... .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~-----~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKE-----GNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCC-----CCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 45656888899998753311 1134679999886543221 2236788888888654443 555655322 58
Q ss_pred EeeCCCCChhHH-------H----------hhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 011385 215 YEFMPRGSLENH-------L----------FRRS---L--PLPWSIRMKIALGA-----------------AKGLAFL-- 253 (487)
Q Consensus 215 ~E~~~~gsL~~~-------l----------~~~~---~--~l~~~~~~~i~~qi-----------------~~~l~yL-- 253 (487)
+||+++.+|... + +... . ...+..+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987776421 0 0000 0 11122332332221 1111122
Q ss_pred --Hh-CCCCCeEecCCCCCcEEEcC-CCcEEEeecCCCCC
Q 011385 254 --HE-EAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 289 (487)
Q Consensus 254 --H~-~~~~~iiHrDLKp~NIll~~-~~~~kl~DFGla~~ 289 (487)
.. ..+..++|+||++.|||+++ ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 11235899999999999986 47899999988764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0034 Score=61.99 Aligned_cols=127 Identities=17% Similarity=0.244 Sum_probs=73.3
Q ss_pred CcEEEEEEec--CCCccCHHHHHHHHHHHhcCCC--CCceeEEEEEEeCC--eeEEEEeeCCCCChhHHHhhcCC-----
Q 011385 164 GLTVAVKTLN--HDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDD--QRLLVYEFMPRGSLENHLFRRSL----- 232 (487)
Q Consensus 164 g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~----- 232 (487)
++.+++. .. ........+..+|+++|+.+.- .-+...+++|.++. ..|.||+|++|..+.+.+.....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~ 126 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA 126 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence 5577777 33 1223334566788888888743 22445566666665 66999999988433221110000
Q ss_pred -------------------C-------CCHHHHHHHHH--------------HHHHHHHHHHhCC-----CCCeEecCCC
Q 011385 233 -------------------P-------LPWSIRMKIAL--------------GAAKGLAFLHEEA-----ERPVIYRDFK 267 (487)
Q Consensus 233 -------------------~-------l~~~~~~~i~~--------------qi~~~l~yLH~~~-----~~~iiHrDLK 267 (487)
. .....+..+.. ....-..+|+... ...++|+|+.
T Consensus 127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~ 206 (321)
T COG3173 127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR 206 (321)
T ss_pred HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence 0 00000001111 1112233444332 2359999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~ 291 (487)
+.||+|+.++-+=|.||+++....
T Consensus 207 ~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 207 PGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCEEEeCCCeeEEEeccccccCC
Confidence 999999988889999999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0004 Score=67.49 Aligned_cols=135 Identities=16% Similarity=0.063 Sum_probs=90.1
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--------------------cC--HHHHHHHHH
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------------------QG--HKEWLAEVN 188 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------------------~~--~~~~~~E~~ 188 (487)
-+.+...||-|--+.||.+-+. .|..+++|.-+.... .. .-...+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 3677889999999999998765 366788886431110 00 112457888
Q ss_pred HHhcCC-CC-CceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011385 189 FLGDLV-HL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 266 (487)
Q Consensus 189 ~l~~l~-Hp-nIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 266 (487)
.|..|. |- -+.+.+++ +..++|||++.|-.|.+.-. ...... +...+..-+.-|-.+| +||+|.
T Consensus 163 fmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHHcC---ceeccc
Confidence 998884 32 24444443 44589999998877755321 112222 2333344455566666 999999
Q ss_pred CCCcEEEcCCCcEEEeecCCCCC
Q 011385 267 KTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 267 Kp~NIll~~~~~~kl~DFGla~~ 289 (487)
.-=||+|++++.++++||--...
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred chheeEEecCCCEEEeechHhhc
Confidence 99999999999999999976544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0021 Score=63.63 Aligned_cols=140 Identities=17% Similarity=0.112 Sum_probs=90.4
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--------------------c--CHH----HHHHHH
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------------------Q--GHK----EWLAEV 187 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------------------~--~~~----~~~~E~ 187 (487)
+-..|..|--+.||.|... .|..+|||+++..-+ . ..+ ....|+
T Consensus 148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4457888999999998764 477899999852110 0 001 135688
Q ss_pred HHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011385 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 267 (487)
Q Consensus 188 ~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 267 (487)
+-|.+|+...|..---... ....|||+|+.. +=+-.=.-+...++...+..+-.|++.-|.-|-... .+||.||.
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLS 292 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLS 292 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchh
Confidence 8888887655432111111 123699999953 211111112234666667777778877777776544 39999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~ 289 (487)
--|+|+ .+|.+.|+|-+-+..
T Consensus 293 EfN~Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 293 EFNLLY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred hhhheE-ECCEEEEEEcccccc
Confidence 999999 577999999887764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0069 Score=59.06 Aligned_cols=30 Identities=30% Similarity=0.401 Sum_probs=25.6
Q ss_pred CeEecCCCCCcEEEcCCCc-EEEeecCCCCC
Q 011385 260 PVIYRDFKTSNILLDADYN-AKLSDFGLAKD 289 (487)
Q Consensus 260 ~iiHrDLKp~NIll~~~~~-~kl~DFGla~~ 289 (487)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987565 46999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.025 Score=55.90 Aligned_cols=30 Identities=27% Similarity=0.344 Sum_probs=25.9
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 259 ~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 45999999999999987 6789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.012 Score=57.53 Aligned_cols=73 Identities=22% Similarity=0.283 Sum_probs=46.2
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCceeEEEEEEeCCee
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~ 211 (487)
.+.|+.|....+|+... .+..+.||+-.... ...|..|..-|+.|. --.+.+.+++....+..
T Consensus 22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~~---~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSESG---RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGGG---CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred eEecCCCChhheEEEEC-----------CCccEEEEecChhh---HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence 45689899999998762 45689999876221 245778888888773 34577889888877778
Q ss_pred EEEEeeCCCC
Q 011385 212 LLVYEFMPRG 221 (487)
Q Consensus 212 ~lv~E~~~~g 221 (487)
||||||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 9999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.013 Score=58.65 Aligned_cols=143 Identities=17% Similarity=0.167 Sum_probs=79.7
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCce-eEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~lv 214 (487)
+.|..|-...+|+....... ..+..|++|+...... ..-+-.+|+.++..+..-++- ++++++. . .+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMI 88 (330)
T ss_pred EEeCCcccceEEEEEecCCC------CCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-C---cEe
Confidence 34555777889988654211 1233788998755432 112235788888888655553 5565552 2 158
Q ss_pred EeeCCCCChhH-------HH-------hh-cCCC------C-CHHHHHHHHHHH----------------------HHHH
Q 011385 215 YEFMPRGSLEN-------HL-------FR-RSLP------L-PWSIRMKIALGA----------------------AKGL 250 (487)
Q Consensus 215 ~E~~~~gsL~~-------~l-------~~-~~~~------l-~~~~~~~i~~qi----------------------~~~l 250 (487)
.+|+++..|.. .+ .+ +... . .+..+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 99998766532 01 00 0111 1 122222222221 1111
Q ss_pred HHH---H-hC-CCCCeEecCCCCCcEEEcC-CCcEEEeecCCCCC
Q 011385 251 AFL---H-EE-AERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD 289 (487)
Q Consensus 251 ~yL---H-~~-~~~~iiHrDLKp~NIll~~-~~~~kl~DFGla~~ 289 (487)
..+ . .. .+.-++|.||.+.|||+++ ++.++++||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 1 11 1223799999999999975 47899999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.025 Score=57.70 Aligned_cols=73 Identities=10% Similarity=0.021 Sum_probs=48.2
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-------cCHHHHHHHHHHHhcCC---CCCceeEEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLV---HLNLVKLIGY 204 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---HpnIv~~~~~ 204 (487)
.+.||.|....||+.... +..|+||.-..... -...+...|+..|..+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 457899999999997652 23588998641111 12334455666666553 3467788887
Q ss_pred EEeCCeeEEEEeeCCC
Q 011385 205 CIEDDQRLLVYEFMPR 220 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~ 220 (487)
+. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 76 456789999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0036 Score=58.39 Aligned_cols=30 Identities=33% Similarity=0.403 Sum_probs=21.1
Q ss_pred CeEecCCCCCcEEE-cCCCcEEEeecCCCCC
Q 011385 260 PVIYRDFKTSNILL-DADYNAKLSDFGLAKD 289 (487)
Q Consensus 260 ~iiHrDLKp~NIll-~~~~~~kl~DFGla~~ 289 (487)
-++|+||.+.|||+ +.++.++|+||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0017 Score=66.69 Aligned_cols=164 Identities=23% Similarity=0.316 Sum_probs=91.5
Q ss_pred HHHHHHHHHHhcCCCCCceeEEEEEEeC-CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 011385 181 KEWLAEVNFLGDLVHLNLVKLIGYCIED-DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER 259 (487)
Q Consensus 181 ~~~~~E~~~l~~l~HpnIv~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~ 259 (487)
.+++...++++.+.|+|...++++.... ....+|||++ +.+|++++..+. +-... + + -|.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s-------~---~--~~~---- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDES-------L---L--AHG---- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhh-------h---c--ccc----
Confidence 5677889999999999999999987654 3467899999 669999885543 11111 1 0 111
Q ss_pred CeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCC
Q 011385 260 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339 (487)
Q Consensus 260 ~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 339 (487)
+.|- | .++++| -++... |- ...+|+|||++|.++.|+.-|.
T Consensus 88 -~~~~-----~-------~~~~td-~~~t~~--------------------~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 88 -VLHL-----N-------IIYITD-HFLTKY--------------------PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred -ccee-----h-------hhhccc-cccccC--------------------CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 3332 1 233344 111110 10 1114999999999999999987
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011385 340 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408 (487)
Q Consensus 340 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 408 (487)
..+....... .................. .....+...++....++..+|+-..|..||...++
T Consensus 129 ~l~~~~~~s~---~l~~i~k~~~~d~~~~~~---a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 129 SLEAELTESE---YLEILLKYYTDDQELLST---AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHH---HHHHHHHhccCchhHHHH---HHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 6654221110 000000000000000000 00112233456678899999999999988865544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.03 Score=55.47 Aligned_cols=31 Identities=16% Similarity=0.170 Sum_probs=28.2
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 259 ~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..+||+|+.+.|||++.++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4599999999999999999999999998865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.037 Score=55.57 Aligned_cols=74 Identities=15% Similarity=0.113 Sum_probs=46.2
Q ss_pred eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEec----C--CC-ccCHHHHHHHHHHHhcCC--CCC-ceeEEEEEE
Q 011385 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN----H--DG-LQGHKEWLAEVNFLGDLV--HLN-LVKLIGYCI 206 (487)
Q Consensus 137 ~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~----~--~~-~~~~~~~~~E~~~l~~l~--Hpn-Iv~~~~~~~ 206 (487)
.||.|....||++.... .+..|+||.-. . .. .....+...|...|.... -|. +.++|. .
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence 47999999999998532 22478999752 1 11 222345567777776653 343 444544 3
Q ss_pred eCCeeEEEEeeCCCC
Q 011385 207 EDDQRLLVYEFMPRG 221 (487)
Q Consensus 207 ~~~~~~lv~E~~~~g 221 (487)
+.+...+|||+++..
T Consensus 71 D~e~~~~vMEdL~~~ 85 (370)
T TIGR01767 71 DTEMAVTVMEDLSHH 85 (370)
T ss_pred ccccceehHhhCccc
Confidence 455667999998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.011 Score=58.49 Aligned_cols=76 Identities=18% Similarity=0.159 Sum_probs=57.4
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
..+.|++|++- |+.|.. + ....++++..|+.+.+..+.-+... .++=||||.-.||||+ +|+|-|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 34566788876 555532 1 2345788889999888766666553 4589999999999999 999999999999
Q ss_pred CCCCC
Q 011385 288 KDGPE 292 (487)
Q Consensus 288 ~~~~~ 292 (487)
+....
T Consensus 369 Rl~~~ 373 (488)
T COG5072 369 RLSYS 373 (488)
T ss_pred ecccC
Confidence 96443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.023 Score=52.63 Aligned_cols=102 Identities=16% Similarity=0.097 Sum_probs=67.7
Q ss_pred EEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHH
Q 011385 167 VAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245 (487)
Q Consensus 167 vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~q 245 (487)
..+|++..-... ...-+..+.+++++++ .|+++..- +.-.+.+++|+|..... .. .-.|..+
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~---~N~i~ag 150 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NF---SNFITAG 150 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------ch---hHHHHHh
Confidence 456666543333 3345678899998875 58887732 33345599999954211 00 1112222
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 246 i~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+.+|.-.|+.. ...+|+|-.|+|||-|..|.+||.|=+..
T Consensus 151 -i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 -IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 45688889654 45999999999999999999999997643
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.01 Score=59.60 Aligned_cols=60 Identities=18% Similarity=0.150 Sum_probs=38.3
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 275 (487)
.|+=+|..|-++..++.... .+++...+++.--+.|+.-+---. +++|.||.|.||++.-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 46667888888888885433 444455555554444443332222 2999999999999943
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.054 Score=55.07 Aligned_cols=75 Identities=20% Similarity=0.225 Sum_probs=48.5
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecC-----CC-ccCHHHHHHHHHHHhcCC--CCC-ceeEEEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH-----DG-LQGHKEWLAEVNFLGDLV--HLN-LVKLIGYC 205 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--Hpn-Iv~~~~~~ 205 (487)
.+.||.|.-.-||++.+.. .+..|+||.-.. .. .-...+...|.++|+.+. -|. +.++|.
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-- 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence 4578999999999998632 134688987421 11 123456677888887663 343 445554
Q ss_pred EeCCeeEEEEeeCCC
Q 011385 206 IEDDQRLLVYEFMPR 220 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~ 220 (487)
.+.+...+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 345566789999854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.13 Score=48.09 Aligned_cols=57 Identities=26% Similarity=0.347 Sum_probs=41.2
Q ss_pred cEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCceeEEEEEEeCCeeEEEEeeCCCCChh
Q 011385 165 LTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLE 224 (487)
Q Consensus 165 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~ 224 (487)
..|-||+=... ....|..|+.-|..|. .-++.+++.+....++.||||||++-|.+.
T Consensus 40 ~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 40 DPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 46778864332 2345777777766664 455778888888999999999999987665
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.1 Score=53.25 Aligned_cols=82 Identities=13% Similarity=0.053 Sum_probs=46.2
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCce-eEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~l 213 (487)
++.|..|-...+|++........ .-..+.|.+....... ...-+-.+|++++..|...++- ++++.+. .++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~---~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKD---RYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCC---ccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEE
Confidence 34565688899999875432100 0001124444432211 1111235789999999766654 4555553 269
Q ss_pred EEeeCCCCChh
Q 011385 214 VYEFMPRGSLE 224 (487)
Q Consensus 214 v~E~~~~gsL~ 224 (487)
|.||++|..|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999988764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.26 Score=56.91 Aligned_cols=32 Identities=44% Similarity=0.473 Sum_probs=26.7
Q ss_pred CCCeEecCCCCCcEEEcCCC--cEE-EeecCCCCC
Q 011385 258 ERPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD 289 (487)
Q Consensus 258 ~~~iiHrDLKp~NIll~~~~--~~k-l~DFGla~~ 289 (487)
+..+||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 34599999999999998875 555 999998765
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.62 Score=46.54 Aligned_cols=71 Identities=17% Similarity=0.104 Sum_probs=42.1
Q ss_pred cCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC--CceeEE---E--EEEeCCeeEE
Q 011385 141 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL--NLVKLI---G--YCIEDDQRLL 213 (487)
Q Consensus 141 G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~~~---~--~~~~~~~~~l 213 (487)
+.-..||+.... .|..+++|+.+... ....++..|++.+..|... .++... | +...++..+.
T Consensus 36 s~eN~vy~v~~~----------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~ 104 (325)
T PRK11768 36 SYENRVYQFGDE----------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA 104 (325)
T ss_pred cccceEEEEecC----------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence 345678987653 35578999875332 2345667788887766321 122211 1 1223456788
Q ss_pred EEeeCCCCC
Q 011385 214 VYEFMPRGS 222 (487)
Q Consensus 214 v~E~~~~gs 222 (487)
|+++++|..
T Consensus 105 l~~~~~G~~ 113 (325)
T PRK11768 105 LFPRRGGRA 113 (325)
T ss_pred EEeeeCCCC
Confidence 999998764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.26 Score=51.39 Aligned_cols=84 Identities=12% Similarity=0.073 Sum_probs=50.2
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCce-eEEEEEEeCCeeE
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLV-KLIGYCIEDDQRL 212 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~~~~~~~~~~~~~ 212 (487)
-++.|..|-.-.+|++....... ...+..+..|.+++.......- -+-..|..++..+...+|- ++++.+. -+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GG 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CC
Confidence 34567778888899987643210 0011235678898875543221 2345688888777655554 4555542 35
Q ss_pred EEEeeCCCCCh
Q 011385 213 LVYEFMPRGSL 223 (487)
Q Consensus 213 lv~E~~~~gsL 223 (487)
.|.||++|..|
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 68999988744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 487 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-40 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 110/321 (34%), Positives = 172/321 (53%), Gaps = 31/321 (9%)
Query: 108 EEELKVAS-RLRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVK 160
+ L+V+ R F+F +LK T NF + +GEGGFG V+KG++
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------ 55
Query: 161 PGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYE 216
TVAVK L + + +++ E+ + H NLV+L+G+ + D LVY
Sbjct: 56 -----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 217 FMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274
+MP GSL + L + PL W +R KIA GAA G+ FLHE I+RD K++NILLD
Sbjct: 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167
Query: 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLE 334
+ AK+SDFGLA+ + +T +++R++GT Y APE + G +T +SD+YSFGVVLLE
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLE 226
Query: 335 MLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHC 394
++TG ++D++R L++ E + ID ++ + +A+ C
Sbjct: 227 IITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQC 283
Query: 395 LSRDPKARPLMSEVVEALKPL 415
L RP + +V + L+ +
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1339), Expect = 0.0
Identities = 116/332 (34%), Positives = 181/332 (54%), Gaps = 17/332 (5%)
Query: 94 TTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEE 153
+ + +NS L V + DL+ AT NF + L+G G FG V+KG + +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 154 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 213
G VA+K + QG +E+ E+ L H +LV LIG+C E ++ +L
Sbjct: 63 ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112
Query: 214 VYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270
+Y++M G+L+ HL+ ++ + W R++I +GAA+GL +LH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGV 330
ILLD ++ K++DFG++K G E D+TH+ST V GT GY PEY + G LT +SDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 331 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 390
VL E+L R ++ ++ P NL EWA + +++DP L + +K
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 391 AAHCLSRDPKARPLMSEVVEALKPLPNLKDMA 422
A CL+ + RP M +V+ L+ L++
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-161
Identities = 119/304 (39%), Positives = 187/304 (61%), Gaps = 18/304 (5%)
Query: 116 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 175
+L++F+ +L++A+ NF +++LG GGFG V+KG + +GT VAVK L +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65
Query: 176 GLQGHK-EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---S 231
QG + ++ EV + VH NL++L G+C+ +RLLVY +M GS+ + L R
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 232 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291
PL W R +IALG+A+GLA+LH+ + +I+RD K +NILLD ++ A + DFGLAK
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351
D THV+T V GT G+ APEY+ TG + ++DV+ +GV+LLE++TG+R+ D R +
Sbjct: 186 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 352 --NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 409
L++W + L + ++ L+D L+G++ + ++ Q+A C P RP MSEVV
Sbjct: 245 DVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 410 EALK 413
L+
Sbjct: 304 RMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 1e-86
Identities = 77/348 (22%), Positives = 129/348 (37%), Gaps = 50/348 (14%)
Query: 97 NAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 156
+ +S ++ +L + + + G FGCV+K +
Sbjct: 2 GHHHHHHSSGVD-----------LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---- 46
Query: 157 APVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLGDLVHLNLVKLIGYCIEDD----Q 210
VAVK +Q + W E V L + H N+++ IG
Sbjct: 47 -------NEYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96
Query: 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAER-------PVIY 263
L+ F +GSL + L + W+ IA A+GLA+LHE+ + +
Sbjct: 97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 264 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS-- 321
RD K+ N+LL + A ++DFGLA G + +GT Y APE +
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214
Query: 322 ---RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--WARPHLGERRRF--YRLIDPR 374
R D+Y+ G+VL E+ + + D E P L + + ++ P
Sbjct: 215 AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPV 274
Query: 375 LEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 421
L ++ G + C D +AR V E + + L ++
Sbjct: 275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-65
Identities = 69/332 (20%), Positives = 121/332 (36%), Gaps = 54/332 (16%)
Query: 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQ 178
++ L N + L+G G +G V+KG E VAVK +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47
Query: 179 GHKEWLAEVN--FLGDLVHLNLVKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS 231
+ ++ E N + + H N+ + I + LLV E+ P GSL +L +
Sbjct: 48 NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT 107
Query: 232 LPLPWSIRMKIALGAAKGLAFLHEEAER------PVIYRDFKTSNILLDADYNAKLSDFG 285
W ++A +GLA+LH E R + +RD + N+L+ D +SDFG
Sbjct: 108 SD--WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 286 LAK------DGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVL 332
L+ G++ + + +GT Y APE + + D+Y+ G++
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 333 LEMLTGRRSMDKNRPNGEHNL----VEWARPHLGERRRF-----YRLIDPRLEGHFSIKG 383
E+ + E+ + P + + R P S+
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-A 284
Query: 384 AQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
+ + C +D +AR E + L
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-62
Identities = 77/301 (25%), Positives = 124/301 (41%), Gaps = 53/301 (17%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
+ ++++ +G G FG V K W VA+K + + +
Sbjct: 7 YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45
Query: 181 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN--HLFRRSLPLPWSI 238
K ++ E+ L + H N+VKL G C+ LV E+ GSL N H +
Sbjct: 46 KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFGLAKDGPEGDKTH 297
M L ++G+A+LH + +I+RD K N+LL A K+ DFG A D
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQT 158
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
T G+ + APE + + + DV+S+G++L E++T R +P E +
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR 212
Query: 358 RP---HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414
H G R + + + L C S+DP RP M E+V+ +
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPI------------ESLMTRCWSKDPSQRPSMEEIVKIMTH 260
Query: 415 L 415
L
Sbjct: 261 L 261
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-62
Identities = 82/313 (26%), Positives = 138/313 (44%), Gaps = 62/313 (19%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 180
N+++ E +G+GGFG V KG + ++ + VA+K+L +G
Sbjct: 18 DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61
Query: 181 ------KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 234
+E+ EV + +L H N+VKL G +V EF+P G L + L ++ P+
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPI 119
Query: 235 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKLSDFGLAKD 289
WS+++++ L A G+ ++ + P+++RD ++ NI L A AK++DFGL++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ- 177
Query: 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTG---HLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
H + ++G + + APE + T ++D YSF ++L +LTG
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGE------G 226
Query: 347 P----NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
P + G R PRL + C S DPK R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL------------RNVIELCWSGDPKKR 274
Query: 403 PLMSEVVEALKPL 415
P S +V+ L L
Sbjct: 275 PHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-61
Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 47/301 (15%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
+ DL + + +G G FG V + W +G+ VAVK L
Sbjct: 36 WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76
Query: 181 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS--LPLPW 236
E+L EV + L H N+V +G + +V E++ RGSL L + L
Sbjct: 77 RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
R+ +A AKG+ +LH P+++R+ K+ N+L+D Y K+ DFGL++ +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE- 355
S GT + APE + +SDVYSFGV+L E+ T + +P G N +
Sbjct: 196 --SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQV 247
Query: 356 -WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414
A +R R ++P++ A + C + +P RP + +++ L+P
Sbjct: 248 VAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRP 295
Query: 415 L 415
L
Sbjct: 296 L 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-60
Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 56/309 (18%)
Query: 130 RNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 183
R FRP L LG+G FG K TG + +K L + + +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L EV + L H N++K IG +D + + E++ G+L + PWS R+ A
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------------DGP 291
A G+A+LH +I+RD + N L+ + N ++DFGLA+
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351
+ V+G + APE + + DV+SFG+VL E++ + P+
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLP 227
Query: 352 NLVEWARPHLGERRRFYRL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
+++ R F P + C DP+ RP
Sbjct: 228 RTMDFGLNV----RGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFV 271
Query: 407 EVVEALKPL 415
++ L+ L
Sbjct: 272 KLEHWLETL 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-59
Identities = 85/309 (27%), Positives = 131/309 (42%), Gaps = 58/309 (18%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
F +L L +G GGFG V++ W G VAVK HD +
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46
Query: 181 ----KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW 236
+ E L H N++ L G C+++ LV EF G L L + +P
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP 104
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--------ADYNAKLSDFGLAK 288
I + A+ A+G+ +LH+EA P+I+RD K+SNIL+ ++ K++DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP- 347
E +T + G Y + APE + + SDV+S+GV+L E+LTG P
Sbjct: 165 ---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPF 214
Query: 348 NGEHNL-VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
G L V + A+L C + DP +RP +
Sbjct: 215 RGIDGLAVAYGVAMNKLALPIPSTCPEPF------------AKLMEDCWNPDPHSRPSFT 262
Query: 407 EVVEALKPL 415
+++ L +
Sbjct: 263 NILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-57
Identities = 67/312 (21%), Positives = 115/312 (36%), Gaps = 70/312 (22%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
F L T+ L E G ++KG W G + VK L
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49
Query: 181 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFR-RSLPLP 235
+++ E L H N++ ++G C + +MP GSL N L + +
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 236 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 295
S +K AL A+G+AFLH E + + ++++D D A++S +
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161
Query: 296 THVSTRVMGTYGYAAPEYVMTG----HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351
+ S M + APE + +D++SF V+L E++T P +
Sbjct: 162 SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADL 214
Query: 352 NLVEWA--------RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
+ +E RP + I P + ++L C++ DP RP
Sbjct: 215 SNMEIGMKVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRP 256
Query: 404 LMSEVVEALKPL 415
+V L+ +
Sbjct: 257 KFDMIVPILEKM 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-57
Identities = 62/351 (17%), Positives = 123/351 (35%), Gaps = 69/351 (19%)
Query: 99 ESNSSTSKLEEELKVASRLRKFT------FNDLKLATRNFRPESLLGEGGFGCVFKG-WI 151
E N S + AS+ F F L++ +G+G FG V+ G W
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW- 54
Query: 152 EENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209
+G VA++ ++ + K + EV H N+V +G C+
Sbjct: 55 --HGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102
Query: 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269
++ +L + + + L + +IA KG+ +LH + ++++D K+
Sbjct: 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159
Query: 270 NILLDADYNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTG--------- 317
N+ D + ++DFGL G + G + APE +
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 318 HLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPR 374
+ SDV++ G + E+ ++ + W + +
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQ------MGTGMKPNLSQ 265
Query: 375 LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSS 425
+ I + C + + + RP +++++ L+ LP K S
Sbjct: 266 IGMGKEIS------DILLFCWAFEQEERPTFTKLMDMLEKLP--KRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-57
Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 42/301 (13%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
+ + R +G G FG V+KG W +G VAVK LN
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62
Query: 181 --KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSI 238
+ + EV L H+N++ +GY Q +V ++ SL +HL
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+ IA A+G+ +LH + +I+RD K++NI L D K+ DFGLA + +H
Sbjct: 122 LIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 299 STRVMGTYGYAAPE---YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355
++ G+ + APE + + +SDVY+FG+VL E++TG+ P N +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRD 232
Query: 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
+G ++ + ++ +L A CL + RP ++ ++ L
Sbjct: 233 QIIEMVGRGSL--SPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
Query: 416 P 416
Sbjct: 287 A 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-56
Identities = 71/311 (22%), Positives = 114/311 (36%), Gaps = 53/311 (17%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 191
+G+G +G V++G W G VAVK + + K W E +
Sbjct: 13 LECVGKGRYGEVWRGSW---QGE---------NVAVKIFSS---RDEKSWFRETELYNTV 57
Query: 192 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
L H N++ I + Q L+ + GSL ++L + L ++I L A
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIA 115
Query: 248 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 300
GLA LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 301 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRP------ 347
+GT Y APE V+ + R D+++FG+VL E+ S
Sbjct: 176 PRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 348 --NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 404
E R + ++ R I R A+L C ++P AR
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQ--RPNIPNRWFSD---PTLTSLAKLMKECWYQNPSARLT 289
Query: 405 MSEVVEALKPL 415
+ + L +
Sbjct: 290 ALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-56
Identities = 68/313 (21%), Positives = 119/313 (38%), Gaps = 45/313 (14%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 191
+G+G +G V+ G W E VAVK W E+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86
Query: 192 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
+ H N++ I I+ Q L+ ++ GSL ++L +S L +K+A +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 248 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 300
GL LH E + +RD K+ NIL+ + ++D GLA +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 301 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE--H 351
+GT Y PE V+ L +D+YSFG++L E+ R + +
Sbjct: 205 TRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPY 262
Query: 352 NLVEWARPHLGERRRF--YRLIDPRLEGHFSIKGAQKA-AQLAAHCLSRDPKARPLMSEV 408
+ + + P + R + + P +S + +L C + +P +R V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 409 VEALKPLPNLKDM 421
+ L + +D+
Sbjct: 323 KKTLAKMSESQDI 335
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 6e-55
Identities = 73/317 (23%), Positives = 123/317 (38%), Gaps = 53/317 (16%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 191
+ +G+G FG V++G W E VAVK + + + W E +
Sbjct: 47 QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91
Query: 192 DLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
L H N++ I +D+ Q LV ++ GSL ++L + +K+AL A
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTA 149
Query: 248 KGLAFLHEEAER-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVST 300
GLA LH E + +RD K+ NIL+ + ++D GLA D
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 301 RVMGTYGYAAPEYVMTGHL-------TSRSDVYSFGVVLLEMLTGRRSMDKNRP------ 347
+GT Y APE V+ + R+D+Y+ G+V E+ +
Sbjct: 210 HRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 348 --NGEHNLVEWARPHLGERRRFYRL-IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 404
VE R + E++ R I R + +++ A++ C + AR
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCEALR---VMAKIMRECWYANGAARLT 323
Query: 405 MSEVVEALKPLPNLKDM 421
+ + L L + +
Sbjct: 324 ALRIKKTLSQLSQQEGI 340
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
+G G FG VF G + + T VAVK+ ++L E L H
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
N+V+LIG C + +V E + G L L +++ AA G+ +L
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE-- 230
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT 316
+ I+RD N L+ K+SDFG++++ +G + APE +
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 317 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPRL 375
G +S SDV+SFG++L E + S N N + VE + RL P
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRL--PCP 337
Query: 376 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
E +L C + +P RP S + + L+ +
Sbjct: 338 ELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 88/302 (29%), Positives = 122/302 (40%), Gaps = 44/302 (14%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 188
R + LGEG FG V + P GTG VAVK L D G Q W E++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L L H +++K G C + LV E++P GSL ++L R S+ L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF--AQQI 143
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 300
+G+A+LH + I+RD N+LLD D K+ DFGLAK PEG + +
Sbjct: 144 CEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 301 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 358
APE + SDV+SFGV L E+LT S E + +
Sbjct: 201 VFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254
Query: 359 PHLGERRRF----YRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411
+ RL P E + L +C + RP ++
Sbjct: 255 MTVLRLTELLERGERLPRPDKCPAEVY----------HLMKNCWETEASFRPTFENLIPI 304
Query: 412 LK 413
LK
Sbjct: 305 LK 306
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 82/306 (26%), Positives = 122/306 (39%), Gaps = 47/306 (15%)
Query: 130 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
R+ + S LG+G FG V + P+ TG VAVK L H G +++ E+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L L +VK G ++ LV E++P G L + L R L S + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 300
KG+ +L R ++RD NIL++++ + K++DFGLAK P +V
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 301 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWAR 358
APE + + +SDV+SFGVVL E+ T +S + E
Sbjct: 194 IFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247
Query: 359 PHLGERRRF----YRLIDPRLEG-----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 409
P L RL P H +L C + P+ RP S +
Sbjct: 248 PALSRLLELLEEGQRL--PAPPACPAEVH----------ELMKLCWAPSPQDRPSFSALG 295
Query: 410 EALKPL 415
L L
Sbjct: 296 PQLDML 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 130 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 300
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ +
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 301 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-----V 354
APE + + SDV+SFGVVL E+ T +
Sbjct: 181 IFWY------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 355 EWARPHLGER-RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ HL E + RL P E + + C + + RP ++
Sbjct: 235 QMIVFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFRDLAL 284
Query: 411 ALKPL 415
+ +
Sbjct: 285 RVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 25/218 (11%)
Query: 130 RNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
R+ + LG+G FG V + P++ TG VAVK L H + +++ E+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L L H N+VK G C +R L+ E++P GSL ++L + + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 300
KG+ +L + I+RD T NIL++ + K+ DFGL K P+ + +
Sbjct: 155 CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 301 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
APE + + SDV+SFGVVL E+ T
Sbjct: 212 IFWY------APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 79/304 (25%), Positives = 119/304 (39%), Gaps = 42/304 (13%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 188
R + LGEG FG V + P TG VAVK+L + G + E+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L +L H N+VK G C ED L+ EF+P GSL+ +L + + ++K A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST------ 300
KG+ +L R ++RD N+L+++++ K+ DFGL K + +
Sbjct: 136 CKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 301 -RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV---E 355
APE +M SDV+SFGV L E+LT + +
Sbjct: 193 VFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ 246
Query: 356 WARPHLGER-RRFYRLIDPR---LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411
L + RL P E + QL C P R ++E
Sbjct: 247 MTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQNLIEG 296
Query: 412 LKPL 415
+ L
Sbjct: 297 FEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-40
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 115 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLN 173
+ LR + K LG G FG V+KG WI E + VA+K L
Sbjct: 7 ALLRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELR 53
Query: 174 HD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 232
+ +KE L E + + + ++ +L+G C+ L+ + MP G L +++
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
+ + + AKG+ +L +R +++RD N+L+ + K++DFGLAK
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+K + + + A E ++ T +SDV+S+GV + E++T G +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVH 195
LGEG FG V +G + GT L VAVKT+ D + +E+L+E + D H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 196 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IALG 245
N+++L+G CIE + +++ FM G L +L + R P I ++ +
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRV- 302
A G+ +L + R ++RD N +L D ++DFGL+K GD + ++
Sbjct: 156 IALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 303 ---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ A E + TS+SDV++FGV + E+ T
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
LG+G FG V++G G +P T VA+KT+N ++ E+L E + + +
Sbjct: 33 LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAA 247
++V+L+G + L++ E M RG L+++L P S +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----- 302
G+A+L ++RD N ++ D+ K+ DFG+ +D E D +
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 303 -MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
M +PE + G T+ SDV+SFGVVL E+ T
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 129 TRNFRPESL-----LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 181
R F+ L LG G FG V KG WI E + + V +K + G Q +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60
Query: 182 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
+ +G L H ++V+L+G C LV +++P GSL +H+ + L + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
+ AKG+ +L E +++R+ N+LL + +++DFG+A P DK + +
Sbjct: 120 WGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+ A E + G T +SDV+S+GV + E++T G
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-38
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
+G G FGCV+ G T G + AVK+LN + ++L E + D H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 197 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
N++ L+G C+ + L+V +M G L N + + + L AKG+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYGYA 309
A + ++RD N +LD + K++DFGLA+D + + V +
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM---- 199
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT 337
A E + T T++SDV+SFGV+L E++T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVH 195
LG G FG V+KG WI E + VA+K L + +KE L E + + +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
++ +L+G C+ L+ + MP G L +++ + + + AKG+ +L
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
+R +++RD N+L+ + K++DFGLAK +K + + + A E ++
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 316 TGHLTSRSDVYSFGVVLLEMLT-GRR 340
T +SDV+S+GV + E++T G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 34/292 (11%)
Query: 54 ISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKV 113
+ R + + S S + + +A + ++ +
Sbjct: 26 LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85
Query: 114 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 173
S L + ++G G FGCV+ G T G + AVK+LN
Sbjct: 86 PSSLI------VHF-------NEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLN 126
Query: 174 HD-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRS 231
+ ++L E + D H N++ L+G C+ + L+V +M G L N + +
Sbjct: 127 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 186
Query: 232 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291
+ L AKG+ FL A + ++RD N +LD + K++DFGLA+D
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 292 EGDKTHVSTRVMG------TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ + V + A E + T T++SDV+SFGV+L E++T
Sbjct: 244 DKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LGEG FG VF E + P + VAVK L +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------MKIA 243
+V+ G C E L+V+E+M G L L + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV- 302
A G+ +L A ++RD T N L+ K+ DFG+++D D V R
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 303 -----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
M PE ++ T+ SDV+SFGVVL E+ T
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG+G F +FKG V +K L+ + + + + L H
Sbjct: 16 LGQGTFTKIFKGVR---REVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 254
+LV G C+ D+ +LV EF+ GSL+ +L + + + W + + A A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129
Query: 255 EEAERPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
E +I+ + NILL + + KLSD G++ D +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184
Query: 307 GYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLT-GRR 340
PE + +L +D +SFG L E+ + G +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVH 195
LG+G FG V + + G+ + VAVK L D + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 196 LNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHL-FRRSLPLPWSIRMK----IAL 244
++ KL+G + + +++ FM G L L R P+++ ++ +
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHVSTRV 302
A G+ +L + R I+RD N +L D ++DFGL++ GD + ++++
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 303 ----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ A E + T SDV++FGV + E++T
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 67/221 (30%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LGEG FG VF E +P K VAVK L L K++ E L +L H +
Sbjct: 23 LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------MKI 242
+VK G C + D ++V+E+M G L L + + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
A A G+ +L A + ++RD T N L+ A+ K+ DFG+++D D V
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 303 ------MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
M PE +M T+ SDV+SFGV+L E+ T
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
+G+G FG V+ G + + A+K+L+ +Q + +L E + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 197 NLVKLIGYCIEDD-QRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFL 253
N++ LIG + + ++ +M G L + +R+ + I L A+G+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG------TYG 307
AE+ ++RD N +LD + K++DFGLA+D + + V T
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
A E + T T++SDV+SFGV+L E+LT
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 75/347 (21%), Positives = 107/347 (30%), Gaps = 51/347 (14%)
Query: 70 HYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSK-LEEELKVASRLRKFTFNDLKLA 128
H+ S D + + S+ L+ SR F
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS---- 58
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAE 186
F+ S LG G +G VFK G AVK G + LAE
Sbjct: 59 ---FQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAE 106
Query: 187 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
V + H V+L E L E SL+ H LP +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
LA LH + +++ D K +NI L KL DFGL + V G
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGD 219
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
Y APE + + + +DV+S G+ +LE+ PH GE
Sbjct: 220 PRYMAPELLQGSY-GTAADVFSLGLTILEVACNME-----------------LPHGGEGW 261
Query: 366 R--FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ + P S + + L DPK R ++
Sbjct: 262 QQLRQGYLPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLA 304
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-37
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 192
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG----- 307
L E+ ++RD N+LL + AK+SDFGL+K D + +
Sbjct: 126 L---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPL 177
Query: 308 -YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+ APE + +SRSDV+S+GV + E L+ G++
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDL 193
E ++G G G V G + G V VA+K L + + ++L+E + +G
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H N+++L G ++V E+M GSL+ L + + G G+ +L
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMGTYGYAAPE 312
++ ++RD N+L+D++ K+SDFGL++ + D + +T + APE
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+ +S SDV+SFGVV+ E+L G R
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 41/305 (13%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G +G V++G W LTVAVKTL D ++ +E+L E + ++ H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 255
NLV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
++ I+R+ N L+ ++ K++DFGL++ GD + APE +
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 316 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR 374
+ +SDV++FGV+L E+ T S + + L+E + YR+ P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERPE 442
Query: 375 LEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTMQA 433
G + +L C +P RP +E+ +A + + SS +
Sbjct: 443 --------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----ESSISDEVEKEL 490
Query: 434 ERIGS 438
+ G+
Sbjct: 491 GKRGT 495
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 193
LG+G FG V +G W +G ++VAVK L D L + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLA 251
H NL++L G + +V E P GSL + L + L R A+ A+G+
Sbjct: 79 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGY 308
+L + I+RD N+LL K+ DFGL + P+ D +V + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
APE + T + SD + FGV L EM T G+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V G W G V AVK + +G E+ E + L H
Sbjct: 16 LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 254
LVK G C ++ +V E++ G L N+L + L + M +G+AFL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAP 311
I+RD N L+D D K+SDFG+ + + +GT ++AP
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAP 174
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
E +S+SDV++FG+++ E+ + G+
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 25/213 (11%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVH 195
+G G FG V+KG +G V VA+KTL + ++L E +G H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE 255
N+++L G + +++ E+M G+L+ L + + + G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTYGY 308
A ++RD NIL++++ K+SDFGL+ +D PE T ++
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
APE + TS SDV+SFG+V+ E++T G R
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+G G FG V G W V A+KT+ +G ++++ E + L H
Sbjct: 16 IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 254
LV+L G C+E LV EFM G L ++L R + M L +G+A+L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYA 309
E VI+RD N L+ + K+SDFG+ + + + T+
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------ 172
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+PE +S+SDV+SFGV++ E+ + G+
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 72/333 (21%), Positives = 123/333 (36%), Gaps = 74/333 (22%)
Query: 115 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 174
+L++ + + ++ LGE FG V+KG G AP + VA+KTL
Sbjct: 1 GKLKEISLSAVRF-------MEELGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKD 49
Query: 175 D-GLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP 233
+E+ E L H N+V L+G +D +++ + G L L RS
Sbjct: 50 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 234 LPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278
+ + A G+ +L + V+++D T N+L+ N
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLN 166
Query: 279 AKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 332
K+SD GL ++ D K ++ + M APE +M G + SD++S+GVVL
Sbjct: 167 VKISDLGLFREVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVL 220
Query: 333 LEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR---LEGHFSIKGA 384
E+ + G + N + ++ L P +
Sbjct: 221 WEVFSYGLQPYCGY----SNQDVVEMIR----------NRQVLPCPDDCPAWVY------ 260
Query: 385 QKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417
L C + P RP ++ L+ N
Sbjct: 261 ----ALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-36
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 123 NDLKLATRNFRPESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGL--QG 179
L L + LG G FG V KG + + V AVK L ++
Sbjct: 16 KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61
Query: 180 HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSI 238
E LAE N + L + +V++IG C E + +LV E G L +L R + I
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+ + G+ +L E ++RD N+LL + AK+SDFGL+K + +
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 299 STRVMGTYG------YAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+ + APE + +S+SDV+SFGV++ E + G++
Sbjct: 176 AQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 195
LGEG FG V E G KP +TVAVK L D + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------M 240
N++ L+G C +D ++ E+ +G+L +L R P +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 298
A+G+ +L A + I+RD N+L+ + K++DFGLA+D D K
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 299 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ R+ M APE + T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
LGEG FG V++G G + VAVKT D +K ++++E + +L H
Sbjct: 20 LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 254
++VKLIG E+ ++ E P G L ++L + SL + + +L K +A+L
Sbjct: 74 HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 309
++RD NIL+ + KL DFGL++ + D S + M
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+PE + T+ SDV+ F V + E+L+ G++
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 187
R + + +G G F V+KG E T + VA L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 188 NFLGDLVHLNLVKLIGYCI---EDDQRLLVY-EFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L L H N+V+ + + +++ E M G+L+ +L +R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWC 135
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAKDGPEGDKTHVSTRV 302
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 136 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
+GT + APE + DVY+FG+ +LEM T E+ E
Sbjct: 191 IGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMAT-----------SEYPYSECQNAAQI 238
Query: 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
RR + + + ++ C+ ++ R
Sbjct: 239 YRRVTSGVKPASFDKVAI----PEVKEIIEGCIRQNKDERY 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-35
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V G W G V A+K + +G E++ E + +L H
Sbjct: 32 LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 254
LV+L G C + ++ E+M G L N+L R + M + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYAAP 311
+ ++RD N L++ K+SDFGL++ + + T +G+ ++ P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPP 190
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
E +M +S+SD+++FGV++ E+ + G+
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDL 193
+ ++G G FG V G ++ + VA+KTL + +++L E + +G
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
H N+++L G + ++V E+M GSL++ L + + + G A G+ +L
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRV----MGTY 306
++ ++RD NIL++++ K+SDFGL +D PE T ++
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT--- 217
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+PE + TS SDV+S+G+VL E+++ G R
Sbjct: 218 ---SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 77/310 (24%), Positives = 127/310 (40%), Gaps = 49/310 (15%)
Query: 66 GTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL 125
G+S H+ + T +AES+SS + +++ +RL +
Sbjct: 2 GSSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPM 61
Query: 126 KLATRN----------FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 170
F + L LGEG FG V E G KP +TVAVK
Sbjct: 62 LAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVK 119
Query: 171 TLNHD-GLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF 228
L D + + ++E+ + + H N++ L+G C +D ++ E+ +G+L +L
Sbjct: 120 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 179
Query: 229 RRSLPLPWSIR---------------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273
R P + A+G+ +L A + I+RD N+L+
Sbjct: 180 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLV 236
Query: 274 DADYNAKLSDFGLAKDGPEGD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYS 327
+ K++DFGLA+D D K + R+ M APE + T +SDV+S
Sbjct: 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWS 290
Query: 328 FGVVLLEMLT 337
FGV++ E+ T
Sbjct: 291 FGVLMWEIFT 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDL 193
+ ++GEG FG V K I+ K G + A+K + H+++ E+ L L
Sbjct: 30 QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 194 V-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------------- 239
H N++ L+G C L E+ P G+L + L R+S L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSS 141
Query: 240 ---MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
+ A A+G+ +L +++ I+RD NIL+ +Y AK++DFGL++ K
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 297 HVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
R+ M A E + T+ SDV+S+GV+L E+++
Sbjct: 199 T-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 71/316 (22%), Positives = 112/316 (35%), Gaps = 50/316 (15%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKE 182
+ + +++ LGEGGF V V+ G A+K + Q +E
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREE 72
Query: 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQR----LLVYEFMPRGSLENHLFRRSL---PLP 235
E + H N+++L+ YC+ + L+ F RG+L N + R L
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 236 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 295
+ + LG +GL +H + +RD K +NILL + L D G +
Sbjct: 133 EDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
Query: 296 THVSTRVM-------GTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
+ T Y APE + R+DV+S G VL M+ G D
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-- 403
G+ L + + P S QL ++ DP RP
Sbjct: 250 FQKGDSVA-------LAVQNQLSIPQSP----RHS----SALWQLLNSMMTVDPHQRPHI 294
Query: 404 --LMSEVVEALKPLPN 417
L+S++ P P
Sbjct: 295 PLLLSQLEALQPPAPG 310
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 69/313 (22%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
+F ++LG+G FG V K A+K + H + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRL-------------LVYEFMPRGSLENHLFRRSLPLP 235
L L H +V+ +E + + E+ G+L + + +L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 236 ----WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 288
W + +I L+++H + +I+RD K NI +D N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 289 ----------DGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEML 336
G ++++ + GT Y A E V+ TGH + D+YS G++ EM+
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 337 TGRRSMDKNRPNGEHNLVE-WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCL 395
+ V + P + + + ++ +
Sbjct: 226 YP--------FSTGMERVNILKKLRSVSIE-----FPPDFDDNKM----KVEKKIIRLLI 268
Query: 396 SRDPKARPLMSEV 408
DP RP +
Sbjct: 269 DHDPNKRPGARTL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 73/309 (23%), Positives = 113/309 (36%), Gaps = 58/309 (18%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
+F+ L+G GGFG VFK G T +K + ++ + +E V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNNEKAERE----VKA 57
Query: 190 LGDLVHLNLVKLIGYCIEDDQRL----------------LVYEFMPRGSLENHL-FRRSL 232
L L H+N+V G D + EF +G+LE + RR
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
L + +++ KG+ ++H + +I RD K SNI L K+ DFGL
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---S 171
Query: 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352
TR GT Y +PE + + D+Y+ G++L E+L
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSK 226
Query: 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
F L D + F +K L LS+ P+ RP SE++ L
Sbjct: 227 F-------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTL 269
Query: 413 KPLPNLKDM 421
+
Sbjct: 270 TVWKKSPEK 278
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 43/230 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
+GEG FG VF+ G P +P T VAVK L + ++ E + + +
Sbjct: 55 IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 239
N+VKL+G C L++E+M G L L S S+
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 240 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293
+ IA A G+A+L +ER ++RD T N L+ + K++DFGL+++
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 294 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
D K + + M PE + T+ SDV+++GVVL E+ +
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 195
LGEG FG V E G KP VAVK L D + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-----------FRRSLPLPWSIRMK--- 241
N++ L+G C +D ++ E+ +G+L +L + S + K
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 242 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KTHV 298
A A+G+ +L A + I+RD N+L+ D K++DFGLA+D D K
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 299 STRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ R+ M APE + T +SDV+SFGV+L E+ T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 39/285 (13%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 193
E LG+G FG V+ G W NGT V A+KTL G + +L E + L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAF 252
H LV+L E+ +V E+M +GSL + L L + +A A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
+ ++RD + +NIL+ + K++DFGLA+ E ++ + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLI 371
+ G T +SDV+SFG++L E+ T R N E + VE R YR+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMP 401
Query: 372 DPRLEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 415
P ++ L C ++P+ RP + L+
Sbjct: 402 CPP--------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGDLVHL 196
+GEG FG V +G L VA+KT + + ++L E + H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLH 254
++VKLIG E+ ++ E G L + L + SL L I A + LA+L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-----RVMGTYGYA 309
+ ++RD N+L+ ++ KL DFGL++ + S + M
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
APE + TS SDV+ FGV + E+L G +
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGD 192
+ LG G FG V +G + V A+K L +E + E +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L + +V+LIG C + + +LV E G L L + +P S ++ + G+ +
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 451
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT---YGYA 309
L E+ ++R+ N+LL + AK+SDFGL+K D + + +
Sbjct: 452 L---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWY 506
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
APE + +SRSDV+S+GV + E L+ G++
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 38 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-------LPWSIRMKIALGAAKG 249
N+V+ IG ++ R ++ E M G L++ L R + P L + +A A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+L E I+RD N LL AK+ DFG+A+D M
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ PE M G TS++D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 197 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 254
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV----MGTYGYAA 310
++RD N+L+ D AK+SDFGL K+ T + ++ A
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------A 182
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
PE + +++SDV+SFG++L E+ + GR
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG G +G V++G V LTVAVKTL + +E+L E + ++ H N
Sbjct: 21 LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHEE 256
LV+L+G C + ++ EFM G+L ++L + + + +A + + +L
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 257 AERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRV----MGTYGYAAP 311
++ I+RD N L+ ++ K++DFGL++ H + AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
E + + +SDV++FGV+L E+ T G
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+G+G FG V G + G VAVK + +D + +LAE + + L H
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 197 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLH 254
NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L + + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305
Query: 255 EEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV 314
++RD N+L+ D AK+SDFGL K+ T + ++ + APE +
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKL--PVKWTAPEAL 358
Query: 315 MTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+++SDV+SFG++L E+ + GR
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
LG G FG V++G + +G VAVKTL Q ++L E + H
Sbjct: 79 LGHGAFGEVYEG--QVSGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL-----PWSIR--MKIALGAAKG 249
N+V+ IG ++ R ++ E M G L++ L R + P ++ + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+L E I+RD N LL AK+ DFG+A+D M
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ PE M G TS++D +SFGV+L E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-34
Identities = 60/287 (20%), Positives = 111/287 (38%), Gaps = 26/287 (9%)
Query: 64 VSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFN 123
V+G + + + ++ S S+ ++ ++ + T+
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDE--EDTYT 378
Query: 124 DLKLATRNFRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GL 177
+ E + +GEG FG V +G + VA+KT +
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSD 432
Query: 178 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 237
+++L E + H ++VKLIG ++ ++ E G L + L R L +
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLA 491
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
+ A + LA+L + ++RD N+L+ ++ KL DFGL++ +
Sbjct: 492 SLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 298 VSTR---VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
S + APE + TS SDV+ FGV + E+L G +
Sbjct: 549 ASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG G FG V+ G + NG V AVK+L G +LAE N + L H
Sbjct: 21 LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 255
LV+L ++ ++ E+M GSL + L + L + + +A A+G+AF+
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD-KTHVSTRVMGTYGYAAPEYV 314
ER I+RD + +NIL+ + K++DFGLA+ + + + + APE +
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAI 182
Query: 315 MTGHLTSRSDVYSFGVVLLEMLT-GRR 340
G T +SDV+SFG++L E++T GR
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-33
Identities = 75/367 (20%), Positives = 123/367 (33%), Gaps = 53/367 (14%)
Query: 74 SKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFR 133
S S + A+ + ++ S + E + + K + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 193
+ +G G FG V + TG AVK + L+ + E+ L
Sbjct: 62 HQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGL 107
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFL 253
+V L G E + E + GSL L ++ LP + A +GL +L
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 254 HEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAK---DGPEGDKTHVSTRVMGTYGYA 309
H +++ D K N+LL +D A L DFG A G + GT +
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 310 APEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
APE VM ++ D++S ++L ML G P W
Sbjct: 224 APEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH------P--------WT--QYFRGPLCL 266
Query: 369 RL-----IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP----LMSEVVEALKPLPNLK 419
++ + + AQ L ++P R L +V +AL+ + LK
Sbjct: 267 KIASEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK 322
Query: 420 DMASSSY 426
Y
Sbjct: 323 SPWKGEY 329
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 66/348 (18%), Positives = 123/348 (35%), Gaps = 39/348 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 187
+ +GEG FG G +K +N + KE EV
Sbjct: 25 KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGA 246
L ++ H N+V+ E+ +V ++ G L + ++ + + +
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
L +H+ R +++RD K+ NI L D +L DFG+A+ + GT
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTP 189
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
Y +PE ++SD+++ G VL E+ T + + + +
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242
Query: 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE---ALKPLPNLKDMAS 423
P + H+S L + R+P+ RP ++ ++E K +
Sbjct: 243 ------PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 424 SSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYASP 471
+ F + GS P + S+S + ++ P Y P
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 68/231 (29%), Positives = 100/231 (43%), Gaps = 45/231 (19%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLVHL 196
LGEG FG V K T TVAVK L + ++ L+E N L + H
Sbjct: 31 LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR----------------- 239
+++KL G C +D LL+ E+ GSL L R S +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 240 -------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
+ A ++G+ +L AE +++RD NIL+ K+SDFGL++D E
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 293 GD--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
D R+ M A E + T++SDV+SFGV+L E++T
Sbjct: 203 EDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 65/309 (21%), Positives = 110/309 (35%), Gaps = 64/309 (20%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 189
+F P LG GGFG VF+ A+K + + +E + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 190 LGDLVHLNLVKLIGYCIEDD---------QRLLVY---EFMPRGSLENHLFRR--SLPLP 235
L L H +V+ +E + ++ +Y + + +L++ + R
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 236 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 288
S+ + I L A+ + FLH + +++RD K SNI D K+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 289 ---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
T +GT Y +PE + + + D++S G++L E+L
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLID----PRLEGHFSIKGAQKAAQLAAHCLSRDPKA 401
+ + ER R + P L + LS P
Sbjct: 226 PFSTQM-----------ERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPME 270
Query: 402 RPLMSEVVE 410
RP ++E
Sbjct: 271 RPEAINIIE 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 50/292 (17%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 187
NFR E +G G F V++ G+ VA+K + L K + E+
Sbjct: 33 NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKIAL 244
+ L L H N++K IED++ +V E G L + ++ +P K +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
L +H R V++RD K +N+ + A KL D GL + T + V G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-G 198
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364
T Y +PE + +SD++S G +L EM + P G++
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDK 240
Query: 365 RRFYRLI--------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
Y L P H+S ++ QL C++ DP+ RP ++ V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 138 LGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
LG+G FG V+ G W NGT V A+KTL G + +L E + L H
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHL-FRRSLPLPWSIRMKIALGAAKGLAFLHE 255
LV+L E+ +V E+M +GSL + L L + +A A G+A++
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 256 EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM 315
++RD + +NIL+ + K++DFGLA+ E ++ + APE +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 316 TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGERRRFYRLIDPR 374
G T +SDV+SFG++L E+ T R N E + VE R YR+ P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMPCPP 487
Query: 375 LEGHFSIKGAQKAA-QLAAHCLSRDPKARPLMSEVVEALKPL 415
++ L C ++P+ RP + L+
Sbjct: 488 --------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 135 ESLLGEGGFGCVFKG-WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL 193
E LG G FG V+ + N V AVKT+ G + +LAE N + L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240
Query: 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKGLAF 252
H LVKL ++ ++ EFM +GSL + L P + + A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
+ +R I+RD + +NIL+ A K++DFGLA+ E ++ + APE
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLT-GRR 340
+ G T +SDV+SFG++L+E++T GR
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 34/221 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 195
LG G FG V + G VAVK L + ++E+ + L H
Sbjct: 54 LGAGAFGKVVEA--TAFGLGKEDAVL--KVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKI 242
N+V L+G C L++ E+ G L N L R+S L +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST-- 300
+ A+G+AFL A + I+RD N+LL + AK+ DFGLA+D V
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 301 ----RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ M APE + T +SDV+S+G++L E+ +
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 195
LG G FG V + + G TVAVK L H+ ++E+ L + H
Sbjct: 35 LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 196 LNLVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSLPLPWSIR--------------- 239
LN+V L+G C + +++ EF G+L +L R +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 240 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD--KT 296
+ + AKG+ FL A R I+RD NILL K+ DFGLA+D +
Sbjct: 150 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 297 HVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
R+ M APE + T +SDV+SFGV+L E+ +
Sbjct: 207 KGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 65/225 (28%), Positives = 91/225 (40%), Gaps = 38/225 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 195
LG G FG V + G TVAVK L L + ++E+ L L H
Sbjct: 31 LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 239
+N+V L+G C L++ E+ G L N L R+ S
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 240 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+ + AKG+AFL A + I+RD NILL K+ DFGLA+D V
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 299 ST------RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ M APE + T SDV+S+G+ L E+ +
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 72/293 (24%), Positives = 112/293 (38%), Gaps = 45/293 (15%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 187
++ LG GG V+ VA+K + + +E L EV
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNI---------KVAIKAI-FIPPREKEETLKRFEREV 62
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
+ L H N+V +I EDD LV E++ +L ++ PL +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQIL 121
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
G+ H+ +++RD K NIL+D++ K+ DFG+AK E T + V+GT
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGE--- 363
Y +PE +D+YS G+VL EML G P NGE V A H+ +
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQDSVP 230
Query: 364 --RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 413
+ I L + +D R + E+ + L
Sbjct: 231 NVTTDVRKDIPQSLS------------NVILRATEKDKANRYKTIQEMKDDLS 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 68/322 (21%), Positives = 118/322 (36%), Gaps = 60/322 (18%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 150
S +T + S + + E +LG+G +G V+ G
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41
Query: 151 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQ 210
+ +A+K + + + E+ L H N+V+ +G E+
Sbjct: 42 --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93
Query: 211 RLLVYEFMPRGSLENHLFRRSLPLPWS---IRMKIALGAAKGLAFLHEEAERPVIYRDFK 267
+ E +P GSL L + PL + I +GL +LH+ +++RD K
Sbjct: 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHDNQ---IVHRDIK 149
Query: 268 TSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV---MTGHLTSRS 323
N+L++ K+SDFG +K + + GT Y APE + G+ +
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAA 206
Query: 324 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--HLGERRRFYRLIDPRLEGHFSI 381
D++S G ++EM TG+ P + L E +G + + P + S
Sbjct: 207 DIWSLGCTIIEMATGK------PPF--YELGEPQAAMFKVGMFK-----VHPEIPESMS- 252
Query: 382 KGAQKAAQLAAHCLSRDPKARP 403
+A C DP R
Sbjct: 253 ---AEAKAFILKCFEPDPDKRA 271
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 57/230 (24%), Positives = 89/230 (38%), Gaps = 43/230 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGDLV-H 195
LG G FG V G + VAVK L + ++E+ + L H
Sbjct: 53 LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIR---------------- 239
N+V L+G C L++E+ G L N+L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 240 ------MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293
+ A AKG+ FL + ++RD N+L+ K+ DFGLA+D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 294 D--KTHVSTRV----MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
+ R+ M APE + G T +SDV+S+G++L E+ +
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 68/295 (23%), Positives = 105/295 (35%), Gaps = 41/295 (13%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 187
+R L+G GG G V++ VA+K + + L + E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
G L ++V + + D Q + + L L RR PL + I
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIG 144
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
L H +RD K NIL+ AD A L DFG+A + T + +GT
Sbjct: 145 SALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERRR 366
Y APE H T R+D+Y+ VL E LTG P G+ + H+ +
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGS------PPYQGDQ--LSVMGAHINQAIP 252
Query: 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLP 416
+ P + + A ++++P+ R L + AL
Sbjct: 253 RPSTVRPGI--------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 37/290 (12%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 187
++ +G G +G K + G + K L++ + + ++EV
Sbjct: 6 EDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56
Query: 188 NFLGDLVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 242
N L +L H N+V+ + L +V E+ G L + + + L +++
Sbjct: 57 NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 243 ALGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
L H + V++RD K +N+ LD N KL DFGLA+ D + T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
V GT Y +PE + +SD++S G +L E+ + +
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 233
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
R+ +S + ++ L+ RP + E++E
Sbjct: 234 ------------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 66/338 (19%), Positives = 107/338 (31%), Gaps = 51/338 (15%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 195
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 196 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 250
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 251 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 307 GYAAPEYVMTGHLTSRS--------DVYSFGVVLLEMLTGRR-------------SMDKN 345
Y P+ L D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405
+ + + D + S + A+ L D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 406 SEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNTR 443
+ + + + + Q M A +I
Sbjct: 298 DQFFAETSDILHRMVIH--VFSLQQMTAHKIYIHSYNT 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 44/381 (11%), Positives = 84/381 (22%), Gaps = 64/381 (16%)
Query: 84 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 143
+ +I + ++ + + L R + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 144 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVK 200
VF A+K E L+ + +
Sbjct: 76 SVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 201 LIGYC-----------------------IEDDQRLLVYEFMPR--------GSLENHLFR 229
+D MP S + ++
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 230 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289
+ + A L + +++ F N+ + D L D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRP 347
G + S+ YA E++ T + + G+ + + P
Sbjct: 243 -KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
+ W RP L + L L+ D + R L E
Sbjct: 299 GIKG---SWKRPSLRVPGTDS--LAFGSCTPLP----DFVKTLIGRFLNFDRRRRLLPLE 349
Query: 408 VVE--ALKPLPNLKDMASSSY 426
+E L N + S+
Sbjct: 350 AMETPEFLQLQNEISSSLSTG 370
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 48/286 (16%), Positives = 87/286 (30%), Gaps = 28/286 (9%)
Query: 73 ESKSTNDTSRDQPA----AAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLA 128
S T D +I + ++ SS E ++ T + +L
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKT--EFQLG 63
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
++ LLGEG F V++ + K +K +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEA--TQGDLNDAK--NKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL----PLPWSIRMKIAL 244
L + +K + + +LV E G+L N + +P + + A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILL-----------DADYNAKLSDFGLAKDGPEG 293
+ +H+ +I+ D K N +L D L D G + D
Sbjct: 180 RMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
K + T T G+ E + + D + + ML G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 67/356 (18%), Positives = 122/356 (34%), Gaps = 55/356 (15%)
Query: 70 HYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLAT 129
H+ S+ R ++ + +++ +S +
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG----- 55
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 187
R + +G GG VF+ V A+K +N + Q + E+
Sbjct: 56 RIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEI 105
Query: 188 NFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
+L L + ++L Y DQ + +V E L + L ++ + R
Sbjct: 106 AYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWK 162
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
+ + +H+ +++ D K +N L+ D KL DFG+A + V +G
Sbjct: 163 NMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 305 TYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHN 352
Y PE + ++ +SDV+S G +L M G+ P N
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIIN 272
Query: 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
+ + + +IDP E F + + CL RDPK R + E+
Sbjct: 273 QIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/242 (27%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 102 SSTSKLEEELKVASRLRKFTFNDLK---LATRNFRPESLLGEGGFGCVFKGWIEENGTAP 158
+LE + + RL F K L +F S LG G G VFK +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP----- 56
Query: 159 VKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 217
+GL +A K ++ + + + E+ L + +V G D + + E
Sbjct: 57 ----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112
Query: 218 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
M GSL+ + +++ +P I K+++ KGL +L E+ +++RD K SNIL+++
Sbjct: 113 MDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRG 169
Query: 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
KL DFG++ + + ++ V GT Y +PE + H + +SD++S G+ L+EM
Sbjct: 170 EIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 338 GR 339
GR
Sbjct: 226 GR 227
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 49/328 (14%), Positives = 92/328 (28%), Gaps = 85/328 (25%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD------------- 175
R ++LG+ + +E TG + V
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 176 ---------GLQGHKEWLAEVNFL--GDLVHLNLVKLIGYCIEDDQRLLV---YEFMPRG 221
G++ K+ + F+ DLV K + D++ + V + PR
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 222 SLENHLFRRSL--------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273
F L L R+++ L + LA LH +++ + +I+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 244
Query: 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----------TGHLTSRS 323
D L+ F +G S G+A PE +T
Sbjct: 245 DQRGGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 324 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG 383
D ++ G+ + + PN + + + + P+
Sbjct: 299 DTWTLGLAIYWIWCAD------LPNTDDAALGGSEWIFRSCKNI-----PQP-------- 339
Query: 384 AQKAAQLAAHCLSRDPKARPLMSEVVEA 411
L L + R L + +E
Sbjct: 340 ---VRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 48/373 (12%), Positives = 95/373 (25%), Gaps = 92/373 (24%)
Query: 84 QPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGF 143
Q S S A+S STS ++L R ++LG+
Sbjct: 33 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE------SELGERPRTLVRGTVLGQEDP 86
Query: 144 GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------------------- 177
+ TG + V
Sbjct: 87 YAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 178 --QGHKEWLAEVNFLGDLVHLNLVKLIGYC--IEDDQRLLVYEFMP-----RGSLENHLF 228
+ H ++ + + D ++++ + R +Y M G +
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 229 RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288
L R+++ L + LA LH +++ + +I+LD L+ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLT 337
+ + G+ PE +T D ++ G+V+ +
Sbjct: 255 ------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 338 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 397
P + + + R + Q L L
Sbjct: 309 AD------LPITKDAALGGSEWIF------------RSCKNIP----QPVRALLEGFLRY 346
Query: 398 DPKARPLMSEVVE 410
+ R L + +E
Sbjct: 347 PKEDRLLPLQAME 359
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 62/297 (20%), Positives = 98/297 (32%), Gaps = 49/297 (16%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGDLVH 195
+LG+G VF+G TG A+K N+ + + E L L H
Sbjct: 16 ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 196 LNLVKLIGYCIEDDQRLLVY---EFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGL 250
N+VKL E+ EF P GSL L + LP S + + G+
Sbjct: 67 KNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 251 AFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
L E +++R+ K NI+ D KL+DFG A++ + ++ + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTE 179
Query: 307 GYAAPEYVMTGHL--------TSRSDVYSFGVVLLEMLTGRR-------------SMDKN 345
Y P+ L + D++S GV TG M K
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
+ + + D + S + A+ L D +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 64/308 (20%), Positives = 111/308 (36%), Gaps = 50/308 (16%)
Query: 118 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 177
F + + R + +G GG VF+ V A+K +N +
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 178 QGH--KEWLAEVNFLGDLVHLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 232
+ E+ +L L + ++L Y DQ + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKK- 122
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
+ R + + +H+ +++ D K +N L+ D KL DFG+A
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178
Query: 293 GDKTHVSTRVMGTYGYAAPEYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRS 341
+ V +GT Y PE + ++ +SDV+S G +L M G+
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT- 237
Query: 342 MDKNRP-NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 400
P N + + + +IDP E F + + CL RDPK
Sbjct: 238 -----PFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 282
Query: 401 ARPLMSEV 408
R + E+
Sbjct: 283 QRISIPEL 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 69/301 (22%), Positives = 105/301 (34%), Gaps = 43/301 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 189
+ + LG GGFG V + + TG VA+K + ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 190 LGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFR--RSLPLPWSIR 239
+ L H N+V + D + LL E+ G L +L + L
Sbjct: 66 MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA---KLSDFGLAKDGPEGDKT 296
+ + L +LHE +I+RD K NI+L K+ D G AK+ +G+
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR---------SMDKNRP 347
V GT Y APE + T D +SFG + E +TG R
Sbjct: 181 T--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
+ + G + L P H S A K + L + R +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294
Query: 408 V 408
Sbjct: 295 N 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 43/289 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+F P+ +LG G G + + VAVK + + EV L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 191 GDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
+ H N+++ + + + E +L+ ++ ++ + + G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 250 LAFLHEEAERPVIYRDFKTSNILL-----DADYNAKLSDFGLAK--DGPEGDKTHVSTRV 302
LA LH +++RD K NIL+ A +SDFGL K + S
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 303 MGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359
GT G+ APE + + T D++S G V +++ P G+ +
Sbjct: 188 -GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ---- 237
Query: 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
L E H A +L ++ DP+ RP V
Sbjct: 238 -ANILLGACSLDCLHPEKHED----VIARELIEKMIAMDPQKRPSAKHV 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 69/307 (22%), Positives = 116/307 (37%), Gaps = 49/307 (15%)
Query: 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 184
L+ R + +LG GG V VAVK L L +
Sbjct: 10 LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56
Query: 185 A----EVNFLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPW 236
E L H +V + + +V E++ +L + + P+
Sbjct: 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTP 115
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
+++ A + L F H+ +I+RD K +NI++ A K+ DFG+A+ + +
Sbjct: 116 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 297 HVST-RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLV 354
T V+GT Y +PE + +RSDVYS G VL E+LTG P G+ + V
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SPV 225
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVV 409
A H+ E L + + L+++P+ R + +++V
Sbjct: 226 SVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLV 277
Query: 410 EALKPLP 416
P
Sbjct: 278 RVHNGEP 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-29
Identities = 59/289 (20%), Positives = 104/289 (35%), Gaps = 53/289 (18%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 190
+ + + GG G ++ G V +K L H G + +AE FL
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVN--------GRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 191 GDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
++VH ++V++ + D+ +V E++ SL+ + LP+ +I L
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQKLPVAEAIA--YLLE 190
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
L++LH ++Y D K NI+L + KL D G + GT
Sbjct: 191 ILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGT 240
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
G+ APE ++ T +D+Y+ G L + + + +G P L
Sbjct: 241 PGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----PVLKTYD 295
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 413
+ RL+ + DP+ R E+ L
Sbjct: 296 SYGRLL--------------------RRAIDPDPRQRFTTAEEMSAQLT 324
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 80/335 (23%), Positives = 121/335 (36%), Gaps = 54/335 (16%)
Query: 85 PAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFG 144
PA A + + + ++ L + R + LG+GGF
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------PRSRRRYVRGRFLGKGGFA 55
Query: 145 CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDLVHLNLVKL 201
F+ T A K + L + E++ L H ++V
Sbjct: 56 KCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 202 IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 260
G+ ED+ + +V E R SL RR R G +LH
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---NR 161
Query: 261 VIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL 319
VI+RD K N+ L+ D K+ DFGLA K +G++ V GT Y APE V++
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKG 217
Query: 320 TS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI---DPRL 375
S DV+S G ++ +L G+ P L E Y I + +
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE-----------TYLRIKKNEYSI 260
Query: 376 EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
H + AA L L DP ARP ++E++
Sbjct: 261 PKHIN----PVAASLIQKMLQTDPTARPTINELLN 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 66/347 (19%), Positives = 124/347 (35%), Gaps = 54/347 (15%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGDLV 194
+G GG VF+ A+K +N + + E+ +L L
Sbjct: 16 QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 195 HLNL--VKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
+ ++L Y DQ + +V E L + L ++ + R + +
Sbjct: 66 QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH 122
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+H+ +++ D K +N L+ D KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 312 EYVM-----------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP 359
E + ++ +SDV+S G +L M G+ P N +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------PFQQIINQIS---- 228
Query: 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE----ALKPL 415
+ + +IDP E F + + CL RDPK R + E++ ++
Sbjct: 229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 416 PNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLS 462
P + ++ + + + +G + A+ +G S +
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 329
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 81/321 (25%), Positives = 113/321 (35%), Gaps = 38/321 (11%)
Query: 31 DEVEVEEEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVI 90
E EV +++ + + + V + +D +
Sbjct: 88 AEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKD------L 141
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL---KLATRNFRPESLLGEGGFGCVF 147
T S + + L R + L + FR +LG+GGFG V
Sbjct: 142 FQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC 201
Query: 148 KGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGY 204
A TG A K L ++ K L E L + +V L Y
Sbjct: 202 ---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-Y 251
Query: 205 CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IALGAAKGLAFLHEEAE 258
E L LV M G L+ H++ R I G L LH E
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLHRER- 306
Query: 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH 318
++YRD K NILLD + ++SD GLA PEG RV GT GY APE V
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNER 361
Query: 319 LTSRSDVYSFGVVLLEMLTGR 339
T D ++ G +L EM+ G+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQ 382
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 75/296 (25%), Positives = 111/296 (37%), Gaps = 60/296 (20%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 186
R + LG+GGF F+ T A K + L + E
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM----- 240
++ L H ++V G+ ED+ + +V E R SL RR +
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEA 117
Query: 241 -KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHV 298
G +LH VI+RD K N+ L+ D K+ DFGLA K +G++ V
Sbjct: 118 RYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 299 STRVMGTYGYAAPEYVMTGHLTS-RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
GT Y APE V++ S DV+S G ++ +L G+ P L E
Sbjct: 175 LC---GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKE-- 222
Query: 358 RPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
Y I + + H + AA L L DP ARP ++E++
Sbjct: 223 ---------TYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 46/281 (16%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGDL 193
LG+G FG V+ + + +A+K L L+ + EV L
Sbjct: 16 PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
H N+++L GY D R+ L+ E+ P G++ L ++ A L++
Sbjct: 67 RHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSY 124
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
H + VI+RD K N+LL + K++DFG + P + GT Y PE
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPE 177
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI- 371
+ + D++S GV+ E L G+ P + E Y+ I
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQE-----------TYKRIS 220
Query: 372 --DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ + +GA+ L + L +P RP++ EV+E
Sbjct: 221 RVEFTFPDFVT-EGARD---LISRLLKHNPSQRPMLREVLE 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 44/231 (19%), Positives = 86/231 (37%), Gaps = 49/231 (21%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 185
L +G F + E++ A+K L+ +++
Sbjct: 39 LNQGKFNKIILC--EKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 186 -----EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL-------FRRSL 232
E+ + D+ + + G I + + ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
+P + I +++H E+ + +RD K SNIL+D + KLSDFG ++ +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
Query: 293 GD-KTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 339
K GTY + PE + + ++ D++S G+ L M
Sbjct: 205 KKIKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 61/302 (20%), Positives = 97/302 (32%), Gaps = 66/302 (21%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 186
T F +G G FG VFK VK G A+K G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 187 VNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL---FRRSLPLPWSIRMKI 242
V L H ++V+ EDD L+ E+ GSL + + +R + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-------------------YNAKLSD 283
L +GL ++H +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--TGHLTSRSDVYSFGVVLLEMLTGRRS 341
G V G + A E + HL +D+++ + ++
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPL 230
Query: 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 401
P +W G PR+ S Q+ +L + DP+
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVLS----QEFTELLKVMIHPDPER 270
Query: 402 RP 403
RP
Sbjct: 271 RP 272
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 69/229 (30%), Positives = 91/229 (39%), Gaps = 38/229 (16%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 183
+ F +LG GGFG VF A TG A K LN L+ K +
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQG 231
Query: 184 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-----RSLPLPW 236
+ E L + +V L Y E L LV M G + H++ P
Sbjct: 232 AMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP- 289
Query: 237 SIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291
R I G L LH+ +IYRD K N+LLD D N ++SD GLA +
Sbjct: 290 --RAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
G GT G+ APE ++ G S D ++ GV L EM+ R
Sbjct: 341 AGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 23/215 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 187
+F+ +LLG+G F V++ TGL VA+K ++ + EV
Sbjct: 12 DFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L H ++++L Y ED + LV E G + +L R P +
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKTHVSTRVMGT 305
G+ +LH +++RD SN+LL + N K++DFGLA + +K + GT
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GT 175
Query: 306 YGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
Y +PE + H SDV+S G + +L GR
Sbjct: 176 PNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 69/348 (19%), Positives = 129/348 (37%), Gaps = 64/348 (18%)
Query: 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 183
++L R +L EGGF V++ + G+G A+K L + + ++
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72
Query: 184 LAEVNFLGDLV-HLNLVKLIGYCIEDDQR-------LLVYEFMPRGSLENHLFRRSL--P 233
+ EV F+ L H N+V+ + L+ + +G L L + P
Sbjct: 73 IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 234 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDG 290
L +KI + + +H + P+I+RD K N+LL KL DFG A
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 291 PEGDKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSRSDVYSFGVVLLEMLTGRR 340
P+ + ++ T Y PE + + + + D+++ G +L + +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ- 250
Query: 341 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLS 396
P + + I + G +SI L L
Sbjct: 251 -----HPFEDGAKLR---------------I---VNGKYSIPPHDTQYTVFHSLIRAMLQ 287
Query: 397 RDPKARPLMSEVVEALKPLPNLKDMASSSYYFQTM-QAERIGSSPNTR 443
+P+ R ++EVV L+ + +++ S + + Q GS+ +R
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSR 335
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 73/327 (22%), Positives = 121/327 (37%), Gaps = 39/327 (11%)
Query: 27 KKVEDEVEVEEEEETGCWVKLRFFGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPA 86
++++ ++E EEE + F + S ++ + +
Sbjct: 87 EEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLF 146
Query: 87 AAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCV 146
I + ++ + + N L +F ++G GGFG V
Sbjct: 147 QPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEV 205
Query: 147 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLN---LVK 200
+ K TG A+K L+ ++ + L E L + + +V
Sbjct: 206 Y---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 201 LIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFL 253
+ Y +L + + M G L HL + M+ I LG L +
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHM 308
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEY 313
H V+YRD K +NILLD + ++SD GLA D + K H V GT+GY APE
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHGYMAPEV 361
Query: 314 VMTGHLTSRS-DVYSFGVVLLEMLTGR 339
+ G S D +S G +L ++L G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 22/207 (10%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGDL 193
LG+G FG V+ + +A+K L L+ L E+ L
Sbjct: 21 PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 194 VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
H N++++ Y D +R+ L+ EF PRG L L ++ A L +
Sbjct: 72 RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHY 129
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPE 312
HE R VI+RD K N+L+ K++DFG + P + GT Y PE
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPE 182
Query: 313 YVMTGHLTSRSDVYSFGVVLLEMLTGR 339
+ + D++ GV+ E L G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 55/296 (18%)
Query: 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 183
+++ + P LG G +G V K +G +AVK + Q K
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52
Query: 184 LAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLEN---HLFRRSLPLPWSIR 239
L +++ + + V G + + E M SL+ + + +P I
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
KIA+ K L LH + VI+RD K SN+L++A K+ DFG++
Sbjct: 112 GKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166
Query: 300 TRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355
G Y APE + + +SD++S G+ ++E+ R
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDS 215
Query: 356 WARPHLGERRRFYRLID-------PRL-EGHFSIKGAQKAAQLAAHCLSRDPKARP 403
W P ++ + P+L FS + + CL ++ K RP
Sbjct: 216 WGTP--------FQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/249 (28%), Positives = 107/249 (42%), Gaps = 39/249 (15%)
Query: 102 SSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 161
S ++ V K + F +LG+G FG VF +++
Sbjct: 3 GSIKEIAITHHVKEGHEKADPSQ-------FELLKVLGQGSFGKVFL--VKKISG----S 49
Query: 162 GTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFM 218
A+K L L+ E + L ++ H +VKL Y + + +L L+ +F+
Sbjct: 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 219 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272
G L L + +K +AL L LH +IYRD K NIL
Sbjct: 109 RGGDLFTRLSKEVMFTEE---DVKFYLAELALA----LDHLHS---LGIIYRDLKPENIL 158
Query: 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGV 330
LD + + KL+DFGL+K+ + +K GT Y APE V+ ++S D +SFGV
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGV 214
Query: 331 VLLEMLTGR 339
++ EMLTG
Sbjct: 215 LMFEMLTGT 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 76/315 (24%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 190
F +G+G FG VFKG + T VA+K ++ + + E + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAA 247
+ K G ++D + ++ E++ GS + L L IA
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREIL 129
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMG 304
KGL +LH E I+RD K +N+LL KL+DFG+A G T + +G
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVG 181
Query: 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHN 352
T + APE + S++D++S G+ +E+ G + + KN P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----- 236
Query: 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE----- 407
P LEG++S + + CL+++P RP E
Sbjct: 237 --------------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272
Query: 408 -VVEALKPLPNLKDM 421
++ K L ++
Sbjct: 273 FILRNAKKTSYLTEL 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 47/243 (19%)
Query: 113 VASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV-KPGTGLTVAVKT 171
V F+ F +G+G FG V V K T A+K
Sbjct: 5 VFDENEDVNFDH-------FEILRAIGKGSFGKVCI----------VQKNDTKKMYAMKY 47
Query: 172 LNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHL 227
+N E E+ + L H LV L Y +D++ + +V + + G L HL
Sbjct: 48 MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 228 FR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281
+ +K + + L +L + +I+RD K NILLD + +
Sbjct: 107 QQNVHFKEE---TVKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHI 156
Query: 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM----TGHLTSRSDVYSFGVVLLEMLT 337
+DF +A P + T + GT Y APE G+ + D +S GV E+L
Sbjct: 157 TDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLR 212
Query: 338 GRR 340
GRR
Sbjct: 213 GRR 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 47/313 (15%)
Query: 100 SNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPV 159
S+ S+ K L + + + NDL+ +G G G V+K +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48
Query: 160 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEF 217
TG +AVK + G + +K L +++ + +V+ G I + + E
Sbjct: 49 ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 218 MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
M E R P+P I K+ + K L +L E+ VI+RD K SNILLD
Sbjct: 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 162
Query: 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-----TSRSDVYSFGVVL 332
KL DFG++ R G Y APE + R+DV+S G+ L
Sbjct: 163 QIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 333 LEMLTGRRSMDKNRPNGE--HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 390
+E+ TG+ + + E +++ P L FS
Sbjct: 220 VELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG------------HMGFS----GDFQSF 263
Query: 391 AAHCLSRDPKARP 403
CL++D + RP
Sbjct: 264 VKDCLTKDHRKRP 276
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 77/275 (28%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 73 ESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNF 132
E + T D + + + ++ E E+ +A + T N+ F
Sbjct: 98 EWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------F 150
Query: 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNF 189
LLG+G FG V + TG A+K L + + E L E
Sbjct: 151 EYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 190 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMKI-ALGA 246
L + H L L Y + RL V E+ G L HL R R R +
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEI 257
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GT 305
L +LH +E+ V+YRD K N++LD D + K++DFGL K+G + T + GT
Sbjct: 258 VSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGT 312
Query: 306 YGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
Y APE V+ + R+ D + GVV+ EM+ GR
Sbjct: 313 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 78/352 (22%), Positives = 120/352 (34%), Gaps = 67/352 (19%)
Query: 72 AESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 131
+ AA S+ E + + K +
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN------- 55
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAEV 187
F +LG G +G VF + + TG A+K L + + E
Sbjct: 56 FELLKVLGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 188 NFLGDLVHLN-LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK--- 241
L + LV L Y + + +L L+ +++ G L HL + ++
Sbjct: 110 QVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYV 165
Query: 242 --IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
I L L LH+ +IYRD K NILLD++ + L+DFGL+K+ +
Sbjct: 166 GEIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 300 TRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNL 353
GT Y AP+ V +GH + D +S GV++ E+LTG + E
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAE--- 273
Query: 354 VEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
R I +P S A L L +DPK R
Sbjct: 274 -------------ISRRILKSEPPYPQEMS----ALAKDLIQRLLMKDPKKR 308
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 84/293 (28%), Positives = 116/293 (39%), Gaps = 62/293 (21%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 183
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 184 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM 240
+ E L + H L L Y + RL V E+ G L HL R R R
Sbjct: 52 TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107
Query: 241 K-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK 295
+ I L +LH R V+YRD K N++LD D + K++DFGL K+G
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 296 THVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353
T + GT Y APE V+ + R+ D + GVV+ EM+ G R
Sbjct: 161 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCG-------RL------ 203
Query: 354 VEWARPHLGE-RRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
P + R + LI + R S +A L A L +DPK R
Sbjct: 204 -----PFYNQDHERLFELILMEEIRFPRTLS----PEAKSLLAGLLKKDPKQR 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 39/255 (15%)
Query: 96 SNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENG 155
A + + + + RK D F+ +LGEG F V
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLA------ 49
Query: 156 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212
+ T A+K L + + E + + L H VKL + +DD++L
Sbjct: 50 ---RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105
Query: 213 -LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRD 265
+ G L ++ + S + I L +LH + +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155
Query: 266 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSD 324
K NILL+ D + +++DFG AK K + +GT Y +PE + SD
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSD 214
Query: 325 VYSFGVVLLEMLTGR 339
+++ G ++ +++ G
Sbjct: 215 LWALGCIIYQLVAGL 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 58/257 (22%), Positives = 97/257 (37%), Gaps = 38/257 (14%)
Query: 103 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 157
S+L ++ VA L+ +++L +F ++G G F V
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--------- 79
Query: 158 PV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 212
V TG A+K +N + E + E + L + + +L + +D+ L
Sbjct: 80 -VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLY 137
Query: 213 LVYEFMPRGSLENHLFR--RSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTS 269
LV E+ G L L + +P + R +A + A + +H ++RD K
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPD 191
Query: 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVY--- 326
NILLD + +L+DFG V GT Y +PE + + Y
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 327 ----SFGVVLLEMLTGR 339
+ GV EM G+
Sbjct: 251 CDWWALGVFAYEMFYGQ 267
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/301 (23%), Positives = 105/301 (34%), Gaps = 59/301 (19%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 182
+ + +G G +G V K + +G +AVK + + K+
Sbjct: 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66
Query: 183 WLAEVNF-LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHL----FRRSLPLPWS 237
L +++ + +V+ G + + E M S + +P
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
I KI L K L L E +I+RD K SNILLD N KL DFG++ + +
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180
Query: 298 VSTRVMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353
TR G Y APE + RSDV+S G+ L E+ TGR K
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------ 234
Query: 354 VEWARPHLGERRRFYRLID-------PRL----EGHFSIKGAQKAAQLAAHCLSRDPKAR 402
+ + P+L E FS CL++D R
Sbjct: 235 -------------VFDQLTQVVKGDPPQLSNSEEREFS----PSFINFVNLCLTKDESKR 277
Query: 403 P 403
P
Sbjct: 278 P 278
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 66/245 (26%), Positives = 101/245 (41%), Gaps = 41/245 (16%)
Query: 108 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 167
E V K F +LG+GG+G VF+ + + TG
Sbjct: 2 SSETSVNRGPEKIRPEC-------FELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIF 48
Query: 168 AVKTLNHDGLQGHK---EW-LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS 222
A+K L + + AE N L ++ H +V LI Y + +L L+ E++ G
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGE 107
Query: 223 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276
L L R I++ L LH++ +IYRD K NI+L+
Sbjct: 108 LFMQLEREGIFMED---TACFYLAEISMA----LGHLHQKG---IIYRDLKPENIMLNHQ 157
Query: 277 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLE 334
+ KL+DFGL K+ T GT Y APE ++ +R+ D +S G ++ +
Sbjct: 158 GHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYD 213
Query: 335 MLTGR 339
MLTG
Sbjct: 214 MLTGA 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 52/306 (16%), Positives = 103/306 (33%), Gaps = 46/306 (15%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 183
+ R + + L G F W+E + + + ++ +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 184 LA--EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLP------ 235
++ + N V + + + + +L++ + RR
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 236 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD------ 289
I ++IA + FLH + +++RD K SNI D K+ DFGL
Sbjct: 167 LHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 219
Query: 290 ----GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345
T +GT Y +PE + + + + D++S G++L E+L +
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-- 277
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLI-DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 404
ER R + + + F+ K + + LS P RP
Sbjct: 278 -----------------ERVRIITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTERPE 319
Query: 405 MSEVVE 410
++++E
Sbjct: 320 ATDIIE 325
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 47/283 (16%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
+ + + N+V + + D+ +V E++ GSL + + + I + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-I-AAVCRECLQ 127
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 307
L FLH VI+RD K+ NILL D + KL+DFG A+ PE K T V GT
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPY 181
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--R 365
+ APE V + D++S G++ +EM+ G P P+L E R
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPLR 223
Query: 366 RFYRLID---PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 403
Y + P L+ S CL D + R
Sbjct: 224 ALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 71/316 (22%), Positives = 107/316 (33%), Gaps = 78/316 (24%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
E +LG G G V G VAVK + + L E+ L
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63
Query: 192 DLV-HLNLVKLIGYCIEDDQRL--LVYEFMPRGSL-----ENHLFRRSLPLPWSIRMKIA 243
+ H N+++ YC E R + E +L ++ +L L
Sbjct: 64 ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 244 L-GAAKGLAFLHEEAERPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAK- 288
L A G+A LH +I+RD K NIL+ + +SDFGL K
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 289 --DGPEGDKTHVSTRVMGTYGYAAPE-------YVMTGHLTSRSDVYSFGVVLLEMLTG- 338
G +T+++ GT G+ APE LT D++S G V +L+
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 339 ------RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAA 392
+ S + N G +L E H + +A L +
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLH---------------DRSLI----AEATDLIS 277
Query: 393 HCLSRDPKARPLMSEV 408
+ DP RP +V
Sbjct: 278 QMIDHDPLKRPTAMKV 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 74/322 (22%), Positives = 126/322 (39%), Gaps = 54/322 (16%)
Query: 97 NAESNSSTSKLEEELKVASRLRKFTFND-LKLATRNFRPESL------LGEGGFGCVFKG 149
+ S+ E + + F L++ P L +GEG G V
Sbjct: 5 HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64
Query: 150 WIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209
+ +G VAVK ++ Q + EV + D H N+V++ + +
Sbjct: 65 ---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269
+ ++ EF+ G+L + + + L + + LA+LH + VI+RD K+
Sbjct: 116 ELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170
Query: 270 NILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSF 328
+ILL D KLSDFG A+ + K + V GT + APE + + D++S
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSLYATEVDIWSL 227
Query: 329 GVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--RRFYRLID---PRLEG--HFSI 381
G++++EM+ G P P+ + + RL D P+L+ S
Sbjct: 228 GIMVIEMVDG-------EP-----------PYFSDSPVQAMKRLRDSPPPKLKNSHKVS- 268
Query: 382 KGAQKAAQLAAHCLSRDPKARP 403
L RDP+ R
Sbjct: 269 ---PVLRDFLERMLVRDPQERA 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 63/289 (21%), Positives = 110/289 (38%), Gaps = 58/289 (20%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
+ LG+G FG V+K TG A K + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 192 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
H +VKL+G D + ++ EF P G+++ + L + + L
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR---VMGTYGY 308
FLH + +I+RD K N+L+ + + +L+DFG++ + +GT +
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYW 183
Query: 309 AAPEYVMTGHLT-----SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
APE VM + ++D++S G+ L+EM P PH
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-------EP-----------PHHEL 225
Query: 364 ---RRRFYRLID----PRLE--GHFSIKGAQKAAQLAAHCLSRDPKARP 403
R I P L +S + L ++P+ RP
Sbjct: 226 NPMRVLL--KIAKSDPPTLLTPSKWS----VEFRDFLKIALDKNPETRP 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 49/284 (17%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
F LGEG +G V+K +E TG VA+K + + +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
+ ++VK G ++ +V E+ GS+ + + R+ L I K
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVSTRVMGTYG 307
GL +LH I+RD K NILL+ + +AKL+DFG+ + K + V+GT
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPF 190
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER--R 365
+ APE + +D++S G+ +EM G +P P+ R
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEG-------KP-----------PYADIHPMR 232
Query: 366 RFYRLID----PRLEG--HFSIKGAQKAAQLAAHCLSRDPKARP 403
+ +I P +S CL + P+ R
Sbjct: 233 AIF-MIPTNPPPTFRKPELWS----DNFTDFVKQCLVKSPEQRA 271
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 83/343 (24%), Positives = 132/343 (38%), Gaps = 60/343 (17%)
Query: 80 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLG 139
+ TT N + EE K A R+ L ++F ++G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 140 EGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-H 195
G + V T A++ + + + ++ E + H
Sbjct: 62 RGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAK 248
LV L C + + RL V E++ G L H+ R R LP + I+L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA--- 165
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYG 307
L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T T GT
Sbjct: 166 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPN 218
Query: 308 YAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGEHNLVEWARPHLG 362
Y APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 219 YIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------------ 265
Query: 363 ERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
+++I R+ S KAA + L++DPK R
Sbjct: 266 TEDYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 304
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 65/252 (25%), Positives = 105/252 (41%), Gaps = 33/252 (13%)
Query: 103 STSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTA 157
L + + + L ++ DL++ ++ ++G G FG V
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--------- 87
Query: 158 PVKP-GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL- 212
V+ T A+K L+ + + + E + + +V+L Y +DD+ L
Sbjct: 88 -VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLY 145
Query: 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKTSNI 271
+V E+MP G L N + +P W+ R A + A L +H I+RD K N+
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199
Query: 272 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----GHLTSRSDVYS 327
LLD + KL+DFG + T V GT Y +PE + + G+ D +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258
Query: 328 FGVVLLEMLTGR 339
GV L EML G
Sbjct: 259 VGVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 63/256 (24%), Positives = 96/256 (37%), Gaps = 36/256 (14%)
Query: 102 SSTSKLEEELKVASRLRKF-----TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 156
+ S L E + L ++L +F ++G G FG V
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAV-------- 92
Query: 157 APV-KPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGDLVHLNLVKLIGYCIEDDQRL 212
V A+K LN + E + E + L + + L Y +DD L
Sbjct: 93 --VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNL 149
Query: 213 -LVYEFMPRGSLENHL--FRRSLPLPWSIRMKIA-LGAAKGLAFLHEEAERPVIYRDFKT 268
LV ++ G L L F LP + R +A + A + +H+ ++RD K
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVHQ---LHYVHRDIKP 203
Query: 269 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS----- 323
NIL+D + + +L+DFG E S V GT Y +PE +
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPEC 262
Query: 324 DVYSFGVVLLEMLTGR 339
D +S GV + EML G
Sbjct: 263 DWWSLGVCMYEMLYGE 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 66/249 (26%), Positives = 101/249 (40%), Gaps = 44/249 (17%)
Query: 104 TSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 163
T+ + + D F +LG+G FG V + GT
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVMLS---------ERKGT 44
Query: 164 GLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFM 218
AVK L D + + + E L L +L C + RL V E++
Sbjct: 45 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYV 103
Query: 219 PRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272
G L H+ + P IA+G L FL + +IYRD K N++
Sbjct: 104 NGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVM 153
Query: 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGV 330
LD++ + K++DFG+ K+ T T+ GT Y APE ++ +S D ++FGV
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGV 209
Query: 331 VLLEMLTGR 339
+L EML G+
Sbjct: 210 LLYEMLAGQ 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 73/262 (27%), Positives = 102/262 (38%), Gaps = 44/262 (16%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 150
NA + ++ S +D F ++G+G FG V
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGKVLLA- 57
Query: 151 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCI 206
+ AVK L + KE ++E N L V H LV L +
Sbjct: 58 --------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSF 108
Query: 207 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAER 259
+ +L V +++ G L HL R R P R + IA L +LH
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---L 158
Query: 260 PVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGH 318
++YRD K NILLD+ + L+DFGL K+ E + T T GT Y APE V+
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQ 214
Query: 319 LTSRS-DVYSFGVVLLEMLTGR 339
R+ D + G VL EML G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGL 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 52/295 (17%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 189
++ + ++G G V VA+K +N + Q + L E+
Sbjct: 16 DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK-----IAL 244
+ H N+V + D+ LV + + GS+ + + + IA
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 245 ---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL-AKDGPEGDKTHVST 300
+GL +LH+ I+RD K NILL D + +++DFG+ A GD T
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 301 R--VMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
R +GT + APE + ++D++SFG+ +E+ TG K P
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--------- 233
Query: 358 RPHLGERRRFYRLI----DPRLEGHFSIKGAQKA-----AQLAAHCLSRDPKARP 403
+ L P LE K K ++ + CL +DP+ RP
Sbjct: 234 --------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 82/349 (23%), Positives = 127/349 (36%), Gaps = 68/349 (19%)
Query: 98 AESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESL------LGEGGFGCVFKGWI 151
N + + R D+ PE L +G G FG V+
Sbjct: 16 TTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-- 73
Query: 152 EENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIED 208
VA+K +++ G Q +++W + EV FL L H N ++ G + +
Sbjct: 74 -------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKT 268
LV E+ GS + L PL + GA +GLA+LH +I+RD K
Sbjct: 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 182
Query: 269 SNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR--VMGTYGYAAPEYVMT---GHLTSRS 323
NILL KL DFG A + ++ +GT + APE ++ G +
Sbjct: 183 GNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 324 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER-RRFYRLID----PRLE-G 377
DV+S G+ +E+ +P P I P L+ G
Sbjct: 235 DVWSLGITCIELAER-------KP-----------PLFNMNAMSALYHIAQNESPALQSG 276
Query: 378 HFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALKPLPNLKDM 421
H+S + CL + P+ RP L V +P + D+
Sbjct: 277 HWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 321
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 74/304 (24%), Positives = 116/304 (38%), Gaps = 33/304 (10%)
Query: 49 FFGSCISSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISST----TTSNAESNSST 104
F GS S++ + + + P + A+ T
Sbjct: 256 FMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGT 315
Query: 105 SKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 164
EE+ N ++ +F +LG+G FG V + GT
Sbjct: 316 KAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLS---------ERKGTD 366
Query: 165 LTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMP 219
AVK L D + + + E L L +L C + RL V E++
Sbjct: 367 ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVN 425
Query: 220 RGSLENHLFR-RSLPLPWSIRMKI-ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
G L H+ + P A A GL FL + +IYRD K N++LD++
Sbjct: 426 GGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 278 NAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEM 335
+ K++DFG+ K+ T T+ GT Y APE ++ +S D ++FGV+L EM
Sbjct: 480 HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEM 535
Query: 336 LTGR 339
L G+
Sbjct: 536 LAGQ 539
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
+GEG +G VFK + TG VA+K L E+ L
Sbjct: 11 IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L H NLV L+ + LV+E+ ++ + L R +P + I + + F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRVMGTYGYA 309
H+ I+RD K NIL+ KL DFG A+ GP V+TR Y
Sbjct: 118 CHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 310 APEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
+PE ++ DV++ G V E+L+G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 66/289 (22%), Positives = 108/289 (37%), Gaps = 62/289 (21%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
LG G +G V T + A+K + + + + L EV L L H
Sbjct: 45 LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 249
N++KL + ED + LV E G L + + R ++ +K L
Sbjct: 96 PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSG--- 148
Query: 250 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+ +LH+ +++RD K N+LL + D K+ DFGL+ K +GT
Sbjct: 149 VTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTA 202
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGERR 365
Y APE V+ + DV+S GV+L +L G P G+ + +
Sbjct: 203 YYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------PPFGGQTD------------Q 243
Query: 366 RFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 408
R + +G ++ + A L L D + R +
Sbjct: 244 EILRKV---EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 73/300 (24%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------------HDGLQGHKEWLA 185
LG G +G V + A+K + + ++ E +
Sbjct: 44 LGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 186 -EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR---- 239
E++ L L H N++KL ED + LV EF G L + R +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAAN 150
Query: 240 -MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDK 295
MK L + +LH + +++RD K NILL ++ N K+ DFGL+ + K
Sbjct: 151 IMKQILSG---ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 296 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLV 354
+GT Y APE V+ + DV+S GV++ +L G P G+++
Sbjct: 205 LR---DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY------PPFGGQND-- 252
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 408
+ + + +G + +A +L L+ D R E
Sbjct: 253 ----------QDIIKKV---EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 68/290 (23%), Positives = 109/290 (37%), Gaps = 63/290 (21%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV 194
LG+G FG V TG AVK ++ ++ + L EV L L
Sbjct: 34 LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 195 HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAK 248
H N++KL + ED LV E G L + + R +S ++ L
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSG-- 138
Query: 249 GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
+ ++H+ +++RD K N+LL D N ++ DFGL+ K +GT
Sbjct: 139 -ITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGT 191
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-R 364
Y APE V+ G + DV+S GV+L +L+G P G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------------------PPFNGANE 232
Query: 365 RRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 408
+ + +G ++ + + A L L+ P R +
Sbjct: 233 YDILKKV---EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 56/295 (18%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 183
L ++F ++G G + V T A+K + + + ++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDW 55
Query: 184 -LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 239
E + H LV L C + + RL V E++ G L H+ R R LP + R
Sbjct: 56 VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113
Query: 240 M---KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
+I+L L +LHE R +IYRD K N+LLD++ + KL+D+G+ K+G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166
Query: 297 HVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR----RSMDKNRPNGE 350
T GT Y APE ++ G S D ++ GV++ EM+ GR + P+
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 351 HNLVEWARPHLGERRRFYRLI---DPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR 402
+++I R+ S KAA + L++DPK R
Sbjct: 223 ------------TEDYLFQVILEKQIRIPRSLS----VKAASVLKSFLNKDPKER 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 72/245 (29%), Positives = 99/245 (40%), Gaps = 44/245 (17%)
Query: 108 EEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 167
E + S K D F +LG+G FG VF T
Sbjct: 2 ELNKERPSLQIKLKIED-------FILHKMLGKGSFGKVFLA---------EFKKTNQFF 45
Query: 168 AVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 222
A+K L D + + + E L H L + + + L V E++ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104
Query: 223 LENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276
L H+ L R I LG L FLH + ++YRD K NILLD D
Sbjct: 105 LMYHIQSCHKFDLS---RATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKD 154
Query: 277 YNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLE 334
+ K++DFG+ K+ GD T GT Y APE ++ G + S D +SFGV+L E
Sbjct: 155 GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYE 210
Query: 335 MLTGR 339
ML G+
Sbjct: 211 MLIGQ 215
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 37/260 (14%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 150
++ S + + K + T + F LG G FG V
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59
Query: 151 IEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCI 206
VK +G A+K L+ + K+ L E L + LVKL +
Sbjct: 60 --------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSF 110
Query: 207 EDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIRM---KIALGAAKGLAFLHEEAERPV 261
+D+ L +V E++ G + +HL R P + R +I L +LH +
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDL 162
Query: 262 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLT 320
IYRD K N+L+D +++DFG AK T + GT APE +++ G+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY-- 215
Query: 321 SRS-DVYSFGVVLLEMLTGR 339
+++ D ++ GV++ EM G
Sbjct: 216 NKAVDWWALGVLIYEMAAGY 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 56/310 (18%), Positives = 91/310 (29%), Gaps = 64/310 (20%)
Query: 139 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHL 196
G V TG V V+ +N + E++ H
Sbjct: 36 GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 197 NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL---GAAKGLAFL 253
N+V I D++ +V FM GS + L + + IA G K L ++
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMN-ELAIAYILQGVLKALDYI 144
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFG-LAKDGPEGDKTHV----STRVMGTYGY 308
H ++R K S+IL+ D LS G + V + +
Sbjct: 145 HHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 309 AAPEYVMTGHL---TSRSDVYSFGVVLLEMLTGR-------------------------- 339
+PE V+ +L ++SD+YS G+ E+ G
Sbjct: 202 LSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 340 ------RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAH 393
+ ++ + + R FS
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQ 316
Query: 394 CLSRDPKARP 403
CL R+P ARP
Sbjct: 317 CLQRNPDARP 326
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 70/250 (28%), Positives = 100/250 (40%), Gaps = 44/250 (17%)
Query: 103 STSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 162
S E + + ++ F +LG+G FG V
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDN-------FEFIRVLGKGSFGKVMLA---------RVKE 46
Query: 163 TGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEF 217
TG AVK L D + + + E L H L +L C + RL V EF
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 218 MPRGSLENHLFR-RSLPLPWSIRMK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNI 271
+ G L H+ + R R + I L FLH+ + +IYRD K N+
Sbjct: 106 VNGGDLMFHIQKSRRFDEA---RARFYAAEIISA----LMFLHD---KGIIYRDLKLDNV 155
Query: 272 LLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM-GTYGYAAPEYVMTGHLTSRS-DVYSFG 329
LLD + + KL+DFG+ K+G T T GT Y APE ++ L + D ++ G
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMG 211
Query: 330 VVLLEMLTGR 339
V+L EML G
Sbjct: 212 VLLYEMLCGH 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 69/289 (23%), Positives = 107/289 (37%), Gaps = 62/289 (21%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 249
N++KL ED +V E G L + + +R +S +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSG--- 133
Query: 250 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTA 187
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE-RR 365
Y APE V+ G + DV+S GV+L +L+G P G+
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNEY 228
Query: 366 RFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 408
+ + G ++ A L L+ P R ++
Sbjct: 229 DILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW- 183
K + ++F+ LG G FG V ++ G A+K L + + K+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVE 51
Query: 184 --LAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFR-RSLPLPWSIR 239
E L + H ++++ +D Q++ ++ +++ G L + L + + P P
Sbjct: 52 HTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---V 107
Query: 240 MK-----IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294
K + L L +LH + +IYRD K NILLD + + K++DFG AK P+
Sbjct: 108 AKFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
Query: 295 KTHVSTRVMGTYGYAAPEYVMT-GHLTSRS-DVYSFGVVLLEMLTGR 339
T + GT Y APE V T + ++S D +SFG+++ EML G
Sbjct: 161 YT-----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 185
+ L+GEG +G V K ++ TG VA+K + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
E+ L L H NLV L+ C + + LV+EF+ ++ + L L + + K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTH-VSTRV 302
G+ F H +I+RD K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 303 MGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
Y APE ++ DV++ G ++ EM G
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 63/296 (21%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 186
N+R +G+G F V TG VA+K ++ L L E
Sbjct: 16 NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64
Query: 187 VNFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
V + L H N+VKL + IE ++ L L+ E+ G + ++L RMK
Sbjct: 65 VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG-------RMKEKE 115
Query: 245 GAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV 298
+K + + H+ + +++RD K N+LLDAD N K++DFG + + G K
Sbjct: 116 ARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172
Query: 299 STRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356
G YAAPE + G DV+S GV+L +++G D NL E
Sbjct: 173 FC---GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE- 221
Query: 357 ARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ L G + I + L L +P R + ++++
Sbjct: 222 ----------LRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 72/303 (23%), Positives = 112/303 (36%), Gaps = 52/303 (17%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV 194
E +LGEG V + T AVK + EV L
Sbjct: 18 EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 195 -HLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAA 247
H N+++LI + E++ R LV+E M GS+ +H+ +R ++ ++ A
Sbjct: 69 GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASA- 123
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 303
L FLH + + +RD K NIL + K+ DF L GD + +ST +
Sbjct: 124 --LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 304 ----GTYGYAAPEYVMTGHLTSRS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 353
G+ Y APE V + D++S GV+L +L+G P G
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCGS 232
Query: 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSE 407
L + EG + A L + L RD K R ++
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292
Query: 408 VVE 410
V++
Sbjct: 293 VLQ 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 62/258 (24%), Positives = 96/258 (37%), Gaps = 62/258 (24%)
Query: 115 SRLRKFTFNDLKLATRNFRPESL---------LGEGGFGCVFKGWIEENGTAPVKPGTGL 165
SR + F F DL + ++ P++L LG G G V + T
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161
Query: 166 TVAVKTLNHDGLQGHKEWLA--------EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEF 217
VA++ ++ A E+ L L H ++K+ + + + +V E
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220
Query: 218 MPRGSLENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFK 267
M G E LF + + L + +LHE +I+RD K
Sbjct: 221 MEGG--E--LFDK-------VVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266
Query: 268 TSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL----T 320
N+LL + D K++DFG +K E T GT Y APE V+
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYN 322
Query: 321 SRSDVYSFGVVLLEMLTG 338
D +S GV+L L+G
Sbjct: 323 RAVDCWSLGVILFICLSG 340
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 81/323 (25%), Positives = 119/323 (36%), Gaps = 76/323 (23%)
Query: 114 ASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN 173
A L + + L+ F L+G G +G V+KG + TG A+K ++
Sbjct: 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58
Query: 174 HDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG------YCIEDDQRLLVYEFMPRGSLE-- 224
G +E E+N L H N+ G DDQ LV EF GS+
Sbjct: 59 VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 225 -NHLFRRSLPLPWSIRMKIAL---GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280
+ +L W IA +GL+ LH+ VI+RD K N+LL + K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169
Query: 281 LSDFGLAKDGPEGDKTHVSTR---VMGTYGYAAPEYVMTGHLT-----SRSDVYSFGVVL 332
L DFG++ R +GT + APE + +SD++S G+
Sbjct: 170 LVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITA 224
Query: 333 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGE---RRRFYRLID----PRLEG-HFSIKGA 384
+EM G P P R F LI PRL+ +S
Sbjct: 225 IEMAEG-------AP-----------PLCDMHPMRALF--LIPRNPAPRLKSKKWS---- 260
Query: 385 QKAAQLAAHCLSRDPKARPLMSE 407
+K CL ++ RP +
Sbjct: 261 KKFQSFIESCLVKNHSQRPATEQ 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 74/403 (18%), Positives = 136/403 (33%), Gaps = 80/403 (19%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G G +G V+K ++ A+K + G+ E+ L +L H N
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 198 LVKLIGYCIED-DQRL-LVYEFMP---RGSLENH----LFRRSLPLPWSIRMKIALGAAK 248
++ L + D+++ L++++ ++ H ++ + LP + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DGPEGDKTHVSTRV 302
G+ +LH V++RD K +NIL+ + K++D G A+ + P + V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 303 MGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEH---- 351
+ T+ Y APE ++ G H T D+++ G + E+LT R D N H
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
Query: 352 ----------NLVEW-----------ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQL 390
+W + +E H + KA L
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS-KAFHL 313
Query: 391 AAHCLSRDPKARPLMSEVVEALK-------PLPNLKDMASSSYYFQTMQAERIGSSPNTR 443
L+ DP R +A++ PLP A + + P+ +
Sbjct: 314 LQKLLTMDPIKRITSE---QAMQDPYFLEDPLPTSDVFAGCQIPYP-KREFLTEEEPDDK 369
Query: 444 NGIRAQGGSLSRNGQRSLSIPNGSYASPYHHQFPHPSPKPNGK 486
+ Q N P + H P K
Sbjct: 370 GDKKNQQQQQGNNHTNGTGHPG-------NQDSSHTQGPPLKK 405
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 6e-20
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
+GEG +G V+K + G T A+K + L+ E + E++ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L H N+VKL + +LV+E + + L+ L L L G+A+
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 310
H+ R V++RD K N+L++ + K++DFGLA+ P TH ++ T Y A
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 311 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
P+ V+ G ++ D++S G + EM+ G
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 42/302 (13%)
Query: 55 SSRSKVDSSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEE-ELKV 113
S VD ++ D+ A + S + + + +
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 114 ASRLRKFTFNDLKLATRNFR------PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTV 167
+ F + +LG G FG V K + TGL +
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKL 117
Query: 168 AVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL--- 223
A K + G++ +E E++ + L H NL++L E + LV E++ G L
Sbjct: 118 AAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDR 176
Query: 224 ---ENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DAD 276
E++ ++ MK G+ +H + +++ D K NIL
Sbjct: 177 IIDESYNLTELDTILF-----MKQICE---GIRHMH---QMYILHLDLKPENILCVNRDA 225
Query: 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEML 336
K+ DFGLA+ +K V GT + APE V ++ +D++S GV+ +L
Sbjct: 226 KQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 337 TG 338
+G
Sbjct: 283 SG 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 185
+ LGEG + V+KG + T VA+K + + H+E +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
EV+ L DL H N+V L + LV+E++ + L+ +L +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVM 303
+GLA+ H + V++RD K N+L++ KL+DFGLA K P + V+
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 304 GTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
T Y P+ ++ G +++ D++ G + EM TGR
Sbjct: 163 -TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 8e-20
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
+GEG +G VFK E T VA+K + L E L E+ L +
Sbjct: 10 IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L H N+V+L D + LV+EF + L+ + + L I KGL F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 310
H R V++RD K N+L++ + KL++FGLA+ P + V+ T Y
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 311 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGRR 340
P+ V+ G ++ D++S G + E+ R
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-20
Identities = 70/272 (25%), Positives = 114/272 (41%), Gaps = 37/272 (13%)
Query: 82 RDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEG 141
R A +A + S+ ++ KV + + + ++ ++G G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65
Query: 142 GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 201
FG V++ + + +G VA+K + LQ + E+ + L H N+V+L
Sbjct: 66 SFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRL 112
Query: 202 IGYCI------EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
Y +D+ L LV +++P + H R LP + LA+
Sbjct: 113 R-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYA 309
+H + +RD K N+LLD D KL DFG AK G+ + +R Y Y
Sbjct: 172 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223
Query: 310 APEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
APE ++ G TS DV+S G VL E+L G+
Sbjct: 224 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 57/287 (19%), Positives = 97/287 (33%), Gaps = 29/287 (10%)
Query: 62 SSVSGTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFT 121
+ G S + ++ T + V +++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 122 FNDLKLATRNFRP----ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 177
+++ + LG G FG V + + TG A K +
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHE 195
Query: 178 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWS 237
+ E+ + L H LV L +D++ +++YEFM G E LF +
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNK 251
Query: 238 IRMKIALGAAK----GLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGP 291
+ A+ + GL +H E ++ D K NI+ KL DFGL
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
V GT +AAPE + +D++S GV+ +L+G
Sbjct: 309 PKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
+GEG +G V+K K G VA+K + L E + E++ L +
Sbjct: 29 VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L H N+V LI + LV+EFM + L+ L L S +G+A
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD--GPEGDKTHVSTRVMGTYGYAA 310
H+ +++RD K N+L+++D KL+DFGLA+ P TH V+ T Y A
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187
Query: 311 PEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
P+ V+ G ++ D++S G + EM+TG+
Sbjct: 188 PD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 72/292 (24%), Positives = 109/292 (37%), Gaps = 66/292 (22%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVHL 196
LG G FG V + +GL +KT+N D Q E + E+ L L H
Sbjct: 30 LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 197 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR----------MKIALG 245
N++K+ ED + +V E G E L R + + MK +
Sbjct: 81 NIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
A LA+ H + V+++D K NIL K+ DFGLA+ + +
Sbjct: 136 A---LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA 187
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
GT Y APE V +T + D++S GVV+ +LTG P G
Sbjct: 188 -GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------------LPFTG 227
Query: 363 E-RRRFYRLIDPRLEGHFSIKGA-----QKAAQLAAHCLSRDPKARPLMSEV 408
+ + +A L L++DP+ RP ++V
Sbjct: 228 TSLEEVQQKA---TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 195
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 248
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 249 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 308 YAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 339
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGD 192
LLGEG +G V + E T AVK L L+ A E+ L
Sbjct: 12 LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 193 LVHLNLVKLIG-YCIEDDQRL-LVYEFMPRGSLE--NHLFRRSLPLPWSIRMKIALGAAK 248
L H N+++L+ E+ Q++ +V E+ G E + + + P+ + L
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL--ID 120
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTHVSTRVMGT 305
GL +LH + ++++D K N+LL K+S G+A D S G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GS 174
Query: 306 YGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 339
+ PE + G T + D++S GV L + TG
Sbjct: 175 PAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
F+ E + G+G FG V G + TG++VA+K + D ++E L +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71
Query: 189 FLGDLVHLNLVKLI------GYCIEDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIR 239
L L H N+V+L G D L +V E++P + +RR + P +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 240 MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKD-GPEGDKTH 297
+ + LH + V +RD K N+L++ AD KL DFG AK P
Sbjct: 132 KVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 298 -VSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
+ +R Y Y APE ++ G H T+ D++S G + EM+ G
Sbjct: 191 YICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-19
Identities = 70/295 (23%), Positives = 104/295 (35%), Gaps = 76/295 (25%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
+G G +G V V+ GT + A K + ++ + E+ + L H N
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 198 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MKIA 243
+++L ED+ + LV E G E LF R + MK
Sbjct: 68 IIRLYET-FEDNTDIYLVMELCTGG--E--LFER-------VVHKRVFRESDAARIMKDV 115
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVST 300
L A +A+ H+ V +RD K N L D KL DFGLA G + T
Sbjct: 116 LSA---VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRT 167
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
+V GT Y +P+ V+ G D +S GV++ +L G P
Sbjct: 168 KV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------------------PPF 207
Query: 361 LGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEV 408
I EG F+ +A L L++ PK R +
Sbjct: 208 SAPTDSEVMLKI---REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 65/313 (20%), Positives = 111/313 (35%), Gaps = 57/313 (18%)
Query: 55 SSRSKVDSSVSGTSTHYAE-SKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKV 113
R + + E ++ + RD P+ + +
Sbjct: 17 KERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQS 76
Query: 114 ASRLRKF-TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 172
+ + K + + P+ ++G G V + V TG AVK +
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIM 127
Query: 173 NHDGLQGHKEWLA--------EVNFLGDLV-HLNLVKLIGYCIEDDQRL-LVYEFMPRGS 222
+ E L E + L + H +++ LI E + LV++ M +G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG- 185
Query: 223 LENHLFRRSLPLPWSIRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNIL 272
E LF + K+AL ++FLH +++RD K NIL
Sbjct: 186 -E--LFDY-------LTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENIL 232
Query: 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DV 325
LD + +LSDFG + G+K GT GY APE ++ + D+
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDL 288
Query: 326 YSFGVVLLEMLTG 338
++ GV+L +L G
Sbjct: 289 WACGVILFTLLAG 301
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 74/292 (25%), Positives = 115/292 (39%), Gaps = 66/292 (22%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGDL 193
LG G FG V G TG VAVK LN ++ E+ L
Sbjct: 18 TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 194 VHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK--- 248
H +++KL Y I +V E++ G L +++ + R++
Sbjct: 69 RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQ 119
Query: 249 ---GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S G+
Sbjct: 120 ILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 306 YGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHV---------- 216
Query: 364 RRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
++ I G F I + L H L DP R + ++ E
Sbjct: 217 -PTLFKKI---RGGVFYIPEYLNRSVAT---LLMHMLQVDPLKRATIKDIRE 261
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 65/212 (30%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
LGEG F V+K + T VA+K + K+ L E+ L +
Sbjct: 18 LGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L H N++ L+ LV++FM LE + SL L S L +GL +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK--DGPEGDKTH-VSTRVMGTYGYA 309
LH+ +++RD K +N+LLD + KL+DFGLAK P TH V TR Y
Sbjct: 128 LHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYR 179
Query: 310 APEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
APE ++ G D+++ G +L E+L
Sbjct: 180 APE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 62/295 (21%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGD 192
+G+G F V + + TG AVK ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 193 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPW------SIRMKIALG 245
L H ++V+L+ D L +V+EFM L + +R+ S M+ L
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
A L + H + +I+RD K +LL + KL FG+A E RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194
Query: 303 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
GT + APE V+ + DV+ GV+L +L+G P
Sbjct: 195 -GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------------------LPFY 234
Query: 362 GERRRFYRLIDPRLEGHFSIKGAQ------KAAQLAAHCLSRDPKARPLMSEVVE 410
G + R + I ++G + + Q A L L DP R + E +
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 39/263 (14%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 150
S T ++ + + L++ KV L + + ++G G FG VF+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAK 60
Query: 151 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI---- 206
+ E+ VA+K + LQ + E+ + + H N+V L
Sbjct: 61 LVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLK-AFFYSNG 105
Query: 207 --EDDQRL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPV 261
+D+ L LV E++P H + +P + + LA++H +
Sbjct: 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGI 162
Query: 262 IYRDFKTSNILLDADYNA-KLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG- 317
+RD K N+LLD KL DFG AK G+ + +R Y Y APE ++ G
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPE-LIFGA 216
Query: 318 -HLTSRSDVYSFGVVLLEMLTGR 339
+ T+ D++S G V+ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
LG G + V+KG + TG+ VA+K + D +E + E++ + +
Sbjct: 13 LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMP---RGSLENHLFRRS-LPLPWSIRMKIALGAAK 248
L H N+V+L +++ LV+EFM + +++ + L ++ +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA--KDGPEGDKTHVSTRVMGTY 306
GLAF HE +++RD K N+L++ KL DFGLA P + V+ T
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172
Query: 307 GYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
Y AP+ V+ G ++ D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 68/255 (26%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGD 192
+G+G +G V ++ T A+K +N + ++ EV +
Sbjct: 34 IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 193 LVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------ 245
L H N+ +L ED+Q + LV E G L + L M +
Sbjct: 85 LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 246 --------------------------AAK-------GLAFLHEEAERPVIYRDFKTSNIL 272
+ L +LH + + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 273 LDADYNA--KLSDFGLAK---DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSD 324
+ + KL DFGL+K G+ ++T+ GT + APE V+ S + D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNESYGPKCD 258
Query: 325 VYSFGVVLLEMLTGR 339
+S GV+L +L G
Sbjct: 259 AWSAGVLLHLLLMGA 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGDLVH 195
LGEG +G V V T VAVK ++ E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK------ 248
N+VK G + L E+ G L + + I M A +
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPD-AQRFFHQLM 115
Query: 249 -GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
G+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 116 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 308 YAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGR 339
Y APE ++ DV+S G+VL ML G
Sbjct: 173 YVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 72/299 (24%), Positives = 107/299 (35%), Gaps = 78/299 (26%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
LG+G FG V K T AVK +N + L EV L L H
Sbjct: 30 LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-------------MK 241
N++KL ED +V E G E LF I +K
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGG--E--LFDE-------IIKRKRFSEHDAARIIK 128
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHV 298
+ ++H+ +++RD K NILL + D + K+ DFGL+ + K
Sbjct: 129 QVFSG---ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 299 STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358
R+ GT Y APE V+ G + DV+S GV+L +L+G
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------P 220
Query: 359 PHLGE-RRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 410
P G+ + + G ++ A L L+ P R ++ +E
Sbjct: 221 PFYGKNEYDILKRV---ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 56/226 (24%), Positives = 84/226 (37%), Gaps = 53/226 (23%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 189
LG G G V + T VA+K ++ A E+
Sbjct: 18 LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG---A 246
L L H ++K+ + + + +V E M G E LF + + L
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG--E--LFDK-------VVGNKRLKEATC 116
Query: 247 AK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 296
+ +LHE +I+RD K N+LL + D K++DFG +K E
Sbjct: 117 KLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSR----SDVYSFGVVLLEMLTG 338
T GT Y APE V+ T+ D +S GV+L L+G
Sbjct: 174 --RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 54/219 (24%), Positives = 83/219 (37%), Gaps = 48/219 (21%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL 196
+LG G F VF + TG A+K + E+ L + H
Sbjct: 16 VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 197 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG------AAK- 248
N+V L E LV + + G E LF R I + G A+
Sbjct: 67 NIVTLEDI-YESTTHYYLVMQLVSGG--E--LFDR-------I---LERGVYTEKDASLV 111
Query: 249 ------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVS 299
+ +LHE +++RD K N+L + + ++DFGL+K G +
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 300 TRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
+ GT GY APE + + D +S GV+ +L G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 68/366 (18%), Positives = 116/366 (31%), Gaps = 77/366 (21%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 185
+ S LG G FG V+ V V VK + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 186 ---EVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGS-LENHLFRRSLPLPWSIRM 240
E+ L + H N++K++ E+ LV E G L + R R+
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHP-------RL 127
Query: 241 KIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294
L + + +L + +I+RD K NI++ D+ KL DFG A G
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 295 KTHVSTRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMD--KNRPNGE 350
+ GT Y APE V+ G+ +++S GV L ++ +
Sbjct: 185 LFYTFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
P S ++ L + L P+ R + ++V
Sbjct: 241 -----------------IHP--PY---LVS----KELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 411 A--LKPLPNLKDMASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSY 468
+ NL D Y ++ + S G + ++ + G
Sbjct: 275 DPWVTQPVNLAD-----YTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEG 329
Query: 469 ASPYHH 474
+HH
Sbjct: 330 HHHHHH 335
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 37/297 (12%), Positives = 78/297 (26%), Gaps = 68/297 (22%)
Query: 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 183
R +R G ++ VA+ ++ G+ +E
Sbjct: 29 ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L+ L + + +++ L+V E++ GSL+ + P P ++
Sbjct: 79 LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGA-IRAM 135
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
A H V S + + D + L+
Sbjct: 136 QSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------------------ 174
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
+ D+ G L +L R + + G + + A
Sbjct: 175 ----TMPDA-------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTAG 220
Query: 364 R----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416
+ R I ++ +AA + D R S ++ ++
Sbjct: 221 QPIEPADIDRDIPFQIS------------AVAARSVQGDGGIRSA-STLLNLMQQAT 264
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 52/258 (20%), Positives = 92/258 (35%), Gaps = 29/258 (11%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRP----ESLLGEGGFGCV 146
+ + + +K+ +++ + LG G FG V
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67
Query: 147 FKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206
+ V+ TG K +N E++ + L H L+ L
Sbjct: 68 HRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-F 117
Query: 207 EDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFLHEEAERPVI 262
ED + L+ EF+ G L + + + M+ A GL +H E ++
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMH---EHSIV 171
Query: 263 YRDFKTSNILL--DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT 320
+ D K NI+ + K+ DFGLA + V T +AAPE V +
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVG 228
Query: 321 SRSDVYSFGVVLLEMLTG 338
+D+++ GV+ +L+G
Sbjct: 229 FYTDMWAIGVLGYVLLSG 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 56/238 (23%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 180
N+ P+ +LG G V + + T AVK ++ + +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 181 KEWLA-EVNFLGDL-VHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWS 237
+E EV+ L + H N+++L E + LV++ M +G E LF
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDY------- 114
Query: 238 IRMKIALG---AAK-------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287
+ K+ L K + LH+ +++RD K NILLD D N KL+DFG +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-------DVYSFGVVLLEMLTG 338
G+K GT Y APE ++ + D++S GV++ +L G
Sbjct: 172 CQLDPGEKL--REVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 53/289 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHL 196
LGEG F K V + AVK ++ ++ E+ L H
Sbjct: 19 LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66
Query: 197 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 250
N+VKL D LV E + G L + ++ +S M+ + A +
Sbjct: 67 NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSA---V 119
Query: 251 AFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+ +H+ V++RD K N+L + + K+ DFG A+ P ++ + T T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLH 174
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367
YAAPE + D++S GV+L ML+G+ P +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCTSA 221
Query: 368 YRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 410
++ +G FS +G Q+A L L+ DP R MS +
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 67/342 (19%), Positives = 113/342 (33%), Gaps = 80/342 (23%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 150
S+ S+ + K+A K ++ LLG GGFG V+ G
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES------QYQVGPLLGSGGFGSVYSG- 62
Query: 151 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGDLVHL--NLVKLI 202
++ L VA+K + D + E EV L + +++L+
Sbjct: 63 --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114
Query: 203 GYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAK------GLAFLH 254
+ E L+ E P L + + R ++ L + + H
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERG-------ALQEELARSFFWQVLEAVRHCH 166
Query: 255 EEAERPVIYRDFKTSNILLDADY-NAKLSDFGLA---KDGPEGDKTHVSTRVMGTYGYAA 310
V++RD K NIL+D + KL DFG KD GT Y+
Sbjct: 167 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFD-----GTRVYSP 216
Query: 311 PEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
PE++ H + V+S G++L +M+ G + + ++
Sbjct: 217 PEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQ----------V 260
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ S + L CL+ P RP E+
Sbjct: 261 FF--RQ---RVS----SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
LGEG +G V+K T TVA+K + L+ +E + EV+ L +
Sbjct: 42 LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L H N+++L + + L++E+ L+ ++ ++ + + G+ F
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--GPEGDKTHVSTRVMGT 305
H R ++RD K N+LL + K+ DFGLA+ P TH ++ T
Sbjct: 148 CH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-T 200
Query: 306 YGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGR 339
Y PE ++ G H ++ D++S + EML
Sbjct: 201 LWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 74/295 (25%), Positives = 117/295 (39%), Gaps = 60/295 (20%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 187
++ LG G FG V G TG VAVK LN ++ E+
Sbjct: 17 HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 188 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
L H +++KL Y I + +V E++ G L +++ + R+
Sbjct: 68 QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKES 118
Query: 246 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
G+ + H V++RD K N+LLDA NAK++DFGL+ +G+ S
Sbjct: 119 RRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 300 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
G+ YAAPE V++G L D++S GV+L +L G D + ++
Sbjct: 176 C---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD------DDHV---- 221
Query: 358 RPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLMSEVVE 410
++ I +G F L H L DP R + ++ E
Sbjct: 222 -------PTLFKKI---CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 49/229 (21%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 186
+ N+ + LG+G F V + V TGL A K +N L ++ E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG- 245
L H N+V+L E+ LV++ + G E LF I +A
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFED-------I---VAREF 101
Query: 246 -----AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDG 290
A+ +A+ H +++R+ K N+LL KL+DFGLA +
Sbjct: 102 YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158
Query: 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 338
+ + H GT GY +PE V+ + D+++ GV+L +L G
Sbjct: 159 NDSEAWH--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 66/305 (21%), Positives = 104/305 (34%), Gaps = 78/305 (25%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWL 184
+R LLG+GGFG VF G + L VA+K + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 185 AEVNFL----GDLVHLNLVKLIGYCIEDDQRL-LVYEF-MPRGSLENHLFRRSLPLPWSI 238
EV L H +++L+ + E + LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKG------- 134
Query: 239 RMKIALGAAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLA---K 288
+ + H R V++RD K NIL+D KL DFG
Sbjct: 135 PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRP 347
D P GT Y+ PE++ + V+S G++L +M+ G
Sbjct: 192 DEPY--TDFD-----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD-------- 236
Query: 348 NGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKG--AQKAAQLAAHCLSRDPKARPLM 405
P ++ I LE + L CL+ P +RP +
Sbjct: 237 ----------IPFERDQE-----I---LEAELHFPAHVSPDCCALIRRCLAPKPSSRPSL 278
Query: 406 SEVVE 410
E++
Sbjct: 279 EEILL 283
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 67/298 (22%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 187
+ LGEG FG V T VA+K ++ L+ + E+
Sbjct: 10 PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 188 NFLGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
++L L H +++KL Y I + +V E+ G L +++ + RM G
Sbjct: 61 SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEG 110
Query: 246 AAK------GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS 299
+ + H +++RD K N+LLD + N K++DFGL+ +G+ S
Sbjct: 111 RRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 300 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
G+ YAAPE V+ G L DV+S G+VL ML GR D + +
Sbjct: 168 C---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFI---- 213
Query: 358 RPHLGERRRFYRLIDPRLEGHFSI-----KGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
++ + + + GAQ L + DP R + E+
Sbjct: 214 -------PNLFKKV---NSCVYVMPDFLSPGAQS---LIRRMIVADPMQRITIQEIRR 258
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 33/238 (13%)
Query: 112 KVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT 171
+ R +F N + N+ + LG+G F V + V TGL A K
Sbjct: 11 QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61
Query: 172 LNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLF 228
+N L ++ E L H N+V+L I+++ LV++ + G L +
Sbjct: 62 INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120
Query: 229 RRSLPLPWSIR-----MKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAK 280
R +S ++ L + +A+ H +++R+ K N+LL K
Sbjct: 121 ARE---FYSEADASHCIQQILES---IAYCHS---NGIVHRNLKPENLLLASKAKGAAVK 171
Query: 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
L+DFGLA + + + H GT GY +PE + + D+++ GV+L +L G
Sbjct: 172 LADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 191
LG G F V K + TGL A K + + + + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 192 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 244
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 300
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
+GEG +G VFK +N G VA+K + +Q +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67
Query: 193 L---VHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 241
L H N+V+L + + +L LV+E + L+ +P
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKD 124
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 300
+ +GL FLH V++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 125 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--- 178
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
V+ T Y APE ++ + D++S G + EM +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 40/218 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 191
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 192 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 244
++H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 71 QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA----TSFIKQIL 125
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 300
G+ +LH + + + D K NI+L + KL DFGLA + +G +
Sbjct: 126 D---GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 61/294 (20%), Positives = 101/294 (34%), Gaps = 62/294 (21%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 195
+LG G G V + TG A+K L + EV+
Sbjct: 36 VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 196 LNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALG 245
++V ++ E+ L++ E M G L + + R ++ R M+
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGT 139
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
A + FLH + +RD K N+L + D KL+DFG AK+ + + T
Sbjct: 140 A---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC 190
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
T Y APE + D++S GV++ +L G ++
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------------YSNTGQA 236
Query: 363 ERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 410
R I G + + A QL L DP R +++ +
Sbjct: 237 ISPGMKRRI---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 42/222 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF-------- 189
+G G +G V+K +G VA+K++ + +
Sbjct: 17 IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64
Query: 190 ---LGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMP---RGSLENHLFRRSLPLPWSI 238
L H N+V+L+ + + ++ LV+E + R L+ LP
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAET 121
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTH 297
+ +GL FLH +++RD K NIL+ + KL+DFGLA+ + T
Sbjct: 122 IKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
V+ T Y APE ++ + D++S G + EM +
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 191
LG G F V K + GTG A K + L + ++ EVN L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 192 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 244
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA----TQFLKQIL 118
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 300
G+ +LH + + + D K NI+L + KL DFG+A G++
Sbjct: 119 D---GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 171 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 42/207 (20%), Positives = 81/207 (39%), Gaps = 26/207 (12%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN 197
LG G FG V + V+ + T K + G E++ L H N
Sbjct: 13 LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62
Query: 198 LVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP---WSIRMKIALGAAKGLAFL 253
++ L E + L +++EF+ + + + L + + L FL
Sbjct: 63 ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC---EALQFL 118
Query: 254 HEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
H + + D + NI+ ++ K+ +FG A+ GD + + Y AP
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTG 338
E +++ +D++S G ++ +L+G
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGD 192
+G+G FG VFK + TG VA+K + ++ KE L E+ L
Sbjct: 25 IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72
Query: 193 LVHLNLVKLIGYCIEDDQRL--------LVYEFMP---RGSLENHLFRRSLPLPWSIRMK 241
L H N+V LI C LV++F G L N L + +L + M+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-MQ 131
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA------KDGPEGDK 295
+ L GL ++H +++RD K +N+L+ D KL+DFGLA K+
Sbjct: 132 MLL---NGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 296 THVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGR 339
T+ RV+ T Y PE ++ D++ G ++ EM T
Sbjct: 186 TN---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 36/114 (31%), Positives = 50/114 (43%), Gaps = 3/114 (2%)
Query: 224 ENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283
E L + + AKG+ FL A R I+RD NILL K+ D
Sbjct: 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
FGLA+D + + APE + T +SDV+SFGV+L E+ +
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 12/107 (11%)
Query: 132 FRPESL-----LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLA 185
F + L LG G FG V + K T TVAVK L H+ ++
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMS 74
Query: 186 EVNFLGDLV-HLNLVKLIGYCIEDDQRLLV-YEFMPRGSLENHLFRR 230
E+ L + HLN+V L+G C + L+V EF G+L +L +
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/294 (22%), Positives = 103/294 (35%), Gaps = 67/294 (22%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 196
+G G + + + T + AVK ++ E E+ L H
Sbjct: 30 IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76
Query: 197 NLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKGL 250
N++ L +D + + +V E M G L + + R+ +S R + +
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKT---V 129
Query: 251 AFLHEEAERPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+LH + V++RD K SNIL D N ++ DFG AK + + T T
Sbjct: 130 EYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTA 184
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHLG 362
+ APE + + D++S GV+L MLTG D
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--------------- 229
Query: 363 ERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 410
I G FS+ G A L + L DP R + V+
Sbjct: 230 ---EILARI---GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 36/215 (16%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
LG G F V + + TG A K L E L E+ L
Sbjct: 37 LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 196 L-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPW--------SIRMKIALGA 246
++ L + +L+ E+ G E +F LP +K L
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQILE- 142
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
G+ +LH + +++ D K NILL + K+ DFG+++ + +M
Sbjct: 143 --GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IM 194
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
GT Y APE + +T+ +D+++ G++ +LT
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 33/222 (14%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
+ ++ +G G G V VA+K L+ K E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 187 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 240
+ + + H N++ L+ +E+ Q + LV E M + + + L RM
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL---DHERM 166
Query: 241 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--H 297
L G+ LH +I+RD K SNI++ +D K+ DFGLA+ +
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
V TR Y APE ++ D++S G ++ EM+ +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 191
LG G F V K + TGL A K + + + ++ EV+ L
Sbjct: 19 LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 192 DLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSL------ENHLFRRSLPLPWSIRMKIAL 244
++ H N++ L E+ + L+ E + G L + L + +K L
Sbjct: 70 EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEA----TEFLKQIL 124
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNAKLSDFGLAKDGPEGDKTHVST 300
+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 125 NG---VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG 338
+ GT + APE V L +D++S GV+ +L+G
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 50/238 (21%), Positives = 89/238 (37%), Gaps = 55/238 (23%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 185
+G+G +G V A+K L+ L +
Sbjct: 20 EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 186 ---------------EVNFLGDLVHLNLVKLIGYCI----EDDQRLLVYEFMPRGSLENH 226
E+ L L H N+VKL + +D +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 227 LFRRSLPLPWSIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284
+ L + + G + +LH + +I+RD K SN+L+ D + K++DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT---SRSDVYSFGVVLLEMLTGR 339
G++ + +G +S V GT + APE + DV++ GV L + G+
Sbjct: 182 GVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 35/219 (15%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+++ LG G + VF+ N V VK L K+ E+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84
Query: 191 GDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL--PWSIR--MKIALG 245
+L N++ L + R F + N F++ + IR M L
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA-KLSDFGLAKDG-PEGDKTH-VSTRV 302
K L + H +++RD K N+++D ++ +L D+GLA+ P + V++R
Sbjct: 141 --KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 303 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRR 340
+ PE ++ + S D++S G +L M+ +
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 66/359 (18%), Positives = 116/359 (32%), Gaps = 64/359 (17%)
Query: 72 AESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRN 131
+S + P + A+ + + V S L+ +
Sbjct: 7 GQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID---DY 63
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 191
+LG G G V + T A+K L + EV
Sbjct: 64 KVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHW 109
Query: 192 DLV-HLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIR-----M 240
++V+++ E+ L+V E + G L + + R ++ R M
Sbjct: 110 RASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIM 167
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDGPEGDKTH 297
K A + +LH + +RD K N+L NA KL+DFG AK+ +
Sbjct: 168 KSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-- 219
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
++T T Y APE + D++S GV++ +L G P ++
Sbjct: 220 LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPF-------YS 265
Query: 358 RPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVVE 410
L I G + ++ L + L +P R ++E +
Sbjct: 266 NHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 65/297 (21%), Positives = 98/297 (32%), Gaps = 60/297 (20%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 189
+ +G G FG T VAVK + E + E+
Sbjct: 21 RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69
Query: 190 LGDLVHLNLVKLIGY-CIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
L H N+V+ I L ++ E+ G L + R
Sbjct: 70 HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG-------RFSEDEARF 120
Query: 248 K------GLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGDKTHVS 299
G+++ H + +RD K N LLD K+ DFG +K +
Sbjct: 121 FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 175
Query: 300 TRVMGTYGYAAPEYVMTGHL--TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
+ V GT Y APE V+ +DV+S GV L ML G + P +
Sbjct: 176 STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPEEPRDY---- 227
Query: 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR----DPKARPLMSEVVE 410
R+ + I L +SI + + H +SR DP R + E+
Sbjct: 228 -------RKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 55/231 (23%), Positives = 89/231 (38%), Gaps = 40/231 (17%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 183
+ + + G +G V G+ VA+K + + G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 184 ------LAEVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSL 232
L E+ L H N++ L + + +L LV E M L + + +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI 129
Query: 233 PLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDG 290
+ ++ GL LHE A V++RD NILL + + + DF LA +D
Sbjct: 130 VIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 291 PEGDKT-HVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
+ +KT +V+ R Y APE VM T D++S G V+ EM +
Sbjct: 186 ADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVH 195
LG+G F V + VK G A +N L H++ E L H
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 196 LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIR-----MKIALGAAKG 249
N+V+L I ++ L+++ + G L + R +S ++ L A
Sbjct: 70 PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEA--- 122
Query: 250 LAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
+ H+ V++R+ K N+LL KL+DFGLA + EG++ GT
Sbjct: 123 VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFA-GTP 177
Query: 307 GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTG 338
GY +PE V+ D+++ GV+L +L G
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 78/364 (21%), Positives = 119/364 (32%), Gaps = 85/364 (23%)
Query: 70 HYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLAT 129
H+ S + + + ++ S T ++ + S + L F
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF--------- 54
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
F ES LG G V++ + GT A+K L K E+
Sbjct: 55 --FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGV 101
Query: 190 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG--- 245
L L H N++KL E + LV E + G L F R I + G
Sbjct: 102 LLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDR-------I---VEKGYYS 146
Query: 246 ---AAK-------GLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPE 292
AA +A+LHE +++RD K N+L D K++DFGL+K
Sbjct: 147 ERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352
V GT GY APE + D++S G++ +L G
Sbjct: 204 QVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF------------- 247
Query: 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMS 406
P ER + L + A L + DPK R
Sbjct: 248 -----EPFYDERGD-QFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTF 301
Query: 407 EVVE 410
+ ++
Sbjct: 302 QALQ 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 53/258 (20%), Positives = 97/258 (37%), Gaps = 71/258 (27%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 187
++ + LG G FG V + + E +G A+K L + E+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51
Query: 188 NFLGDLVHLNLVKLIGY-------------------------------------CIEDDQ 210
+ + L H+N++KL+ Y ++
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 211 RL-LVYEFMPR--GSLENHLFRRSLPLPWSIRMKIAL-GAAKGLAFLHEEAERPVIYRDF 266
L ++ E++P + R +P + I + + + F+H + +RD
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRDI 167
Query: 267 KTSNILLDA-DYNAKLSDFGLAKDGPEGDK-TH-VSTRVMGTYGYAAPEYVMTG--HLTS 321
K N+L+++ D KL DFG AK + + +R + Y APE +M G T
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTP 221
Query: 322 RSDVYSFGVVLLEMLTGR 339
D++S G V E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 33/222 (14%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
+ ++ +G G G V VA+K L+ K E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 187 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 240
+ + + H N++ L+ +E+ Q + +V E M +L + + L RM
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL-CQVIQMEL---DHERM 129
Query: 241 KIAL-GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA-KDGPEGDKT-H 297
L G+ LH +I+RD K SNI++ +D K+ DFGLA G T +
Sbjct: 130 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR 339
V TR Y APE ++ D++S G ++ EM+ G
Sbjct: 187 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 54/232 (23%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
+ + + +G G +G V + +G VA+K L+ K E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 187 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLPWSIRM 240
+ L + H N++ L+ + + LV FM + L + + +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK-------IMGL 121
Query: 241 KIA-----------LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289
K + L KGL ++H A V++RD K N+ ++ D K+ DFGLA+
Sbjct: 122 KFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR- 174
Query: 290 GPEGDKTH-VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
+ + T V TR + Y APE +++ H D++S G ++ EMLTG+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
++ S +G G +G V + + TGL VAVK L+ + K E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 187 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 238
+ L + H N++ L+ +E+ + LV M L + L
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDH 133
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 297
+ +GL ++H A+ +I+RD K SN+ ++ D K+ DFGLA+ + T +
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGY 189
Query: 298 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
V+TR Y APE ++ H D++S G ++ E+LTGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 56/243 (23%), Positives = 94/243 (38%), Gaps = 42/243 (17%)
Query: 117 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 176
+ F+ + LG GG G VF V VA+K +
Sbjct: 2 MNIHGFD----LGSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTD 48
Query: 177 LQGHKEWLAEVNFLGDLVHLNLVKLI-------------GYCIEDDQRL-LVYEFMPRGS 222
Q K L E+ + L H N+VK+ + + + +V E+M
Sbjct: 49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM---- 104
Query: 223 LENHLFR--RSLPLPWSIRMK-IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYN 278
E L PL + +GL ++H A V++RD K +N+ ++ D
Sbjct: 105 -ETDLANVLEQGPLL-EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLV 159
Query: 279 AKLSDFGLAK-DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEML 336
K+ DFGLA+ P + + T Y +P +++ + T D+++ G + EML
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 337 TGR 339
TG+
Sbjct: 220 TGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
+R +G G +G V V TG VA+K L K E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 187 VNFLGDLVHLNLVKLI-----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSI 238
+ L + H N++ L+ ++D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDR 129
Query: 239 RMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT-H 297
+ KGL ++H A +I+RD K N+ ++ D K+ DFGLA+ + + T +
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTGY 185
Query: 298 VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
V TR Y APE ++ T D++S G ++ EM+TG+
Sbjct: 186 VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 35/225 (15%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 187
+ S +GEG +G V + VA+K ++ + + L E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREI 76
Query: 188 NFLGDLVHLNLVKLIG----YCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 240
L H N++ + IE + + +V + M E L++ ++ L + +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHI 130
Query: 241 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK-DGPEGDK 295
L +GL ++H A V++RD K SN+LL+ + K+ DFGLA+ P+ D
Sbjct: 131 CYFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 296 THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGR 339
T T + T Y APE ++ T D++S G +L EML+ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 52/330 (15%), Positives = 100/330 (30%), Gaps = 85/330 (25%)
Query: 66 GTSTHYAESKSTNDTSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDL 125
G+S A ++ N ++ + + S+ T+ + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPR--------PHSDWQ-- 50
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 185
+ L+G G +G V + VA+K +
Sbjct: 51 --IPDRYEIRHLIGTGSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDC 96
Query: 186 -----EVNFLGDLVHLNLVKL----IGYCIEDDQRL-LVYEFMPRGSLENHLFRRSLPLP 235
E+ L L H ++VK+ I +E L +V E ++ +
Sbjct: 97 KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK------ 145
Query: 236 WSIRMKIALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285
R + L G+ ++H A +++RD K +N L++ D + K+ DFG
Sbjct: 146 -LFRTPVYLTELHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFG 201
Query: 286 LA---------KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH------------LTSRS- 323
LA ++ + +TGH L +
Sbjct: 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY 261
Query: 324 ----DVYSFGVVLLEMLTGRRSMDKNRPNG 349
DV+S G + E+L + +
Sbjct: 262 TEAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 187
+ +F+ +SLLGEG +G V TG VA+K + D L E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 188 NFLGDLVHLNLVKLI----GYCIEDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRM 240
L H N++ + E+ + ++ E M + L R + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHI 114
Query: 241 KI----ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA----KDGPE 292
+ L + + LH + VI+RD K SN+L++++ + K+ DFGLA + +
Sbjct: 115 QYFIYQTL---RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 293 GDKTHVSTRVMGTY----GYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGR 339
+ M + Y APE ++T + DV+S G +L E+ R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 62/258 (24%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
N+ + L+G G +G V+ T VA+K +N + L K L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRL-----LVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
+ L L +++L I DD +V E ++ L + +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK-------LFKTP 123
Query: 242 IALGAA----------KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---- 287
I L G F+HE + +I+RD K +N LL+ D + K+ DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-----------------SDVYSFGV 330
+ + + +T H+ +R D++S G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240
Query: 331 VLLEMLTGRRSMDKNRPN 348
+ E+L +S + N
Sbjct: 241 IFAELLNMLQSHINDPTN 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 44/240 (18%), Positives = 79/240 (32%), Gaps = 46/240 (19%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 179
R ++ +S G +++ + ++K DG
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 180 HKEWLAEVNFLGDLVHLNLVKLIGY-CIEDDQRLLVYEFMPR--GSLENHLFRRSLPLPW 236
+ + L L + +G+ +D R LV +P SL+ S
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQ-SALDVSPKHVL 156
Query: 237 SIRM--KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAK---D 289
S R ++A L FLH E ++ + NI +D + ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 290 GPEGDKTHVSTR------VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
HV+ G + + M H + RSD+ S G +L+ L G
Sbjct: 214 ----SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 53/247 (21%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 195
LG G F V+ N T VA+K + D + E+ L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74
Query: 196 LNLVKLIG----YCIEDDQRLLVYEFMPRGSLENHLF------RRSL----------PLP 235
+ K + + +LL + F +G H+ +L +P
Sbjct: 75 ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 236 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD------ADYNAKLSDFGLAKD 289
+I+ GL ++H +I+ D K N+L++ K++D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-----RSMDK 344
E + TR Y +PE ++ +D++S ++ E++TG
Sbjct: 188 YDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242
Query: 345 NRPNGEH 351
+ +H
Sbjct: 243 YTKDDDH 249
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 49/277 (17%)
Query: 91 SSTTTSNAESNSSTSKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGW 150
+S+ L E+ V + ++ +G+GGFGC++
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAA-------AWKVGLPIGQGGFGCIYLAD 55
Query: 151 IEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGDLVHLNLVKLIG-- 203
+ + G+ VK D E A+ + + +K +G
Sbjct: 56 MNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111
Query: 204 ---YCIEDDQRLLVYEF--MPR-G-SLENHLFR---RSLPLPWSIRMKIALGAAKGLAFL 253
D+ Y F M R G L+ ++ + ++ ++L L ++
Sbjct: 112 KYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSRK-TVLQ-LSLRILDILEYI 168
Query: 254 HEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-GPEGDKTHVSTR----VMGTY 306
H E ++ D K SN+LL+ + L D+GLA PEG + GT
Sbjct: 169 H---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI 225
Query: 307 GYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
+ + + H + R D+ G +++ LTG
Sbjct: 226 EFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 194
++G+G FG V K + + VA+K + N H++ E+ L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151
Query: 195 HL------NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPW 236
N++ ++ C+ E LL +YE + + + LP
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYELIKKNKF------QGFSLP- 200
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDGPEGD 294
+R K A + L LH+ +I+ D K NILL + K+ DFG + +
Sbjct: 201 LVR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGR 339
T++ +R Y APE V+ G D++S G +L E+LTG
Sbjct: 257 YTYIQSRF-----YRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 56/239 (23%), Positives = 101/239 (42%), Gaps = 46/239 (19%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 186
R + LG+G +G V+K + TG VAVK + + E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 187 VNFLGDL-VHLNLVKLIGYCI-EDDQRL-LVYEFMPRGSLENHLFR--RSLPLPWSIRMK 241
+ L +L H N+V L+ ++D+ + LV+++M E L R+ L + +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQ 112
Query: 242 -IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA---KDGPEGDKTH 297
+ K + +LH +++RD K SNILL+A+ + K++DFGL+ +
Sbjct: 113 YVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 298 VSTRVMGTYGYAAPEYVMTGH------------LTSRS-----DVYSFGVVLLEMLTGR 339
+ T + + ++T + L S D++S G +L E+L G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 56/243 (23%), Positives = 91/243 (37%), Gaps = 54/243 (22%)
Query: 119 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 177
+ R + +SL+G+G FG V K + VA+K + N
Sbjct: 45 IVKNGEK-WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF 93
Query: 178 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 219
+ EV L + +V L + C+ E +L +Y+
Sbjct: 94 --LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-- 145
Query: 220 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279
L N FR + ++ K A L FL +I+ D K NILL +
Sbjct: 146 ---LRNTNFR---GVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRS 198
Query: 280 --KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEML 336
K+ DFG + + ++ +R Y +PE V+ G + D++S G +L+EM
Sbjct: 199 AIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMH 252
Query: 337 TGR 339
TG
Sbjct: 253 TGE 255
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 188
+++ +GEG FG +F+G VA+K D Q E+
Sbjct: 11 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 245
G + + + E +LV + + SLE L R + ++ M A
Sbjct: 62 LAG---CTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQ 114
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTH 297
+ +H E+ ++YRD K N L+ + + DFG+ K D K H
Sbjct: 115 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQH 169
Query: 298 VSTR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
+ R + GT Y + + HL + R D+ + G V + L G
Sbjct: 170 IPYREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 38/225 (16%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+R +G G FG ++ G G VA+K H + E
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58
Query: 191 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 246
+ + + E D ++V E + SLE LF R L ++ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 301
+ ++H + I+RD K N L+ + DFGLAK H+ R
Sbjct: 115 ISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 302 ---VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
+ GT YA+ + HL + R D+ S G VL+ G
Sbjct: 172 NKNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 54/301 (17%), Positives = 92/301 (30%), Gaps = 98/301 (32%)
Query: 138 LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL 196
LG G G V + T A+K L + EV
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71
Query: 197 NLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG-----A 246
++V+++ E+ L+V E + G E LF R I+ + A
Sbjct: 72 HIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSR-------IQDRGDQAFTEREA 119
Query: 247 A-------KGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFGLAKDGPEGDKT 296
+ + + +LH + +RD K N+L + KL+DFG A E
Sbjct: 120 SEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---- 169
Query: 297 HVSTRVMGT-YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355
G Y + D++S GV++ +L G P
Sbjct: 170 -----TTGEKYDKSC-------------DMWSLGVIMYILLCGY------PPF------- 198
Query: 356 WARPHLGERRRFYRLIDPRLEGHFSIKGA------QKAAQLAAHCLSRDPKARPLMSEVV 409
++ L I G + ++ L + L +P R ++E +
Sbjct: 199 YSNHGLAISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
Query: 410 E 410
Sbjct: 256 N 256
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 55/229 (24%), Positives = 84/229 (36%), Gaps = 44/229 (19%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
NFR +G G FG + G T VA+K E F
Sbjct: 10 NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 191 GDLVH-LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 246
L + ++ + +V E + SLE LF R+ L ++ M IA+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DGPEGDKTHV 298
+ ++H + +IYRD K N L+ N + DF LAK D K H+
Sbjct: 115 ISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHI 169
Query: 299 STR----VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
R + GT Y + + HL + R D+ + G + + L G
Sbjct: 170 PYREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 41/278 (14%), Positives = 76/278 (27%), Gaps = 88/278 (31%)
Query: 213 LVYEFMPRGSLENHLFR-RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 271
+V+E + L + + LP KI +GL +LH + +I+ D K NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178
Query: 272 LLDAD-------------------------------------------------YNAKLS 282
LL + K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 342
D G A + + TR Y + E ++ + +D++S + E+ TG
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293
Query: 343 DKNRPNGEHN-------------------LVEWARPHL-----GERRRFYRLIDPRLEG- 377
+ + +V G+ + +L L
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 378 -----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+S + A L P+ R +E +
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 41/238 (17%), Positives = 80/238 (33%), Gaps = 45/238 (18%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 184
+ +G GGFG ++ + VK + E +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 185 AEVNFLGDLVHLNLVKLIG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRRSL 232
A+ + + + + +G R +V M R L+ + ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNG 146
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK--LSDFGLAKD- 289
S +++ + L ++H E ++ D K +N+LL + L+D+GL+
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 290 GPEGDKTHVSTRV----MGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
P G+ GT + + + H + RSDV G +L L G+
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 59/225 (26%), Positives = 89/225 (39%), Gaps = 38/225 (16%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
FR +G G FG ++ G + VA+K N H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56
Query: 191 GDLVHLNLV-KLIGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGA 246
L + + + +E D +LV + + SLE LF R L L ++ M +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-GPEGDKTHVSTR- 301
+ F+H + ++RD K N L+ A + DFGLAK H+ R
Sbjct: 113 INRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Query: 302 ---VMGTYGYAAPEYVMTGHL----TSRSDVYSFGVVLLEMLTGR 339
+ GT YA+ + HL + R D+ S G VL+ L G
Sbjct: 170 NKNLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 60/259 (23%), Positives = 87/259 (33%), Gaps = 72/259 (27%)
Query: 119 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 177
D L R + LGEG FG V + VA+K + N
Sbjct: 10 VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59
Query: 178 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 219
+ E+N L + V + + CI E LL +EF
Sbjct: 60 --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111
Query: 220 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 278
L+ + F+ P P +A L FLHE + + D K NIL ++++
Sbjct: 112 ---LKENNFQ---PYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE 162
Query: 279 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL- 319
+++DFG A E T V+TR Y PE V+
Sbjct: 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELGW 216
Query: 320 TSRSDVYSFGVVLLEMLTG 338
DV+S G +L E G
Sbjct: 217 AQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 67/259 (25%), Positives = 95/259 (36%), Gaps = 72/259 (27%)
Query: 119 KFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGL 177
D+ L+ R + LGEG FG V + + G G VAVK + N D
Sbjct: 5 ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54
Query: 178 QGHKEWLAEVNFLGDLVHL------NLVKLIGY-------CI--EDDQRLL---VYEFMP 219
+ +E+ L L V+++ + CI E LL Y+F
Sbjct: 55 --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106
Query: 220 RGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYN 278
++ + F P K+A K + FLH + + D K NIL +DY
Sbjct: 107 ---IKENGFL---PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157
Query: 279 A------------------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL- 319
K+ DFG A E T VSTR Y APE V+
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGW 211
Query: 320 TSRSDVYSFGVVLLEMLTG 338
+ DV+S G +L+E G
Sbjct: 212 SQPCDVWSIGCILIEYYLG 230
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 4e-07
Identities = 39/225 (17%), Positives = 59/225 (26%), Gaps = 63/225 (28%)
Query: 111 LKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 170
+ S+ F+ L T + +GEG FG VF+ VA+K
Sbjct: 2 MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49
Query: 171 TLNHDGLQGH--------KEWLAEVNFLGDLVHL---------NLVKLIGYCI------- 206
+ +G +E L E+ +L L + L
Sbjct: 50 IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109
Query: 207 -----------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
+DDQ +V EF G + + + I
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSIL 167
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288
LA +RD N+LL KL K
Sbjct: 168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 54/247 (21%), Positives = 83/247 (33%), Gaps = 76/247 (30%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGDLV 194
+G+G FG V +N AVK + N + E + L +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 195 HL-----NLVKLIGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRRSLPLPWS 237
+ N+VK G C+ E L +YE + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIE 137
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL-DADYNA----------------- 279
+ K L +L + + + + D K NILL D +
Sbjct: 138 DIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 280 -------KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRS-DVYSFGVV 331
KL DFG A + + ++TR Y APE V+ S D++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCV 248
Query: 332 LLEMLTG 338
L E+ TG
Sbjct: 249 LAELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 61/385 (15%), Positives = 126/385 (32%), Gaps = 97/385 (25%)
Query: 80 TSRDQPAAAVISSTTTSNAESNSSTSKLEEELKVASRLRKFT---FNDLKLATRNFRPE- 135
T+R + +S+ TT++ + + L + +V S L K+ DL P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 136 -SLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD 192
S++ E + W N K T + ++ L + + L+ V F
Sbjct: 330 LSIIAESIRDGLATWDNWKHVNCD---KLTTIIESSLNVLEPAEYRKMFDRLS-V-FPPS 384
Query: 193 LVHLN---LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
H+ L + I+ D ++V + +E ++ +P SI +++ +
Sbjct: 385 -AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP-SIYLEL-KVKLEN 441
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDK---THVSTRVMGTY 306
LH ++D YN + P D+ +H+
Sbjct: 442 EYALH---------------RSIVDH-YNIPKTFDSDDLIPPYLDQYFYSHI-------- 477
Query: 307 GYAAPEYVMTGHLTS--RSDVYS-FGVVLLEMLTGRRSMD-KNRPNGEHNLVEWARPHLG 362
G+ HL + + + F +V L+ R ++ K R + + +
Sbjct: 478 GH---------HLKNIEHPERMTLFRMVFLDF----RFLEQKIRHDSTAWNASGSILNTL 524
Query: 363 ERRRFYR----LIDPRLE------GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-A 411
++ +FY+ DP+ E F ++ + + ++ A
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLP-------KIEENLI-CSKYTD-----LLRIA 571
Query: 412 LKPLPNLKDMASSSYYFQTMQAERI 436
L MA F+ +A +
Sbjct: 572 L--------MAEDEAIFE--EAHKQ 586
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 487 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.68 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.62 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.1 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.54 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.0 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.75 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.85 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.38 | |
| 2khx_A | 85 | Ribonuclease 3; drosha, RNA binding domain, hydrol | 84.97 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.69 | |
| 1x49_A | 97 | Interferon-induced, double-stranded RNA- activated | 81.7 | |
| 1x48_A | 88 | Interferon-induced, double-stranded RNA- activated | 80.83 | |
| 3adj_A | 76 | F21M12.9 protein; HYL1, miRNA processing, RNA bind | 80.53 | |
| 1whq_A | 99 | RNA helicase A; double-stranded RNA binding domain | 80.33 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-61 Score=477.53 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=204.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+++|++|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 689999999999999999999875 6789999999765433 24568999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
++.+|||||||+||+|.++|..+ ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999999754 456799999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|+...... ...+..+||+.|||||++.+..|+.++||||||||||||+||+.||.+.... .+.. ......
T Consensus 172 a~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~---~i~~~~-- 241 (350)
T 4b9d_A 172 ARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVL---KIISGS-- 241 (350)
T ss_dssp ESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHHTC--
T ss_pred ceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH---HHHcCC--
Confidence 98764321 1234578999999999999999999999999999999999999999764321 1111 111100
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+.+.. ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 242 -----~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 -----FPPVSL----HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122 234678999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-61 Score=469.48 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=217.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+++|++|+|||||++++++.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 479999999999999999999875 67899999996432 233567899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 999999999999999999999654 47999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|+..............+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.... .+... .....
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~---i~~~~-- 250 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAK---IIKLE-- 250 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHTC--
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHcCC--
Confidence 99875544433455679999999999999999999999999999999999999999754321 11111 11110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HhcCCCCCccCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE--ALKPLPNLKDMA 422 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~--~L~~l~~~~~~~ 422 (487)
.. ++...+.++.+||.+||+.||.+|||+.|++. .|..++.+.++.
T Consensus 251 ------~~----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 251 ------YD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp ------CC----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ------CC----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 11 12223467899999999999999999999753 345566665544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-60 Score=470.68 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=207.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|.+.+.||+|+||+||+|+++.. ....++..||||+++.......++|.+|+++|++|+|||||+++++|.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35778889999999999999998631 12236789999999876655567899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS--------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
+.+|||||||++|+|.++|.... .++++..++.|+.||+.||.|||+++ ||||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 99999999999999999996532 35899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 353 (487)
.++.+||+|||+++.....+.....+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EA 269 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HH
Confidence 999999999999997655444444556789999999999999999999999999999999999 89999754321 11
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... .... .+ .++..++..+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 270 ~~~i----~~g~------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 270 IDCI----TQGR------EL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHH----HHTC------CC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHH----HcCC------CC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1111 1100 11 11223457899999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=467.59 Aligned_cols=263 Identities=30% Similarity=0.446 Sum_probs=214.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|.+.+.||+|+||+||+|++... ....++..||||+++.......++|.+|+++|++|+|||||+++++|.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 46788999999999999999998642 11235789999999876655567899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRR------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
+.+|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 9999999999999999999653 246999999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~ 355 (487)
+.+||+|||+|+.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+..
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence 9999999999987544433333344679999999999999999999999999999999999 89999764321 1111
Q ss_pred hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... ... .+ ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 242 ~i~----~~~------~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 CIT----QGR------VL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHH----HTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----cCC------CC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 100 01 12223457899999999999999999999999988754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=463.03 Aligned_cols=261 Identities=26% Similarity=0.455 Sum_probs=206.1
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||+||+|++.. .||||+++.... ...+.|.+|+++|++|+|||||+++++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345688899999999999999998643 699999975433 234679999999999999999999998
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+. ++.+|||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||++++.+||+||
T Consensus 101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DF 176 (307)
T 3omv_A 101 MT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDF 176 (307)
T ss_dssp EC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCC
T ss_pred EE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeec
Confidence 75 46789999999999999999877778999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|+|+..............+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+...... +... .
T Consensus 177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~----~ 250 (307)
T 3omv_A 177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFM----V 250 (307)
T ss_dssp SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH----H
T ss_pred cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHH----H
Confidence 99987654433334455789999999999864 4699999999999999999999999975432111 1110 1
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... ...|.+ ...+..++..+.+|+.+||+.||++|||+.||+++|+.+
T Consensus 251 ~~~-----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 251 GRG-----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp HTT-----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred hcC-----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 100 111111 122234557899999999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-60 Score=470.02 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=211.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
...|++++.||+|+||+||+|++.. +|+.||||++........+.+.+|+++|+.|+|||||+++++|.++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 143 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 143 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3579999999999999999999875 6789999999766555566789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.+|||||||+||+|.+++.+ ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence 999999999999999998865 35999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... .....+||+.|||||++.+..|+.++||||||||||||++|..||.+..... +.....
T Consensus 219 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~---------- 283 (346)
T 4fih_A 219 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR---------- 283 (346)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----------
T ss_pred ecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHH----------
Confidence 7654322 2345799999999999999999999999999999999999999997543211 111111
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+.+. .....+..+.+||.+||+.||++|||+.|++++
T Consensus 284 ~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSCCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111111 111234678999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=463.19 Aligned_cols=264 Identities=26% Similarity=0.375 Sum_probs=214.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++++++.||+|+||+||+|.+.... ...+++.||||+++.... ...++|.+|+.+|++|+|||||+++|+|.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 46777889999999999999975311 122567899999975433 3357799999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
+.++||||||++|+|.++|..+. ..+++..++.|+.||+.||+|||+++ ||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence 99999999999999999996432 35899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 352 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 352 (487)
++++.+||+|||+++.....+.....+..+||+.|||||++.+..|+.++|||||||+||||+| |..||.+... .+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999987654443334455789999999999999999999999999999999998 8999976432 12
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
+..... ... ....+..++..+.+|+.+||+.||.+||+|.||+++|+.+.+
T Consensus 256 ~~~~i~----~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 VVEMIR----NRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHHHHH----cCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 221111 110 011223455789999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=477.13 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=212.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+.|++++.||+|+||.||+|++.. +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 220 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC
Confidence 3679999999999999999999875 6789999999876666667789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.+|||||||+||+|.+++... .+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence 9999999999999999998543 5999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... .....+||+.|||||++.+..|+.++||||||||||||++|..||.+.... .+.....
T Consensus 296 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~---------- 360 (423)
T 4fie_A 296 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIR---------- 360 (423)
T ss_dssp ECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH----------
T ss_pred ECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHH----------
Confidence 7654322 234578999999999999999999999999999999999999999754321 1111111
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....+.+. .....+..+.+||.+||+.||.+|||+.|+|++
T Consensus 361 ~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 361 DNLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HSCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111111 111234678999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-59 Score=461.37 Aligned_cols=252 Identities=24% Similarity=0.249 Sum_probs=206.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
+.|++.+.||+|+||+||+|++.. +|+.||||+++.... ..+|+.+|+.|+|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 467888899999999999999875 678999999976543 247999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeecCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFGLAK 288 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~DFGla~ 288 (487)
.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 999999999999999999655 46999999999999999999999988 99999999999999987 69999999998
Q ss_pred CCCCCCcc---eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 289 DGPEGDKT---HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 289 ~~~~~~~~---~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
........ ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...........+. ....
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~ 273 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPP 273 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCC
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCC
Confidence 76543221 12234689999999999999999999999999999999999999997655433221111 1100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.+ ..++..++..+.+||.+||+.||.+|||+.||+++|..
T Consensus 274 ~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 PI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 00 11222345678999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-58 Score=448.36 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=199.3
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe--
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 207 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 207 (487)
|++.+.||+|+||+||+|++.. ++..||||++...... ..+.|.+|+++|++|+|||||+++++|.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 3667789999999999999875 6779999999654332 24568999999999999999999999875
Q ss_pred --CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeec
Q 011385 208 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 284 (487)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~~kl~DF 284 (487)
++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ .+||||||||+||||+. +|.+||+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeC
Confidence 35689999999999999999654 57999999999999999999999876 45999999999999974 799999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+..... ..
T Consensus 177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~---~~- 245 (290)
T 3fpq_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT---SG- 245 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT---TT-
T ss_pred cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHH---cC-
Confidence 999864332 2345789999999998864 69999999999999999999999996532211 1111100 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+.+.. ..++++.+||.+||+.||++|||+.|+++|
T Consensus 246 -----~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 246 -----VKPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----CCCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111 123578999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-58 Score=443.53 Aligned_cols=248 Identities=27% Similarity=0.347 Sum_probs=193.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++.... .....+.+|+++|+.++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 589999999999999999998765 678999999975433 23457899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++.+||||||| +|+|.++|.++ ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 68999999655 57999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
|+...... .....+||+.|||||++.+..| +.++|||||||+||||+||+.||.+.... .+... .....
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~---i~~~~- 228 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKN---ISNGV- 228 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHTC-
T ss_pred CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHcCC-
Confidence 98764432 2345789999999999998876 57999999999999999999999754211 11111 11110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+.. ..+..+.+||.+||+.||++|||+.|++++-
T Consensus 229 -------~~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 229 -------YTLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp -------CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred -------CCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 11112 2346789999999999999999999999853
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=453.00 Aligned_cols=251 Identities=28% Similarity=0.346 Sum_probs=199.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++..+. .+++.||||+++..... ....+.+|+++|++|+|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGS------DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSST------TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCC------CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57999999999999999999875432 26789999999754321 22457899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999999999654 47999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
+....... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.... .+... .....
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~---i~~~~--- 242 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTM---ILKAK--- 242 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCC---
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHH---HHcCC---
Confidence 87543322 234578999999999999999999999999999999999999999754321 11111 11110
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 410 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~ 410 (487)
.. ++...+.++.+||.+||+.||++||++ +|+++
T Consensus 243 -----~~----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 -----LG----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CC----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11 122234678999999999999999985 45554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=460.08 Aligned_cols=271 Identities=28% Similarity=0.385 Sum_probs=219.3
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCC-CCce
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH-LNLV 199 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H-pnIv 199 (487)
...+++..++|++.+.||+|+||+||+|.+..... ..+++.||||+++..... ..+.|.+|+++|.++.| ||||
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 34455677899999999999999999999875322 234568999999765443 24568999999999965 8999
Q ss_pred eEEEEEEeC-CeeEEEEeeCCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 011385 200 KLIGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIY 263 (487)
Q Consensus 200 ~~~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH 263 (487)
+++++|.+. +.+|||||||++|+|.++|... ...+++..++.|+.||+.||+|||+++ |||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence 999998764 5689999999999999999643 234889999999999999999999988 999
Q ss_pred cCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCC
Q 011385 264 RDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSM 342 (487)
Q Consensus 264 rDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf 342 (487)
|||||+||||+.++.+||+|||+|+...........+..+||+.|||||++.+..|+.++|||||||+||||+| |..||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998765544444556789999999999999999999999999999999998 99999
Q ss_pred CCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 343 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+..... .+.. .+.... .+. .+..++.++.+|+.+||+.||.+|||+.||+++|+.+
T Consensus 289 ~~~~~~~--~~~~----~i~~g~------~~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 289 PGVKIDE--EFCR----RLKEGT------RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TTCCCSH--HHHH----HHHHTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHH--HHHH----HHHcCC------CCC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 7654321 1111 111111 111 1223356799999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=439.64 Aligned_cols=269 Identities=26% Similarity=0.342 Sum_probs=199.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHH--HHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .+.+ ..|+..+.+++|||||++++++.+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~ 68 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 4678889999999999999987 36789999996543 2333 456666778999999999999987
Q ss_pred CC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCc
Q 011385 208 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 208 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDLKp~NIll~~~~~ 278 (487)
++ .+|||||||++|+|.++|... .+++..++.|+.|++.||+|||++. ..+||||||||+||||+.++.
T Consensus 69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred cCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 54 579999999999999999654 5899999999999999999999861 234999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcce--eeeeccccccccCCceeccC------CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 011385 279 AKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 350 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~------~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 350 (487)
+||+|||+|+......... .....+||+.|||||++.+. .|+.++|||||||+||||+||.+||........
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 9999999998654332211 22346899999999998754 477899999999999999999988754332111
Q ss_pred ch--h--hHhhhhhhhcccccccccCCccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 351 HN--L--VEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 351 ~~--~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. . .......+.. ......++|.+... ...++...+.+|+.+||+.||++||||.||++.|+.+
T Consensus 227 p~~~~~~~~~~~~~~~~-~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhcccccchHHHHHH-HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00 0 0000000000 00011122222221 1235667889999999999999999999999999765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-56 Score=435.25 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=189.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++++.||+|+||+||+|+++. +|+.||||+++..... ..+.+.+|+++|++|+|||||+++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 469999999999999999999875 6779999999754432 235688999999999999999999998765
Q ss_pred C------------eeEEEEeeCCCCChhHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 209 D------------QRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 209 ~------------~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
+ .+|||||||++|+|.+++..+.. ..++..++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence 4 36899999999999999965432 3566778999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcc----------eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKT----------HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 344 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 344 (487)
.++.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 9999999999999876443211 11234689999999999999999999999999999999996 6642
Q ss_pred CCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 345 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. +...... .+.+..... ......+.+.+||.+||+.||.+|||+.|++++
T Consensus 230 ~~-----~~~~~~~----------~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 230 QM-----ERVRTLT----------DVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-----HHHHHHH----------HHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc-----HHHHHHH----------HHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 1110000 000000000 011233457889999999999999999999974
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=438.58 Aligned_cols=269 Identities=23% Similarity=0.297 Sum_probs=204.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++..... ..+.+.+|+++|+.|+|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 579999999999999999999875 6889999999754332 23568899999999999999999999764
Q ss_pred ------CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 208 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 208 ------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
.+.+|||||||+ |+|.++|.. ...+++..+..|+.||+.||.|||+++ ||||||||+||||+.+|.+||
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEE
Confidence 367899999995 689999854 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCC--cceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 282 SDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 282 ~DFGla~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+|||+|+...... ........+||+.|||||++.+. .|+.++||||||||||||++|++||.+.........+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 9999998754321 11223457999999999998875 56999999999999999999999997654322211111000
Q ss_pred hhhhc----------ccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 PHLGE----------RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... .......+.+..... +....+..+.+||.+||..||.+|||+.|+|+|-
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 00000 000000000000000 0011246789999999999999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=426.06 Aligned_cols=203 Identities=25% Similarity=0.332 Sum_probs=173.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
..++|++++.||+|+||+||+|+++.+ ..+++.||||.+.... ...++.+|+++|..+ +|||||++++++.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 457899999999999999999987632 2357899999986543 346788999999998 6999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~kl~DFG 285 (487)
+.+++|||||||++|+|.+++ ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 999999999999999999988 25899999999999999999999988 9999999999999877 899999999
Q ss_pred CCCCCCCCCc--------------------------ceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhC
Q 011385 286 LAKDGPEGDK--------------------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTG 338 (487)
Q Consensus 286 la~~~~~~~~--------------------------~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG 338 (487)
+|+....... ....+..+||+.|||||++.+. .|+.++||||+|||+|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9976533211 0112345899999999998765 589999999999999999999
Q ss_pred CCCCCCC
Q 011385 339 RRSMDKN 345 (487)
Q Consensus 339 ~~pf~~~ 345 (487)
+.||...
T Consensus 244 ~~Pf~~~ 250 (361)
T 4f9c_A 244 RYPFYKA 250 (361)
T ss_dssp CSSSSCC
T ss_pred CCCCCCC
Confidence 9999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=452.30 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=213.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++++.||+|+||+||+|+++. +|+.||||++........+.+.+|+++|+.|+|||||+++++|.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4689999999999999999999875 6789999999776655556788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~--~~~kl~DFGl 286 (487)
+.+|||||||+||+|.++|......+++..+..|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence 9999999999999999999766678999999999999999999999988 9999999999999854 8999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|+...... .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+..... ..... ......
T Consensus 304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~~i---~~~~~~ 374 (573)
T 3uto_A 304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNV---KSCDWN 374 (573)
T ss_dssp CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH---HTTCCC
T ss_pred eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHH---HhCCCC
Confidence 99875543 2345689999999999999999999999999999999999999997543211 11110 000000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
++...... .+..+.+||.+||+.||.+||++.|+|+|-
T Consensus 375 ----~~~~~~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 375 ----MDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp ----CCSGGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred ----CCcccccC----CCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 11111122 246789999999999999999999999964
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=448.76 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=203.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHH---HHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~HpnIv~~~ 202 (487)
.++|+++++||+|+||.||+|++.. +|+.||||++++... .....+. .++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 4789999999999999999999875 688999999964321 1122233 446777888999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
++|.+.+.+|||||||+||+|.++|.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|++||+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEec
Confidence 9999999999999999999999999655 46999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||+|+...... ....+||+.|||||++.. ..|+.++||||||||||||++|.+||.+........+... ..
T Consensus 335 DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~ 407 (689)
T 3v5w_A 335 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL 407 (689)
T ss_dssp CCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HH
T ss_pred ccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hc
Confidence 999998765432 234689999999999964 5899999999999999999999999975443322211111 11
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
.. ... ++...+..+.+||.+||+.||.+|++ +.||++|
T Consensus 408 ~~--------~~~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 408 TM--------AVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HC--------CCC----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC--------CCC----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11 111 12223467899999999999999998 5777654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=399.00 Aligned_cols=281 Identities=40% Similarity=0.699 Sum_probs=237.4
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeE
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
+.++....++|++.+.||+|+||.||+|++. +|..||||++........+.+.+|+.+++.++||||+++
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 100 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL 100 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3334456789999999999999999999864 367899999977666666789999999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177 (321)
T ss_dssp EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCC
T ss_pred EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCC
Confidence 999999999999999999999999986543 35899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|..
T Consensus 178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 99999999986544333333344679999999999999999999999999999999999999998776665555555443
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. .....+...+++.+...+....+..+.+|+.+||+.||.+||++.|++++|+.+.
T Consensus 258 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 258 ES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp HH-HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hc-cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22 2223344566666777778888999999999999999999999999999998653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=389.83 Aligned_cols=287 Identities=41% Similarity=0.740 Sum_probs=234.5
Q ss_pred ccccChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCC
Q 011385 117 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVH 195 (487)
Q Consensus 117 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H 195 (487)
+..+.+.++....++|++.+.||+|+||.||+|++. +|..||||++...... ....+.+|++++..++|
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h 86 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH 86 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence 566888999999999999999999999999999643 3668999999765432 22368999999999999
Q ss_pred CCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 196 pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
|||+++++++.+.+..++||||+++|+|.+++... ...+++..++.|+.||+.||.|||+....+|+||||||+|||
T Consensus 87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil 166 (326)
T 3uim_A 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166 (326)
T ss_dssp TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence 99999999999999999999999999999999654 234999999999999999999999982123999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--CCCc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR--PNGE 350 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~--~~~~ 350 (487)
|+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.... ....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 167 LDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp ECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred ECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 99999999999999987644332 22344669999999999988999999999999999999999999996211 1112
Q ss_pred chhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.....+..... ....+....+..+...+.......+.+|+.+||+.||.+|||+.||+++|+..
T Consensus 246 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 246 VMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 22233332222 22334455666677778888899999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.91 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=210.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 34689999999999999999998764 577999999976666666788999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..+||||||++|+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999999999654 5899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ .....+||+.|+|||++.+..|+.++|||||||++|||++|..||............ ....
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~--- 232 (297)
T 3fxz_A 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG--- 232 (297)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC---
T ss_pred eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC---
Confidence 87654322 233467999999999999999999999999999999999999999654321110000 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+ ....+...+..+.+|+.+||+.||.+||++.|++++-
T Consensus 233 ----~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 233 ----TP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp ----SC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ----CC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 00 0011122346789999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=388.50 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=213.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||+||+|.+.. ++..||+|++........+.+.+|++++..++||||+++++++.++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 3678999999999999999999865 5779999998766555567799999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence 9999999999999999999876778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcce------------eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 289 DGPEGDKTH------------VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 289 ~~~~~~~~~------------~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
......... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 236 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence 654332211 01145799999999999999999999999999999999999999875433221110000
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
..... ... +..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 237 -~~~~~------~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 237 -RGFLD------RYC--------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -HHHHH------HTC--------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hcccc------ccC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 001 1122346889999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=399.60 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=214.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+..... ....++..||||+++..... ..+.+.+|+.+|..+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 45789999999999999999998753211 12235678999999765332 245689999999999 899999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
.+.+.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999997543 34789999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 011385 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 349 (487)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 349 (487)
|||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |..||.......
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999986654333222334567899999999999999999999999999999999 999997643221
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.... ... . ....+..++..+.+||.+||+.||.+||++.|+++.|+.+
T Consensus 314 ---~~~~~----~~~------~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 ---LFKLL----KEG------H----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp ---HHHHH----HTT------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHH----hcC------C----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11110 000 0 1111223356789999999999999999999999999865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=389.41 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=207.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4689999999999999999998865 677999999965432 23456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999999999655 46999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++....... ....+||+.|+|||++.+..+. .++|||||||++|||++|..||...... .+.. .......
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~---~i~~~~~ 231 (328)
T 3fe3_A 161 SNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRE---RVLRGKY 231 (328)
T ss_dssp CGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCCC
T ss_pred ceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC
Confidence 986544332 3446899999999999888775 7999999999999999999999754321 1111 1111100
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ++...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus 232 --------~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 232 --------R----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp --------C----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred --------C----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence 0 11123467889999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=390.67 Aligned_cols=272 Identities=26% Similarity=0.337 Sum_probs=208.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|++. ++.||||++..... ....+.+|+.+|.+++|||||++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 4578999999999999999999873 56899999965432 22446679999999999999999999987
Q ss_pred CC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCcEEE
Q 011385 208 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE----------AERPVIYRDFKTSNILL 273 (487)
Q Consensus 208 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------~~~~iiHrDLKp~NIll 273 (487)
.. .++||||||++|+|.+++... .+++..++.++.||+.||.|||+. + |+||||||+||||
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill 164 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL 164 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence 54 369999999999999999654 489999999999999999999997 6 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 348 (487)
+.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999999999999976544333222334679999999999876 35667899999999999999999999865443
Q ss_pred CcchhhHhhhh--hhhcc--cccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 349 GEHNLVEWARP--HLGER--RRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 349 ~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
........... ..... ........+.+...+ ....+..+.+||.+||+.||.+|||+.||++.|+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 32222111000 00000 000011111111111 1245667999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=387.77 Aligned_cols=251 Identities=30% Similarity=0.363 Sum_probs=207.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++++.||+|+||.||+|++.. +|+.||||+++... ......+.+|+.+|..++||||+++++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 74 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence 3689999999999999999998865 67799999996532 23456788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||
T Consensus 75 ~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999998654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.. ......
T Consensus 151 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~- 221 (337)
T 1o6l_A 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILMEE- 221 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC-
T ss_pred chhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH---HHHcCC-
Confidence 9986433221 234468999999999999999999999999999999999999999653211 1111 011110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
.. ++...+..+.+||.+||+.||.+|| ++.||+++-
T Consensus 222 -------~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 222 -------IR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp -------CC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred -------CC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 01 1122346789999999999999999 899998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=388.17 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=210.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+...+. .+..||||+++.... ...+.+.+|+.+|..++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4689999999999999999999875332 355799999976533 234568999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..||||||+++|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999999776678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 288 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 288 ~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+.... ..
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~----~~-- 269 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSV----EE-- 269 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHH----HT--
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----Hc--
Confidence 876543221 12233457889999999999999999999999999999999 99999654321 111110 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ..+..++..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 270 ----~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 270 ----GYRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011 11223346789999999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=385.78 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=209.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCceeE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
..++|++.+.||+|+||.||+|++.. +|..||||+++..... ..+.+.+|+.+|..++||||+++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 34689999999999999999998865 6779999999754432 34678999999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---- 277 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---- 277 (487)
++++.+.+.+|||||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCcc
Confidence 9999999999999999999999999954 457999999999999999999999988 99999999999998776
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
.+||+|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ......
T Consensus 157 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i 230 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANI 230 (361)
T ss_dssp CEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH
T ss_pred CEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 799999999987654322 23467999999999999999999999999999999999999999754321 111100
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...... .++.... ..+..+.+||.+||..||.+||++.|++++-.
T Consensus 231 ---~~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 231 ---TAVSYD----FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp ---HTTCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred ---HhcCCC----CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 000000 0000111 12357899999999999999999999998543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=383.20 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=206.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4689999999999999999998865 5779999999654332 23568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..|||||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 9999999999999999998854 356999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+..............+||+.|+|||++.+..+ +.++|||||||++|||++|..||........ ....+... .
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~-----~- 225 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK-----K- 225 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT-----C-
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc-----c-
Confidence 86543333333345689999999999987776 7789999999999999999999975443211 11111100 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
....+ . ...+..+.+|+.+||+.||.+||++.|++++..
T Consensus 226 --~~~~~--~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 226 --TYLNP--W----KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp --TTSTT--G----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --ccCCc--c----ccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 00000 0 122467889999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=379.47 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=210.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999998865 67799999997543 2345688999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--~~~~kl~DFGl 286 (487)
+..+||||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 9999999999999999999766667999999999999999999999988 999999999999987 78999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... .......
T Consensus 151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~---i~~~~~~ 221 (321)
T 1tki_A 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIEN---IMNAEYT 221 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH---HHHTCCC
T ss_pred CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHH---HHcCCCC
Confidence 987654432 34467999999999999888999999999999999999999999754321 11110 0000000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+..... ..+..+.+|+.+||..||.+|||+.|++++-.
T Consensus 222 ----~~~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 222 ----FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ----CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----CChhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 0000001 12457899999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=390.87 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=201.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCceeEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 203 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~~ 203 (487)
..++|++++.||+|+||.||+|++.. +|+.||||+++... ......+.+|+.+|..+ +||||+++++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~ 91 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence 44789999999999999999999875 57799999997532 22345678999999988 7999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++.+.+.+|||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 92 CFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999999654 46999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+... ....
T Consensus 168 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~---i~~~ 239 (353)
T 3txo_A 168 FGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEA---ILND 239 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHC
T ss_pred ccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHH---HHcC
Confidence 999986433221 234578999999999999999999999999999999999999999754321 11111 1111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 411 (487)
.. .++...+..+.+||.+||+.||.+||++ .||+++
T Consensus 240 ~~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 EV------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CC------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 00 1111234678999999999999999998 677764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=375.74 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=208.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|++.. ++..||||++....... .+.+.+|+.++..++||||++++++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 79 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV 79 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence 34689999999999999999998765 57799999986543332 3568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999999999655 47999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .........
T Consensus 156 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~ 228 (294)
T 4eqm_A 156 GIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS 228 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC
T ss_pred CCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc
Confidence 999876443221 2334679999999999999999999999999999999999999997543211 000000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPNL 418 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~~~ 418 (487)
.+.....+....+..+.+++.+||+.||.+|| ++.++++.|..+...
T Consensus 229 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 -------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00000111112346789999999999999999 899999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=391.17 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=204.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
.++|+++++||+|+||.||+|++.. +++.||||+++..... ....+..|+.+|.++ +|||||+++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 4679999999999999999999875 6779999999754322 224578899999887 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+.+|||||||++|+|..++.+. ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|.+||+||
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999998654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhh-hhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWAR-PHL 361 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~-~~~ 361 (487)
|+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||......... ....... ...
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~ 275 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence 99986332221 234578999999999999999999999999999999999999999653322111 0000000 001
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 411 (487)
.. .. .++...+..+.+||.+||+.||.+||++ .||+++
T Consensus 276 ~~--------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 276 EK--------QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HC--------CC----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cc--------cc----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 10 01 1122234678999999999999999986 566654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=379.94 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=202.1
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||+||+|.+ +|..||||++...... ..+.+.+|+++|++++||||++++++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3457899999999999999999976 3668999999765432 23568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+.+.+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEEC
Confidence 9999999999999999999999965432 3899999999999999999999865 349999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... .
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~--~- 253 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVG--F- 253 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHH--H-
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH--h-
Confidence 999998643321 12334679999999999999999999999999999999999999997543211 111000 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
..... .++...+..+.+||.+||+.||.+||++.+|++.|+.+.
T Consensus 254 ------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 254 ------KCKRL----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp ------SCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------cCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00011 112223467899999999999999999999999997653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=392.42 Aligned_cols=273 Identities=29% Similarity=0.395 Sum_probs=217.2
Q ss_pred cChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCC
Q 011385 120 FTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLN 197 (487)
Q Consensus 120 ~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~Hpn 197 (487)
+....+....++|++.+.||+|+||.||+|++.... ...+++.||||+++..... ..+.+.+|++++.++ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 344555567789999999999999999999875421 2236789999999765332 235689999999999 7999
Q ss_pred ceeEEEEEEeCCe-eEEEEeeCCCCChhHHHhhcCC--------------------------------------------
Q 011385 198 LVKLIGYCIEDDQ-RLLVYEFMPRGSLENHLFRRSL-------------------------------------------- 232 (487)
Q Consensus 198 Iv~~~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------- 232 (487)
||++++++.+.+. .++|||||++|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999987654 8999999999999999965432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 233 ---------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 233 ---------------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
.+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 1889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
............||+.|+|||++.+..++.++|||||||++|||++ |..||........ +... +...
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~----~~~~------ 312 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR----LKEG------ 312 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHH----HHHT------
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHH----HHcC------
Confidence 5444344455678999999999999999999999999999999998 9999976443211 1110 0000
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... +...+..+.+|+.+||+.||.+||++.||+++|+.+
T Consensus 313 ~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 313 TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00111 112346789999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.69 Aligned_cols=272 Identities=22% Similarity=0.269 Sum_probs=214.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 4679999999999999999999865 577999999975432 345678899999999999999999999987
Q ss_pred CC--eeEEEEeeCCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcE
Q 011385 208 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNA 279 (487)
Q Consensus 208 ~~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~~ 279 (487)
.+ ..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence 65 7799999999999999996542 34899999999999999999999988 9999999999999 778889
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceec--------cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM--------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~--------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|..||.........
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 9999999987654332 23457999999999886 578999999999999999999999999754332211
Q ss_pred -hhhHhhhhhhh-c-ccccccc--------cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 352 -NLVEWARPHLG-E-RRRFYRL--------IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 352 -~~~~~~~~~~~-~-~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+......... . ...+... -.......+....+..+.+|+.+||+.||++||++.|++++....
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111100000 0 0000000 011122356677888999999999999999999999999988643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=368.61 Aligned_cols=281 Identities=37% Similarity=0.615 Sum_probs=224.2
Q ss_pred ccccChhHHHHHhcCCCCC------CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC----ccCHHHHHHH
Q 011385 117 LRKFTFNDLKLATRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE 186 (487)
Q Consensus 117 ~~~~~~~~~~~~~~~y~~~------~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E 186 (487)
...|.+.++...+++|... +.||+|+||.||+|.+ ++..||||++.... ....+.+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence 4567777888888777766 8999999999999976 35689999986532 1224678899
Q ss_pred HHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 011385 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR--SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYR 264 (487)
Q Consensus 187 ~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHr 264 (487)
+.+++.++||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence 99999999999999999999999999999999999999998632 456999999999999999999999988 9999
Q ss_pred CCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 011385 265 DFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 344 (487)
Q Consensus 265 DLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 344 (487)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999999987654333333344679999999998754 689999999999999999999999976
Q ss_pred CCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 345 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
......... +..........+...+++.+ .......+..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 237 HREPQLLLD--IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp TBSSSBTTH--HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcchHHHHH--HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 544322111 11111111112222333322 334567788899999999999999999999999999865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=387.17 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=206.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++++.||+|+||.||+|.+.. +++.||||++.... ......+.+|+++|..++|||||++++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3689999999999999999998865 67799999986432 23346788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..|+|||||.+|+|..++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG 160 (384)
T 4fr4_A 85 QDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160 (384)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccc
Confidence 999999999999999999999854 457999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceecc---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
+++...... .....+||+.|+|||++.. ..|+.++|||||||++|||++|..||..........+......
T Consensus 161 ~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--- 234 (384)
T 4fr4_A 161 IAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--- 234 (384)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---
T ss_pred eeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---
Confidence 998764432 2345689999999999863 4689999999999999999999999976544332222211110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVE 410 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~ 410 (487)
. ...++...+..+.+||.+||+.||.+||+ +.+|++
T Consensus 235 ~------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 T------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 01112223467899999999999999998 677665
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=376.99 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=204.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++. +|+.||||++...... ....+.+|+++++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 468999999999999999999874 3678999999754332 2356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..+|||||++ |+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence 9999999999997 4898888777777999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh-----
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH----- 360 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~----- 360 (487)
++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 987543221 2334578999999999876 56899999999999999999999999865544322211110000
Q ss_pred ---hhcc----cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 ---LGER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ---~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+. ..............+....+.++.+||.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 00000000000000011123578899999999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=395.16 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=211.4
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+..++|.+.+.||+|+||.||+|.+.. ++..||||+++..... ...++.+|+++|+.++|||||+++++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455789999999999999999999865 5679999999754322 22357899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..||||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence 99999999999999999999999776667999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++...............+++.|+|||++.+..++.++|||||||+||||++ |..||...... .+... ...
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~----~~~ 330 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREF----VEK 330 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHH----HHT
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHc
Confidence 99986543221111122346788999999998999999999999999999998 99999754321 11111 110
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. .. ..+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus 331 ~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 331 GG------RL----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC------CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 00 00 11122346789999999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=385.16 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=210.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++..........+.+|+.+|..++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 4689999999999999999998865 5779999999766544456788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--~~~~kl~DFGl 286 (487)
...+||||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999999999999766667999999999999999999999988 999999999999974 47899999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ...... .....
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i---~~~~~- 267 (387)
T 1kob_A 198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNV---KRCDW- 267 (387)
T ss_dssp CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH---HHCCC-
T ss_pred ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCC-
Confidence 987654322 23457999999999999999999999999999999999999999754321 111110 00000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..++.... ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 268 ---~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 268 ---EFDEDAFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp ---CCCSSTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred ---CCCccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 01111111 23467899999999999999999999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=380.24 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=207.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
.++|++.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+|..++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3578999999999999999998865 5779999999754332 356789999999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 278 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 278 (487)
+++.+.+..+||||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 999999999999999999999999954 357999999999999999999999988 99999999999998887 8
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~ 230 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS 230 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH
Confidence 99999999987643322 234579999999999998999999999999999999999999996542211 111000
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..... ....... ..+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 231 ---~~~~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 231 ---AVNYE----FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp ---HTCCC----CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ---hcCCC----cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00000 0000001 12357889999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=378.50 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=206.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++++.||+|+||.||+|++.. +|+.||||+++... ....+.+.+|+.++..++||||+++++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 75 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 75 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence 3679999999999999999998865 57799999996532 23346688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+.+||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 76 QDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecC
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... ... .......
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~---~~i~~~~- 219 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTY---EKILNAE- 219 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHCC-
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC-
Confidence 99875432 23468999999999999999999999999999999999999999654221 111 1111110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
.. ++...+..+.+||.+||..||.+|| ++.+|+++-
T Consensus 220 -------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 220 -------LR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp -------CC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -------CC----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 01 1112346789999999999999999 888887643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=370.20 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=204.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|.+.. +|+.||||++....... ...+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 578999999999999999999865 57799999997554332 3668899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..+|||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999965 777777666678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh----
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---- 362 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 362 (487)
+....... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||....... ...........
T Consensus 149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCCh
Confidence 87543221 233457899999999987765 8999999999999999999988864332211 11111000000
Q ss_pred -cccccccc---------cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 -ERRRFYRL---------IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 -~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
........ ........+....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 00000000 000000111123456789999999999999999999999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=380.13 Aligned_cols=276 Identities=24% Similarity=0.356 Sum_probs=209.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++++.||+|+||.||+|++.. ....++..||||++........+.+.+|++++..++||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34689999999999999999998642 1223688999999987655555678999999999999999999999865
Q ss_pred C--CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 208 D--DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 208 ~--~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
. ...+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence 3 5689999999999999999776667999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc-
Q 011385 286 LAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE- 363 (487)
Q Consensus 286 la~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~- 363 (487)
+++........ .......|+..|+|||++.+..++.++|||||||++|||++|..||...... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~ 235 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ 235 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccc
Confidence 99876443221 1223356788899999999999999999999999999999999998532110 00000000000
Q ss_pred --ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 --RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.......+........+..++..+.+|+.+||+.||.+||++.||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000000000011112223456799999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=374.11 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=207.6
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCee
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~ 211 (487)
|...+.||+|+||.||+|++.. +|+.||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 6667799999999999998864 5779999999877666677899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCC
Q 011385 212 LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291 (487)
Q Consensus 212 ~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~ 291 (487)
+|||||+++|+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 118 ~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence 999999999999998854 36899999999999999999999988 9999999999999999999999999998754
Q ss_pred CCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 292 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ....... ...
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~----------~~~ 257 (321)
T 2c30_A 193 KDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR----------DSP 257 (321)
T ss_dssp SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH----------HSS
T ss_pred cCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----------cCC
Confidence 4321 123467999999999999999999999999999999999999999654221 1111110 001
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+.+. .....+..+.+|+.+||+.||.+||++.|++++..
T Consensus 258 ~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 258 PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11110 01123467899999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=386.01 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=205.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCceeEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 202 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~ 202 (487)
...++|++.+.||+|+||.||+|++.. +|+.||||+++... ......+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 455789999999999999999999865 67899999997542 23345678899999877 999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+++.+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999999999654 46999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.... ..
T Consensus 161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~ 232 (345)
T 1xjd_A 161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI---RM 232 (345)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH
T ss_pred EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---Hh
Confidence 9999986433222 234578999999999999999999999999999999999999999754321 111110 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~ 411 (487)
. .+. ++...+..+.+||.+||+.||.+||++. +|+++
T Consensus 233 ~--------~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 233 D--------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp C--------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred C--------CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0 111 1112346789999999999999999997 66543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=398.37 Aligned_cols=265 Identities=20% Similarity=0.241 Sum_probs=212.1
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCc
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 198 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI 198 (487)
+.+..+..++|+++++||+|+||+||+|++.. +++.||||+++.... .....+.+|+.++..++||||
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I 136 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 44455667899999999999999999999875 577999999964211 112337899999999999999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
++++++|.+.+.+|||||||++|+|.+++.+....+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence 99999999999999999999999999999776678999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||+||||++|+.||........
T Consensus 214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--- 289 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--- 289 (437)
T ss_dssp EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---
T ss_pred EEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---
Confidence 99999999987654332 2234468999999999987 56799999999999999999999999975432111
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEAL 412 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 412 (487)
... .+.... ...-+..... .+..+.+||.+||..+|++ ||++.|++++-
T Consensus 290 ~~~---i~~~~~---~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 290 YGK---IMNHKE---RFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp HHH---HHTHHH---HCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred HHh---hhhccc---cccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 110 000000 0001111111 2467899999999988888 99999998854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=366.64 Aligned_cols=256 Identities=30% Similarity=0.554 Sum_probs=206.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-------HHHHHHHHHHHhcCCCCCceeE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
.++|++.+.||+|+||.||+|++.. ++..||||++....... .+.+.+|+.++..++||||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 4689999999999999999999865 56799999996544322 1578899999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--- 278 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--- 278 (487)
++++.+.. ++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCS
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCc
Confidence 99986654 7999999999999999777778999999999999999999999865 34999999999999988776
Q ss_pred --EEEeecCCCCCCCCCCcceeeeeccccccccCCcee--ccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 279 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV--MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 279 --~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~--~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+||+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|..||.......... .
T Consensus 166 ~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~ 239 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-I 239 (287)
T ss_dssp CCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-H
T ss_pred eeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-H
Confidence 99999999986433 13346799999999998 35568899999999999999999999997544321110 1
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... . ....+ .++...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 240 ~~~~---~------~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIR---E------EGLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHH---H------SCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHh---c------cCCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1000 0 01111 12223356789999999999999999999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=368.21 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=212.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+++.+|++++.+++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4568999999999999999999775 355799999976543 34679999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
....++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999999999776667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||....... .... ....
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~-- 221 (268)
T 3sxs_A 152 RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLK----VSQG-- 221 (268)
T ss_dssp EECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH----HHTT--
T ss_pred eecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHHH----HHcC--
Confidence 876543322 2233457788999999998899999999999999999999 999996543211 1100 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
..... .. ..+..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 222 -~~~~~---~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 222 -HRLYR---PH----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CCCCC---CT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCCCC---CC----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 00111 11 124578999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=388.15 Aligned_cols=262 Identities=25% Similarity=0.424 Sum_probs=200.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
...+|++.+.||+|+||.||+|++.... .++..||||+++.... ...+++.+|+.+|.+++||||+++++++.
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3468999999999999999999876322 2466899999976532 23456899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999999999877678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 287 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 287 a~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++......... ......+++.|+|||++.+..++.++|||||||+||||++ |..||...... .+.... ...
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i----~~~ 266 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAV----DEG 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHH----HTT
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcC
Confidence 98764432211 1122346788999999999999999999999999999998 99999654321 111111 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. ....+..++..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 267 ~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 Y----------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp E----------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0 0011112346789999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=370.78 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=210.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ..+++.+|++++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4689999999999999999998753 55799999976543 346799999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence 9999999999999999999777777999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... ...... ..
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~----~~---- 222 (269)
T 4hcu_A 155 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDI----ST---- 222 (269)
T ss_dssp GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HT----
T ss_pred ccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH----hc----
Confidence 6543211 11223457889999999998999999999999999999999 99999754321 111110 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....... ...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 223 --~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 223 --GFRLYKP----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp --TCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CccCCCC----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 0011111 12246789999999999999999999999999765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=387.93 Aligned_cols=268 Identities=27% Similarity=0.377 Sum_probs=215.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+..++|.+.+.||+|+||.||+|++..... .....+..||||+++..... ....+.+|++++..+ +|||||+++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 345789999999999999999999754221 12234568999999765332 235688999999999 99999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
+.+.+..+|||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 999999999999999999999997543 35899999999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654433333344568899999999999999999999999999999999 99999654321
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.+..... . ..... .+..++..+.+|+.+||+.||.+||++.||+++|+.+.
T Consensus 301 ---~~~~~~~----~------~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 ---ELFKLLK----E------GHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ---HHHHHHH----T------TCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHH----c------CCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111110 0 00111 11123467899999999999999999999999998664
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=391.86 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=208.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++++.||+|+||.||+|.+.... ...++..||||+++.... .....+.+|+.++..++|||||++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 467899999999999999999975321 123677999999965432 233568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---c
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---N 278 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~ 278 (487)
....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 999999999999999999997543 35899999999999999999999988 99999999999998555 5
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||...... .+....
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i 299 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV 299 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999975322221122334578999999999999999999999999999999998 99999754321 111111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .. ... ..+..++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 300 ~----~~------~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 T----SG------GRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp H----TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----cC------CCC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 00 000 11122346789999999999999999999999999755
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=388.47 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=207.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|..||+|++...... ..+.+.+|+.+|+.++|||||++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45689999999999999999998765 6789999999765432 235688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~~kl~ 282 (487)
.+.+..|||||||++|+|.+++..+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999999999998655 46999999999999999999999988 99999999999998 45789999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... .+.... ..
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~ 227 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQI---KA 227 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HH
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHH---Hh
Confidence 9999987654322 223468999999999999999999999999999999999999999654321 111110 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
... .. ...... ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 228 ~~~---~~-~~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 228 GAY---DF-PSPEWD----TVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp TCC---CC-CTTTTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred CCC---CC-Cccccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 000 00 111111 22467899999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=381.27 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=205.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-----ccCHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
.++|++.+.||+|+||.||+|++.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4579999999999999999998865 57799999985321 123577899999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 278 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-- 278 (487)
++.+.+..|||||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCC
Confidence 999999999999999999999888543 345899999999999999999999988 999999999999987654
Q ss_pred -EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 279 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 -~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... .+....
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i 244 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGI 244 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHH
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHH
Confidence 99999999987654322 23346799999999999999999999999999999999999999975311 111100
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...... ..+..... .+..+.+||.+||+.||.+||++.|++++-
T Consensus 245 ---~~~~~~----~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 245 ---IKGKYK----MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp ---HHTCCC----CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HcCCCC----CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 000000 00000111 236789999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=374.76 Aligned_cols=261 Identities=19% Similarity=0.186 Sum_probs=210.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+|+++++.| +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4689999999999999999998764 6789999998755332 4588999999999 99999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-----EEEe
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKLS 282 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-----~kl~ 282 (487)
.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 99999999776678999999999999999999999988 999999999999998887 9999
Q ss_pred ecCCCCCCCCCCcce-----eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 283 DFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 283 DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
|||+++......... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999998654332211 123468999999999999999999999999999999999999999876443322222111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...... ..... +.. ..+ .+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 233 ~~~~~~--~~~~~----~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 233 GDTKRA--TPIEV----LCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHH--SCHHH----HTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hhhhcc--CCHHH----Hhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 100000 00000 000 123 789999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=380.72 Aligned_cols=261 Identities=23% Similarity=0.384 Sum_probs=205.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|++...+.. ....||+|.+.... ....+++.+|+.++++++||||+++++++.+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 46799999999999999999998653321 12357899886443 2345779999999999999999999999987
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence 54 78999999999999999887778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~- 236 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE- 236 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC-
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC-
Confidence 87544433333344567889999999999999999999999999999999 999997653322111110 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....+..++..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011122346789999999999999999999999999765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=394.18 Aligned_cols=264 Identities=20% Similarity=0.240 Sum_probs=209.6
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCc
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNL 198 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI 198 (487)
+.+.....++|++++.||+|+||.||+|++.. +|+.||||+++.... .....+.+|+.++..++||||
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I 123 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe
Confidence 34445567899999999999999999999865 677999999964321 112347889999999999999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
+++++++.+.+.+|||||||++|+|.+++.+....+++..++.++.||+.||.|||+.+ ||||||||+||||+.+++
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence 99999999999999999999999999999776667999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceec-------cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
+||+|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||........
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~- 278 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET- 278 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-
Confidence 99999999987654322 1223468999999999987 35789999999999999999999999975432111
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHh
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR---PLMSEVVEAL 412 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~L 412 (487)
.... ...... ...+.... ..+..+.+||.+||. +|.+| |++.||+++-
T Consensus 279 --~~~i---~~~~~~---~~~p~~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 279 --YGKI---VHYKEH---LSLPLVDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp --HHHH---HTHHHH---CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred --HHHH---HhcccC---cCCCcccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 1000 000000 00011111 234678999999999 99998 5899998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.70 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=204.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
.++|++++.||+|+||.||+|++.. +++.||||+++...... ...+.+|+.++.++ +|||||+++++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 78 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 78 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence 3579999999999999999999865 67899999997654332 34578899999988 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 79 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF 154 (345)
T 3a8x_A 79 FQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154 (345)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCG
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~ 362 (487)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... .........+.
T Consensus 155 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 155 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp GGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred cccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 99986432221 234468999999999999999999999999999999999999999653221110 00000000000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM------SEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~ 411 (487)
.. .. .++...+..+.+||.+||+.||.+||++ .+++++
T Consensus 233 ~~-------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 233 EK-------QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HC-------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred cC-------CC----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00 01 1122234678999999999999999996 566553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=381.70 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=206.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++++.||+|+||.||+|++.. +|+.||||++.... ....+.+.+|+++|..++||||+++++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4689999999999999999999865 57799999986432 23456788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+.+||||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccc
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.. ......
T Consensus 187 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~---~i~~~~- 254 (350)
T 1rdq_E 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---KIVSGK- 254 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHCC-
T ss_pred cceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHH---HHHcCC-
Confidence 99875432 23468999999999999999999999999999999999999999754321 1111 011110
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L 412 (487)
.. ++...+..+.+||.+||+.||.+||+ +.+|+++-
T Consensus 255 -------~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 255 -------VR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp -------CC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred -------CC----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 01 11123467899999999999999998 77777643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=382.72 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=207.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|..||||++...... ..+.+.+|+.+++.|+|||||++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45689999999999999999998865 5779999999765432 235688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~~kl~ 282 (487)
.+.+..|||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence 9999999999999999999998554 56899999999999999999999988 9999999999999765 459999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... .+.... ..
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i---~~ 244 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI---KA 244 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---Hh
Confidence 9999987654322 23467999999999999989999999999999999999999999654221 111110 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... . ...... ..+..+.+||.+||+.||.+||++.+++++-
T Consensus 245 ~~~~---~-~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 245 GAYD---Y-PSPEWD----TVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp TCCC---C-CTTGGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred CCCC---C-Cccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0000 0 000111 2246789999999999999999999999763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=381.57 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=207.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+...+.. ....||+|.+.... ......+.+|+.++..++||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 36899999999999999999998753321 12358888885443 223355779999999999999999999886
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..++||||+++|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcc
Confidence 56789999999999999999766667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~- 234 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-------GE- 234 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-------TC-
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CC-
Confidence 98755444434455678899999999999999999999999999999999 9999976543221111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
... .+..++..+.+|+.+||+.||.+||++.+++++|+.+.
T Consensus 235 --~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 --RLA-------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp --BCC-------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred --CCC-------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 01112235779999999999999999999999998664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=381.47 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=213.6
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
...++|++.+.||+|+||.||+|.+.... ...++..||||++..... .....+.+|+.+|.++ .||||++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34578999999999999999999974321 123567899999975432 2346789999999999 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSL----------------------PLPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
+...+..+|||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 194 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 194 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 9999999999999999999999975432 3789999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 341 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 341 (487)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654433333444678899999999999999999999999999999998 9999
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
|....... .+..... . .... ..+...+..+.+|+.+||+.||.+||++.+|+++|+.+.
T Consensus 275 ~~~~~~~~--~~~~~~~----~------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 275 YPGIPVDA--NFYKLIQ----N------GFKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp STTCCCSH--HHHHHHH----T------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cccCCcHH--HHHHHHh----c------CCCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 97654321 1111110 0 0011 111223467899999999999999999999999998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=382.18 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=205.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCceeEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLIG 203 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~~ 203 (487)
..++|++++.||+|+||.||+|++.. +|+.||||+++... ......+..|..+|..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 45789999999999999999998865 57799999997542 23346688999999988 8999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++.+.+.+|||||||+||+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999999999999654 46999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+.. .....
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~ 236 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEH 236 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhC
Confidence 999986433221 234468999999999999999999999999999999999999999754221 1111 11111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
. . .++...+..+.+||.+||..||.+||+ +.+|+++
T Consensus 237 ~--------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 N--------V----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp C--------C----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred C--------C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 0 112223467899999999999999996 4666654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=369.87 Aligned_cols=260 Identities=24% Similarity=0.363 Sum_probs=199.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+..... .+..||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 45689999999999999999999865322 4567999998764332 2356889999999999999999999974
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccc
Confidence 56789999999999999999877667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ...... ..
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i~----~~- 233 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NG- 233 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TT-
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHHH----cC-
Confidence 9876443221 2233467889999999998999999999999999999997 999997543321 111110 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ++...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 234 -----~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 234 -----ERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011 1122346789999999999999999999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=381.57 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=213.6
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
...++|++.+.||+|+||.||+|++.... ...++..||||+++..... ....+.+|+.+++.++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcC----CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45678999999999999999999986421 1124578999999765432 245688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 99999999999999999999997542 56899999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 341 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 341 (487)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976433222222334578999999999999999999999999999999999 9999
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
|...... .+.... .... .. .++..++..+.+|+.+||+.||.+||++.+++++|+.+..
T Consensus 277 ~~~~~~~---~~~~~~----~~~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 277 YYGMAHE---EVIYYV----RDGN------IL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTSCHH---HHHHHH----HTTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCChH---HHHHHH----hCCC------cC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9654221 111110 0000 00 1112234678999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=378.35 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=205.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999999865 67799999986432 12235788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..+|||||+ +|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 9999999999999 78999988654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........
T Consensus 154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------- 219 (336)
T 3h4j_B 154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------- 219 (336)
T ss_dssp CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------
T ss_pred cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------
Confidence 9987654332 234679999999999988776 7899999999999999999999975432211100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+.. ....++...+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 220 ------i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 220 ------VNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ------CCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ------HHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 000 001112223467899999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.67 Aligned_cols=264 Identities=24% Similarity=0.376 Sum_probs=191.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++++.||+|+||.||+|.+.. +|+.||||+++.... .....+.+|+++|+.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 3589999999999999999998764 577999999975433 234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRS-----LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
++..+|||||++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence 999999999997 59999886432 45899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh---
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--- 358 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--- 358 (487)
|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+....
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987543221 1234579999999999876 468999999999999999999999997643321111110000
Q ss_pred -----hhhhccccc------------ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 -----PHLGERRRF------------YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 -----~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+.......+ ...+.+.... ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000 0000011111 123578999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=376.97 Aligned_cols=265 Identities=28% Similarity=0.403 Sum_probs=214.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
...++|.+.+.||+|+||.||+|.+.... ...++..||||++..... ...+.+.+|+++++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 45678999999999999999999875321 122567899999975432 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 99999999999999999999997543 23889999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 341 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 341 (487)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987655443333334568899999999999999999999999999999999 9999
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
|...........+ . .. ... ..+...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 253 ~~~~~~~~~~~~~---~----~~------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 253 YPGIPPERLFNLL---K----TG------HRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp STTCCGGGHHHHH---H----TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHh---h----cC------CcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9765432111111 0 00 001 11122346789999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.97 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=197.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--------------------------CHHH
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE 182 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------------------------~~~~ 182 (487)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence 3689999999999999999998865 5779999999654321 1245
Q ss_pred HHHHHHHHhcCCCCCceeEEEEEEe--CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011385 183 WLAEVNFLGDLVHLNLVKLIGYCIE--DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERP 260 (487)
Q Consensus 183 ~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ 260 (487)
+.+|+++|+.++||||+++++++.+ .+..||||||+++++|.+++. ...+++..++.++.||+.||.|||+.+
T Consensus 83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8899999999999999999999987 568899999999999988653 346999999999999999999999988
Q ss_pred eEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCC---CCchhhhhhHHHHHHHHHh
Q 011385 261 VIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLT 337 (487)
Q Consensus 261 iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~---~~~~~DiwSlGvil~ellt 337 (487)
|+||||||+||||+.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999999999999999999999999987654322 233467999999999987655 4788999999999999999
Q ss_pred CCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 338 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 338 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
|..||...... .+. ....... ........ .+..+.+||.+||+.||.+||++.|++++
T Consensus 236 g~~pf~~~~~~---~~~---~~~~~~~------~~~~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 236 GQCPFMDERIM---CLH---SKIKSQA------LEFPDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCSSCCSSHH---HHH---HHHHHCC------CCCCSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCCCCccHH---HHH---HHHhccc------CCCCCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999653211 111 0000000 00001111 23678999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=369.56 Aligned_cols=267 Identities=23% Similarity=0.327 Sum_probs=201.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||.||+|++. +|+.||||++..... .....+.+|+++++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47899999999999999999873 467899999965432 223678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999975 999998776678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h-------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R------- 358 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~------- 358 (487)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+... .
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 76432211 1234578999999999875 46899999999999999999999999754321111000000 0
Q ss_pred hhhhccccc---ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 PHLGERRRF---YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+.......+ .....+.....+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000000000 000000000111122346788999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=374.71 Aligned_cols=254 Identities=22% Similarity=0.375 Sum_probs=198.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++++.||+|+||.||+|++.. +|+.||||+++..... ..+.+.+|+++|++++|||||+++++|.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34679999999999999999999865 5779999999754433 3467899999999999999999999986
Q ss_pred eCC---------------------------------------------------------eeEEEEeeCCCCChhHHHhh
Q 011385 207 EDD---------------------------------------------------------QRLLVYEFMPRGSLENHLFR 229 (487)
Q Consensus 207 ~~~---------------------------------------------------------~~~lv~E~~~~gsL~~~l~~ 229 (487)
+.. ..++|||||++|+|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 643 37999999999999999965
Q ss_pred cC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcc----------e
Q 011385 230 RS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT----------H 297 (487)
Q Consensus 230 ~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~ 297 (487)
.. ...++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++........ .
T Consensus 155 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~ 231 (332)
T 3qd2_B 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231 (332)
T ss_dssp CCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------
T ss_pred ccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccc
Confidence 43 23566778999999999999999988 999999999999999999999999999876543211 1
Q ss_pred eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCC
Q 011385 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEG 377 (487)
Q Consensus 298 ~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (487)
.....+||+.|+|||++.+..++.++|||||||++|||++|..|+.. ...... .. .... ..
T Consensus 232 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~-~~---------~~~~-~~ 292 (332)
T 3qd2_B 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIIT-DV---------RNLK-FP 292 (332)
T ss_dssp CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHH-HH---------HTTC-CC
T ss_pred cccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHH-Hh---------hccC-CC
Confidence 12335799999999999999999999999999999999998766421 000000 00 0000 00
Q ss_pred CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 378 HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 378 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.........+.+|+.+||+.||.+||++.|++++-
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 327 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENA 327 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence 01123345678999999999999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=376.66 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=196.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++++.||+|+||+||+|++.. +++.||||++...... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 3589999999999999999999875 5779999999765433 36788999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--EEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--~kl~DFGl 286 (487)
+..+||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY 164 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence 9999999999999999998654 46999999999999999999999988 999999999999987765 99999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ .........
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~ 239 (361)
T 3uc3_A 165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKY 239 (361)
T ss_dssp C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCC
T ss_pred cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCC
Confidence 98543222 2234579999999999988888766 89999999999999999999765432221111 100010000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+ . ... ..+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 240 ~~----~--~~~----~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 240 SI----P--DDI----RISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CC----C--TTS----CCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CC----C--CcC----CCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 00 0 001 12367889999999999999999999998743
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=374.19 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=215.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
...++|++.+.||+|+||.||+|.+... ....++..||||++..... ...+.+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 3457899999999999999999986431 1233678999999976543 2346688999999999 99999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSL-----------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 267 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 267 (487)
+.+.+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999975532 4899999999999999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 346 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~ 346 (487)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987765444333444668899999999999999999999999999999999 999997643
Q ss_pred CCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... .... ... ...... +...+..+.+|+.+||+.||.+||++.|++++|+.+
T Consensus 253 ~~~~--~~~~----~~~------~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 253 VDSK--FYKM----IKE------GFRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SSHH--HHHH----HHH------TCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhH--HHHH----hcc------CCCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 3211 1111 000 001111 112346789999999999999999999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=387.07 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=208.7
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCcee
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVK 200 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~ 200 (487)
++....++|++++.||+|+||.||+|++.. +++.||||+++.... .....+.+|+.++..++|||||+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344566899999999999999999999875 577999999864211 12234789999999999999999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
+++++.+.+.+|||||||+||+|.+++... .+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|.+|
T Consensus 134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEE
Confidence 999999999999999999999999998653 5899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCC----CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH----LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~----~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
|+|||+++....... ......+||+.|+|||++.+.. |+.++|||||||+||||++|..||....... ....
T Consensus 209 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~ 284 (410)
T 3v8s_A 209 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYSK 284 (410)
T ss_dssp ECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH
T ss_pred EeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHHH
Confidence 999999987654322 2233578999999999998665 8899999999999999999999997543211 1110
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHhc
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA--RPLMSEVVEALK 413 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~ 413 (487)
.+..... ..-+ .... .+..+.+||.+||..+|.+ ||++.||++|-.
T Consensus 285 ---i~~~~~~---~~~p-~~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 285 ---IMNHKNS---LTFP-DDND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp ---HHTHHHH---CCCC-TTCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ---HHhcccc---ccCC-Cccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 0000000 0000 0111 2467899999999999988 999999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=378.08 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=193.6
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||.||+|.+...+. ....||||+++.... ...+.+.+|++++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 455789999999999999999998765321 223799999976532 334678999999999999999999999
Q ss_pred EEeCCee------EEEEeeCCCCChhHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 205 CIEDDQR------LLVYEFMPRGSLENHLFRR-----SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 205 ~~~~~~~------~lv~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
+...... ++||||+++|+|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEE
Confidence 9877655 9999999999999998643 225899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 352 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 352 (487)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-- 248 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-- 248 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence 9999999999999987655443333344567889999999999999999999999999999999 9999976433211
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .. .... .+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 249 -~~~~~---~~-------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 249 -YNYLI---GG-------NRLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp -HHHHH---TT-------CCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHh---cC-------CCCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11100 00 0011 1112346789999999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=399.44 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=215.5
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.+...+|++.+.||+|+||.||+|.+.. ++..||||+++... ...+++.+|+.+|++++|||||++++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3455688999999999999999999875 46789999997654 3467899999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
.+.+..|||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence 9999999999999999999999754 356899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++....... .......+++.|+|||++....|+.++|||||||+||||++ |..||....... +.... ..
T Consensus 363 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~ 434 (495)
T 1opk_A 363 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EK 434 (495)
T ss_dssp TCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HT
T ss_pred ccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence 99987644321 12223456789999999999999999999999999999999 999997643221 11111 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
. .....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 435 ~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 D----------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C----------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 0111122345678999999999999999999999999997743
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=371.84 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=207.6
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+++.+|++++..++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 34568999999999999999999875 356799999976543 3477999999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccc
Confidence 999999999999999999999765667999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .... +..
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~~-- 236 (283)
T 3gen_A 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEH----IAQ-- 236 (283)
T ss_dssp GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH----HHT--
T ss_pred ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHH----Hhc--
Confidence 986543211 11223457889999999998999999999999999999998 999997543211 1110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
........ ..+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 237 ----~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 237 ----GLRLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----TCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----ccCCCCCC----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01111111 1246789999999999999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.66 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=196.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.++|++.+.||+|+||.||+|.+. |..||||++..... ...+.+.+|+++++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 468999999999999999999873 56899999875432 224678899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--------C
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--------D 276 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--------~ 276 (487)
+.+.+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+..+|+||||||+|||++. +
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 9999999999999999999998843 46899999999999999999999987445899999999999986 6
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
+.+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. .
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~-~ 224 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VA-Y 224 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH-H
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-H
Confidence 789999999998654322 223579999999999999999999999999999999999999997542111 00 0
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .. .......++...+..+.+|+.+||+.||.+||++.|++++|+.+
T Consensus 225 ~--~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 G--VA----------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp H--HH----------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred h--hh----------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 00 00011112223346789999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=379.35 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=200.3
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~lv 214 (487)
.++||+|+||.||+|.+.. +|..||||+++.......+.+.+|+++|.+++|||||++++++.+.+..+||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5689999999999998865 5779999999876655567799999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE--cCCCcEEEeecCCCCCCCC
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL--DADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll--~~~~~~kl~DFGla~~~~~ 292 (487)
||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999999776667999999999999999999999988 9999999999999 5678999999999987654
Q ss_pred CCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccC
Q 011385 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLID 372 (487)
Q Consensus 293 ~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (487)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... .... ....... ..
T Consensus 242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~~~~----~~ 308 (373)
T 2x4f_A 242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TLNN---ILACRWD----LE 308 (373)
T ss_dssp TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH---HHHTCCC----SC
T ss_pred ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhccCC----CC
Confidence 332 233579999999999998999999999999999999999999997543211 1110 0100000 01
Q ss_pred CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 373 PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 373 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... ..+..+.+||.+||+.||.+||++.|++++-
T Consensus 309 ~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 309 DEEFQ----DISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp SGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhhhc----cCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 11111 1246789999999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=381.07 Aligned_cols=260 Identities=26% Similarity=0.328 Sum_probs=202.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHH-HhcCCCCCceeEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNF-LGDLVHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~HpnIv~~~~~ 204 (487)
.++|++++.||+|+||.||+|++.. ++..||||+++..... ....+..|..+ ++.++|||||+++++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~ 107 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS 107 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence 3579999999999999999999865 5779999999765432 23456777777 577899999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+.+|||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||||+.+|++||+||
T Consensus 108 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 108 FQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999999999998654 46889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+. ...+...
T Consensus 184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~---~~i~~~~ 255 (373)
T 2r5t_A 184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMY---DNILNKP 255 (373)
T ss_dssp CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHH---HHHHHSC
T ss_pred ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHH---HHHHhcc
Confidence 99986332221 234578999999999999999999999999999999999999999654221 111 1111110
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCCccC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDM 421 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~~~~ 421 (487)
..+.. ..+..+.+||.+||+.||.+||++.+.++.+..++.+..+
T Consensus 256 --------~~~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 256 --------LQLKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp --------CCCCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred --------cCCCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 01111 2246789999999999999999987666666666665544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=366.64 Aligned_cols=264 Identities=17% Similarity=0.162 Sum_probs=212.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.. +|..||||++..... ...+.+|+.++..+ +|+||+++++++.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 45689999999999999999998754 577999999865432 24578999999999 7999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-----EEE
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-----AKL 281 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-----~kl 281 (487)
+....++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEE
Confidence 999999999999 99999999877667999999999999999999999988 999999999999987776 999
Q ss_pred eecCCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 282 SDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 282 ~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 999999865443221 112346799999999999999999999999999999999999999987544332222211
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
....... ... +.+.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 233 ~~~~~~~-~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 233 IGEKKQS-TPL-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHHHHH-SCH-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhhccC-ccH-----HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1110000 000 00011 12467899999999999999999999999998653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=365.83 Aligned_cols=262 Identities=27% Similarity=0.473 Sum_probs=197.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||.||+|++.. .||||+++..... ..+.+.+|+.+++.++||||++++++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 345789999999999999999997642 5999999765432 23568899999999999999999996
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+ .....++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccc
Confidence 5 566789999999999999999777778999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|+++...............||+.|+|||++. +..++.++|||||||++|||++|..||....... .+.....
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~--- 239 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVG--- 239 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHH---
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhc---
Confidence 9998654333222334467999999999886 6678999999999999999999999997543211 1111110
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. ...+. ...+...++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 240 -~~-----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 -RG-----SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -HT-----SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -cc-----ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 00 00110 11112233467999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=370.76 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=207.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+...+... ...+..||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYG--QLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGG--CEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccc--cccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 468999999999999999999987532100 001247999999766556667899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--------EE
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--------AK 280 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--------~k 280 (487)
+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999776666999999999999999999999988 999999999999998887 99
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....... ....
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~---- 229 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ---- 229 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH----
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH----
Confidence 999999976533 123568999999999987 779999999999999999999655443221110 0000
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 418 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 418 (487)
....... + ... .+..+.+|+.+||+.||.+||++.+++++|+.+...
T Consensus 230 ~~~~~~~----~----~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 230 FYEDRHQ----L----PAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHHTTCC----C----CCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HhhccCC----C----CCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0011111 1 111 124578999999999999999999999999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=368.05 Aligned_cols=262 Identities=26% Similarity=0.365 Sum_probs=201.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|++ +|..||||++... ....+..|.+++.. ++||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 356899999999999999999987 3678999998654 23556667777666 8999999999987
Q ss_pred EeC----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcEEE
Q 011385 206 IED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 206 ~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiHrDLKp~NIll 273 (487)
... ...++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill 146 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILV 146 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEE
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEE
Confidence 543 458899999999999999943 46999999999999999999999 766 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcce--eeeeccccccccCCceeccC------CCCchhhhhhHHHHHHHHHhC-------
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTG------- 338 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~------~~~~~~DiwSlGvil~elltG------- 338 (487)
+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999997644332211 12234799999999998876 456799999999999999999
Q ss_pred ---CCCCCCCCCCCcchhhHhhhhhhhcccccccccCCcc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 339 ---RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 339 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
..||................ ... ....+.+ ...+....+..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKV-VCV------DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHH-HTT------SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHH-Hhc------cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 78886544332211110000 000 0011111 111233567889999999999999999999999999874
Q ss_pred C
Q 011385 415 L 415 (487)
Q Consensus 415 l 415 (487)
+
T Consensus 300 i 300 (301)
T 3q4u_A 300 I 300 (301)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=390.72 Aligned_cols=269 Identities=22% Similarity=0.314 Sum_probs=188.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 3689999999999999999998865 577999999965422 23456889999999999999999999985
Q ss_pred eC-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 207 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
.. ..+||||||+ +|+|.+++.. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence 43 5689999998 5799998854 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc-------------------------eeeeeccccccccCCcee-ccCCCCchhhhhhHHHHHHHH
Q 011385 282 SDFGLAKDGPEGDKT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEM 335 (487)
Q Consensus 282 ~DFGla~~~~~~~~~-------------------------~~~~~~~Gt~~y~APE~~-~~~~~~~~~DiwSlGvil~el 335 (487)
+|||+++........ ...+..+||+.|+|||++ ....|+.++||||||||||||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999875422110 123446899999999976 466799999999999999999
Q ss_pred Hh-----------CCCCCCCCCCCCc-----------------chhhHhhhhhhhc-------------ccccccccC--
Q 011385 336 LT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGE-------------RRRFYRLID-- 372 (487)
Q Consensus 336 lt-----------G~~pf~~~~~~~~-----------------~~~~~~~~~~~~~-------------~~~~~~~~~-- 372 (487)
++ |.++|.+...... .+........++. ...+...+.
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 6666654332100 0000000000000 000000000
Q ss_pred --CccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 373 --PRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 373 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+...+ ...+..+.+||.+||..||.+|||+.|+|++-
T Consensus 358 ~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 358 EGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp CCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 0011111 12246789999999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=374.39 Aligned_cols=254 Identities=27% Similarity=0.356 Sum_probs=198.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.++|++.+.||+|+||.||+|+.... ..+|+.||||+++.... .....+.+|+.+|+.++||||++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTG------ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSS------TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEecc------CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 46799999999999999999987532 22678999999976532 223457889999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..|||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeC
Confidence 99999999999999999999999654 46899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... .....
T Consensus 166 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~~~~ 237 (327)
T 3a62_A 166 GLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDK---ILKCK 237 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---HHHTC
T ss_pred CcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhCC
Confidence 99986433221 223467999999999999999999999999999999999999999754321 11110 11100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
.. ++...+..+.+||.+||+.||.+|| ++.|++++-
T Consensus 238 --------~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 238 --------LN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp --------CC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred --------CC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 01 1112346789999999999999999 778888754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=377.51 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=198.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCC--CCceeEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVH--LNLVKLIG 203 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H--pnIv~~~~ 203 (487)
..++|++++.||+|+||.||+|.+. ++..||||++...... ..+.+.+|+.+|..+.| +||+++++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 76 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence 3467999999999999999999764 4678999999755432 23568899999999986 99999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++.+.+..+||||+ .+++|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 77 YEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp EEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred eEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence 99999999999995 588999999654 57999999999999999999999988 99999999999997 67899999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceecc-----------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
||+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---- 226 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 226 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----
Confidence 999987655443333445689999999999865 67899999999999999999999999643211
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.. . +...+++.....++...+..+.+|+.+||+.||.+||++.|++++..
T Consensus 227 ~~-~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 227 IS-K----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HH-H----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HH-H----------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 00 0 01111111122222223467899999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.20 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=204.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+|+++|.++ .||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 34679999999999999999998865 6789999999765432 45788888888 7999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC----CcEEEe
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLS 282 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----~~~kl~ 282 (487)
+.+..|||||||++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEE
Confidence 999999999999999999998654 56999999999999999999999988 9999999999998443 359999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+..... .
T Consensus 163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~ 237 (342)
T 2qr7_A 163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---S 237 (342)
T ss_dssp CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---H
T ss_pred ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---c
Confidence 9999987544322 2334689999999999988889999999999999999999999997543222222221111 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
... .+...+....+..+.+||.+||..||.+||++.+++++-.
T Consensus 238 ~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 238 GKF--------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp CCC--------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCc--------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 000 0111111223467899999999999999999999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=392.95 Aligned_cols=252 Identities=29% Similarity=0.367 Sum_probs=198.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC---CccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++++.||+|+||.||+|.+.. +|..||||++... .......+.+|+++|..++||||++++++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 34679999999999999999998865 6779999999643 22233567899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+.+.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||+ .+ ||||||||+||||+.++.+||+|
T Consensus 217 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 217 FQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECC
T ss_pred EeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEcc
Confidence 99999999999999999999998654 479999999999999999999998 77 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||...... .+... ....
T Consensus 293 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---i~~~ 364 (446)
T 4ejn_A 293 FGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILME 364 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHC
T ss_pred CCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHH---HHhC
Confidence 999986433222 234478999999999999999999999999999999999999999654321 11111 1111
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
.. . ++...+..+.+||.+||+.||.+|| ++.|++++-
T Consensus 365 ~~--------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 365 EI--------R----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp CC--------C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CC--------C----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 00 1 1112346789999999999999999 999998754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=373.20 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=204.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++++.||+|+||.||+|.+...+.. ....||+|.+.... ....+.+.+|+.++..++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 46899999999999999999998754321 12357888885443 3446789999999999999999999999987
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.. .++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 54 78999999999999999877778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...............||+.|+|||++.+..|+.++|||||||++|||++ |..||...........+. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~-- 235 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG-- 235 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TT--
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cC--
Confidence 87654433333334567889999999999999999999999999999999 999997654322111110 00
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
. ....+...+..+.+|+.+||+.||.+||++.|+++.|+.+.
T Consensus 236 ----~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 236 ----E----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----C----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----C----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 00111123457899999999999999999999999998664
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=380.51 Aligned_cols=254 Identities=21% Similarity=0.252 Sum_probs=196.0
Q ss_pred hcCCCCC-CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHh-cCCCCCceeEEEEEE
Q 011385 129 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG-DLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~~ 206 (487)
.++|.+. ++||+|+||+||+|++.. +|+.||||++... ..+.+|+.++. .++||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3567766 689999999999998865 6779999999643 56788999874 458999999999987
Q ss_pred e----CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011385 207 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 278 (487)
Q Consensus 207 ~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 278 (487)
. ...+|||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCC
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCcc
Confidence 5 567899999999999999997543 46999999999999999999999988 999999999999987 789
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~ 357 (487)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.......... .....
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i 279 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence 9999999998754322 2345689999999999999999999999999999999999999997654332111 11110
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. .... ....+ ... ..+..+.+||.+||+.||.+||++.|++++..
T Consensus 280 ~---~~~~---~~~~~-~~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 280 R---MGQY---EFPNP-EWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp H---HTCC---CCCTT-TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred H---cCcc---cCCCc-ccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 0000 00000 011 23467899999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=371.32 Aligned_cols=248 Identities=25% Similarity=0.269 Sum_probs=196.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||+||+|++.. +|+.||||++...... ....+..|+..+..+ .||||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 4579999999999999999999875 5779999998654332 223455666666555 899999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999999 77999999877778999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|..+|.... .... +..
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~-----~~~-- 266 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQ-----LRQ-- 266 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHH-----HTT--
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHH-----Hhc--
Confidence 998764332 2334579999999998875 79999999999999999999977664311 0000 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....+.+.. ..+..+.+|+.+||+.||.+||++.|++++-
T Consensus 267 ---~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 267 ---GYLPPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp ---TCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ---cCCCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 000111111 1246789999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=387.11 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=206.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|+||.||+|.+. |..||||+++... ..+.+.+|+++|++++|||||++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 34578999999999999999999873 5689999997654 3478999999999999999999999987
Q ss_pred eCC-eeEEEEeeCCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 207 EDD-QRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 207 ~~~-~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
..+ ..|||||||++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeC
Confidence 765 78999999999999999976543 4799999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++..... .....+++.|+|||++.+..++.++|||||||+||||++ |..||........ .... ..
T Consensus 334 G~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i----~~ 401 (450)
T 1k9a_A 334 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EK 401 (450)
T ss_dssp TTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHH----HT
T ss_pred CCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----Hc
Confidence 999864322 122367899999999999999999999999999999998 9999976543221 1111 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. . ....+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 402 ~------~----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 402 G------Y----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp T------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------C----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0 0111223457899999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=376.27 Aligned_cols=255 Identities=24% Similarity=0.281 Sum_probs=192.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|++.. +++.||||++.... ..+.+.+|+++|.+++||||+++++++.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 45689999999999999999998865 56789999997543 23567899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~~kl~DF 284 (487)
.+..+|||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccC
Confidence 99999999999999999998554 46899999999999999999999988 999999999999975 889999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..... .....
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~---i~~~~ 267 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRR---ILNCE 267 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHH---HHTTC
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHH---HHhCC
Confidence 9998754322 2234679999999999999999999999999999999999999996543211 01100 00000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ... ..... ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 268 ~---~~~-~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 268 Y---YFI-SPWWD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp C---CCC-TTTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred C---ccC-Cchhh----hCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 0 000 11111 23467899999999999999999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=369.56 Aligned_cols=274 Identities=28% Similarity=0.391 Sum_probs=209.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++++.||+|+||.||+|++... ...+++.||||++..... .....+.+|++++..++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-----GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-----SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-----cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 5688999999999999999986432 123688999999975432 3456789999999999999999999999876
Q ss_pred --CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 209 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
...++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence 6689999999999999999777677999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh--c
Q 011385 287 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--E 363 (487)
Q Consensus 287 a~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~ 363 (487)
+......... .......||..|+|||++.+..++.++|||||||++|||++|..|+..... .......+... .
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccC
Confidence 9876544322 223346789999999999999999999999999999999999988642210 00000000000 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...+...+........+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000000000011112223346789999999999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=380.85 Aligned_cols=274 Identities=22% Similarity=0.265 Sum_probs=214.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.++||+|+||.||+|++.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 4679999999999999999999865 577999999975432 335678899999999999999999999987
Q ss_pred CC--eeEEEEeeCCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----cCCCcE
Q 011385 208 DD--QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----DADYNA 279 (487)
Q Consensus 208 ~~--~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~~~~~~ 279 (487)
.+ ..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence 65 7799999999999999996532 34999999999999999999999988 9999999999999 777889
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceecc--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc-
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 350 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~- 350 (487)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 9999999987644321 234679999999998865 5778899999999999999999999975433221
Q ss_pred chhhHhhhhhhhc--cccccc--------ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 351 HNLVEWARPHLGE--RRRFYR--------LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 351 ~~~~~~~~~~~~~--~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
............. ...+.. .-.......++...+..+.+|+.+||+.||++||++.++++.|+.+..
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111111100000 000000 001112334567788899999999999999999999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=381.31 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=197.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCC--CCCceeEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV--HLNLVKLIGYC 205 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--HpnIv~~~~~~ 205 (487)
.+|++++.||+|+||.||+|.+. ++..||||++...... ....+.+|+.+|..|. |||||++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 56999999999999999999764 3668999999765432 3456889999999996 59999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
...+.+||||| +.+++|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG 199 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 199 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecC
Confidence 99999999999 5688999999655 47899999999999999999999988 99999999999995 5899999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceecc-----------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+++..............+||+.|+|||++.+ ..|+.++||||||||||||++|..||...... .
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~ 274 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 274 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----H
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----H
Confidence 9987654433333345689999999999865 46899999999999999999999999643211 0
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.... .++++.....++...+..+.+||.+||+.||.+||++.|++++..
T Consensus 275 ~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 275 SKLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHH----------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 0000 111111111122222467899999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=377.99 Aligned_cols=276 Identities=27% Similarity=0.351 Sum_probs=214.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE--
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-- 206 (487)
.++|++.+.||+|+||.||+|++... ...++..||||++........+.+.+|+++++.++||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 46899999999999999999986431 22367899999998766555567899999999999999999999987
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+....+|||||+++++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence 456689999999999999999765567999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h-hhhhc
Q 011385 287 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R-PHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~-~~~~~ 363 (487)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... . .....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~ 249 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPA 249 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhccccccccc
Confidence 9876543322 1223356889999999999999999999999999999999999998532110 00000 0 00000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
...+...+........+..++..+.+|+.+||+.||.+||++.+++++|+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000111111111222334577999999999999999999999999998763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=376.00 Aligned_cols=267 Identities=25% Similarity=0.391 Sum_probs=212.7
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
...++|++.+.||+|+||.||+|.+..... ....++..||||+++.... .....+.+|++++..+ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 345789999999999999999999864221 1223577899999976543 2345688999999999 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
+.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 999999999999999999999997543 24889999999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987655433333334567899999999998999999999999999999999 99999654221
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+.... ... .... .+..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 267 ---~~~~~~----~~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 ---ELFKLL----KEG------HRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ---HHHHHH----HHT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHH----hcC------CCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111110 000 0011 1122346789999999999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=394.87 Aligned_cols=256 Identities=30% Similarity=0.419 Sum_probs=210.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++.++||+|+||.||+|++.. +|+.||||++.... ......+.+|+++|..++|||||+++++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 252 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 45789999999999999999999865 67899999996432 2234568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+.+.+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|
T Consensus 253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999986543 35999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....... ....+||+.|+|||++.+..|+.++|||||||+||||++|..||...........+... ...
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--i~~- 403 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKE- 403 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH--HHH-
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH--hhc-
Confidence 999987654332 23468999999999999999999999999999999999999999765432221111100 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 412 (487)
... .++...+..+.+||.+||+.||.+|| ++.||+++-
T Consensus 404 -------~~~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 404 -------VPE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp -------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred -------ccc----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 011 11222346789999999999999999 788888753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=372.04 Aligned_cols=252 Identities=25% Similarity=0.296 Sum_probs=181.3
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~l 213 (487)
.+.||+|+||.||+|.+.. +|+.||||++... ....+.+|+.++..+. ||||+++++++.+....||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 4789999999999999865 5779999999653 2466889999999997 9999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC---cEEEeecCCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY---NAKLSDFGLAKDG 290 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~---~~kl~DFGla~~~ 290 (487)
|||||++|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999654 57999999999999999999999988 99999999999997765 8999999999865
Q ss_pred CCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhhhhhccccccc
Q 011385 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGERRRFYR 369 (487)
Q Consensus 291 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 369 (487)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.......... ............
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----- 232 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----- 232 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-----
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-----
Confidence 44322 2334678999999999999999999999999999999999999997644321111 111100000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 370 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+........+..+.+||.+||+.||.+||++.+++++-
T Consensus 233 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 233 ---FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp ---CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ---CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 0000000012346789999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=379.40 Aligned_cols=271 Identities=19% Similarity=0.226 Sum_probs=205.2
Q ss_pred hcCCCCCCeeccc--CceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 129 TRNFRPESLLGEG--GFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.++|++++.||+| +||.||+|++.. +|+.||||++...... ..+.+.+|+.+++.++|||||+++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4689999999999 999999999875 5779999999755322 23567889999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+.+..|||||||++|+|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence 99999999999999999999999654 356999999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-----eeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-H
Q 011385 284 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E 355 (487)
Q Consensus 284 FGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~ 355 (487)
||++......... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||............ .
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 9998654221110 11122479999999999987 67999999999999999999999999765433211100 0
Q ss_pred hhhhhhhcc-----cc-------------ccccc---------CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 011385 356 WARPHLGER-----RR-------------FYRLI---------DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408 (487)
Q Consensus 356 ~~~~~~~~~-----~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 408 (487)
...+.+.+. .. +...+ .......+....+..+.+||.+||+.||.+|||+.|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 000000000 00 00000 0000001222334678999999999999999999999
Q ss_pred HHH
Q 011385 409 VEA 411 (487)
Q Consensus 409 l~~ 411 (487)
+++
T Consensus 332 l~h 334 (389)
T 3gni_B 332 LNH 334 (389)
T ss_dssp TTS
T ss_pred hcC
Confidence 975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=367.07 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=215.1
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
++....++|++.+.||+|+||.||+|.+.. ++..||||++.... ...+.+.+|+++++.++||||+++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~ 76 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG 76 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 334566789999999999999999999875 56789999997543 33467899999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999754 356899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||............ .
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---~--- 226 (288)
T 3kfa_A 154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E--- 226 (288)
T ss_dssp CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H---
T ss_pred cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---h---
Confidence 9999987654332 22334567889999999999999999999999999999999 99999754322111111 0
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .... ..+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 227 -~------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 227 -K------DYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -T------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -c------cCCC----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0 0111 11122346789999999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=374.12 Aligned_cols=276 Identities=23% Similarity=0.279 Sum_probs=211.5
Q ss_pred ccccChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC--
Q 011385 117 LRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-- 194 (487)
Q Consensus 117 ~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-- 194 (487)
...+.+.+.....++|++++.||+|+||.||+|++.. +++.||||++.... .....+..|+.+++.+.
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~ 91 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQND 91 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhccc
Confidence 3456666667778999999999999999999999865 57799999997432 22355778999999986
Q ss_pred ---CCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 195 ---HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 195 ---HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
|||||++++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 167 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN 167 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence 999999999999999999999999 899999997553 45999999999999999999999988 9999999999
Q ss_pred EEEcC-------------------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhh
Q 011385 271 ILLDA-------------------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDV 325 (487)
Q Consensus 271 Ill~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~Di 325 (487)
|||+. ++.+||+|||+++..... .....||+.|+|||++.+..|+.++||
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 242 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM 242 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence 99975 789999999999865432 234579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc----------ccccc-----cccCCccCC----------CCC
Q 011385 326 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE----------RRRFY-----RLIDPRLEG----------HFS 380 (487)
Q Consensus 326 wSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~-----~~~~~~~~~----------~~~ 380 (487)
|||||++|||++|+.||...........+......... ..... ....+.... ..+
T Consensus 243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 99999999999999999764322111111110000000 00000 000000000 000
Q ss_pred ---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 381 ---IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 381 ---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
......+.+||.+||+.||.+|||+.|+|++
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0012567899999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=392.34 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=210.7
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+++|+.++|||||++++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 4556789999999999999999998752 5689999997654 3467899999999999999999999998
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
. .+..+||||||++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECST
T ss_pred e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeC
Confidence 6 66789999999999999999643 236889999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++....... .......+++.|+|||++....++.++|||||||+||||++ |+.||...... .+.... ..
T Consensus 329 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~ 400 (454)
T 1qcf_A 329 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ER 400 (454)
T ss_dssp TGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH----HH
T ss_pred CCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hc
Confidence 99987543211 11223456889999999998999999999999999999999 99999754321 111111 11
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
.. ... .+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 401 ~~---~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 401 GY---RMP-------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp TC---CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CC---CCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00 010 112235678999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=367.15 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=195.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||.||+|++.. +++.||||++....... ...+.+|++++..++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4689999999999999999998865 57799999997654433 34688999999999999999999998
Q ss_pred EeCCe----eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 206 IEDDQ----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 206 ~~~~~----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
..... .||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 76543 49999999999999999654 46999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 282 SDFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 282 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....... . ....
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~---~~~~ 231 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---V---AYQH 231 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---H---HHHH
Confidence 999999875443221 12234579999999999999999999999999999999999999996543211 0 0000
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
......... .... ..+..+.+|+.+||+.||.+||++.+++.+
T Consensus 232 ~~~~~~~~~----~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 232 VREDPIPPS----ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHCCCCCHH----HHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hcCCCCCcc----cccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 110000000 0011 124678899999999999999987776653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=364.94 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=207.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
.++|++.+.||+|+||.||+|++.. +|..||||++...... ..+.+.+|+.++..++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 4679999999999999999998865 5779999999654332 356799999999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 278 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 278 (487)
+++.+.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999999999999954 457899999999999999999999988 99999999999999887 7
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i- 230 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANI- 230 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH-
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH-
Confidence 99999999987654322 23457999999999999999999999999999999999999999654221 111100
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..... ..++.... ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 231 --~~~~~----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 231 --TSVSY----DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp --HTTCC----CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred --Hhccc----ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00000 00000111 12357899999999999999999999998643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=373.23 Aligned_cols=268 Identities=26% Similarity=0.415 Sum_probs=212.9
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
+....++|++.+.||+|+||.||+|.+... ....++..||||.+..... .....+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 344567899999999999999999987621 1112467899999975433 22346889999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRS---------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 9999999999999999999999986431 45789999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~ 353 (487)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH
Confidence 999999999999986543322222333567899999999999999999999999999999999 88998654221 11
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.... ... .. . ..+...+..+.+|+.+||+.||.+||++.|++++|+.+.
T Consensus 250 ~~~~----~~~-~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 LRFV----MEG-GL-----L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHH----HTT-CC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHH----HcC-Cc-----C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1110 000 00 0 011123467899999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=376.14 Aligned_cols=273 Identities=19% Similarity=0.241 Sum_probs=206.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-----------HHHHHHHHHHHhcCCCC
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGDLVHL 196 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~Hp 196 (487)
..++|++.+.||+|+||.||+|.+..... ...++.||||++....... ...+..|+..+..++||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 34689999999999999999998865322 1245789999987654211 12245566778888999
Q ss_pred CceeEEEEEEeC----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 197 NLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 197 nIv~~~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
||+++++++... ...||||||| +++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 999999998775 4589999999 99999999877678999999999999999999999988 999999999999
Q ss_pred Ec--CCCcEEEeecCCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 011385 273 LD--ADYNAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345 (487)
Q Consensus 273 l~--~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 345 (487)
|+ .++.+||+|||+++........ ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8899999999999765432111 1113356999999999999999999999999999999999999999753
Q ss_pred CCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ........... ..+..++++.+.. ...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 265 ~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 265 LKDP--KYVRDSKIRYR--ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TTCH--HHHHHHHHHHH--HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccCH--HHHHHHHHHhh--hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 3221 11111111110 1111111111110 11246789999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=387.43 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=206.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|.+.+.||+|+||.||+|++.. +|+.||||++.... ......+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4689999999999999999998865 67799999996432 12346788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..|||||||++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 999999999999999999999954 456999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+++....... ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||...... .+.... ....
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i---~~~~ 232 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKI---CDGI 232 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHH---HTTC
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHH---hcCC
Confidence 9987654332 234689999999999988766 68999999999999999999999754321 111110 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. ..+...+..+.+||.+||+.||.+|||+.||+++
T Consensus 233 ------~------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 ------F------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------C------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------c------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 0111123578999999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=376.14 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=203.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+.|++.+.||+|+||.||+|++.. +|..||||++....... .+.+.+|+++|.+++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458899999999999999998764 57799999997553322 346889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..+|||||+. |+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999996 6888888766678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
++..... ...+||+.|+|||++. ...++.++|||||||++|||++|..||....... ... .....
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~~---~~~~~ 268 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALY---HIAQN 268 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHS
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHH---HHHhc
Confidence 9875432 2357999999999885 5679999999999999999999999996542211 100 00000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..+.+. ....+..+.+||.+||+.||.+||++.+++++..
T Consensus 269 -------~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 269 -------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -------CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -------CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 001111 1122467889999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=366.63 Aligned_cols=270 Identities=25% Similarity=0.311 Sum_probs=200.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCC---CCCc
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGDLV---HLNL 198 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---HpnI 198 (487)
...++|++.+.||+|+||+||+|++.. +|+.||||++..... .....+.+|+.+++.+. ||||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni 76 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred ccccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence 356799999999999999999998754 577999999864321 12346778888777764 9999
Q ss_pred eeEEEEEEeCC-----eeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 199 VKLIGYCIEDD-----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 199 v~~~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
+++++++.... ..++||||+. |+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil 152 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL 152 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 99999998765 5789999996 59999986553 34999999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
|+.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 229 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998764332 2344689999999999999999999999999999999999999997643321111
Q ss_pred hhHhhhhhh--hccccccc----ccCCccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 353 LVEWARPHL--GERRRFYR----LIDPRLE---GHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 353 ~~~~~~~~~--~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+....... ........ .+.+... ..+....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 110000000 00000000 0000000 000012246788999999999999999999999854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=383.65 Aligned_cols=271 Identities=24% Similarity=0.325 Sum_probs=193.7
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC-CCCceeEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLV-HLNLVKLIG 203 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~~~~ 203 (487)
...++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+|..+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 345789999999999999999998865 677999999864422 23456789999999997 999999999
Q ss_pred EEEeCC--eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 204 YCIEDD--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 204 ~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
++...+ .+|||||||+ |+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence 997654 6899999996 599998865 36899999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCC-------------------cceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCC
Q 011385 282 SDFGLAKDGPEGD-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 282 ~DFGla~~~~~~~-------------------~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~p 341 (487)
+|||+++...... .....+..+||+.|+|||++.+ ..|+.++||||||||||||++|++|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999998643211 1112344689999999999876 6799999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhh--hhhhcc---------------cccccccCCccCCCCC------------HHHHHHHHHHHH
Q 011385 342 MDKNRPNGEHNLVEWAR--PHLGER---------------RRFYRLIDPRLEGHFS------------IKGAQKAAQLAA 392 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~--~~~~~~---------------~~~~~~~~~~~~~~~~------------~~~~~~l~~li~ 392 (487)
|.+.........+.... +..... ..............++ ...+..+.+|+.
T Consensus 231 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 97654321111110000 000000 0000000000000000 012457899999
Q ss_pred HhcccCCCCCCCHHHHHHHh
Q 011385 393 HCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 393 ~cl~~dP~~RPs~~ell~~L 412 (487)
+||+.||.+|||+.|++++-
T Consensus 311 ~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTST
T ss_pred HhhccCcccCCCHHHHhCCH
Confidence 99999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=363.41 Aligned_cols=269 Identities=25% Similarity=0.273 Sum_probs=201.6
Q ss_pred hcCCCCC-CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 129 TRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
.+.|++. ++||+|+||.||+|.+.. +++.||||++..........+.+|+++|.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3578874 789999999999998764 5779999999776655667899999999985 7999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---EEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~---~kl~D 283 (487)
+.+..||||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence 999999999999999999999654 46899999999999999999999988 999999999999988766 99999
Q ss_pred cCCCCCCCCCCc-----ceeeeeccccccccCCceecc-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 284 FGLAKDGPEGDK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 284 FGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~~~~-----~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
||++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 999986532211 111223569999999999875 5689999999999999999999999976543321100
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSI----KGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.......... ..+..+... ...++. ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 238 ~~~~~~~~~~-~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 238 RGEACPACQN-MLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp ---CCHHHHH-HHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred ccccchhHHH-HHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 0000000000 000000000 001111 12457899999999999999999999998543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=372.87 Aligned_cols=264 Identities=24% Similarity=0.411 Sum_probs=204.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
...+|.+.+.||+|+||.||+|.+..... ..+..||||++...... ....+.+|+.++..++||||+++++++.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 34678889999999999999998864321 12456999999755332 2346889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..+|||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999999877678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 287 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 287 a~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+.... ...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~----~~~ 266 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAI----NDG 266 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HTT
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HCC
Confidence 98764432211 1222456889999999999999999999999999999999 99999654221 111111 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.... .+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 267 ------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 267 ------FRLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ------CCCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CcCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001 11123467899999999999999999999999997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=361.17 Aligned_cols=260 Identities=26% Similarity=0.379 Sum_probs=207.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.... +++..||||.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 4468999999999999999999876432 2455799999976532 33467889999999999999999999976
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+ +..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCC
Confidence 5 4568999999999999999877677999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ...... ...
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~----~~~ 231 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLE----KGD 231 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHH----HTC
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHh----cCC
Confidence 9876543221 1233567889999999998999999999999999999998 999996543221 111100 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...... ..+..+.+|+.+||+.||.+||++.|++++|+.+
T Consensus 232 ------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ------RLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 001111 2246789999999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=369.95 Aligned_cols=272 Identities=28% Similarity=0.391 Sum_probs=215.8
Q ss_pred ChhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCc
Q 011385 121 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNL 198 (487)
Q Consensus 121 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnI 198 (487)
....+....++|++.+.||+|+||.||+|.+.... ...+++.||||++...... ..+.+.+|+.++..+ +||||
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 33444556789999999999999999999875311 1236789999999765432 235688999999999 79999
Q ss_pred eeEEEEEEeCC-eeEEEEeeCCCCChhHHHhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 199 VKLIGYCIEDD-QRLLVYEFMPRGSLENHLFRRSL---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 199 v~~~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
+++++++...+ ..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999988755 48999999999999999975432 2789999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 341 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 341 (487)
||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987655443333444678999999999999999999999999999999998 9999
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
|....... .+... +... ....... ..+..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 251 ~~~~~~~~--~~~~~----~~~~------~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 251 YPGVKIDE--EFCRR----LKEG------TRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp STTCCCSH--HHHHH----HHHT------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccchhH--HHHHH----hccC------ccCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 97543221 11110 0000 0011111 2246789999999999999999999999999754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=359.70 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=204.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|++. +..||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 468999999999999999999873 568999999765432 2456899999999999999999999998
Q ss_pred eC--CeeEEEEeeCCCCChhHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 207 ED--DQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 207 ~~--~~~~lv~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+. ...++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence 87 788999999999999999975533 5899999999999999999999865 4499999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCc---hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTS---RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~---~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|..||....... ... ..
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~---~~ 223 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---IGM---KV 223 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---HHH---HH
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---HHH---HH
Confidence 988765322 2246899999999998765554 8999999999999999999996542211 000 00
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. ....+.+ +...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 224 ~~------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 224 AL------EGLRPTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HH------SCCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred Hh------cCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 00 0111112 2223467899999999999999999999999998653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=359.30 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=186.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+.++..++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 579999999999999999998764 57799999986432 123467889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecc
Confidence 999999999999999999999776678999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||............ .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~----- 225 (278)
T 3cok_A 159 ATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------V----- 225 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------C-----
T ss_pred eeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------h-----
Confidence 987543221 122357999999999999889999999999999999999999999754332111000 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..+.. ++...+..+.+|+.+||+.||.+||++.+++++-
T Consensus 226 ---~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 226 ---LADYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp ---SSCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ---hcccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 00001 1112346788999999999999999999998743
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=389.96 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=204.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.++||+|+||.||+|++.. +|+.||||++..... .....+.+|+++|..++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4789999999999999999998865 678999999964322 2346788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
.+.+.+||||||++||+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence 9999999999999999999998654 346999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||........... .......
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~--~~~~i~~ 407 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRVLE 407 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH--HHHHHHH
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH--HHHHHhh
Confidence 9999987654322 12346899999999999999999999999999999999999999976543221111 1111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 405 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 405 (487)
.. ..++...+..+.+||.+||+.||.+||++
T Consensus 408 ~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 408 QA------------VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cc------------cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 10 01122234678999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.48 Aligned_cols=265 Identities=25% Similarity=0.372 Sum_probs=212.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+...+. ...+..||||.+..... ...+.+.+|+.++..+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGK----EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSS----SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCc----ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34689999999999999999999865322 12345899999976543 2345688999999999 899999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRR-------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
.+.+..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 9999999999999999999998643 345899999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH 351 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~ 351 (487)
|+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 99999999999999986544333333344568899999999999999999999999999999999 9999975432211
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... ... .... .+...+..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 276 -~~~~~----~~~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 -FYKLV----KDG------YQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHH----HHT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHH----hcC------CCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11110 000 0001 1111246789999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.37 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=209.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|++++..++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 468899999999999999999875 256899999976543 346799999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence 9999999999999999999877677999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
...... ........|++.|+|||++.+..++.++|||||||++|||++ |..||...... ..... +...
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----i~~~--- 221 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----ISTG--- 221 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTT---
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----HhcC---
Confidence 654321 111223467889999999998999999999999999999999 89999654221 11111 0000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... .+...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 222 ---~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 222 ---FRLY----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcCC----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 1112246789999999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=359.15 Aligned_cols=252 Identities=22% Similarity=0.270 Sum_probs=205.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+.. ++..||+|++........+.+.+|+++++.++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4579999999999999999998865 5678999999776666678899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeecC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDFG 285 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl~DFG 285 (487)
+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 9999999999999999988654 46899999999999999999999988 9999999999999 788999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++........ .....||+.|+|||++.+ .++.++|||||||++|||++|..||...... ...... .....
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~---~~~~~ 224 (277)
T 3f3z_A 155 LAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKI---REGTF 224 (277)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHCCC
T ss_pred cceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HhCCC
Confidence 9987654332 234579999999998765 4999999999999999999999999754321 111100 00000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+ ...... ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 225 ~~----~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 TF----PEKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CC----CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CC----Cchhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 124678999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=364.77 Aligned_cols=269 Identities=23% Similarity=0.354 Sum_probs=201.8
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC--CCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL--VHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~~~~ 203 (487)
....++|++.+.||+|+||.||+|++. |..||||++.... ...+.+|.+++..+ +||||+++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 345678999999999999999999873 5689999986432 34455666666554 8999999999
Q ss_pred EEEeC----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEc
Q 011385 204 YCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLD 274 (487)
Q Consensus 204 ~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDLKp~NIll~ 274 (487)
++... ...+|||||+++|+|.+++... .+++..++.++.||+.||.|||+.. ..+|+||||||+||||+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 99887 7889999999999999999554 5899999999999999999999870 11399999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcce--eeeeccccccccCCceeccCCCCch------hhhhhHHHHHHHHHhC--------
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGHLTSR------SDVYSFGVVLLEMLTG-------- 338 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~~~~~------~DiwSlGvil~elltG-------- 338 (487)
.++.+||+|||+++......... ......||+.|+|||++.+..+... +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997654332211 1123579999999999987766654 9999999999999999
Q ss_pred --CCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 339 --RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 339 --~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..||................ . ......+.+...+ ...++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREI--V-----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHH--H-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCchhhhHHH--H-----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 55554433222111000000 0 0011111111111 125678899999999999999999999999999865
Q ss_pred CC
Q 011385 416 PN 417 (487)
Q Consensus 416 ~~ 417 (487)
..
T Consensus 330 ~~ 331 (337)
T 3mdy_A 330 SE 331 (337)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.66 Aligned_cols=268 Identities=24% Similarity=0.314 Sum_probs=200.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||.||+|.+.. +|..||||++....... .+.+.+|++++.+++||||+++++++.+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 579999999999999999999865 57799999986554322 3557899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999999988774 3456999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH------ 360 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~------ 360 (487)
+....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 87543222 2234579999999999876 67899999999999999999999999765432211111100000
Q ss_pred --hhccccc--ccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 361 --LGERRRF--YRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 361 --~~~~~~~--~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
......+ ....++.....+ ....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 0000000 000010000000 012245688999999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=369.66 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=200.4
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
.+..++|.+.+.||+|+||.||+|.+.... .++..||||+++..... ..+.+.+|+.++.+++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQED------GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTT------SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccC------CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 345678999999999999999999886532 25678999999755332 2356889999999999999999999
Q ss_pred EEEeCC-----eeEEEEeeCCCCChhHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 204 YCIEDD-----QRLLVYEFMPRGSLENHLFR-----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 204 ~~~~~~-----~~~lv~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
++.+.+ ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence 998755 35999999999999999853 2356999999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011385 274 DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN 352 (487)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~ 352 (487)
+.++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 257 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--- 257 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---
Confidence 9999999999999987654433233334568899999999999999999999999999999999 889986543221
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...... . ....... ...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 258 ~~~~~~---~-------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 258 MYDYLL---H-------GHRLKQP----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHHHH---T-------TCCCCCB----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH---c-------CCCCCCC----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 0 0001111 12346789999999999999999999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=388.04 Aligned_cols=266 Identities=23% Similarity=0.258 Sum_probs=197.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4689999999999999999998865 67799999997542 223456889999999999999999999997
Q ss_pred eC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
.. ..+||||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 55 356999999965 57666632 4899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh-
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR- 358 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~- 358 (487)
|+|||+++...... ..+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+.. ..
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998764422 23456899999999999999999999999999999999999999976542211111000 00
Q ss_pred --------------hhhhcc-----cccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 359 --------------PHLGER-----RRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 359 --------------~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
...... ..+.......+.. ......+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 000000 0000000000000 011122567899999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.39 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=206.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 4679999999999999999998865 567999999865433 234678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999999999998854 356999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
................||+.|+|||++.+..+ +.++|||||||++|||++|..||........ ....+.. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-----~~~ 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-----KKT 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT-----TCT
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh-----ccc
Confidence 86543322222344679999999999987665 7799999999999999999999976443211 1111110 000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... .. ...+..+.+|+.+||+.||.+||++.|++++.
T Consensus 227 ---~~~--~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 227 ---YLN--PW----KKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ---TST--TG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---ccC--ch----hhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 000 00 12245788999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=367.53 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=204.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--------CHHHHHHHHHHHhcCCCCCce
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGDLVHLNLV 199 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv 199 (487)
..++|++.+.||+|+||.||+|++.. ++..||||++...... ....+.+|+.+|..++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 34689999999999999999998765 5779999999765421 223567899999999999999
Q ss_pred eEEEEEEeCCeeEEEEeeCCCC-ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 200 KLIGYCIEDDQRLLVYEFMPRG-SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 200 ~~~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
++++++.+.+..++||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 9999999999999999999777 99998854 456999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++....... ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 99999999987654332 234679999999999988877 88999999999999999999999642110
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.. ..... ... .+..+.+||.+||+.||.+||++.+++++-.
T Consensus 237 ---~~------~~~~~--~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 237 ---VE------AAIHP--PYL----VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp ---TT------TCCCC--SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred ---Hh------hccCC--Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 00 00000 111 2467899999999999999999999999654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=359.11 Aligned_cols=251 Identities=27% Similarity=0.329 Sum_probs=198.6
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+++|+.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 578899999999999999998865 577999999865432 3457789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEe
Q 011385 209 DQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLS 282 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl~ 282 (487)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence 999999999999999998853 2467999999999999999999999988 9999999999999 456889999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++|..||....... ...... .
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~~---~ 239 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKAT---Y 239 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---H
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhhc---c
Confidence 999998754432 233467999999999875 678999999999999999999999997543211 110000 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... .. ..... .+..+.+|+.+||+.||.+||++.|++++
T Consensus 240 ~~~~----~~-~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 KEPN----YA-VECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCC----CC-C--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCcc----cc-cccCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 00011 23578899999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=359.96 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+.+++.++||||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence 34689999999999999999998865 567899999854321 234568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 78 FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSC
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEec
Confidence 99999999999999999999998654 46899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... +..
T Consensus 154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~- 221 (279)
T 3fdn_A 154 GWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKR----ISR- 221 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHH----HHH-
T ss_pred cccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HHHH----HHh-
Confidence 9987644322 234579999999999999999999999999999999999999997542211 1000 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... ++...+..+.+||.+||+.||.+||++.||+++-
T Consensus 222 ------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 222 ------VEFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ------TCCC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ------CCCC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0011 1112346788999999999999999999999854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=360.61 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=208.5
Q ss_pred hcCCCCCC-eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+.+.+|++++..++||||+++++++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 35666766 999999999999987532 2467899999976532 2346688999999999999999999998
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence 556789999999999999999776677999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 287 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 287 a~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~----~~ 229 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QG 229 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TT
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHh----cC
Confidence 98764432211 1223457899999999988899999999999999999998 99999754321 1111110 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..+ .++...+..+.+||.+||+.||.+||++.+++++|+.+
T Consensus 230 ------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 230 ------KRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ------CCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CcC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001 11223356899999999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=363.34 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=204.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE-
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI- 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~- 206 (487)
..+|++.+.||+|+||.||+|.+..... .+..||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 4578899999999999999998764322 345689999876433 23456889999999999999999999865
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
.++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccc
Confidence 456789999999999999999776777999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc--eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
++........ .......||+.|+|||++.+..++.++|||||||++|||++ |.+||........... .. ..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~---~~ 248 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL---QG 248 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HH---TT
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---Hh---cC
Confidence 9876443211 12233568899999999999999999999999999999999 5566654433221111 00 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....... ..+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 249 -------~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 249 -------RRLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -------CCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000111 1235789999999999999999999999999765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.05 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=206.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
-.|.+.++||+|+||.||+|.+..... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eEEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 356677899999999999999765322 345799999975433 2345688999999999999999999999876
Q ss_pred Cee-EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 DQR-LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 ~~~-~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+.. ++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 665 8999999999999999776778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc--eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 288 KDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 288 ~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..|+...... ..+..... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~----~-- 243 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLA----Q-- 243 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHH----T--
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhh----c--
Confidence 865432211 1223356899999999999999999999999999999999966554332211 11111110 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 244 ----~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 244 ----GRRLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00011 1112346789999999999999999999999999765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.19 Aligned_cols=201 Identities=28% Similarity=0.385 Sum_probs=167.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|++.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4689999999999999999998865 678999999975422 23457889999999999999999999997
Q ss_pred eC-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 207 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
.. ...||||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 76 57899999995 599998854 457999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcc--------------------eeeeeccccccccCCcee-ccCCCCchhhhhhHHHHHHHHHhCCC
Q 011385 282 SDFGLAKDGPEGDKT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTSRSDVYSFGVVLLEMLTGRR 340 (487)
Q Consensus 282 ~DFGla~~~~~~~~~--------------------~~~~~~~Gt~~y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~ 340 (487)
+|||+++........ ...+..+||+.|+|||++ ....|+.++||||||||||||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876433211 123457899999999986 46679999999999999999998655
Q ss_pred CCC
Q 011385 341 SMD 343 (487)
Q Consensus 341 pf~ 343 (487)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=375.34 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=197.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe-
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 207 (487)
..|.+.+.||+|+||.||+|.+..... .+..||||.++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 357788899999999999998864221 234689999865432 334678999999999999999999998754
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..++||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence 56789999999999999999777677899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc--eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 288 KDGPEGDKT--HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 288 ~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+........ .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.......... ... ..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~----~~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLL----QG 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHH----TT
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHH----cC
Confidence 865433211 11233567889999999999999999999999999999999 677776544322111 110 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .... +..++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 313 ~---~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 313 R---RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp C---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0011 112346789999999999999999999999999764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=367.68 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=198.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
++|++++.||+|+||.||+|++.. ++..||||++....... ...+.+|+++|+.++||||+++++++.+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 578999999999999999998865 57799999997543221 12356799999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..+|||||++ |+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 5999999877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh--------
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-------- 359 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-------- 359 (487)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.....
T Consensus 149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 149 AKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 6543221 2234578999999999876 5789999999999999999999999976533211111100000
Q ss_pred hhhcccccccccCCccCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGH----FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.......+.....+..... .....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0000000000000000000 0011245788999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.78 Aligned_cols=264 Identities=19% Similarity=0.244 Sum_probs=208.3
Q ss_pred cChhHHHHHhcCCCCC-CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcC-CC
Q 011385 120 FTFNDLKLATRNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDL-VH 195 (487)
Q Consensus 120 ~~~~~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H 195 (487)
..+.......++|.+. +.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.++..+ .|
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 88 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC
Confidence 4455556667788887 899999999999998865 57799999997543 23357789999999999 56
Q ss_pred CCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 196 pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
|||+++++++.+.+..++|||||++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+
T Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~ 165 (327)
T 3lm5_A 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS 165 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEe
Confidence 99999999999999999999999999999998543 457999999999999999999999988 99999999999998
Q ss_pred C---CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 275 A---DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 275 ~---~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 240 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-- 240 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--
Confidence 7 78999999999987643321 234679999999999999999999999999999999999999996543211
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... ... ............+..+.+||.+||+.||.+||++.+++++-
T Consensus 241 -~~~~i---~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 241 -TYLNI---SQV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp -HHHHH---HHT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred -HHHHH---Hhc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 10000 000 00001111112346789999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=358.78 Aligned_cols=264 Identities=20% Similarity=0.213 Sum_probs=205.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEE-E
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-I 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~ 206 (487)
..++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+|+.++..+.|++++..+.++ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 45789999999999999999998765 5779999987654332 3578999999999988877666554 6
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl~D 283 (487)
..+..+|||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEec
Confidence 678889999999 99999999766678999999999999999999999988 9999999999999 7889999999
Q ss_pred cCCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 284 FGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 284 FGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 9999875443221 11234679999999999999999999999999999999999999998755443332222111
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
..... ... +.+... .+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 232 ~~~~~--~~~----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 232 EKKMS--TPI----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHH--SCH----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ccccc--chh----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 10000 000 000111 2357899999999999999999999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=370.59 Aligned_cols=269 Identities=18% Similarity=0.224 Sum_probs=200.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-----------CHHHHHHHHHHHhcCCCCC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGDLVHLN 197 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hpn 197 (487)
.++|++.+.||+|+||.||+|.+...+. ++..||||++...... ....+.+|+.++..+.|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 4689999999999999999999865222 4568999998765321 1134678899999999999
Q ss_pred ceeEEEEEEe----CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE
Q 011385 198 LVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 273 (487)
Q Consensus 198 Iv~~~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll 273 (487)
|+++++++.. ....||||||+ +++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence 9999999988 67899999999 999999986554 7999999999999999999999988 9999999999999
Q ss_pred cCCC--cEEEeecCCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 274 DADY--NAKLSDFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 274 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8887 9999999999765332111 01134579999999999999999999999999999999999999996432
Q ss_pred CCCcchhhHhhhhhhhcccc-cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 347 PNGEHNLVEWARPHLGERRR-FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.... ............... +..... .. ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 265 ~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPV-AVQTAKTNLLDELPQSVLKWAP---SG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHH-HHHHHHHHHHHTTTHHHHHHSC---TT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccH-HHHHHHHhhcccccHHHHhhcc---cc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2111 111000000000000 000000 00 12357899999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=361.78 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=204.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|.+.+.||+|+||.||+|++.. +|+.||||++..........+.+|+.++..++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 34679999999999999999998865 577999999986554445678899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl~DF 284 (487)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred CCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccC
Confidence 99999999999999999998654 46899999999999999999999988 9999999999999 77899999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|++....... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.... ....
T Consensus 154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i---~~~~ 223 (304)
T 2jam_A 154 GLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKI---KEGY 223 (304)
T ss_dssp STTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HHCC
T ss_pred CcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HcCC
Confidence 9997654321 23357999999999999999999999999999999999999999654321 111100 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. .... +....+..+.+||.+||+.||.+||++.+++++-
T Consensus 224 ~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 224 YE----FESP----FWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp CC----CCTT----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CC----CCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 00 0111 1112346789999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=369.91 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=194.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++.. +++.||||+++...... ...+.+|+++|+.++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3579999999999999999998765 57799999997554322 345789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-----CCCcEEE
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-----ADYNAKL 281 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-----~~~~~kl 281 (487)
+.+..+|||||++ |+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+ .++.+||
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999997 5999998654 46999999999999999999999988 99999999999994 4556999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 358 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 358 (487)
+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+....
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999976532211 23345789999999998864 58999999999999999999999997543221111000000
Q ss_pred hh------hhcccccc----cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 PH------LGERRRFY----RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ~~------~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+. ........ ......+...+....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 00000000 00000000000011246788999999999999999999999743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=356.26 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=206.1
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|..||+|++...... ..+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 34789999999999999999998865 5779999999654332 235688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc---EEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN---AKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~---~kl~ 282 (487)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEe
Confidence 9999999999999999999988655 46999999999999999999999988 999999999999976655 9999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... ..
T Consensus 151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~---~~ 221 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI---KA 221 (284)
T ss_dssp CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HH
T ss_pred eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHH---Hh
Confidence 9999987654322 23467999999999999999999999999999999999999999654221 111100 00
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ....+ ... ..+..+.+|+.+||+.||.+||++.|++++-
T Consensus 222 ~~~---~~~~~-~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 222 GAY---DYPSP-EWD----TVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp TCC---CCCTT-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred ccc---cCCch-hhc----ccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 000 00000 111 2246789999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=367.73 Aligned_cols=273 Identities=31% Similarity=0.422 Sum_probs=207.9
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 208 (487)
.|++++.||+|+||.||++.+.. ....+|+.||||+++.... ...+.+.+|+++|+.++||||+++++++.+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34899999999999999997653 2234788999999976543 2245688999999999999999999999874
Q ss_pred -CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 209 -DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 209 -~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
...+|||||+++|+|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence 6789999999999999999654 4899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||....... .....+..... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~ 259 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLR 259 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHH
Confidence 876554322 12334568899999999999999999999999999999999999985421100 00000000000 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+...+........+..++..+.+||.+||+.||.+||++.|+++.|+.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0111111111122223456899999999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=367.35 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=199.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCC-----CccCHHHHHHHHHHHhcCCCCCceeE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGDLVHLNLVKL 201 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~~ 201 (487)
...++|++.+.||+|+||.||+|.+.. ++..||||++... .....+.+.+|+++++.++||||+++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 93 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence 345689999999999999999998765 5779999998643 22334678999999999999999999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhc---------------------------------------CCCCCHHHHHHH
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRR---------------------------------------SLPLPWSIRMKI 242 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i 242 (487)
++++.+.+..+||||||++|+|.+++... ...+++..++.|
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 99999999999999999999999988421 112356778899
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC--cEEEeecCCCCCCCCCC--cceeeeeccccccccCCceecc--
Q 011385 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY--NAKLSDFGLAKDGPEGD--KTHVSTRVMGTYGYAAPEYVMT-- 316 (487)
Q Consensus 243 ~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~--~~kl~DFGla~~~~~~~--~~~~~~~~~Gt~~y~APE~~~~-- 316 (487)
+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++...... .........||+.|+|||++.+
T Consensus 174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 999999999999988 99999999999998776 89999999998543211 1112334679999999999865
Q ss_pred CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcc
Q 011385 317 GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLS 396 (487)
Q Consensus 317 ~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 396 (487)
..++.++|||||||++|||++|..||....... .. ......... ...+. . ...+..+.+||.+||+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~~~~~~~~---~~~~~-~----~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD---TI---SQVLNKKLC---FENPN-Y----NVLSPLARDLLSNLLN 316 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCCC---TTSGG-G----GGSCHHHHHHHHHHSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH---HH---HHHHhcccc---cCCcc-c----ccCCHHHHHHHHHHcC
Confidence 688999999999999999999999997543211 11 001111000 00000 0 1124678999999999
Q ss_pred cCCCCCCCHHHHHHHh
Q 011385 397 RDPKARPLMSEVVEAL 412 (487)
Q Consensus 397 ~dP~~RPs~~ell~~L 412 (487)
.||.+||++.+++++-
T Consensus 317 ~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 317 RNVDERFDAMRALQHP 332 (345)
T ss_dssp SCTTTSCCHHHHHHSH
T ss_pred CChhHCCCHHHHhcCh
Confidence 9999999999999853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=383.40 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=205.2
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+++|++++||||+++++++.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 455789999999999999999998853 3579999997654 34578999999999999999999999987
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+ +..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCc
Confidence 6 6789999999999999999643 356899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+++....... .......+++.|+|||++.+..++.++|||||||+||||++ |..||...... .+.... ...
T Consensus 326 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~ 397 (452)
T 1fmk_A 326 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----ERG 397 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTT
T ss_pred cceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcC
Confidence 9987644321 12223457889999999999999999999999999999999 99999754321 111111 000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
... ..+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus 398 ------~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 398 ------YRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ------CCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 001 1112345678999999999999999999999999987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=365.16 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=205.0
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 34689999999999999999998865 577999999876555555678999999999999999999999873
Q ss_pred ----CCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 208 ----DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 208 ----~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
....++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEE
Confidence 3478899999999999999865 3567999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcce-------eeeeccccccccCCceeccCC---CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 011385 281 LSDFGLAKDGPEGDKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 350 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~APE~~~~~~---~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 350 (487)
|+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||........
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence 99999987643211000 011245799999999987554 78999999999999999999999953111100
Q ss_pred chhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
. .... ... ....... ...+..+.+||.+||+.||.+||++.+++++|+.+..
T Consensus 255 ~-~~~~----~~~------~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 255 S-VALA----VQN------QLSIPQS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C-HHHH----HHC------C--CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred h-hhHH----hhc------cCCCCcc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0000 000 0000001 1224678999999999999999999999999987643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=369.04 Aligned_cols=268 Identities=24% Similarity=0.314 Sum_probs=201.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-----HHHHHHHHHHHhcCCCCCceeEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|++++..++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 34689999999999999999998764 57799999997543221 24678999999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+++.+.+..++||||+++ +|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999975 899988777677999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||........ ........
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~ 229 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETL 229 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHH
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHc
Confidence 9999987643322 23346799999999998654 589999999999999999999999976432111 11100000
Q ss_pred h-----ccccccc---ccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 362 G-----ERRRFYR---LIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 362 ~-----~~~~~~~---~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ....... .+........+ ...+..+.+||.+||+.||.+|||+.|++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0 0000000 00000000001 122467899999999999999999999998654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=360.48 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=205.0
Q ss_pred HhcCCCCCC-eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|.+.+ .||+|+||.||+|.+... .++..||||+++...... .+++.+|++++..++||||++++++
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cchhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 346788888 999999999999976432 246789999997654322 4678999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 8 567789999999999999999654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|++.......... ......|++.|+|||++.+..++.++|||||||++|||++ |..||...... .+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~---- 234 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE---- 234 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----
Confidence 9998765433221 1223457789999999998899999999999999999999 99999754321 1111110
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. ..+ .++...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 235 ~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 KG------ERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TT------CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cC------CCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 001 11223346799999999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=356.73 Aligned_cols=263 Identities=21% Similarity=0.210 Sum_probs=208.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEE-Ee
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC-IE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~ 207 (487)
.++|++.+.||+|+||.||+|++.. +|+.||||++...... ..+.+|+.++..+.|++++..+.++ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 4689999999999999999998764 5779999998765433 4688999999999988866655544 66
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl~DF 284 (487)
.+..++||||+ +++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 77889999999 89999999766678999999999999999999999988 9999999999999 48899999999
Q ss_pred CCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 285 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 285 Gla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 999875443221 112346799999999999999999999999999999999999999986544333222211111
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.... ...+.+.. ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 233 ~~~~------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 233 KKMS------TPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHH------SCHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred cccC------CchHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0000 00000111 12367899999999999999999999999998653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=365.67 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=203.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcE--EEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCceeEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGDL-VHLNLVKLIGYC 205 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~ 205 (487)
++|++.+.||+|+||.||+|++.. +|.. ||||.+.... ....+.+.+|++++.++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 689999999999999999999875 3444 4999986532 22345688999999999 899999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
.+.+..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 99999999999999999999996543 46899999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCC
Q 011385 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNG 349 (487)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~ 349 (487)
|||+.++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~- 248 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA- 248 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred EEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence 999999999999999997532211 1223467889999999998899999999999999999998 99999654321
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+... +.. .... ..+...+..+.+|+.+||+.||.+||++.+++++|+.+
T Consensus 249 --~~~~~----~~~------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 249 --ELYEK----LPQ------GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp --HHHHH----GGG------TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHH----hhc------CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11110 000 0011 11122346789999999999999999999999999765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=375.15 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=195.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--------cCHHHHHHHHHHHhcCCCCCc
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNL 198 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnI 198 (487)
...++|.+.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 456799999999999999999998865 677999999865321 111247899999999999999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-- 276 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-- 276 (487)
|++++++. .+..|||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCC
Confidence 99999975 45689999999999999988544 57999999999999999999999988 9999999999999654
Q ss_pred -CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 277 -YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 277 -~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
+.+||+|||+++...... .....+||+.|+|||++. ...|+.++|||||||++|||++|..||........
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-- 352 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-- 352 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence 459999999998764422 234468999999999885 36788999999999999999999999975433221
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+...... .... ..+.... ..+..+.+||.+||+.||.+||++.|++++-.
T Consensus 353 ~~~~i~~---~~~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 353 LKDQITS---GKYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HHHHHHT---TCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHhc---CCCC----CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 1111000 0000 0000011 12467899999999999999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=356.36 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=205.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
...+|++.+.||+|+||.||+|.+.. +|+.||||++.... ..+.+|++++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 45679999999999999999999865 57799999997653 457799999999999999999998864
Q ss_pred ----------------CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCc
Q 011385 208 ----------------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSN 270 (487)
Q Consensus 208 ----------------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~N 270 (487)
....++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 152 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN 152 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence 44578999999999999999654 357999999999999999999999988 9999999999
Q ss_pred EEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 011385 271 ILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 350 (487)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 350 (487)
||++.++.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 153 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 224 (284)
T 2a19_B 153 IFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224 (284)
T ss_dssp EEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred EEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence 9999999999999999987654322 23357999999999999999999999999999999999999887311
Q ss_pred chhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 351 HNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
..... . +....+...+ +..+.+|+.+||+.||.+||++.|++++|+.+..
T Consensus 225 ---~~~~~-~---------~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 ---SKFFT-D---------LRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp ---HHHHH-H---------HHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred ---HHHHH-H---------hhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00000 0 0111111222 3568899999999999999999999999986543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=361.31 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=197.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.+|++.+.||+|+||.||+|.+.. +|..||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 579999999999999999998865 5679999999754332 2356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
..+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence 99999999999999999999863 3556899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....... ......|++.|+|||++.+..++.++|||||||++|||++|..||....... ..+.... ..
T Consensus 180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~ 252 (310)
T 2wqm_A 180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI----EQ 252 (310)
T ss_dssp C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHH----HT
T ss_pred ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHh----hc
Confidence 999986543221 1234579999999999999999999999999999999999999996543211 0111100 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
.. ..+.... ..+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 253 -~~----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 253 -CD----YPPLPSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -TC----SCCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cc----CCCCccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 0000111 23467899999999999999999999999998664
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=372.23 Aligned_cols=259 Identities=27% Similarity=0.348 Sum_probs=205.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
++|++++.||+|+||.||+|++... ..+|+.||||+++.... .....+.+|+++|..+ +||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEccc------CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 5799999999999999999988532 12678999999865321 2335577899999999 69999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+...+..+||||||++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 99999999999999999999999654 46999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|..||...........+ ......
T Consensus 204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~ 280 (355)
T 1vzo_A 204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK 280 (355)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH
T ss_pred CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhc
Confidence 99986543221 12334689999999999875 45789999999999999999999999754433221111 111111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHhc
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEALK 413 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 413 (487)
. .+. ++...+..+.+||.+||+.||.+|| ++.|++++..
T Consensus 281 ~--------~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 281 S--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp C--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred c--------CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0 111 1122346788999999999999999 9999998664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=393.67 Aligned_cols=258 Identities=25% Similarity=0.375 Sum_probs=204.1
Q ss_pred cCCCCCC-eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~-~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|.+.+ .||+|+||.||+|.+.... ++..||||+++.... ...+++.+|+++|++++|||||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSS-------CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCC-------CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3444444 7999999999999886421 456799999976533 345789999999999999999999999876
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
+..+||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 5689999999999999999777777999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 288 KDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 288 ~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+........ .......+++.|+|||++.+..|+.++|||||||+||||++ |..||...... .+..... ...
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~----~~~ 556 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QGK 556 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHH----TTC
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 876443221 11222456789999999999999999999999999999998 99999765432 1111111 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...++..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 557 ----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0112223457899999999999999999999999998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=365.27 Aligned_cols=275 Identities=24% Similarity=0.352 Sum_probs=211.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++++.||+|+||.||+|++.. ....+|..||||++........+.+.+|+++++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3578999999999999999998642 12236889999999876555567799999999999999999999998765
Q ss_pred C--eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 209 D--QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 209 ~--~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+ ..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence 4 789999999999999999877677999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh---
Q 011385 287 AKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--- 362 (487)
Q Consensus 287 a~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--- 362 (487)
++......... ......++..|+|||++.+..++.++|||||||++|||++|..||..... ...........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhh
Confidence 98765433221 12234678889999999988999999999999999999999998853210 00000000000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....+...+........+..++..+.+||.+||+.||.+||++.+|++.|+.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000000000001111223356799999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=361.08 Aligned_cols=252 Identities=31% Similarity=0.479 Sum_probs=196.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++.+.||+|+||.||+|.+. +..||||++.... ..+.+.+|+++|++++||||+++++++.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 71 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL-- 71 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 357889999999999999999873 5689999996543 3467899999999999999999999876
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-EEEeecC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSL--PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-AKLSDFG 285 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-~kl~DFG 285 (487)
+..+|||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+..+|+||||||+||||+.++. +||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg 151 (307)
T 2eva_A 72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151 (307)
T ss_dssp TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence 458999999999999999965432 4788999999999999999999943334999999999999998887 7999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.. .
T Consensus 152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~---~--- 218 (307)
T 2eva_A 152 TACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWAV---H--- 218 (307)
T ss_dssp C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHHH---H---
T ss_pred cccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHHH---h---
Confidence 99765332 2234699999999999999999999999999999999999999975432110 0 00100 0
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
....+.+... .+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 219 ---~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 219 ---NGTRPPLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp ---TTCCCCCBTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCCCCcccc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0011111222 245788999999999999999999999999765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=367.57 Aligned_cols=257 Identities=18% Similarity=0.160 Sum_probs=204.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCceeEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIG 203 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~ 203 (487)
+..++|.+.+.||+|+||+||+|.+.... ...+++.||||++.... ..++..|++++..+. |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34578999999999999999999653311 12367899999997653 456778888888886 999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC----
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---- 275 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---- 275 (487)
++...+..|||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+.+ ||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 99999999999999999999999964 3457999999999999999999999988 999999999999988
Q ss_pred -------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCC
Q 011385 276 -------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348 (487)
Q Consensus 276 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 348 (487)
++.+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997543222333445678999999999999999999999999999999999999999532211
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 415 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l 415 (487)
. ..+...+. ... ....+.+|+..||+.+|.+|+ ++.++.+.|+.+
T Consensus 292 ~---------------~~~~~~~~----~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 292 E---------------CKPEGLFR----RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E---------------EEECSCCT----TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred c---------------eeechhcc----ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 00001111 101 145678999999999999995 778888777654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=379.30 Aligned_cols=262 Identities=22% Similarity=0.244 Sum_probs=209.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC-CCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~ 207 (487)
.++|+++++||+|+||.||+|++.. +++.||||++...... .++.+|++++..|.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4689999999999999999998765 5779999998655432 357899999999987 556667777778
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl~DF 284 (487)
.+..+|||||+ +++|.+++......+++..++.|+.||+.||.|||+++ ||||||||+|||| +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeC
Confidence 88999999999 99999999766678999999999999999999999988 9999999999999 68899999999
Q ss_pred CCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 285 GLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 285 Gla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+++........ ......+||+.|+|||++.+..++.++||||||||||||++|..||.................
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 999876543221 112256899999999999999999999999999999999999999987654433222221111
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ..+. .+... ++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 231 ~~~~-~~~~-----~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 231 KKVA-TSIE-----ALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHH-SCHH-----HHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccc-ccHH-----HHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 0000 00111 236789999999999999999999999998765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=368.89 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=203.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|++.... ...++..||||++..... ....++.+|+.++..++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3468999999999999999999864311 123677999999965432 23456889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRS------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DY 277 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~ 277 (487)
+.+..||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. +.
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcc
Confidence 9999999999999999999997553 35889999999999999999999988 999999999999984 45
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 356 (487)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~ 257 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF 257 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHH
Confidence 699999999875433222222334578999999999999999999999999999999998 99999654221 11111
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.. .. .... .+..++..+.+|+.+||+.||.+||++.+|+++|+.+
T Consensus 258 ~~----~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 VT----SG------GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HH----TT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hh----cC------CCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10 00 0011 1112346789999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=366.13 Aligned_cols=271 Identities=24% Similarity=0.307 Sum_probs=204.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||.||+|++.. +|+.||||++...... ....+.+|+++++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 589999999999999999999865 5779999998654332 24578899999999999999999999987
Q ss_pred --------CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 208 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 208 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
.+..+||||||++ +|.+.+......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 3468999999975 888888766677999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCc--ceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 280 KLSDFGLAKDGPEGDK--THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 280 kl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
||+|||+++....... ........||+.|+|||++.+ ..|+.++|||||||++|||++|..||...........+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999986542211 112234678999999998876 5689999999999999999999999976543221111111
Q ss_pred hhhhhhc-------ccccccccCCccCCCCCH--H-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 357 ARPHLGE-------RRRFYRLIDPRLEGHFSI--K-----GAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 357 ~~~~~~~-------~~~~~~~~~~~~~~~~~~--~-----~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
....... .......+.......... . .+..+.+||.+||+.||.+||++.|++++-.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 0000000 000000000000000000 0 1345889999999999999999999998543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=365.84 Aligned_cols=268 Identities=26% Similarity=0.396 Sum_probs=201.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|++.. +|+.||||++....... .+.+.+|+.++..++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 3589999999999999999999865 57799999986544322 345789999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+.+..+|||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence 9999999999999988888764 4456999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h------
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R------ 358 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~------ 358 (487)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||............... .
T Consensus 171 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 171 ARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 986543221 22345799999999998765 7899999999999999999999999765332111100000 0
Q ss_pred -hhhhcccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 -PHLGERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.....+.....+.+....+ ...+..+.+||.+||+.||.+||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000011111111111 1234678999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=399.69 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=205.8
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCceeEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDL-VHLNLVKLI 202 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~~~ 202 (487)
...++|+++++||+|+||.||+|++.. +++.||||+++... ......+..|..+|..+ +||||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 445789999999999999999999875 67799999997432 22346688999999988 799999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+++.+.+.+||||||+++|+|.++|... ..+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++++||+
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEEC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999999999655 46999999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||...... .+.. ..+.
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~~ 556 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIME 556 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHS
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH---HHHh
Confidence 9999986433222 234578999999999999999999999999999999999999999764321 1111 1111
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM-----SEVVE 410 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~ 410 (487)
.. ..++...+..+.+||.+||+.||.+||++ .||++
T Consensus 557 ~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 HN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SC------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CC------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 10 11222335679999999999999999997 56654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.37 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=202.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
.++|++.+.||+|+||.||+|++.. +|..||||+++..... ..+.+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 3578999999999999999998865 5779999998654322 357799999999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 278 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 278 (487)
+++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence 9999999999999999999999999654 46899999999999999999999988 99999999999998877 8
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~ 224 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLTNIS 224 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHHHhH
Confidence 99999999987644321 23457999999999999899999999999999999999999999754321 1110000
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... ........ ..+..+.+|+.+||+.||.+||++.+++++
T Consensus 225 ---~~~~----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 225 ---AVNY----DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---TTCC----CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---hccc----CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000 00000001 123578999999999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=367.90 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=189.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~ 206 (487)
...+|++.+.||+|+||.||+|++.. +|+.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 34689999999999999999999865 57799999986665555567899999999996 999999999984
Q ss_pred --------eCCeeEEEEeeCCCCChhHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 207 --------EDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 207 --------~~~~~~lv~E~~~~gsL~~~l~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
.....++||||+. |+|.+++.. ....+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTT
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCC
Confidence 3345789999995 799998864 3456999999999999999999999865 349999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcce----------eeeeccccccccCCcee---ccCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 011385 277 YNAKLSDFGLAKDGPEGDKTH----------VSTRVMGTYGYAAPEYV---MTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~APE~~---~~~~~~~~~DiwSlGvil~elltG~~pf~ 343 (487)
+.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 999999999998765432211 11135699999999998 56778999999999999999999999996
Q ss_pred CCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 344 KNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
....... . .. ........ ..+..+.+|+.+||+.||.+||++.|++++|+.+.
T Consensus 255 ~~~~~~~---~-------~~------~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 255 DGAKLRI---V-------NG------KYSIPPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ---------------------------CCCCTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHh---h-------cC------cccCCccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5322110 0 00 00000011 11235789999999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=377.77 Aligned_cols=242 Identities=18% Similarity=0.208 Sum_probs=190.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHH---HHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEV---NFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~HpnIv~~~ 202 (487)
.++|++.+.||+|+||.||+|++.. +|+.||||++.... ....+.+.+|+ ++|+.++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4679999999999999999998754 57799999997432 23346788999 556666899999998
Q ss_pred -------EEEEeCC-----------------eeEEEEeeCCCCChhHHHhhcCC------CCCHHHHHHHHHHHHHHHHH
Q 011385 203 -------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRRSL------PLPWSIRMKIALGAAKGLAF 252 (487)
Q Consensus 203 -------~~~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~------~l~~~~~~~i~~qi~~~l~y 252 (487)
+++.+.+ ..||||||+ +|+|.+++..... .+++..++.|+.||+.||.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666553 278999999 6899999965421 23357888999999999999
Q ss_pred HHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-----------CCCc
Q 011385 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-----------HLTS 321 (487)
Q Consensus 253 LH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-----------~~~~ 321 (487)
||+.+ |+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .|+.
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 99988 99999999999999999999999999986432 2344678 999999999877 8999
Q ss_pred hhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 011385 322 RSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKA 401 (487)
Q Consensus 322 ~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 401 (487)
++|||||||+||||++|+.||........... +... ...+ +..+.+||.+||+.||.+
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~----------------~~~~--~~~~----~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEW----------------IFRS--CKNI----PQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGG----------------GGSS--CCCC----CHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhh----------------hhhh--ccCC----CHHHHHHHHHHcCCCchh
Confidence 99999999999999999999965433221111 0000 0112 367899999999999999
Q ss_pred CCCHHHHHHH
Q 011385 402 RPLMSEVVEA 411 (487)
Q Consensus 402 RPs~~ell~~ 411 (487)
||++.+++++
T Consensus 351 Rpt~~e~l~h 360 (377)
T 3byv_A 351 RLLPLQAMET 360 (377)
T ss_dssp CCCHHHHHTS
T ss_pred CCCHHHHhhC
Confidence 9999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=357.58 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=207.6
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.+..++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+++++.++||||+++++++
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 345678999999999999999999864 35689999997654 3457799999999999999999999998
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
. .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 153 (279)
T 1qpc_A 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF 153 (279)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCC
Confidence 6 456899999999999999986432 36899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|++........ .......|++.|+|||++.+..++.++|||||||++|||++ |..||...... .+.... ..
T Consensus 154 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~----~~ 225 (279)
T 1qpc_A 154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL----ER 225 (279)
T ss_dssp TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HT
T ss_pred cccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHH----hc
Confidence 99987654322 12223457889999999998899999999999999999999 99999654321 111110 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 226 ------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 226 ------GYRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------ccCCC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 00111 1112346789999999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=355.85 Aligned_cols=248 Identities=21% Similarity=0.254 Sum_probs=200.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|.+.. ++..||||++...... ...++.+|+.++..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34689999999999999999998865 5779999999764332 345688999999999 99999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-----
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD----- 276 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~----- 276 (487)
+.+.+..+|||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcc
Confidence 99999999999999999999999653 256899999999999999999999988 9999999999999844
Q ss_pred --------------CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCC
Q 011385 277 --------------YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 277 --------------~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~p 341 (487)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|||++|.++
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999998764422 23599999999998765 667899999999999999999887
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
+.... ...... ....+.+... .+..+.+|+.+||+.||.+||++.+++++-.
T Consensus 231 ~~~~~-----~~~~~~-----------~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 231 PRNGD-----QWHEIR-----------QGRLPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp CSSSH-----HHHHHH-----------TTCCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred Ccchh-----HHHHHH-----------cCCCCCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 64221 110000 0001111222 2467899999999999999999999998543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=374.38 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=198.5
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
...++|++.+.||+|+||+||+|++.. +|+.||||++..... ...+|+++|+.++|||||++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheee
Confidence 456789999999999999999998865 677999999865532 2347999999999999999999984
Q ss_pred e--------------------------------------CCeeEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHH
Q 011385 207 E--------------------------------------DDQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALG 245 (487)
Q Consensus 207 ~--------------------------------------~~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~q 245 (487)
. ...++|||||++ |+|.+.+. .....+++..++.++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 4 334889999997 58877775 34567999999999999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchh
Q 011385 246 AAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRS 323 (487)
Q Consensus 246 i~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~ 323 (487)
|+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++....... .....||+.|+|||++.+. .|+.++
T Consensus 150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 999999999988 99999999999997 689999999999987644332 2345789999999988765 599999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh-hhhh------c---ccccccccCCccCCCCCHHHHHHHHHHHH
Q 011385 324 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR-PHLG------E---RRRFYRLIDPRLEGHFSIKGAQKAAQLAA 392 (487)
Q Consensus 324 DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~-~~~~------~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 392 (487)
|||||||++|||++|+.||...........+.. .. +... . ...+.......+...++...+..+.+||.
T Consensus 224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 999999999999999999976432211110000 00 0000 0 00000000111111122234567899999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 011385 393 HCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 393 ~cl~~dP~~RPs~~ell~~ 411 (487)
+||+.||.+|||+.|++++
T Consensus 304 ~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHCCSSGGGSCCHHHHHTS
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=373.98 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=204.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|.+.. +|..||+|++..... ...+.+.+|+.++..++||||+++++++.
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 34689999999999999999999865 577999999976532 22356889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+++..+|||||+++++|.+++... ..+++..+..++.||+.||.|||+. + |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECC
Confidence 999999999999999999999654 4689999999999999999999985 7 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh-h----
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-H---- 360 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~---- 360 (487)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||................. .
T Consensus 178 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 178 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp CCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred CCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 98653221 12345799999999999999999999999999999999999999975432111000000000 0
Q ss_pred ----------h-------hcccc----cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 361 ----------L-------GERRR----FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 361 ----------~-------~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. ..... +..+.............+..+.+||.+||+.||.+|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0 00000 0000000000001111245789999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.54 Aligned_cols=260 Identities=23% Similarity=0.274 Sum_probs=199.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||.||+|.+.. ++..||||++....... .+.+.+|+.++..++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 3689999999999999999998765 57799999997553332 35688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
..++..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence 9999999999999999999999654 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ...+....
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~---~~~~~~~~ 251 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM---GAHINQAI 251 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH---HHHHHSCC
T ss_pred cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH---HHHhccCC
Confidence 99875443221 223457999999999999999999999999999999999999999753211 00 00111000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCCCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPLPN 417 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l~~ 417 (487)
.. ...+....+..+.+|+.+||+.||.+|| ++.++++.|+....
T Consensus 252 ~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 252 PR--------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp CC--------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CC--------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 00 0011112335788999999999999999 99999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=355.98 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=205.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|++++..++||||+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3689999999999999999998865 56789999985432 12346788999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999999999999655 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++....... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....... .. .....
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~--- 226 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---RRIVN--- 226 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHT---
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---HHHhc---
Confidence 987654322 233579999999999999999999999999999999999999996532111 10 00000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+.. ++...+..+.+||.+||+.||.+||++.+++++
T Consensus 227 -----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 227 -----VDLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----TCCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----cccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0111 111234678999999999999999999999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=380.37 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=199.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++.. ++..||||++..... .....+.+|+.+|+.++|||||++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4579999999999999999999865 577999999975432 23467899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~~kl~D 283 (487)
+....|||||||++|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.. +.+||+|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999999999999988654 46899999999999999999999988 9999999999999764 5599999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++...... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... .+.... ...
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i---~~~ 252 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKV---EKG 252 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHT
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC
Confidence 99998764432 233467999999999875 57999999999999999999999999764321 111111 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... .+...... .+..+.+||.+||+.||.+|||+.|++++
T Consensus 253 ~~~----~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 KYT----FDSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCC----CCSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC----CCchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 01111111 24678999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=366.12 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=206.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4689999999999999999998865 5679999998654322 235688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..||||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999999999988654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ... .......
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~~~~~~- 257 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETY---LRIKKNE- 257 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH---HHHHHTC-
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHH---HHHhcCC-
Confidence 9987543222 123467999999999999999999999999999999999999999653211 110 0000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.. ..+..+.+||.+||+.||.+||++.|++++
T Consensus 258 -------~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -------YSIPK----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -------CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111 223578899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=359.98 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=201.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|++.. +++.||||+++... .+.+.+|+.+|..+. ||||+++++++.+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 3689999999999999999998865 57799999997433 467899999999997 9999999999988
Q ss_pred --CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeec
Q 011385 208 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDF 284 (487)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~DF 284 (487)
....++||||+++++|.+++. .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 667899999999999999883 3889999999999999999999988 99999999999999776 8999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh----h
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----P 359 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~----~ 359 (487)
|+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||......... +..... .
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~ 251 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTE 251 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCc
Confidence 99987554332 233579999999999876 67999999999999999999999999543321110 000000 0
Q ss_pred hh----hc-----------------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HL----GE-----------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~----~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. .. ......... .......+..+.+||.+||+.||.+|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH----SENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC----TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhcc----ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 00 00 000000111 111112346789999999999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.16 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=203.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+.. +|..||||.+.... ....+.+|+.++..++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45789999999999999999998865 57799999997643 34678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccc
Confidence 99999999999999999999766678999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ...
T Consensus 173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~---- 239 (314)
T 3com_A 173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIFM----IPT---- 239 (314)
T ss_dssp EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH----HHH----
T ss_pred hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHHH----Hhc----
Confidence 76543221 2234579999999999999899999999999999999999999996532211 0000 000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...+.+ ..+...+..+.+|+.+||+.||.+||++.+++++-
T Consensus 240 --~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 240 --NPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp --SCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred --CCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 000000 01112246789999999999999999999998743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=370.64 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=197.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+++|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 4689999999999999999998865 6779999999654322 2356889999999999999999999998
Q ss_pred eCC------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
... .+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEE
Confidence 653 459999999 8899999865 46899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||+++..... .+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999875432 234679999999999887 6899999999999999999999999976432211110000000
Q ss_pred h--------hh--ccc----ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 H--------LG--ERR----RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~--------~~--~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. +. ... .+.......+. .+....+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0 00 000 00000001111 11112346789999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.06 Aligned_cols=265 Identities=23% Similarity=0.359 Sum_probs=188.5
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
+..++|++.+.||+|+||.||+|.+.. ++..||||++..... ....++.+|+.++..++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 456789999999999999999998764 567999999865432 2345688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFR-------RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
...+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 159 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGS 159 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCC
Confidence 999999999999999999999863 2456899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCc---ceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011385 279 AKLSDFGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~---~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~ 354 (487)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 236 (303)
T 2vwi_A 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--- 236 (303)
T ss_dssp EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---
T ss_pred EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---
Confidence 99999999876543221 111234579999999998875 57899999999999999999999999764332111
Q ss_pred Hhhhhhhhcccccc-cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 355 EWARPHLGERRRFY-RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 355 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... ......+. ...++..... .+..+.+|+.+||+.||.+||++.+++++-
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 237 MLTL--QNDPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp HHHH--TSSCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTST
T ss_pred HHHh--ccCCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 0000 00000000 0011111122 235788999999999999999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=379.55 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=203.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||+||+|++.. +|+.||||++.... ......+.+|+++|++++|||||++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 4579999999999999999998865 57799999985432 234567899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEee
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSD 283 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~~kl~D 283 (487)
+....|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence 999999999999999999988655 46999999999999999999999988 99999999999995 456799999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .+..... ..
T Consensus 168 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~---~~ 237 (486)
T 3mwu_A 168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE---TG 237 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HT
T ss_pred CCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---hC
Confidence 99998754432 2234679999999998865 5999999999999999999999999754321 1111100 00
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... .+..... ..+..+.+||.+||+.||.+|||+.+++++-
T Consensus 238 ~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 238 KYA----FDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp CCC----SCSGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CCC----CCCcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 000 0000011 2246789999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=356.94 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=197.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+ +|..||||+++... ..+.+.+|++++..++||||+++++++.+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 346899999999999999999976 35689999997553 34678999999999999999999999765
Q ss_pred C-CeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 208 D-DQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 208 ~-~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
. +..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecc
Confidence 4 47899999999999999996543 23789999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++...... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+.... ..
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~----~~- 229 (278)
T 1byg_A 163 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EK- 229 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TT-
T ss_pred cccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hc-
Confidence 99865432 122467899999999999999999999999999999998 99999754321 111110 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ..+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus 230 -----~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 230 -----GYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp -----TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0011 11222346789999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=353.15 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=201.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|....+||+|+||.||+|.+.. ++..||||.+........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 456666799999999999998865 56799999998766555678999999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-CCcEEEeecCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGL 286 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-~~~~kl~DFGl 286 (487)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999999999997653 34678889999999999999999988 999999999999987 89999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||....... ........
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~---- 240 (295)
T 2clq_A 170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGM---- 240 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHH----
T ss_pred ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcc----
Confidence 987543221 12345799999999998764 38999999999999999999999996432110 00000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
....+.+. ...+..+.+|+.+||+.||.+||++.+++++-
T Consensus 241 ----~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 241 ----FKVHPEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp ----HCCCCCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred ----cccccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 01111122 22346789999999999999999999998743
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=384.41 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=206.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|++.. +|+.||||++..... .....+.+|+.+|++++|||||+++++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34679999999999999999998865 577999999965432 345779999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE---cCCCcEEE
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL---DADYNAKL 281 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll---~~~~~~kl 281 (487)
+.+.+..|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEE
Confidence 99999999999999999999988554 56999999999999999999999988 9999999999999 56789999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
+|||+++....... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .+.....
T Consensus 171 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~--- 240 (484)
T 3nyv_A 171 IDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILKKVE--- 240 (484)
T ss_dssp CCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---
T ss_pred EeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---
Confidence 99999987544322 234679999999998865 7999999999999999999999999764321 1111110
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... ....... ..+..+.+||.+||+.||.+|||+.|++++-
T Consensus 241 ~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 241 KGKYT----FELPQWK----KVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp HCCCC----CCSGGGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred cCCCC----CCCcccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 00000 0000011 2346789999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=391.67 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=210.9
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+.+..++|++.+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|++|+|||||+++++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34556788999999999999999998853 3579999997654 345789999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
+.+ +..|||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcc
Confidence 876 6789999999999999999643 346899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
||+++...... ........++..|+|||++....|+.++|||||||+||||++ |..||...... .+.... .
T Consensus 407 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i----~ 478 (535)
T 2h8h_A 407 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQV----E 478 (535)
T ss_dssp TTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHH----H
T ss_pred cccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----H
Confidence 99998764321 111223457889999999999999999999999999999999 99999754321 111111 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCC
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPN 417 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~ 417 (487)
.. ... ..+..++..+.+||.+||+.||++||++.+|++.|+.+..
T Consensus 479 ~~------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 479 RG------YRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp TT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred cC------CCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 00 000 1112335678999999999999999999999999997743
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=371.82 Aligned_cols=254 Identities=15% Similarity=0.053 Sum_probs=184.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHH---HHHhcCCCCCceeEE-
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEV---NFLGDLVHLNLVKLI- 202 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~HpnIv~~~- 202 (487)
.+|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+ ++|.. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458899999999999999999865 5779999999875432 234566775 45555 799988865
Q ss_pred ------EEEEeC-----------------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHH------HHHHHHHHHHHHHH
Q 011385 203 ------GYCIED-----------------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIR------MKIALGAAKGLAFL 253 (487)
Q Consensus 203 ------~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~------~~i~~qi~~~l~yL 253 (487)
+++... ...|||||||+ |+|.+++......+++..+ +.++.||+.||+||
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~L 210 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence 444433 33799999998 8999999765445566666 78889999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc--CCCCchhhhhhHHHH
Q 011385 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVV 331 (487)
Q Consensus 254 H~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvi 331 (487)
|+++ ||||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..|+.++|||||||+
T Consensus 211 H~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 211 QSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 9988 999999999999999999999999999875321 224567799999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 332 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 332 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
||||++|+.||............ ..... ......+........+..+.+||.+||+.||.+||++.+++++
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWK---RPSLR------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCC---BCCTT------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HHHHHhCCCCCCCcCcccccchh---hhhhh------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99999999999765432211100 00000 0000000101111234678999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=359.93 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=199.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||.||+|.+.... +.+..||||+++.... ...+.+.+|++++..++||||+++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 468999999999999999999875421 1234699999875432 2346788999999999999999999998
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.. .++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccc
Confidence 8765 88999999999999999776667999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 286 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 286 la~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
++.......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... ...... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~~ 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKE 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTS
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHH---Hcc
Confidence 998765433221 2233568889999999998899999999999999999999 99999754321 111100 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
. .... .+...+..+.+|+.+||+.||.+||++.+++++|+.+.
T Consensus 241 ~------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 G------ERLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C------CCCC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 0 0001 11123467899999999999999999999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=356.98 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=206.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++...... ..+.+.+|+.+++.+.||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 4689999999999999999998865 5679999998654322 235688999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999999999999999988554 46999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ......
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~~~-- 230 (294)
T 2rku_A 161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---LRIKKN-- 230 (294)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHTT--
T ss_pred CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHhhc--
Confidence 9987543222 1234579999999999998899999999999999999999999996532111 00 000000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ++...+..+.+|+.+||+.||.+||++.+++++.
T Consensus 231 ------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 231 ------EYS----IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp ------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ------cCC----CccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 001 1112245788999999999999999999998743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=352.90 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=208.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.+.|++.+.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.++..+.||||+++++++.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3578999999999999999998764 577999999975543 345778999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccc
Confidence 9999999999999999999854 46899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... ..
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~----- 232 (303)
T 3a7i_A 167 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IP----- 232 (303)
T ss_dssp EECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HH-----
T ss_pred eecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hh-----
Confidence 77543221 223467999999999999999999999999999999999999999654221 11100 00
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
....+.+...+ +..+.+|+.+||+.||.+||++.+++++..
T Consensus 233 -~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 233 -KNNPPTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -HSCCCCCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -cCCCCCCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 01111122223 357899999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=360.45 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=202.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..........+.+|++++..++||||+++++++.+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 34689999999999999999999865 577999999987766667889999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999999998776677999999999999999999999988 999999999999999999999999987
Q ss_pred CCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
...... ........||+.|+|||++. ...++.++|||||||++|+|++|..||...... .... ....
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~~ 236 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLL---KIAK 236 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHH
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH---HHhc
Confidence 532110 01122357999999999883 677899999999999999999999999754321 1100 0000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. .+.. ..+...+..+.+|+.+||+.||.+||++.+++++-
T Consensus 237 ~~-------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 237 SD-------PPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp SC-------CCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred cC-------Cccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00 0000 01112346789999999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.90 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=199.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 457888899999999999998865 567899999875433 234568899999999999999999999875
Q ss_pred ----CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEe
Q 011385 208 ----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLS 282 (487)
Q Consensus 208 ----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~~kl~ 282 (487)
....++||||+++|+|.+++... ..+++..++.|+.||+.||.|||+.+ .+|+||||||+||||+ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEe
Confidence 35689999999999999999654 46899999999999999999999865 3499999999999997 78999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||++....... .....||+.|+|||++. ..++.++|||||||++|+|++|..||....... ....... .
T Consensus 175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~---~ 244 (290)
T 1t4h_A 175 DLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT---S 244 (290)
T ss_dssp CTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT---T
T ss_pred eCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHh---c
Confidence 999997654322 23457999999999776 569999999999999999999999996532211 1111000 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. .....+.. ..+..+.+||.+||+.||.+||++.+++++-
T Consensus 245 ~------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 245 G------VKPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp T------CCCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred c------CCccccCC----CCCHHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 0 00001111 1235789999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=379.42 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=202.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-------------cCHHHHHHHHHHHhcCC
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGDLV 194 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 194 (487)
..++|++++.||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.+|+.++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 45789999999999999999999865 577999999975432 22467889999999999
Q ss_pred CCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 195 HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
|||||++++++.+....|||||||++|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence 999999999999999999999999999999998654 46999999999999999999999988 99999999999998
Q ss_pred CCC---cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 275 ADY---NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 275 ~~~---~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
.++ .+||+|||+++....... ....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.......
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-- 254 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-- 254 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 776 699999999987654322 23467999999999876 579999999999999999999999997643211
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+..... ..... .+..... ..+..+.+||.+||+.||.+|||+.|++++-
T Consensus 255 -~~~~i~---~~~~~----~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 255 -IIKKVE---KGKYY----FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp -HHHHHH---HCCCC----CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHHHHH---cCCCC----CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 111100 00000 0000001 1236789999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=370.23 Aligned_cols=266 Identities=20% Similarity=0.245 Sum_probs=205.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC--------CCCce
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV--------HLNLV 199 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv 199 (487)
..++|++.+.||+|+||+||+|++.. +++.||||++.... ...+.+.+|+++|+.+. |+||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 34789999999999999999998765 57799999997542 22456889999999985 78899
Q ss_pred eEEEEEE----eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEE
Q 011385 200 KLIGYCI----EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILL 273 (487)
Q Consensus 200 ~~~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll 273 (487)
++++++. .....||||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ + |+||||||+||||
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll 180 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILL 180 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEE
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeE
Confidence 9999987 556889999999 66777766544 35799999999999999999999997 7 9999999999999
Q ss_pred cCCC-------------------------------------------------cEEEeecCCCCCCCCCCcceeeeeccc
Q 011385 274 DADY-------------------------------------------------NAKLSDFGLAKDGPEGDKTHVSTRVMG 304 (487)
Q Consensus 274 ~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~G 304 (487)
+.++ .+||+|||+++..... ....+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 8775 7999999999875432 233579
Q ss_pred cccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH---hhhhhhhc------------------
Q 011385 305 TYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGE------------------ 363 (487)
Q Consensus 305 t~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~---~~~~~~~~------------------ 363 (487)
|+.|+|||++.+..|+.++|||||||+||||++|+.||............. .....+..
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 335 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence 999999999999999999999999999999999999997655433211110 00000000
Q ss_pred ccccccccCCc---------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPR---------LEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...+..+.+.. -...++...+..+.+||.+||+.||.+|||+.||+++-
T Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence 00000000000 01124566778899999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=363.73 Aligned_cols=268 Identities=24% Similarity=0.387 Sum_probs=195.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHH--HhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF--LGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|++ ++..||||++.... ...+..|.++ +..++||||+++++++.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence 46899999999999999999976 36789999996443 2444445444 55689999999998654
Q ss_pred e-----CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCcEE
Q 011385 207 E-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE---------AERPVIYRDFKTSNIL 272 (487)
Q Consensus 207 ~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------~~~~iiHrDLKp~NIl 272 (487)
. ...++||||||++|+|.+++... ..++..++.++.||+.||.|||+. + |+||||||+|||
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nil 152 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVL 152 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEE
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEE
Confidence 3 23568999999999999999654 358899999999999999999998 6 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCc------ceeeeeccccccccCCceecc-------CCCCchhhhhhHHHHHHHHHhCC
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDK------THVSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLTGR 339 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~Gt~~y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~ 339 (487)
|+.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999986543211 112234579999999999876 45678999999999999999998
Q ss_pred CCCCCCCCCCcchhh-Hh---hhhhhhcccc--cccccCCccCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 340 RSMDKNRPNGEHNLV-EW---ARPHLGERRR--FYRLIDPRLEGHF--SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 340 ~pf~~~~~~~~~~~~-~~---~~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.||............ .. ..+....... ......+.+...+ ....+..+.+||.+||+.||.+|||+.|+++.
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 776543322211110 00 0000000000 0001111111111 12456789999999999999999999999999
Q ss_pred hcCC
Q 011385 412 LKPL 415 (487)
Q Consensus 412 L~~l 415 (487)
|+.+
T Consensus 313 L~~l 316 (336)
T 3g2f_A 313 MAEL 316 (336)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=376.97 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=196.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC-
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED- 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~- 208 (487)
.+|++.+.||+|+||.||+|++.. +|+.||||++..... .+.+|+++|+.|+|||||++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 468899999999999999999865 577999999865432 234799999999999999999988542
Q ss_pred -----CeeEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-CcE
Q 011385 209 -----DQRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNA 279 (487)
Q Consensus 209 -----~~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~~ 279 (487)
..++|||||+++ +|.+++. .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence 236799999975 6666654 34567999999999999999999999988 9999999999999965 568
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
||+|||+++....... ....+||+.|+|||++.+. .|+.++||||||||||||++|+.||.+..... .+.....
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~ 271 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK 271 (420)
T ss_dssp EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 9999999987644322 2345799999999998764 79999999999999999999999997643211 1111110
Q ss_pred h-------hhhc-ccccccccCCcc-----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 P-------HLGE-RRRFYRLIDPRL-----EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ~-------~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. .+.. ...+....-+.+ ...+....+..+.+||.+||+.||.+||++.|++++-
T Consensus 272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0 0000 000000000100 0012223356799999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=357.44 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=203.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3578999999999999999998865 5779999999765432 2356889999999999999999999885
Q ss_pred e--CCeeEEEEeeCCCCChhHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCcE
Q 011385 207 E--DDQRLLVYEFMPRGSLENHLFRR---SLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 207 ~--~~~~~lv~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDLKp~NIll~~~~~~ 279 (487)
+ ....++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 56889999999999999999643 345999999999999999999999865 2349999999999999999999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+....
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i-- 228 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI-- 228 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH--
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHH--
Confidence 9999999987543221 12235799999999999999999999999999999999999999975432 1111110
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
... ..+.+ +...+..+.+|+.+||+.||.+||++.||+++++.
T Consensus 229 --~~~------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 229 --REG------KFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --HHT------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --hhc------ccccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 000 00111 11234678999999999999999999999997764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=357.83 Aligned_cols=264 Identities=27% Similarity=0.384 Sum_probs=205.9
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGD--LVHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~~~~ 203 (487)
....++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 34567899999999999999999987 3678999999643 24667889998887 78999999999
Q ss_pred EEEeCC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCcE
Q 011385 204 YCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH--------EEAERPVIYRDFKTSNI 271 (487)
Q Consensus 204 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiHrDLKp~NI 271 (487)
++.... ..++||||+++|+|.+++.+. .+++..++.++.||+.||.||| +.+ |+||||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 998876 789999999999999999653 5899999999999999999999 666 99999999999
Q ss_pred EEcCCCcEEEeecCCCCCCCCCCcce--eeeeccccccccCCceeccC------CCCchhhhhhHHHHHHHHHhC-----
Q 011385 272 LLDADYNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTG------HLTSRSDVYSFGVVLLEMLTG----- 338 (487)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~------~~~~~~DiwSlGvil~elltG----- 338 (487)
||+.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997654432211 12345799999999998765 334789999999999999999
Q ss_pred -----CCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 339 -----RRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGH-FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 339 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..||.......... ..+..... .....+.+... ....+...+.+|+.+||+.||.+||++.+|+++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSV-EEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCH-HHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCcccH-HHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67776543322111 11110000 01111111111 1235677899999999999999999999999999
Q ss_pred cCC
Q 011385 413 KPL 415 (487)
Q Consensus 413 ~~l 415 (487)
+.+
T Consensus 332 ~~i 334 (342)
T 1b6c_B 332 SQL 334 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=361.16 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=206.0
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcC-CC
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDL-VH 195 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~H 195 (487)
.....++|++.+.||+|+||.||+|++.. +|+.||||++....... .+.+.+|+.++.++ +|
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h 159 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34456789999999999999999998864 57799999986543211 24578899999999 79
Q ss_pred CCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011385 196 LNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275 (487)
Q Consensus 196 pnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 275 (487)
|||+++++++......||||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 160 p~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~ 235 (365)
T 2y7j_A 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235 (365)
T ss_dssp TTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999999654 46999999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCC
Q 011385 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNG 349 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 349 (487)
++.+||+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 236 ~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~- 311 (365)
T 2y7j_A 236 NMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI- 311 (365)
T ss_dssp TCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred CCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-
Confidence 99999999999987654332 234689999999998863 36899999999999999999999999653211
Q ss_pred cchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 350 EHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
...... ......+ ..+ .... .+..+.+||.+||+.||.+||++.+++++-
T Consensus 312 --~~~~~i---~~~~~~~---~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 312 --LMLRMI---MEGQYQF---SSP-EWDD----RSSTVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp --HHHHHH---HHTCCCC---CHH-HHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred --HHHHHH---HhCCCCC---CCc-cccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 111110 0000000 000 0011 235688999999999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=364.16 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=194.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 4689999999999999999998765 577999999975432 22356889999999999999999999998
Q ss_pred eCC------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
..+ ..|||||||+ |+|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccccccccceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 765 7899999996 47888874 35889999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh---
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--- 357 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--- 357 (487)
|+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........+...
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998754321 233467999999999999999999999999999999999999999764321110000000
Q ss_pred -------------hhhhhcccc-----cccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 358 -------------RPHLGERRR-----FYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 358 -------------~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
......... +.......... ......+..+.+||.+||+.||.+|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000000 00000000000 01123366799999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=356.29 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=199.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--------cCHHHHHHHHHHHhcCCCCCce
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLVHLNLV 199 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv 199 (487)
..++|++.+.||+|+||.||+|.+.. ++..||||++..... .....+.+|+++|..++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 44689999999999999999998865 577999999965432 1123478999999999999999
Q ss_pred eEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc-
Q 011385 200 KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN- 278 (487)
Q Consensus 200 ~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~- 278 (487)
++++++..++ .|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 9999987655 8999999999999998854 457999999999999999999999988 999999999999987654
Q ss_pred --EEEeecCCCCCCCCCCcceeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 279 --AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 279 --~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
+||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 228 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L 228 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H
Confidence 9999999998764321 123457999999999874 56789999999999999999999999975443221 1
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... ..... ..+.... ..+..+.+|+.+||+.||.+||++.+++++-
T Consensus 229 ~~~~~---~~~~~----~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 229 KDQIT---SGKYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp HHHHH---HTCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHH---hCccc----cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 11100 00000 0000011 1246789999999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=353.35 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=199.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC----ccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... ......+.+|+++++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4689999999999999999998764 57799999996542 1234678999999999999999999999
Q ss_pred EE--eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 205 CI--EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 205 ~~--~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
+. +....+|||||++++ |.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl 150 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI 150 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence 84 456789999999876 77777543 456999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCC--CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~--~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
+|||++................||+.|+|||++.+.. ++.++|||||||++|||++|..||...... .....
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~--- 224 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFEN--- 224 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH---
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHH---
Confidence 9999998765433333334467999999999887643 478999999999999999999999753211 11110
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... ..+.. ..+..+.+|+.+||+.||.+||++.|++++.
T Consensus 225 i~~~~--------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 225 IGKGS--------YAIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp HHHCC--------CCCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred HhcCC--------CCCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 00000 01111 2346788999999999999999999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.44 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=196.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||.||+|++.. +|+.||||++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 34679999999999999999998765 57799999996432 234568899999999999999999998865
Q ss_pred -------------CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 208 -------------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 208 -------------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
....|+||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFID 150 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEc
Confidence 35678999999999999999877667889999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCc------------ceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCC
Q 011385 275 ADYNAKLSDFGLAKDGPEGDK------------THVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~p 341 (487)
.++.+||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++ |
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence 999999999999987543210 1112345799999999998764 78999999999999999998 4
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
|... ........ .+. .....+...++...+..+.+|+.+||+.||.+||++.+++++-.
T Consensus 228 ~~~~-----~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 228 FSTG-----MERVNILK-KLR-------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp CSSH-----HHHHHHHH-HHH-------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred cCCc-----hhHHHHHH-hcc-------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 4311 00000000 000 01111222233344567899999999999999999999998643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.65 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=187.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HH-HHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HK-EWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~-~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++....... .. .+.++...++.++||||+++++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~ 75 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL 75 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence 34689999999999999999999865 57799999997653221 22 244555568889999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
.+.+..++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999997 588877753 456799999999999999999999997 7 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCcee----ccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~----~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|||++|..||...... .....
T Consensus 152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~ 224 (290)
T 3fme_A 152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQLK 224 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHHHH
T ss_pred eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHHHH
Confidence 99999987544321 2234799999999996 5667899999999999999999999999643221 10000
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. .... ..+... ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 225 ~-~~~~-------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 225 Q-VVEE-------PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp H-HHHS-------CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred H-Hhcc-------CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 0 0000 000000 11224678999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=361.36 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=198.2
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
....++|++.+.||+|+||.||+|++.. +|+.||||++..... ....+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 3456789999999999999999999865 577999999965432 346789999999999 79999999999
Q ss_pred EEe------CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 205 CIE------DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 205 ~~~------~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
+.. .+..+|||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 987 46789999999999999999754 356899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--- 241 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--- 241 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---
Confidence 999999999987543211 123457999999999986 5678999999999999999999999996533211
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... ... ...+.+. ....+..+.+||.+||..||.+||++.+++++
T Consensus 242 ~~~~---~~~-------~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ALFL---IPR-------NPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHH---HHH-------SCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHH---hhc-------CccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 000 0001010 11124678999999999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.21 Aligned_cols=251 Identities=27% Similarity=0.340 Sum_probs=197.7
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++.... ......+.+|+.+++.++||||++++++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 79 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 34689999999999999999998865 57799999986432 2334678899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCC
T ss_pred EecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeec
Confidence 99999999999999999999999654 46899999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...... ...
T Consensus 156 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~---~~~ 226 (276)
T 2h6d_A 156 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKI---RGG 226 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC
T ss_pred ccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHh---hcC
Confidence 99987654321 233579999999999887765 68999999999999999999999653211 111100 000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. ..+.. ..+..+.+|+.+||+.||.+||++.+++++-
T Consensus 227 ~--------~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 227 V--------FYIPE----YLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp C--------CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred c--------ccCch----hcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 0 00111 2235788999999999999999999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.67 Aligned_cols=199 Identities=22% Similarity=0.338 Sum_probs=172.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC------CCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL------VHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~ 202 (487)
..+|++++.||+|+||.||+|.+.. +++.||||++.... .....+.+|++++..+ +|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4579999999999999999998865 57799999997542 2235577888888877 578999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--E
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN--A 279 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~--~ 279 (487)
+++...+..+|||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++. +
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCE
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcce
Confidence 99999999999999995 69999887553 45999999999999999999999988 999999999999999887 9
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||+||||++|.+||....
T Consensus 242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999765432 223579999999999999999999999999999999999999997654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=367.13 Aligned_cols=274 Identities=23% Similarity=0.302 Sum_probs=199.7
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-----------HHHHHHHHHHH
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFL 190 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l 190 (487)
+.++....++|++.+.||+|+||.||+|.+. .|..||||++....... .+.+.+|++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 83 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHH
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHH
Confidence 4556677899999999999999999999864 36789999986432211 26789999999
Q ss_pred hcCCCCCceeEEEEEEeC-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 011385 191 GDLVHLNLVKLIGYCIED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 265 (487)
Q Consensus 191 ~~l~HpnIv~~~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD 265 (487)
..++||||+++++++... ...||||||++ |+|.+++......+++..++.++.||+.||.|||+.+ |+|||
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 159 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecC
Confidence 999999999999998542 36799999997 6898888776678999999999999999999999988 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 011385 266 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDK 344 (487)
Q Consensus 266 LKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~ 344 (487)
|||+||||+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 160 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 160 LHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998643322 2334679999999998876 6799999999999999999999999976
Q ss_pred CCCCCcchhhH-hhh------------hhhhcc-cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 011385 345 NRPNGEHNLVE-WAR------------PHLGER-RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410 (487)
Q Consensus 345 ~~~~~~~~~~~-~~~------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 410 (487)
.........+. ... ...... ...................+..+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 43221111000 000 000000 0000000000000011122456889999999999999999999998
Q ss_pred Hh
Q 011385 411 AL 412 (487)
Q Consensus 411 ~L 412 (487)
+-
T Consensus 317 hp 318 (362)
T 3pg1_A 317 HP 318 (362)
T ss_dssp SG
T ss_pred Cc
Confidence 54
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=390.86 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=198.0
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 213 (487)
+.||+|+||.||+|.+... .++..||||+++.... ...+++.+|+++|.+|+|||||++++++.. +..+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 4799999999999977532 2467899999976433 235779999999999999999999999864 56889
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
|||||++|+|.+++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 9999999999999954 457999999999999999999999988 999999999999999999999999999876443
Q ss_pred Cc-ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 294 DK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 294 ~~-~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
.. ........||+.|+|||++.+..|+.++|||||||+||||++ |+.||....... +.... ... .
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i----~~~------~ 589 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML----EKG------E 589 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT------C
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC------C
Confidence 22 122333567899999999999999999999999999999998 999997543211 11111 000 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
...++..++..+.+||.+||+.||++||++.+|++.|+.
T Consensus 590 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 590 ----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111122345789999999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=369.17 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=185.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3689999999999999999998765 678999999965432 23456889999999999999999999987
Q ss_pred eC------CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 ED------DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~------~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
.. ...|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEE
Confidence 54 5679999999 7899998854 46999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||+++..... .+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875432 234679999999999876 6899999999999999999999999976543211111100000
Q ss_pred h--------hh--cccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 H--------LG--ERRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~--------~~--~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
. +. ....+...+.......+ ....+..+.+||.+||+.||.+|||+.|++++-
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0 00 00000000000000000 001245789999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=350.37 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=204.8
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---------cCHHHHHHHHHHHhcCC-CCC
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGDLV-HLN 197 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-Hpn 197 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|++++.++. |||
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 85 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 34689999999999999999998865 677999999975431 11245789999999995 999
Q ss_pred ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 198 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
|+++++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM 161 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence 999999999999999999999999999999654 46899999999999999999999988 99999999999999999
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceec------cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVM------TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
.+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|||++|..||......
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 235 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--- 235 (298)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---
Confidence 999999999987654322 23457999999999885 457899999999999999999999999653221
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... ...... ....+ .. ...+..+.+|+.+||+.||.+||++.|++++-
T Consensus 236 ~~~~~---~~~~~~---~~~~~-~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 236 LMLRM---IMSGNY---QFGSP-EW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHHH---HHHTCC---CCCTT-TG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHH---HhcCCc---ccCcc-cc----cccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 11110 000000 00000 01 12346789999999999999999999998743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=364.24 Aligned_cols=271 Identities=18% Similarity=0.225 Sum_probs=204.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCcee--------
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVK-------- 200 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-------- 200 (487)
.++|++.+.||+|+||.||+|++...... .....++.||||++... ..+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 36899999999999999999998652110 00013678999999754 45789999999999999987
Q ss_pred -------EEEEEEe-CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcE
Q 011385 201 -------LIGYCIE-DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNI 271 (487)
Q Consensus 201 -------~~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NI 271 (487)
+++++.. +...||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 77889999999 99999999754 357999999999999999999999988 99999999999
Q ss_pred EEcCCC--cEEEeecCCCCCCCCCCcce-----eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCC
Q 011385 272 LLDADY--NAKLSDFGLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 344 (487)
Q Consensus 272 ll~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 344 (487)
||+.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|..||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998654322110 11335799999999999999999999999999999999999999975
Q ss_pred CCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 345 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
...... .+............ .+...... ....+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 271 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNTE-DIMKQKQKFVDKPG---PFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCHH-HHHHHHHHHHHSCC---CEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCHH-HHHHHHHhccCChh---hhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 432211 11111111111111 11110000 0012367899999999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=363.41 Aligned_cols=270 Identities=23% Similarity=0.287 Sum_probs=203.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|++++.||+|+||.||+|++.. ++..||||++...... ..+.+.+|+++|.+++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 3689999999999999999998765 5779999999754322 23568899999999999999999999876
Q ss_pred C-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 208 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 208 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
. ...|+||||++ |+|.+++... .+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEE
Confidence 5 36899999996 5999988553 5899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 283 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 283 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
|||+++........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+......
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999875432211 1123458999999999865 456899999999999999999999999765433222111100000
Q ss_pred -hhc---------cccc-ccccCCcc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 361 -LGE---------RRRF-YRLIDPRL--EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 361 -~~~---------~~~~-~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
..+ ...+ ........ ...+....+..+.+||.+||+.||.+|||+.|++++-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 000 0000 00000000 00000112457899999999999999999999998543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=356.86 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=198.7
Q ss_pred hhHHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCC--CCC
Q 011385 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLV--HLN 197 (487)
Q Consensus 122 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--Hpn 197 (487)
+..+.+..++|++.+.||+|+||.||+|.+. ++..||||++...... ....+.+|+.++.++. |+|
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 89 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTT
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCc
Confidence 3333455678999999999999999999864 3668999999754332 3456889999999997 599
Q ss_pred ceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC
Q 011385 198 LVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277 (487)
Q Consensus 198 Iv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~ 277 (487)
|+++++++.+.+..+|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++
T Consensus 90 iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~ 163 (313)
T 3cek_A 90 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DG 163 (313)
T ss_dssp BCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TT
T ss_pred eEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CC
Confidence 9999999999999999999 5588999999654 47899999999999999999999988 99999999999996 48
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc-----------CCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-----------~~~~~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 999999999987654333222334679999999999865 478899999999999999999999996432
Q ss_pred CCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. .. ... ..+++.....++...+..+.+|+.+||+.||.+||++.|++++.
T Consensus 244 ~~----~~-~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 244 NQ----IS-KLH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp SH----HH-HHH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HH----HH-HHH----------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 21 00 000 01111111112222246789999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=365.75 Aligned_cols=271 Identities=22% Similarity=0.313 Sum_probs=186.4
Q ss_pred cCCCC-CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe-
Q 011385 130 RNFRP-ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 207 (487)
Q Consensus 130 ~~y~~-~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 207 (487)
+.|++ .++||+|+||.||+|++... .++..||||++...... ..+.+|+.+|+.|+|||||++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 45666 45899999999999997642 14678999999765432 578899999999999999999999954
Q ss_pred -CCeeEEEEeeCCCCChhHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE----c
Q 011385 208 -DDQRLLVYEFMPRGSLENHLFRR--------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL----D 274 (487)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll----~ 274 (487)
....||||||+. |+|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 678999999996 5888877522 224899999999999999999999988 9999999999999 6
Q ss_pred CCCcEEEeecCCCCCCCCCCc-ceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc--
Q 011385 275 ADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 350 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-- 350 (487)
.++.+||+|||+++....... .......+||+.|+|||++.+ ..|+.++||||||||||||++|..||........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 779999999999987643211 112334689999999999887 4599999999999999999999999975543210
Q ss_pred ----chhhHhhhhhhhc-----cccc---------ccccCCccCCCCC---------HHHHHHHHHHHHHhcccCCCCCC
Q 011385 351 ----HNLVEWARPHLGE-----RRRF---------YRLIDPRLEGHFS---------IKGAQKAAQLAAHCLSRDPKARP 403 (487)
Q Consensus 351 ----~~~~~~~~~~~~~-----~~~~---------~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RP 403 (487)
.+.+......++. ...+ ...+......... ...+..+.+||.+||+.||.+||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 0110000000000 0000 0000000000000 00135688999999999999999
Q ss_pred CHHHHHHHhc
Q 011385 404 LMSEVVEALK 413 (487)
Q Consensus 404 s~~ell~~L~ 413 (487)
|+.|+|++-.
T Consensus 327 ta~e~L~hp~ 336 (405)
T 3rgf_A 327 TSEQAMQDPY 336 (405)
T ss_dssp CHHHHHTSGG
T ss_pred CHHHHhcChh
Confidence 9999998754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=360.95 Aligned_cols=261 Identities=20% Similarity=0.345 Sum_probs=201.9
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIG 203 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~ 203 (487)
.+..++|++.+.||+|+||.||+|.+.. .||+|+++.... ...+.+.+|+.+++.++||||+++++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 3456789999999999999999998743 499999865432 22345778999999999999999999
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
++.+.+..++||||+++++|.+++......+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECC
T ss_pred EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEee
Confidence 999999999999999999999999776667999999999999999999999988 99999999999998 68999999
Q ss_pred cCCCCCCCCCCc---ceeeeeccccccccCCceecc---------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 284 FGLAKDGPEGDK---THVSTRVMGTYGYAAPEYVMT---------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 284 FGla~~~~~~~~---~~~~~~~~Gt~~y~APE~~~~---------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
||+++....... ........||+.|+|||++.. ..++.++|||||||++|||++|..||......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--- 249 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--- 249 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 999876432111 111223569999999998864 45789999999999999999999999654321
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCCCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNL 418 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~~~ 418 (487)
..... ... ...+.+.. ...+..+.+|+.+||..||.+||++.++++.|+.+...
T Consensus 250 ~~~~~----~~~------~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 AIIWQ----MGT------GMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHH----HHT------TCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHH----hcc------CCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11100 000 00111110 01234688999999999999999999999999988654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=369.33 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=193.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
.+|++.++||+|+||+||+|++.. +..||+|++...... ..+|+++|+.++|||||++++++....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 578999999999999999998864 234888888554322 237999999999999999999986543
Q ss_pred ------eeEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcE
Q 011385 210 ------QRLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNA 279 (487)
Q Consensus 210 ------~~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~~ 279 (487)
.++||||||+++ |.+.+. .....+++..++.++.||+.||.|||+.+ |+||||||+||||+ .++.+
T Consensus 106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcE
Confidence 378999999764 443332 23567999999999999999999999988 99999999999999 78999
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA 357 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~ 357 (487)
||+|||+++....... .....||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.........+ ...
T Consensus 182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999987644332 2345789999999988764 5999999999999999999999999765322111100 000
Q ss_pred h-h------hhhcc---cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 R-P------HLGER---RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~-~------~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. + ..... ..+.......+...+....+..+.+||.+||+.||.+||++.|++++
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 0 00000 00000000011111222234689999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=360.81 Aligned_cols=265 Identities=19% Similarity=0.260 Sum_probs=204.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-----------------HHHHHHHHHHH
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFL 190 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l 190 (487)
..++|++.+.||+|+||.||+|.+ +|..||||++....... ...+.+|+.++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 97 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHH
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHH
Confidence 346899999999999999999987 36799999986432211 17789999999
Q ss_pred hcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHH------Hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeE
Q 011385 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENH------LFRR-SLPLPWSIRMKIALGAAKGLAFLHE-EAERPVI 262 (487)
Q Consensus 191 ~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~ii 262 (487)
..++||||+++++++.+.+..++||||+++|+|.++ +... ...+++..++.++.||+.||.|||+ .+ |+
T Consensus 98 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~ 174 (348)
T 2pml_X 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---IC 174 (348)
T ss_dssp TTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Ee
Confidence 999999999999999999999999999999999998 5432 5679999999999999999999998 77 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCc-hhhhhhHHHHHHHHHhCCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTS-RSDVYSFGVVLLEMLTGRR 340 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~-~~DiwSlGvil~elltG~~ 340 (487)
||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999875432 23446799999999999877 6766 9999999999999999999
Q ss_pred CCCCCCCCCcchhhHhhhhhhhcc----cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 341 SMDKNRPNGEHNLVEWARPHLGER----RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 341 pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
||...... .............. ..+................+..+.+|+.+||+.||.+||++.|++++-
T Consensus 251 pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 251 PFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp SSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 99765431 11111111000000 000000000000001122346789999999999999999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.51 Aligned_cols=257 Identities=26% Similarity=0.349 Sum_probs=181.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHH-HHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVN-FLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +|+.||||++...... ...++..|+. +++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 34689999999999999999998865 5779999999765322 2344566666 77888999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEE
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFR----RSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
.+.+..+|||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+|
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 91 FREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp ECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEE
T ss_pred EeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEE
Confidence 999999999999975 88877752 246789999999999999999999997 7 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCcee----ccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----MTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~----~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
|+|||+++...... ......||+.|+|||++ .+..++.++|||||||++|||++|..||........ .
T Consensus 167 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~ 238 (327)
T 3aln_A 167 LCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q 238 (327)
T ss_dssp ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred EccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H
Confidence 99999998764332 12334799999999998 466789999999999999999999999975322110 0
Q ss_pred hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. .......+.+........+..+.+|+.+||+.||.+||++.+|+++.
T Consensus 239 ~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 239 LT-------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp -C-------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred HH-------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 00 00000111111111112346789999999999999999999998743
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=358.10 Aligned_cols=269 Identities=26% Similarity=0.335 Sum_probs=190.2
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
...++|++.+.||+|+||.||+|++.. +|..||||++...... ...+.+|++.+..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp HHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 455789999999999999999999865 5779999998654322 245678888999999999999999987
Q ss_pred eCCe-------eEEEEeeCCCCChhHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCcEEEc
Q 011385 207 EDDQ-------RLLVYEFMPRGSLENHLF---RRSLPLPWSIRMKIALGAAKGLAFLH--EEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 207 ~~~~-------~~lv~E~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~l~yLH--~~~~~~iiHrDLKp~NIll~ 274 (487)
.... .+|||||+++ +|.+.+. .....+++..++.++.||+.||.||| +.+ |+||||||+||||+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVN 165 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEE
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEe
Confidence 6443 7899999976 5555443 34567899999999999999999999 777 99999999999999
Q ss_pred C-CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 275 A-DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 275 ~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||..........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 7 89999999999987654332 2345799999999988655 48999999999999999999999997643221111
Q ss_pred hhHhhh--------hhhhcccccccccCC------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 353 LVEWAR--------PHLGERRRFYRLIDP------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 353 ~~~~~~--------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+.... ..+..........+. ..........+..+.+||.+||+.||.+|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 110000 000000000000000 000111122457899999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=385.87 Aligned_cols=262 Identities=24% Similarity=0.369 Sum_probs=208.2
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+..++|++.+.||+|+||.||+|.+...+. .+..||||.+...... ..+.+.+|+.+|+.++||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3445789999999999999999999865322 4568999998754332 23568899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+. ++..||||||+++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 85 56789999999999999999877667999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
|+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+..... .
T Consensus 536 G~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~----~ 607 (656)
T 2j0j_A 536 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE----N 607 (656)
T ss_dssp CCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----H
T ss_pred CCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----c
Confidence 999876543221 2233567889999999999999999999999999999997 99999754321 1111110 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .... ++..++..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 608 ~------~~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 608 G------ERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp T------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C------CCCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0011 1122346789999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.96 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=204.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC------CceeE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL------NLVKL 201 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~~ 201 (487)
..++|++.+.||+|+||.||+|.+.. .++..||||+++... .....+.+|++++..++|+ +|+++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 45689999999999999999998742 156799999996542 2235688899999988765 49999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA----- 275 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~----- 275 (487)
++++.+.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEE
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccc
Confidence 99999999999999999 889999997553 46899999999999999999999988 999999999999987
Q ss_pred --------------CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCC
Q 011385 276 --------------DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 276 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 341 (487)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 678999999999875432 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhhc-------ccccc------------------cccCCc-cCCCCCHHHHHHHHHHHHHhc
Q 011385 342 MDKNRPNGEHNLVEWARPHLGE-------RRRFY------------------RLIDPR-LEGHFSIKGAQKAAQLAAHCL 395 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~-------~~~~~------------------~~~~~~-~~~~~~~~~~~~l~~li~~cl 395 (487)
|..................... ..... ....+. .........+..+.+||.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 9764332111111100000000 00000 000000 001122345678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 011385 396 SRDPKARPLMSEVVEA 411 (487)
Q Consensus 396 ~~dP~~RPs~~ell~~ 411 (487)
+.||.+|||+.|++++
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=357.97 Aligned_cols=268 Identities=25% Similarity=0.291 Sum_probs=199.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999998865 577999999964432 223567899999999999999999998876
Q ss_pred C-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 208 D-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 208 ~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
. ...++||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 4 67899999996 699998865 36899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcce--------eeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 283 DFGLAKDGPEGDKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 283 DFGla~~~~~~~~~~--------~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
|||+++......... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998754322110 1223578999999998764 7899999999999999999999999976432111000
Q ss_pred hHhhhhhh--------------hcc-cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 354 VEWARPHL--------------GER-RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 354 ~~~~~~~~--------------~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
+....... .+. ..+.......+. ......+..+.+||.+||+.||.+||++.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00000000 000 000000000000 00012346788999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=351.92 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=195.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE--
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI-- 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-- 206 (487)
.++|++.+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4689999999999999999998865 57799999997665555577899999999999999999999874
Q ss_pred ------------eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 207 ------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 207 ------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
+....++||||++ |+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 3467899999997 699998853 46899999999999999999999988 99999999999997
Q ss_pred -CCCcEEEeecCCCCCCCCCCc-ceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011385 275 -ADYNAKLSDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351 (487)
Q Consensus 275 -~~~~~kl~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 351 (487)
.++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567999999999987543211 111233568999999998865 68999999999999999999999999765321111
Q ss_pred hhhHhhhhhh--hcccccccc--------c-CCcc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 352 NLVEWARPHL--GERRRFYRL--------I-DPRL-EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 352 ~~~~~~~~~~--~~~~~~~~~--------~-~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+....+.. .....+... . .+.. ...+....+..+.+||.+||+.||.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1000000000 000000000 0 0000 000001124678999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.78 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=175.0
Q ss_pred hcCCCCCC-eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHH-HHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-NFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|.+.+ +||+|+||.||+|++.. +|+.||||++... ....+|+ ..+..+.||||+++++++.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence 46888854 69999999999999875 5779999999653 2233333 3456679999999999987
Q ss_pred e----CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011385 207 E----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 278 (487)
Q Consensus 207 ~----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 278 (487)
. ....+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCC
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCce
Confidence 6 455899999999999999997653 46999999999999999999999988 999999999999976 455
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 243 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-- 243 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--
Confidence 9999999998654322 2345789999999999888999999999999999999999999965433211100000
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... .... ...... ...+..+.+||.+||+.||.+||++.|++++-
T Consensus 244 -~~~~--~~~~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 244 -RIRL--GQYG-FPNPEW----SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ----------C-CCTTTS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred -hhhc--cccc-cCchhh----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000 0000 000011 12346789999999999999999999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=360.11 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=197.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 4689999999999999999998865 6789999999764332 2356889999999999999999999998
Q ss_pred eCCee------EEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~~~------~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
..+.. |+||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+|
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 77655 99999996 68888773 34899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR 358 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~ 358 (487)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.. ..
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999865332 234679999999999876 7899999999999999999999999976432111100000 00
Q ss_pred hh-------hhc--ccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 359 PH-------LGE--RRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 359 ~~-------~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.. +.. ...+...+....... +....+..+.+||.+||+.||.+||++.|++++-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00 000 000000000000000 0012246789999999999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=350.81 Aligned_cols=269 Identities=24% Similarity=0.325 Sum_probs=201.2
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC---CCCCceeEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDL---VHLNLVKLI 202 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~~~ 202 (487)
..++|++.+.||+|+||.||+|++.. .+|..||||++..... .....+.+|+.+++.+ .||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 45789999999999999999998842 1467899999864322 1123466777777666 899999999
Q ss_pred EEEE-----eCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC
Q 011385 203 GYCI-----EDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD 276 (487)
Q Consensus 203 ~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~ 276 (487)
+++. .....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS 156 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence 9987 5567899999997 69999997653 45899999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh-H
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E 355 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~-~ 355 (487)
+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+ .
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999998754321 223467999999999999999999999999999999999999999764321111000 0
Q ss_pred hhh-hhhhccc-------ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 356 WAR-PHLGERR-------RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 356 ~~~-~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... +...... .............+....+..+.+|+.+||+.||.+||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000000 0000000000111122334678999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=358.48 Aligned_cols=203 Identities=24% Similarity=0.284 Sum_probs=172.1
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CC-----Ccee
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HL-----NLVK 200 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~ 200 (487)
...++|++.+.||+|+||+||+|++.. +++.||||+++... ....++..|++++..+. |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 445789999999999999999998865 57799999997542 22355778888888875 44 4999
Q ss_pred EEEEEEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCC
Q 011385 201 LIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADY 277 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~--~~~ 277 (487)
+++++...+..||||||++ |+|.+++.... ..+++..+..++.||+.||.|||.+. .+||||||||+||||+ .++
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSC
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCC
Confidence 9999999999999999995 59999997653 56999999999999999999999532 3499999999999994 478
Q ss_pred cEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Q 011385 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346 (487)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 346 (487)
.+||+|||+++..... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||....
T Consensus 199 ~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999999876432 234579999999999999999999999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.99 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=202.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|++++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 34689999999999999999998865 56799999986443 23457789999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC---CcEEEe
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD---YNAKLS 282 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~---~~~kl~ 282 (487)
.+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~ 166 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence 9999999999999999999988654 46899999999999999999999988 9999999999999754 479999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .+..... .
T Consensus 167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~---~ 236 (287)
T 2wei_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVE---T 236 (287)
T ss_dssp STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---H
T ss_pred ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---c
Confidence 9999986543321 223568999999998765 5999999999999999999999999754321 1111100 0
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... .+...... .+..+.+|+.+||+.||.+||++.|++++
T Consensus 237 ~~~~----~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 GKYA----FDLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCC----CCSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCC----CCchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 00000111 23578999999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=358.27 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=201.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-----------CCC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLN 197 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpn 197 (487)
..+|++.+.||+|+||.||+|++.. +++.||||++.... .....+.+|+.++.++. |+|
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 4689999999999999999998765 57799999997542 22356789999999886 899
Q ss_pred ceeEEEEEEeCC----eeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcE
Q 011385 198 LVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNI 271 (487)
Q Consensus 198 Iv~~~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NI 271 (487)
|+++++++...+ ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+. + |+||||||+||
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI 163 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV 163 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence 999999988654 789999999 88999999754 34599999999999999999999997 7 99999999999
Q ss_pred EEc------CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Q 011385 272 LLD------ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN 345 (487)
Q Consensus 272 ll~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 345 (487)
||+ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 3457999999999875432 23357999999999999999999999999999999999999999754
Q ss_pred CCCCcc---hhhHhhhhhhhc------------------ccccccccCC---------ccCCCCCHHHHHHHHHHHHHhc
Q 011385 346 RPNGEH---NLVEWARPHLGE------------------RRRFYRLIDP---------RLEGHFSIKGAQKAAQLAAHCL 395 (487)
Q Consensus 346 ~~~~~~---~~~~~~~~~~~~------------------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl 395 (487)
...... .........+.. ...+..+... .....++...+..+.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 422111 000000000000 0000000000 0012355677889999999999
Q ss_pred ccCCCCCCCHHHHHHHh
Q 011385 396 SRDPKARPLMSEVVEAL 412 (487)
Q Consensus 396 ~~dP~~RPs~~ell~~L 412 (487)
+.||.+|||+.||+++-
T Consensus 319 ~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHP 335 (373)
T ss_dssp CSSTTTCBCHHHHHTCG
T ss_pred ccCccccCCHHHHhhCh
Confidence 99999999999999854
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=352.50 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=197.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|.+.+.||+|+||.||+|++.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3689999999999999999998865 6789999999764332 2356889999999999999999999998
Q ss_pred eCCe------eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDDQ------RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~~------~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
..+. .|+||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEE
T ss_pred cccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEE
Confidence 7654 499999996 68888763 34899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.....
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999865332 234578999999998876 6889999999999999999999999976432111000000000
Q ss_pred --------hhhcc------cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 --------HLGER------RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 --------~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.+... ..+.......+ .......+..+.+||.+||+.||.+||++.+++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000 00000000001 111123356899999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.55 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=193.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC------HHHHHHHHHHHhcC----CCC
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG------HKEWLAEVNFLGDL----VHL 196 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~------~~~~~~E~~~l~~l----~Hp 196 (487)
...++|++.+.||+|+||.||+|++.. +++.||||++....... ...+.+|+.++.++ +||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 345789999999999999999998764 57799999997654321 22356799999888 899
Q ss_pred CceeEEEEEEeCCeeEEEEee-CCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-
Q 011385 197 NLVKLIGYCIEDDQRLLVYEF-MPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD- 274 (487)
Q Consensus 197 nIv~~~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~- 274 (487)
||+++++++.+.+..++|||| +.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 999999999999999999999 7899999999654 46999999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLT-SRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 353 (487)
.++.+||+|||+++...... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||.... ..
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~ 245 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI 245 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH
Confidence 88999999999998765432 2345799999999998877664 58999999999999999999995321 00
Q ss_pred hHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
. ... . .++...+..+.+||.+||+.||.+||++.|++++-.
T Consensus 246 ~-------~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 246 L-------EAE--------L----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp H-------HTC--------C----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred h-------hhc--------c----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0 000 0 011123467889999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=349.87 Aligned_cols=266 Identities=21% Similarity=0.262 Sum_probs=201.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC------ceeE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN------LVKL 201 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~~ 201 (487)
..++|++.+.||+|+||.||+|.+... .+..||||+++... .....+.+|+.+++.+.|++ |+.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 457899999999999999999988642 23689999997532 22356788999999987765 9999
Q ss_pred EEEEEeCCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEE-------
Q 011385 202 IGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL------- 273 (487)
Q Consensus 202 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll------- 273 (487)
++++...+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEE
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccc
Confidence 99999999999999999 667777776543 56999999999999999999999988 9999999999999
Q ss_pred ------------cCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCC
Q 011385 274 ------------DADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 274 ------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 341 (487)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 66789999999999865432 2335799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHhhhhhhhc-------cccc------------------ccccCCc-cCCCCCHHHHHHHHHHHHHhc
Q 011385 342 MDKNRPNGEHNLVEWARPHLGE-------RRRF------------------YRLIDPR-LEGHFSIKGAQKAAQLAAHCL 395 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~-------~~~~------------------~~~~~~~-~~~~~~~~~~~~l~~li~~cl 395 (487)
|...........+......... .... .....+. .........+..+.+||.+||
T Consensus 239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 9754322111111100000000 0000 0000000 000112234568899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 011385 396 SRDPKARPLMSEVVEA 411 (487)
Q Consensus 396 ~~dP~~RPs~~ell~~ 411 (487)
+.||.+|||+.|++++
T Consensus 319 ~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 319 EFDPAQRITLAEALLH 334 (355)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=349.74 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=201.3
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCC--CCCc
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNL 198 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnI 198 (487)
...++|++.+.||+|+||.||+|++.. +++.||||++...... ....+.+|+.++..+. |+||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 455789999999999999999998765 5779999999654322 1234678999999996 5999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCC-CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CC
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-AD 276 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~ 276 (487)
+++++++...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+ .+
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 9999999999999999999976 8999998654 46899999999999999999999988 99999999999999 78
Q ss_pred CcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011385 277 YNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355 (487)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~ 355 (487)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.... ..
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~-- 255 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-- 255 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH--
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh--
Confidence 999999999998765432 234579999999999887666 688999999999999999999995321 00
Q ss_pred hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
..... .+... .+..+.+||.+||+.||.+||++.+|+++-
T Consensus 256 -----~~~~~--------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 256 -----IRGQV--------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp -----HHCCC--------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -----hcccc--------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00000 01111 235788999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=342.17 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=183.1
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHH-HHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKE-WLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~-~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||.||+|.+.. +|+.||||++....... ..+ +..+..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 4688999999999999999999865 57799999997654322 222 445556788889999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+.+..+|||||+ ++.+..++......+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999 5566666555566799999999999999999999985 7 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
++....... ......||+.|+|||++. ...++.++|||||||++|||++|..||...... ...... .
T Consensus 171 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~---~ 242 (318)
T 2dyl_A 171 ISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTK---V 242 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH---H
T ss_pred CchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHH---H
Confidence 997654322 123457999999999984 567899999999999999999999999753221 111110 1
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
.... .+.+... ...+..+.+|+.+||+.||.+||++.+|+++-
T Consensus 243 ~~~~-------~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 243 LQEE-------PPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp HHSC-------CCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred hccC-------CCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 1110 0001100 01246789999999999999999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=355.89 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=188.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~ 208 (487)
+.|.+.++||+|+||+||.+... +|+.||||++.... .+.+.+|+++|.++ +|||||++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 45566789999999999865432 47799999986532 35678999999876 899999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC------
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLP------LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD------ 276 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~------l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~------ 276 (487)
+..|||||||. |+|.+++...... ..+..++.++.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence 99999999995 6999999654321 122345789999999999999988 9999999999999754
Q ss_pred -------CcEEEeecCCCCCCCCCCcce--eeeeccccccccCCceecc-------CCCCchhhhhhHHHHHHHHHh-CC
Q 011385 277 -------YNAKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSRSDVYSFGVVLLEMLT-GR 339 (487)
Q Consensus 277 -------~~~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~-------~~~~~~~DiwSlGvil~ellt-G~ 339 (487)
+.+||+|||+++......... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 489999999998765432211 1234679999999999865 678999999999999999999 99
Q ss_pred CCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 340 RSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 340 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.||....... ..+. ..... .+.+........+..+.+||.+||+.||.+||++.+|+++-.
T Consensus 238 ~Pf~~~~~~~-~~i~-------~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 238 HPFGDKYSRE-SNII-------RGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp CTTCSTTTHH-HHHH-------HTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCchhhH-HHHh-------cCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 9996432211 0110 00000 011111223456788999999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=356.79 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=189.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 207 (487)
..+|.+.++||+|+||+||..... +|+.||||++...... .+.+|+++|+.+ +|||||++++++.+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 457888999999999996543222 4678999999754432 356899999999 79999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----CCcEEEe
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 282 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-----~~~~kl~ 282 (487)
....|||||||. |+|.+++......+.+..++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 999999999995 6999999776655666667899999999999999988 999999999999943 2458899
Q ss_pred ecCCCCCCCCCCcc-eeeeeccccccccCCceec---cCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011385 283 DFGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM---TGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 283 DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~---~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 357 (487)
|||+++........ ......+||+.|+|||++. ...++.++|||||||++|||++ |..||...... .....
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~~ 241 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANIL 241 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHHH
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHHH
Confidence 99999876543211 1233467999999999987 4577889999999999999999 89998543211 00000
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ... .. .......+..+.+||.+||+.||.+||++.+|+++-
T Consensus 242 ---~~~-~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 242 ---LGA-CSL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp ---TTC-CCC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred ---hcc-CCc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 000 000 00 011123456788999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=368.83 Aligned_cols=258 Identities=27% Similarity=0.358 Sum_probs=198.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe-
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE- 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 207 (487)
++|++.+.||+|+||.||+|.+.. +|..||||++..... .....+.+|++++..++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 689999999999999999997754 577899999875432 234568899999999999999999998765
Q ss_pred -----CCeeEEEEeeCCCCChhHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc--
Q 011385 208 -----DDQRLLVYEFMPRGSLENHLFRRS--LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN-- 278 (487)
Q Consensus 208 -----~~~~~lv~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~-- 278 (487)
.+..+||||||++|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 677899999999999999996543 36889999999999999999999988 999999999999987765
Q ss_pred -EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 279 -AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 -~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...|.
T Consensus 162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~ 233 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH 233 (676)
T ss_dssp EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence 99999999987654332 2346799999999999999999999999999999999999999965311 01110
Q ss_pred hhh-------------hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 011385 358 RPH-------------LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV 409 (487)
Q Consensus 358 ~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell 409 (487)
... ......+... ......+....+..+.+||.+||..||.+||++.+++
T Consensus 234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000 0000000000 0112234455678899999999999999999997744
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.17 Aligned_cols=232 Identities=14% Similarity=0.090 Sum_probs=184.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
..++|++.+.||+|+||.||+|++.. +|+.||||++....... .+.+.+|+.++..++||||++++++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~ 99 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV 99 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence 34689999999999999999998865 57799999997664433 3568999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+.+..||||||++|++|.+++... .....+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+++
T Consensus 100 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 100 VHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence 99999999999999999999998432 355568889999999999999988 999999999999999999999854
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
| |++ .++.++|||||||+||||++|+.||............. ......
T Consensus 174 ~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~ 221 (286)
T 3uqc_A 174 A----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQ 221 (286)
T ss_dssp C----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSC
T ss_pred c----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccC
Confidence 3 333 37899999999999999999999998654432110000 000000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... ...+....+..+.+||.+||+.||.+| |+.|+++.|+.+
T Consensus 222 ~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 222 PIE--------PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp BCC--------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred CCC--------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 000 000111234678999999999999999 999999999754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=328.54 Aligned_cols=228 Identities=21% Similarity=0.278 Sum_probs=180.8
Q ss_pred cCCCCC-CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHH-hcCCCCCceeEEEEEEe
Q 011385 130 RNFRPE-SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~~~~~~~~ 207 (487)
++|.+. ++||+|+||.||+|.+.. +++.||||++... ..+.+|+.++ +.+.||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567776 789999999999998865 5779999999643 5678899988 56699999999999887
Q ss_pred ----CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCcE
Q 011385 208 ----DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYNA 279 (487)
Q Consensus 208 ----~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~~ 279 (487)
....+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence 677899999999999999997653 46999999999999999999999988 999999999999988 7889
Q ss_pred EEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 280 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
||+|||++.... +..|+.++|||||||++|||++|..||...........
T Consensus 160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~------ 209 (299)
T 3m2w_A 160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------ 209 (299)
T ss_dssp EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC------
T ss_pred EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH------
Confidence 999999986432 24578899999999999999999999965432211000
Q ss_pred hhhcccccccccCCccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 360 HLGERRRFYRLIDPRLEGHFS----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
... ..... ...++ ...+..+.+|+.+||+.||.+||++.|++++.
T Consensus 210 -~~~-----~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 210 -MKT-----RIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp -SCC-----SSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -HHH-----HHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 000 00000 00011 11246789999999999999999999999854
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=365.27 Aligned_cols=240 Identities=25% Similarity=0.396 Sum_probs=191.5
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||.||+|++... +|+.||||++..... .....+.+|+++|.+++|||||++++++.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 347899999999999999999988641 467899999865432 23356889999999999999999999998
Q ss_pred eCCe-----eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 207 EDDQ-----RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 207 ~~~~-----~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
..+. .||||||+++++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence 7665 7999999999999987743 6999999999999999999999988 9999999999999875 9999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||........
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------- 284 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------- 284 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence 999999876432 335799999999988764 58999999999999999999988754211100
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhc
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEALK 413 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~ 413 (487)
. ........+..+.+||.+||+.||.+||+ +.++.+.|.
T Consensus 285 ----------~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 ----------P---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ----------C---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------c---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00001123457889999999999999996 455555443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=347.21 Aligned_cols=241 Identities=19% Similarity=0.205 Sum_probs=182.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCC-CCc-------
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGDLVH-LNL------- 198 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H-pnI------- 198 (487)
..|...++||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+.++..+.| .|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457788899999999999999865 5779999999743322 24678999999999987 221
Q ss_pred --e------------eEEEEEEe-----CCeeEEEEeeCCCCChhHHHh------hcCCCCCHHHHHHHHHHHHHHHHHH
Q 011385 199 --V------------KLIGYCIE-----DDQRLLVYEFMPRGSLENHLF------RRSLPLPWSIRMKIALGAAKGLAFL 253 (487)
Q Consensus 199 --v------------~~~~~~~~-----~~~~~lv~E~~~~gsL~~~l~------~~~~~l~~~~~~~i~~qi~~~l~yL 253 (487)
+ .++.++.. ...++++|+++ +++|.+++. .....+++..++.|+.||+.||.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 11111111 22457778876 679999884 2234577889999999999999999
Q ss_pred HhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCcee----------ccCCCCchh
Q 011385 254 HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYV----------MTGHLTSRS 323 (487)
Q Consensus 254 H~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~----------~~~~~~~~~ 323 (487)
|+++ ||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....|+.++
T Consensus 228 H~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 9988 999999999999999999999999998864321 344678 999999998 555688999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 011385 324 DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403 (487)
Q Consensus 324 DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 403 (487)
|||||||+||||++|+.||.......... .++.. ...+ +..+.+||.+||+.||.+||
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS--CKNI----PQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS--CCCC----CHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh--cccC----CHHHHHHHHHHccCChhhCc
Confidence 99999999999999999997543221111 01110 0112 36789999999999999999
Q ss_pred CHHHHHHH
Q 011385 404 LMSEVVEA 411 (487)
Q Consensus 404 s~~ell~~ 411 (487)
++.+++++
T Consensus 357 t~~~~l~~ 364 (413)
T 3dzo_A 357 LPLQAMET 364 (413)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 99998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=340.04 Aligned_cols=244 Identities=16% Similarity=0.152 Sum_probs=186.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--------cCHHHHHHHHHHHhcCC------
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGDLV------ 194 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 194 (487)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ...+.+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 46789999999999999999987 367999999975532 23467889999998885
Q ss_pred ---CCCceeEEEEEE------------------------------eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHH
Q 011385 195 ---HLNLVKLIGYCI------------------------------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 241 (487)
Q Consensus 195 ---HpnIv~~~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~ 241 (487)
|||||++++++. +.+..|||||||++|+|.+.+.+ ..+++..++.
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~ 165 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKS 165 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHH
Confidence 888888887653 26789999999999977776643 4689999999
Q ss_pred HHHHHHHHHHHHH-hCCCCCeEecCCCCCcEEEcCCC--------------------cEEEeecCCCCCCCCCCcceeee
Q 011385 242 IALGAAKGLAFLH-EEAERPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDGPEGDKTHVST 300 (487)
Q Consensus 242 i~~qi~~~l~yLH-~~~~~~iiHrDLKp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~ 300 (487)
|+.||+.||.||| +.+ ||||||||+||||+.++ .+||+|||+++.....
T Consensus 166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 9999999999999 888 99999999999999887 8999999999865431
Q ss_pred eccccccccCCceeccCCCCchhhhhhHHHH-HHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCC
Q 011385 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHF 379 (487)
Q Consensus 301 ~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvi-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (487)
..+||+.|||||++.+.. +.++||||||++ .+++++|..||... .........+.... ..........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~----~~~~~~~~~~ 304 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQM----TFKTKCNTPA 304 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTC----CCSSCCCSHH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhh----ccCcccchhh
Confidence 247999999999988666 899999998777 78888899988320 00000000000000 0011111112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 011385 380 SIKGAQKAAQLAAHCLSRDPKARPLMSEVV-EA 411 (487)
Q Consensus 380 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell-~~ 411 (487)
....+..+.+||.+||+.| |+.|++ ++
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 3456788999999999977 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.35 Aligned_cols=169 Identities=19% Similarity=0.158 Sum_probs=127.7
Q ss_pred CCcEEEEEEecCCCcc----------CHHHHHHHHHHHhcC-CCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcC
Q 011385 163 TGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS 231 (487)
Q Consensus 163 ~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~ 231 (487)
.|+.||||++...... ..++|.+|+++|+++ .|+||++++++++++...|||||||+|++|.++|.+.
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~- 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG- 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence 6789999999755321 134689999999999 7999999999999999999999999999999999654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCC
Q 011385 232 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311 (487)
Q Consensus 232 ~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~AP 311 (487)
.+++.. .|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+....... .....+||+.||||
T Consensus 337 ~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAP 408 (569)
T 4azs_A 337 EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVN 408 (569)
T ss_dssp CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccH
Confidence 567654 47899999999999998 99999999999999999999999999987654322 23457899999999
Q ss_pred ceeccCCCCchhhhhhHHHHHHHHHhCCCC
Q 011385 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRS 341 (487)
Q Consensus 312 E~~~~~~~~~~~DiwSlGvil~elltG~~p 341 (487)
|++.+ .+..++|+|++|+++++|.++..+
T Consensus 409 E~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 409 ELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHC------------------CCCCTTHHH
T ss_pred HHhCC-CCCCcccccccccchhhhccccch
Confidence 98865 577889999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=275.75 Aligned_cols=185 Identities=18% Similarity=0.233 Sum_probs=145.4
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--------HKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
...++||+|+||.||+|.. .+..+|+|+........ .+.+.+|+++|++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 4456899999999999954 35689999875433221 2347899999999999999966555
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+...+..|||||||++++|.+++.. ++.|+.||+.||.|||+++ |+||||||+|||++. .+||+||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEEC
Confidence 5677888999999999999999854 5689999999999999988 999999999999998 9999999
Q ss_pred CCCCCCCCCCcce-----eeeeccccccccCCceecc--CCCCchhhhhhHHHHHHHHHhCCCCC
Q 011385 285 GLAKDGPEGDKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSRSDVYSFGVVLLEMLTGRRSM 342 (487)
Q Consensus 285 Gla~~~~~~~~~~-----~~~~~~Gt~~y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf 342 (487)
|+++......... .....+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999875432111 1235789999999999986 67888999999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-26 Score=223.45 Aligned_cols=159 Identities=14% Similarity=0.080 Sum_probs=122.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------------------CHHHHHHHHHH
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNF 189 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~ 189 (487)
....|.+.+.||+|+||.||+|.+ . +|..||||+++..... ....+.+|+.+
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred CCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 345677779999999999999988 3 5779999999643221 13458899999
Q ss_pred HhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 190 l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
|..++| +++++++.. +..|+|||||+||+|.+ +.. .....++.||+.||.|||+.+ |+||||||+
T Consensus 158 l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 158 LQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp HHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 999984 555554433 55699999999999988 421 224579999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceecc----------CCCCchhhhhh
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT----------GHLTSRSDVYS 327 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~----------~~~~~~~DiwS 327 (487)
||||+ ++.+||+|||+++. +..|+|||++.. ..|+..+|+|.
T Consensus 223 NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99999 99999999999863 345789998753 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-22 Score=192.93 Aligned_cols=137 Identities=18% Similarity=0.049 Sum_probs=105.8
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcE--EEEEEecCCCccC------------------------HHHHHH
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT--VAVKTLNHDGLQG------------------------HKEWLA 185 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~--vavK~~~~~~~~~------------------------~~~~~~ 185 (487)
|.+.+.||+|+||.||+|.+.. +|.. ||||+++...... ...+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 6678899999999999998843 4678 9999975432110 125789
Q ss_pred HHHHHhcCCCCCc--eeEEEEEEeCCeeEEEEeeCCC-C----ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q 011385 186 EVNFLGDLVHLNL--VKLIGYCIEDDQRLLVYEFMPR-G----SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLH-EEA 257 (487)
Q Consensus 186 E~~~l~~l~HpnI--v~~~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~ 257 (487)
|+.+|..|.|++| ..++++ +..+|||||+.+ | +|.+++.. .++..+..++.||+.+|.||| +.+
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999988764 444443 356899999942 4 67665432 224457789999999999999 887
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCCCC
Q 011385 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290 (487)
Q Consensus 258 ~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~ 290 (487)
||||||||+|||++. .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.9e-19 Score=178.35 Aligned_cols=136 Identities=15% Similarity=0.126 Sum_probs=99.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-----c---------CHHH--------HHHHHH
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-----Q---------GHKE--------WLAEVN 188 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-----~---------~~~~--------~~~E~~ 188 (487)
-|++.+.||+|+||.||+|... +|+.||||+++.... . .... ..+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 3899999999999999999864 477999999753211 0 0111 235677
Q ss_pred HHhcCCCCCce--eEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 011385 189 FLGDLVHLNLV--KLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDF 266 (487)
Q Consensus 189 ~l~~l~HpnIv--~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDL 266 (487)
.|.+|.+.++. ..+++ . ..+|||||++|+.|.++.. .+ ....++.||+.+|.|||..+ ||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~-----~~--~~~~l~~qll~~l~~lH~~g---IVHrDL 231 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS-----VP--DPASLYADLIALILRLAKHG---LIHGDF 231 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC-----CS--CHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcc-----cH--HHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 77777554432 23332 1 2379999999988876432 11 23567899999999999988 999999
Q ss_pred CCCcEEEcCCC----------cEEEeecCCCCCC
Q 011385 267 KTSNILLDADY----------NAKLSDFGLAKDG 290 (487)
Q Consensus 267 Kp~NIll~~~~----------~~kl~DFGla~~~ 290 (487)
||.||||++++ .+.|+||+-+...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 99999998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.5e-13 Score=131.38 Aligned_cols=143 Identities=15% Similarity=-0.001 Sum_probs=110.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~ 207 (487)
...|++...++.|+++.||++.. .+..+++|+...........+.+|+.+|+.|. |..+.++++++.+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 35688888899999999999864 24589999986432122245889999999884 6778899999998
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------ 257 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------ 257 (487)
.+..|+||||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 889999999999999987531 11223467889999999999821
Q ss_pred --------------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 258 --------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 258 --------------------------~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=4.9e-12 Score=120.22 Aligned_cols=137 Identities=17% Similarity=0.042 Sum_probs=98.5
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEEEEeC
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGYCIED 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~~~~~ 208 (487)
.|.+..+.+.|..+.||++... +|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3444333345666999998642 35579999976542 245778999999886545 45688888888
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 257 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------- 257 (487)
+..++||||++|.+|. .. ... ...++.+++..|..||...
T Consensus 88 ~~~~~v~e~i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 8899999999998884 21 112 2256777888888888743
Q ss_pred ------------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 258 ------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 258 ------------------------~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
+..++|+||+|.|||++.++.+.|+|||.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776667999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.4e-11 Score=121.75 Aligned_cols=142 Identities=15% Similarity=0.195 Sum_probs=105.8
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEec--CCCc-cCHHHHHHHHHHHhcCC--CCCceeEEEEEEeC
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN--HDGL-QGHKEWLAEVNFLGDLV--HLNLVKLIGYCIED 208 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--HpnIv~~~~~~~~~ 208 (487)
.++.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 3567899999999998753 3478888876 3321 22346788999999987 45678899888776
Q ss_pred ---CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 011385 209 ---DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------- 257 (487)
Q Consensus 209 ---~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~---------------------------- 257 (487)
+..|+||||++|..|.+.. -..++...+..++.+++..|..||...
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 4479999999998875421 134678888899999999999999731
Q ss_pred ---------------------------CCCeEecCCCCCcEEEcCCCc--EEEeecCCCCC
Q 011385 258 ---------------------------ERPVIYRDFKTSNILLDADYN--AKLSDFGLAKD 289 (487)
Q Consensus 258 ---------------------------~~~iiHrDLKp~NIll~~~~~--~kl~DFGla~~ 289 (487)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987753 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3.5e-11 Score=117.66 Aligned_cols=183 Identities=19% Similarity=0.205 Sum_probs=121.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCC--ceeEEEEEEeCC--
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLN--LVKLIGYCIEDD-- 209 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~~~~~~~~~~-- 209 (487)
++.|+.|.+..||++. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 4679999999999852 25889986533 22356889999998873 333 345555443333
Q ss_pred -eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 011385 210 -QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------- 257 (487)
Q Consensus 210 -~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------- 257 (487)
..|+|||+++|..|..... ..++...+..++.+++..|..||+..
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3479999999988875432 24667777888888888888888621
Q ss_pred ------------------------CCCeEecCCCCCcEEEcC--CCcEEEeecCCCCCCCCCCcceeeeeccccccc---
Q 011385 258 ------------------------ERPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY--- 308 (487)
Q Consensus 258 ------------------------~~~iiHrDLKp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y--- 308 (487)
...++|+|++|.|||++. ...+.|+||+.+........ ......+
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~ 239 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEE 239 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTS
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccc
Confidence 124899999999999988 45678999998865322100 0001111
Q ss_pred cCCceecc-----C---------CCCchhhhhhHHHHHHHHHhCCCCC
Q 011385 309 AAPEYVMT-----G---------HLTSRSDVYSFGVVLLEMLTGRRSM 342 (487)
Q Consensus 309 ~APE~~~~-----~---------~~~~~~DiwSlGvil~elltG~~pf 342 (487)
..|+.... + ......+.|++|.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221110 0 1122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=1.8e-07 Score=89.27 Aligned_cols=136 Identities=17% Similarity=0.081 Sum_probs=94.4
Q ss_pred eecccCce-eEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEeCCeeEEE
Q 011385 137 LLGEGGFG-CVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLV 214 (487)
Q Consensus 137 ~LG~G~fg-~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~~~~~lv 214 (487)
.+..|..| .||+..... .+..+++|+-... ...++.+|+.+|+.|. +--+.++++++.+.+..|+|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 45556555 689876543 3456889986543 2356788999998884 33467888999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 011385 215 YEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------------- 257 (487)
Q Consensus 215 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------------- 257 (487)
||+++|.++.+..... ......+..+++..|.-||...
T Consensus 99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999998887654321 1122345556666666666421
Q ss_pred ------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 258 ------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 258 ------------------~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
+..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999877777999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.5e-07 Score=90.30 Aligned_cols=136 Identities=21% Similarity=0.154 Sum_probs=93.8
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC---CceeEEEEEE-eCCe
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHL---NLVKLIGYCI-EDDQ 210 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~~~~~~~-~~~~ 210 (487)
++.++.|....||+. |..+++|+.... .....+.+|+++|..|.+. .+.+++.++. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 456888988999987 225888885321 2235688999999999752 3556676664 4456
Q ss_pred eEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 011385 211 RLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------------- 257 (487)
Q Consensus 211 ~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--------------------------------- 257 (487)
.|+||||++|..|...... .++......++.+++..|..||+..
T Consensus 88 ~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 7899999999888763211 2344455555555666555555432
Q ss_pred ------------------------CCCeEecCCCCCcEEEcC---CCcE-EEeecCCCCC
Q 011385 258 ------------------------ERPVIYRDFKTSNILLDA---DYNA-KLSDFGLAKD 289 (487)
Q Consensus 258 ------------------------~~~iiHrDLKp~NIll~~---~~~~-kl~DFGla~~ 289 (487)
+..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999987 4554 8999998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.6e-07 Score=93.47 Aligned_cols=87 Identities=3% Similarity=-0.100 Sum_probs=55.1
Q ss_pred CCee-cccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCC---CCceeEEEEEEe
Q 011385 135 ESLL-GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVH---LNLVKLIGYCIE 207 (487)
Q Consensus 135 ~~~L-G~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H---pnIv~~~~~~~~ 207 (487)
.+.| +.|....+|+........ ....+..+++|+..... ......+.+|+.+|+.|.. ..+.+++.++.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~---~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQD---GRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEET---TEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEecccC---CCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3567 888889999876530000 00014578899875432 1112356788888888742 346778887765
Q ss_pred C---CeeEEEEeeCCCCChh
Q 011385 208 D---DQRLLVYEFMPRGSLE 224 (487)
Q Consensus 208 ~---~~~~lv~E~~~~gsL~ 224 (487)
. ...|+||||++|..|.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999987664
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=9.3e-07 Score=89.38 Aligned_cols=76 Identities=13% Similarity=0.063 Sum_probs=49.4
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-------cCHHHHHHHHHHHhcCCC--CC-ceeEEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGDLVH--LN-LVKLIGY 204 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--pn-Iv~~~~~ 204 (487)
.+.||.|.++.||++.... .+..|+||....... .....+..|+++|..+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4579999999999996542 345799998643211 122456788888887742 33 4455543
Q ss_pred EEeCCeeEEEEeeCCCC
Q 011385 205 CIEDDQRLLVYEFMPRG 221 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~g 221 (487)
+.+..+|||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=3.3e-06 Score=83.04 Aligned_cols=139 Identities=16% Similarity=0.206 Sum_probs=79.0
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC--CCceeEEE------EEEe
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIG------YCIE 207 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~------~~~~ 207 (487)
+.|+.|..+.||++... +..+++|+.... ..++..|+.++..|.. -.+.+++. +...
T Consensus 38 ~~l~gG~~n~~~~v~~~-----------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~ 102 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-----------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH 102 (346)
T ss_dssp EECC----CEEEEEEET-----------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred eeccccccCcEEEEEeC-----------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence 45666778999998653 235899998752 2444556666655531 12333332 1234
Q ss_pred CCeeEEEEeeCCCCChh-----------HHH---hh--cCC--C---------CCHHHH---------------------
Q 011385 208 DDQRLLVYEFMPRGSLE-----------NHL---FR--RSL--P---------LPWSIR--------------------- 239 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~-----------~~l---~~--~~~--~---------l~~~~~--------------------- 239 (487)
.+..++||||++|..+. ..| .. ... + ..|...
T Consensus 103 ~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 182 (346)
T 2q83_A 103 GSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKED 182 (346)
T ss_dssp TTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred CCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCC
Confidence 66789999999986542 011 11 100 0 112110
Q ss_pred ----------HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 240 ----------MKIALGAAKGLAFLHE----------EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 240 ----------~~i~~qi~~~l~yLH~----------~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..+..++..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 183 PFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666653 0234599999999999998888999999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.10 E-value=2.3e-05 Score=76.47 Aligned_cols=75 Identities=19% Similarity=0.122 Sum_probs=58.7
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCceeEEEEEEeCCee
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV---HLNLVKLIGYCIEDDQR 211 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~~~~~~~~~~~~ 211 (487)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|+..|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 45789999999999864 2447889987543 2456888999998884 35688899888888889
Q ss_pred EEEEeeCCCCCh
Q 011385 212 LLVYEFMPRGSL 223 (487)
Q Consensus 212 ~lv~E~~~~gsL 223 (487)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.6e-05 Score=79.45 Aligned_cols=76 Identities=14% Similarity=0.186 Sum_probs=47.0
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccc--cccccCCceeccC---CCCchhhhhhHHHHHH
Q 011385 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG--TYGYAAPEYVMTG---HLTSRSDVYSFGVVLL 333 (487)
Q Consensus 259 ~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G--t~~y~APE~~~~~---~~~~~~DiwSlGvil~ 333 (487)
..++|+||+|.|||++.++ ++|+||+.+......-. . ....+ ...|++|+..... .-....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4499999999999998776 99999999875322100 0 00111 1346666644311 1122345567888888
Q ss_pred HHHhC
Q 011385 334 EMLTG 338 (487)
Q Consensus 334 elltG 338 (487)
+++++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.85 E-value=7.1e-05 Score=71.93 Aligned_cols=80 Identities=19% Similarity=0.138 Sum_probs=56.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC---CCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH---LNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~~~~~~~ 206 (487)
....-++.+|.|..+.||+.... +|+.|+||+...........|..|+..|+.|.- --+.+++++.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred CCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence 34445677999999999999875 477899998765544434567889999988842 2345555542
Q ss_pred eCCeeEEEEeeCCCCCh
Q 011385 207 EDDQRLLVYEFMPRGSL 223 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL 223 (487)
.-++||||++++..
T Consensus 84 ---~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 ---DRTLAMEWVDERPP 97 (288)
T ss_dssp ---TTEEEEECCCCCCC
T ss_pred ---CceEEEEeecccCC
Confidence 23789999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=9.9e-05 Score=71.92 Aligned_cols=140 Identities=13% Similarity=0.106 Sum_probs=76.5
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEE------EEe
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY------CIE 207 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~------~~~ 207 (487)
+.|+.|....||+..... | .+++|+..... ....+..|+.++..|...+ +.+++.. ...
T Consensus 28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred eccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 457778889999986532 2 58899886531 1134566777777663212 2233211 123
Q ss_pred CCeeEEEEeeCCCCChhH-----------H---Hhhc--C--CC----CC---HHHHHH------------HHHHHHHHH
Q 011385 208 DDQRLLVYEFMPRGSLEN-----------H---LFRR--S--LP----LP---WSIRMK------------IALGAAKGL 250 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~-----------~---l~~~--~--~~----l~---~~~~~~------------i~~qi~~~l 250 (487)
.+..++||+|++|..+.. . +... . .. .. |...+. +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 456789999998865421 0 1110 0 00 11 111000 001134445
Q ss_pred HHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 251 AFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 251 ~yLH~~----~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
.+++.. .+..+||+|+.+.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 555532 23459999999999999877656899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=6.9e-05 Score=72.50 Aligned_cols=137 Identities=8% Similarity=0.019 Sum_probs=75.8
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeE
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRL 212 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~ 212 (487)
-++.|+.|....+|++ . .+++|+....... ..+..+|+.+++.+...++ .+++++ +.+.-+
T Consensus 22 ~i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~ 83 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGV 83 (301)
T ss_dssp SCEEEESCSSEEEEEE--T-------------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCC
T ss_pred ceeEcCCcccccccee--e-------------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCE
Confidence 3678999999999998 1 4888987643211 1123468877777643333 355543 344567
Q ss_pred EEEeeC-CCCChhHHH------------------hhcCCCC----C-HHHHHHHHHH--------------HHHHHH---
Q 011385 213 LVYEFM-PRGSLENHL------------------FRRSLPL----P-WSIRMKIALG--------------AAKGLA--- 251 (487)
Q Consensus 213 lv~E~~-~~gsL~~~l------------------~~~~~~l----~-~~~~~~i~~q--------------i~~~l~--- 251 (487)
+|+||+ +|..|.... +.....+ . +..+..+... +...+.
T Consensus 84 ~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 163 (301)
T 3dxq_A 84 MVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR 163 (301)
T ss_dssp EEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred EEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence 899999 665553210 0011101 1 1111111110 111111
Q ss_pred -HHHh-CCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 252 -FLHE-EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 252 -yLH~-~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.|.. ..+..++|+|+.+.||| ..++.+.|+||..+..
T Consensus 164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1111 12234899999999999 5667889999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00028 Score=64.19 Aligned_cols=98 Identities=15% Similarity=0.088 Sum_probs=66.6
Q ss_pred ChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeee
Q 011385 222 SLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301 (487)
Q Consensus 222 sL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 301 (487)
+|.+.|...+.++.++++|.++.|.+.+|.-+-.... -..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence 7999998888999999999999999998877622110 11233457999999999998764 2111
Q ss_pred ccccccccCCceeccCCCCchhhhhhHHHHHHHHHh
Q 011385 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337 (487)
Q Consensus 302 ~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt 337 (487)
.....+.|||... ...+.+.=|||||++||.-+-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888653 455678889999999999885
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00017 Score=73.53 Aligned_cols=81 Identities=19% Similarity=0.108 Sum_probs=51.3
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~l 213 (487)
++.|+.|....||++....... .....+..|++|+..... ....+.+|+.++..|...++ .++++++.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568888889999997642110 001124678999884321 12456789999988854344 567765532 38
Q ss_pred EEeeCCCCCh
Q 011385 214 VYEFMPRGSL 223 (487)
Q Consensus 214 v~E~~~~gsL 223 (487)
||||++|..|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00043 Score=67.50 Aligned_cols=140 Identities=16% Similarity=0.123 Sum_probs=78.9
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ceeEEEE-----EEeC
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN--LVKLIGY-----CIED 208 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~~~~~-----~~~~ 208 (487)
..|+ |....||++... .|..+++|....... ....+..|+.++..|.... +.+++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 4577 888899987542 245689999864321 3456777888887774222 3344432 1234
Q ss_pred CeeEEEEeeCCCCChh-----HH------H---hh--cC------CCCCHHHH----HHH---------------HHHHH
Q 011385 209 DQRLLVYEFMPRGSLE-----NH------L---FR--RS------LPLPWSIR----MKI---------------ALGAA 247 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~-----~~------l---~~--~~------~~l~~~~~----~~i---------------~~qi~ 247 (487)
+..++||||++|..+. .+ | .. .. ....+... ..+ ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5668899999875432 11 1 10 00 01121110 000 01111
Q ss_pred HHHHHHHhC----CCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 248 KGLAFLHEE----AERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 248 ~~l~yLH~~----~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..+..+... .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 122232211 234589999999999998 4 899999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0006 Score=66.74 Aligned_cols=32 Identities=31% Similarity=0.378 Sum_probs=27.5
Q ss_pred CCeEecCCCCCcEEEcCC----CcEEEeecCCCCCC
Q 011385 259 RPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDG 290 (487)
Q Consensus 259 ~~iiHrDLKp~NIll~~~----~~~kl~DFGla~~~ 290 (487)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999874 67999999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00041 Score=69.40 Aligned_cols=148 Identities=15% Similarity=0.115 Sum_probs=84.0
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~l 213 (487)
++.|..|-...+|++.....-. .....+..|++|+... .......+.+|.++++.|.-.+ ..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 3567778889999987632100 0011346799998633 2234566779999998885323 3566666543 38
Q ss_pred EEeeCCCCChhHH--------------H---hhc----CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 011385 214 VYEFMPRGSLENH--------------L---FRR----SLPLP--WSIRMKIALGAAK-------------------GLA 251 (487)
Q Consensus 214 v~E~~~~gsL~~~--------------l---~~~----~~~l~--~~~~~~i~~qi~~-------------------~l~ 251 (487)
||||++|..|..- | ..- ..... +..+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998665311 1 011 11111 3445555544322 223
Q ss_pred HHH----hC-CCCCeEecCCCCCcEEEcCC----CcEEEeecCCCCC
Q 011385 252 FLH----EE-AERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKD 289 (487)
Q Consensus 252 yLH----~~-~~~~iiHrDLKp~NIll~~~----~~~kl~DFGla~~ 289 (487)
.|. .. .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 22 22358999999999999876 7899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00039 Score=71.42 Aligned_cols=75 Identities=13% Similarity=-0.003 Sum_probs=47.4
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~l 213 (487)
++.|+.|-...+|++.... .+..|++|+...... ..-+..+|+.++..|...++ .++++++. + .+
T Consensus 113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 3568888889999987642 235788998754321 11112588999988865555 46777662 2 35
Q ss_pred EEeeCCCCCh
Q 011385 214 VYEFMPRGSL 223 (487)
Q Consensus 214 v~E~~~~gsL 223 (487)
||||++|..|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00053 Score=68.22 Aligned_cols=83 Identities=10% Similarity=0.034 Sum_probs=44.9
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~l 213 (487)
.+.|+.|....||++....... ...+..+..|++|+....... ..+...|+.++..|...+ +.++++.. . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 3467888889999987642100 000011357888887543211 112357888888775334 34666544 2 378
Q ss_pred EEeeCCCCCh
Q 011385 214 VYEFMPRGSL 223 (487)
Q Consensus 214 v~E~~~~gsL 223 (487)
||||++|..|
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0037 Score=61.43 Aligned_cols=31 Identities=13% Similarity=0.153 Sum_probs=27.3
Q ss_pred CCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 259 RPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 259 ~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.025 Score=57.27 Aligned_cols=82 Identities=12% Similarity=0.042 Sum_probs=48.5
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ceeEEEEEEeCCeeEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIEDDQRLL 213 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~~~~~l 213 (487)
++.|..|-...+|++........ ....+..|++++..... ...-+..+|.++++.|...+ ..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 34677788899999887521100 00114679999865432 11122357888888774333 34566533 2 378
Q ss_pred EEeeCCCCCh
Q 011385 214 VYEFMPRGSL 223 (487)
Q Consensus 214 v~E~~~~gsL 223 (487)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.75 E-value=0.17 Score=50.68 Aligned_cols=29 Identities=28% Similarity=0.319 Sum_probs=24.6
Q ss_pred eEecCCCCCcEEE------cCCCcEEEeecCCCCC
Q 011385 261 VIYRDFKTSNILL------DADYNAKLSDFGLAKD 289 (487)
Q Consensus 261 iiHrDLKp~NIll------~~~~~~kl~DFGla~~ 289 (487)
++|+|+.+.|||+ +++..+.|+||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4457799999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.85 E-value=0.59 Score=42.23 Aligned_cols=123 Identities=8% Similarity=0.023 Sum_probs=82.3
Q ss_pred HHHHHhcCCCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 011385 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 265 (487)
Q Consensus 186 E~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD 265 (487)
|+.+| ...||+++.. .+-.+++.+.|.++.-+. ...|-. -..++...+++++.+|+....+++. =+|--
T Consensus 36 el~LL-~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~--ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~ 104 (215)
T 4ann_A 36 LMYLL-EQHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN--IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFV 104 (215)
T ss_dssp GGGGG-GSCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG--GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECC
T ss_pred HHHHH-hccCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH--HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEE
Confidence 44444 2368888876 455666766666655432 222211 1346788899999999987766654 47888
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 011385 266 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343 (487)
Q Consensus 266 LKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 343 (487)
|.|+||+++.++.++|.-.|+-... +|. .++...=+-.+=|++..+++++..|.
T Consensus 105 L~P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 105 LAPDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CSGGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EecceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999999877754322 222 22333335567888999999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.38 E-value=1.1 Score=40.62 Aligned_cols=115 Identities=10% Similarity=0.084 Sum_probs=77.0
Q ss_pred CCCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCcEE
Q 011385 194 VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA-FLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 194 ~HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~-yLH~~~~~~iiHrDLKp~NIl 272 (487)
.||++ -..+-.+++.+.|.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 57887 333446677777777665443222233 24678889999998887666 5544 578889999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCC
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMD 343 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 343 (487)
++.++.++|.-.|+-.. ++|.- ++..-=+-.+=|++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987775432 33331 2222234467788888998877763
|
| >2khx_A Ribonuclease 3; drosha, RNA binding domain, hydrolase, gene regulation, NUCL protein, gene regulation,nuclear protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.97 E-value=0.16 Score=38.76 Aligned_cols=26 Identities=12% Similarity=-0.165 Sum_probs=23.2
Q ss_pred ccccccccchhhhhhhhccccccccc
Q 011385 9 KVKKASWDSSKSKAKKKKKKVEDEVE 34 (487)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (487)
+.|+.|.|++|++|+|.||+.+.+.+
T Consensus 49 ~~~~~G~G~SKK~AEq~AA~~AL~~L 74 (85)
T 2khx_A 49 ERIGCGKGPSIQQAEMGAAMDALEKY 74 (85)
T ss_dssp EECCCEEESSHHHHHHHHHHHHHTTC
T ss_pred EEEEEEeeCCHHHHHHHHHHHHHHHH
Confidence 67899999999999999999887665
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.69 E-value=0.11 Score=53.15 Aligned_cols=62 Identities=8% Similarity=0.093 Sum_probs=18.0
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEE------EEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV------KTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+.+.|| ||.||+|.+... ...||| |.++.... +....+.+|..++..++|||+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4556776 999999988542 236777 76654332 223468889999999999999999887
Q ss_pred EE
Q 011385 205 CI 206 (487)
Q Consensus 205 ~~ 206 (487)
..
T Consensus 213 ~~ 214 (463)
T 3cxl_A 213 KV 214 (463)
T ss_dssp EE
T ss_pred EE
Confidence 64
|
| >1x49_A Interferon-induced, double-stranded RNA- activated protein kinase; structure genomics, DSRM domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=81.70 E-value=0.25 Score=38.72 Aligned_cols=28 Identities=18% Similarity=0.095 Sum_probs=24.5
Q ss_pred cccccccccchhhhhhhhccccccccch
Q 011385 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (487)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (487)
++.|+.|.|++|++|+|.||+.+.+.+.
T Consensus 55 g~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 82 (97)
T 1x49_A 55 EKEFPEAKGRSKQEARNAAAKLAVDILD 82 (97)
T ss_dssp SCCCCCEEESSHHHHHHHHHHHHHHHHT
T ss_pred CEEEEEEeeCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999887774
|
| >1x48_A Interferon-induced, double-stranded RNA- activated protein kinase; structure genomics, DSRM domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.50.1.1 | Back alignment and structure |
|---|
Probab=80.83 E-value=0.26 Score=37.88 Aligned_cols=28 Identities=14% Similarity=0.027 Sum_probs=24.5
Q ss_pred cccccccccchhhhhhhhccccccccch
Q 011385 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (487)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (487)
++.|+.|.|++|++|+|.||+.+.+.+.
T Consensus 46 g~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 73 (88)
T 1x48_A 46 QTMYGTGSGVTKQEAKQLAAKEAYQKLL 73 (88)
T ss_dssp SCEEEEEEESSHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEeecCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999887774
|
| >3adj_A F21M12.9 protein; HYL1, miRNA processing, RNA binding protein, gene regulation; 3.00A {Arabidopsis thaliana} PDB: 2l2m_A | Back alignment and structure |
|---|
Probab=80.53 E-value=0.3 Score=36.28 Aligned_cols=26 Identities=8% Similarity=-0.116 Sum_probs=22.7
Q ss_pred ccccccccchhhhhhhhccccccccc
Q 011385 9 KVKKASWDSSKSKAKKKKKKVEDEVE 34 (487)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (487)
+.++.|.|++|++|+|.||+.+...+
T Consensus 47 ~~~~~G~G~sKK~Aeq~AA~~al~~L 72 (76)
T 3adj_A 47 IKYTGAATRTKKDAEISAGRTALLAI 72 (76)
T ss_dssp EEEECCCBSSHHHHHHHHHHHHHHHH
T ss_pred EEEEEeccCCHHHHHHHHHHHHHHHH
Confidence 57889999999999999999877655
|
| >1whq_A RNA helicase A; double-stranded RNA binding domain, DSRBD, DSRM, riken structural genomics/proteomics initiative, RSGI, structural genomics; NMR {Mus musculus} SCOP: d.50.1.1 PDB: 2rs6_A | Back alignment and structure |
|---|
Probab=80.33 E-value=0.38 Score=37.81 Aligned_cols=31 Identities=13% Similarity=-0.063 Sum_probs=25.9
Q ss_pred Ccccccccccccchhhhhhhhccccccccch
Q 011385 5 GENGKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (487)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (487)
++|.+.++.|+|++||+|+|.||+.+.+.+.
T Consensus 44 v~g~~~~~~G~G~SKK~Aeq~AA~~AL~~L~ 74 (99)
T 1whq_A 44 VEGFNYAGMGNSTNKKDAQSNAARDFVNYLV 74 (99)
T ss_dssp CTTCSCCEEEEESSHHHHHHHHHHHHHHHHH
T ss_pred ECCeEEEEEeccCCHHHHHHHHHHHHHHHHH
Confidence 3444678999999999999999999887774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 487 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-76 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 6e-76
Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 33/290 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 188
+G G FG V+KG VAVK LN Q + + EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
L H+N++ +GY Q +V ++ SL +HL + IA A+
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+ +LH + +I+RD K++NI L D K+ DFGLA +H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 309 AAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
APE + + +SDVY+FG+VL E++TG+ P N + +G
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGY 226
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
L ++ + + +L A CL + RPL +++ +++ L
Sbjct: 227 LSPDL--SKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (560), Expect = 1e-68
Identities = 73/309 (23%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 120 FTFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVK 170
FTF D A R F E ++G G FG V G ++ G + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 171 TLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR 229
TL + +++L+E + +G H N++ L G + +++ EFM GSL++ L +
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120
Query: 230 RSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289
+ + G A G+ +L + ++RD NIL++++ K+SDFGL++
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 290 GPEGDKTHVSTRV---MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
+ T + APE + TS SDV+S+G+V+ E+++ R
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----R 232
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
P + + I+ + QL C +D RP
Sbjct: 233 PYWDMTNQDV-----------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 407 EVVEALKPL 415
++V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 5e-68
Identities = 85/326 (26%), Positives = 136/326 (41%), Gaps = 36/326 (11%)
Query: 105 SKLEEELKVASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 164
S L EL A + + L + +F ++G G FGCV+ G + +N G
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIV---HF--NEVIGRGHFGCVYHGTLLDND------GKK 55
Query: 165 LTVAVKTLNHDGLQGH-KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQR-LLVYEFMPRGS 222
+ AVK+LN G ++L E + D H N++ L+G C+ + L+V +M G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 223 LENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282
L N + + + L AKG+ FL + ++RD N +LD + K++
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 172
Query: 283 DFGLAKD--GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 340
DFGLA+D E D H T + A E + T T++SDV+SFGV+L E++T
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 341 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPK 400
P + N + L + RL+ P ++ C +
Sbjct: 233 -----PPYPDVNTFDITVYLL----QGRRLLQPEYC-------PDPLYEVMLKCWHPKAE 276
Query: 401 ARPLMSEVVEALKPLPNLKDMASSSY 426
RP SE+V + + Y
Sbjct: 277 MRPSFSELVSRISAI--FSTFIGEHY 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-67
Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 31/284 (10%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
++ LG G FG V G VA+K + E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
+ +L H LV+L G C + ++ E+M G L N+L +++ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
+ +L + ++RD N L++ K+SDFGL++ + D+ S ++
Sbjct: 113 MEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369
PE +M +S+SD+++FGV++ E+ + + + N E
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAE 212
Query: 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
I L + ++K + C RP ++ +
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-67
Identities = 77/285 (27%), Positives = 124/285 (43%), Gaps = 31/285 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+G G FG V G+ VA+KT+ ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
L H LV+L G C+E LV+EFM G L ++L + + + L +G+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
A+L E VI+RD N L+ + K+SDFG+ + + D+ ST +A+
Sbjct: 115 AYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWAS 170
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
PE +S+SDV+SFGV++ E+ + + +NR N E +VE +RL
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDI-------STGFRL 221
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
PRL + Q+ HC P+ RP S ++ L +
Sbjct: 222 YKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 9e-66
Identities = 67/313 (21%), Positives = 125/313 (39%), Gaps = 43/313 (13%)
Query: 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 183
++L +F S LG G G VFK +GL +A K ++ + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
+ E+ L + +V G D + + E M GSL+ L + +P I K++
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 110
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
+ KGL +L E+ +++RD K SNIL+++ KL DFG++ + ++ +
Sbjct: 111 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR----------------------- 340
GT Y +PE + H + +SD++S G+ L+EM GR
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 341 ---SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 397
+ + +RP + +++ S + + CL +
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 398 DPKARPLMSEVVE 410
+P R + +++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-65
Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 33/286 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+ LG G FG V+ G+ VAVK+L +LAE N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKG 249
L H LV+L + ++ E+M GSL + L S + L + + +A A+G
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
+AF+ E R I+RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT 177
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369
APE + G T +SDV+SFG++L E++T R P E + R YR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNL----ERGYR 228
Query: 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
++ P + ++ QL C P+ RP + L+
Sbjct: 229 MVRPD---NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 3e-65
Identities = 69/299 (23%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 118 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 177
++ ++ + + LG G +G V++G V LTVAVKTL D +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTM 55
Query: 178 QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPW 236
+ +E+L E + ++ H NLV+L+G C + ++ EFM G+L ++L + +
Sbjct: 56 EV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 237 SIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT 296
+ + +A + + +L + + I+RD N L+ ++ K++DFGL++ GD
Sbjct: 115 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 170
Query: 297 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356
+ APE + + +SDV++FGV+L E+ T S +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------ 224
Query: 357 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
Y L++ +K +L C +P RP +E+ +A + +
Sbjct: 225 ----------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-64
Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 31/310 (10%)
Query: 124 DLKLATRNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 181
L L N + LG G FG V +G + VA+K L + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54
Query: 182 EWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
E + E + L + +V+LIG C + + +LV E G L L + +P S +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 113
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVST 300
+ + G+ +L E + ++RD N+LL + AK+SDFGL+K G + +
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
+ APE + +SRSDV+S+GV + E L+ + +P + E
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE----- 220
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK-PLPNLK 419
I+ + + L + C + RP V + ++ +L
Sbjct: 221 ------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 420 DMASSSYYFQ 429
++
Sbjct: 275 SKVEGHHHHH 284
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-64
Identities = 70/307 (22%), Positives = 113/307 (36%), Gaps = 46/307 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 189
N +LG G FG V K G + VAVK L +E ++E+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 190 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL---------------- 232
+ L H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 233 ------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286
L + + A AKG+ FL + ++RD N+L+ K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNR 346
A+D V + APE + G T +SDV+S+G++L E+ + +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS 406
P + FY+LI + ++ + C + D + RP
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 407 EVVEALK 413
+ L
Sbjct: 316 NLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-64
Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 30/304 (9%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 184
++ + ++G G FG V+KG ++ + + VA+KTL + + ++L
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57
Query: 185 AEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
E +G H N+++L G + +++ E+M G+L+ L + + +
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVM 303
G A G+ +L ++RD NIL++++ K+SDFGL++ + + T+ ++
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
+ APE + TS SDV+SFG+V+ E++T N E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL----PNLK 419
+ I+ + QL C ++ RP +++V L L +LK
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278
Query: 420 DMAS 423
+A
Sbjct: 279 TLAD 282
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-64
Identities = 77/314 (24%), Positives = 117/314 (37%), Gaps = 46/314 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 189
LG G FG V + +K +TVAVK L +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 190 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-----------------S 231
L L H+N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 232 LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGP 291
L L + + AKG+AFL + I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 292 EGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 351
V + APE + T SDV+S+G+ L E+ + S P
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411
FY++I + + C DP RP ++V+
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 412 LKPLPNLKDMASSS 425
++ K ++ S+
Sbjct: 302 IE-----KQISEST 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 1e-63
Identities = 71/318 (22%), Positives = 116/318 (36%), Gaps = 47/318 (14%)
Query: 122 FNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 180
L+ N +GEG FG VF+ + VAVK L +
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 181 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-------- 232
++ E + + + N+VKL+G C L++E+M G L L S
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 233 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
PL + ++ IA A G+A+L E R ++RD T N L+ +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
K++DFGL+++ D + PE + T+ SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 338 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 397
+ E ++ + R G L L C S+
Sbjct: 238 YGLQPYYGMAHEE--VIYYVRD--GNILACPENCPLEL------------YNLMRLCWSK 281
Query: 398 DPKARPLMSEVVEALKPL 415
P RP + L+ +
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-63
Identities = 70/313 (22%), Positives = 119/313 (38%), Gaps = 35/313 (11%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
R + +G+G FG V++G G VAVK + + AE+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50
Query: 190 LGDLVHLNLVKLIGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
L H N++ I +D+ Q LV ++ GSL ++L R + +K+AL
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALS 108
Query: 246 AAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKT--HV 298
A GLA LH E + + +RD K+ NIL+ + ++D GLA T
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 299 STRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRR----SMDKNRPN 348
+GT Y APE + R+D+Y+ G+V E+ D P
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV 408
+ + + + + +L S + + A++ C + AR +
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 409 VEALKPLPNLKDM 421
+ L L + +
Sbjct: 289 KKTLSQLSQQEGI 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-63
Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 39/286 (13%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 189
+ + +G+G FG V G G VAVK + +D + +LAE +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53
Query: 190 LGDLVHLNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAA 247
+ L H NLV+L+G +E+ L +V E+M +GSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+ + +L ++RD N+L+ D AK+SDFGL K+ T
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367
+ APE + +++SDV+SFG++L E+ + R P L + R
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PRV 213
Query: 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
+ ++ +C D RP ++ E L+
Sbjct: 214 EKGYKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-62
Identities = 76/288 (26%), Positives = 119/288 (41%), Gaps = 29/288 (10%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 186
++ R LG+G FG V +G + G ++VAVK L D L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
VN + L H NL++L G + ++ V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHV-STRVMGT 305
A+G+ +L + I+RD N+LL K+ DFGL + P+ D +V
Sbjct: 121 AEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 306 YGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365
+ + APE + T + SD + FGV L EM T + P N + E
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGE 232
Query: 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
R PR E Q + C + P+ RP + + L
Sbjct: 233 RL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-62
Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 33/296 (11%)
Query: 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGD 192
+ LG G FG V KG+ + TVAVK L ++ E LAE N +
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 193 LVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAF 252
L + +V++IG C E + +LV E G L +L + + +++ + G+ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKY 122
Query: 253 LHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG-DKTHVSTRVMGTYGYAAP 311
L E ++RD N+LL + AK+SDFGL+K + T + AP
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 312 EYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371
E + +S+SDV+SFGV++ E + + +P E ++
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAML 223
Query: 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLPNLKDMASSSYY 427
+ ++ L C + D + RP + V L+ D+ + ++
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGHH 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 9e-62
Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 26/285 (9%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 190
F+ +LG G FG V+KG G + VA+K L + +KE L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
+ + ++ +L+G C+ +L + + MP G L +++ + + + AKG+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
+L + R +++RD N+L+ + K++DFGLAK +K + + + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
E ++ T +SDV+S+GV + E++T P E +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
++ + C D +RP E++ +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 9e-62
Identities = 72/308 (23%), Positives = 123/308 (39%), Gaps = 47/308 (15%)
Query: 129 TRNFRPE------SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 182
TR+ PE LG+G FG V+K T + A K ++ + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55
Query: 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 242
++ E++ L H N+VKL+ ++ ++ EF G+++ + PL S +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
L +LH + +I+RD K NIL D + KL+DFG++ +
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 303 MGTYGYAAPEYVMT-----GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357
+GT + APE VM ++DV+S G+ L+EM P+ E N +
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVL 224
Query: 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEV-------VE 410
+ L P +S CL ++ AR S++ V+
Sbjct: 225 LKIA--KSEPPTLAQPS---RWS----SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
Query: 411 ALKPLPNL 418
+ KP+ L
Sbjct: 276 SNKPIREL 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-61
Identities = 68/296 (22%), Positives = 112/296 (37%), Gaps = 45/296 (15%)
Query: 118 RKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 177
R++ D F LG+G FG V+ + + +A+K L L
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQL 44
Query: 178 ---QGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPL 234
+ EV L H N+++L GY + + L+ E+ P G++ L + S
Sbjct: 45 EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KF 103
Query: 235 PWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGD 294
A L++ H + VI+RD K N+LL + K++DFG + P
Sbjct: 104 DEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
Query: 295 KTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354
+T + GT Y PE + + D++S GV+ E L G+ P +
Sbjct: 161 RTTL----CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQ 210
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
E + F + A L + L +P RP++ EV+E
Sbjct: 211 ETYKRISRVEFTFPDFVTE------------GARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-61
Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 53/318 (16%)
Query: 115 SRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH 174
+ +ND+K + ++GEG FG V K I+++G + A+K +
Sbjct: 2 TIYPVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKE 47
Query: 175 DGL-QGHKEWLAEVNFLGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 232
H+++ E+ L L H N++ L+G C L E+ P G+L + L + +
Sbjct: 48 YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107
Query: 233 ---------------PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY 277
L + A A+G+ +L + + I+RD NIL+ +Y
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 164
Query: 278 NAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT 337
AK++DFGL++ K T + A E + T+ SDV+S+GV+L E+++
Sbjct: 165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 338 GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSR 397
+ P E Y + + + L C
Sbjct: 222 LGGT-----PYCGMTCAEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWRE 265
Query: 398 DPKARPLMSEVVEALKPL 415
P RP ++++ +L +
Sbjct: 266 KPYERPSFAQILVSLNRM 283
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-60
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 33/286 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+ R E LG+G FG V+ G VA+KTL + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF-RRSLPLPWSIRMKIALGAAKG 249
L H LV+L ++ +V E+M +GSL + L L + +A A G
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
+A++ ++RD + +NIL+ + K++DFGLA+ + ++ +
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWT 181
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYR 369
APE + G T +SDV+SFG++L E+ T R N E
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225
Query: 370 LIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
++ + + L C ++P+ RP + L+
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-60
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 189
++ LGEG +G V V T VAVK ++ + + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
L H N+VK G+ E + + L E+ G L + + +P + G
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAG 115
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
+ +LH + +RD K N+LLD N K+SDFGLA ++ + ++ GT Y
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 310 APEYVMTGHLTSR-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
APE + + DV+S G+VL ML G D+ + + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YS 217
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ + + K L L +P AR + ++ +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-59
Identities = 61/289 (21%), Positives = 111/289 (38%), Gaps = 37/289 (12%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 188
++ +G G +G K + G + K L++ + + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLL--VYEFMPRGSLENHLFRRSL---PLPWSIRMKIA 243
L +L H N+V+ I+ L V E+ G L + + + + L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 244 LGAAKGLAFLHE--EAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
L H + V++RD K +N+ LD N KL DFGLA+ T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
+GT Y +PE + +SD++S G +L E+ P + E A
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227
Query: 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ R+ +S + ++ L+ RP + E++E
Sbjct: 228 EGKF-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 7e-59
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 38/288 (13%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 187
R + + +G G F V+KG + T + VA L L + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 188 NFLGDLVHLNLVKLIGYCIE----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L L H N+V+ +LV E M G+L+ +L R + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWC 118
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDGPEGDKTHVSTRV 302
KGL FLH P+I+RD K NI + + K+ D GLA + + V
Sbjct: 119 RQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
+GT + APE + DVY+FG+ +LEM T + + +
Sbjct: 174 IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 221
Query: 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ R+ F + ++ C+ ++ R + +++
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-58
Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 30/287 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 189
+GEG FG V +G L VA+KT + +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKG 249
+ H ++VKLIG ++ ++ E G L + L R L + + A +
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 250 LAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYA 309
LA+L + ++RD N+L+ ++ KL DFGL++ + + +++ +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWM 176
Query: 310 APEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-GERRRFY 368
APE + TS SDV+ FGV + E+L +P + GER
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERLPMP 231
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
P L L C + DP RP +E+ L +
Sbjct: 232 PNCPPTL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 3e-58
Identities = 67/289 (23%), Positives = 116/289 (40%), Gaps = 43/289 (14%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 185
+ F +G G FG V+ VA+K +++ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
EV FL L H N ++ G + + LV E+ + + + PL + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHG 123
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGT 305
A +GLA+LH +I+RD K NILL KL DFG A + +GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGT 174
Query: 306 YGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHL 361
+ APE ++ G + DV+S G+ +E+ + + + N + +++ + P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-- 232
Query: 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
GH+S + CL + P+ RP +++
Sbjct: 233 -----------ALQSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-57
Identities = 74/309 (23%), Positives = 129/309 (41%), Gaps = 37/309 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 189
LG+G FG V++G VK VA+KT+N ++ E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 190 LGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLF---------RRSLPLPWSIRM 240
+ + ++V+L+G + L++ E M RG L+++L P S +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
++A A G+A+L+ ++RD N ++ D+ K+ DFG+ +D E D
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
+ + + +PE + G T+ SDV+SFGVVL E+ T + N +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------- 243
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL--PNL 418
R + +L C +PK RP E++ ++K P
Sbjct: 244 ------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
Query: 419 KDMASSSYY 427
+++ S YY
Sbjct: 298 REV--SFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-56
Identities = 63/302 (20%), Positives = 116/302 (38%), Gaps = 36/302 (11%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 188
+ + +G+G G V+ + TG VA++ +N + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
+ + + N+V + + D+ +V E++ GSL + + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQ 127
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
L FLH VI+RD K+ NILL D + KL+DFG + ++GT +
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
APE V + D++S G++ +EM+ G P N +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TNGTP 234
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE-----ALKPLPNLKDMAS 423
L +P S CL D + R E+++ KPL +L + +
Sbjct: 235 ELQNPE---KLS----AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287
Query: 424 SS 425
++
Sbjct: 288 AA 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 4e-56
Identities = 82/303 (27%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 189
+ LG G FG V + K T TVAVK L H+ ++E+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 190 LGDLVH-LNLVKLIGYCIEDDQRL-LVYEFMPRGSLENHLFRR---------------SL 232
L + H LN+V L+G C + L ++ EF G+L +L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 233 PLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292
L + + AKG+ FL R I+RD NILL K+ DFGLA+D +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 293 GDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352
+ APE + T +SDV+SFGV+L E+ + S P
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241
Query: 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412
+ E L E R R + + + Q C +P RP SE+VE L
Sbjct: 242 IDEEFCRRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 413 KPL 415
L
Sbjct: 292 GNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-55
Identities = 75/302 (24%), Positives = 118/302 (39%), Gaps = 38/302 (12%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 189
LGEG FG V E G KP VAVK L D + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 190 LGDLV-HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP--------------- 233
+ + H N++ L+G C +D ++ E+ +G+L +L R P
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 234 LPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293
L + A A+G+ +L + I+RD N+L+ D K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 294 DKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 353
D +T + APE + T +SDV+SFGV+L E+ T S P E
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245
Query: 354 VEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
++L+ + + C P RP ++VE L
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 414 PL 415
+
Sbjct: 293 RI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-53
Identities = 59/289 (20%), Positives = 99/289 (34%), Gaps = 34/289 (11%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 182
K +F+ +LGEG F V + T A+K L +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 183 WLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 242
E + + L H VKL +D++ + G L ++ + +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFY 113
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
L +LH + +I+RD K NILL+ D + +++DFG AK K +
Sbjct: 114 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
+GT Y +PE + SD+++ G ++ +++ G P N + +
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIK 224
Query: 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411
F P KA L L D R E+
Sbjct: 225 LEYDFPEKFFP------------KARDLVEKLLVLDATKRLGCEEMEGY 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (460), Expect = 2e-53
Identities = 61/282 (21%), Positives = 98/282 (34%), Gaps = 31/282 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
++ LG G FG V + + TG A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
L H LV L +D++ +++YEFM G L + + ++ KGL
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYN--AKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
+H E ++ D K NI+ + KL DFGL V GT +
Sbjct: 138 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 191
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
AAPE + +D++S GV+ +L+G P G N E R
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMD 245
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ ++ L DP R + + +E
Sbjct: 246 DSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (458), Expect = 4e-53
Identities = 70/344 (20%), Positives = 126/344 (36%), Gaps = 38/344 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+ LG G FG V + V+ TG K +N E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
L H L+ L + + +L+ EF+ G L + + + + + A +GL
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
+H E +++ D K NI+ + + K+ DFGLA + T +
Sbjct: 141 KHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
AAPE V + +D+++ GV+ +L+G P + +E + F
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFD 248
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKP-LPNLKDMASSS 425
+ +A + L ++P+ R + + +E LK NL SS
Sbjct: 249 EDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300
Query: 426 YYFQTMQ--AERIGSSPNTRNGIR--AQGGSLSRNGQRSLSIPN 465
Y + Q E+ P + I A SL ++ + I +
Sbjct: 301 RYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (434), Expect = 2e-50
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 36/290 (12%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 188
+ +LG GG V VAVK L D + + + E
Sbjct: 9 YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRL----LVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
L H +V + + +V E++ +L + + P+ +++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIA 118
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVM 303
A + L F H+ +I+RD K +NI++ A K+ DFG+A+ G+ + V+
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
GT Y +PE + +RSDVYS G VL E+LTG P + V A H+ E
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVRE 229
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-MSEVVEAL 412
L + + L+++P+ R +E+ L
Sbjct: 230 DPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (425), Expect = 4e-49
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 46/296 (15%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 181
N+ P+ +LG G V + + T AVK ++ G + +
Sbjct: 4 NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 182 EWLAEVNFLGDL-VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRM 240
L EV+ L + H N+++L + LV++ M +G L ++L + L
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR 113
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVST 300
KI + + LH+ +++RD K NILLD D N KL+DFG + G+K
Sbjct: 114 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167
Query: 301 RVMGTYGYAAPEYVMTGHL------TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 354
V GT Y APE + D++S GV++ +L G P +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQM 221
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
R + +F + L + L P+ R E +
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-49
Identities = 57/350 (16%), Positives = 124/350 (35%), Gaps = 45/350 (12%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+ LG G FG V + V+ + T K + G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
H N++ L ++ ++++EF+ + + + L + + L
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNA--KLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
FLH + + D + NI+ ++ K+ +FG A+ GD + + Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368
APE +++ +D++S G ++ +L+G P + + F
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFD 223
Query: 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EALKPLPN--LKD 420
+ + +A L ++ K+R SE + + ++ + ++
Sbjct: 224 EEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275
Query: 421 MASSSYYFQTMQAERIGSSPNTRNGIRAQGGSLSRNGQRSLSIPNGSYAS 470
+ YY ++ + R + GG++ Q+ +S+ AS
Sbjct: 276 LKHRRYYHTLIKKDLNMVVSAAR---ISCGGAIRS--QKGVSVAKVKVAS 320
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 170 bits (431), Expect = 5e-49
Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 39/280 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 187
+F ++G GGFG V+ K TG A+K L+ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 188 N---FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIAL 244
+ +V + D+ + + M G L HL + + +R A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAA 114
Query: 245 GAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMG 304
GL +H R V+YRD K +NILLD + ++SD GLA D + +G
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167
Query: 305 TYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
T+GY APE + G S +D +S G +L ++L G +++ +H +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 224
Query: 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
L FS + L L RD R
Sbjct: 225 --------AVELPDSFS----PELRSLLEGLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-48
Identities = 52/298 (17%), Positives = 94/298 (31%), Gaps = 33/298 (11%)
Query: 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 183
+L++ R +R +G G FG ++ G G VA+K H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49
Query: 184 LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
E + + I +C + ++ + SLE+ S + +A
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDGPEGD-----K 295
+ ++H + I+RD K N L + DFGLAK +
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166
Query: 296 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 355
+ + GT YA+ + + R D+ S G VL+ G + + E
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 356 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413
+ L + + A C S +P S + + +
Sbjct: 227 R------ISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 4e-48
Identities = 55/280 (19%), Positives = 94/280 (33%), Gaps = 28/280 (10%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 190
+ +LG G F V T VA+K + L+G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
+ H N+V L L+ + + G L + + + ++ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAV 120
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAA 310
+LH+ + LD D +SDFGL+K D V + GT GY A
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVA 177
Query: 311 PEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370
PE + + D +S GV+ +L G P + N + L F
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSP 231
Query: 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
+ + A H + +DP+ R + ++
Sbjct: 232 YWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-47
Identities = 70/277 (25%), Positives = 102/277 (36%), Gaps = 37/277 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 187
+F +LG+G FG VF T A+K L D + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 188 NFLG-DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L H L + + V E++ G L H+ S A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEI 112
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
GL FLH + ++YRD K NILLD D + K++DFG+ K+ GD GT
Sbjct: 113 ILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
Y APE ++ D +SFGV+L EML G+ P + E +
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPF 221
Query: 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
+ R ++ A L R+P+ R
Sbjct: 222 YPRWLEKE------------AKDLLVKLFVREPEKRL 246
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-46
Identities = 67/308 (21%), Positives = 124/308 (40%), Gaps = 32/308 (10%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 188
NF+ +GEG +G V+K TG VA+K + D + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
L +L H N+VKL+ +++ LV+EF+ + + +P + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
GLAF H V++RD K N+L++ + KL+DFGLA+ +T+ + V+ +
Sbjct: 114 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 358
A + + ++ D++S G + EM+T R + G + V W
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 359 P-HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVV------EA 411
+ + + + + + L + L DP R + +
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
Query: 412 LKPLPNLK 419
KP+P+L+
Sbjct: 290 TKPVPHLR 297
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 7e-46
Identities = 67/290 (23%), Positives = 110/290 (37%), Gaps = 31/290 (10%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 191
LGEG F V+K T VA+K + K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 192 DLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
+L H N++ L+ LV++FM LE + SL L S L +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAP 311
+LH+ +++RD K +N+LLD + KL+DFGLAK ++ + T + T Y AP
Sbjct: 115 YLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 312 EYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARPH 360
E + + D+++ G +L E+L + + G +W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
++ H L +P AR ++ ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 2e-45
Identities = 69/277 (24%), Positives = 108/277 (38%), Gaps = 39/277 (14%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 186
++F+ LG G FG V G A+K L + + K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 187 VNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGA 246
L + H ++++ G + Q ++ +++ G L R+S P + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 247 AKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
L +LH + +IYRD K NILLD + + K++DFG AK P+ T GT
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165
Query: 307 GYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366
Y APE V T D +SFG+++ EML G P + N ++ L R
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELR 219
Query: 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
F + L + ++RD R
Sbjct: 220 FPPFFNE------------DVKDLLSRLITRDLSQRL 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (401), Expect = 2e-45
Identities = 44/295 (14%), Positives = 86/295 (29%), Gaps = 34/295 (11%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+++ +GEG FG +F+G VA+K + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 191 GDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGL 250
L + + Y ++ ++ + SLE+ L A +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDGPEGD-----KTHVST 300
+HE + ++YRD K N L+ + + DFG+ K +
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 301 RVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360
+ GT Y + + + R D+ + G V + L G + E
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228
Query: 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415
+ L F ++ + + + A P + +
Sbjct: 229 ---GEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-45
Identities = 68/315 (21%), Positives = 115/315 (36%), Gaps = 37/315 (11%)
Query: 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 183
A + + + +GEG +G VFK +NG G VA+K + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56
Query: 184 -LAEVNFLGDLVHLNLVKLIGYCIEDDQR-----LLVYEFMPRGSLENHLFRRSLPLPWS 237
+A + L H N+V+L C LV+E + + +P
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 238 IRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTH 297
+ +GL FLH V++RD K NIL+ + KL+DFGLA+
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 170
Query: 298 VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 354
T V+ T Y APE ++ + D++S G + EM + + + +
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 355 -------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSE 407
+W R R+ F+ +E + + L CL+ +P R
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 408 VVEA--LKPLPNLKD 420
+ + L K+
Sbjct: 290 ALSHPYFQDLERCKE 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-45
Identities = 60/300 (20%), Positives = 112/300 (37%), Gaps = 30/300 (10%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 187
+ S +GEG +G V + + VA+K ++ Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 188 NFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFR--RSLPLPWSIRMKIALG 245
L H N++ + + ++ + L++ ++ L
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD-GPEGDKTHVSTRVMG 304
+GL ++H V++RD K SN+LL+ + K+ DFGLA+ P+ D T T +
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 305 TYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363
T Y APE ++ ++S D++S G +L EML+ R + N + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 364 RRRFYRLIDPRLEGHFSIKGAQK-------------AAQLAAHCLSRDPKARPLMSEVVE 410
+ S+ K A L L+ +P R + + +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-44
Identities = 60/289 (20%), Positives = 100/289 (34%), Gaps = 40/289 (13%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 185
+ LG G F V K + TGL A K + + + ++
Sbjct: 12 YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 186 EVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 245
EV+ L ++ H N++ L +L+ E + G L + L + L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQ 121
Query: 246 AAKGLAFLHEEAERPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDGPEGDKTHVSTR 301
G+ +LH + + D K NI+L K+ DFGLA G++
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
+ GT + APE V L +D++S GV+ +L+G P E
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVS 229
Query: 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
F + A L +DPK R + + ++
Sbjct: 230 AVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 78/281 (27%), Positives = 105/281 (37%), Gaps = 36/281 (12%)
Query: 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 183
K+ +F LLG+G FG V + TG A+K L + + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 184 -LAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKI 242
+ E L + H L L D+ V E+ G L HL R
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFY 110
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRV 302
L +LH R V+YRD K N++LD D + K++DFGL K+G T
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTF 165
Query: 303 MGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362
GT Y APE + D + GVV+ EM+ GR P + L
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILM 219
Query: 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP 403
E RF R + P +A L A L +DPK R
Sbjct: 220 EEIRFPRTLSP------------EAKSLLAGLLKKDPKQRL 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-43
Identities = 61/289 (21%), Positives = 99/289 (34%), Gaps = 50/289 (17%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 185
++ LLG GGFG V+ G ++ L VA+K + D + E
Sbjct: 6 YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 186 EVNFLGDL--VHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
EV L + +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRV 302
+ + H V++RD K NIL+D + KL DFG K V T
Sbjct: 117 WQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169
Query: 303 MGTYGYAAPEYVMTGHLTSRS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
GT Y+ PE++ RS V+S G++L +M+ G + + ++
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRG----- 219
Query: 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
S + L CL+ P RP E+
Sbjct: 220 ----------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 8e-43
Identities = 60/293 (20%), Positives = 110/293 (37%), Gaps = 28/293 (9%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 188
+ +GEG +G V+K G T A+K + + + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
L +L H N+VKL + +LV+E + L+ L L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
G+A+ H+ R V++RD K N+L++ + K++DFGLA+ + + ++ +
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYR 167
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWAR 358
A + + ++ D++S G + EM+ G G N W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 359 -PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
L + + + +P F + L + L DP R + +E
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 68/322 (21%), Positives = 113/322 (35%), Gaps = 47/322 (14%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
++ ++G G FG V++ +G VA+K + D + E+ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67
Query: 191 GDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLEN--HLFRRSLPLPWSIRMKI 242
L H N+V+L + ++ LV +++P H R LP
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 243 ALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTR 301
+ LA++H + +RD K N+LLD D KL DFG AK G+ +
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361
+ Y A TS DV+S G VL E+L G+ + + +
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 362 GE-----------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKAR-------- 402
+F ++ F + +A L + L P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 403 -PLMSEVVEALKPLPNLKDMAS 423
E+ + LPN +D +
Sbjct: 303 HSFFDELRDPNVKLPNGRDTPA 324
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-40
Identities = 55/283 (19%), Positives = 93/283 (32%), Gaps = 39/283 (13%)
Query: 137 LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-H 195
+LG G G V + T A+K L + EV
Sbjct: 19 VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 196 LNLVKLIGYC----IEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGL 250
++V+++ L+V E + G L + + R +I + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 251 AFLHEEAERPVIYRDFKTSNILLDADYN---AKLSDFGLAKDGPEGDKTHVSTRVMGTYG 307
+LH + +RD K N+L + KL+DFG AK+ + T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178
Query: 308 YAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367
Y APE + D++S GV++ +L G H L R
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQ 233
Query: 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
Y +P S ++ L + L +P R ++E +
Sbjct: 234 YEFPNPEWS-EVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-39
Identities = 63/307 (20%), Positives = 105/307 (34%), Gaps = 40/307 (13%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 188
+ + +G+G FG VFK TG VA+K + + + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 189 FLGDLVHLNLVKLIGYCIEDDQR--------LLVYEFMPRGSLENHLFRRSLPLPWSIRM 240
L L H N+V LI C LV++F S
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIK 120
Query: 241 KIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVS- 299
++ GL ++H +++RD K +N+L+ D KL+DFGLA+ + +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 300 -TRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 354
T + T Y PE ++ D++ G ++ EM T M N + L+
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 355 ----------EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ-LAAHCLSRDPKARP 403
L E+ + +++ A L L DP R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 404 LMSEVVE 410
+ +
Sbjct: 298 DSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 1e-38
Identities = 60/294 (20%), Positives = 102/294 (34%), Gaps = 28/294 (9%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 188
+ +GEG +G VFK T VA+K + D L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 189 FLGDLVHLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAK 248
L +L H N+V+L D + LV+EF + + I K
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLK 112
Query: 249 GLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGY 308
GL F H R V++RD K N+L++ + KL++FGLA+ + + S V+ +
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYR 168
Query: 309 AAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEWA 357
++ D++S G + E+ R + G +W
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 358 R-PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
L + + + + K L + L +P R E ++
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-37
Identities = 66/323 (20%), Positives = 113/323 (34%), Gaps = 42/323 (13%)
Query: 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 189
+R +G G +G V V TG VA+K L K E+
Sbjct: 20 YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 190 LGDLVHLNLVKLIGYCIEDDQR------LLVYEFMPRGSLENHLFRRSLPLPWSIRMKIA 243
L + H N++ L+ D+ LV FM G+ L + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLV 127
Query: 244 LGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVM 303
KGL ++H +I+RD K N+ ++ D K+ DFGLA+ ++ V+
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVV 180
Query: 304 GTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--------- 354
+ A + T D++S G ++ EM+TG+ + + +
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 355 EWARPHLGERRRFYRLIDPRLEG----HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
E+ + + + Y P LE + A L L D + R E +
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
Query: 411 A--LKPLPNLKDMASSSYYFQTM 431
+ L + +D Y +
Sbjct: 301 HPYFESLHDTEDEPQVQKYDDSF 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 7e-37
Identities = 68/314 (21%), Positives = 108/314 (34%), Gaps = 42/314 (13%)
Query: 96 SNAESNSSTSKLEEELKVASR--LRKFTFNDLKLATRN-FRPESLLGEGGFGCVFKGWIE 152
+ A+ S ++E L A L+K+ A + F LG G FG V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV--- 60
Query: 153 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGDLVHLNLVKLIGYCIEDD 209
+G A+K L+ + K+ L E L + LVKL ++
Sbjct: 61 ------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269
+V E++ G + +HL R A +LH +IYRD K
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPE 170
Query: 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFG 329
N+L+D +++DFG AK T + GT APE +++ D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 330 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQ 389
V++ EM G P ++ + + RF
Sbjct: 226 VLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS------------DLKD 267
Query: 390 LAAHCLSRDPKARP 403
L + L D R
Sbjct: 268 LLRNLLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-36
Identities = 73/326 (22%), Positives = 118/326 (36%), Gaps = 33/326 (10%)
Query: 116 RLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 175
R T + K+ NF +LG G +G VF TG A+K L
Sbjct: 10 RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKA 63
Query: 176 GL----QGHKEWLAEVNFLGDLVHL-NLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR 230
+ + + E L + LV L + + L+ +++ G L HL +R
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR 123
Query: 231 SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDG 290
L LH+ +IYRD K NILLD++ + L+DFGL+K+
Sbjct: 124 E-RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179
Query: 291 PEGDKTHVSTRVMGTYGYAAPEYVMTGH--LTSRSDVYSFGVVLLEMLTGRRSMDKNRPN 348
+ + GT Y AP+ V G D +S GV++ E+LTG
Sbjct: 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDG 236
Query: 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSE 407
+++ E +R L + + + A L L +DPK R
Sbjct: 237 EKNSQAEISRRILKSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRLGCGPR 284
Query: 408 VVEALKPLPNLKDMASSSYYFQTMQA 433
+ +K + + + + A
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVPA 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (316), Expect = 4e-33
Identities = 53/305 (17%), Positives = 99/305 (32%), Gaps = 47/305 (15%)
Query: 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 190
+++ LG G + VF+ + V VK L K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 191 GDL-VHLNLVKLIGYCIEDDQRL--LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAA 247
+L N++ L + R LV+E + + L
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEIL 139
Query: 248 KGLAFLHEEAERPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDGPEGDKTHVSTRVMGTY 306
K L + H +++RD K N+++D + +L D+GLA+ G + + +
Sbjct: 140 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 307 GYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLV 354
+ PE ++ D++S G +L M+ + N G +L
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQK---------AAQLAAHCLSRDPKARPLM 405
++ + E + I R + A L D ++R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 406 SEVVE 410
E +E
Sbjct: 314 REAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 60/313 (19%), Positives = 106/313 (33%), Gaps = 51/313 (16%)
Query: 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 187
+ ++ +G G G V + VA+K L+ K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 188 NFLGDLVHLNLVKLIGYCI------EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSY 123
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
+ G+ LH +I+RD K SNI++ +D K+ DFGLA+ T
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR----------------RSMDKN 345
+ T Y APE ++ D++S G ++ EM+ + +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 346 RPNGEHNLVEWARPHLGERRRFYRLIDPRL--------EGHFSIKGAQKAAQLAAHCLSR 397
P L R ++ R ++ L P+L + + A +A L + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 398 DPKARPLMSEVVE 410
DP R + + ++
Sbjct: 298 DPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 7e-30
Identities = 65/330 (19%), Positives = 120/330 (36%), Gaps = 40/330 (12%)
Query: 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 186
++ S +G G +G V + TGL VAVK L+ K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 187 VNFLGDLVHLNLVKLIGYC-----IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMK 241
+ L + H N++ L+ +E+ + + + L N + + L
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125
Query: 242 IALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTR 301
+ +GL ++H +I+RD K SN+ ++ D K+ DFGLA+ + +V+TR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
Query: 302 VMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEH 351
+ A + H D++S G ++ E+LTGR R G
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
Query: 352 NLVEWARPHLGERRRFYRLIDPRLEGHFS---IKGAQKAAQLAAHCLSRDPKARPLMSEV 408
+ R + + + + +F+ I A L L D R ++
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
Query: 409 VEA--LKPLPNLKDMASSSYYFQTMQAERI 436
+ + D + Y Q+ ++ +
Sbjct: 299 LAHAYFAQYHDPDDEPVADPYDQSFESRDL 328
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 3e-27
Identities = 56/336 (16%), Positives = 103/336 (30%), Gaps = 63/336 (18%)
Query: 121 TFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGH 180
+ D + + LG G F V+ N T VA+K + D +
Sbjct: 9 PYKDAR-----YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-T 53
Query: 181 KEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLLVY---------------EFMPRGSLEN 225
+ E+ L + + K +LL + E + L
Sbjct: 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL 113
Query: 226 HLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-DYNAKLSDF 284
+P +I+ GL ++H +I+ D K N+L++ D L
Sbjct: 114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171
Query: 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDK 344
+A G T + T Y +PE ++ +D++S ++ E++TG +
Sbjct: 172 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
Query: 345 NRPNGEHNLVEWAR------------------------PHLGERRRFYRLIDPRLEG--- 377
+ + + G R +L LE
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291
Query: 378 ---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVE 410
FS A++ + + L DP+ R +V
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 2e-15
Identities = 25/158 (15%), Positives = 50/158 (31%), Gaps = 16/158 (10%)
Query: 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH 195
L+GEG VF + E+ G VK + K + G +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 196 LNLVKLIGYCIED----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLA 251
L KL G + + ++ E + L ++ + +A
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117
Query: 252 FLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289
+ R +++ D N+L+ + + DF + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 487 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.81 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d1qu6a2 | 89 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 93.74 | |
| d1x48a1 | 76 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 93.14 | |
| d1x49a1 | 85 | dsRNA-dependent protein kinase pkr {Mouse (Mus mus | 86.35 | |
| d1x47a1 | 85 | Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | 83.96 | |
| d1qu6a1 | 90 | dsRNA-dependent protein kinase pkr {Human (Homo sa | 83.91 | |
| d1o0wa2 | 69 | RNase III, C-terminal domain {Thermotoga maritima | 81.11 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-58 Score=443.16 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=207.3
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++++.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3579999999999999999999875 6779999999755432 33568899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..|||||||++|+|.++|.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhh
Confidence 9999999999999999999854 457999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
+...........+..+||+.|||||++.+..| +.++|||||||+||||++|+.||.......... .... ....
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~-----~~~~ 224 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK-----EKKT 224 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHH-----TTCT
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHHh-----cCCC
Confidence 87654443334456789999999999988876 578999999999999999999997544322111 1100 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
........+..+.+|+.+||+.||++|||+.|++++
T Consensus 225 ---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 ---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000011224678899999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=440.68 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=205.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||+||+|+++. .||||+++.... ...+.|.+|+.+|++++|||||+++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 445789999999999999999997642 699999975433 334678999999999999999999998
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+. ++.++||||||++|+|.++|......+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+||
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccc
Confidence 75 45689999999999999999777778999999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceecc---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|+|+...............||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+...... +....
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~---- 222 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMV---- 222 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHH----
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHH----
Confidence 99987655443334456789999999999864 3589999999999999999999999976433211 11100
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... ...+. ....+..+++.+.+|+.+||+.||.+|||+.||+++|+.+
T Consensus 223 ~~~-----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 223 GRG-----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp HHT-----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcC-----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 000 00111 1112223456899999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=441.85 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=210.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++++.||+|+||+||+|++.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 3579999999999999999998765 6789999999766656667899999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.+|||||||++|+|.+++.++ .+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhe
Confidence 9999999999999999987553 5999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+..... ..... ....
T Consensus 165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~---~~~~---- 232 (293)
T d1yhwa1 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI---ATNG---- 232 (293)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HHHC----
T ss_pred eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHH---HhCC----
Confidence 7654332 2344689999999999999999999999999999999999999996543211 11100 0000
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+ ....+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 233 ---~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 ---TP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---SC--CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CC--CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 001112234678999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=436.89 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=207.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 579999999999999999999865 67799999986432 233467889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++..|||||||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999999999999654 46999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++...... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... .+... ....
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~---i~~~--- 219 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKR---ISRV--- 219 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH---HHTT---
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHH---HHcC---
Confidence 98765432 33468999999999999999999999999999999999999999754321 11110 0000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. .++...++.+.+|+.+||+.||.+|||+.|++++
T Consensus 220 -----~~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 220 -----EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----CC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 01 1122234678999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=440.21 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=210.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
+.|++++.||+|+||+||+|++.. +|..||||+++.......+.+.+|+++|++++|||||++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 568999999999999999999875 67799999998766666678999999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..|||||||++|+|.+++.+....+++..+..|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhc
Confidence 999999999999999998776678999999999999999999999988 99999999999999999999999999976
Q ss_pred CCCCCcceeeeeccccccccCCceec-----cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVM-----TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
..... ......+||+.|||||++. ...|+.++|||||||+||||++|+.||........ .... ....
T Consensus 160 ~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i---~~~~ 231 (288)
T d2jfla1 160 NTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKI---AKSE 231 (288)
T ss_dssp CHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHH---HHSC
T ss_pred cCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHH---HcCC
Confidence 43211 1223468999999999984 45689999999999999999999999976543221 1100 0000
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.+.+ ..+...+..+.+||.+||+.||.+|||+.|++++
T Consensus 232 -------~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 -------PPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -------CCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -------CCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 1112334678999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-57 Score=440.75 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=215.7
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+++..++|++.+.||+|+||+||+|++.. +|+.||||+++... ...++|.+|+++|++++|||||+++++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~ 81 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 81 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCcc
Confidence 34456789999999999999999999875 57799999997654 345789999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
|.+++..+||||||++|+|.+++.+. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~D 158 (287)
T d1opja_ 82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 158 (287)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcc
Confidence 99999999999999999999999754 457899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 284 FGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
||+++....... .......||+.|||||++.+..|+.++|||||||++|||++|..||...... ..+.... .
T Consensus 159 FG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i----~- 230 (287)
T d1opja_ 159 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL----E- 230 (287)
T ss_dssp CCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH----H-
T ss_pred ccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHH----h-
Confidence 999997654332 2233456899999999999999999999999999999999977766432211 1111111 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
......++..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 231 ---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 231 ---------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01111122234567999999999999999999999999998663
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=441.12 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=208.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||+||+|++.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 579999999999999999999865 67799999986432 233467899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++.+|||||||++|+|.+++... ..+++..++.++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccccc
Confidence 999999999999999999988654 47999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|+..............+||+.|||||++.+..|+.++|||||||+||||++|..||...... .+... ....
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~---i~~~--- 225 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQK---IIKL--- 225 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHTT---
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHH---HHcC---
Confidence 98765444333344578999999999999999999999999999999999999999754321 11110 0110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--hcCCCCCcc
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA--LKPLPNLKD 420 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~l~~~~~ 420 (487)
... ++...+..+.+||.+||+.||.+|||+.|++++ +..++.+.+
T Consensus 226 -----~~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 226 -----EYD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp -----CCC----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred -----CCC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 011 122234678999999999999999999997653 334444433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-57 Score=433.29 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=200.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|++++.||+|+||+||+|++. ++..||||+++... ...++|.+|++++++++|||||++++++.+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 57889999999999999999875 35679999997644 34578999999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
..+||||||++|+|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhee
Confidence 999999999999999999877778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......||+.|||||++.+..|+.++|||||||+||||+|+ .+||..... ..+..... .. .
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~----~~---~ 219 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIS----TG---F 219 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHH----HT---C
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----hc---C
Confidence 6543322 23345799999999999999999999999999999999995 454433211 11111111 00 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.. .+..++..+.+|+.+||+.||++|||++||+++|+.+
T Consensus 220 ~~~-------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 220 RLY-------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 1122346789999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=434.70 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=195.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|+++. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999999875 6779999999766443 23558899999999999999999999865
Q ss_pred --CCeeEEEEeeCCCCChhHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCcEEEcCCCcEE
Q 011385 208 --DDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLAFLHEEA--ERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDLKp~NIll~~~~~~k 280 (487)
++.+|||||||++|+|.+++.+ ....+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 4568999999999999999863 3567999999999999999999999864 13499999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
|+|||+++....... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...... .+.....
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~-- 227 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIR-- 227 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH--
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHH--
Confidence 999999987654322 234578999999999999999999999999999999999999999754321 1111110
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. . .+.+. ...+..+.+||.+||+.||.+|||+.||+++
T Consensus 228 -~~--~-----~~~~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 -EG--K-----FRRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -HT--C-----CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cC--C-----CCCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 0 01111 2234678999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-56 Score=437.72 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=202.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.++|++.++||+|+||+||+|+++.++. ....||||.+...... ..++|.+|+++|++|+|||||++++++.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 3578888999999999999999875322 2346899998654333 34579999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++.++||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999999999777778999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCccee---eeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 288 KDGPEGDKTHV---STRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 288 ~~~~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+.......... .....||+.|||||++.+..|+.++|||||||+||||+| |..||...... .+..... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~----~ 248 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE----Q 248 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH----T
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence 87654322211 122468999999999999999999999999999999998 89999754321 1111111 0
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. . ....+..++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 249 ~------~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 249 D------Y----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp T------C----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C------C----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 0 1111223457789999999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=446.33 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=206.9
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++++.||+|+||+||+|++.. +|+.||||+++...... ...+.+|+.+|++++|||||+++++|.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 35789999999999999999998865 67899999997653333 456899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEE-AERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
+++++|||||||++|+|.+++.+. ..+++..+..++.||+.||.|||+. + ||||||||+||||+.+|.+||+|||
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCC
Confidence 999999999999999999999655 4699999999999999999999974 6 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhhhhhc-
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLGE- 363 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~~~~~~- 363 (487)
+|+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.............. .......
T Consensus 151 la~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 99864321 23346899999999999999999999999999999999999999976443211000000 0000000
Q ss_pred ---------------------------ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 ---------------------------RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.........+.+.. ...+.++.+||.+||+.||.+|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000011110 1123578999999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=441.86 Aligned_cols=264 Identities=24% Similarity=0.388 Sum_probs=212.1
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||+||+|++..... ......||||.+..... .....+.+|+.+|.++ +|||||+++++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 345689999999999999999999875322 12345799999865432 3346789999999998 89999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVI 262 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii 262 (487)
+.+.+.+|||||||++|+|.++|..+. ..+++..++.|+.||+.||.|||+++ ||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---Ii 186 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV 186 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999996543 24889999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCC
Q 011385 263 YRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRS 341 (487)
Q Consensus 263 HrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 341 (487)
||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |..|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999999999999999999999999987655444444455679999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 342 MDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
|.+...... +... +... .....+..++..+.+||.+||+.||++|||+.||+++|.
T Consensus 267 f~~~~~~~~--~~~~----~~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDAN--FYKL----IQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHH--HHHH----HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHH--HHHH----HhcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 976543211 1111 1110 111122234568999999999999999999999999984
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.2e-56 Score=442.31 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=212.0
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++++.||+|+||+||+|++.. +|+.||||++........+.+.+|+++|++|+|||||++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3689999999999999999999865 6789999999776555556789999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC--CCcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA--DYNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~--~~~~kl~DFGl 286 (487)
+.+|||||||+||+|.+++.+....+++..++.|+.||+.||.|||+++ ||||||||+||||+. ++.+||+|||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence 9999999999999999999766667999999999999999999999988 999999999999964 58899999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... .+.... ......
T Consensus 173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~~~~~ 243 (350)
T d1koaa2 173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNV---KSCDWN 243 (350)
T ss_dssp CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCC
T ss_pred heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---HhCCCC
Confidence 98765433 234468999999999999999999999999999999999999999754321 111110 000000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
....... ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 244 ----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 ----MDDSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----SCCGGGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CCccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111 224678999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-56 Score=435.15 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=192.7
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
.+.|++.+.||+|+||+||+|++.. +|+.||||++....... ...+.+|+.+|++++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4679999999999999999998865 67799999997654332 3457899999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEeec
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDF 284 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~~kl~DF 284 (487)
++.+|||||||+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+||
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 9999999999999999999955 457999999999999999999999988 99999999999994 5789999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++...... .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.... .+.... ....
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i---~~~~ 225 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQI---LKAE 225 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HTTC
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---hccC
Confidence 9998754432 233468999999999999999999999999999999999999999754321 111111 1100
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. .+........+..+.+||.+||+.||.+|||+.|++++
T Consensus 226 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 Y--------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C--------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 01111112334678999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-55 Score=441.93 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=212.0
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++.........+.+|+++|++|+|||||+++++|.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999998865 67899999998765555567889999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc--CCCcEEEeecCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD--ADYNAKLSDFGLA 287 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~--~~~~~kl~DFGla 287 (487)
.+|||||||+||+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999999999999988777778999999999999999999999988 99999999999997 5789999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
+...... ......||+.|||||++.+..|+.++|||||||+||||+||+.||.+.... .+.... ...
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i---~~~---- 243 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNV---KRC---- 243 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH---HHC----
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC----
Confidence 9875543 234468999999999999999999999999999999999999999754321 111110 000
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+..+........+..+.+||.+||+.||.+|||+.|++++
T Consensus 244 ----~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 244 ----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111112234678999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=425.40 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=198.4
Q ss_pred CCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe--
Q 011385 132 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE-- 207 (487)
Q Consensus 132 y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-- 207 (487)
|++.+.||+|+||+||+|++.. ++..||+|.+...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 3667789999999999998865 5779999998654332 23568899999999999999999999875
Q ss_pred --CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc-CCCcEEEeec
Q 011385 208 --DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD-ADYNAKLSDF 284 (487)
Q Consensus 208 --~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~-~~~~~kl~DF 284 (487)
+..+|||||||++|+|.+++.+. ..+++..++.|+.||+.||+|||+++ .+||||||||+||||+ .++.+||+||
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeec
Confidence 35679999999999999999654 47999999999999999999999865 4599999999999996 5789999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
|+++..... .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .+..... ..
T Consensus 160 Gla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~----~~ 228 (270)
T d1t4ha_ 160 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT----SG 228 (270)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT----TT
T ss_pred CcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHH----cC
Confidence 999864332 2335689999999998865 69999999999999999999999996432211 1111100 00
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
...+. ++...++.+.+||.+||+.||++|||+.|++++
T Consensus 229 -----~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 229 -----VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00011 111223568999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=421.50 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=213.5
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeCC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIEDD 209 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~ 209 (487)
++|++++.||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++|||||++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 68999999999999999999985 356899999986544 3578999999999999999999999999999
Q ss_pred eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 210 QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 210 ~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
.+++||||+++|+|.+++......+++..++.|+.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhee
Confidence 999999999999999998777778999999999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcccccc
Q 011385 290 GPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFY 368 (487)
Q Consensus 290 ~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (487)
....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... ++.... ... .
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i----~~~---~ 218 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHI----AQG---L 218 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHH----HTT---C
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHHHHH----HhC---C
Confidence 6543322 2334679999999999999999999999999999999998 89999755321 111111 110 0
Q ss_pred cccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 369 RLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
+.. .+..++..+.+||.+||+.||++|||+.+|+++|..+
T Consensus 219 ~~~-------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLY-------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCC-------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCC-------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 1122346789999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=427.29 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=208.7
Q ss_pred hcCCCCCCe-ecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESL-LGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~-LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|.+.+. ||+|+||+||+|.++..+ ++..||||+++..... ..++|.+|+++|++++|||||++++++.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 356667775 999999999999886422 3568999999765432 3467999999999999999999999986
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+ +.+|||||||++|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 5 5689999999999999998776778999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 287 AKDGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 287 a~~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
++........ .......||+.|||||++.+..|+.++|||||||++|||+| |..||...... ++..... ..
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~----~~ 228 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE----QG 228 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----TT
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cC
Confidence 9876543322 22234578999999999999999999999999999999998 99999764321 1111111 10
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
..+ .++..++..+.+||.+||+.||++||++.+|++.|+.
T Consensus 229 ------~~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 229 ------KRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ------CCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 011 1222345688999999999999999999999998863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-56 Score=428.79 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=206.4
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
+..++|++.+.||+|+||+||+|+++ ++..||||+++... ...+.|.+|+++|++++|||||++++++.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 44578999999999999999999875 35689999997654 34578999999999999999999999875
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
++..+||||||++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence 45679999999999999987533 336899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+|+....... .......||+.|||||++.+..|+.++|||||||+||||+||..|+...... ..+.... ..
T Consensus 155 la~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i----~~-- 225 (272)
T d1qpca_ 155 LARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNL----ER-- 225 (272)
T ss_dssp TCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HT--
T ss_pred ceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHH----Hh--
Confidence 9987654332 2234467999999999999999999999999999999999966555332211 1111111 10
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
...+... ..++..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 226 ----~~~~~~p----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 226 ----GYRMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ----TCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cCCCCCc----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1111111 2234678999999999999999999999998874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-55 Score=432.76 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=203.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..|+.++.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+++|++|+|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 358999999999999999998865 67899999997654432 346889999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++..|||||||.+|+|..++.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCEEEEEEEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccc
Confidence 99999999999999999766644 457999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceecc---CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMT---GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~---~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
++.... ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||...... ..... ....
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~---i~~~ 229 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYH---IAQN 229 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---HHHS
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhC
Confidence 987543 233579999999999864 46899999999999999999999999754321 11100 0000
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..+.+. +...+..+.+||.+||+.||.+|||+.|++++
T Consensus 230 -------~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 -------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -------CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -------CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 001111 11234678999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=421.55 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=198.5
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCceeEEEEEEeCCeeEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGDLVHLNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~~l 213 (487)
+.||+|+||+||+|.+... .+++.||||+++...... .++|.+|+++|++++|||||++++++.+ +..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 4799999999999987642 246789999997543322 3579999999999999999999999865 46789
Q ss_pred EEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCCC
Q 011385 214 VYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPEG 293 (487)
Q Consensus 214 v~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~~ 293 (487)
|||||++|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.....
T Consensus 85 vmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 99999999999998654 57999999999999999999999988 999999999999999999999999999876543
Q ss_pred Ccc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccccccc
Q 011385 294 DKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRFYRLI 371 (487)
Q Consensus 294 ~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (487)
... .......||+.|||||++.+..|+.++|||||||++|||+| |..||.+.... .+.... ... .
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i----~~~------~ 227 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML----EKG------E 227 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTT------C
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHH----HcC------C
Confidence 322 22334679999999999999999999999999999999998 89999754321 111111 110 0
Q ss_pred CCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhc
Q 011385 372 DPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALK 413 (487)
Q Consensus 372 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 413 (487)
.+ .++..++..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 228 ~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 228 RM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 11 122234567899999999999999999999998875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=431.82 Aligned_cols=250 Identities=30% Similarity=0.370 Sum_probs=208.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++++.||+|+||.||+|++.. +|+.||||+++... ....+.+.+|+.+|+.++|||||++++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 4679999999999999999999865 67899999996432 23456789999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.+.+|||||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecc
Confidence 9999999999999999999998654 46899999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... .+.. .....
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~---~i~~~-- 220 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE---LILME-- 220 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHC--
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHH---HHhcC--
Confidence 9987543222 234578999999999999999999999999999999999999999765321 1111 11111
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
... ++...+..+.+||.+||+.||.+|++ +.|+++|
T Consensus 221 ------~~~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 ------EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCC----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111 12223467899999999999999995 7777764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=424.51 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=203.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
+.|++.++||+|+||.||+|.++..+. .....||||+++..... ...+|.+|+++|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 568888999999999999999875321 12247999999754433 234689999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..++|||||.+|+|.+++......+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999999988877778999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcc-eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKT-HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~-~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
........ .......||+.|||||++.+..|+.++|||||||+||||++|..||...... ..+.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----~~---- 228 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----ND---- 228 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HT----
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH----hc----
Confidence 76443221 2233457899999999999999999999999999999999976665432211 1111111 11
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
......+..++..+.+||.+||+.||++||++.||++.|+.+
T Consensus 229 ------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 229 ------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 011112223456799999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-55 Score=425.83 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=207.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc------cCHHHHHHHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~ 202 (487)
.++|++++.||+|+||+||+|++.. +|+.||||+++.... ...+.+.+|+++|++|+|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3679999999999999999999865 678999999965432 2356799999999999999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC----c
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY----N 278 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~----~ 278 (487)
+++.+++.+|||||||++|+|.++|... ..+++..++.++.||+.||+|||+.+ ||||||||+|||++.++ .
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence 9999999999999999999999999654 47999999999999999999999988 99999999999998776 5
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++....... .....||+.|||||++.+..|+.++|||||||+||||++|..||.+..... .....
T Consensus 156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i- 228 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANV- 228 (293)
T ss_dssp EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-
T ss_pred eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHH-
Confidence 99999999987654332 334679999999999999999999999999999999999999997543211 11100
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
......+ ...... ..+..+.+||.+||+.||.+|||+.|++++
T Consensus 229 --~~~~~~~----~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 229 --SAVNYEF----EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp --HTTCCCC----CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HhcCCCC----CchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 000011 224678899999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=422.18 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=201.6
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
..++|++.+.||+|+||+||+|++...+. .+..||||.++...... .+.+.+|+++|++++|||||++++++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 45689999999999999999999875332 45679999986544332 356899999999999999999999985
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
++.+|||||||++|+|.+++......+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence 56789999999999999998777778999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
++....... ...+...||+.|+|||++.+..|+.++|||||||+||||++ |.+||....... +..... ..
T Consensus 155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~----~~- 225 (273)
T d1mp8a_ 155 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NG- 225 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH----TT-
T ss_pred heeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cC-
Confidence 987654322 22344678999999999999999999999999999999998 899997654322 111111 00
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..+. ++..++..+.+||.+||+.||.+|||+.||+++|+.+
T Consensus 226 -----~~~~----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 226 -----ERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp -----CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0111 2223456899999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-54 Score=424.74 Aligned_cols=246 Identities=27% Similarity=0.378 Sum_probs=205.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||+||+|+++. +|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 579999999999999999999865 67799999996432 234567899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+++.+|+|||||+||+|..++... ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999999999988544 56889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|+..... ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+..... +.. ......
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~~-- 217 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KILNAE-- 217 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHCC--
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HHH---HHHcCC--
Confidence 9876442 234689999999999999999999999999999999999999997543211 111 111110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
.. ++...+..+.+++.+||+.||.+|+ ++.++++|
T Consensus 218 ------~~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ------LR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------CC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------CC----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11 1112346789999999999999996 88888875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=423.61 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=206.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+|+++++||+|+||+||+|.+..++.. ....||||.++... ....+++.+|+++|++++|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4799999999999999999998753321 23369999986543 34467899999999999999999999999865
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
..+++|||+.+|+|.+++......+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 567889999999999999888888999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhccccc
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGERRRF 367 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (487)
...............||+.|||||++.++.|+.++|||||||+||||+| |.+||....... +.... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i----~~~--- 229 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKG--- 229 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH----HHT---
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcC---
Confidence 7655444434445679999999999999999999999999999999998 788887543321 11111 010
Q ss_pred ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 368 YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..+ ..+..++..+.+|+.+||+.||.+|||+.||+++|+.+
T Consensus 230 ---~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ---ERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ---CCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 001 11223346789999999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-53 Score=426.17 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=202.5
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHH---HHHHHHhcCCCCCceeEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGDLVHLNLVKLI 202 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~HpnIv~~~ 202 (487)
.++|+++++||+|+||.||+|++.. +|+.||||++..... .....+. .|+++++.++|||||+++
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 3689999999999999999999875 678999999864321 1222333 457788888999999999
Q ss_pred EEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEe
Q 011385 203 GYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLS 282 (487)
Q Consensus 203 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~ 282 (487)
+++.+++.+|||||||++|+|.++|.+. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEEC
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEe
Confidence 9999999999999999999999999654 56899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 283 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
|||+|+...... ....+||+.|||||++.. ..|+.++|||||||+||||+||+.||..........+... ..
T Consensus 150 DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~ 222 (364)
T d1omwa3 150 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL 222 (364)
T ss_dssp CCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SS
T ss_pred eeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cc
Confidence 999998765432 234579999999999874 5799999999999999999999999976544322221111 00
Q ss_pred hcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 362 GERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
. ....+.. ..+..+.+||.+||+.||.+||+ +.||++|
T Consensus 223 ~--------~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 T--------MAVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp S--------CCCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred c--------CCCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 0111122 23467899999999999999999 5777764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=414.49 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=208.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.++|++++.||+|+||+||+|++.. +|+.||||+++..... ...+.+|+++|+.++|||||++++++.++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4689999999999999999998875 6789999999765432 34578999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC--CcEEEeecCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD--YNAKLSDFGL 286 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~--~~~kl~DFGl 286 (487)
+.+|||||||+||+|.++|..+...+++..++.|+.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccch
Confidence 9999999999999999999777668999999999999999999999988 9999999999999754 5899999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .+... .......
T Consensus 151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~---i~~~~~~ 221 (321)
T d1tkia_ 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIEN---IMNAEYT 221 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH---HHHTCCC
T ss_pred hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhCCCC
Confidence 98765433 234467999999999999999999999999999999999999999764321 11110 0110000
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+ +..... ..+.++.+||.+||+.||.+|||+.|++++
T Consensus 222 ~----~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 F----DEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp C----CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----Chhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000011 124578999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-54 Score=421.28 Aligned_cols=267 Identities=24% Similarity=0.361 Sum_probs=213.4
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
+...++|++++.||+|+||+||+|+++... ...++..||||+++...... .+++.+|+++|++++||||++++++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 345678999999999999999999986321 12356789999997654332 4569999999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS-----------------------LPLPWSIRMKIALGAAKGLAFLHEEAERPV 261 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~i 261 (487)
+...+..++||||+++|+|.++|.... ..+++..++.|+.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999986432 24889999999999999999999988 9
Q ss_pred EecCCCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCC-C
Q 011385 262 IYRDFKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-R 340 (487)
Q Consensus 262 iHrDLKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~-~ 340 (487)
|||||||+||||+.++.+||+|||+++...........+...||+.|+|||++.+..|+.++|||||||+||||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998654443333444578999999999999999999999999999999999986 5
Q ss_pred CCCCCCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 341 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 341 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
||...... .+.... .... .+.. +..++.++.+||.+||+.||++||||.||+++|+.+.
T Consensus 242 p~~~~~~~---e~~~~v----~~~~------~~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE---EVIYYV----RDGN------ILAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH---HHHHHH----HTTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH---HHHHHH----HcCC------CCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 67543221 111111 1100 1111 2233467899999999999999999999999998663
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=421.34 Aligned_cols=269 Identities=28% Similarity=0.379 Sum_probs=203.6
Q ss_pred HHHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeE
Q 011385 124 DLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKL 201 (487)
Q Consensus 124 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~ 201 (487)
.+.+..++|++++.||+|+||.||+|++.... +..+++.||||+++..... ..+.+.+|+.++.++ +|+|||.+
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTT----SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCC----cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 33445678999999999999999999986532 2235678999999754332 345678888888877 68999999
Q ss_pred EEEEEeC-CeeEEEEeeCCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 011385 202 IGYCIED-DQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRD 265 (487)
Q Consensus 202 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD 265 (487)
++++... ..+++|||||++|+|.++|... ...+++..++.++.||+.||.|||+++ |||||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9988764 4689999999999999999643 234889999999999999999999988 99999
Q ss_pred CCCCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCC-CCCCC
Q 011385 266 FKTSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSMDK 344 (487)
Q Consensus 266 LKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~-~pf~~ 344 (487)
|||+||||+.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+||. +||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765544433444568999999999999999999999999999999999975 56754
Q ss_pred CCCCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 345 NRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... .+... +... ..+.. +...+..+.+||.+||+.||++|||+.||+++|+.+
T Consensus 240 ~~~~~--~~~~~----~~~~------~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 VKIDE--EFCRR----LKEG------TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCCSH--HHHHH----HHHT------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH--HHHHH----HhcC------CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 43221 11111 1111 11111 122346789999999999999999999999999754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-53 Score=425.39 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=206.3
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
++|++++.||+|+||.||+|+++. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 689999999999999999999865 67899999986432 233467899999999999999999999999
Q ss_pred eCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 207 EDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 207 ~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
+....++||||+.+|+|..++.+. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999999999999655 46999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
|+..... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.... .+... ....
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~---i~~~--- 253 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEK---IVSG--- 253 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHC---
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHH---HhcC---
Confidence 9876432 23468999999999999999999999999999999999999999754321 11110 0110
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-----LMSEVVEA 411 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 411 (487)
...... ..+.++.+||.+||+.||.+|+ ++.+|++|
T Consensus 254 -----~~~~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 -----KVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 011111 2346789999999999999994 88888864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=415.54 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=202.4
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++.+.||+|+||+||+|+++. +..||||+++... ...+.|.+|+.+|++++|||||++++++.
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~- 82 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 82 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence 34689999999999999999998863 4579999997554 34578999999999999999999999985
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGL 286 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGl 286 (487)
++..++|||||++|+|..++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++++||+|||+
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence 45689999999999999988643 356999999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccc
Q 011385 287 AKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRR 366 (487)
Q Consensus 287 a~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 366 (487)
++....... .......||+.|+|||++....++.++|||||||+||||++|..||...... ..+..... .
T Consensus 160 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----~--- 229 (285)
T d1fmka3 160 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----R--- 229 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----T---
T ss_pred hhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----h---
Confidence 987644332 2234467999999999999999999999999999999999976666433221 11111111 0
Q ss_pred cccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCCC
Q 011385 367 FYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPLP 416 (487)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l~ 416 (487)
..... .+..++..+.+||.+||+.||++||++.+|+++|+.+.
T Consensus 230 ---~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 230 ---GYRMP----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ---TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---cCCCC----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 01111 22234567999999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-53 Score=408.32 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=201.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++.+.||+|+||+||+|++.. +|+.||||+++...... ...+.+|+++|+.++|||||++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 4679999999999999999999865 67899999997654433 34688999999999999999999998
Q ss_pred EeCC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 206 IEDD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 206 ~~~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
...+ .+|||||||+||+|.+++... ..+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.++|
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCcccccee
Confidence 8754 378999999999999988654 46999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCc-ceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 282 SDFGLAKDGPEGDK-THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 282 ~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
+|||++........ .......+||+.|||||++.+..|+.++|||||||+||||+||+.||....... .....
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~ 226 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQH 226 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHH
Confidence 99999876533221 122345689999999999999999999999999999999999999997543211 11111
Q ss_pred hhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhcCC
Q 011385 361 LGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARP-LMSEVVEALKPL 415 (487)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~l 415 (487)
+......... ... ..+..+.+||.+||+.||.+|| +++++++.|.++
T Consensus 227 ~~~~~~~~~~----~~~----~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 227 VREDPIPPSA----RHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHCCCCCGGG----TSS----SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhcCCCCCch----hcc----CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1111111001 111 2346789999999999999999 899998877643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=419.55 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=201.5
Q ss_pred hcCCCCCC-eecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCceeEEEEEE
Q 011385 129 TRNFRPES-LLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDL-VHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~ 206 (487)
.++|+++. +||+|+||+||+|++.. +|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 36788874 69999999999999865 6779999999643 5688999987655 8999999999987
Q ss_pred e----CCeeEEEEeeCCCCChhHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC---CCc
Q 011385 207 E----DDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA---DYN 278 (487)
Q Consensus 207 ~----~~~~~lv~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~---~~~ 278 (487)
+ +..+|||||||+||+|.++|.++ ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++. .+.
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCC
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccc
Confidence 5 46789999999999999999765 356999999999999999999999988 999999999999975 567
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++....... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+............
T Consensus 153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~-- 227 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-- 227 (335)
T ss_dssp EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--
Confidence 99999999987654332 3346899999999999999999999999999999999999999976543221111000
Q ss_pred hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. ......+........++++.+||.+||+.||.+|||+.|++++
T Consensus 228 -~i-------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 -RI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -CC-------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HH-------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 0000001111112345789999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=414.14 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=200.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCceeEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGDLVHLNLVKLIGYC 205 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 205 (487)
.++|++++.||+|+||+||+|++..... ....||||+++.... ...++|.+|+.+|++++|||||++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~------~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSG------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTS------CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCC------cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3679999999999999999998864321 334789999875433 2245789999999999999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+ +..+||||||++|+|.+++..+...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred ee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence 65 5678999999999999988777778999999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcce-eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhc
Q 011385 286 LAKDGPEGDKTH-VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGE 363 (487)
Q Consensus 286 la~~~~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 363 (487)
+++......... ......|+..|+|||++.+..|+.++|||||||++|||+| |..||.+.... ...... ...
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i---~~~ 230 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKE 230 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTS
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH---HhC
Confidence 999865543322 2234568889999999999999999999999999999998 89999754321 111111 011
Q ss_pred ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 364 RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
. ..+. .+...+..+.+|+.+||+.||++|||+.||++.|++
T Consensus 231 ~------~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 G------ERLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp C------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C------CCCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0 1111 122234678999999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=410.15 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=198.3
Q ss_pred HhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 128 ATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 128 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..++|++++.||+|+||.||+|+++ |..||||+++... ..+.+.+|+++|++++|||||++++++.+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 3467889999999999999999873 5689999997653 34679999999999999999999999865
Q ss_pred -CCeeEEEEeeCCCCChhHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 208 -DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 208 -~~~~~lv~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+.++|||||+++|+|.++|..+. ..+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred cCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccc
Confidence 466899999999999999996542 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhhhhhcc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGER 364 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 364 (487)
+++..... .....+|..|+|||++.+..|+.++|||||||++|||+| |++||...... ++......
T Consensus 149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~----- 215 (262)
T d1byga_ 149 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK----- 215 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT-----
T ss_pred cceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc-----
Confidence 99875432 233568999999999999999999999999999999998 67777654322 22211110
Q ss_pred cccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 365 RRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
...+ .++...+..+.+|+.+||+.||.+|||+.+|+++|+.+
T Consensus 216 -----~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 216 -----GYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -----TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0111 12223346889999999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-53 Score=406.93 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=206.6
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC---------HHHHHHHHHHHhcCC-CCCc
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGDLV-HLNL 198 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-HpnI 198 (487)
.++|++++.||+|+||+||+|++.. +|+.||||++....... .+.+.+|+.+|++|+ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 3689999999999999999999865 57799999997654321 135789999999997 9999
Q ss_pred eeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 199 VKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 199 v~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
|++++++.+++..|||||||++|+|.++|..+ ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 148 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCC
Confidence 99999999999999999999999999999654 47999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceecc------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT------GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 352 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~------~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 352 (487)
+||+|||+++....... ....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.....
T Consensus 149 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--- 222 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--- 222 (277)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred eEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---
Confidence 99999999987654332 344689999999998853 457889999999999999999999997653211
Q ss_pred hhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 353 LVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.... ....... +........++.+.+|+.+||+.||.+||++.||+++
T Consensus 223 ~~~~---i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 MLRM---IMSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHH---HHHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHH---HHhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 0111000 0111111234679999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=418.98 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=204.9
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHh-cCCCCCceeEEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-DLVHLNLVKLIGYC 205 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~ 205 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++... ....+.+..|+.++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999999875 68899999996432 233456777877765 68999999999999
Q ss_pred EeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecC
Q 011385 206 IEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 285 (487)
Q Consensus 206 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFG 285 (487)
.+++.+|||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccc
Confidence 9999999999999999999999654 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhccc
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERR 365 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 365 (487)
+++....... ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... .+.... ...
T Consensus 149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i---~~~-- 218 (320)
T d1xjda_ 149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSI---RMD-- 218 (320)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC--
T ss_pred hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC--
Confidence 9987544322 234468999999999999999999999999999999999999999754321 111110 000
Q ss_pred ccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 011385 366 RFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMS-EVVEA 411 (487)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ell~~ 411 (487)
.+. ++...+..+.+||.+||+.||.+||++. ++++|
T Consensus 219 ------~~~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 ------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ------CCC----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 111 1222346789999999999999999985 67653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=413.64 Aligned_cols=267 Identities=27% Similarity=0.393 Sum_probs=209.9
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+..++|++++.||+|+||.||+|++...... ...++..||||+++.+... ...++.+|+..+.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 4457899999999999999999987653221 1224568999999765542 346788999999888 79999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS---------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTS 269 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~ 269 (487)
|.+++..++|||||++|+|.++|..+. ..+++..++.++.||+.||+|||+.+ ||||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 999999999999999999999996442 35899999999999999999999988 999999999
Q ss_pred cEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCCC
Q 011385 270 NILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNRPN 348 (487)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~ 348 (487)
|||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999997655444334455689999999999999999999999999999999998 68888654321
Q ss_pred CcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 349 GEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+... +... ..+.... .++..+.+||.+||+.||.+|||+.||++.|+.+
T Consensus 245 ---~~~~~----i~~~------~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFKL----LKEG------HRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHH----HHTT------CCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHH----HHcC------CCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11111 1111 1111122 2346789999999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=413.30 Aligned_cols=263 Identities=24% Similarity=0.271 Sum_probs=196.4
Q ss_pred CCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccC-----HHHHHHHHHHHhcCCCCCceeEEEEEEeC
Q 011385 134 PESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGDLVHLNLVKLIGYCIED 208 (487)
Q Consensus 134 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 208 (487)
.+++||+|+||+||+|++.. +|+.||||+++...... .+.+.+|+.+|++++|||||++++++.++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 35789999999999998765 67899999996543321 24588999999999999999999999999
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+..|||||||.++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 73 ~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp TCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred CceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccc
Confidence 9999999999887666544 55567999999999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--hhh---h
Q 011385 289 DGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PHL---G 362 (487)
Q Consensus 289 ~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~~---~ 362 (487)
....... .....+||+.|||||++.. ..|+.++|||||||++|||++|.+||...........+.... +.. .
T Consensus 149 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 149 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 7654332 2234679999999998864 468999999999999999999999997643321111100000 000 0
Q ss_pred cccccccccCCccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFS-----IKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..........-......+ ...+..+.+||.+||+.||++|||+.|+|+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000000000000 1224678999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=414.49 Aligned_cols=265 Identities=27% Similarity=0.399 Sum_probs=214.7
Q ss_pred HHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCceeEEEE
Q 011385 127 LATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDL-VHLNLVKLIGY 204 (487)
Q Consensus 127 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~~~~~ 204 (487)
+..++|++.+.||+|+||.||+|++... .+..++..||||+++..... ...++.+|+.++.++ +|||||+++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3457899999999999999999998532 12236789999999765432 345688999999999 69999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRS-----------------LPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFK 267 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLK 267 (487)
+.+.+..+||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++ |||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 999999999999999999999986532 25889999999999999999999988 9999999
Q ss_pred CCcEEEcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHh-CCCCCCCCC
Q 011385 268 TSNILLDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLT-GRRSMDKNR 346 (487)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~ 346 (487)
|+|||++.++.+||+|||+++...........+..+||+.|+|||++.+..++.++|||||||++|||+| |.+||....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998766555555556789999999999999999999999999999999999 555554433
Q ss_pred CCCcchhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcC
Q 011385 347 PNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKP 414 (487)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 414 (487)
.... +.... .. ...+ ..+...+..+.+||.+||+.||.+|||+.+|+++|+.
T Consensus 253 ~~~~--~~~~i----~~------~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 253 VDSK--FYKMI----KE------GFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SSHH--HHHHH----HH------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH--HHHHH----hc------CCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2211 11111 00 0111 1112234679999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=409.07 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=200.8
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++..... ....+.+|+++|++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 589999999999999999999875 6779999999654322 24678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++.+|||||||.++.+..........+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 73 ~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcc
Confidence 99999999999764444333445667999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h-------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R------- 358 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~------- 358 (487)
+....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+............. .
T Consensus 150 ~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 86543222 233457999999999887665 478999999999999999999999754321110000000 0
Q ss_pred hhhhcccccccccCCccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRFYRLIDPRLEGH---FSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.................... .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000000000000000 001123578999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=410.75 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=203.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDL-VHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 207 (487)
++|++.++||+|+||+||+|+++..+. ...||||+++.... ...+.+.+|+++|.++ +|||||++++++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGL-------RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE-------EEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCe-------EEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 688899999999999999999875221 12578888754322 3345799999999999 79999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEE
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRR---------------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNIL 272 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIl 272 (487)
++.++||||||++|+|.++|..+ ...+++..++.++.||+.||.|||+.+ ||||||||+|||
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 159 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence 99999999999999999998643 356999999999999999999999988 999999999999
Q ss_pred EcCCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCC-CCCCCCCCCcc
Q 011385 273 LDADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR-SMDKNRPNGEH 351 (487)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~-pf~~~~~~~~~ 351 (487)
++.++.+||+|||+++...... ......||..|+|||.+.+..|+.++|||||||++|||++|.. ||..... .
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~ 233 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---A 233 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H
T ss_pred EcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---H
Confidence 9999999999999998654322 1223569999999999999999999999999999999999765 5644321 1
Q ss_pred hhhHhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 352 NLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.+..... .. ..+ .++..++..+.+||.+||+.||++|||+.||+++|+.+
T Consensus 234 ~~~~~i~----~~------~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 234 ELYEKLP----QG------YRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHGG----GT------CCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHH----hc------CCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111 10 111 12223456899999999999999999999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=406.27 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=203.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCceeEEEEEEe-CCeeE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGDLVHLNLVKLIGYCIE-DDQRL 212 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~~ 212 (487)
.++||+|+||+||+|++..... +...||||+++... ....++|.+|+++|++++|||||++++++.. +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 5789999999999999865321 34469999997533 2334679999999999999999999999876 46789
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCCCCC
Q 011385 213 LVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKDGPE 292 (487)
Q Consensus 213 lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~~~~ 292 (487)
+|||||++|+|.+++......+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 999999999999999877777889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCcce--eeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhhcccccccc
Q 011385 293 GDKTH--VSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGERRRFYRL 370 (487)
Q Consensus 293 ~~~~~--~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (487)
..... ......||+.|+|||.+....++.++|||||||+||||+||..||....... ++..... .. . +.
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~---~g-~---~~ 253 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL---QG-R---RL 253 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TT-C---CC
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH---cC-C---CC
Confidence 33221 2223578999999999999999999999999999999999888876433211 1111111 00 0 01
Q ss_pred cCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 371 IDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 371 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
. .+..++..+.+||.+||+.||++||++.||+++|+.+
T Consensus 254 ~-------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 L-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1122346789999999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=408.74 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=212.1
Q ss_pred HHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCceeEEEE
Q 011385 126 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGDLVHLNLVKLIGY 204 (487)
Q Consensus 126 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~~~ 204 (487)
.+..++|++.+.||+|+||+||+|.+.... +..++..||||+++..... ....+.+|++++++++|||||+++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 344578899999999999999999885311 1123568999999754332 23458899999999999999999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRR---------SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA 275 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~ 275 (487)
+..++..+||||||++|+|.+++... ...+++..+..++.||+.||.|||+++ ||||||||+||||+.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence 99999999999999999999988532 134789999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCC-CCCCCCCCCCcchhh
Q 011385 276 DYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLV 354 (487)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~-~pf~~~~~~~~~~~~ 354 (487)
++++||+|||+++...............||+.|+|||.+.+..++.++|||||||+||||+||. +||...... ...
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~ 245 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL 245 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 9999999999998765444333344567999999999999999999999999999999999985 666543221 111
Q ss_pred HhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 355 EWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
... .... .+. .+..++..+.+||.+||+.||++|||+.+|+++|+..
T Consensus 246 ~~i----~~~~------~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 RFV----MEGG------LLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHH----HTTC------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHH----HhCC------CCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111 0100 011 1122346799999999999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=402.28 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=201.9
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC---CCCCceeEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDL---VHLNLVKLIG 203 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~~~~ 203 (487)
.++|++++.||+|+||+||+|++... +++.||||+++..... ....+.+|+.+|+.| +|||||++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 46899999999999999999988542 3567999998643221 223466777777665 7999999999
Q ss_pred EEEe-----CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCc
Q 011385 204 YCIE-----DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 204 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~ 278 (487)
+|.. ....+++||||+++.+..........+++..++.++.||+.||+|||+++ ||||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 9853 34678999999888776666566677999999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 358 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 358 (487)
+||+|||+++...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+....
T Consensus 155 ~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 155 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 9999999998654322 2345789999999999999999999999999999999999999997654321111110000
Q ss_pred hh-----hh-----cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PH-----LG-----ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~-----~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. .. ....+.. ........+....++.+.+||.+||+.||.+|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCchhcccccccchhhhhcc-ccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 0000000 00001111222334678899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=399.27 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=198.4
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCC--CCCcee
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGDLV--HLNLVK 200 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~ 200 (487)
.++|++.++||+|+||+||+|++.. +|+.||||+++..... ...++.+|+.+|++++ |||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 3579999999999999999999865 6779999998654322 1234678999999986 899999
Q ss_pred EEEEEEeCCeeEEEEeeCCC-CChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCC-Cc
Q 011385 201 LIGYCIEDDQRLLVYEFMPR-GSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAD-YN 278 (487)
Q Consensus 201 ~~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~-~~ 278 (487)
+++++.+.+..++||||+.+ ++|.+++..+ ..+++..++.++.||+.||.|||+.+ ||||||||+||||+.+ +.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCe
Confidence 99999999999999999976 5777777544 57999999999999999999999988 9999999999999854 79
Q ss_pred EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 279 AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHL-TSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
+||+|||+++..... ..+..+||+.|||||++.+..+ +.++|||||||+||||++|+.||.... .+.
T Consensus 150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--- 217 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--- 217 (273)
T ss_dssp EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---
T ss_pred EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh---
Confidence 999999999875432 2345689999999999987765 577999999999999999999996421 110
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
... ..+...+ +.++.+||.+||+.||.+|||+.|++++
T Consensus 218 ----~~~--------~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 ----RGQ--------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----HCC--------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hcc--------cCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 0111222 4678999999999999999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=402.50 Aligned_cols=270 Identities=26% Similarity=0.350 Sum_probs=199.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHH--HHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|.+.+.||+|+||.||+|++ +|+.||||+++... .+.+.+ |+..+..++|||||++++++.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~ 68 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK 68 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence 5678889999999999999986 36799999996543 234444 5555667899999999999987
Q ss_pred CC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCcEEEcCCCc
Q 011385 208 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-----ERPVIYRDFKTSNILLDADYN 278 (487)
Q Consensus 208 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDLKp~NIll~~~~~ 278 (487)
++ .+|||||||++|+|.++|.+. .+++..++.++.|++.||.|||+.. .++||||||||+||||+.++.
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred CCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 54 578999999999999999654 5899999999999999999999741 235999999999999999999
Q ss_pred EEEeecCCCCCCCCCCcce--eeeeccccccccCCceeccCC------CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCc
Q 011385 279 AKLSDFGLAKDGPEGDKTH--VSTRVMGTYGYAAPEYVMTGH------LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGE 350 (487)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~~~~~~------~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 350 (487)
+||+|||+++......... .....+||+.|||||++.+.. ++.++|||||||+||||+||..||........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 9999999998754432211 233468999999999887542 67799999999999999999988854332211
Q ss_pred chhhH-hhhhhhhc--ccccccccCCccCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 351 HNLVE-WARPHLGE--RRRFYRLIDPRLEGHF-SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 351 ~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
..... ........ .......++|.+.... .......+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11000 00000000 0001111222222221 234556799999999999999999999999999754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.8e-51 Score=396.31 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=200.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999874 467999999966533 224679999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
++..+++|||+.++.+..+. .....+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccc
Confidence 99999999999776665554 55578999999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-------- 358 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-------- 358 (487)
........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.........+....
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 76543222 22335799999999998754 56899999999999999999999997543211111000000
Q ss_pred hhhhccccc---ccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 PHLGERRRF---YRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
......... .....+.....+....++.+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00001111111122234678999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=400.74 Aligned_cols=262 Identities=25% Similarity=0.323 Sum_probs=195.7
Q ss_pred CCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCceeEEEEEEeC--
Q 011385 131 NFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNLVKLIGYCIED-- 208 (487)
Q Consensus 131 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-- 208 (487)
+|+.+++||+|+||+||+|++.. +|+.||||++...... +.+|+++|++++|||||+++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 57888999999999999999875 6789999999765422 34799999999999999999998542
Q ss_pred ----CeeEEEEeeCCCCChhHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEE
Q 011385 209 ----DQRLLVYEFMPRGSLENHLF--RRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKL 281 (487)
Q Consensus 209 ----~~~~lv~E~~~~gsL~~~l~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl 281 (487)
.++|||||||+++.+..+.. .....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence 35789999997654433322 34567999999999999999999999988 99999999999999775 8999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceecc-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMT-GHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-- 358 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 358 (487)
+|||+++....... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||...........+....
T Consensus 165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987654332 234679999999998765 578999999999999999999999997553221111100000
Q ss_pred ------hhhhc---ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 ------PHLGE---RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ------~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
..... ...+.......+........+..+.+||.+||..||.+|||+.|+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000001100011111112335678999999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=388.75 Aligned_cols=270 Identities=23% Similarity=0.294 Sum_probs=197.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++.. +|+.||||++..... .....+.+|+++|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 689999999999999999999865 677999999865432 234678999999999999999999998865
Q ss_pred --------CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcE
Q 011385 208 --------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 279 (487)
Q Consensus 208 --------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~ 279 (487)
++..|+|||||.++.+.. +......+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ----------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred ccccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 346799999998766554 4355567999999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCCCCCCCCcc--eeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011385 280 KLSDFGLAKDGPEGDKT--HVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 356 (487)
Q Consensus 280 kl~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~ 356 (487)
||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+..
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765432221 112235799999999998765 689999999999999999999999975432211111111
Q ss_pred hhhhhhcc-------cccccccCCccCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 011385 357 ARPHLGER-------RRFYRLIDPRLEGHFSI-------KGAQKAAQLAAHCLSRDPKARPLMSEVVEAL 412 (487)
Q Consensus 357 ~~~~~~~~-------~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 412 (487)
........ ................. .....+.+||.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 10000000 00000000000000000 1134678999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-49 Score=385.23 Aligned_cols=260 Identities=20% Similarity=0.207 Sum_probs=201.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLN-LVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~~~ 208 (487)
++|++++.||+|+||+||+|++.. +|+.||||++...... .++..|+++++.++|+| |+.+.+++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 579999999999999999998865 6779999998765332 45789999999998776 55556667788
Q ss_pred CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc---CCCcEEEeecC
Q 011385 209 DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD---ADYNAKLSDFG 285 (487)
Q Consensus 209 ~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~---~~~~~kl~DFG 285 (487)
+..++||||| +++|.+.+......+++..++.++.||+.||+|||+++ ||||||||+|||++ .+..+||+|||
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred CEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccC
Confidence 8899999999 66787777777778999999999999999999999988 99999999999985 35679999999
Q ss_pred CCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhh
Q 011385 286 LAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARP 359 (487)
Q Consensus 286 la~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~~ 359 (487)
+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++|..||.............. ...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99876543221 123346899999999999999999999999999999999999999976544332222111 110
Q ss_pred hhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 360 HLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ..+.+.. .++.++.+|+.+||+.||++||++.+|.+.|+.+
T Consensus 232 ~~~~-------~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 232 KMST-------PIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHS-------CHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cCCC-------ChhHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 0000111 1236789999999999999999999988877643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=393.34 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=195.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++.. +|+.||||+++..... ..+.+.+|+++|+.++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999999865 6789999999754332 2356889999999999999999999998
Q ss_pred eCC------eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEE
Q 011385 207 EDD------QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAK 280 (487)
Q Consensus 207 ~~~------~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~k 280 (487)
..+ .+||||||| +++|..++.. ..+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccc
Confidence 654 569999999 6678776643 36999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhh
Q 011385 281 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 359 (487)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 359 (487)
|+|||+++..... .+...||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...............
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 9999999876432 2346799999999998764 568999999999999999999999976532211110000000
Q ss_pred h--------h--hc----ccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 360 H--------L--GE----RRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 360 ~--------~--~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
. . .. ...+.......+. ......+..+.+||.+||..||.+|||+.|||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 00 0000001111111 1111234578899999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=393.55 Aligned_cols=269 Identities=21% Similarity=0.280 Sum_probs=197.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
..+|++++.||+|+||+||+|++.. +|+.||||+++.... ...+.+.+|+.+|++|+|||||++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 3579999999999999999998765 678999999975443 224568899999999999999999999876
Q ss_pred CC----eeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEee
Q 011385 208 DD----QRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSD 283 (487)
Q Consensus 208 ~~----~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~D 283 (487)
.. ..+++|+|+.+|+|.+++..+ .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred ccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence 53 234555666799999999654 6899999999999999999999988 99999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeeeccccccccCCceec-cCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhh
Q 011385 284 FGLAKDGPEGDKT-HVSTRVMGTYGYAAPEYVM-TGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 361 (487)
Q Consensus 284 FGla~~~~~~~~~-~~~~~~~Gt~~y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 361 (487)
||+++........ ......+||+.|+|||++. ...|+.++||||+||++|||++|+.||...................
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999865432211 1223467999999999885 5577999999999999999999999997654321111110000000
Q ss_pred hc----------ccccccccCCccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 362 GE----------RRRFYRLIDPRLEG---HFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 362 ~~----------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. .............. ......+.++.+|+.+||+.||.+|||+.|+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000000000000 0001123568899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=390.56 Aligned_cols=257 Identities=27% Similarity=0.349 Sum_probs=205.4
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCC-CCceeEEEE
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGDLVH-LNLVKLIGY 204 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H-pnIv~~~~~ 204 (487)
++|++++.||+|+||+||+|++..+ +.+|+.||||+++.... ...+.+.+|+++|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSS------TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECcc------CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 5799999999999999999988543 23788999999864322 234567899999999976 899999999
Q ss_pred EEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeec
Q 011385 205 CIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 284 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DF 284 (487)
+.+....++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeec
Confidence 99999999999999999999998655 45788999999999999999999988 999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeeeccccccccCCceeccC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh
Q 011385 285 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG--HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 362 (487)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 362 (487)
|+++........ ......|++.|+|||.+.+. .++.++|||||||+||||++|..||...........+... ...
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~ 250 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILK 250 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHH
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--ccc
Confidence 999876443222 23346899999999998754 4788999999999999999999999876544332221111 000
Q ss_pred cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 011385 363 ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL-----MSEVVEA 411 (487)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 411 (487)
. .+. ++...+..+.+|+.+||+.||.+||+ ++|+++|
T Consensus 251 ~--------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 S--------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp C--------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred C--------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 111 12233578999999999999999995 7888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=378.50 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=205.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++..... ....+.+|+.+|+.++|||||++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999999865 6779999999655432 24678999999999999999999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCC
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 287 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla 287 (487)
.+..++|||++.+++|..++ .....+++..+..++.|++.||+|||+++ ||||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchh
Confidence 99999999999998888776 45567899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCcceeeeeccccccccCCceeccCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhhhh----
Q 011385 288 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGH-LTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---- 362 (487)
Q Consensus 288 ~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---- 362 (487)
+........ .....+++.|+|||++.... ++.++|||||||++|||++|+.||....... +..........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTE 224 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCT
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCCh
Confidence 876543322 23346788999999887655 6899999999999999999999975432211 11110000000
Q ss_pred ----------cccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 363 ----------ERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 363 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
+....................+..+.+|+.+||+.||.+|||++|||++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000111222334678899999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-48 Score=380.03 Aligned_cols=262 Identities=17% Similarity=0.168 Sum_probs=208.8
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC-CCceeEEEEEEe
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH-LNLVKLIGYCIE 207 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~~ 207 (487)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+.+|++++..|.| +||+.+++++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 4689999999999999999999865 577999999865432 2347789999999975 899999999999
Q ss_pred CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcC-----CCcEEEe
Q 011385 208 DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDA-----DYNAKLS 282 (487)
Q Consensus 208 ~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~-----~~~~kl~ 282 (487)
....++||||| +++|.+++......+++..+..++.|++.||+|||+.+ ||||||||+||||+. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 78999999777778999999999999999999999988 999999999999964 5789999
Q ss_pred ecCCCCCCCCCCcc-----eeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011385 283 DFGLAKDGPEGDKT-----HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 357 (487)
Q Consensus 283 DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~ 357 (487)
|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 99999875432211 1233468999999999999999999999999999999999999999865544332221111
Q ss_pred hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhcCC
Q 011385 358 RPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 415 (487)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~l 415 (487)
.... ...... .+... +++.+.+|+..|+..+|++||++..+.+.|+.+
T Consensus 229 ~~~~-~~~~~~-----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 229 GEKK-QSTPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHH-HHSCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred Hhcc-CCCChH-----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1000 000000 01111 235788999999999999999999988877654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=387.89 Aligned_cols=260 Identities=19% Similarity=0.232 Sum_probs=199.1
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEEEEEeC
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIGYCIED 208 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~~~ 208 (487)
++|++++.||+|+||+||+|++.. +|+.||||+++... .+++.+|+++|..+. ||||+++++++...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 589999999999999999999865 67899999997543 467899999999995 99999999999753
Q ss_pred --CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCC-cEEEeecC
Q 011385 209 --DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADY-NAKLSDFG 285 (487)
Q Consensus 209 --~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~-~~kl~DFG 285 (487)
..+++|||||.+++|..+. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.++ .+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccc
Confidence 5689999999999997754 46899999999999999999999988 99999999999998655 69999999
Q ss_pred CCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhh--Hhhh----
Q 011385 286 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--EWAR---- 358 (487)
Q Consensus 286 la~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~--~~~~---- 358 (487)
+|+....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||............ ....
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9987654332 3346799999999998764 5799999999999999999999999754432111000 0000
Q ss_pred ------hhhhcccccccccCC--------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 ------PHLGERRRFYRLIDP--------RLEGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ------~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
........+...... ..........+.++.+||.+||..||.+|||++|+|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 00001111234678999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=386.33 Aligned_cols=263 Identities=23% Similarity=0.293 Sum_probs=191.7
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEEe
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCIE 207 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 207 (487)
++|+++++||+|+||+||+|++.. +|+.||||++...... ...++.+|+.+|++++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 689999999999999999999865 6889999999755432 23468899999999999999999999964
Q ss_pred ------CCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 208 ------DDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 208 ------~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
...+|+|||||.++ |.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred ccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 36789999999665 444442 35899999999999999999999998 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhh--
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WAR-- 358 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~-- 358 (487)
+|||+++...... ..+..+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+. ...
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999988765432 2345689999999999999999999999999999999999999997543211110000 000
Q ss_pred ---------hh----hhcc-----cccccccCCcc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 359 ---------PH----LGER-----RRFYRLIDPRL---EGHFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 359 ---------~~----~~~~-----~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. .... ........... ........+..+.+||.+||..||++|||++|||+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000 00000110000 111123456788999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=380.46 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=196.2
Q ss_pred hcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCceeEEEEEE
Q 011385 129 TRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGDLVHLNLVKLIGYCI 206 (487)
Q Consensus 129 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 206 (487)
.++|++++.||+|+||+||+|++.. +|+.||||+++..... ..+.+.+|+++|+.|+|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999998865 6789999999765432 2356889999999999999999999986
Q ss_pred eC-----CeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEcCCCcEEE
Q 011385 207 ED-----DQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKL 281 (487)
Q Consensus 207 ~~-----~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~~~~~~kl 281 (487)
.. ...++||+|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccc
Confidence 43 344677788889999998854 36999999999999999999999988 999999999999999999999
Q ss_pred eecCCCCCCCCCCcceeeeeccccccccCCceeccC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhhh
Q 011385 282 SDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTG-HLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 360 (487)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 360 (487)
+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 163 ~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999765332 2346799999999987765 4688999999999999999999999765322111111000000
Q ss_pred hh----------cccccccccCCccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 011385 361 LG----------ERRRFYRLIDPRLEGHF---SIKGAQKAAQLAAHCLSRDPKARPLMSEVVEA 411 (487)
Q Consensus 361 ~~----------~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 411 (487)
.. ................+ ....+..+.+||.+||..||.+|||+.|+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 00000000000000000 01124578899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-43 Score=351.01 Aligned_cols=264 Identities=21% Similarity=0.238 Sum_probs=193.2
Q ss_pred cCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-----------CCCc
Q 011385 130 RNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-----------HLNL 198 (487)
Q Consensus 130 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnI 198 (487)
.+|+++++||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+++|+.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 469999999999999999999865 678999999976532 2356788999988875 5789
Q ss_pred eeEEEEEEe--CCeeEEEEeeCCCCChhHHH--hhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCcEEE
Q 011385 199 VKLIGYCIE--DDQRLLVYEFMPRGSLENHL--FRRSLPLPWSIRMKIALGAAKGLAFLHE-EAERPVIYRDFKTSNILL 273 (487)
Q Consensus 199 v~~~~~~~~--~~~~~lv~E~~~~gsL~~~l--~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDLKp~NIll 273 (487)
|++++++.. ....+++|+++..+...... ......+++..+..++.||+.||.|||+ .+ |+||||||+||||
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence 999988764 45667777777665443332 2345678999999999999999999998 66 9999999999999
Q ss_pred cCCCc------EEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHHHHHHhCCCCCCCCCC
Q 011385 274 DADYN------AKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRP 347 (487)
Q Consensus 274 ~~~~~------~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 347 (487)
+.++. ++|+|||.+...... ....+||+.|+|||++....|+.++|||||||+++||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 76653 999999999865432 2346799999999999999999999999999999999999999976443
Q ss_pred CCcchhhHhhh---hhhhc-----------------ccccccccCC----------ccCCCCCHHHHHHHHHHHHHhccc
Q 011385 348 NGEHNLVEWAR---PHLGE-----------------RRRFYRLIDP----------RLEGHFSIKGAQKAAQLAAHCLSR 397 (487)
Q Consensus 348 ~~~~~~~~~~~---~~~~~-----------------~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~ 397 (487)
........... ..++. .......+.. .....+....+..+.+||.+||..
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 22111110000 00000 0000000000 012234566778899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 011385 398 DPKARPLMSEVVEA 411 (487)
Q Consensus 398 dP~~RPs~~ell~~ 411 (487)
||.+|||+.|+|+|
T Consensus 315 dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 315 DPRKRADAGGLVNH 328 (362)
T ss_dssp STTTCBCHHHHHTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4.4e-26 Score=206.81 Aligned_cols=169 Identities=15% Similarity=0.105 Sum_probs=119.5
Q ss_pred CCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCcc-----C-------------HHHHHHHHHHHhcCC
Q 011385 133 RPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQ-----G-------------HKEWLAEVNFLGDLV 194 (487)
Q Consensus 133 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~-----~-------------~~~~~~E~~~l~~l~ 194 (487)
.+.+.||+|+||+||+|++. +|+.||||+++..... . .....+|+..+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 45679999999999999874 4779999987532110 0 122456889999999
Q ss_pred CCCceeEEEEEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCcEEEc
Q 011385 195 HLNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLD 274 (487)
Q Consensus 195 HpnIv~~~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDLKp~NIll~ 274 (487)
|++++..+++.. .+|||||++++.+.+ ++......++.|++.+|.|||+++ |+||||||+|||++
T Consensus 73 ~~~v~~~~~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCcceEEEecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeee
Confidence 999999887632 379999998866543 233445678999999999999988 99999999999998
Q ss_pred CCCcEEEeecCCCCCCCCCCcceeeeeccccccccCCceeccCCCCchhhhhhHHHHH
Q 011385 275 ADYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVL 332 (487)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~~~~DiwSlGvil 332 (487)
++ .++|+|||+|+............+.+... .+ +....|+.++|+||+.--+
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~~----~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWREILERDVRNI----IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHHHHHHHHHHHH----HH-HHHHHHCCCCCHHHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcHHHHHHHHHHH----HH-HHcCCCCCcccHHHHHHHH
Confidence 65 59999999997754322111000000000 01 1246788999999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=2.3e-08 Score=92.67 Aligned_cols=148 Identities=16% Similarity=0.019 Sum_probs=98.2
Q ss_pred HHHHhcCCCCCCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCceeEEE
Q 011385 125 LKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLV-HLNLVKLIG 203 (487)
Q Consensus 125 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~ 203 (487)
+......|+..+..+-++.+.||+... .+..++||+...........+.+|+..+..|. +--+.+++.
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~ 77 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE
Confidence 334445666666555455578998753 34568899886544333345778888887774 434677888
Q ss_pred EEEeCCeeEEEEeeCCCCChhHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------
Q 011385 204 YCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------- 257 (487)
Q Consensus 204 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-------------------------- 257 (487)
+..+++..++||++++|..+.+..... .. ...++.+++..+..||+..
T Consensus 78 ~~~~~~~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 78 FERHDGWSNLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEecCCceEEEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 888888999999999998876543211 11 2233445555555555411
Q ss_pred ------------------------------CCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 258 ------------------------------ERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 258 ------------------------------~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999998776667999997753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=8.6e-06 Score=74.35 Aligned_cols=75 Identities=20% Similarity=0.112 Sum_probs=51.9
Q ss_pred eecccCc-eeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC--CCceeEEEEEEeCCeeEE
Q 011385 137 LLGEGGF-GCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVH--LNLVKLIGYCIEDDQRLL 213 (487)
Q Consensus 137 ~LG~G~f-g~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~~~~~~l 213 (487)
.+..|.. +.||+.... .+..+++|....... ..+..|+..|+.|.. -.+.+++++..+++..++
T Consensus 17 ~~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECT----------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeC----------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3445543 678987653 355688898765433 246678887776643 335678888888888999
Q ss_pred EEeeCCCCChh
Q 011385 214 VYEFMPRGSLE 224 (487)
Q Consensus 214 v~E~~~~gsL~ 224 (487)
||++++|.++.
T Consensus 84 v~~~i~G~~~~ 94 (255)
T d1nd4a_ 84 LLGEVPGQDLL 94 (255)
T ss_dssp EEECCSSEETT
T ss_pred EEEeeeccccc
Confidence 99999887663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.91 E-value=2.4e-05 Score=76.59 Aligned_cols=78 Identities=14% Similarity=0.104 Sum_probs=48.6
Q ss_pred CCeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecC------CC-ccCHHHHHHHHHHHhcCC-C--CCceeEEEE
Q 011385 135 ESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGDLV-H--LNLVKLIGY 204 (487)
Q Consensus 135 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~-H--pnIv~~~~~ 204 (487)
.+.||.|....||++.... ++..|+||.-.. .. .....+...|++.|+.+. + ..+.+++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 3468999999999987643 356789997432 11 112234567888877662 2 345566654
Q ss_pred EEeCCeeEEEEeeCCCCCh
Q 011385 205 CIEDDQRLLVYEFMPRGSL 223 (487)
Q Consensus 205 ~~~~~~~~lv~E~~~~gsL 223 (487)
+.+..++|||++.+..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 45567899999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.39 E-value=0.00033 Score=68.12 Aligned_cols=80 Identities=19% Similarity=0.130 Sum_probs=53.0
Q ss_pred CeecccCceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-eeEEEEEEeCCeeEEE
Q 011385 136 SLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL-VKLIGYCIEDDQRLLV 214 (487)
Q Consensus 136 ~~LG~G~fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~~~~~~~~~~~~~lv 214 (487)
+.|+.|-.-.+|++....... +.......|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 578888889999998764321 22223456777776532 233456789999988853444 477777642 689
Q ss_pred EeeCCCCCh
Q 011385 215 YEFMPRGSL 223 (487)
Q Consensus 215 ~E~~~~gsL 223 (487)
|||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.81 E-value=0.002 Score=60.09 Aligned_cols=31 Identities=29% Similarity=0.256 Sum_probs=27.1
Q ss_pred CCCeEecCCCCCcEEEcCCCcEEEeecCCCC
Q 011385 258 ERPVIYRDFKTSNILLDADYNAKLSDFGLAK 288 (487)
Q Consensus 258 ~~~iiHrDLKp~NIll~~~~~~kl~DFGla~ 288 (487)
+.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4469999999999999988777899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0028 Score=59.48 Aligned_cols=134 Identities=16% Similarity=0.094 Sum_probs=75.1
Q ss_pred ceeEEEEEEccCCCCCccCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc--eeEE-----EEEEeCCeeEEEE
Q 011385 143 FGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHLNL--VKLI-----GYCIEDDQRLLVY 215 (487)
Q Consensus 143 fg~V~~~~~~~~~~~~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~HpnI--v~~~-----~~~~~~~~~~lv~ 215 (487)
--.||++... +|..|++|+.+... ....++..|...|..|...+| +..+ ..+......+.|+
T Consensus 35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 3579998764 46789999986543 234667888888887743222 1111 1223466778999
Q ss_pred eeCCCCChh-----HH------H---hh--c------CCCCCH-------------------H---HHHHHHHHHHHHHH
Q 011385 216 EFMPRGSLE-----NH------L---FR--R------SLPLPW-------------------S---IRMKIALGAAKGLA 251 (487)
Q Consensus 216 E~~~~gsL~-----~~------l---~~--~------~~~l~~-------------------~---~~~~i~~qi~~~l~ 251 (487)
++++|..+. .+ + .. . ....+. . .....+.++...+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999764331 10 0 00 0 011111 1 11122222332222
Q ss_pred HH-HhCCCCCeEecCCCCCcEEEcCCCcEEEeecCCCCC
Q 011385 252 FL-HEEAERPVIYRDFKTSNILLDADYNAKLSDFGLAKD 289 (487)
Q Consensus 252 yL-H~~~~~~iiHrDLKp~NIll~~~~~~kl~DFGla~~ 289 (487)
-+ ....+..+||+|+.+.|||++++ ..++||+-+..
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 22 12224568999999999999743 45899998764
|
| >d1qu6a2 d.50.1.1 (A:91-179) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.74 E-value=0.0046 Score=46.14 Aligned_cols=33 Identities=24% Similarity=0.120 Sum_probs=28.1
Q ss_pred ccccccccccchhhhhhhhccccccccchhhhh
Q 011385 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVEEEE 39 (487)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 39 (487)
+++.|+.|.|++||+||+.||+.++..+..++.
T Consensus 53 ~g~~~~~g~G~sKK~Akq~AA~~Al~~L~~~~~ 85 (89)
T d1qu6a2 53 GQKEYSIGTGSTKQEAKQLAAKLAYLQILSEET 85 (89)
T ss_dssp ETTBCCEEEESSHHHHHHHHHHHHHHHHHHCCC
T ss_pred CCccccccccchHHHHHHHHHHHHHHHHHccCC
Confidence 456889999999999999999999988865443
|
| >d1x48a1 d.50.1.1 (A:8-83) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.14 E-value=0.0062 Score=43.90 Aligned_cols=30 Identities=13% Similarity=0.044 Sum_probs=26.6
Q ss_pred ccccccccccchhhhhhhhccccccccchh
Q 011385 7 NGKVKKASWDSSKSKAKKKKKKVEDEVEVE 36 (487)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 36 (487)
++++|+.|+|++|++|+|.||+.+.+.+..
T Consensus 38 ~~~~~~~g~G~sKK~Aeq~AA~~Al~~L~~ 67 (76)
T d1x48a1 38 GQTMYGTGSGVTKQEAKQLAAKEAYQKLLK 67 (76)
T ss_dssp SSCEEEEEEESSHHHHHHHHHHHHHHHHHH
T ss_pred CCEEeCCcCccHHHHHHHHHHHHHHHHHHc
Confidence 456889999999999999999999988854
|
| >d1x49a1 d.50.1.1 (A:8-92) dsRNA-dependent protein kinase pkr {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Mouse (Mus musculus) [TaxId: 10090]
Probab=86.35 E-value=0.058 Score=39.42 Aligned_cols=28 Identities=18% Similarity=0.095 Sum_probs=24.6
Q ss_pred cccccccccchhhhhhhhccccccccch
Q 011385 8 GKVKKASWDSSKSKAKKKKKKVEDEVEV 35 (487)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (487)
++.|+.|+|++||+|++.||+.+.+.+.
T Consensus 48 g~~~~~g~g~sKK~Aeq~AA~~aL~~L~ 75 (85)
T d1x49a1 48 EKEFPEAKGRSKQEARNAAAKLAVDILD 75 (85)
T ss_dssp SCCCCCEEESSHHHHHHHHHHHHHHHHT
T ss_pred ceEeeccccccHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999887774
|
| >d1x47a1 d.50.1.1 (A:8-92) Dgcr8 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: Dgcr8 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.96 E-value=0.076 Score=38.74 Aligned_cols=27 Identities=30% Similarity=0.204 Sum_probs=23.6
Q ss_pred cccccccccchhhhhhhhccccccccc
Q 011385 8 GKVKKASWDSSKSKAKKKKKKVEDEVE 34 (487)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (487)
+++|+.|+|.+|+.|++.||+.+.+.+
T Consensus 49 g~~~~~g~G~sKK~Aeq~AA~~AL~~L 75 (85)
T d1x47a1 49 GVTYGSGTASSKKLAKNKAARATLEIL 75 (85)
T ss_dssp TEEEEEEEESSHHHHHHHHHHHHHHHH
T ss_pred CEEEecCCcchHHHHHHHHHHHHHHHH
Confidence 457899999999999999999887665
|
| >d1qu6a1 d.50.1.1 (A:1-90) dsRNA-dependent protein kinase pkr {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: dsRNA-dependent protein kinase pkr species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.91 E-value=0.073 Score=39.29 Aligned_cols=29 Identities=24% Similarity=0.191 Sum_probs=24.8
Q ss_pred cccccccccchhhhhhhhccccccccchh
Q 011385 8 GKVKKASWDSSKSKAKKKKKKVEDEVEVE 36 (487)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 36 (487)
++.++.|+|++||+|++.||+.+.+.+..
T Consensus 54 ~~~~~~g~G~sKK~Aeq~AA~~aL~~L~~ 82 (90)
T d1qu6a1 54 GREFPEGEGRSKKEAKNAAAKLAVEILNK 82 (90)
T ss_dssp SSCCCEEECCSSHHHHHHHHHHHHHHHHS
T ss_pred ceeeeccCCCcHHHHHHHHHHHHHHHHHh
Confidence 45778999999999999999999877743
|
| >d1o0wa2 d.50.1.1 (A:168-236) RNase III, C-terminal domain {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: dsRBD-like superfamily: dsRNA-binding domain-like family: Double-stranded RNA-binding domain (dsRBD) domain: RNase III, C-terminal domain species: Thermotoga maritima [TaxId: 2336]
Probab=81.11 E-value=0.11 Score=36.03 Aligned_cols=26 Identities=23% Similarity=0.294 Sum_probs=21.6
Q ss_pred cccccccccchhhhhhhhcccccccc
Q 011385 8 GKVKKASWDSSKSKAKKKKKKVEDEV 33 (487)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 33 (487)
++.++.|+|++|++|+|.||+.+.+.
T Consensus 42 ~~~~~~g~g~sKK~Aeq~AA~~aL~~ 67 (69)
T d1o0wa2 42 GKTIATGKGRTKKEAEKEAARIAYEK 67 (69)
T ss_dssp TEEEEEEEESSHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEeCCHHHHHHHHHHHHHHH
Confidence 34678899999999999999876554
|